##fileformat=VCFv4.2
##fileDate=20250801
##reference=ftp://ftp.ncbi.nih.gov/genbank/genomes/Eukaryotes/vertebrates_mammals/Homo_sapiens/GRCh37/special_requests/GRCh37-lite.fa.gz
##source=CIViCpy_v5.0.0
##aboutURL=https://civicdb.org/help/evidence/overview
##INFO=<ID=GN,Number=1,Type=String,Description="HGNC Gene Symbol">
##INFO=<ID=VT,Number=1,Type=String,Description="CIViC Variant Name">
##INFO=<ID=CSQ,Number=.,Type=String,Description="Consequence annotations from CIViC. Format: Allele|Consequence|SYMBOL|Entrez Gene ID|Feature_type|Feature|HGVSc|HGVSp|CIViC Variant Name|CIViC Variant ID|CIViC Variant Aliases|CIViC Variant URL|CIViC Molecular Profile Name|CIViC Molecular Profile ID|CIViC Molecular Profile Aliases|CIViC Molecular Profile URL|CIViC HGVS|Allele Registry ID|ClinVar IDs|CIViC Molecular Profile Score|CIViC Entity Type|CIViC Entity ID|CIViC Entity URL|CIViC Entity Source|CIViC Entity Variant Origin|CIViC Entity Status|CIViC Entity Significance|CIViC Entity Direction|CIViC Entity Disease|CIViC Entity Therapies|CIViC Entity Therapy Interaction Type|CIViC Evidence Phenotypes|CIViC Evidence Level|CIViC Evidence Rating|CIViC Assertion ACMG Codes|CIViC Assertion AMP Category|CIViC Assertion NCCN Guideline|CIViC Assertion Regulatory Approval|CIViC Assertion FDA Companion Test">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
1	8073509	691	C	A	.	.	GN=ERRFI1;CSQ=A|Stop Gained&Loss Of Function Variant|ERRFI1|54206|transcript|ENST00000377482.5|||E384*|691|E384X&GLU384TER|https://civicdb.org/links/variants/691|ERRFI1 E384*|672|E384X&GLU384TER|https://civicdb.org/links/molecular-profiles/672|NC_000001.10:g.8073509C>A|CA338219584|NONE FOUND|5.0|evidence|1724|https://civicdb.org/links/evidence/1724|24550739 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cholangiocarcinoma|Erlotinib (NCIt ID C65530)|||C|2|||||;VT=E384*
1	11177096	609	C	A	.	.	VT=M2327I;GN=MTOR;CSQ=A|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6981G>T||M2327I|609|MET2327ILE|https://civicdb.org/links/variants/609|MTOR M2327I|605|MET2327ILE|https://civicdb.org/links/molecular-profiles/605|NC_000001.10:g.11177096C>A&ENST00000361445.4:c.6981G>T|CA338383476|NONE FOUND|7.0|evidence|1544|https://civicdb.org/links/evidence/1544|27279227 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|MTOR Kinase Inhibitor AZD8055 (NCIt ID C78856)|||D|4|||||,A|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6981G>T||M2327I|609|MET2327ILE|https://civicdb.org/links/variants/609|MTOR M2327I|605|MET2327ILE|https://civicdb.org/links/molecular-profiles/605|NC_000001.10:g.11177096C>A&ENST00000361445.4:c.6981G>T|CA338383476|NONE FOUND|7.0|evidence|1545|https://civicdb.org/links/evidence/1545|27279227 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Breast Cancer|RapaLink-1&Sirolimus (NCIt ID C1212)|SUBSTITUTES||D|3|||||
1	11184573	542	G	T	.	.	CSQ=T|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6644C>A||S2215Y|542|SER2215TYR|https://civicdb.org/links/variants/542|MTOR S2215Y|538|SER2215TYR|https://civicdb.org/links/molecular-profiles/538|NC_000001.10:g.11184573G>T&ENST00000361445.4:c.6644C>A&NM_004958.3:c.6644C>A&NP_004949.1:p.Ser2215Tyr|CA16602587|376129|2.0|evidence|1319|https://civicdb.org/links/evidence/1319|24631838 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Endometrial Adenocarcinoma|Sirolimus (NCIt ID C1212)|||D|2|||||;GN=MTOR;VT=S2215Y
1	11184580	284	G	A	.	.	VT=P2213S;GN=MTOR;CSQ=A|Missense Variant&Gain Of Function Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6637C>T||P2213S|284|PRO2213SER|https://civicdb.org/links/variants/284|MTOR P2213S|280|PRO2213SER|https://civicdb.org/links/molecular-profiles/280|NC_000001.10:g.11184580G>A&ENST00000361445.4:c.6637C>T&NM_004958.3:c.6637C>T&NP_004949.1:p.Pro2213Ser|CA16602798|376358|3.0|evidence|722|https://civicdb.org/links/evidence/722|26490311 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Capivasertib (NCIt ID C102564)&PI3K/BET Inhibitor LY294002 (NCIt ID C148229)|COMBINATION||D|3|||||
1	11187094	470	G	T	.	.	CSQ=T|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|https://civicdb.org/links/variants/470|MTOR F2108L|466|PHE2108LEU|https://civicdb.org/links/molecular-profiles/466|NC_000001.10:g.11187094G>T&ENST00000361445.4:c.6324C>A|CA338391533|NONE FOUND|16.5|evidence|1110|https://civicdb.org/links/evidence/1110|25295501 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Thyroid Gland Carcinoma|Everolimus (NCIt ID C48387)|||C|5|||||,T|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6324C>A||F2108L|470|PHE2108LEU|https://civicdb.org/links/variants/470|MTOR F2108L|466|PHE2108LEU|https://civicdb.org/links/molecular-profiles/466|NC_000001.10:g.11187094G>T&ENST00000361445.4:c.6324C>A|CA338391533|NONE FOUND|16.5|evidence|1543|https://civicdb.org/links/evidence/1543|27279227 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Sirolimus (NCIt ID C1212)|||D|4|||||;GN=MTOR;VT=F2108L
1	11187796	610	G	A	.	.	CSQ=A|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6101C>T||A2034V|610|ALA2034VAL|https://civicdb.org/links/variants/610|MTOR A2034V|606|ALA2034VAL|https://civicdb.org/links/molecular-profiles/606|NC_000001.10:g.11187796G>A&ENST00000361445.4:c.6101C>T|CA338393920|NONE FOUND|8.0|evidence|1547|https://civicdb.org/links/evidence/1547|27279227 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Sirolimus (NCIt ID C1212)|||D|4|||||,A|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.6101C>T||A2034V|610|ALA2034VAL|https://civicdb.org/links/variants/610|MTOR A2034V|606|ALA2034VAL|https://civicdb.org/links/molecular-profiles/606|NC_000001.10:g.11187796G>A&ENST00000361445.4:c.6101C>T|CA338393920|NONE FOUND|8.0|evidence|1548|https://civicdb.org/links/evidence/1548|27279227 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Breast Cancer|MTOR Kinase Inhibitor AZD8055 (NCIt ID C78856)&RapaLink-1|SUBSTITUTES||D|4|||||;GN=MTOR;VT=A2034V
1	11187857	572	C	T	.	.	CSQ=T|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|||E2014K|572||https://civicdb.org/links/variants/572|MTOR E2014K AND MTOR E2419K|4368||https://civicdb.org/links/molecular-profiles/4368|NM_004958.4:c.6040G>A&NC_000001.10:g.11187857C>T&NP_004949.1:p.Glu2014Lys|CA16602589|376131|5.0|evidence|1438|https://civicdb.org/links/evidence/1438|24625776 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Transitional Cell Carcinoma|Everolimus (NCIt ID C48387)&Pazopanib (NCIt ID C74547)|COMBINATION||C|2|||||;VT=E2014K;GN=MTOR
1	11188519	283	G	A	.	.	VT=H1968Y;GN=MTOR;CSQ=A|Missense Variant&Gain Of Function Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.5902C>T||H1968Y|283|HIS1968TYR|https://civicdb.org/links/variants/283|MTOR H1968Y|279|HIS1968TYR|https://civicdb.org/links/molecular-profiles/279|ENST00000361445.4:c.5902C>T&NC_000001.10:g.11188519G>A&NM_004958.3:c.5902C>T&NP_004949.1:p.His1968Tyr|CA16602797|376357|3.0|evidence|713|https://civicdb.org/links/evidence/713|26490311 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Capivasertib (NCIt ID C102564)&PI3K/BET Inhibitor LY294002 (NCIt ID C148229)|SUBSTITUTES||D|3|||||
1	11190804	544	C	T	.	.	VT=E1799K;CSQ=T|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.5395G>A||E1799K|544|GLU1799LYS&RS863225264|https://civicdb.org/links/variants/544|MTOR E1799K|540|GLU1799LYS&RS863225264|https://civicdb.org/links/molecular-profiles/540|NM_004958.3:c.5395G>A&NP_004949.1:p.Glu1799Lys&NC_000001.10:g.11190804C>T&ENST00000361445.4:c.5395G>A|CA279594|217823|2.0|evidence|1321|https://civicdb.org/links/evidence/1321|24631838 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Clear Cell Renal Cell Carcinoma|Sirolimus (NCIt ID C1212)|||D|2|||||;GN=MTOR
1	11217230	543	C	T	.	.	CSQ=T|Missense Variant|MTOR|2475|transcript|ENST00000361445.4|ENST00000361445.4:c.4448G>A||C1483Y|543|CYS1483TYR|https://civicdb.org/links/variants/543|MTOR C1483Y|539|CYS1483TYR|https://civicdb.org/links/molecular-profiles/539|NC_000001.10:g.11217230C>T&ENST00000361445.4:c.4448G>A&NM_004958.3:c.4448G>A&NP_004949.1:p.Cys1483Tyr|CA16602888|376453|2.0|evidence|1320|https://civicdb.org/links/evidence/1320|24631838 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|T-cell Acute Lymphoblastic Leukemia|Sirolimus (NCIt ID C1212)|||D|2|||||;VT=C1483Y;GN=MTOR
1	11856378	258	G	A	.	.	VT=A222V;GN=MTHFR;CSQ=A|Missense Variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|RS1801133&C677T&ALA222VAL|https://civicdb.org/links/variants/258|MTHFR A222V|254|RS1801133&C677T&ALA222VAL|https://civicdb.org/links/molecular-profiles/254|NM_005957.4:c.665C>T&NP_005948.3:p.Ala222Val&ENST00000376592.1:c.665G>A&NC_000001.10:g.11856378G>A|CA170990|3520|55.0|evidence|1756|https://civicdb.org/links/evidence/1756|27819322 (PUBMED)|COMMON_GERMLINE|accepted|PROTECTIVENESS|SUPPORTS|Pancreatic Cancer||||B|4|||||,A|Missense Variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|RS1801133&C677T&ALA222VAL|https://civicdb.org/links/variants/258|MTHFR A222V|254|RS1801133&C677T&ALA222VAL|https://civicdb.org/links/molecular-profiles/254|NM_005957.4:c.665C>T&NP_005948.3:p.Ala222Val&ENST00000376592.1:c.665G>A&NC_000001.10:g.11856378G>A|CA170990|3520|55.0|evidence|1757|https://civicdb.org/links/evidence/1757|26693073 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Rectum Cancer|Fluorouracil (NCIt ID C505)|||B|4|||||,A|Missense Variant|MTHFR|4524|transcript|ENST00000376592.1|ENST00000376592.1:c.665G>A||A222V|258|RS1801133&C677T&ALA222VAL|https://civicdb.org/links/variants/258|MTHFR A222V|254|RS1801133&C677T&ALA222VAL|https://civicdb.org/links/molecular-profiles/254|NM_005957.4:c.665C>T&NP_005948.3:p.Ala222Val&ENST00000376592.1:c.665G>A&NC_000001.10:g.11856378G>A|CA170990|3520|55.0|evidence|669|https://civicdb.org/links/evidence/669|18704422 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Stomach Cancer|Fluorouracil (NCIt ID C505)|||B|3|||||
1	17350521	2411	G	GGCAGCTGGTGCT	.	.	VT=p.193_196dupSTSC (c.577_588dupAGCACCAGCTGC);GN=SDHB;CSQ=GCAGCTGGTGCT|Inframe Insertion|SDHB|6390|transcript|ENST00000375499.3|||p.193_196dupSTSC (c.577_588dupAGCACCAGCTGC)|2411|C.589_600DUP|https://civicdb.org/links/variants/2411|SDHB p.193_196dupSTSC (c.577_588dupAGCACCAGCTGC)|2284|C.589_600DUP|https://civicdb.org/links/molecular-profiles/2284|NM_003000.2:c.577_588dupAGCACCAGCTGC&NP_002991.2:p.193_196dupSTSC&NC_000001.10:g.17350522_17350533dup|CA658820851||5.0|evidence|6442|https://civicdb.org/links/evidence/6442|20193854 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Paraganglioma||||C|2|||||
1	27057658	1510	C	T	.	.	VT=Q456*;CSQ=T|Stop Gained|ARID1A|8289|transcript|ENST00000324856.7|ENST00000324856.7:c.1366C>T||Q456*|1510|Q73X|https://civicdb.org/links/variants/1510|ARID1A Q456*|1418|Q73X|https://civicdb.org/links/molecular-profiles/1418|ENST00000324856.7:c.1366C>T|CA339267901|NONE FOUND|0.0|evidence|4487|https://civicdb.org/links/evidence/4487|27364904 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dasatinib (NCIt ID C38713)|||D|3|||||;GN=ARID1A
1	36933434	2387	G	A	.	.	VT=T618I;CSQ=A|Missense Variant|CSF3R|1441|transcript|ENST00000373103.1|ENST00000373103.1:c.1853G>A||T618I|2387|THR618ILE|https://civicdb.org/links/variants/2387|CSF3R T618I|2260|THR618ILE|https://civicdb.org/links/molecular-profiles/2260|NP_724781.1:p.Thr618Ile&NM_156039.3:c.1853C>T&ENST00000373103.1:c.1853G>A&NC_000001.10:g.36933434G>A&NC_000001.11:g.36467833G>A|CA204418|208339|14.0|evidence|6381|https://civicdb.org/links/evidence/6381|25180155 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Neutrophilic Leukemia|Ruxolitinib (NCIt ID C77888)|||C|4|||||,A|Missense Variant|CSF3R|1441|transcript|ENST00000373103.1|ENST00000373103.1:c.1853G>A||T618I|2387|THR618ILE|https://civicdb.org/links/variants/2387|CSF3R T618I|2260|THR618ILE|https://civicdb.org/links/molecular-profiles/2260|NP_724781.1:p.Thr618Ile&NM_156039.3:c.1853C>T&ENST00000373103.1:c.1853G>A&NC_000001.10:g.36933434G>A&NC_000001.11:g.36467833G>A|CA204418|208339|14.0|evidence|6380|https://civicdb.org/links/evidence/6380|24081659 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Neutrophilic Leukemia|Ruxolitinib (NCIt ID C77888)|||D|4|||||;GN=CSF3R
1	65311203	822	C	A	.	.	GN=JAK1;VT=S703I;CSQ=A|Missense Variant|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.2108G>T||S703I|822|SER703ILE|https://civicdb.org/links/variants/822|JAK1 S703I|800|SER703ILE|https://civicdb.org/links/molecular-profiles/800|ENST00000342505.4:c.2108G>T&NC_000001.10:g.65311203C>A|CA340667333|NONE FOUND|4.0|evidence|1900|https://civicdb.org/links/evidence/1900|26701727 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Hepatocellular Carcinoma|Ruxolitinib (NCIt ID C77888)|||D|4|||||
1	65321333	614	G	A	.	.	GN=JAK1;VT=Q503*;CSQ=A|Stop Gained|JAK1|3716|transcript|ENST00000342505.4|ENST00000342505.4:c.1507C>T||Q503*|614|Q503X&GLN503TER|https://civicdb.org/links/variants/614|JAK1 Q503*|610|Q503X&GLN503TER|https://civicdb.org/links/molecular-profiles/610|NC_000001.10:g.65321333G>A&ENST00000342505.4:c.1507C>T|CA340669637|NONE FOUND|10.0|evidence|1567|https://civicdb.org/links/evidence/1567|27433843 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|Pembrolizumab (NCIt ID C106432)|||C|4|||||
1	68152388	705	T	C	.	.	CSQ=C|Coding Transcript Intron Variant|GADD45A|1647|transcript|ENST00000370986.4|||rs681673|705|1506T>C|https://civicdb.org/links/variants/705|GADD45A rs681673|686|1506T>C|https://civicdb.org/links/molecular-profiles/686||CA10728634||15.0|evidence|1751|https://civicdb.org/links/evidence/1751|26422378 (PUBMED)|COMMON_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Ovarian Cancer||||B|3|||||;GN=GADD45A;VT=rs681673
1	97915614	737	C	T	.	.	VT=DPYD*2A HOMOZYGOSITY;GN=DPYD;CSQ=T|Splice Donor Variant|DPYD|1806|transcript|ENST00000370192.3|ENST00000370192.3:c.1905+1G>A||DPYD*2A HOMOZYGOSITY|737|RS3918290&DPYD*2A&DPYD:IVS14 + 1G>A&C.1905+1G>A|https://civicdb.org/links/variants/737|DPYD DPYD*2A HOMOZYGOSITY|718|RS3918290&DPYD*2A&DPYD:IVS14 + 1G>A&C.1905+1G>A|https://civicdb.org/links/molecular-profiles/718|NC_000001.10:g.97915614C>T&NM_000110.3:c.1905+1G>A&ENST00000370192.3:c.1905+1G>A|CA114277|432|50.0|evidence|1800|https://civicdb.org/links/evidence/1800|23988873 (PUBMED)|COMMON_GERMLINE|accepted|ADVERSE_RESPONSE|SUPPORTS|Cancer|Capecitabine (NCIt ID C1794)&Fluorouracil (NCIt ID C505)&Tegafur (NCIt ID C513)|SUBSTITUTES||A|5|||||
1	97981343	738	A	C	.	.	CSQ=C|Missense Variant|DPYD|1806|transcript|ENST00000370192.3|ENST00000370192.3:c.1679T>G||DPYD*13 HOMOZYGOSITY|738|RS55886062&ILE560SER&I560S|https://civicdb.org/links/variants/738|DPYD DPYD*13 HOMOZYGOSITY|719|RS55886062&ILE560SER&I560S|https://civicdb.org/links/molecular-profiles/719|NM_000110.3:c.1679T>G&NP_000101.2:p.Ile560Ser&ENST00000370192.3:c.1679T>G&NC_000001.10:g.97981343A>C|CA228118|88975|50.0|evidence|1801|https://civicdb.org/links/evidence/1801|23988873 (PUBMED)|COMMON_GERMLINE|accepted|ADVERSE_RESPONSE|SUPPORTS|Cancer|Capecitabine (NCIt ID C1794)&Fluorouracil (NCIt ID C505)&Tegafur (NCIt ID C513)|SUBSTITUTES||A|5|||||;GN=DPYD;VT=DPYD*13 HOMOZYGOSITY
1	115256528	893	T	G	.	.	VT=Q61H;CSQ=G|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.183A>C||Q61H|893|RS121913255&GLN61HIS|https://civicdb.org/links/variants/893|NRAS Q61H|867|RS121913255&GLN61HIS|https://civicdb.org/links/molecular-profiles/867|NM_002524.4:c.183A>C&NP_002515.1:p.Gln61His&NC_000001.10:g.115256528T>G&ENST00000369535.4:c.183A>C|CA16602358|375871|5.0|evidence|3690|https://civicdb.org/links/evidence/3690|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|2|||||;GN=NRAS
1	115256529	95	T	A	.	.	CSQ=A|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|GLN61LEU&RS11554290|https://civicdb.org/links/variants/95|NRAS Q61L|95|GLN61LEU&RS11554290|https://civicdb.org/links/molecular-profiles/95|NP_002515.1:p.Gln61Leu&NC_000001.10:g.115256529T>A&NM_002524.4:c.182A>T&ENST00000369535.4:c.182A>T|CA16602361|375874|12.5|evidence|2181|https://civicdb.org/links/evidence/2181|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||,A|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>T||Q61L|95|GLN61LEU&RS11554290|https://civicdb.org/links/variants/95|NRAS Q61L|95|GLN61LEU&RS11554290|https://civicdb.org/links/molecular-profiles/95|NP_002515.1:p.Gln61Leu&NC_000001.10:g.115256529T>A&NM_002524.4:c.182A>T&ENST00000369535.4:c.182A>T|CA16602361|375874|12.5|evidence|22|https://civicdb.org/links/evidence/22|21576590 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Temozolomide (NCIt ID C1244)|||C|2|||||;VT=Q61L;GN=NRAS
1	115256529	96	T	C	.	.	VT=Q61R;GN=NRAS;CSQ=C|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|GLN61ARG&RS11554290|https://civicdb.org/links/variants/96|NRAS Q61R|96|GLN61ARG&RS11554290|https://civicdb.org/links/molecular-profiles/96|NM_002524.4:c.182A>G&NP_002515.1:p.Gln61Arg&NC_000001.10:g.115256529T>C&ENST00000369535.4:c.182A>G|CA123618|13900|10.0|evidence|23|https://civicdb.org/links/evidence/23|21576590 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Temozolomide (NCIt ID C1244)|||C|2|||||,C|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.182A>G||Q61R|96|GLN61ARG&RS11554290|https://civicdb.org/links/variants/96|NRAS Q61R|96|GLN61ARG&RS11554290|https://civicdb.org/links/molecular-profiles/96|NM_002524.4:c.182A>G&NP_002515.1:p.Gln61Arg&NC_000001.10:g.115256529T>C&ENST00000369535.4:c.182A>G|CA123618|13900|10.0|evidence|2184|https://civicdb.org/links/evidence/2184|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|2|||||
1	115256530	427	G	T	.	.	GN=NRAS;CSQ=T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|GLN61LYS&RS121913254|https://civicdb.org/links/variants/427|NRAS Q61K|423|GLN61LYS&RS121913254|https://civicdb.org/links/molecular-profiles/423|NM_002524.4:c.181C>A&NP_002515.1:p.Gln61Lys&NC_000001.10:g.115256530G>T&ENST00000369535.4:c.181C>A|CA151263|73058|24.5|evidence|2189|https://civicdb.org/links/evidence/2189|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Chemotherapy (NCIt ID C15632)|COMBINATION||C|3|||||,T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|GLN61LYS&RS121913254|https://civicdb.org/links/variants/427|NRAS Q61K|423|GLN61LYS&RS121913254|https://civicdb.org/links/molecular-profiles/423|NM_002524.4:c.181C>A&NP_002515.1:p.Gln61Lys&NC_000001.10:g.115256530G>T&ENST00000369535.4:c.181C>A|CA151263|73058|24.5|evidence|8933|https://civicdb.org/links/evidence/8933|30809568 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovary Serous Adenocarcinoma|Trametinib (NCIt ID C77908)|||C|2|||||,T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|GLN61LYS&RS121913254|https://civicdb.org/links/variants/427|NRAS Q61K|423|GLN61LYS&RS121913254|https://civicdb.org/links/molecular-profiles/423|NM_002524.4:c.181C>A&NP_002515.1:p.Gln61Lys&NC_000001.10:g.115256530G>T&ENST00000369535.4:c.181C>A|CA151263|73058|24.5|evidence|1002|https://civicdb.org/links/evidence/1002|26821351 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Binimetinib (NCIt ID C84865)&Everolimus (NCIt ID C48387)|COMBINATION||D|3|||||,T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|GLN61LYS&RS121913254|https://civicdb.org/links/variants/427|NRAS Q61K|423|GLN61LYS&RS121913254|https://civicdb.org/links/molecular-profiles/423|NM_002524.4:c.181C>A&NP_002515.1:p.Gln61Lys&NC_000001.10:g.115256530G>T&ENST00000369535.4:c.181C>A|CA151263|73058|24.5|evidence|2192|https://civicdb.org/links/evidence/2192|22392911 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|3|||||,T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|GLN61LYS&RS121913254|https://civicdb.org/links/variants/427|NRAS Q61K|423|GLN61LYS&RS121913254|https://civicdb.org/links/molecular-profiles/423|NM_002524.4:c.181C>A&NP_002515.1:p.Gln61Lys&NC_000001.10:g.115256530G>T&ENST00000369535.4:c.181C>A|CA151263|73058|24.5|evidence|1474|https://civicdb.org/links/evidence/1474|22194965 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|Vemurafenib (NCIt ID C64768)|||D|2|||||,T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|GLN61LYS&RS121913254|https://civicdb.org/links/variants/427|NRAS Q61K|423|GLN61LYS&RS121913254|https://civicdb.org/links/molecular-profiles/423|NM_002524.4:c.181C>A&NP_002515.1:p.Gln61Lys&NC_000001.10:g.115256530G>T&ENST00000369535.4:c.181C>A|CA151263|73058|24.5|evidence|1475|https://civicdb.org/links/evidence/1475|22194965 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Selumetinib (NCIt ID C66939)|||D|2|||||,T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.181C>A||Q61K|427|GLN61LYS&RS121913254|https://civicdb.org/links/variants/427|NRAS Q61K|423|GLN61LYS&RS121913254|https://civicdb.org/links/molecular-profiles/423|NM_002524.4:c.181C>A&NP_002515.1:p.Gln61Lys&NC_000001.10:g.115256530G>T&ENST00000369535.4:c.181C>A|CA151263|73058|24.5|evidence|2907|https://civicdb.org/links/evidence/2907|23515407 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Selumetinib (NCIt ID C66939)&Trametinib (NCIt ID C77908)|SUBSTITUTES||D|2|||||;VT=Q61K
1	115258744	93	C	T	.	.	VT=G13D;GN=NRAS;CSQ=T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.38G>A||G13D|93|GLY13ASP&RS121434596|https://civicdb.org/links/variants/93|NRAS G13D|93|GLY13ASP&RS121434596|https://civicdb.org/links/molecular-profiles/93|NM_002524.4:c.38G>A&NP_002515.1:p.Gly13Asp&NC_000001.10:g.115258744C>T&ENST00000369535.4:c.38G>A|CA123620|13901|5.0|evidence|21|https://civicdb.org/links/evidence/21|18375819 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Tanespimycin (NCIt ID C37899)|||C|2|||||
1	115258745	896	C	G	.	.	VT=G13R;GN=NRAS;CSQ=G|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>C||G13R|896|RS121434595&GLY13ARG|https://civicdb.org/links/variants/896|NRAS G13R|870|RS121434595&GLY13ARG|https://civicdb.org/links/molecular-profiles/870|NM_002524.4:c.37G>C&NP_002515.1:p.Gly13Arg&NC_000001.10:g.115258745C>G&ENST00000369535.4:c.37G>C|CA151261|13899|5.0|evidence|2204|https://civicdb.org/links/evidence/2204|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|1|||||,G|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.37G>C||G13R|896|RS121434595&GLY13ARG|https://civicdb.org/links/variants/896|NRAS G13R|870|RS121434595&GLY13ARG|https://civicdb.org/links/molecular-profiles/870|NM_002524.4:c.37G>C&NP_002515.1:p.Gly13Arg&NC_000001.10:g.115258745C>G&ENST00000369535.4:c.37G>C|CA151261|13899|5.0|evidence|3842|https://civicdb.org/links/evidence/3842|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|1|||||
1	115258747	878	C	T	.	.	VT=G12D;GN=NRAS;CSQ=T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|RS121913237&GLY12ASP|https://civicdb.org/links/variants/878|NRAS G12D|852|RS121913237&GLY12ASP|https://civicdb.org/links/molecular-profiles/852|NM_002524.4:c.35G>A&NP_002515.1:p.Gly12Asp&NC_000001.10:g.115258747C>T&ENST00000369535.4:c.35G>A|CA130425|39648|7.5|evidence|3693|https://civicdb.org/links/evidence/3693|25666295 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|None|||||,T|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.35G>A||G12D|878|RS121913237&GLY12ASP|https://civicdb.org/links/variants/878|NRAS G12D|852|RS121913237&GLY12ASP|https://civicdb.org/links/molecular-profiles/852|NM_002524.4:c.35G>A&NP_002515.1:p.Gly12Asp&NC_000001.10:g.115258747C>T&ENST00000369535.4:c.35G>A|CA130425|39648|7.5|evidence|2002|https://civicdb.org/links/evidence/2002|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||
1	115258748	897	C	A	.	.	VT=G12C;GN=NRAS;CSQ=A|Missense Variant|NRAS|4893|transcript|ENST00000369535.4|ENST00000369535.4:c.34G>T||G12C|897|RS121913250&GLY12CYS|https://civicdb.org/links/variants/897|NRAS G12C|871|RS121913250&GLY12CYS|https://civicdb.org/links/molecular-profiles/871|NM_002524.4:c.34G>T&NP_002515.1:p.Gly12Cys&NC_000001.10:g.115258748C>A&ENST00000369535.4:c.34G>T|CA297020|40468|7.5|evidence|3845|https://civicdb.org/links/evidence/3845|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Chemotherapy (NCIt ID C15632)|COMBINATION||C|3|||||
1	161479745	456	A	G	.	.	GN=FCGR2A;VT=H167R;CSQ=G|Missense Variant|FCGR2A|2212|transcript|ENST00000271450.6|ENST00000271450.6:c.500A>G||H167R|456|RS1801274&H131R&H166R&HIS167ARG|https://civicdb.org/links/variants/456|FCGR2A H167R|452|RS1801274&H131R&H166R&HIS167ARG|https://civicdb.org/links/molecular-profiles/452|NM_001136219.1:c.500A>G&NP_001129691.1:p.His167Arg&ENST00000271450.6:c.500A>G&NC_000001.10:g.161479745A>G|CA124361|14823|35.0|evidence|1088|https://civicdb.org/links/evidence/1088|24989892 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||B|4|||||,G|Missense Variant|FCGR2A|2212|transcript|ENST00000271450.6|ENST00000271450.6:c.500A>G||H167R|456|RS1801274&H131R&H166R&HIS167ARG|https://civicdb.org/links/variants/456|FCGR2A H167R|452|RS1801274&H131R&H166R&HIS167ARG|https://civicdb.org/links/molecular-profiles/452|NM_001136219.1:c.500A>G&NP_001129691.1:p.His167Arg&ENST00000271450.6:c.500A>G&NC_000001.10:g.161479745A>G|CA124361|14823|35.0|evidence|1084|https://civicdb.org/links/evidence/1084|22906996 (PUBMED)|COMMON_GERMLINE|accepted|NA|DOES_NOT_SUPPORT|Breast Cancer||||B|3|||||
1	161514542	457	A	C	.	.	CSQ=C|Missense Variant|FCGR3A|2214|transcript|ENST00000367969.3|ENST00000367969.3:c.526T>G||F212V|457|RS396991&V158F&PHE176VAL|https://civicdb.org/links/variants/457|FCGR3A F212V|453|RS396991&V158F&PHE176VAL|https://civicdb.org/links/molecular-profiles/453|NC_000001.10:g.161514542A>C&NM_001127593.1:c.526T>G&NP_001121065.1:p.Phe176Val&ENST00000367969.3:c.526T>G|CA1211378|225994|35.0|evidence|1087|https://civicdb.org/links/evidence/1087|24989892 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||B|4|||||,C|Missense Variant|FCGR3A|2214|transcript|ENST00000367969.3|ENST00000367969.3:c.526T>G||F212V|457|RS396991&V158F&PHE176VAL|https://civicdb.org/links/variants/457|FCGR3A F212V|453|RS396991&V158F&PHE176VAL|https://civicdb.org/links/molecular-profiles/453|NC_000001.10:g.161514542A>C&NM_001127593.1:c.526T>G&NP_001121065.1:p.Phe176Val&ENST00000367969.3:c.526T>G|CA1211378|225994|35.0|evidence|1085|https://civicdb.org/links/evidence/1085|22906996 (PUBMED)|COMMON_GERMLINE|accepted|NA|DOES_NOT_SUPPORT|Breast Cancer||||B|3|||||;GN=FCGR3A;VT=F212V
1	161643798	458	T	C	.	.	VT=I232T;GN=FCGR2B;CSQ=C|Missense Variant|FCGR2B|2213|transcript|ENST00000358671.5|ENST00000358671.5:c.695T>C||I232T|458|RS1050501&ILE232THR|https://civicdb.org/links/variants/458|FCGR2B I232T|454|RS1050501&ILE232THR|https://civicdb.org/links/molecular-profiles/454|NM_004001.4:c.695T>C&NP_003992.3:p.Ile232Thr&ENST00000358671.5:c.695T>C&NC_000001.10:g.161643798T>C|CA117549|5467|20.0|evidence|1086|https://civicdb.org/links/evidence/1086|24989892 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|4|||||
1	162724415	139	C	G	.	.	GN=DDR2;VT=L63V;CSQ=G|Missense Variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.187C>G||L63V|139|LEU63VAL|https://civicdb.org/links/variants/139|DDR2 L63V|139|LEU63VAL|https://civicdb.org/links/molecular-profiles/139|NM_006182.2:c.187C>G&NP_006173.2:p.Leu63Val&ENST00000367922.3:c.187C>G&NC_000001.10:g.162724415C>G|CA1217196||4.0|evidence|271|https://civicdb.org/links/evidence/271|22328973 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)|||D|4|||||
1	162729630	140	T	G	.	.	CSQ=G|Missense Variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.716T>G||L239R|140|LEU239ARG|https://civicdb.org/links/variants/140|DDR2 L239R|140|LEU239ARG|https://civicdb.org/links/molecular-profiles/140|ENST00000367922.3:c.716T>G&NC_000001.10:g.162729630T>G|CA16602598|376141|4.0|evidence|270|https://civicdb.org/links/evidence/270|22328973 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)|||D|4|||||;GN=DDR2;VT=L239R
1	162729671	141	G	T	.	.	GN=DDR2;CSQ=T|Missense Variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.757G>T||G253C|141|GLY253CYS|https://civicdb.org/links/variants/141|DDR2 G253C|141|GLY253CYS|https://civicdb.org/links/molecular-profiles/141|ENST00000367922.3:c.757G>T&NC_000001.10:g.162729671G>T|CA16602599|376142|4.0|evidence|266|https://civicdb.org/links/evidence/266|22328973 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)|||D|4|||||;VT=G253C
1	162741822	142	G	A	.	.	GN=DDR2;VT=G505S;CSQ=A|Missense Variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.1513G>A||G505S|142|GLY505SER&RS115169993|https://civicdb.org/links/variants/142|DDR2 G505S|142|GLY505SER&RS115169993|https://civicdb.org/links/molecular-profiles/142|NM_006182.2:c.1513G>A&NP_006173.2:p.Gly505Ser&ENST00000367922.3:c.1513G>A&NC_000001.10:g.162741822G>A|CA1217584|282994|4.0|evidence|267|https://civicdb.org/links/evidence/267|22328973 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)|||D|4|||||
1	162745497	143	A	T	.	.	GN=DDR2;VT=I638F;CSQ=T|Missense Variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.1912A>T||I638F|143|ILE638PHE&RS1057519789|https://civicdb.org/links/variants/143|DDR2 I638F|143|ILE638PHE&RS1057519789|https://civicdb.org/links/molecular-profiles/143|ENST00000367922.3:c.1912A>T&NC_000001.10:g.162745497A>T&NM_001014796.1:c.1912A>T&NP_001014796.1:p.Ile638Phe|CA16602600|376143|4.0|evidence|269|https://civicdb.org/links/evidence/269|22328973 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)|||D|4|||||
1	162748390	145	T	A	.	.	GN=DDR2;CSQ=A|Missense Variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.2304T>A||S768R|145|SER768ARG|https://civicdb.org/links/variants/145|DDR2 S768R|145|SER768ARG|https://civicdb.org/links/molecular-profiles/145|ENST00000367922.3:c.2304T>A&NC_000001.10:g.162748390T>A|CA16602365|375878|7.5|evidence|272|https://civicdb.org/links/evidence/272|22328973 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)&Erlotinib (NCIt ID C65530)|COMBINATION||C|3|||||;VT=S768R
1	162748407	144	G	T	.	.	GN=DDR2;VT=G774V;CSQ=T|Missense Variant|DDR2|4921|transcript|ENST00000367922.3|ENST00000367922.3:c.2321G>T||G774V|144|GLY774VAL|https://civicdb.org/links/variants/144|DDR2 G774V|144|GLY774VAL|https://civicdb.org/links/molecular-profiles/144|ENST00000367922.3:c.2321G>T&NC_000001.10:g.162748407G>T|CA16602601|376144|4.0|evidence|268|https://civicdb.org/links/evidence/268|22328973 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)|||D|4|||||
1	243859016	1227	C	T	.	.	VT=E17K;GN=AKT3;CSQ=T|Missense Variant|AKT3|10000|transcript|ENST00000366539.1|ENST00000366539.1:c.49G>A||E17K|1227|RS397514606&GLU17LYS|https://civicdb.org/links/variants/1227|AKT3 E17K|1201|RS397514606&GLU17LYS|https://civicdb.org/links/molecular-profiles/1201|NM_001206729.1:c.49G>A&NP_001193658.1:p.Glu17Lys&NC_000001.10:g.243859016C>T&ENST00000366539.1:c.49G>A|CA130584|39816|3.0|evidence|4521|https://civicdb.org/links/evidence/4521|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|3|||||
2	29432664	9	C	T	.	.	GN=ALK;VT=R1275Q;CSQ=T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/variants/9|ALK R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/molecular-profiles/9|NM_004304.4:c.3824G>A&NP_004295.2:p.Arg1275Gln&NC_000002.11:g.29432664C>T&ENST00000389048.3:c.3824G>A|CA341482|18083|23.0|evidence|1269|https://civicdb.org/links/evidence/1269|23598171 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Crizotinib (NCIt ID C74061)|||C|2|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/variants/9|ALK R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/molecular-profiles/9|NM_004304.4:c.3824G>A&NP_004295.2:p.Arg1275Gln&NC_000002.11:g.29432664C>T&ENST00000389048.3:c.3824G>A|CA341482|18083|23.0|evidence|1270|https://civicdb.org/links/evidence/1270|23598171 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Crizotinib (NCIt ID C74061)|||C|2|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/variants/9|ALK R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/molecular-profiles/9|NM_004304.4:c.3824G>A&NP_004295.2:p.Arg1275Gln&NC_000002.11:g.29432664C>T&ENST00000389048.3:c.3824G>A|CA341482|18083|23.0|evidence|1331|https://civicdb.org/links/evidence/1331|26554404 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Lorlatinib (NCIt ID C113655)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/variants/9|ALK R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/molecular-profiles/9|NM_004304.4:c.3824G>A&NP_004295.2:p.Arg1275Gln&NC_000002.11:g.29432664C>T&ENST00000389048.3:c.3824G>A|CA341482|18083|23.0|evidence|48|https://civicdb.org/links/evidence/48|18923525 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Neuroblastoma|ALK Inhibitor TAE684 (NCIt ID C171615)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/variants/9|ALK R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/molecular-profiles/9|NM_004304.4:c.3824G>A&NP_004295.2:p.Arg1275Gln&NC_000002.11:g.29432664C>T&ENST00000389048.3:c.3824G>A|CA341482|18083|23.0|evidence|143|https://civicdb.org/links/evidence/143|22072639 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Crizotinib (NCIt ID C74061)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3824G>A||R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/variants/9|ALK R1275Q|9|ARG1275GLN&RS113994087|https://civicdb.org/links/molecular-profiles/9|NM_004304.4:c.3824G>A&NP_004295.2:p.Arg1275Gln&NC_000002.11:g.29432664C>T&ENST00000389048.3:c.3824G>A|CA341482|18083|23.0|evidence|39|https://civicdb.org/links/evidence/39|18923525 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|ALK Inhibitor TAE684 (NCIt ID C171615)|||D|2|||||
2	29432682	308	C	G	.	.	VT=G1269A;GN=ALK;CSQ=G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||G1269A|308|RS1057519781|https://civicdb.org/links/variants/308|EML4::ALK Fusion AND ALK G1269A|4312|EML4-ALK G1269A&EML4-ALK GLY1269ALA|https://civicdb.org/links/molecular-profiles/4312|ENST00000389048.3:c.3806G>C&NC_000002.11:g.29432682C>G&NM_004304.4:c.3806G>C&NP_004295.2:p.Gly1269Ala|CA16602590|376132|17.5|evidence|764|https://civicdb.org/links/evidence/764|22235099 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||G1269A|308|RS1057519781|https://civicdb.org/links/variants/308|EML4::ALK Fusion AND ALK G1269A|4312|EML4-ALK G1269A&EML4-ALK GLY1269ALA|https://civicdb.org/links/molecular-profiles/4312|ENST00000389048.3:c.3806G>C&NC_000002.11:g.29432682C>G&NM_004304.4:c.3806G>C&NP_004295.2:p.Gly1269Ala|CA16602590|376132|17.5|evidence|765|https://civicdb.org/links/evidence/765|23344087 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||G1269A|308|RS1057519781|https://civicdb.org/links/variants/308|ALK G1269A AND v::ALK Fusion|4311||https://civicdb.org/links/molecular-profiles/4311|ENST00000389048.3:c.3806G>C&NC_000002.11:g.29432682C>G&NM_004304.4:c.3806G>C&NP_004295.2:p.Gly1269Ala|CA16602590|376132|10.0|evidence|1342|https://civicdb.org/links/evidence/1342|24675041 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||D|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||G1269A|308|RS1057519781|https://civicdb.org/links/variants/308|ALK G1269A AND v::ALK Fusion|4311||https://civicdb.org/links/molecular-profiles/4311|ENST00000389048.3:c.3806G>C&NC_000002.11:g.29432682C>G&NM_004304.4:c.3806G>C&NP_004295.2:p.Gly1269Ala|CA16602590|376132|10.0|evidence|1354|https://civicdb.org/links/evidence/1354|25727400 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Alectinib (NCIt ID C101790)|||D|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||G1269A|308|RS1057519781|https://civicdb.org/links/variants/308|ALK G1269A AND v::ALK Fusion|4311||https://civicdb.org/links/molecular-profiles/4311|ENST00000389048.3:c.3806G>C&NC_000002.11:g.29432682C>G&NM_004304.4:c.3806G>C&NP_004295.2:p.Gly1269Ala|CA16602590|376132|10.0|evidence|1353|https://civicdb.org/links/evidence/1353|25727400 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Brigatinib (NCIt ID C98831)|||D|2|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3806G>C||G1269A|308|RS1057519781|https://civicdb.org/links/variants/308|ALK G1269A AND v::ALK Fusion|4311||https://civicdb.org/links/molecular-profiles/4311|ENST00000389048.3:c.3806G>C&NC_000002.11:g.29432682C>G&NM_004304.4:c.3806G>C&NP_004295.2:p.Gly1269Ala|CA16602590|376132|10.0|evidence|1355|https://civicdb.org/links/evidence/1355|25727400 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Ceritinib (NCIt ID C115112)|||D|2|||||
2	29436859	549	A	C	.	.	GN=ALK;VT=F1245C;CSQ=C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|PHE1245CYS&RS863225283|https://civicdb.org/links/variants/549|EML4::ALK Fusion AND ALK F1245C|4221||https://civicdb.org/links/molecular-profiles/4221|NM_004304.4:c.3734T>G&NP_004295.2:p.Phe1245Cys&NC_000002.11:g.29436859A>C&ENST00000389048.3:c.3734T>G|CA279597|217856|14.5|evidence|1338|https://civicdb.org/links/evidence/1338|26775591 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||C|3|||||,C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|PHE1245CYS&RS863225283|https://civicdb.org/links/variants/549|EML4::ALK Fusion AND ALK F1245C|4221||https://civicdb.org/links/molecular-profiles/4221|NM_004304.4:c.3734T>G&NP_004295.2:p.Phe1245Cys&NC_000002.11:g.29436859A>C&ENST00000389048.3:c.3734T>G|CA279597|217856|14.5|evidence|1339|https://civicdb.org/links/evidence/1339|26775591 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|2|||||,C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|PHE1245CYS&RS863225283|https://civicdb.org/links/variants/549|EML4::ALK Fusion AND ALK F1245C|4221||https://civicdb.org/links/molecular-profiles/4221|NM_004304.4:c.3734T>G&NP_004295.2:p.Phe1245Cys&NC_000002.11:g.29436859A>C&ENST00000389048.3:c.3734T>G|CA279597|217856|14.5|evidence|1337|https://civicdb.org/links/evidence/1337|22034911 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Crizotinib (NCIt ID C74061)|||D|2|||||,C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|PHE1245CYS&RS863225283|https://civicdb.org/links/variants/549|ALK F1245C|545|PHE1245CYS&RS863225283|https://civicdb.org/links/molecular-profiles/545|NM_004304.4:c.3734T>G&NP_004295.2:p.Phe1245Cys&NC_000002.11:g.29436859A>C&ENST00000389048.3:c.3734T>G|CA279597|217856|10.5|evidence|1333|https://civicdb.org/links/evidence/1333|23598171 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Neuroblastoma|Crizotinib (NCIt ID C74061)|||C|3|||||,C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3734T>G||F1245C|549|PHE1245CYS&RS863225283|https://civicdb.org/links/variants/549|ALK F1245C|545|PHE1245CYS&RS863225283|https://civicdb.org/links/molecular-profiles/545|NM_004304.4:c.3734T>G&NP_004295.2:p.Phe1245Cys&NC_000002.11:g.29436859A>C&ENST00000389048.3:c.3734T>G|CA279597|217856|10.5|evidence|1330|https://civicdb.org/links/evidence/1330|26554404 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Lorlatinib (NCIt ID C113655)|||D|3|||||
2	29436860	1295	A	C	.	.	GN=ALK;CSQ=C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3733T>G||F1245V|1295|PHE1245VAL&RS281864720|https://civicdb.org/links/variants/1295|ALK F1245V|1269|PHE1245VAL&RS281864720|https://civicdb.org/links/molecular-profiles/1269|NM_004304.4:c.3733T>G&NP_004295.2:p.Phe1245Val&NC_000002.11:g.29436860A>C&ENST00000389048.3:c.3733T>G|CA345003|65671|7.5|evidence|2987|https://civicdb.org/links/evidence/2987|28183697 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Entrectinib (NCIt ID C114984)|||C|3|||||;VT=F1245V
2	29443600	172	G	T	.	.	GN=ALK;VT=S1206Y;CSQ=T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||S1206Y|172|RS1057519782|https://civicdb.org/links/variants/172|EML4::ALK Fusion AND ALK S1206Y|4309||https://civicdb.org/links/molecular-profiles/4309|ENST00000389048.3:c.3617C>A&NC_000002.11:g.29443600G>T&NM_004304.4:c.3617C>A&NP_004295.2:p.Ser1206Tyr|CA16602591|376133|6.0|evidence|443|https://civicdb.org/links/evidence/443|22277784 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3617C>A||S1206Y|172|RS1057519782|https://civicdb.org/links/variants/172|EML4::ALK Fusion AND ALK S1206Y|4309||https://civicdb.org/links/molecular-profiles/4309|ENST00000389048.3:c.3617C>A&NC_000002.11:g.29443600G>T&NM_004304.4:c.3617C>A&NP_004295.2:p.Ser1206Tyr|CA16602591|376133|6.0|evidence|1343|https://civicdb.org/links/evidence/1343|24675041 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Ceritinib (NCIt ID C115112)|||D|2|||||
2	29443613	171	C	T	.	.	GN=ALK;VT=G1202R;CSQ=T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||G1202R|171|RS1057519783|https://civicdb.org/links/variants/171|EML4::ALK Fusion AND ALK G1202R|4237||https://civicdb.org/links/molecular-profiles/4237|ENST00000389048.3:c.3604G>A&NC_000002.11:g.29443613C>T&NM_004304.4:c.3604G>A&NP_004295.2:p.Gly1202Arg|CA16602592|376134|16.0|evidence|441|https://civicdb.org/links/evidence/441|22277784 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||G1202R|171|RS1057519783|https://civicdb.org/links/variants/171|EML4::ALK Fusion AND ALK G1202R|4237||https://civicdb.org/links/molecular-profiles/4237|ENST00000389048.3:c.3604G>A&NC_000002.11:g.29443613C>T&NM_004304.4:c.3604G>A&NP_004295.2:p.Gly1202Arg|CA16602592|376134|16.0|evidence|1345|https://civicdb.org/links/evidence/1345|24675041 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||G1202R|171|RS1057519783|https://civicdb.org/links/variants/171|EML4::ALK Fusion AND ALK G1202R|4237||https://civicdb.org/links/molecular-profiles/4237|ENST00000389048.3:c.3604G>A&NC_000002.11:g.29443613C>T&NM_004304.4:c.3604G>A&NP_004295.2:p.Gly1202Arg|CA16602592|376134|16.0|evidence|1350|https://civicdb.org/links/evidence/1350|25727400 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Alectinib (NCIt ID C101790)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||G1202R|171|RS1057519783|https://civicdb.org/links/variants/171|EML4::ALK Fusion AND ALK G1202R|4237||https://civicdb.org/links/molecular-profiles/4237|ENST00000389048.3:c.3604G>A&NC_000002.11:g.29443613C>T&NM_004304.4:c.3604G>A&NP_004295.2:p.Gly1202Arg|CA16602592|376134|16.0|evidence|1351|https://civicdb.org/links/evidence/1351|25727400 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Brigatinib (NCIt ID C98831)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||G1202R|171|RS1057519783|https://civicdb.org/links/variants/171|EML4::ALK Fusion AND ALK G1202R|4237||https://civicdb.org/links/molecular-profiles/4237|ENST00000389048.3:c.3604G>A&NC_000002.11:g.29443613C>T&NM_004304.4:c.3604G>A&NP_004295.2:p.Gly1202Arg|CA16602592|376134|16.0|evidence|1352|https://civicdb.org/links/evidence/1352|22277784 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Tanespimycin (NCIt ID C37899)|||D|2|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||G1202R|171|RS1057519783|https://civicdb.org/links/variants/171|ALK G1202R AND v::ALK Fusion|4236|ALK FUSION GLY1202ARG|https://civicdb.org/links/molecular-profiles/4236|ENST00000389048.3:c.3604G>A&NC_000002.11:g.29443613C>T&NM_004304.4:c.3604G>A&NP_004295.2:p.Gly1202Arg|CA16602592|376134|7.5|evidence|1357|https://civicdb.org/links/evidence/1357|22277784 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Crizotinib (NCIt ID C74061)|||C|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3604G>A||G1202R|171|RS1057519783|https://civicdb.org/links/variants/171|EML4::ALK Fusion AND ALK G1202R AND ALK I1171N AND ALK L1196M|4329||https://civicdb.org/links/molecular-profiles/4329|ENST00000389048.3:c.3604G>A&NC_000002.11:g.29443613C>T&NM_004304.4:c.3604G>A&NP_004295.2:p.Gly1202Arg|CA16602592|376134|7.5|evidence|11114|https://civicdb.org/links/evidence/11114|32600123 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Malignant Pleural Mesothelioma|Lorlatinib (NCIt ID C113655)|||C|3|||||
2	29443625	1275	G	A	.	.	GN=ALK;VT=L1198F;CSQ=A|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3592C>T||L1198F|1275|LEU1198PHE&RS751306825|https://civicdb.org/links/variants/1275|EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y|4253||https://civicdb.org/links/molecular-profiles/4253|ENST00000389048.3:c.3592C>T&NC_000002.11:g.29443625G>A&NM_004304.4:c.3592C>T&NP_004295.2:p.Leu1198Phe|CA346473048|NONE FOUND|20.0|evidence|843|https://civicdb.org/links/evidence/843|26698910 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Lorlatinib (NCIt ID C113655)|||C|4|||||,A|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3592C>T||L1198F|1275|LEU1198PHE&RS751306825|https://civicdb.org/links/variants/1275|EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y|4253||https://civicdb.org/links/molecular-profiles/4253|ENST00000389048.3:c.3592C>T&NC_000002.11:g.29443625G>A&NM_004304.4:c.3592C>T&NP_004295.2:p.Leu1198Phe|CA346473048|NONE FOUND|20.0|evidence|844|https://civicdb.org/links/evidence/844|26698910 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||
2	29443631	4324	G	T	.	.	GN=ALK;CSQ=T|Missense Variant|ALK|238|transcript|ENST00000389048.3|||L1196M|4324|LEU1196MET|https://civicdb.org/links/variants/4324|EML4::ALK Fusion AND ALK L1196M|4230||https://civicdb.org/links/molecular-profiles/4230||CA16602593|376135|21.0|evidence|237|https://civicdb.org/links/evidence/237|20979473 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|||L1196M|4324|LEU1196MET|https://civicdb.org/links/variants/4324|EML4::ALK Fusion AND ALK L1196M|4230||https://civicdb.org/links/molecular-profiles/4230||CA16602593|376135|21.0|evidence|442|https://civicdb.org/links/evidence/442|22277784 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|||L1196M|4324|LEU1196MET|https://civicdb.org/links/variants/4324|EML4::ALK Fusion AND ALK L1196M|4230||https://civicdb.org/links/molecular-profiles/4230||CA16602593|376135|21.0|evidence|1341|https://civicdb.org/links/evidence/1341|24675041 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|||L1196M|4324|LEU1196MET|https://civicdb.org/links/variants/4324|EML4::ALK Fusion AND ALK L1196M|4230||https://civicdb.org/links/molecular-profiles/4230||CA16602593|376135|21.0|evidence|141|https://civicdb.org/links/evidence/141|21575866 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Alectinib (NCIt ID C101790)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|||L1196M|4324|LEU1196MET|https://civicdb.org/links/variants/4324|EML4::ALK Fusion AND ALK I1171N AND ALK L1196M|4328||https://civicdb.org/links/molecular-profiles/4328||CA16602593|376135|17.5|evidence|11115|https://civicdb.org/links/evidence/11115|32600123 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Malignant Pleural Mesothelioma|Alectinib (NCIt ID C101790)|||C|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|||L1196M|4324|LEU1196MET|https://civicdb.org/links/variants/4324|EML4::ALK Fusion AND ALK I1171N AND ALK L1196M|4328||https://civicdb.org/links/molecular-profiles/4328||CA16602593|376135|17.5|evidence|11113|https://civicdb.org/links/evidence/11113|32600123 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Malignant Pleural Mesothelioma|Lorlatinib (NCIt ID C113655)|||C|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|||L1196M|4324|LEU1196MET|https://civicdb.org/links/variants/4324|EML4::ALK Fusion AND ALK G1202R AND ALK I1171N AND ALK L1196M|4329||https://civicdb.org/links/molecular-profiles/4329||CA16602593|376135|7.5|evidence|11114|https://civicdb.org/links/evidence/11114|32600123 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Malignant Pleural Mesothelioma|Lorlatinib (NCIt ID C113655)|||C|3|||||;VT=L1196M
2	29443679	528	C	G	.	.	GN=ALK;CSQ=G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||V1180L|528||https://civicdb.org/links/variants/528|EML4::ALK Fusion AND ALK V1180L|4351|EML4-ALK VAL1180LEU&EML4-ALK V1180L|https://civicdb.org/links/molecular-profiles/4351|ENST00000389048.3:c.3538G>C&NC_000002.11:g.29443679C>G&NP_004295.2:p.Val1180Leu&NM_004304.5:c.3538G>C|CA346473150|1705031|13.0|evidence|1286|https://civicdb.org/links/evidence/1286|25228534 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Alectinib (NCIt ID C101790)|||D|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||V1180L|528||https://civicdb.org/links/variants/528|EML4::ALK Fusion AND ALK V1180L|4351|EML4-ALK VAL1180LEU&EML4-ALK V1180L|https://civicdb.org/links/molecular-profiles/4351|ENST00000389048.3:c.3538G>C&NC_000002.11:g.29443679C>G&NP_004295.2:p.Val1180Leu&NM_004304.5:c.3538G>C|CA346473150|1705031|13.0|evidence|1289|https://civicdb.org/links/evidence/1289|25228534 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||D|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||V1180L|528||https://civicdb.org/links/variants/528|EML4::ALK Fusion AND ALK V1180L|4351|EML4-ALK VAL1180LEU&EML4-ALK V1180L|https://civicdb.org/links/molecular-profiles/4351|ENST00000389048.3:c.3538G>C&NC_000002.11:g.29443679C>G&NP_004295.2:p.Val1180Leu&NM_004304.5:c.3538G>C|CA346473150|1705031|13.0|evidence|1290|https://civicdb.org/links/evidence/1290|25228534 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|ALK Inhibitor TAE684 (NCIt ID C171615)|||D|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||V1180L|528||https://civicdb.org/links/variants/528|EML4::ALK Fusion AND ALK V1180L|4351|EML4-ALK VAL1180LEU&EML4-ALK V1180L|https://civicdb.org/links/molecular-profiles/4351|ENST00000389048.3:c.3538G>C&NC_000002.11:g.29443679C>G&NP_004295.2:p.Val1180Leu&NM_004304.5:c.3538G>C|CA346473150|1705031|13.0|evidence|1288|https://civicdb.org/links/evidence/1288|25228534 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|2|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3538G>C||V1180L|528||https://civicdb.org/links/variants/528|EML4::ALK Fusion AND ALK V1180L|4351|EML4-ALK VAL1180LEU&EML4-ALK V1180L|https://civicdb.org/links/molecular-profiles/4351|ENST00000389048.3:c.3538G>C&NC_000002.11:g.29443679C>G&NP_004295.2:p.Val1180Leu&NM_004304.5:c.3538G>C|CA346473150|1705031|13.0|evidence|1291|https://civicdb.org/links/evidence/1291|25228534 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Brigatinib (NCIt ID C98831)|||D|2|||||;VT=V1180L
2	29443695	8	G	T	.	.	GN=ALK;CSQ=T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|1271|https://civicdb.org/links/evidence/1271|23598171 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Neuroblastoma|Crizotinib (NCIt ID C74061)|||C|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|142|https://civicdb.org/links/evidence/142|18923525 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|ALK Inhibitor TAE684 (NCIt ID C171615)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|1329|https://civicdb.org/links/evidence/1329|26554404 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Lorlatinib (NCIt ID C113655)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|32|https://civicdb.org/links/evidence/32|21030459 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Inflammatory Myofibroblastic Tumor|Crizotinib (NCIt ID C74061)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|33|https://civicdb.org/links/evidence/33|21030459 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|37|https://civicdb.org/links/evidence/37|21575866 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Alectinib (NCIt ID C101790)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|38|https://civicdb.org/links/evidence/38|21948233 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|Crizotinib (NCIt ID C74061)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|125|https://civicdb.org/links/evidence/125|22072639 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Neuroblastoma|Crizotinib (NCIt ID C74061)|||D|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3522C>A||F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/variants/8|ALK F1174L|8|PHE1174LEU&RS863225281|https://civicdb.org/links/molecular-profiles/8|NM_004304.4:c.3522C>A&NP_004295.2:p.Phe1174Leu&NC_000002.11:g.29443695G>T&ENST00000389048.3:c.3522C>A|CA279586|217851|33.5|evidence|1327|https://civicdb.org/links/evidence/1327|26786851 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Neuroblastoma|AZD3463|||D|3|||||;VT=F1174L
2	29445213	527	A	G	.	.	GN=ALK;CSQ=G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||I1171|527|ILE1171|https://civicdb.org/links/variants/527|ALK I1171|523|ILE1171|https://civicdb.org/links/molecular-profiles/523|ENST00000389048.3:c.3512T>C&NC_000002.11:g.29445213A>G&NM_004304.4:c.3512T>C&NP_004295.2:p.Ile1171Thr|CA346462880|375888|42.5|evidence|1283|https://civicdb.org/links/evidence/1283|25228534 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Alectinib (NCIt ID C101790)|||C|4|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||I1171|527|ILE1171|https://civicdb.org/links/variants/527|ALK I1171|523|ILE1171|https://civicdb.org/links/molecular-profiles/523|ENST00000389048.3:c.3512T>C&NC_000002.11:g.29445213A>G&NM_004304.4:c.3512T>C&NP_004295.2:p.Ile1171Thr|CA346462880|375888|42.5|evidence|1284|https://civicdb.org/links/evidence/1284|25228534 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||C|4|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||I1171|527|ILE1171|https://civicdb.org/links/variants/527|ALK I1171|523|ILE1171|https://civicdb.org/links/molecular-profiles/523|ENST00000389048.3:c.3512T>C&NC_000002.11:g.29445213A>G&NM_004304.4:c.3512T>C&NP_004295.2:p.Ile1171Thr|CA346462880|375888|42.5|evidence|1368|https://civicdb.org/links/evidence/1368|25736571 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||C|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||I1171|527|ILE1171|https://civicdb.org/links/variants/527|ALK I1171|523|ILE1171|https://civicdb.org/links/molecular-profiles/523|ENST00000389048.3:c.3512T>C&NC_000002.11:g.29445213A>G&NM_004304.4:c.3512T>C&NP_004295.2:p.Ile1171Thr|CA346462880|375888|42.5|evidence|1367|https://civicdb.org/links/evidence/1367|25736571 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Alectinib (NCIt ID C101790)|||C|2|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||I1171|527|ILE1171|https://civicdb.org/links/variants/527|ALK I1171|523|ILE1171|https://civicdb.org/links/molecular-profiles/523|ENST00000389048.3:c.3512T>C&NC_000002.11:g.29445213A>G&NM_004304.4:c.3512T>C&NP_004295.2:p.Ile1171Thr|CA346462880|375888|42.5|evidence|1344|https://civicdb.org/links/evidence/1344|24675041 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)|||D|4|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||I1171|527|ILE1171|https://civicdb.org/links/variants/527|ALK I1171|523|ILE1171|https://civicdb.org/links/molecular-profiles/523|ENST00000389048.3:c.3512T>C&NC_000002.11:g.29445213A>G&NM_004304.4:c.3512T>C&NP_004295.2:p.Ile1171Thr|CA346462880|375888|42.5|evidence|1285|https://civicdb.org/links/evidence/1285|25228534 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|ALK Inhibitor TAE684 (NCIt ID C171615)|||D|3|||||,G|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>C||I1171|527|ILE1171|https://civicdb.org/links/variants/527|ALK I1171|523|ILE1171|https://civicdb.org/links/molecular-profiles/523|ENST00000389048.3:c.3512T>C&NC_000002.11:g.29445213A>G&NM_004304.4:c.3512T>C&NP_004295.2:p.Ile1171Thr|CA346462880|375888|42.5|evidence|1287|https://civicdb.org/links/evidence/1287|25228534 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|3|||||;VT=I1171
2	29445213	588	A	T	.	.	GN=ALK;CSQ=T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>A||I1171N|588|RS1057519698|https://civicdb.org/links/variants/588|EML4::ALK Fusion AND ALK I1171N AND ALK L1196M|4328||https://civicdb.org/links/molecular-profiles/4328|ENST00000389048.3:c.3512T>A&NC_000002.11:g.29445213A>T&NM_004304.4:c.3512T>A&NP_004295.2:p.Ile1171Asn|CA16602371|375888|17.5|evidence|11115|https://civicdb.org/links/evidence/11115|32600123 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Malignant Pleural Mesothelioma|Alectinib (NCIt ID C101790)|||C|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>A||I1171N|588|RS1057519698|https://civicdb.org/links/variants/588|EML4::ALK Fusion AND ALK I1171N AND ALK L1196M|4328||https://civicdb.org/links/molecular-profiles/4328|ENST00000389048.3:c.3512T>A&NC_000002.11:g.29445213A>T&NM_004304.4:c.3512T>A&NP_004295.2:p.Ile1171Asn|CA16602371|375888|17.5|evidence|11113|https://civicdb.org/links/evidence/11113|32600123 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Malignant Pleural Mesothelioma|Lorlatinib (NCIt ID C113655)|||C|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>A||I1171N|588|RS1057519698|https://civicdb.org/links/variants/588|EML4::ALK Fusion AND ALK G1202R AND ALK I1171N AND ALK L1196M|4329||https://civicdb.org/links/molecular-profiles/4329|ENST00000389048.3:c.3512T>A&NC_000002.11:g.29445213A>T&NM_004304.4:c.3512T>A&NP_004295.2:p.Ile1171Asn|CA16602371|375888|7.5|evidence|11114|https://civicdb.org/links/evidence/11114|32600123 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Malignant Pleural Mesothelioma|Lorlatinib (NCIt ID C113655)|||C|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>A||I1171N|588|RS1057519698|https://civicdb.org/links/variants/588|ALK I1171N AND HIP1::ALK Fusion|4332||https://civicdb.org/links/molecular-profiles/4332|ENST00000389048.3:c.3512T>A&NC_000002.11:g.29445213A>T&NM_004304.4:c.3512T>A&NP_004295.2:p.Ile1171Asn|CA16602371|375888|5.0|evidence|1483|https://civicdb.org/links/evidence/1483|25393796 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Alectinib (NCIt ID C101790)&Crizotinib (NCIt ID C74061)|SEQUENTIAL||C|2|||||;VT=I1171N
2	29445213	589	A	C	.	.	GN=ALK;CSQ=C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3512T>G||I1171S|589|ILE1171SER|https://civicdb.org/links/variants/589|EML4::ALK Fusion AND ALK I1171S|4357||https://civicdb.org/links/molecular-profiles/4357|ENST00000389048.3:c.3512T>G&NC_000002.11:g.29445213A>C|CA346462883|NONE FOUND|5.0|evidence|1484|https://civicdb.org/links/evidence/1484|25393796 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Alectinib (NCIt ID C101790)&Crizotinib (NCIt ID C74061)|SEQUENTIAL||C|2|||||;VT=I1171S
2	29445258	4331	C	T	.	.	GN=ALK;CSQ=T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||C1156Y|4331|RS1057519859&CYS1156TYR|https://civicdb.org/links/variants/4331|EML4::ALK Fusion AND ALK C1156Y|4225||https://civicdb.org/links/molecular-profiles/4225|ENST00000389048.3:c.3467G>A&NC_000002.11:g.29445258C>T&NM_004304.4:c.3467G>A&NP_004295.2:p.Cys1156Tyr|CA16602783|376340|29.0|evidence|236|https://civicdb.org/links/evidence/236|20979473 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||C1156Y|4331|RS1057519859&CYS1156TYR|https://civicdb.org/links/variants/4331|EML4::ALK Fusion AND ALK C1156Y|4225||https://civicdb.org/links/molecular-profiles/4225|ENST00000389048.3:c.3467G>A&NC_000002.11:g.29445258C>T&NM_004304.4:c.3467G>A&NP_004295.2:p.Cys1156Tyr|CA16602783|376340|29.0|evidence|841|https://civicdb.org/links/evidence/841|26698910 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Ceritinib (NCIt ID C115112)&Crizotinib (NCIt ID C74061)&Luminespib (NCIt ID C71467)|SEQUENTIAL||C|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||C1156Y|4331|RS1057519859&CYS1156TYR|https://civicdb.org/links/variants/4331|EML4::ALK Fusion AND ALK C1156Y|4225||https://civicdb.org/links/molecular-profiles/4225|ENST00000389048.3:c.3467G>A&NC_000002.11:g.29445258C>T&NM_004304.4:c.3467G>A&NP_004295.2:p.Cys1156Tyr|CA16602783|376340|29.0|evidence|842|https://civicdb.org/links/evidence/842|26698910 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Lorlatinib (NCIt ID C113655)|||C|3|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||C1156Y|4331|RS1057519859&CYS1156TYR|https://civicdb.org/links/variants/4331|EML4::ALK Fusion AND ALK C1156Y|4225||https://civicdb.org/links/molecular-profiles/4225|ENST00000389048.3:c.3467G>A&NC_000002.11:g.29445258C>T&NM_004304.4:c.3467G>A&NP_004295.2:p.Cys1156Tyr|CA16602783|376340|29.0|evidence|1346|https://civicdb.org/links/evidence/1346|24675041 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||C1156Y|4331|RS1057519859&CYS1156TYR|https://civicdb.org/links/variants/4331|EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y|4253||https://civicdb.org/links/molecular-profiles/4253|ENST00000389048.3:c.3467G>A&NC_000002.11:g.29445258C>T&NM_004304.4:c.3467G>A&NP_004295.2:p.Cys1156Tyr|CA16602783|376340|20.0|evidence|843|https://civicdb.org/links/evidence/843|26698910 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Lorlatinib (NCIt ID C113655)|||C|4|||||,T|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3467G>A||C1156Y|4331|RS1057519859&CYS1156TYR|https://civicdb.org/links/variants/4331|EML4::ALK Fusion AND ALK L1198F AND ALK C1156Y|4253||https://civicdb.org/links/molecular-profiles/4253|ENST00000389048.3:c.3467G>A&NC_000002.11:g.29445258C>T&NM_004304.4:c.3467G>A&NP_004295.2:p.Cys1156Tyr|CA16602783|376340|20.0|evidence|844|https://civicdb.org/links/evidence/844|26698910 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||;VT=C1156Y
2	29445270	307	A	C	.	.	CSQ=C|Missense Variant|ALK|238|transcript|ENST00000389048.3|ENST00000389048.3:c.3455T>G||L1152R|307|RS1057519785&LEU1152ARG|https://civicdb.org/links/variants/307|EML4::ALK Fusion AND ALK L1152R|4255||https://civicdb.org/links/molecular-profiles/4255|ENST00000389048.3:c.3455T>G&NC_000002.11:g.29445270A>C&NM_004304.4:c.3455T>G&NP_004295.2:p.Leu1152Arg|CA16602594|376136|10.0|evidence|763|https://civicdb.org/links/evidence/763|21791641 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||;GN=ALK;VT=L1152R
2	29445271	4389	G	GCGT	.	.	GN=ALK;CSQ=CGT|Inframe Insertion|ALK|238|transcript|ENST00000389048.8|||T1151dup|4389|T1151_L1152INST|https://civicdb.org/links/variants/4389|EML4::ALK Fusion AND ALK T1151dup|4308||https://civicdb.org/links/molecular-profiles/4308|NC_000002.11:g.29445271_29445272insCGT|CA645528802||18.0|evidence|444|https://civicdb.org/links/evidence/444|22277784 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||,CGT|Inframe Insertion|ALK|238|transcript|ENST00000389048.8|||T1151dup|4389|T1151_L1152INST|https://civicdb.org/links/variants/4389|EML4::ALK Fusion AND ALK T1151dup|4308||https://civicdb.org/links/molecular-profiles/4308|NC_000002.11:g.29445271_29445272insCGT|CA645528802||18.0|evidence|1347|https://civicdb.org/links/evidence/1347|22277784 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Alectinib (NCIt ID C101790)|||D|3|||||,CGT|Inframe Insertion|ALK|238|transcript|ENST00000389048.8|||T1151dup|4389|T1151_L1152INST|https://civicdb.org/links/variants/4389|EML4::ALK Fusion AND ALK T1151dup|4308||https://civicdb.org/links/molecular-profiles/4308|NC_000002.11:g.29445271_29445272insCGT|CA645528802||18.0|evidence|1348|https://civicdb.org/links/evidence/1348|22277784 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|ALK Inhibitor TAE684 (NCIt ID C171615)|||D|3|||||,CGT|Inframe Insertion|ALK|238|transcript|ENST00000389048.8|||T1151dup|4389|T1151_L1152INST|https://civicdb.org/links/variants/4389|EML4::ALK Fusion AND ALK T1151dup|4308||https://civicdb.org/links/molecular-profiles/4308|NC_000002.11:g.29445271_29445272insCGT|CA645528802||18.0|evidence|1349|https://civicdb.org/links/evidence/1349|22277784 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Tanespimycin (NCIt ID C37899)|||D|2|||||;VT=T1151dup
2	47630413	763	A	AG	.	.	GN=MSH2;CSQ=G|Frameshift Elongation|MSH2|4436|transcript|ENST00000233146.2|||E28FS|763||https://civicdb.org/links/variants/763|MSH2 E28FS|744||https://civicdb.org/links/molecular-profiles/744|NC_000002.11:g.47630414dupG|CA913189237|NONE FOUND|2.5|evidence|1827|https://civicdb.org/links/evidence/1827|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;VT=E28FS
2	47637380	770	A	T	.	.	GN=MSH2;VT=K172*;CSQ=T|Stop Gained|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.514A>T||K172*|770|K172X&LYS172TER|https://civicdb.org/links/variants/770|MSH2 K172*|751|K172X&LYS172TER|https://civicdb.org/links/molecular-profiles/751|ENST00000233146.2:c.514A>T&NC_000002.11:g.47637380A>T|CA346730730|NONE FOUND|2.5|evidence|1834|https://civicdb.org/links/evidence/1834|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
2	47641432	762	GT	G	.	.	VT=V273FS;GN=MSH2;CSQ=-|Frameshift Variant|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.818delT||V273FS|762||https://civicdb.org/links/variants/762|MSH2 V273FS|743||https://civicdb.org/links/molecular-profiles/743|ENST00000233146.2:c.818delT&NC_000002.11:g.47641433del|CA913090558||2.5|evidence|1826|https://civicdb.org/links/evidence/1826|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
2	47656951	727	C	T	.	.	CSQ=T|Stop Gained|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.1147C>T||R383*|727|R383X&ARG383TER&RS63749849|https://civicdb.org/links/variants/727|MSH2 R383*|708|R383X&ARG383TER&RS63749849|https://civicdb.org/links/molecular-profiles/708|NM_000251.2:c.1147C>T&NP_000242.1:p.Arg383Ter&ENST00000233146.2:c.1147C>T&NC_000002.11:g.47656951C>T|CA017356|90554|2.5|evidence|1790|https://civicdb.org/links/evidence/1790|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Cancer||||C|1|||||;VT=R383*;GN=MSH2
2	47690231	773	A	G	.	.	CSQ=G|Missense Variant|MSH2|4436|transcript|ENST00000233146.2|ENST00000233146.2:c.1448A>G||E483G|773|GLU483GLY|https://civicdb.org/links/variants/773|MSH2 E483G|754|GLU483GLY|https://civicdb.org/links/molecular-profiles/754|NC_000002.11:g.47690231A>G&ENST00000233146.2:c.1448A>G|CA346726930|NONE FOUND|2.5|evidence|1837|https://civicdb.org/links/evidence/1837|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Cancer||||C|1|||||;VT=E483G;GN=MSH2
2	48018217	761	C	A	.	.	VT=P138T;GN=MSH6;CSQ=A|Missense Variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.412C>A||P138T|761|PRO138THR|https://civicdb.org/links/variants/761|MSH6 P138T|742|PRO138THR|https://civicdb.org/links/molecular-profiles/742|ENST00000234420.5:c.412C>A&NC_000002.11:g.48018217C>A|CA346737117|NONE FOUND|2.5|evidence|1825|https://civicdb.org/links/evidence/1825|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
2	48026176	775	G	A	.	.	VT=V352I;GN=MSH6;CSQ=A|Missense Variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.1054G>A||V352I|775|VAL352ILE&RS730881787|https://civicdb.org/links/variants/775|MSH6 V352I|756|VAL352ILE&RS730881787|https://civicdb.org/links/molecular-profiles/756|NM_000179.2:c.1054G>A&NP_000170.1:p.Val352Ile&ENST00000234420.5:c.1054G>A&NC_000002.11:g.48026176G>A|CA007915|182617|2.5|evidence|1839|https://civicdb.org/links/evidence/1839|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Cancer||||C|1|||||
2	48027793	765	ATC	A	.	.	GN=MSH6;VT=I891FS;CSQ=-|Frameshift Truncation|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.2672_2673delTC||I891FS|765|ILE891FS|https://civicdb.org/links/variants/765|MSH6 I891FS|746|ILE891FS|https://civicdb.org/links/molecular-profiles/746|ENST00000234420.5:c.2672_2673delTC&NC_000002.11:g.48027794_48027795del|CA913090565|NONE FOUND|2.5|evidence|1829|https://civicdb.org/links/evidence/1829|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
2	48033420	776	C	T	.	.	VT=R1242C;GN=MSH6;CSQ=T|Missense Variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.3724C>T||R1242C|776|ARG1242CYS&RS587779285|https://civicdb.org/links/variants/776|MSH6 R1242C|757|ARG1242CYS&RS587779285|https://civicdb.org/links/molecular-profiles/757|NM_000179.2:c.3724C>T&NP_000170.1:p.Arg1242Cys&ENST00000234420.5:c.3724C>T&NC_000002.11:g.48033420C>T|CA10578156|232375|2.5|evidence|1840|https://civicdb.org/links/evidence/1840|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
2	48033421	767	G	A	.	.	CSQ=A|Missense Variant|MSH6|2956|transcript|ENST00000234420.5|ENST00000234420.5:c.3725G>A||R1242H|767|ARG1242HIS&RS63750119|https://civicdb.org/links/variants/767|MSH6 R1242H|748|ARG1242HIS&RS63750119|https://civicdb.org/links/molecular-profiles/748|NM_000179.2:c.3725G>A&NP_000170.1:p.Arg1242His&ENST00000234420.5:c.3725G>A&NC_000002.11:g.48033421G>A|CA014077|140866|2.5|evidence|1831|https://civicdb.org/links/evidence/1831|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;GN=MSH6;VT=R1242H
2	158622516	1686	C	A	.	.	VT=G328V;CSQ=A|Missense Variant|ACVR1|90|transcript|ENST00000434821.1|ENST00000434821.1%3Ac.983G>T||G328V|1686|GLY328VAL&RS387906589|https%3A//civicdb.org/links/variants/1686|ACVR1 G328V|1594|GLY328VAL&RS387906589|https%3A//civicdb.org/links/molecular-profiles/1594|NM_001105.4%3Ac.983G>T&NP_001096.1%3Ap.Gly328Val&NC_000002.11%3Ag.158622516C>A&ENST00000434821.1%3Ac.983G>T|CA16602802|376363|35.0|evidence|4846|https%3A//civicdb.org/links/evidence/4846|24705250 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Diffuse Midline Glioma%2C H3 K27M-mutant||||B|3|||||,A|Missense Variant|ACVR1|90|transcript|ENST00000434821.1|ENST00000434821.1%3Ac.983G>T||G328V|1686|GLY328VAL&RS387906589|https%3A//civicdb.org/links/variants/1686|ACVR1 G328V|1594|GLY328VAL&RS387906589|https%3A//civicdb.org/links/molecular-profiles/1594|NM_001105.4%3Ac.983G>T&NP_001096.1%3Ap.Gly328Val&NC_000002.11%3Ag.158622516C>A&ENST00000434821.1%3Ac.983G>T|CA16602802|376363|35.0|evidence|6955|https%3A//civicdb.org/links/evidence/6955|24705254 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Diffuse Midline Glioma%2C H3 K27M-mutant||||B|3|||||,A|Missense Variant|ACVR1|90|transcript|ENST00000434821.1|ENST00000434821.1%3Ac.983G>T||G328V|1686|GLY328VAL&RS387906589|https%3A//civicdb.org/links/variants/1686|ACVR1 G328V|1594|GLY328VAL&RS387906589|https%3A//civicdb.org/links/molecular-profiles/1594|NM_001105.4%3Ac.983G>T&NP_001096.1%3Ap.Gly328Val&NC_000002.11%3Ag.158622516C>A&ENST00000434821.1%3Ac.983G>T|CA16602802|376363|35.0|evidence|10011|https%3A//civicdb.org/links/evidence/10011|24705252 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Diffuse Midline Glioma%2C H3 K27M-mutant||||C|2|||||,A|Missense Variant|ACVR1|90|transcript|ENST00000434821.1|ENST00000434821.1%3Ac.983G>T||G328V|1686|GLY328VAL&RS387906589|https%3A//civicdb.org/links/variants/1686|ACVR1 G328V|1594|GLY328VAL&RS387906589|https%3A//civicdb.org/links/molecular-profiles/1594|NM_001105.4%3Ac.983G>T&NP_001096.1%3Ap.Gly328Val&NC_000002.11%3Ag.158622516C>A&ENST00000434821.1%3Ac.983G>T|CA16602802|376363|35.0|assertion|9|https%3A//civicdb.org/links/assertion/9||SOMATIC|accepted|POSITIVE|SUPPORTS|Diffuse Midline Glioma%2C H3 K27M-mutant (DOID 0080684)|||||||TIER_II_LEVEL_C|||;GN=ACVR1
2	158622517	2280	C	A	.	.	CSQ=A|Missense Variant|ACVR1|90|transcript|ENST00000263640.3|ENST00000263640.3%3Ac.982G>T||G328W|2280|GLY328TRP|https%3A//civicdb.org/links/variants/2280|ACVR1 G328W|2156|GLY328TRP|https%3A//civicdb.org/links/molecular-profiles/2156|NM_001105.4%3Ac.982G>T&NP_001096.1%3Ap.Gly328Trp&NC_000002.11%3Ag.158622517C>A&ENST00000263640.3%3Ac.982G>T|CA128481|29594|5.0|evidence|10013|https%3A//civicdb.org/links/evidence/10013|24705252 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Diffuse Midline Glioma%2C H3 K27M-mutant||||C|2|||||;VT=G328W;GN=ACVR1
2	198266834	565	T	C	.	.	GN=SF3B1;VT=K700E;CSQ=C|Missense Variant|SF3B1|23451|transcript|ENST00000335508.6|ENST00000335508.6:c.2098A>G||K700E|565|LYS700GLU&RS559063155|https://civicdb.org/links/variants/565|SF3B1 K700E|561|LYS700GLU&RS559063155|https://civicdb.org/links/molecular-profiles/561|NC_000002.11:g.198266834T>C&NM_012433.3:c.2098A>G&NP_036565.2:p.Lys700Glu&ENST00000335508.6:c.2098A>G|CA2042597|376004|5.0|evidence|10139|https://civicdb.org/links/evidence/10139|35027467 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Leukemia|Etoposide (NCIt ID C491)&Olaparib (NCIt ID C71721)|SUBSTITUTES||D|3|||||,C|Missense Variant|SF3B1|23451|transcript|ENST00000335508.6|ENST00000335508.6:c.2098A>G||K700E|565|LYS700GLU&RS559063155|https://civicdb.org/links/variants/565|SF3B1 K700E|561|LYS700GLU&RS559063155|https://civicdb.org/links/molecular-profiles/561|NC_000002.11:g.198266834T>C&NM_012433.3:c.2098A>G&NP_036565.2:p.Lys700Glu&ENST00000335508.6:c.2098A>G|CA2042597|376004|5.0|evidence|1417|https://civicdb.org/links/evidence/1417|25424858 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Spliceostatin A|||D|2|||||
2	198267359	114	C	A	.	.	VT=K666N;GN=SF3B1;CSQ=A|Missense Variant|SF3B1|23451|transcript|ENST00000335508.6|ENST00000335508.6:c.1998G>T||K666N|114|LYS666ASN&RS377023736|https://civicdb.org/links/variants/114|SF3B1 K666N|114|LYS666ASN&RS377023736|https://civicdb.org/links/molecular-profiles/114|NM_012433.3:c.1998G>T&NP_036565.2:p.Lys666Asn&ENST00000335508.6:c.1998G>T&NC_000002.11:g.198267359C>A|CA280929|219098|2.0|evidence|1418|https://civicdb.org/links/evidence/1418|25424858 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Spliceostatin A|||D|2|||||
2	202149589	650	G	C	.	.	VT=D302H;CSQ=C|Missense Variant&Polymorphic Sequence Variant|CASP8|841|transcript|ENST00000264275.5|ENST00000264275.5:c.904G>C||D302H|650|RS1045485&D285H&ASP302HIS|https://civicdb.org/links/variants/650|CASP8 D302H|646|RS1045485&D285H&ASP302HIS|https://civicdb.org/links/molecular-profiles/646|NM_001228.4:c.904G>C&NP_001219.2:p.Asp302His&ENST00000264275.5:c.904G>C&NC_000002.11:g.202149589G>C|CA119051|7762|15.0|evidence|1654|https://civicdb.org/links/evidence/1654|25502557 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Neuroblastoma||||B|3|||||;GN=CASP8
2	209113112	420	C	T	.	.	GN=IDH1;VT=R132H;CSQ=T|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.395G>A||R132H|420|ARG132HIS&RS121913500|https://civicdb.org/links/variants/420|IDH1 R132H|416|ARG132HIS&RS121913500|https://civicdb.org/links/molecular-profiles/416|NM_001282386.1:c.395G>A&NP_005887.2:p.Arg132His&NC_000002.11:g.209113112C>T&ENST00000415913.1:c.395G>A|CA170874|156444|9.0|evidence|5987|https://civicdb.org/links/evidence/5987|27466707 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Pancreatic Ductal Adenocarcinoma|Ivosidenib (NCIt ID C114383)|||C|2|||||,T|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.395G>A||R132H|420|ARG132HIS&RS121913500|https://civicdb.org/links/variants/420|IDH1 R132H|416|ARG132HIS&RS121913500|https://civicdb.org/links/molecular-profiles/416|NM_001282386.1:c.395G>A&NP_005887.2:p.Arg132His&NC_000002.11:g.209113112C>T&ENST00000415913.1:c.395G>A|CA170874|156444|9.0|evidence|979|https://civicdb.org/links/evidence/979|23558169 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Oligodendroglioma|AGI-5198|||D|4|||||,T|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.395G>A||R132H|420|ARG132HIS&RS121913500|https://civicdb.org/links/variants/420|IDH1 R132C OR IDH1 R132H OR IDH1 R132L OR IDH1 R132G OR IDH1 R132S|5298||https://civicdb.org/links/molecular-profiles/5298|NM_001282386.1:c.395G>A&NP_005887.2:p.Arg132His&NC_000002.11:g.209113112C>T&ENST00000415913.1:c.395G>A|CA170874|156444|0.0|evidence|11508|https://civicdb.org/links/evidence/11508|37272516 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Vorasidenib (NCIt ID C152914)|||A|5|||||
2	209113112	880	C	A	.	.	GN=IDH1;CSQ=A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.395G>T||R132L|880|RS121913500&ARG132LEU|https://civicdb.org/links/variants/880|IDH1 R132C OR IDH1 R132H OR IDH1 R132L OR IDH1 R132G OR IDH1 R132S|5298||https://civicdb.org/links/molecular-profiles/5298|NM_001282386.1:c.395G>T&NP_001269315.1:p.Arg132Leu&NC_000002.11:g.209113112C>A&ENST00000415913.1:c.395G>T|CA16602372|375889|0.0|evidence|11508|https://civicdb.org/links/evidence/11508|37272516 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Vorasidenib (NCIt ID C152914)|||A|5|||||;VT=R132L
2	209113113	59	G	A	.	.	GN=IDH1;VT=R132C;CSQ=A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|224|https://civicdb.org/links/evidence/224|20538800 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Acute Myeloid Leukemia||||B|3|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|324|https://civicdb.org/links/evidence/324|20538800 (PUBMED)|SOMATIC|accepted|NA|DOES_NOT_SUPPORT|Acute Myeloid Leukemia||||B|2|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|2327|https://civicdb.org/links/evidence/2327|20975057 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Brain Glioma|Temozolomide (NCIt ID C1244)|||B|2|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|2331|https://civicdb.org/links/evidence/2331|25583779 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Ivosidenib (NCIt ID C114383)|||B|2|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|732|https://civicdb.org/links/evidence/732|26436839 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|GSK321|||D|3|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|2332|https://civicdb.org/links/evidence/2332|24333121 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|BPTES|||D|3|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|10144|https://civicdb.org/links/evidence/10144|28148839 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Olaparib (NCIt ID C71721)|||D|3|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/molecular-profiles/59|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|56.0|evidence|2329|https://civicdb.org/links/evidence/2329|23558169 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|High Grade Glioma|AGI-5198|||D|2|||||,A|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>T||R132C|59|RS121913499&ARG132CYS|https://civicdb.org/links/variants/59|IDH1 R132C OR IDH1 R132H OR IDH1 R132L OR IDH1 R132G OR IDH1 R132S|5298||https://civicdb.org/links/molecular-profiles/5298|NM_005896.3:c.394C>T&NP_005887.2:p.Arg132Cys&NC_000002.11:g.209113113G>A&ENST00000415913.1:c.394C>T|CA16602374|375891|0.0|evidence|11508|https://civicdb.org/links/evidence/11508|37272516 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Vorasidenib (NCIt ID C152914)|||A|5|||||
2	209113113	927	G	C	.	.	GN=IDH1;CSQ=C|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>G||R132G|927|RS121913499&ARG132GLY|https://civicdb.org/links/variants/927|IDH1 R132C OR IDH1 R132H OR IDH1 R132L OR IDH1 R132G OR IDH1 R132S|5298||https://civicdb.org/links/molecular-profiles/5298|NM_001282386.1:c.394C>G&NP_001269315.1:p.Arg132Gly&NC_000002.11:g.209113113G>C&ENST00000415913.1:c.394C>G|CA16602375|375892|0.0|evidence|11508|https://civicdb.org/links/evidence/11508|37272516 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Vorasidenib (NCIt ID C152914)|||A|5|||||;VT=R132G
2	209113113	928	G	T	.	.	GN=IDH1;VT=R132S;CSQ=T|Missense Variant|IDH1|3417|transcript|ENST00000415913.1|ENST00000415913.1:c.394C>A||R132S|928|RS121913499&ARG132SER|https://civicdb.org/links/variants/928|IDH1 R132C OR IDH1 R132H OR IDH1 R132L OR IDH1 R132G OR IDH1 R132S|5298||https://civicdb.org/links/molecular-profiles/5298|NM_001282386.1:c.394C>A&NP_001269315.1:p.Arg132Ser&NC_000002.11:g.209113113G>T&ENST00000415913.1:c.394C>A|CA16602376|375893|0.0|evidence|11508|https://civicdb.org/links/evidence/11508|37272516 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Vorasidenib (NCIt ID C152914)|||A|5|||||
2	234668881	729	T	TTATATATATATATA	.	.	CSQ=TATATATATATATA|Microsatellite|UGT1A1|54658|transcript|ENST00000305208.5|||UGT1A1*28|729|RS8175347|https://civicdb.org/links/variants/729|UGT1A1 UGT1A1*28|710|RS8175347|https://civicdb.org/links/molecular-profiles/710|NC_000002.11:g.234668881_234668882TA[7]|unregistered|226028|50.0|evidence|1792|https://civicdb.org/links/evidence/1792|26313268 (PUBMED)|COMMON_GERMLINE|accepted|ADVERSE_RESPONSE|SUPPORTS|Cancer|Belinostat (NCIt ID C48812)|||A|5|||||;VT=UGT1A1*28;GN=UGT1A1
3	10183530	847	GAATGCCCCGGAGGGCGGAGAA	G	.	.	CSQ=-|Start Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.1-1_20del21||M1? (c.1-1_20del21)|847|MET1 LOSS&START LOSS&NO INITIATION&C.1-1_20DEL21|https://civicdb.org/links/variants/847|VHL M1? (c.1-1_20del21)|821|MET1 LOSS&START LOSS&NO INITIATION&C.1-1_20DEL21|https://civicdb.org/links/molecular-profiles/821|NP_000542.1:p.0&NP_000542.1:p.Met1?&NM_000551.3:c.1-1_20del21&ENST00000256474.2:c.1-1_20del21&NC_000003.11:g.10183531_10183551del|CA645524624|NONE FOUND|2.5|evidence|1946|https://civicdb.org/links/evidence/1946|15932632 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||;VT=M1? (c.1-1_20del21);GN=VHL
3	10183531	846	AATGCCCCGGAGGGCGGA	A	.	.	CSQ=-|Start Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.1_17del17||M1FS (c.1_17del17)|846|C.1_17DEL17&MET1FS|https://civicdb.org/links/variants/846|VHL M1FS (c.1_17del17)|820|C.1_17DEL17&MET1FS|https://civicdb.org/links/molecular-profiles/820|ENST00000256474.2:c.1_17del17&NC_000003.11:g.10183532_10183548del&NM_000551.3:c.1_17del|CA645524623|NONE FOUND|2.5|evidence|1945|https://civicdb.org/links/evidence/1945|15932632 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Chromophobe Renal Cell Carcinoma||||C|1|||||;VT=M1FS (c.1_17del17);GN=VHL
3	10183534	848	G	A	.	.	VT=M1? (c.3G>A);GN=VHL;CSQ=A|Start Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.3G>A||M1? (c.3G>A)|848|MET1 LOSS&START LOSS&NO INITIATION&C.3G>A&RS578091032|https://civicdb.org/links/variants/848|VHL M1? (c.3G>A)|822|MET1 LOSS&START LOSS&NO INITIATION&C.3G>A&RS578091032|https://civicdb.org/links/molecular-profiles/822|NP_000542.1:p.0&NP_000542.1:p.Met1?&NM_000551.3:c.3G>A&ENST00000256474.2:c.3G>A&NC_000003.11:g.10183534G>A|CA020331|135406|2.5|evidence|1947|https://civicdb.org/links/evidence/1947|11505222 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||
3	10183550	849	A	G	.	.	GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.19A>G||N7D (c.19A>G)|849|ASN7ASP&C.19A>G&RS1311403806|https://civicdb.org/links/variants/849|VHL N7D (c.19A>G)|823|ASN7ASP&C.19A>G&RS1311403806|https://civicdb.org/links/molecular-profiles/823|NC_000003.11:g.10183550A>G&NM_000551.3:c.19A>G&ENST00000256474.2:c.19A>G&NP_000542.1:c.Asn7Asp|CA351747044|NONE FOUND|2.5|evidence|1948|https://civicdb.org/links/evidence/1948|11536052 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Renal Cell Carcinoma||||C|1|||||;VT=N7D (c.19A>G)
3	10183555	1294	G	A	.	.	GN=VHL;VT=W8* (c.24G>A);CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.24G>A||W8* (c.24G>A)|1294|TRP8X&TRP8STOP&C.24G>A|https://civicdb.org/links/variants/1294|VHL W8* (c.24G>A)|1268|TRP8X&TRP8STOP&C.24G>A|https://civicdb.org/links/molecular-profiles/1268|NM_000551.3:c.24G>A&ENST00000256474.2:c.24G>A&NC_000003.11:g.10183555G>A&NP_000542.1:p.Trp8Ter|CA351747069|NONE FOUND|2.5|evidence|2986|https://civicdb.org/links/evidence/2986|11536052 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Renal Cell Carcinoma||||C|1|||||
3	10183605	850	C	T	.	.	GN=VHL;VT=P25L (c.74C>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.74C>T||P25L (c.74C>T)|850|PRO25LEU&C.74C>T&RS35460768|https://civicdb.org/links/variants/850|VHL P25L (c.74C>T)|824|PRO25LEU&C.74C>T&RS35460768|https://civicdb.org/links/molecular-profiles/824|NM_000551.3:c.74C>T&NP_000542.1:p.Pro25Leu&ENST00000256474.2:c.74C>T&NC_000003.11:g.10183605C>T|CA020538|93330|7.5|evidence|1949|https://civicdb.org/links/evidence/1949|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183667	1733	G	T	.	.	CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.136G>T||E46* (c.136G>T)|1733|GLU46TER&E46X&C.136G>T|https://civicdb.org/links/variants/1733|VHL E46* (c.136G>T)|1609|GLU46TER&E46X&C.136G>T|https://civicdb.org/links/molecular-profiles/1609|ENST00000256474.2:c.136G>T&NC_000003.11:g.10183667G>T&NM_000551.3:c.136G>T&NP_000542.1:p.Glu46Ter|CA351748085|NONE FOUND|10.0|evidence|4895|https://civicdb.org/links/evidence/4895|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=E46* (c.136G>T)
3	10183685	1734	G	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.154G>A||E52K (c.154G>A)|1734|GLU52LYS&C.154G>A&RS373068386|https://civicdb.org/links/variants/1734|VHL E52K (c.154G>A)|1610|GLU52LYS&C.154G>A&RS373068386|https://civicdb.org/links/molecular-profiles/1610|NM_000551.3:c.154G>A&NP_000542.1:p.Glu52Lys&NC_000003.11:g.10183685G>A&ENST00000256474.2:c.154G>A|CA020056|161402|15.0|evidence|4896|https://civicdb.org/links/evidence/4896|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.154G>A||E52K (c.154G>A)|1734|GLU52LYS&C.154G>A&RS373068386|https://civicdb.org/links/variants/1734|VHL E52K (c.154G>A)|1610|GLU52LYS&C.154G>A&RS373068386|https://civicdb.org/links/molecular-profiles/1610|NM_000551.3:c.154G>A&NP_000542.1:p.Glu52Lys&NC_000003.11:g.10183685G>A&ENST00000256474.2:c.154G>A|CA020056|161402|15.0|evidence|5272|https://civicdb.org/links/evidence/5272|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=E52K (c.154G>A)
3	10183690	1889	GT	G	.	.	GN=VHL;VT=M54fs (c.161dup);CSQ=-|Plus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||M54fs (c.161dup)|1889|M54IFS*78 (C.161DUP)&M54FS (C.161INST)&M54FS (C.161DUPT)|https://civicdb.org/links/variants/1889|VHL M54fs (c.161dup)|1765|M54IFS*78 (C.161DUP)&M54FS (C.161INST)&M54FS (C.161DUPT)|https://civicdb.org/links/molecular-profiles/1765|NC_000003.11:g.10183692dup&NM_000551.3:c.161dup&NP_000542.1:p.Met54IlefsTer?&NC_000003.12:g.10142008dup|CA2586965629|NONE FOUND|17.5|evidence|5151|https://civicdb.org/links/evidence/5151|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,-|Plus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||M54fs (c.161dup)|1889|M54IFS*78 (C.161DUP)&M54FS (C.161INST)&M54FS (C.161DUPT)|https://civicdb.org/links/variants/1889|VHL M54fs (c.161dup)|1765|M54IFS*78 (C.161DUP)&M54FS (C.161INST)&M54FS (C.161DUPT)|https://civicdb.org/links/molecular-profiles/1765|NC_000003.11:g.10183692dup&NM_000551.3:c.161dup&NP_000542.1:p.Met54IlefsTer?&NC_000003.12:g.10142008dup|CA2586965629|NONE FOUND|17.5|evidence|5283|https://civicdb.org/links/evidence/5283|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183692	829	TGGAGG	T	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.162_166delGGAGG||M54IFS (c.162_166delGGAGG)|829|C.162_166DELGGAGG&MET54ILEFS|https://civicdb.org/links/variants/829|VHL M54IFS (c.162_166delGGAGG)|807|C.162_166DELGGAGG&MET54ILEFS|https://civicdb.org/links/molecular-profiles/807|NM_000551.2:c.162_166delGGAGG&NP_000542.1:p.Met54IlefsTer76&NC_000003.11:g.10183693_10183697del&ENST00000256474.2:c.162_166delGGAGG|CA645524639|NONE FOUND|2.5|evidence|1914|https://civicdb.org/links/evidence/1914|8187067 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||;GN=VHL;VT=M54IFS (c.162_166delGGAGG)
3	10183693	764	GGA	G	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.163_164delGA||E55FS (c.163_164delGA)|764|C.163_164DELGA&GLU55FS|https://civicdb.org/links/variants/764|VHL E55FS (c.163_164delGA)|745|C.163_164DELGA&GLU55FS|https://civicdb.org/links/molecular-profiles/745|NP_000542.1:p.Glu55fs&NC_000003.11:g.10183694_10183695del&ENST00000256474.2:c.163_164delGA|CA645524641|NONE FOUND|2.5|evidence|1828|https://civicdb.org/links/evidence/1828|10408776 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Renal Cell Carcinoma||||C|1|||||;VT=E55FS (c.163_164delGA);GN=VHL
3	10183693	766	GG	G	.	.	GN=VHL;CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.163delG||E55RfsTer11 (c.163delG)|766|C.163DELG&GLU55ARGFS|https://civicdb.org/links/variants/766|VHL E55RfsTer11 (c.163delG)|747|C.163DELG&GLU55ARGFS|https://civicdb.org/links/molecular-profiles/747|NP_000542.1:p.Glu55fs&NP_000542.1:p.Glu55ArgfsTer11&NM_000551.2:c.163delG&NC_000003.11:g.10183694del&ENST00000256474.2:c.163delG|CA432536363|428800|7.5|evidence|1830|https://civicdb.org/links/evidence/1830|8956040 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=E55RfsTer11 (c.163delG)
3	10183694	1736	G	T	.	.	CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.163G>T||E55* (c.163G>T)|1736|GLU55TER|https://civicdb.org/links/variants/1736|VHL E55* (c.163G>T)|1612|GLU55TER|https://civicdb.org/links/molecular-profiles/1612|ENST00000256474.2:c.163G>T&NC_000003.11:g.10183694G>T&NC_000003.12:g.10142010G>T&NM_000551.4:c.163G>T&NP_000542.1:p.Glu55Ter|CA351748495|NONE FOUND|7.5|evidence|4898|https://civicdb.org/links/evidence/4898|23298237 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=E55* (c.163G>T)
3	10183695	771	A	AG	.	.	VT=A56FS (c.164_165insG);GN=VHL;CSQ=G|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||A56FS (c.164_165insG)|771|164INSG&C.164_165INSG&377_378INSG|https://civicdb.org/links/variants/771|VHL A56FS (c.164_165insG)|752|164INSG&C.164_165INSG&377_378INSG|https://civicdb.org/links/molecular-profiles/752|NP_000542.1:p.Ala56fs&NP_000542.1:p.Ala56GlyfsTer74&NM_000551.2:c.164_165insG&NC_000003.11:g.10183695_10183696insG&NC_000003.11:g.10183697dupG|CA645524645|NONE FOUND|7.5|evidence|1835|https://civicdb.org/links/evidence/1835|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183695	793	A	AA	.	.	VT=A56fs (c.164_165insA);GN=VHL;CSQ=A|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||A56fs (c.164_165insA)|793|165INSA&C.164_165INSA|https://civicdb.org/links/variants/793|VHL A56fs (c.164_165insA)|771|165INSA&C.164_165INSA|https://civicdb.org/links/molecular-profiles/771|NP_000542.1:p.Ala56fs&NP_000542.1:p.Ala56GlyfsTer74&NM_000551.2:c.164_165insA&NC_000003.11:g.10183695_10183696insA&NC_000003.11:g.10183695dupA&NC_000003.12:g.10142011dup|CA658795187|NONE FOUND|5.0|evidence|1857|https://civicdb.org/links/evidence/1857|7987306 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183696	2144	G	GG	.	.	CSQ=G|Plus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|||A56fs (c.166dup)|2144|C.165DUP&C.165_166DUPG&A56GFS*76 (C.166DUP)|https://civicdb.org/links/variants/2144|VHL A56fs (c.166dup)|2020|C.165DUP&C.165_166DUPG&A56GFS*76 (C.166DUP)|https://civicdb.org/links/molecular-profiles/2020|NP_000542.1:p.Ala56fs&NC_000003.11:g.10183697dup&NC_000003.12:g.10142013dup&NM_000551.3:c.166dup|CA645524645|NONE FOUND|7.5|evidence|5742|https://civicdb.org/links/evidence/5742|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=A56fs (c.166dup)
3	10183696	794	G	A	.	.	VT=E55E (c.165G>A);GN=VHL;CSQ=A|Synonymous Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.165G>A||E55E (c.165G>A)|794|GLU55GLU&C.165G>A&RS1553619391&GLU55=&E55E (C.165G>A)|https://civicdb.org/links/variants/794|VHL E55E (c.165G>A)|772|GLU55GLU&C.165G>A&RS1553619391&GLU55=&E55E (C.165G>A)|https://civicdb.org/links/molecular-profiles/772|NM_000551.2:c.165G>A&NC_000003.11:g.10183696G>A&ENST00000256474.2:c.165G>A&NP_000542.1:p.Glu55=|CA432536364|486721|5.0|evidence|1858|https://civicdb.org/links/evidence/1858|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183697	1785	G	GA	.	.	CSQ=A|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.166_167insA||A56fs (c.166_167insA)|1785|L15409.1:380INSA&380INSA|https://civicdb.org/links/variants/1785|VHL A56fs (c.166_167insA)|1661|L15409.1:380INSA&380INSA|https://civicdb.org/links/molecular-profiles/1661|NC_000003.11:g.10183697_10183698insA&NC_000003.12:g.10142013_10142014insA&NM_000551.3:c.166_167insA&NP_000542.1:p.Ala56AspfsTer?&ENST00000256474.2:c.166_167insA|CA432536366|NONE FOUND|5.0|evidence|4956|https://civicdb.org/links/evidence/4956|7987306 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=A56fs (c.166_167insA);GN=VHL
3	10183704	851	G	GC	.	.	GN=VHL;VT=P59fs (c.173_174insC);CSQ=C|Frameshift Truncation&Plus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.173_174insC||P59fs (c.173_174insC)|851|PRO59FS&C.173_174INSC|https://civicdb.org/links/variants/851|VHL P59fs (c.173_174insC)|825|PRO59FS&C.173_174INSC|https://civicdb.org/links/molecular-profiles/825|ENST00000256474.2:c.173_174insC&NP_000542.1:p.Pro59AlafsTer73&NM_000551.3:c.173_174insC&NC_000003.11:g.10183704_10183705insC|CA658795188|NONE FOUND|7.5|evidence|1950|https://civicdb.org/links/evidence/1950|19270817 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183706	1929	CC	C	.	.	GN=VHL;CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.176delC||P59fs (c.176delC)|1929|PRO59FS&C.176DELC&P59RFS*8 (C.176DELC)|https://civicdb.org/links/variants/1929|VHL P59fs (c.176delC)|1805|PRO59FS&C.176DELC&P59RFS*8 (C.176DELC)|https://civicdb.org/links/molecular-profiles/1805|ENST00000256474.2:c.176delC&NC_000003.11:g.10183707del&NM_000551.3:c.176del&NP_000542.1:p.Pro59ArgfsTer8|CA432536374|NONE FOUND|10.0|evidence|5155|https://civicdb.org/links/evidence/5155|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;VT=P59fs (c.176delC)
3	10183709	1964	CG	C	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.179delG||R60FS (c.179delG)|1964|C.179DELG&ARG60FS|https://civicdb.org/links/variants/1964|VHL R60FS (c.179delG)|1840|C.179DELG&ARG60FS|https://civicdb.org/links/molecular-profiles/1840|ENST00000256474.2:c.179delG|CA020069|NONE FOUND|7.5|evidence|5290|https://civicdb.org/links/evidence/5290|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=R60FS (c.179delG)
3	10183712	2145	CCCGT	C	.	.	CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.182_185delCCGT||P61FS (c.182_185delCCGT)|2145|C.182_185DELCCGT&PRO61FS|https://civicdb.org/links/variants/2145|VHL P61FS (c.182_185delCCGT)|2021|C.182_185DELCCGT&PRO61FS|https://civicdb.org/links/molecular-profiles/2021|ENST00000256474.2:c.182_185delCCGT&NC_000003.11:g.10183713_10183716del&NM_000551.3:c.182_185delCCGT&NP_000542.1:p.Pro61ArgfsTer5|CA658820712|NONE FOUND|10.0|evidence|5743|https://civicdb.org/links/evidence/5743|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=P61FS (c.182_185delCCGT)
3	10183722	1867	G	C	.	.	GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.191G>C||R64P (c.191G>C)|1867|C.191G>C&ARG64PRO&RS104893826|https://civicdb.org/links/variants/1867|VHL R64P (c.191G>C)|1743|C.191G>C&ARG64PRO&RS104893826|https://civicdb.org/links/molecular-profiles/1743|NM_000551.3:c.191G>C&NP_000542.1:p.Arg64Pro&NC_000003.11:g.10183722G>C&ENST00000256474.2:c.191G>C|CA020089|2226|7.5|evidence|5094|https://civicdb.org/links/evidence/5094|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=R64P (c.191G>C)
3	10183724	2011	T	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.193T>G||S65A (c.193T>G)|2011|C.193T>G&SER65ALA&RS869025616|https://civicdb.org/links/variants/2011|VHL S65A (c.193T>G)|1887|C.193T>G&SER65ALA&RS869025616|https://civicdb.org/links/molecular-profiles/1887|NM_000551.3:c.193T>G&NP_000542.1:p.Ser65Ala&NC_000003.11:g.10183724T>G&ENST00000256474.2:c.193T>G|CA357048|223160|7.5|evidence|5413|https://civicdb.org/links/evidence/5413|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=S65A (c.193T>G)
3	10183724	2130	TC	T	.	.	VT=S65FS (c.194delC);GN=VHL;CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194delC||S65FS (c.194delC)|2130|C.194DELC&SER65FS|https://civicdb.org/links/variants/2130|VHL S65FS (c.194delC)|2006|C.194DELC&SER65FS|https://civicdb.org/links/molecular-profiles/2006|ENST00000256474.2:c.194delC&NC_000003.11:g.10183725delC&NM_000551.3:c.194delC&NP_000542.1:p.Ser65TrpfsTer2|CA432536395|NONE FOUND|7.5|evidence|5727|https://civicdb.org/links/evidence/5727|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||
3	10183724	1903	T	C	.	.	VT=S65P (c.193T>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.193T>C||S65P (c.193T>C)|1903|C.193T>C&SER65PRO&RS869025616|https://civicdb.org/links/variants/1903|VHL S65P (c.193T>C)|1779|C.193T>C&SER65PRO&RS869025616|https://civicdb.org/links/molecular-profiles/1779|ENST00000256474.2:c.193T>C&NC_000003.11:g.10183724T>C&NM_000551.3:c.193T>C&NP_000542.1:p.Ser65Pro|CA351748798|547829|10.0|evidence|5160|https://civicdb.org/links/evidence/5160|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL
3	10183725	1811	C	A	.	.	GN=VHL;CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>A||S65* (c.194C>A)|1811|C.194C>A&S65X&SER65TER&RS5030826|https://civicdb.org/links/variants/1811|VHL S65* (c.194C>A)|1687|C.194C>A&S65X&SER65TER&RS5030826|https://civicdb.org/links/molecular-profiles/1687|NM_000551.3:c.194C>A&NP_000542.1:p.Ser65Ter&NC_000003.11:g.10183725C>A&ENST00000256474.2:c.194C>A|CA357085|223161|15.0|evidence|5033|https://civicdb.org/links/evidence/5033|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>A||S65* (c.194C>A)|1811|C.194C>A&S65X&SER65TER&RS5030826|https://civicdb.org/links/variants/1811|VHL S65* (c.194C>A)|1687|C.194C>A&S65X&SER65TER&RS5030826|https://civicdb.org/links/molecular-profiles/1687|NM_000551.3:c.194C>A&NP_000542.1:p.Ser65Ter&NC_000003.11:g.10183725C>A&ENST00000256474.2:c.194C>A|CA357085|223161|15.0|evidence|5422|https://civicdb.org/links/evidence/5422|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=S65* (c.194C>A)
3	10183725	1788	C	T	.	.	GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|4959|https://civicdb.org/links/evidence/4959|7987306 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|5104|https://civicdb.org/links/evidence/5104|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|5582|https://civicdb.org/links/evidence/5582|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|6710|https://civicdb.org/links/evidence/6710|26308528 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|6791|https://civicdb.org/links/evidence/6791|28388566 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|5159|https://civicdb.org/links/evidence/5159|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|5287|https://civicdb.org/links/evidence/5287|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|5499|https://civicdb.org/links/evidence/5499|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|6644|https://civicdb.org/links/evidence/6644|28379443 (PUBMED)|UNKNOWN|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|6662|https://civicdb.org/links/evidence/6662|25834951 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|6728|https://civicdb.org/links/evidence/6728|23797736 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|6131|https://civicdb.org/links/evidence/6131|11505222 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>T||S65L (c.194C>T)|1788|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/variants/1788|VHL S65L (c.194C>T)|1664|C.194C>T&SER65LEU&RS5030826|https://civicdb.org/links/molecular-profiles/1664|NM_000551.3:c.194C>T&NP_000542.1:p.Ser65Leu&NC_000003.11:g.10183725C>T&ENST00000256474.2:c.194C>T|CA020104|182975|72.5|evidence|6890|https://civicdb.org/links/evidence/6890|7915601 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Renal Carcinoma||||C|1|||||;VT=S65L (c.194C>T)
3	10183725	1787	C	G	.	.	VT=S65W (c.194C>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|4917|https://civicdb.org/links/evidence/4917|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|4958|https://civicdb.org/links/evidence/4958|7987306 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|4998|https://civicdb.org/links/evidence/4998|8730290 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5026|https://civicdb.org/links/evidence/5026|17661816 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5034|https://civicdb.org/links/evidence/5034|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5161|https://civicdb.org/links/evidence/5161|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5328|https://civicdb.org/links/evidence/5328|20518900 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5693|https://civicdb.org/links/evidence/5693|23384228 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5765|https://civicdb.org/links/evidence/5765|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|6352|https://civicdb.org/links/evidence/6352|28650583 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|6468|https://civicdb.org/links/evidence/6468|26622630 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|6661|https://civicdb.org/links/evidence/6661|25834951 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|6789|https://civicdb.org/links/evidence/6789|28388566 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5212|https://civicdb.org/links/evidence/5212|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.194C>G||S65W (c.194C>G)|1787|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/variants/1787|VHL S65W (c.194C>G)|1663|C.194C>G&SER65TRP&RS5030826|https://civicdb.org/links/molecular-profiles/1663|ENST00000256474.2:c.194C>G&NM_000551.3:c.194C>G&NP_000542.1:p.Ser65Trp&NC_000003.11:g.10183725C>G|CA020099|43597|105.0|evidence|5592|https://civicdb.org/links/evidence/5592|22156657 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183727	2099	GTGAACTCGCGCGAGC	G	.	.	GN=VHL;CSQ=-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|||V66del (c.197_220del)|2099|197DEL24|https://civicdb.org/links/variants/2099|VHL V66del (c.197_220del)|1975|197DEL24|https://civicdb.org/links/molecular-profiles/1975||unregistered||5.0|evidence|5653|https://civicdb.org/links/evidence/5653|9829912 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=V66del (c.197_220del)
3	10183733	1873	T	C	.	.	VT=S68P (c.202T>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.202T>C||S68P (c.202T>C)|1873|C.202T>C&SER68PRO|https://civicdb.org/links/variants/1873|VHL S68P (c.202T>C)|1749|C.202T>C&SER68PRO|https://civicdb.org/links/molecular-profiles/1749|ENST00000256474.2:c.202T>C&NC_000003.11:g.10183733T>C&NM_000551.3:c.202T>C&NP_000542.1:p.Ser68Pro|CA16621912|NONE FOUND|7.5|evidence|5105|https://civicdb.org/links/evidence/5105|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183734	2012	C	G	.	.	GN=VHL;VT=S68W (c.203C>G);CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|||S68W (c.203C>G)|2012||https://civicdb.org/links/variants/2012|VHL S68W (c.203C>G)|1888||https://civicdb.org/links/molecular-profiles/1888|NP_000542.1:p.Ser68Trp&NC_000003.11:g.10183734C>G&NC_000003.12:g.10142050C>G&NM_000551.3:c.203C>G|CA351748895|NONE FOUND|7.5|evidence|5414|https://civicdb.org/links/evidence/5414|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183739	1834	G	T	.	.	GN=VHL;VT=E70* (c.208G>T);CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70* (c.208G>T)|1834|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/variants/1834|VHL E70* (c.208G>T)|1710|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/molecular-profiles/1710|NM_000551.3:c.208G>T&NP_000542.1:p.Glu70Ter&NC_000003.11:g.10183739G>T&ENST00000256474.2:c.208G>T|CA16602179|428806|27.5|evidence|6059|https://civicdb.org/links/evidence/6059|7728151 (PUBMED)|NA|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70* (c.208G>T)|1834|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/variants/1834|VHL E70* (c.208G>T)|1710|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/molecular-profiles/1710|NM_000551.3:c.208G>T&NP_000542.1:p.Glu70Ter&NC_000003.11:g.10183739G>T&ENST00000256474.2:c.208G>T|CA16602179|428806|27.5|evidence|5035|https://civicdb.org/links/evidence/5035|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70* (c.208G>T)|1834|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/variants/1834|VHL E70* (c.208G>T)|1710|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/molecular-profiles/1710|NM_000551.3:c.208G>T&NP_000542.1:p.Glu70Ter&NC_000003.11:g.10183739G>T&ENST00000256474.2:c.208G>T|CA16602179|428806|27.5|evidence|5361|https://civicdb.org/links/evidence/5361|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>T||E70* (c.208G>T)|1834|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/variants/1834|VHL E70* (c.208G>T)|1710|C.208G>T&E70X&GLU70TER&RS5030802|https://civicdb.org/links/molecular-profiles/1710|NM_000551.3:c.208G>T&NP_000542.1:p.Glu70Ter&NC_000003.11:g.10183739G>T&ENST00000256474.2:c.208G>T|CA16602179|428806|27.5|evidence|5445|https://civicdb.org/links/evidence/5445|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183739	1956	G	A	.	.	VT=E70K (c.208G>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K (c.208G>A)|1956|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/variants/1956|VHL E70K (c.208G>A)|1832|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/molecular-profiles/1832|NM_000551.3:c.208G>A&NP_000542.1:p.Glu70Lys&NC_000003.11:g.10183739G>A&ENST00000256474.2:c.208G>A|CA020108|43598|37.5|evidence|5805|https://civicdb.org/links/evidence/5805|25715769 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K (c.208G>A)|1956|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/variants/1956|VHL E70K (c.208G>A)|1832|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/molecular-profiles/1832|NM_000551.3:c.208G>A&NP_000542.1:p.Glu70Lys&NC_000003.11:g.10183739G>A&ENST00000256474.2:c.208G>A|CA020108|43598|37.5|evidence|6742|https://civicdb.org/links/evidence/6742|27439424 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K (c.208G>A)|1956|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/variants/1956|VHL E70K (c.208G>A)|1832|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/molecular-profiles/1832|NM_000551.3:c.208G>A&NP_000542.1:p.Glu70Lys&NC_000003.11:g.10183739G>A&ENST00000256474.2:c.208G>A|CA020108|43598|37.5|evidence|6860|https://civicdb.org/links/evidence/6860|25078357 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K (c.208G>A)|1956|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/variants/1956|VHL E70K (c.208G>A)|1832|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/molecular-profiles/1832|NM_000551.3:c.208G>A&NP_000542.1:p.Glu70Lys&NC_000003.11:g.10183739G>A&ENST00000256474.2:c.208G>A|CA020108|43598|37.5|evidence|5273|https://civicdb.org/links/evidence/5273|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K (c.208G>A)|1956|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/variants/1956|VHL E70K (c.208G>A)|1832|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/molecular-profiles/1832|NM_000551.3:c.208G>A&NP_000542.1:p.Glu70Lys&NC_000003.11:g.10183739G>A&ENST00000256474.2:c.208G>A|CA020108|43598|37.5|evidence|5780|https://civicdb.org/links/evidence/5780|25562111 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K (c.208G>A)|1956|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/variants/1956|VHL E70K (c.208G>A)|1832|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/molecular-profiles/1832|NM_000551.3:c.208G>A&NP_000542.1:p.Glu70Lys&NC_000003.11:g.10183739G>A&ENST00000256474.2:c.208G>A|CA020108|43598|37.5|evidence|6503|https://civicdb.org/links/evidence/6503|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.208G>A||E70K (c.208G>A)|1956|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/variants/1956|VHL E70K (c.208G>A)|1832|C.208G>A&GLU70LYS&RS5030802|https://civicdb.org/links/molecular-profiles/1832|NM_000551.3:c.208G>A&NP_000542.1:p.Glu70Lys&NC_000003.11:g.10183739G>A&ENST00000256474.2:c.208G>A|CA020108|43598|37.5|assertion|14|https://civicdb.org/links/assertion/14||RARE_GERMLINE|accepted|LIKELY_PATHOGENIC|SUPPORTS|Von Hippel-Lindau Disease (DOID 14175)||||||PM1&PM2&PP1&PP4||||
3	10183744	1816	CT	C	.	.	GN=VHL;CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.214delT||S72fs (c.214del)|1816|C.214DELT&SER72FS&S72FS (C.214DELT)|https://civicdb.org/links/variants/1816|VHL S72fs (c.214del)|1692|C.214DELT&SER72FS&S72FS (C.214DELT)|https://civicdb.org/links/molecular-profiles/1692|ENST00000256474.2:c.214delT&NC_000003.12:g.10142061del&NM_000551.4:c.214del&NP_000542.1:p.Ser72ProfsTer?&NC_000003.11:g.10183745del|CA658795180|NONE FOUND|10.0|evidence|5163|https://civicdb.org/links/evidence/5163|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|4|||||;VT=S72fs (c.214del)
3	10183745	1904	T	C	.	.	VT=S72P (c.214T>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.214T>C||S72P (c.214T>C)|1904|C.214T>C&SER72PRO&RS869025618|https://civicdb.org/links/variants/1904|VHL S72P (c.214T>C)|1780|C.214T>C&SER72PRO&RS869025618|https://civicdb.org/links/molecular-profiles/1780|NM_000551.3:c.214T>C&NP_000542.1:p.Ser72Pro&NC_000003.11:g.10183745T>C&ENST00000256474.2:c.214T>C|CA357006|223163|10.0|evidence|5162|https://civicdb.org/links/evidence/5162|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL
3	10183747	2041	CC	C	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.217delC||Q73FS (c.217delC)|2041|C.217DELC&GLN73FS|https://civicdb.org/links/variants/2041|VHL Q73FS (c.217delC)|1917|C.217DELC&GLN73FS|https://civicdb.org/links/molecular-profiles/1917|ENST00000256474.2:c.217delC&NC_000003.11:g.10183748del&NM_000551.3:c.217del&NP_000542.1:p.Gln73ArgfsTer?|CA432536422|NONE FOUND|5.0|evidence|5500|https://civicdb.org/links/evidence/5500|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=Q73FS (c.217delC)
3	10183748	1752	C	T	.	.	VT=Q73* (c.217C>T);GN=VHL;CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.217C>T||Q73* (c.217C>T)|1752|Q73X&C.217C>T&GLN73TER&RS869025619|https://civicdb.org/links/variants/1752|VHL Q73* (c.217C>T)|1628|Q73X&C.217C>T&GLN73TER&RS869025619|https://civicdb.org/links/molecular-profiles/1628|NM_000551.3:c.217C>T&NP_000542.1:p.Gln73Ter&NC_000003.11:g.10183748C>T&ENST00000256474.2:c.217C>T|CA357036|223164|27.5|evidence|4918|https://civicdb.org/links/evidence/4918|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.217C>T||Q73* (c.217C>T)|1752|Q73X&C.217C>T&GLN73TER&RS869025619|https://civicdb.org/links/variants/1752|VHL Q73* (c.217C>T)|1628|Q73X&C.217C>T&GLN73TER&RS869025619|https://civicdb.org/links/molecular-profiles/1628|NM_000551.3:c.217C>T&NP_000542.1:p.Gln73Ter&NC_000003.11:g.10183748C>T&ENST00000256474.2:c.217C>T|CA357036|223164|27.5|evidence|5135|https://civicdb.org/links/evidence/5135|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.217C>T||Q73* (c.217C>T)|1752|Q73X&C.217C>T&GLN73TER&RS869025619|https://civicdb.org/links/variants/1752|VHL Q73* (c.217C>T)|1628|Q73X&C.217C>T&GLN73TER&RS869025619|https://civicdb.org/links/molecular-profiles/1628|NM_000551.3:c.217C>T&NP_000542.1:p.Gln73Ter&NC_000003.11:g.10183748C>T&ENST00000256474.2:c.217C>T|CA357036|223164|27.5|evidence|5270|https://civicdb.org/links/evidence/5270|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183752	1999	T	G	.	.	VT=V74G (c.221T>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.221T>G||V74G (c.221T>G)|1999|C.221T>G&VAL74GLY&RS5030803|https://civicdb.org/links/variants/1999|VHL V74G (c.221T>G)|1875|C.221T>G&VAL74GLY&RS5030803|https://civicdb.org/links/molecular-profiles/1875|ENST00000256474.2:c.221T>G&NM_000551.3:c.221T>G&NP_000542.1:p.Val74Gly&NC_000003.11:g.10183752T>G|CA70042528|NONE FOUND|15.0|evidence|5374|https://civicdb.org/links/evidence/5374|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.221T>G||V74G (c.221T>G)|1999|C.221T>G&VAL74GLY&RS5030803|https://civicdb.org/links/variants/1999|VHL V74G (c.221T>G)|1875|C.221T>G&VAL74GLY&RS5030803|https://civicdb.org/links/molecular-profiles/1875|ENST00000256474.2:c.221T>G&NM_000551.3:c.221T>G&NP_000542.1:p.Val74Gly&NC_000003.11:g.10183752T>G|CA70042528|NONE FOUND|15.0|evidence|5424|https://civicdb.org/links/evidence/5424|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.221T>G||V74G (c.221T>G)|1999|C.221T>G&VAL74GLY&RS5030803|https://civicdb.org/links/variants/1999|VHL V74G (c.221T>G)|1875|C.221T>G&VAL74GLY&RS5030803|https://civicdb.org/links/molecular-profiles/1875|ENST00000256474.2:c.221T>G&NM_000551.3:c.221T>G&NP_000542.1:p.Val74Gly&NC_000003.11:g.10183752T>G|CA70042528|NONE FOUND|15.0|evidence|5446|https://civicdb.org/links/evidence/5446|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183754	2088	ATCT	A	.	.	VT=F76del (c.227_229del);CSQ=-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|4919|https://civicdb.org/links/evidence/4919|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5682|https://civicdb.org/links/evidence/5682|23143947 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5386|https://civicdb.org/links/evidence/5386|10761708 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5641|https://civicdb.org/links/evidence/5641|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5650|https://civicdb.org/links/evidence/5650|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5744|https://civicdb.org/links/evidence/5744|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5749|https://civicdb.org/links/evidence/5749|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5750|https://civicdb.org/links/evidence/5750|20151405 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5766|https://civicdb.org/links/evidence/5766|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|6121|https://civicdb.org/links/evidence/6121|17661816 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|6862|https://civicdb.org/links/evidence/6862|25078357 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|8969|https://civicdb.org/links/evidence/8969|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5203|https://civicdb.org/links/evidence/5203|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5340|https://civicdb.org/links/evidence/5340|8641976 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5426|https://civicdb.org/links/evidence/5426|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5447|https://civicdb.org/links/evidence/5447|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|5654|https://civicdb.org/links/evidence/5654|9829912 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|6547|https://civicdb.org/links/evidence/6547|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|8651|https://civicdb.org/links/evidence/8651|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|evidence|6557|https://civicdb.org/links/evidence/6557|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.224_226delTCT||F76del (c.227_229del)|2088|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/variants/2088|VHL F76del (c.227_229del)|1964|PHE76DEL&C.224_226DELTCT&C.226_228DELTTC&C.227_229DELTCT&DELPHE76&F76DEL (C.227_229DELTCT)|https://civicdb.org/links/molecular-profiles/1964|ENST00000256474.2:c.224_226delTCT&NP_000542.1:p.Phe76del&NC_000003.11:g.10183758_10183760del&NC_000003.12:g.10142074_10142076del&NM_000551.3:c.227_229del&ENSP00000256474.2:p.Phe76del|CA357012|223166|120.0|assertion|17|https://civicdb.org/links/assertion/17||RARE_GERMLINE|accepted|PATHOGENIC|SUPPORTS|Von Hippel-Lindau Disease (DOID 14175)||||||PS2&PM2&PM4&PP1||||;GN=VHL
3	10183754	1912	A	AT	.	.	CSQ=T|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||F76fs (c.223_224insT)|1912|ILE75FS&C.224DUPT&C.223_224INST|https://civicdb.org/links/variants/1912|VHL F76fs (c.223_224insT)|1788|ILE75FS&C.224DUPT&C.223_224INST|https://civicdb.org/links/molecular-profiles/1788|NC_000003.11:g.10183755dupT&NM_000551.3:c.224dupT&NP_000542.1:p.F76Lfs*56&NC_000003.12:g.10142071dupT&NP_937799.1:p.Phe76LeufsTer?&NP_001341652.1:p.Phe76LeufsTer?|CA913189239||7.5|evidence|5174|https://civicdb.org/links/evidence/5174|19270817 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=F76fs (c.223_224insT)
3	10183758	2132	T	TC	.	.	VT=C77fs (c.228dup);CSQ=C||VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.228dup||C77fs (c.228dup)|2132|440_441INSC&C.227_228INSC&F76FS&C.227INSC|https://civicdb.org/links/variants/2132|VHL C77fs (c.228dup)|2008|440_441INSC&C.227_228INSC&F76FS&C.227INSC|https://civicdb.org/links/molecular-profiles/2008|NC_000003.11:g.10183759dup&NC_000003.12:g.10142075dup&NM_000551.3:c.228dup&ENST00000256474.2:c.228dup&NP_000542.1:p.Cys77LeufsTer?&ENSP00000256474.2:p.Cys77LeufsTer?|CA658795177|NONE FOUND|17.5|evidence|5729|https://civicdb.org/links/evidence/5729|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|4|||||,C||VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.228dup||C77fs (c.228dup)|2132|440_441INSC&C.227_228INSC&F76FS&C.227INSC|https://civicdb.org/links/variants/2132|VHL C77fs (c.228dup)|2008|440_441INSC&C.227_228INSC&F76FS&C.227INSC|https://civicdb.org/links/molecular-profiles/2008|NC_000003.11:g.10183759dup&NC_000003.12:g.10142075dup&NM_000551.3:c.228dup&ENST00000256474.2:c.228dup&NP_000542.1:p.Cys77LeufsTer?&ENSP00000256474.2:p.Cys77LeufsTer?|CA658795177|NONE FOUND|17.5|evidence|4961|https://civicdb.org/links/evidence/4961|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10183758	1835	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.227T>C||F76S (c.227T>C)|1835|PHE76SER&C.277T>C&RS730882033|https://civicdb.org/links/variants/1835|VHL F76S (c.227T>C)|1711|PHE76SER&C.277T>C&RS730882033|https://civicdb.org/links/molecular-profiles/1711|ENST00000256474.2:c.227T>C&NC_000003.11:g.10183758T>C&NM_000551.3:c.227T>C&NP_000542.1:p.Phe76Ser|CA020125|182976|7.5|evidence|5037|https://civicdb.org/links/evidence/5037|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=F76S (c.227T>C)
3	10183761	3096	G	GTCT	.	.	VT=C77_N78insL (c.230_231insTCT);GN=VHL;CSQ=TCT|Disruptive Inframe Insertion|VHL|7428|transcript|ENST00000256474.2|||C77_N78insL (c.230_231insTCT)|3096|77INSL|https://civicdb.org/links/variants/3096|VHL C77_N78insL (c.230_231insTCT)|2965|77INSL|https://civicdb.org/links/molecular-profiles/2965|NC_000003.12:g.10142077_10142078insTCT&NC_000003.11:g.10183761_10183762insTCT&NM_000551.3:c.230_231insTCT&NP_000542.1:p.Cys77_Asn78insLeu|CA2499214029|NONE FOUND|12.5|evidence|7894|https://civicdb.org/links/evidence/7894|11850829 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,TCT|Disruptive Inframe Insertion|VHL|7428|transcript|ENST00000256474.2|||C77_N78insL (c.230_231insTCT)|3096|77INSL|https://civicdb.org/links/variants/3096|VHL C77_N78insL (c.230_231insTCT)|2965|77INSL|https://civicdb.org/links/molecular-profiles/2965|NC_000003.12:g.10142077_10142078insTCT&NC_000003.11:g.10183761_10183762insTCT&NM_000551.3:c.230_231insTCT&NP_000542.1:p.Cys77_Asn78insLeu|CA2499214029|NONE FOUND|12.5|evidence|5364|https://civicdb.org/links/evidence/5364|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183763	1754	A	C	.	.	GN=VHL;VT=N78H (c.232A>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.232A>C||N78H (c.232A>C)|1754|C.232A>C&ASN78HIS|https://civicdb.org/links/variants/1754|VHL N78H (c.232A>C)|1630|C.232A>C&ASN78HIS|https://civicdb.org/links/molecular-profiles/1630|ENST00000256474.2:c.232A>C&NC_000003.11:g.10183763A>C&NM_000551.3:c.232A>C&NP_000542.1:p.Asn78His|CA351749283|NONE FOUND|32.5|evidence|5130|https://civicdb.org/links/evidence/5130|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Renal Cell Carcinoma||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.232A>C||N78H (c.232A>C)|1754|C.232A>C&ASN78HIS|https://civicdb.org/links/variants/1754|VHL N78H (c.232A>C)|1630|C.232A>C&ASN78HIS|https://civicdb.org/links/molecular-profiles/1630|ENST00000256474.2:c.232A>C&NC_000003.11:g.10183763A>C&NM_000551.3:c.232A>C&NP_000542.1:p.Asn78His|CA351749283|NONE FOUND|32.5|evidence|4920|https://civicdb.org/links/evidence/4920|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.232A>C||N78H (c.232A>C)|1754|C.232A>C&ASN78HIS|https://civicdb.org/links/variants/1754|VHL N78H (c.232A>C)|1630|C.232A>C&ASN78HIS|https://civicdb.org/links/molecular-profiles/1630|ENST00000256474.2:c.232A>C&NC_000003.11:g.10183763A>C&NM_000551.3:c.232A>C&NP_000542.1:p.Asn78His|CA351749283|NONE FOUND|32.5|evidence|4962|https://civicdb.org/links/evidence/4962|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.232A>C||N78H (c.232A>C)|1754|C.232A>C&ASN78HIS|https://civicdb.org/links/variants/1754|VHL N78H (c.232A>C)|1630|C.232A>C&ASN78HIS|https://civicdb.org/links/molecular-profiles/1630|ENST00000256474.2:c.232A>C&NC_000003.11:g.10183763A>C&NM_000551.3:c.232A>C&NP_000542.1:p.Asn78His|CA351749283|NONE FOUND|32.5|evidence|5341|https://civicdb.org/links/evidence/5341|8641976 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183764	2037	A	T	.	.	GN=VHL;VT=N78I (c.233A>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>T||N78I (c.233A>T)|2037|C.233A>T&ASN78ILE&RS5030804|https://civicdb.org/links/variants/2037|VHL N78I (c.233A>T)|1913|C.233A>T&ASN78ILE&RS5030804|https://civicdb.org/links/molecular-profiles/1913|NM_000551.3:c.233A>T&NP_000542.1:p.Asn78Ile&NC_000003.11:g.10183764A>T&ENST00000256474.2:c.233A>T|CA357063|223169|5.0|evidence|5489|https://civicdb.org/links/evidence/5489|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183764	1755	A	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|5020|https://civicdb.org/links/evidence/5020|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|4921|https://civicdb.org/links/evidence/4921|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|5027|https://civicdb.org/links/evidence/5027|17661816 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|5250|https://civicdb.org/links/evidence/5250|19464396 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|7893|https://civicdb.org/links/evidence/7893|11850829 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|8970|https://civicdb.org/links/evidence/8970|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|9539|https://civicdb.org/links/evidence/9539|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|5376|https://civicdb.org/links/evidence/5376|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|5491|https://civicdb.org/links/evidence/5491|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|6289|https://civicdb.org/links/evidence/6289|26984080 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>G||N78S (c.233A>G)|1755|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/variants/1755|VHL N78S (c.233A>G)|1631|C.233A>G&ASN78SER&RS5030804|https://civicdb.org/links/molecular-profiles/1631|NM_000551.3:c.233A>G&NP_000542.1:p.Asn78Ser&NC_000003.11:g.10183764A>G&ENST00000256474.2:c.233A>G|CA020131|93326|72.5|evidence|6548|https://civicdb.org/links/evidence/6548|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=N78S (c.233A>G)
3	10183764	1756	A	C	.	.	GN=VHL;VT=N78T (c.233A>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.233A>C||N78T (c.233A>C)|1756|C.233A>C&ASN78THR&RS5030804|https://civicdb.org/links/variants/1756|VHL N78T (c.233A>C)|1632|C.233A>C&ASN78THR&RS5030804|https://civicdb.org/links/molecular-profiles/1632|NM_000551.3:c.233A>C&NP_000542.1:p.Asn78Thr&NC_000003.11:g.10183764A>C&ENST00000256474.2:c.233A>C|CA357095|223168|5.0|evidence|4922|https://civicdb.org/links/evidence/4922|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183767	1791	G	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.236G>C||R79P (c.236G>C)|1791|C.236G>C&ARG79PRO|https://civicdb.org/links/variants/1791|VHL R79P (c.236G>C)|1667|C.236G>C&ARG79PRO|https://civicdb.org/links/molecular-profiles/1667|ENST00000256474.2:c.236G>C&NC_000003.11:g.10183767G>C&NM_000551.3:c.236G>C&NP_000542.1:p.Arg79Pro|CA351749311|NONE FOUND|7.5|evidence|4963|https://civicdb.org/links/evidence/4963|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=R79P (c.236G>C)
3	10183769	1963	A	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.238A>C||S80R (c.238A>C)|1963|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/variants/1963|VHL S80R (c.238A>C)|1839|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/molecular-profiles/1839|ENST00000256474.2:c.238A>C&NC_000003.11:g.10183769A>C&NM_000551.3:c.238A>C&NP_000542.1:p.Ser80Arg|CA16621913|496052|32.5|evidence|5510|https://civicdb.org/links/evidence/5510|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.238A>C||S80R (c.238A>C)|1963|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/variants/1963|VHL S80R (c.238A>C)|1839|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/molecular-profiles/1839|ENST00000256474.2:c.238A>C&NC_000003.11:g.10183769A>C&NM_000551.3:c.238A>C&NP_000542.1:p.Ser80Arg|CA16621913|496052|32.5|evidence|5288|https://civicdb.org/links/evidence/5288|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.238A>C||S80R (c.238A>C)|1963|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/variants/1963|VHL S80R (c.238A>C)|1839|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/molecular-profiles/1839|ENST00000256474.2:c.238A>C&NC_000003.11:g.10183769A>C&NM_000551.3:c.238A>C&NP_000542.1:p.Ser80Arg|CA16621913|496052|32.5|evidence|5547|https://civicdb.org/links/evidence/5547|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.238A>C||S80R (c.238A>C)|1963|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/variants/1963|VHL S80R (c.238A>C)|1839|SER80ARG&C.238A>C&RS786202787|https://civicdb.org/links/molecular-profiles/1839|ENST00000256474.2:c.238A>C&NC_000003.11:g.10183769A>C&NM_000551.3:c.238A>C&NP_000542.1:p.Ser80Arg|CA16621913|496052|32.5|evidence|5548|https://civicdb.org/links/evidence/5548|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=S80R (c.238A>C)
3	10183769	2511	AG	A	.	.	CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239del||S80fs (c.239del)|2511|C.239DELG&SER80ILEFS*79&S80IFS*79 (C.239DELG)|https://civicdb.org/links/variants/2511|VHL S80fs (c.239del)|2384|C.239DELG&SER80ILEFS*79&S80IFS*79 (C.239DELG)|https://civicdb.org/links/molecular-profiles/2384|NP_000542.1:p.Ser80IlefsTer&ENST00000256474.2:c.239del&NC_000003.11:g.10183770del&NM_000551.3:c.239del|CA913189245|NONE FOUND|7.5|evidence|8996|https://civicdb.org/links/evidence/8996|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=S80fs (c.239del)
3	10183770	1757	G	T	.	.	GN=VHL;VT=S80I (c.239G>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>T||S80I (c.239G>T)|1757|C.239G>T&SER80ILE&RS5030805|https://civicdb.org/links/variants/1757|VHL S80I (c.239G>T)|1633|C.239G>T&SER80ILE&RS5030805|https://civicdb.org/links/molecular-profiles/1633|ENST00000256474.2:c.239G>T&NM_000551.3:c.239G>T&NP_000542.1:p.Ser80Ile&NC_000003.11:g.10183770G>T|CA16621914|NONE FOUND|15.0|evidence|4923|https://civicdb.org/links/evidence/4923|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>T||S80I (c.239G>T)|1757|C.239G>T&SER80ILE&RS5030805|https://civicdb.org/links/variants/1757|VHL S80I (c.239G>T)|1633|C.239G>T&SER80ILE&RS5030805|https://civicdb.org/links/molecular-profiles/1633|ENST00000256474.2:c.239G>T&NM_000551.3:c.239G>T&NP_000542.1:p.Ser80Ile&NC_000003.11:g.10183770G>T|CA16621914|NONE FOUND|15.0|evidence|5428|https://civicdb.org/links/evidence/5428|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183770	1874	G	A	.	.	VT=S80N (c.239G>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N (c.239G>A)|1874|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/variants/1874|VHL S80N (c.239G>A)|1750|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/molecular-profiles/1750|ENST00000256474.2:c.239G>A&NC_000003.11:g.10183770G>A&NM_000551.3:c.239G>A&NP_000542.1:p.Ser80Asn|CA70046108|NONE FOUND|25.0|evidence|5289|https://civicdb.org/links/evidence/5289|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N (c.239G>A)|1874|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/variants/1874|VHL S80N (c.239G>A)|1750|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/molecular-profiles/1750|ENST00000256474.2:c.239G>A&NC_000003.11:g.10183770G>A&NM_000551.3:c.239G>A&NP_000542.1:p.Ser80Asn|CA70046108|NONE FOUND|25.0|evidence|5415|https://civicdb.org/links/evidence/5415|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N (c.239G>A)|1874|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/variants/1874|VHL S80N (c.239G>A)|1750|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/molecular-profiles/1750|ENST00000256474.2:c.239G>A&NC_000003.11:g.10183770G>A&NM_000551.3:c.239G>A&NP_000542.1:p.Ser80Asn|CA70046108|NONE FOUND|25.0|evidence|5371|https://civicdb.org/links/evidence/5371|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Renal Cell Carcinoma||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.239G>A||S80N (c.239G>A)|1874|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/variants/1874|VHL S80N (c.239G>A)|1750|C.239G>A&SER80ASN&RS5030805|https://civicdb.org/links/molecular-profiles/1750|ENST00000256474.2:c.239G>A&NC_000003.11:g.10183770G>A&NM_000551.3:c.239G>A&NP_000542.1:p.Ser80Asn|CA70046108|NONE FOUND|25.0|evidence|5427|https://civicdb.org/links/evidence/5427|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183771	1792	T	G	.	.	VT=S80R (c.240T>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.240T>G||S80R (c.240T>G)|1792|C.240T>G&SER80ARG|https://civicdb.org/links/variants/1792|VHL S80R (c.240T>G)|1668|C.240T>G&SER80ARG|https://civicdb.org/links/molecular-profiles/1668|ENST00000256474.2:c.240T>G|CA351750515|NONE FOUND|12.5|evidence|4964|https://civicdb.org/links/evidence/4964|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.240T>G||S80R (c.240T>G)|1792|C.240T>G&SER80ARG|https://civicdb.org/links/variants/1792|VHL S80R (c.240T>G)|1668|C.240T>G&SER80ARG|https://civicdb.org/links/molecular-profiles/1668|ENST00000256474.2:c.240T>G|CA351750515|NONE FOUND|12.5|evidence|5448|https://civicdb.org/links/evidence/5448|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183772	1837	C	T	.	.	GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.241C>T||P81S (c.241C>T)|1837|C.241C>T&PRO81SER&RS104893829|https://civicdb.org/links/variants/1837|VHL P81S (c.241C>T)|1713|C.241C>T&PRO81SER&RS104893829|https://civicdb.org/links/molecular-profiles/1713|NM_000551.3:c.241C>T&NP_000542.1:p.Pro81Ser&NC_000003.11:g.10183772C>T&ENST00000256474.2:c.241C>T|CA020148|2233|20.0|evidence|6505|https://civicdb.org/links/evidence/6505|24132471 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.241C>T||P81S (c.241C>T)|1837|C.241C>T&PRO81SER&RS104893829|https://civicdb.org/links/variants/1837|VHL P81S (c.241C>T)|1713|C.241C>T&PRO81SER&RS104893829|https://civicdb.org/links/molecular-profiles/1713|NM_000551.3:c.241C>T&NP_000542.1:p.Pro81Ser&NC_000003.11:g.10183772C>T&ENST00000256474.2:c.241C>T|CA020148|2233|20.0|evidence|8971|https://civicdb.org/links/evidence/8971|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.241C>T||P81S (c.241C>T)|1837|C.241C>T&PRO81SER&RS104893829|https://civicdb.org/links/variants/1837|VHL P81S (c.241C>T)|1713|C.241C>T&PRO81SER&RS104893829|https://civicdb.org/links/molecular-profiles/1713|NM_000551.3:c.241C>T&NP_000542.1:p.Pro81Ser&NC_000003.11:g.10183772C>T&ENST00000256474.2:c.241C>T|CA020148|2233|20.0|evidence|5369|https://civicdb.org/links/evidence/5369|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=P81S (c.241C>T)
3	10183773	2089	CGCGCGTCGT	C	.	.	VT=R82_V84del (c.243_251del);GN=VHL;CSQ=-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|||R82_V84del (c.243_251del)|2089|P81DELRVV (C.243_251DELGCGCGTCGT)&ARG82_VAL84DEL|https://civicdb.org/links/variants/2089|VHL R82_V84del (c.243_251del)|1965|P81DELRVV (C.243_251DELGCGCGTCGT)&ARG82_VAL84DEL|https://civicdb.org/links/molecular-profiles/1965|NC_000003.11:g.10183774_10183782del&NC_000003.12:g.10142092_10142100del&NM_000551.4:c.245_253del&NP_000542.1:p.Arg82_Val84del|CA658820713|NONE FOUND|17.5|evidence|5726|https://civicdb.org/links/evidence/5726|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|||R82_V84del (c.243_251del)|2089|P81DELRVV (C.243_251DELGCGCGTCGT)&ARG82_VAL84DEL|https://civicdb.org/links/variants/2089|VHL R82_V84del (c.243_251del)|1965|P81DELRVV (C.243_251DELGCGCGTCGT)&ARG82_VAL84DEL|https://civicdb.org/links/molecular-profiles/1965|NC_000003.11:g.10183774_10183782del&NC_000003.12:g.10142092_10142100del&NM_000551.4:c.245_253del&NP_000542.1:p.Arg82_Val84del|CA658820713|NONE FOUND|17.5|evidence|5637|https://civicdb.org/links/evidence/5637|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183774	2264	GCGCGTCGTG	G	.	.	VT=R82_V84del (c.244_252del);GN=VHL;CSQ=-|Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|||R82_V84del (c.244_252del)|2264|C.244_252DEL&C.245_253DEL|https://civicdb.org/links/variants/2264|VHL R82_V84del (c.244_252del)|2140|C.244_252DEL&C.245_253DEL|https://civicdb.org/links/molecular-profiles/2140||CA658820713|NONE FOUND|10.0|evidence|6060|https://civicdb.org/links/evidence/6060|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183776	1980	G	C	.	.	VT=R82P (c.245G>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.245G>C||R82P (c.245G>C)|1980|C.245G>C&ARG82PRO&RS794726890|https://civicdb.org/links/variants/1980|VHL R82P (c.245G>C)|1856|C.245G>C&ARG82PRO&RS794726890|https://civicdb.org/links/molecular-profiles/1856|NM_000551.3:c.245G>C&NP_000542.1:p.Arg82Pro&NC_000003.11:g.10183776G>C&ENST00000256474.2:c.245G>C|CA020159|193118|17.5|evidence|5511|https://civicdb.org/links/evidence/5511|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.245G>C||R82P (c.245G>C)|1980|C.245G>C&ARG82PRO&RS794726890|https://civicdb.org/links/variants/1980|VHL R82P (c.245G>C)|1856|C.245G>C&ARG82PRO&RS794726890|https://civicdb.org/links/molecular-profiles/1856|NM_000551.3:c.245G>C&NP_000542.1:p.Arg82Pro&NC_000003.11:g.10183776G>C&ENST00000256474.2:c.245G>C|CA020159|193118|17.5|evidence|5864|https://civicdb.org/links/evidence/5864|9829912 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10183781	1815	G	T	.	.	GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.250G>T||V84L (c.250G>T)|1815|C.250G>T&VAL84LEU&RS5030827|https://civicdb.org/links/variants/1815|VHL V84L (c.250G>T)|1691|C.250G>T&VAL84LEU&RS5030827|https://civicdb.org/links/molecular-profiles/1691|NM_000551.3:c.250G>T&NP_000542.1:p.Val84Leu&NC_000003.11:g.10183781G>T&ENST00000256474.2:c.250G>T|CA020170|2236|10.0|evidence|5430|https://civicdb.org/links/evidence/5430|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.250G>T||V84L (c.250G>T)|1815|C.250G>T&VAL84LEU&RS5030827|https://civicdb.org/links/variants/1815|VHL V84L (c.250G>T)|1691|C.250G>T&VAL84LEU&RS5030827|https://civicdb.org/links/molecular-profiles/1691|NM_000551.3:c.250G>T&NP_000542.1:p.Val84Leu&NC_000003.11:g.10183781G>T&ENST00000256474.2:c.250G>T|CA020170|2236|10.0|evidence|5801|https://civicdb.org/links/evidence/5801|24877602 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=V84L (c.250G>T)
3	10183781	2101	G	A	.	.	VT=V84M (c.250G>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.250G>A||V84M (c.250G>A)|2101|C.250G>A&VAL84MET&RS5030827|https://civicdb.org/links/variants/2101|VHL V84M (c.250G>A)|1977|C.250G>A&VAL84MET&RS5030827|https://civicdb.org/links/molecular-profiles/1977|NM_000551.3:c.250G>A&NP_000542.1:p.Val84Met&NC_000003.11:g.10183781G>A&ENST00000256474.2:c.250G>A|CA351750580|428813|5.0|evidence|5660|https://civicdb.org/links/evidence/5660|22438210 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183785	2020	T	C	.	.	VT=L85P (c.254T>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.254T>C||L85P (c.254T>C)|2020|C.254T>C&LEU85PRO&RS5030828|https://civicdb.org/links/variants/2020|VHL L85P (c.254T>C)|1896|C.254T>C&LEU85PRO&RS5030828|https://civicdb.org/links/molecular-profiles/1896|NM_000551.3:c.254T>C&NP_000542.1:p.Leu85Pro&NC_000003.11:g.10183785T>C&ENST00000256474.2:c.254T>C|CA16602675|376222|5.0|evidence|5431|https://civicdb.org/links/evidence/5431|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183785	1758	T	TC	.	.	VT=P86fs (c.254_255insC);GN=VHL;CSQ=C|Plus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||P86fs (c.254_255insC)|1758|P86AFS*46|https://civicdb.org/links/variants/1758|VHL P86fs (c.254_255insC)|1634|P86AFS*46|https://civicdb.org/links/molecular-profiles/1634|NC_000003.11:g.10183785_10183786insC&NM_000551.3:c.254_255insC&NC_000003.12:g.10142101_10142102insC&NP_000542.1:p.Pro86fs|CA2497028737|NONE FOUND|10.0|evidence|4924|https://civicdb.org/links/evidence/4924|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||
3	10183787	1759	C	G	.	.	GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>G||P86A (c.256C>G)|1759|C.256C>G&PRO86ALA&RS398123481|https://civicdb.org/links/variants/1759|VHL P86A (c.256C>G)|1635|C.256C>G&PRO86ALA&RS398123481|https://civicdb.org/links/molecular-profiles/1635|NM_000551.3:c.256C>G&NP_000542.1:p.Pro86Ala&NC_000003.11:g.10183787C>G&ENST00000256474.2:c.256C>G|CA020174|93327|5.0|evidence|4925|https://civicdb.org/links/evidence/4925|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>G||P86A (c.256C>G)|1759|C.256C>G&PRO86ALA&RS398123481|https://civicdb.org/links/variants/1759|VHL P86A (c.256C>G)|1635|C.256C>G&PRO86ALA&RS398123481|https://civicdb.org/links/molecular-profiles/1635|NM_000551.3:c.256C>G&NP_000542.1:p.Pro86Ala&NC_000003.11:g.10183787C>G&ENST00000256474.2:c.256C>G|CA020174|93327|5.0|evidence|6550|https://civicdb.org/links/evidence/6550|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=P86A (c.256C>G)
3	10183787	1902	C	T	.	.	VT=P86S (c.256C>T);GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>T||P86S (c.256C>T)|1902|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/variants/1902|VHL P86S (c.256C>T)|1778|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/molecular-profiles/1778|NM_000551.3:c.256C>T&NP_000542.1:p.Pro86Ser&NC_000003.11:g.10183787C>T&ENST00000256474.2:c.256C>T|CA020180|178692|42.5|evidence|5158|https://civicdb.org/links/evidence/5158|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>T||P86S (c.256C>T)|1902|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/variants/1902|VHL P86S (c.256C>T)|1778|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/molecular-profiles/1778|NM_000551.3:c.256C>T&NP_000542.1:p.Pro86Ser&NC_000003.11:g.10183787C>T&ENST00000256474.2:c.256C>T|CA020180|178692|42.5|evidence|5286|https://civicdb.org/links/evidence/5286|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>T||P86S (c.256C>T)|1902|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/variants/1902|VHL P86S (c.256C>T)|1778|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/molecular-profiles/1778|NM_000551.3:c.256C>T&NP_000542.1:p.Pro86Ser&NC_000003.11:g.10183787C>T&ENST00000256474.2:c.256C>T|CA020180|178692|42.5|evidence|8771|https://civicdb.org/links/evidence/8771|18580449 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>T||P86S (c.256C>T)|1902|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/variants/1902|VHL P86S (c.256C>T)|1778|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/molecular-profiles/1778|NM_000551.3:c.256C>T&NP_000542.1:p.Pro86Ser&NC_000003.11:g.10183787C>T&ENST00000256474.2:c.256C>T|CA020180|178692|42.5|evidence|8972|https://civicdb.org/links/evidence/8972|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>T||P86S (c.256C>T)|1902|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/variants/1902|VHL P86S (c.256C>T)|1778|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/molecular-profiles/1778|NM_000551.3:c.256C>T&NP_000542.1:p.Pro86Ser&NC_000003.11:g.10183787C>T&ENST00000256474.2:c.256C>T|CA020180|178692|42.5|evidence|5775|https://civicdb.org/links/evidence/5775|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.256C>T||P86S (c.256C>T)|1902|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/variants/1902|VHL P86S (c.256C>T)|1778|C.256C>T&PRO86SER&RS398123481|https://civicdb.org/links/molecular-profiles/1778|NM_000551.3:c.256C>T&NP_000542.1:p.Pro86Ser&NC_000003.11:g.10183787C>T&ENST00000256474.2:c.256C>T|CA020180|178692|42.5|evidence|6551|https://civicdb.org/links/evidence/6551|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183788	1760	C	T	.	.	VT=P86L (c.257C>T);GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.257C>T||P86L (c.257C>T)|1760|C.257C>T&PRO86LEU&RS730882034|https://civicdb.org/links/variants/1760|VHL P86L (c.257C>T)|1636|C.257C>T&PRO86LEU&RS730882034|https://civicdb.org/links/molecular-profiles/1636|NM_000551.3:c.257C>T&NP_000542.1:p.Pro86Leu&NC_000003.11:g.10183788C>T&ENST00000256474.2:c.257C>T|CA020186|182977|27.5|evidence|4926|https://civicdb.org/links/evidence/4926|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.257C>T||P86L (c.257C>T)|1760|C.257C>T&PRO86LEU&RS730882034|https://civicdb.org/links/variants/1760|VHL P86L (c.257C>T)|1636|C.257C>T&PRO86LEU&RS730882034|https://civicdb.org/links/molecular-profiles/1636|NM_000551.3:c.257C>T&NP_000542.1:p.Pro86Leu&NC_000003.11:g.10183788C>T&ENST00000256474.2:c.257C>T|CA020186|182977|27.5|evidence|5157|https://civicdb.org/links/evidence/5157|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.257C>T||P86L (c.257C>T)|1760|C.257C>T&PRO86LEU&RS730882034|https://civicdb.org/links/variants/1760|VHL P86L (c.257C>T)|1636|C.257C>T&PRO86LEU&RS730882034|https://civicdb.org/links/molecular-profiles/1636|NM_000551.3:c.257C>T&NP_000542.1:p.Pro86Leu&NC_000003.11:g.10183788C>T&ENST00000256474.2:c.257C>T|CA020186|182977|27.5|evidence|8973|https://civicdb.org/links/evidence/8973|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183788	1849	C	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.257C>G||P86R (c.257C>G)|1849|C.257C>G&PRO86ARG&RS730882034|https://civicdb.org/links/variants/1849|VHL P86R (c.257C>G)|1725|C.257C>G&PRO86ARG&RS730882034|https://civicdb.org/links/molecular-profiles/1725|NM_000551.3:c.257C>G&NP_000542.1:p.Pro86Arg&NC_000003.11:g.10183788C>G&ENST00000256474.2:c.257C>G|CA357142|223170|17.5|evidence|5156|https://civicdb.org/links/evidence/5156|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.257C>G||P86R (c.257C>G)|1849|C.257C>G&PRO86ARG&RS730882034|https://civicdb.org/links/variants/1849|VHL P86R (c.257C>G)|1725|C.257C>G&PRO86ARG&RS730882034|https://civicdb.org/links/molecular-profiles/1725|NM_000551.3:c.257C>G&NP_000542.1:p.Pro86Arg&NC_000003.11:g.10183788C>G&ENST00000256474.2:c.257C>G|CA357142|223170|17.5|evidence|5059|https://civicdb.org/links/evidence/5059|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=P86R (c.257C>G)
3	10183790	2432	G	GA	.	.	VT=V87fs (c.259_260insA);GN=VHL;CSQ=A|Plus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.259_260insA||V87fs (c.259_260insA)|2432|C.259_260INSA&VAL87FS&V87DFS*45|https://civicdb.org/links/variants/2432|VHL V87fs (c.259_260insA)|2305|C.259_260INSA&VAL87FS&V87DFS*45|https://civicdb.org/links/molecular-profiles/2305|ENST00000256474.2:c.259_260insA&NC_000003.11:g.10183790_10183791insA&NM_000551.3:c.259_260insA&NP_000542.1:p.Val87AspfsTer?&NC_000003.12:g.10142106_10142107insA|CA913189242|NONE FOUND|7.5|evidence|6506|https://civicdb.org/links/evidence/6506|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183791	2299	T	TA	.	.	CSQ=A|Plus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.3|ENST00000256474.3:c.261dup||W88fs (c.261dup)|2299|C.261DUP&C.261INSA&TRP88METFSTER44&W88MFS*44|https://civicdb.org/links/variants/2299|VHL W88fs (c.261dup)|2172|C.261DUP&C.261INSA&TRP88METFSTER44&W88MFS*44|https://civicdb.org/links/molecular-profiles/2172|NC_000003.11:g.10183792dup&NM_000551.3:c.261dup&NP_000542.1:p.Trp88MetfsTer44&ENST00000256474.3:c.261dup&NC_000003.12:g.10142108dup|CA2573050932|NONE FOUND|7.5|evidence|6122|https://civicdb.org/links/evidence/6122|17661816 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=W88fs (c.261dup)
3	10183793	2039	TGGC	TTT	.	.	VT=W88FS (c.263_265delGGCinsTT);CSQ=-|Frameshift Variant&Delins|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.263_265delGGCinsTT||W88FS (c.263_265delGGCinsTT)|2039|C.263_265DELGGCINSTT&TRP88FS|https://civicdb.org/links/variants/2039|VHL W88FS (c.263_265delGGCinsTT)|1915|C.263_265DELGGCINSTT&TRP88FS|https://civicdb.org/links/molecular-profiles/1915|ENST00000256474.2:c.263_265delGGCinsTT&NC_000003.11:g.10183794_10183796delinsTT&NM_000551.3:c.263_265delinsTT&NP_000542.1:p.Trp88PhefsTer?|CA658683075|NONE FOUND|5.0|evidence|5495|https://civicdb.org/links/evidence/5495|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL
3	10183793	1761	T	A	.	.	VT=W88R (c.262T>A);CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.262T>A||W88R (c.262T>A)|1761|C.262T>A&TRP88ARG&RS1553619431|https://civicdb.org/links/variants/1761|VHL W88R (c.262T>A)|1637|C.262T>A&TRP88ARG&RS1553619431|https://civicdb.org/links/molecular-profiles/1637|ENST00000256474.2:c.262T>A&NP_000542.1:p.Trp88Arg&NC_000003.11:g.10183793T>A&NM_000551.3:c.262T>A|CA351750671|456577|10.0|evidence|4927|https://civicdb.org/links/evidence/4927|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.262T>A||W88R (c.262T>A)|1761|C.262T>A&TRP88ARG&RS1553619431|https://civicdb.org/links/variants/1761|VHL W88R (c.262T>A)|1637|C.262T>A&TRP88ARG&RS1553619431|https://civicdb.org/links/molecular-profiles/1637|ENST00000256474.2:c.262T>A&NP_000542.1:p.Trp88Arg&NC_000003.11:g.10183793T>A&NM_000551.3:c.262T>A|CA351750671|456577|10.0|evidence|5168|https://civicdb.org/links/evidence/5168|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL
3	10183793	2056	T	C	.	.	VT=W88R (c.262T>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.262T>C||W88R (c.262T>C)|2056|TRP88ARG&C.262T>C&RS1553619431|https://civicdb.org/links/variants/2056|VHL W88R (c.262T>C)|1932|TRP88ARG&C.262T>C&RS1553619431|https://civicdb.org/links/molecular-profiles/1932|ENST00000256474.2:c.262T>C&NC_000003.11:g.10183793T>C&NM_000551.3:c.262T>C&NP_000542.1:p.Trp88Arg|CA351750667|496053|7.5|evidence|5549|https://civicdb.org/links/evidence/5549|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183794	2151	G	A	.	.	VT=W88* (c.263G>A);GN=VHL;CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.263G>A||W88* (c.263G>A)|2151|W88X&TRP88TER&C.263G>A&RS119103277|https://civicdb.org/links/variants/2151|VHL W88* (c.263G>A)|2027|W88X&TRP88TER&C.263G>A&RS119103277|https://civicdb.org/links/molecular-profiles/2027|NM_000551.3:c.263G>A&NP_000542.1:p.Trp88Ter&NC_000003.11:g.10183794G>A&ENST00000256474.2:c.263G>A|CA020197|182978|7.5|evidence|5776|https://civicdb.org/links/evidence/5776|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183794	1966	G	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.263G>C||W88S (c.263G>C)|1966|C.263G>C&TRP88SER&RS119103277|https://civicdb.org/links/variants/1966|VHL W88S (c.263G>C)|1842|C.263G>C&TRP88SER&RS119103277|https://civicdb.org/links/molecular-profiles/1842|NM_000551.3:c.263G>C&NP_000542.1:p.Trp88Ser&NC_000003.11:g.10183794G>C&ENST00000256474.2:c.263G>C|CA020202|2220|12.5|evidence|8985|https://civicdb.org/links/evidence/8985|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.263G>C||W88S (c.263G>C)|1966|C.263G>C&TRP88SER&RS119103277|https://civicdb.org/links/variants/1966|VHL W88S (c.263G>C)|1842|C.263G>C&TRP88SER&RS119103277|https://civicdb.org/links/molecular-profiles/1842|NM_000551.3:c.263G>C&NP_000542.1:p.Trp88Ser&NC_000003.11:g.10183794G>C&ENST00000256474.2:c.263G>C|CA020202|2220|12.5|evidence|5296|https://civicdb.org/links/evidence/5296|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=W88S (c.263G>C)
3	10183795	1908	G	A	.	.	CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.264G>A||W88* (c.264G>A)|1908|C.264G>A&W88X&TRP88TER|https://civicdb.org/links/variants/1908|VHL W88* (c.264G>A)|1784|C.264G>A&W88X&TRP88TER|https://civicdb.org/links/molecular-profiles/1784|ENST00000256474.2:c.264G>A&NP_000542.1:p.Trp88Ter&NC_000003.11:g.10183795G>A&NM_000551.3:c.264G>A|CA351750677|936684|7.5|evidence|5169|https://civicdb.org/links/evidence/5169|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=W88* (c.264G>A)
3	10183797	1793	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.266T>C||L89P (c.266T>C)|1793|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/variants/1793|VHL L89P (c.266T>C)|1669|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/molecular-profiles/1669|NM_000551.3:c.266T>C&NP_000542.1:p.Leu89Pro&NC_000003.11:g.10183797T>C&ENST00000256474.2:c.266T>C|CA020207|182979|27.5|evidence|4965|https://civicdb.org/links/evidence/4965|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.266T>C||L89P (c.266T>C)|1793|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/variants/1793|VHL L89P (c.266T>C)|1669|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/molecular-profiles/1669|NM_000551.3:c.266T>C&NP_000542.1:p.Leu89Pro&NC_000003.11:g.10183797T>C&ENST00000256474.2:c.266T>C|CA020207|182979|27.5|evidence|5150|https://civicdb.org/links/evidence/5150|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.266T>C||L89P (c.266T>C)|1793|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/variants/1793|VHL L89P (c.266T>C)|1669|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/molecular-profiles/1669|NM_000551.3:c.266T>C&NP_000542.1:p.Leu89Pro&NC_000003.11:g.10183797T>C&ENST00000256474.2:c.266T>C|CA020207|182979|27.5|evidence|5368|https://civicdb.org/links/evidence/5368|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.266T>C||L89P (c.266T>C)|1793|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/variants/1793|VHL L89P (c.266T>C)|1669|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/molecular-profiles/1669|NM_000551.3:c.266T>C&NP_000542.1:p.Leu89Pro&NC_000003.11:g.10183797T>C&ENST00000256474.2:c.266T>C|CA020207|182979|27.5|evidence|5449|https://civicdb.org/links/evidence/5449|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.266T>C||L89P (c.266T>C)|1793|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/variants/1793|VHL L89P (c.266T>C)|1669|C.266T>C&LEU89PRO&RS5030807|https://civicdb.org/links/molecular-profiles/1669|NM_000551.3:c.266T>C&NP_000542.1:p.Leu89Pro&NC_000003.11:g.10183797T>C&ENST00000256474.2:c.266T>C|CA020207|182979|27.5|evidence|6552|https://civicdb.org/links/evidence/6552|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=L89P (c.266T>C)
3	10183804	2294	C	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|||F91L (c.273C>G)|2294|C.273C>G&PHE91LEU|https://civicdb.org/links/variants/2294|VHL F91L (c.273C>G)|2170|C.273C>G&PHE91LEU|https://civicdb.org/links/molecular-profiles/2170|NC_000003.11:g.10183804C>G&NC_000003.12:g.10142120C>G&NP_000542.1:p.Phe91Leu|CA351750747|NONE FOUND|5.0|evidence|6111|https://civicdb.org/links/evidence/6111|9829912 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=F91L (c.273C>G)
3	10183805	2097	GACGGCGAGCCGCAGCCC	G	.	.	GN=VHL;CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|||G93_Y98del (c.275_292del)|2097|D92_Y98DEL|https://civicdb.org/links/variants/2097|VHL G93_Y98del (c.275_292del)|1973|D92_Y98DEL|https://civicdb.org/links/molecular-profiles/1973||CA891843321|574427|7.5|evidence|5649|https://civicdb.org/links/evidence/5649|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=G93_Y98del (c.275_292del)
3	10183806	2449	A	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.275A>G||D92G (c.275A>G)|2449|C.275A>G&ASP92GLY|https://civicdb.org/links/variants/2449|VHL D92G (c.275A>G)|2322|C.275A>G&ASP92GLY|https://civicdb.org/links/molecular-profiles/2322|ENST00000256474.2:c.275A>G&NC_000003.11:g.10183806A>G&NM_000551.3:c.275A>G&NP_000542.1:p.Asp92Gly|CA351750765|NONE FOUND|5.0|evidence|6553|https://civicdb.org/links/evidence/6553|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=D92G (c.275A>G)
3	10183808	2008	G	T	.	.	GN=VHL;VT=G93C (c.277G>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>T||G93C (c.277G>T)|2008|C.277G>T&GLY93CYS&RS5030808|https://civicdb.org/links/variants/2008|VHL G93C (c.277G>T)|1884|C.277G>T&GLY93CYS&RS5030808|https://civicdb.org/links/molecular-profiles/1884|ENST00000256474.2:c.277G>T&NM_000551.3:c.277G>T&NP_000542.1:p.Gly93Cys&NC_000003.11:g.10183808G>T|CA357106|223175|7.5|evidence|5406|https://civicdb.org/links/evidence/5406|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183808	1920	G	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>C||G93R (c.277G>C)|1920|C.277G>C&GLY93ARG&RS5030808|https://civicdb.org/links/variants/1920|VHL G93R (c.277G>C)|1796|C.277G>C&GLY93ARG&RS5030808|https://civicdb.org/links/molecular-profiles/1796|NM_000551.3:c.277G>C&NP_000542.1:p.Gly93Arg&NC_000003.11:g.10183808G>C&ENST00000256474.2:c.277G>C|CA357130|223174|10.0|evidence|5432|https://civicdb.org/links/evidence/5432|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>C||G93R (c.277G>C)|1920|C.277G>C&GLY93ARG&RS5030808|https://civicdb.org/links/variants/1920|VHL G93R (c.277G>C)|1796|C.277G>C&GLY93ARG&RS5030808|https://civicdb.org/links/molecular-profiles/1796|NM_000551.3:c.277G>C&NP_000542.1:p.Gly93Arg&NC_000003.11:g.10183808G>C&ENST00000256474.2:c.277G>C|CA357130|223174|10.0|evidence|5450|https://civicdb.org/links/evidence/5450|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=G93R (c.277G>C);GN=VHL
3	10183808	1859	G	A	.	.	VT=G93S (c.277G>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>A||G93S (c.277G>A)|1859|C.277G>A&GLY93SER&RS5030808|https://civicdb.org/links/variants/1859|VHL G93S (c.277G>A)|1735|C.277G>A&GLY93SER&RS5030808|https://civicdb.org/links/molecular-profiles/1735|NM_000551.3:c.277G>A&NP_000542.1:p.Gly93Ser&NC_000003.11:g.10183808G>A&ENST00000256474.2:c.277G>A|CA020230|2237|22.5|evidence|5100|https://civicdb.org/links/evidence/5100|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>A||G93S (c.277G>A)|1859|C.277G>A&GLY93SER&RS5030808|https://civicdb.org/links/variants/1859|VHL G93S (c.277G>A)|1735|C.277G>A&GLY93SER&RS5030808|https://civicdb.org/links/molecular-profiles/1735|NM_000551.3:c.277G>A&NP_000542.1:p.Gly93Ser&NC_000003.11:g.10183808G>A&ENST00000256474.2:c.277G>A|CA020230|2237|22.5|evidence|5407|https://civicdb.org/links/evidence/5407|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.277G>A||G93S (c.277G>A)|1859|C.277G>A&GLY93SER&RS5030808|https://civicdb.org/links/variants/1859|VHL G93S (c.277G>A)|1735|C.277G>A&GLY93SER&RS5030808|https://civicdb.org/links/molecular-profiles/1735|NM_000551.3:c.277G>A&NP_000542.1:p.Gly93Ser&NC_000003.11:g.10183808G>A&ENST00000256474.2:c.277G>A|CA020230|2237|22.5|evidence|6507|https://civicdb.org/links/evidence/6507|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183809	2127	GC	G	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.279delC||E94FS (c.279delC)|2127|C.279DELC&GLY93FS&GLU94FS|https://civicdb.org/links/variants/2127|VHL E94FS (c.279delC)|2003|C.279DELC&GLY93FS&GLU94FS|https://civicdb.org/links/molecular-profiles/2003|ENST00000256474.2:c.279delC&NC_000003.11:g.10183810del&NM_000551.3:c.279del&NP_000542.1:p.Glu94SerfsTer?|CA658820711|NONE FOUND|5.0|evidence|5722|https://civicdb.org/links/evidence/5722|10862095 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=E94FS (c.279delC)
3	10183809	1858	G	A	.	.	VT=G93D (c.278G>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.278G>A||G93D (c.278G>A)|1858|C.278G>A&GLY93ASP&RS1553619440|https://civicdb.org/links/variants/1858|VHL G93D (c.278G>A)|1734|C.278G>A&GLY93ASP&RS1553619440|https://civicdb.org/links/molecular-profiles/1734|ENST00000256474.2:c.278G>A&NC_000003.11:g.10183809G>A&NM_000551.3:c.278G>A&NP_000542.1:p.Gly93Asp|CA351750781|496054|0.0|evidence|5080|https://civicdb.org/links/evidence/5080|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183809	2009	G	T	.	.	VT=G93V (c.278G>T);GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.278G>T||G93V (c.278G>T)|2009|C.278G>T&GLY93VAL|https://civicdb.org/links/variants/2009|VHL G93V (c.278G>T)|1885|C.278G>T&GLY93VAL|https://civicdb.org/links/molecular-profiles/1885|ENST00000256474.2:c.278G>T&NC_000003.11:g.10183809G>T&NM_000551.3:c.278G>T&NP_000542.1:p.Gly93Val|CA351750779|625232|7.5|evidence|5408|https://civicdb.org/links/evidence/5408|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183811	1794	G	T	.	.	GN=VHL;CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94* (c.280G>T)|1794|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/variants/1794|VHL E94* (c.280G>T)|1670|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/molecular-profiles/1670|ENST00000256474.2:c.280G>T&NM_198156.2:c.280G>T&NP_000542.1:p.Glu94Ter&NC_000003.11:g.10183811G>T|CA70046202|584477|40.0|evidence|5137|https://civicdb.org/links/evidence/5137|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94* (c.280G>T)|1794|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/variants/1794|VHL E94* (c.280G>T)|1670|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/molecular-profiles/1670|ENST00000256474.2:c.280G>T&NM_198156.2:c.280G>T&NP_000542.1:p.Glu94Ter&NC_000003.11:g.10183811G>T|CA70046202|584477|40.0|evidence|5405|https://civicdb.org/links/evidence/5405|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94* (c.280G>T)|1794|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/variants/1794|VHL E94* (c.280G>T)|1670|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/molecular-profiles/1670|ENST00000256474.2:c.280G>T&NM_198156.2:c.280G>T&NP_000542.1:p.Glu94Ter&NC_000003.11:g.10183811G>T|CA70046202|584477|40.0|evidence|5433|https://civicdb.org/links/evidence/5433|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94* (c.280G>T)|1794|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/variants/1794|VHL E94* (c.280G>T)|1670|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/molecular-profiles/1670|ENST00000256474.2:c.280G>T&NM_198156.2:c.280G>T&NP_000542.1:p.Glu94Ter&NC_000003.11:g.10183811G>T|CA70046202|584477|40.0|evidence|5550|https://civicdb.org/links/evidence/5550|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94* (c.280G>T)|1794|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/variants/1794|VHL E94* (c.280G>T)|1670|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/molecular-profiles/1670|ENST00000256474.2:c.280G>T&NM_198156.2:c.280G>T&NP_000542.1:p.Glu94Ter&NC_000003.11:g.10183811G>T|CA70046202|584477|40.0|evidence|5561|https://civicdb.org/links/evidence/5561|22133049 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.280G>T||E94* (c.280G>T)|1794|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/variants/1794|VHL E94* (c.280G>T)|1670|C.280G>T&E94X&GLU94TER&RS5030829|https://civicdb.org/links/molecular-profiles/1670|ENST00000256474.2:c.280G>T&NM_198156.2:c.280G>T&NP_000542.1:p.Glu94Ter&NC_000003.11:g.10183811G>T|CA70046202|584477|40.0|evidence|5771|https://civicdb.org/links/evidence/5771|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=E94* (c.280G>T)
3	10183817	1848	C	T	.	.	VT=Q96* (c.286C>T);GN=VHL;CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.286C>T||Q96* (c.286C>T)|1848|C.286C>T&Q96X&GLN96TER&RS1131690959|https://civicdb.org/links/variants/1848|VHL Q96* (c.286C>T)|1724|C.286C>T&Q96X&GLN96TER&RS1131690959|https://civicdb.org/links/molecular-profiles/1724|NM_000551.3:c.286C>T&NP_000542.1:p.Gln96Ter&NC_000003.11:g.10183817C>T&ENST00000256474.2:c.286C>T|CA351750811|428804|22.5|evidence|5058|https://civicdb.org/links/evidence/5058|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.286C>T||Q96* (c.286C>T)|1848|C.286C>T&Q96X&GLN96TER&RS1131690959|https://civicdb.org/links/variants/1848|VHL Q96* (c.286C>T)|1724|C.286C>T&Q96X&GLN96TER&RS1131690959|https://civicdb.org/links/molecular-profiles/1724|NM_000551.3:c.286C>T&NP_000542.1:p.Gln96Ter&NC_000003.11:g.10183817C>T&ENST00000256474.2:c.286C>T|CA351750811|428804|22.5|evidence|5271|https://civicdb.org/links/evidence/5271|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.286C>T||Q96* (c.286C>T)|1848|C.286C>T&Q96X&GLN96TER&RS1131690959|https://civicdb.org/links/variants/1848|VHL Q96* (c.286C>T)|1724|C.286C>T&Q96X&GLN96TER&RS1131690959|https://civicdb.org/links/molecular-profiles/1724|NM_000551.3:c.286C>T&NP_000542.1:p.Gln96Ter&NC_000003.11:g.10183817C>T&ENST00000256474.2:c.286C>T|CA351750811|428804|22.5|evidence|5583|https://civicdb.org/links/evidence/5583|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183818	3246	AGCC	A	.	.	CSQ=-|Disruptive Inframe Deletion|VHL|7428|transcript|ENST00000256474.2|||Q96_P97delinsH (c.288_290del)|3246|C.288DELGCC&C.288_290DELGCC|https://civicdb.org/links/variants/3246|VHL Q96_P97delinsH (c.288_290del)|3115|C.288DELGCC&C.288_290DELGCC|https://civicdb.org/links/molecular-profiles/3115|NC_000003.12:g.10142135_10142137del&NC_000003.11:g.10183819_10183821del&NM_000551.3:c.288_290del&NP_000542.1:p.Gln96_Pro97delinsHis|CA2573106244|NONE FOUND|7.5|evidence|8999|https://civicdb.org/links/evidence/8999|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=Q96_P97delinsH (c.288_290del)
3	10183821	852	CCTACCCAACGCTGCCGCCTG	C	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.291_310del||Y98FS (c.291_310del20)|852|C.291_310DEL20&TYR98FS|https://civicdb.org/links/variants/852|VHL Y98FS (c.291_310del20)|826|C.291_310DEL20&TYR98FS|https://civicdb.org/links/molecular-profiles/826|ENST00000256474.2:c.291_310del&NC_000003.11:g.10183822_10183841del&NM_000551.3:c.291_310del&NP_000542.1:p.Tyr98HisfsTer27|CA645524819|NONE FOUND|2.5|evidence|1951|https://civicdb.org/links/evidence/1951|15932632 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||;GN=VHL;VT=Y98FS (c.291_310del20)
3	10183821	2160	CC	C	.	.	VT=Y98FS (c.291delC);GN=VHL;CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.291delC||Y98FS (c.291delC)|2160|TYR98FS&C.291DELC|https://civicdb.org/links/variants/2160|VHL Y98FS (c.291delC)|2036|TYR98FS&C.291DELC|https://civicdb.org/links/molecular-profiles/2036|ENST00000256474.2:c.291delC&NC_000003.11:g.10183822delC&NM_000551.3:c.291delC&NP_000542.1:p.Tyr98ThrfsTer|CA432420512|NONE FOUND|10.0|evidence|5794|https://civicdb.org/links/evidence/5794|24396697 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||
3	10183823	1741	T	C	.	.	VT=Y98H (c.292T>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|7645|https://civicdb.org/links/evidence/7645|7759077 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||B|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|4906|https://civicdb.org/links/evidence/4906|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|4967|https://civicdb.org/links/evidence/4967|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|5418|https://civicdb.org/links/evidence/5418|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|5372|https://civicdb.org/links/evidence/5372|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|5451|https://civicdb.org/links/evidence/5451|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|5474|https://civicdb.org/links/evidence/5474|20846682 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|5807|https://civicdb.org/links/evidence/5807|25883647 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.292T>C||Y98H (c.292T>C)|1741|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/variants/1741|VHL Y98H (c.292T>C)|1617|C.292T>C&TYR98HIS&RS5030809|https://civicdb.org/links/molecular-profiles/1617|NM_000551.3:c.292T>C&NP_000542.1:p.Tyr98His&NC_000003.11:g.10183823T>C&ENST00000256474.2:c.292T>C|CA020246|2223|67.5|evidence|6554|https://civicdb.org/links/evidence/6554|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183824	1933	A	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.293A>G||Y98C  (c.293A>G)|1933|C.293A>G&TYR98CYS&RS864321643|https://civicdb.org/links/variants/1933|VHL Y98C  (c.293A>G)|1809|C.293A>G&TYR98CYS&RS864321643|https://civicdb.org/links/molecular-profiles/1809|NM_000551.3:c.293A>G&NP_000542.1:p.Tyr98Cys&NC_000003.11:g.10183824A>G&ENST00000256474.2:c.293A>G|CA357072|223176|5.0|evidence|5217|https://civicdb.org/links/evidence/5217|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=Y98C  (c.293A>G)
3	10183832	1838	CT	GG	.	.	CSQ=GG|Delins|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.301_302delinsGG||L101G (c.301_302delinsGG)|1838|C.301_302CT>GG|https://civicdb.org/links/variants/1838|VHL L101G (c.301_302delinsGG)|1714|C.301_302CT>GG|https://civicdb.org/links/molecular-profiles/1714|NM_000551.3:c.301_302delinsGG&NP_000542.1:p.Leu101Gly&ENST00000256474.2:c.301_302delinsGG&ENSP00000256474.2:p.Leu101Gly&NC_000003.11:g.10183832_10183833delinsGG&NC_000003.12:g.10142148_10142149delinsGG|CA915940707|NONE FOUND|5.0|evidence|5040|https://civicdb.org/links/evidence/5040|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=L101G (c.301_302delinsGG)
3	10183835	2058	CC	C	.	.	VT=P102fs (c.305delC);CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.305delC||P102fs (c.305delC)|2058|C.305DELC&PRO102FS|https://civicdb.org/links/variants/2058|VHL P102fs (c.305delC)|1934|C.305DELC&PRO102FS|https://civicdb.org/links/molecular-profiles/1934|ENST00000256474.2:c.305delC&NC_000003.11:g.10183836del&NM_000551.3:c.305del&NP_000542.1:p.Pro102ArgfsTer?|CA658820710|NONE FOUND|7.5|evidence|5554|https://civicdb.org/links/evidence/5554|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10183839	1795	CTG	C	.	.	VT=P103FS (c.309_310delTG);GN=VHL;CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.309_310delTG||P103FS (c.309_310delTG)|1795|C.309_310DELTG&PRO103FS|https://civicdb.org/links/variants/1795|VHL P103FS (c.309_310delTG)|1671|C.309_310DELTG&PRO103FS|https://civicdb.org/links/molecular-profiles/1671|ENST00000256474.2:c.309_310delTG&NC_000003.11:g.10183840_10183841del&NM_000551.3:c.309_310del&NP_000542.1:p.Gly104HisfsTer27|CA658795178|NONE FOUND|7.5|evidence|5138|https://civicdb.org/links/evidence/5138|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183842	2043	G	C	.	.	VT=G104A (c.311G>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.311G>C||G104A (c.311G>C)|2043|C.311G>C&GLY104ALA&RS869025630|https://civicdb.org/links/variants/2043|VHL G104A (c.311G>C)|1919|C.311G>C&GLY104ALA&RS869025630|https://civicdb.org/links/molecular-profiles/1919|NM_000551.3:c.311G>C&NP_000542.1:p.Gly104Ala&NC_000003.11:g.10183842G>C&ENST00000256474.2:c.311G>C|CA16611067|411966|15.0|evidence|5512|https://civicdb.org/links/evidence/5512|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.311G>C||G104A (c.311G>C)|2043|C.311G>C&GLY104ALA&RS869025630|https://civicdb.org/links/variants/2043|VHL G104A (c.311G>C)|1919|C.311G>C&GLY104ALA&RS869025630|https://civicdb.org/links/molecular-profiles/1919|NM_000551.3:c.311G>C&NP_000542.1:p.Gly104Ala&NC_000003.11:g.10183842G>C&ENST00000256474.2:c.311G>C|CA16611067|411966|15.0|evidence|6109|https://civicdb.org/links/evidence/6109|9829912 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||
3	10183842	2428	G	T	.	.	VT=G104V (c.311G>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.311G>T||G104V (c.311G>T)|2428|C.311G>T&GLY104VAL&RS869025630|https://civicdb.org/links/variants/2428|VHL G104V (c.311G>T)|2301|C.311G>T&GLY104VAL&RS869025630|https://civicdb.org/links/molecular-profiles/2301|ENST00000256474.2:c.311G>T&NM_000551.3:c.311G>T&NP_000542.1:p.Gly104Val&NC_000003.11:g.10183842G>T|CA357033|223183|7.5|evidence|7134|https://civicdb.org/links/evidence/7134|29789510 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10183843	2293	C	G	.	.	GN=VHL;CSQ=G|Synonymous Variant|VHL|7428|transcript|ENST00000256474.2|||G104G (c.312C>G)|2293|G104G (C.312C>G)|https://civicdb.org/links/variants/2293|VHL G104G (c.312C>G)|2169|G104G (C.312C>G)|https://civicdb.org/links/molecular-profiles/2169|NC_000003.11:g.10183843C>G&NC_000003.12:g.10142159C>G&NP_000542.1:p.Gly104=&NP_001341652.1:p.Gly104=|CA432420538|NONE FOUND|2.5|evidence|6110|https://civicdb.org/links/evidence/6110|9829912 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|1|||||;VT=G104G (c.312C>G)
3	10183844	1839	A	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.313A>C||T105P (c.313A>C)|1839|C.313A>C&THR105PRO&RS1553619461|https://civicdb.org/links/variants/1839|VHL T105P (c.313A>C)|1715|C.313A>C&THR105PRO&RS1553619461|https://civicdb.org/links/molecular-profiles/1715|ENST00000256474.2:c.313A>C&NC_000003.11:g.10183844A>C&NM_000551.3:c.313A>C&NP_000542.1:p.Thr105Pro|CA351751116|496055|12.5|evidence|5293|https://civicdb.org/links/evidence/5293|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.313A>C||T105P (c.313A>C)|1839|C.313A>C&THR105PRO&RS1553619461|https://civicdb.org/links/variants/1839|VHL T105P (c.313A>C)|1715|C.313A>C&THR105PRO&RS1553619461|https://civicdb.org/links/molecular-profiles/1715|ENST00000256474.2:c.313A>C&NC_000003.11:g.10183844A>C&NM_000551.3:c.313A>C&NP_000542.1:p.Thr105Pro|CA351751116|496055|12.5|evidence|5041|https://civicdb.org/links/evidence/5041|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=T105P (c.313A>C)
3	10183849	2021	C	CCGC	.	.	CSQ=CGC|Conservative Inframe Insertion|VHL|7428|transcript|ENST00000256474.2|||R108dup (c.322_324dup)|2021|R107DUP&R108INS (C.324INSCGC)|https://civicdb.org/links/variants/2021|VHL R108dup (c.322_324dup)|1897|R107DUP&R108INS (C.324INSCGC)|https://civicdb.org/links/molecular-profiles/1897|NC_000003.11:g.10183853_10183855dup&NC_000003.12:g.10142169_10142171dup&NP_000542.1:p.Arg108dup&NM_000551.4:c.322_324dup&NM_000551.3:c.322_324dup|CA916832608|NONE FOUND|5.0|evidence|5434|https://civicdb.org/links/evidence/5434|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=R108dup (c.322_324dup)
3	10183850	2007	C	G	.	.	VT=R107G  (c.319C>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.319C>G||R107G  (c.319C>G)|2007|C.319C>G&ARG107GLY&RS397516440|https://civicdb.org/links/variants/2007|VHL R107G  (c.319C>G)|1883|C.319C>G&ARG107GLY&RS397516440|https://civicdb.org/links/molecular-profiles/1883|NM_000551.3:c.319C>G&NP_000542.1:p.Arg107Gly&NC_000003.11:g.10183850C>G&ENST00000256474.2:c.319C>G|CA020257|43599|7.5|evidence|5399|https://civicdb.org/links/evidence/5399|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183851	2044	G	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.320G>A||R107H (c.320G>A)|2044|C.320G>A&ARG107HIS&RS193922609|https://civicdb.org/links/variants/2044|VHL R107H (c.320G>A)|1920|C.320G>A&ARG107HIS&RS193922609|https://civicdb.org/links/molecular-profiles/1920|NM_000551.3:c.320G>A&NP_000542.1:p.Arg107His&NC_000003.11:g.10183851G>A&ENST00000256474.2:c.320G>A|CA357135|223184|10.0|evidence|5513|https://civicdb.org/links/evidence/5513|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=R107H (c.320G>A)
3	10183851	1840	G	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.320G>C||R107P (c.320G>C)|1840|C.320G>C&ARG107PRO&RS193922609|https://civicdb.org/links/variants/1840|VHL R107P (c.320G>C)|1716|C.320G>C&ARG107PRO&RS193922609|https://civicdb.org/links/molecular-profiles/1716|NM_000551.3:c.320G>C&NP_000542.1:p.Arg107Pro&NC_000003.11:g.10183851G>C&ENST00000256474.2:c.320G>C|CA020262|36900|7.5|evidence|5042|https://civicdb.org/links/evidence/5042|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=R107P (c.320G>C)
3	10183861	1853	CA	TT	.	.	CSQ=TT|Delins|VHL|7428|transcript|ENST00000256474.2|||S111C (c.330_331delinsTT)|1853|S111C (C.330_331CA>TT)|https://civicdb.org/links/variants/1853|VHL S111C (c.330_331delinsTT)|1729|S111C (C.330_331CA>TT)|https://civicdb.org/links/molecular-profiles/1729|NP_000542.1:p.Ser111Cys&NP_001341652.1:p.Ser111Cys&NC_000003.11:g.10183861_10183862delinsTT&NC_000003.12:g.10142177_10142178delinsTT|CA2573106137|NONE FOUND|7.5|evidence|5067|https://civicdb.org/links/evidence/5067|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=S111C (c.330_331delinsTT)
3	10183861	1762	CA	C	.	.	GN=VHL;VT=S111FS (c.331delA);CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.331del||S111FS (c.331delA)|1762|C.331DELA&SER111FS|https://civicdb.org/links/variants/1762|VHL S111FS (c.331delA)|1638|C.331DELA&SER111FS|https://civicdb.org/links/molecular-profiles/1638|NC_000003.12:g.10142178del&NC_000003.11:g.10183862del&NM_000551.3:c.331del&NM_198156.2:c.331del&NP_937799.1:p.Ser111AlafsTer7&NM_001354723.1:c.331del&NP_001341652.1:p.Ser111AlafsTer6&ENST00000256474.2:c.331del|CA432420649|NONE FOUND|10.0|evidence|4928|https://civicdb.org/links/evidence/4928|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||
3	10183862	2045	A	T	.	.	GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|||S111C (c.331A>T)|2045|SER111CYS&RS1559426203&C.331A>T|https://civicdb.org/links/variants/2045|VHL S111C (c.331A>T)|1921|SER111CYS&RS1559426203&C.331A>T|https://civicdb.org/links/molecular-profiles/1921|NC_000003.11:g.10183862A>T&NM_000551.3:c.331A>T&NP_000542.1:p.Ser111Cys|CA351751322|565557|17.5|evidence|5514|https://civicdb.org/links/evidence/5514|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|||S111C (c.331A>T)|2045|SER111CYS&RS1559426203&C.331A>T|https://civicdb.org/links/variants/2045|VHL S111C (c.331A>T)|1921|SER111CYS&RS1559426203&C.331A>T|https://civicdb.org/links/molecular-profiles/1921|NC_000003.11:g.10183862A>T&NM_000551.3:c.331A>T&NP_000542.1:p.Ser111Cys|CA351751322|565557|17.5|evidence|6600|https://civicdb.org/links/evidence/6600|25867206 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||;VT=S111C (c.331A>T)
3	10183863	1763	G	A	.	.	GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.332G>A||S111N (c.332G>A)|1763|C.332G>A&SER111ASN&RS869025631|https://civicdb.org/links/variants/1763|VHL S111N (c.332G>A)|1639|C.332G>A&SER111ASN&RS869025631|https://civicdb.org/links/molecular-profiles/1639|NM_000551.3:c.332G>A&NP_000542.1:p.Ser111Asn&NC_000003.11:g.10183863G>A&ENST00000256474.2:c.332G>A|CA357091|223186|12.5|evidence|6601|https://civicdb.org/links/evidence/6601|25867206 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.332G>A||S111N (c.332G>A)|1763|C.332G>A&SER111ASN&RS869025631|https://civicdb.org/links/variants/1763|VHL S111N (c.332G>A)|1639|C.332G>A&SER111ASN&RS869025631|https://civicdb.org/links/molecular-profiles/1639|NM_000551.3:c.332G>A&NP_000542.1:p.Ser111Asn&NC_000003.11:g.10183863G>A&ENST00000256474.2:c.332G>A|CA357091|223186|12.5|evidence|4929|https://civicdb.org/links/evidence/4929|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=S111N (c.332G>A)
3	10183864	1764	C	G	.	.	GN=VHL;VT=S111R (c.333C>G);CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.333C>G||S111R (c.333C>G)|1764|C.333C>G&SER111ARG&RS765978945|https://civicdb.org/links/variants/1764|VHL S111R (c.333C>G)|1640|C.333C>G&SER111ARG&RS765978945|https://civicdb.org/links/molecular-profiles/1640|NM_000551.3:c.333C>G&NP_000542.1:p.Ser111Arg&NC_000003.11:g.10183864C>G&ENST00000256474.2:c.333C>G|CA040305|223187|15.0|evidence|4930|https://civicdb.org/links/evidence/4930|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.333C>G||S111R (c.333C>G)|1764|C.333C>G&SER111ARG&RS765978945|https://civicdb.org/links/variants/1764|VHL S111R (c.333C>G)|1640|C.333C>G&SER111ARG&RS765978945|https://civicdb.org/links/molecular-profiles/1640|NM_000551.3:c.333C>G&NP_000542.1:p.Ser111Arg&NC_000003.11:g.10183864C>G&ENST00000256474.2:c.333C>G|CA040305|223187|15.0|evidence|5498|https://civicdb.org/links/evidence/5498|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183865	1865	T	C	.	.	GN=VHL;VT=Y112H (c.334T>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.334T>C||Y112H (c.334T>C)|1865|C.334T>C&TYR112HIS&RS104893824|https://civicdb.org/links/variants/1865|VHL Y112H (c.334T>C)|1741|C.334T>C&TYR112HIS&RS104893824|https://civicdb.org/links/molecular-profiles/1741|NM_000551.3:c.334T>C&NP_000542.1:p.Tyr112His&NC_000003.11:g.10183865T>C&ENST00000256474.2:c.334T>C|CA020277|2222|10.0|evidence|5475|https://civicdb.org/links/evidence/5475|20846682 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.334T>C||Y112H (c.334T>C)|1865|C.334T>C&TYR112HIS&RS104893824|https://civicdb.org/links/variants/1865|VHL Y112H (c.334T>C)|1741|C.334T>C&TYR112HIS&RS104893824|https://civicdb.org/links/molecular-profiles/1741|NM_000551.3:c.334T>C&NP_000542.1:p.Tyr112His&NC_000003.11:g.10183865T>C&ENST00000256474.2:c.334T>C|CA020277|2222|10.0|evidence|6428|https://civicdb.org/links/evidence/6428|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183867	2143	CC	C	.	.	GN=VHL;VT=R113FS (c.337delC);CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337delC||R113FS (c.337delC)|2143|C.337DELC&ARG113FS|https://civicdb.org/links/variants/2143|VHL R113FS (c.337delC)|2019|C.337DELC&ARG113FS|https://civicdb.org/links/molecular-profiles/2019|ENST00000256474.2:c.337delC&NC_000003.11:g.10183868delC&NM_000551.3:c.337delC&NP_000542.1:p.Arg113GlufsTer?|CA432420675|NONE FOUND|7.5|evidence|5741|https://civicdb.org/links/evidence/5741|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10183867	1766	C	A	.	.	CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.336C>A||Y112* (c.336C>A)|1766|C.336C>A&Y112X&TYR112TER|https://civicdb.org/links/variants/1766|VHL Y112* (c.336C>A)|1642|C.336C>A&Y112X&TYR112TER|https://civicdb.org/links/molecular-profiles/1642|ENST00000256474.2:c.336C>A&NC_000003.11:g.10183867C>A&NM_000551.3:c.336C>A&NP_000542.1:p.Tyr112Ter|CA16602183|NONE FOUND|10.0|evidence|4932|https://civicdb.org/links/evidence/4932|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=Y112* (c.336C>A)
3	10183868	1796	C	T	.	.	CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113* (c.337C>T)|1796|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/variants/1796|VHL R113* (c.337C>T)|1672|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/molecular-profiles/1672|NM_000551.3:c.337C>T&NP_000542.1:p.Arg113Ter&NC_000003.11:g.10183868C>T&ENST00000256474.2:c.337C>T|CA348491|220414|52.5|evidence|5043|https://civicdb.org/links/evidence/5043|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113* (c.337C>T)|1796|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/variants/1796|VHL R113* (c.337C>T)|1672|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/molecular-profiles/1672|NM_000551.3:c.337C>T&NP_000542.1:p.Arg113Ter&NC_000003.11:g.10183868C>T&ENST00000256474.2:c.337C>T|CA348491|220414|52.5|evidence|5177|https://civicdb.org/links/evidence/5177|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113* (c.337C>T)|1796|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/variants/1796|VHL R113* (c.337C>T)|1672|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/molecular-profiles/1672|NM_000551.3:c.337C>T&NP_000542.1:p.Arg113Ter&NC_000003.11:g.10183868C>T&ENST00000256474.2:c.337C>T|CA348491|220414|52.5|evidence|5260|https://civicdb.org/links/evidence/5260|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113* (c.337C>T)|1796|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/variants/1796|VHL R113* (c.337C>T)|1672|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/molecular-profiles/1672|NM_000551.3:c.337C>T&NP_000542.1:p.Arg113Ter&NC_000003.11:g.10183868C>T&ENST00000256474.2:c.337C>T|CA348491|220414|52.5|evidence|5352|https://civicdb.org/links/evidence/5352|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113* (c.337C>T)|1796|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/variants/1796|VHL R113* (c.337C>T)|1672|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/molecular-profiles/1672|NM_000551.3:c.337C>T&NP_000542.1:p.Arg113Ter&NC_000003.11:g.10183868C>T&ENST00000256474.2:c.337C>T|CA348491|220414|52.5|evidence|5379|https://civicdb.org/links/evidence/5379|10761708 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113* (c.337C>T)|1796|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/variants/1796|VHL R113* (c.337C>T)|1672|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/molecular-profiles/1672|NM_000551.3:c.337C>T&NP_000542.1:p.Arg113Ter&NC_000003.11:g.10183868C>T&ENST00000256474.2:c.337C>T|CA348491|220414|52.5|evidence|6602|https://civicdb.org/links/evidence/6602|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.337C>T||R113* (c.337C>T)|1796|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/variants/1796|VHL R113* (c.337C>T)|1672|C.337C>T&R113X&ARG113TER&RS5030810|https://civicdb.org/links/molecular-profiles/1672|NM_000551.3:c.337C>T&NP_000542.1:p.Arg113Ter&NC_000003.11:g.10183868C>T&ENST00000256474.2:c.337C>T|CA348491|220414|52.5|evidence|9541|https://civicdb.org/links/evidence/9541|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=R113* (c.337C>T)
3	10183871	1797	G	T	.	.	VT=G114C (c.340G>T);GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>T||G114C (c.340G>T)|1797|C.340G>T&GLY114CYS|https://civicdb.org/links/variants/1797|VHL G114C (c.340G>T)|1673|C.340G>T&GLY114CYS|https://civicdb.org/links/molecular-profiles/1673|ENST00000256474.2:c.340G>T&NC_000003.11:g.10183871G>T&NM_000551.3:c.340G>T&NP_000542.1:p.Gly114Cys|CA351751376|NONE FOUND|12.5|evidence|4970|https://civicdb.org/links/evidence/4970|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>T||G114C (c.340G>T)|1797|C.340G>T&GLY114CYS|https://civicdb.org/links/variants/1797|VHL G114C (c.340G>T)|1673|C.340G>T&GLY114CYS|https://civicdb.org/links/molecular-profiles/1673|ENST00000256474.2:c.340G>T&NC_000003.11:g.10183871G>T&NM_000551.3:c.340G>T&NP_000542.1:p.Gly114Cys|CA351751376|NONE FOUND|12.5|evidence|5139|https://civicdb.org/links/evidence/5139|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183871	1857	G	C	.	.	VT=G114R (c.340G>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>C||G114R (c.340G>C)|1857|C.340G>C&GLY114ARG&RS869025636|https://civicdb.org/links/variants/1857|VHL G114R (c.340G>C)|1733|C.340G>C&GLY114ARG&RS869025636|https://civicdb.org/links/molecular-profiles/1733|NM_000551.3:c.340G>C&NP_000542.1:p.Gly114Arg&NC_000003.11:g.10183871G>C&ENST00000256474.2:c.340G>C|CA357101|223193|12.5|evidence|5305|https://civicdb.org/links/evidence/5305|19464396 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>C||G114R (c.340G>C)|1857|C.340G>C&GLY114ARG&RS869025636|https://civicdb.org/links/variants/1857|VHL G114R (c.340G>C)|1733|C.340G>C&GLY114ARG&RS869025636|https://civicdb.org/links/molecular-profiles/1733|NM_000551.3:c.340G>C&NP_000542.1:p.Gly114Arg&NC_000003.11:g.10183871G>C&ENST00000256474.2:c.340G>C|CA357101|223193|12.5|evidence|9067|https://civicdb.org/links/evidence/9067|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>C||G114R (c.340G>C)|1857|C.340G>C&GLY114ARG&RS869025636|https://civicdb.org/links/variants/1857|VHL G114R (c.340G>C)|1733|C.340G>C&GLY114ARG&RS869025636|https://civicdb.org/links/molecular-profiles/1733|NM_000551.3:c.340G>C&NP_000542.1:p.Gly114Arg&NC_000003.11:g.10183871G>C&ENST00000256474.2:c.340G>C|CA357101|223193|12.5|evidence|5476|https://civicdb.org/links/evidence/5476|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10183871	2026	G	A	.	.	GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340G>A||G114S (c.340G>A)|2026|C.340G>A&GLY114SER|https://civicdb.org/links/variants/2026|VHL G114S (c.340G>A)|1902|C.340G>A&GLY114SER|https://civicdb.org/links/molecular-profiles/1902|ENST00000256474.2:c.340G>A&NC_000003.11:g.10183871G>A&NM_000551.3:c.340G>A&NP_000542.1:p.Gly114Ser|CA351751372|583094|5.0|evidence|5452|https://civicdb.org/links/evidence/5452|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=G114S (c.340G>A)
3	10183872	2114	G	A	.	.	CSQ=A|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splice Site (c.340+1G>A)|2114|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/variants/2114|VHL Splice Site (c.340+1G>A)|1990|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/molecular-profiles/1990|NM_000551.3:c.340+1G>A&NC_000003.11:g.10183872G>A&ENST00000256474.2:c.340+1G>A|CA357042|223190|50.0|evidence|5689|https://civicdb.org/links/evidence/5689|23298237 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,A|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splice Site (c.340+1G>A)|2114|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/variants/2114|VHL Splice Site (c.340+1G>A)|1990|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/molecular-profiles/1990|NM_000551.3:c.340+1G>A&NC_000003.11:g.10183872G>A&ENST00000256474.2:c.340+1G>A|CA357042|223190|50.0|evidence|5845|https://civicdb.org/links/evidence/5845|25952756 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,A|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splice Site (c.340+1G>A)|2114|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/variants/2114|VHL Splice Site (c.340+1G>A)|1990|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/molecular-profiles/1990|NM_000551.3:c.340+1G>A&NC_000003.11:g.10183872G>A&ENST00000256474.2:c.340+1G>A|CA357042|223190|50.0|evidence|5099|https://civicdb.org/links/evidence/5099|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splice Site (c.340+1G>A)|2114|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/variants/2114|VHL Splice Site (c.340+1G>A)|1990|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/molecular-profiles/1990|NM_000551.3:c.340+1G>A&NC_000003.11:g.10183872G>A&ENST00000256474.2:c.340+1G>A|CA357042|223190|50.0|evidence|5332|https://civicdb.org/links/evidence/5332|20518900 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splice Site (c.340+1G>A)|2114|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/variants/2114|VHL Splice Site (c.340+1G>A)|1990|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/molecular-profiles/1990|NM_000551.3:c.340+1G>A&NC_000003.11:g.10183872G>A&ENST00000256474.2:c.340+1G>A|CA357042|223190|50.0|evidence|6509|https://civicdb.org/links/evidence/6509|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+1G>A||Splice Site (c.340+1G>A)|2114|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/variants/2114|VHL Splice Site (c.340+1G>A)|1990|C.340+1G>A&C.553+1G>A|https://civicdb.org/links/molecular-profiles/1990|NM_000551.3:c.340+1G>A&NC_000003.11:g.10183872G>A&ENST00000256474.2:c.340+1G>A|CA357042|223190|50.0|evidence|8215|https://civicdb.org/links/evidence/8215|11148816 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=Splice Site (c.340+1G>A)
3	10183876	2104	G	C	.	.	CSQ=C|Intron Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.340+5G>C||Splice Region (c.340+5G>C)|2104|C.340+5G>C&C.533+5G>C&IVS1+5G>C|https://civicdb.org/links/variants/2104|VHL Splice Region (c.340+5G>C)|1980|C.340+5G>C&C.533+5G>C&IVS1+5G>C|https://civicdb.org/links/molecular-profiles/1980|NM_000551.3:c.340+5G>C&NC_000003.11:g.10183876G>C&ENST00000256474.2:c.340+5G>C&NP_000542.1:p.?&NC_000003.12:g.10142192G>C|CA020288|36901|5.0|evidence|5246|https://civicdb.org/links/evidence/5246|21972040 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=Splice Region (c.340+5G>C)
3	10188196	2133	A	C	.	.	GN=VHL;VT=Splice Site (c.341-2A>C);CSQ=C|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.341-2A>C||Splice Site (c.341-2A>C)|2133|C.341-2A>C|https://civicdb.org/links/variants/2133|VHL Splice Site (c.341-2A>C)|2009|C.341-2A>C|https://civicdb.org/links/molecular-profiles/2009|NC_000003.11:g.10188196A>C&NM_000551.3:c.341-2A>C&ENST00000256474.2:c.341-2A>C|CA351753579|NONE FOUND|12.5|evidence|5748|https://civicdb.org/links/evidence/5748|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.341-2A>C||Splice Site (c.341-2A>C)|2133|C.341-2A>C|https://civicdb.org/links/variants/2133|VHL Splice Site (c.341-2A>C)|2009|C.341-2A>C|https://civicdb.org/links/molecular-profiles/2009|NC_000003.11:g.10188196A>C&NM_000551.3:c.341-2A>C&ENST00000256474.2:c.341-2A>C|CA351753579|NONE FOUND|12.5|evidence|5730|https://civicdb.org/links/evidence/5730|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Renal Cell Carcinoma||||C|2|||||
3	10188200	1921	C	T	.	.	GN=VHL;VT=H115Y (c.343C>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.343C>T||H115Y (c.343C>T)|1921|C.343C>T&HIS115TYR&RS5030811|https://civicdb.org/links/variants/1921|VHL H115Y (c.343C>T)|1797|C.343C>T&HIS115TYR&RS5030811|https://civicdb.org/links/molecular-profiles/1797|ENST00000256474.2:c.343C>T&NC_000003.11:g.10188200C>T&NM_000551.3:c.343C>T&NP_000542.1:p.His115Tyr|CA16621930|NONE FOUND|10.0|evidence|5193|https://civicdb.org/links/evidence/5193|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.343C>T||H115Y (c.343C>T)|1921|C.343C>T&HIS115TYR&RS5030811|https://civicdb.org/links/variants/1921|VHL H115Y (c.343C>T)|1797|C.343C>T&HIS115TYR&RS5030811|https://civicdb.org/links/molecular-profiles/1797|ENST00000256474.2:c.343C>T&NC_000003.11:g.10188200C>T&NM_000551.3:c.343C>T&NP_000542.1:p.His115Tyr|CA16621930|NONE FOUND|10.0|evidence|5363|https://civicdb.org/links/evidence/5363|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188200	2057	CA	C	.	.	GN=VHL;VT=H115fs (c.344del);CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344del||H115fs (c.344del)|2057|C.344DELA&HIS115FS&RS1553619937&HIS115PROFSTER44 (C.344DEL)&H115FS (C.344DELA)&H115PFS*44 (C.344DEL)|https://civicdb.org/links/variants/2057|VHL H115fs (c.344del)|1933|C.344DELA&HIS115FS&RS1553619937&HIS115PROFSTER44 (C.344DEL)&H115FS (C.344DELA)&H115PFS*44 (C.344DEL)|https://civicdb.org/links/molecular-profiles/1933|NC_000003.11:g.10188201del&NM_000551.3:c.344delA&ENST00000256474.2:c.344del&NP_000542.1:p.His115ProfsTer44|CA70049370|NONE FOUND|7.5|evidence|5553|https://civicdb.org/links/evidence/5553|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188201	1885	A	C	.	.	GN=VHL;VT=H115P (c.344A>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344A>C||H115P (c.344A>C)|1885|C.344A>C&HIS115PRO&RS5030812|https://civicdb.org/links/variants/1885|VHL H115P (c.344A>C)|1761|C.344A>C&HIS115PRO&RS5030812|https://civicdb.org/links/molecular-profiles/1761|ENST00000256474.2:c.344A>C&NC_000003.11:g.10188201A>C&NM_000551.3:c.344A>C&NP_000542.1:p.His115Pro|CA351753626|560744|7.5|evidence|5140|https://civicdb.org/links/evidence/5140|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188201	2000	A	G	.	.	VT=H115R (c.344A>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344A>G||H115R (c.344A>G)|2000|C.344A>G&HIS115ARG&RS5030812|https://civicdb.org/links/variants/2000|VHL H115R (c.344A>G)|1876|C.344A>G&HIS115ARG&RS5030812|https://civicdb.org/links/molecular-profiles/1876|ENST00000256474.2:c.344A>G&NC_000003.11:g.10188201A>G&NM_000551.3:c.344A>G&NP_000542.1:p.His115Arg|CA70049376|664415|10.0|evidence|5377|https://civicdb.org/links/evidence/5377|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.344A>G||H115R (c.344A>G)|2000|C.344A>G&HIS115ARG&RS5030812|https://civicdb.org/links/variants/2000|VHL H115R (c.344A>G)|1876|C.344A>G&HIS115ARG&RS5030812|https://civicdb.org/links/molecular-profiles/1876|ENST00000256474.2:c.344A>G&NC_000003.11:g.10188201A>G&NM_000551.3:c.344A>G&NP_000542.1:p.His115Arg|CA70049376|664415|10.0|evidence|5772|https://civicdb.org/links/evidence/5772|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188202	1742	C	A	.	.	VT=H115Q (c.345C>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.345C>A||H115Q (c.345C>A)|1742|C.345C>A&HIS115GLN&RS864622646|https://civicdb.org/links/variants/1742|VHL H115Q (c.345C>A)|1618|C.345C>A&HIS115GLN&RS864622646|https://civicdb.org/links/molecular-profiles/1618|ENST00000256474.2:c.345C>A&NP_000542.1:p.His115Gln&NC_000003.11:g.10188202C>A&NM_000551.3:c.345C>A|CA351753631|496057|5.0|evidence|4907|https://civicdb.org/links/evidence/4907|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188202	1957	C	G	.	.	VT=H115Q (c.345C>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.345C>G||H115Q (c.345C>G)|1957|HIS115GLN&C.345C>G&RS864622646|https://civicdb.org/links/variants/1957|VHL H115Q (c.345C>G)|1833|HIS115GLN&C.345C>G&RS864622646|https://civicdb.org/links/molecular-profiles/1833|ENST00000256474.2:c.345C>G&NC_000003.11:g.10188202C>G&NM_000551.3:c.345C>G&NP_000542.1:p.His115Gln|CA351753634|496058|22.5|evidence|5515|https://civicdb.org/links/evidence/5515|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.345C>G||H115Q (c.345C>G)|1957|HIS115GLN&C.345C>G&RS864622646|https://civicdb.org/links/variants/1957|VHL H115Q (c.345C>G)|1833|HIS115GLN&C.345C>G&RS864622646|https://civicdb.org/links/molecular-profiles/1833|ENST00000256474.2:c.345C>G&NC_000003.11:g.10188202C>G&NM_000551.3:c.345C>G&NP_000542.1:p.His115Gln|CA351753634|496058|22.5|evidence|6604|https://civicdb.org/links/evidence/6604|25867206 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.345C>G||H115Q (c.345C>G)|1957|HIS115GLN&C.345C>G&RS864622646|https://civicdb.org/links/variants/1957|VHL H115Q (c.345C>G)|1833|HIS115GLN&C.345C>G&RS864622646|https://civicdb.org/links/molecular-profiles/1833|ENST00000256474.2:c.345C>G&NC_000003.11:g.10188202C>G&NM_000551.3:c.345C>G&NP_000542.1:p.His115Gln|CA351753634|496058|22.5|evidence|5274|https://civicdb.org/links/evidence/5274|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188203	1820	C	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.346C>G||L116V (c.346C>G)|1820|C.346C>G&LEU116VAL|https://civicdb.org/links/variants/1820|VHL L116V (c.346C>G)|1696|C.346C>G&LEU116VAL|https://civicdb.org/links/molecular-profiles/1696|ENST00000256474.2:c.346C>G&NC_000003.11:g.10188203C>G&NM_000551.3:c.346C>G&NP_000542.1:p.Leu116Val|CA351753642|NONE FOUND|10.0|evidence|5022|https://civicdb.org/links/evidence/5022|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=L116V (c.346C>G)
3	10188206	2027	T	TT	.	.	CSQ=T|Plus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.349dupT||W117fs (c.349dup)|2027|TRP117LEUFS&C.349DUPT|https://civicdb.org/links/variants/2027|VHL W117fs (c.349dup)|1903|TRP117LEUFS&C.349DUPT|https://civicdb.org/links/molecular-profiles/1903|NC_000003.11:g.10188206dup&ENST00000256474.2:c.349dupT&NM_000551.3:c.349dup&NP_000542.1:p.cTrp117LeufsTer15|CA432421788|NONE FOUND|5.0|evidence|5453|https://civicdb.org/links/evidence/5453|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=W117fs (c.349dup)
3	10188208	1767	G	T	.	.	GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.351G>T||W117C (c.351G>T)|1767|C.351G>T&TRP117CYS&RS727504215|https://civicdb.org/links/variants/1767|VHL W117C (c.351G>T)|1643|C.351G>T&TRP117CYS&RS727504215|https://civicdb.org/links/molecular-profiles/1643|NM_000551.3:c.351G>T&NP_000542.1:p.Trp117Cys&NC_000003.11:g.10188208G>T&ENST00000256474.2:c.351G>T|CA020294|167827|22.5|evidence|4933|https://civicdb.org/links/evidence/4933|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.351G>T||W117C (c.351G>T)|1767|C.351G>T&TRP117CYS&RS727504215|https://civicdb.org/links/variants/1767|VHL W117C (c.351G>T)|1643|C.351G>T&TRP117CYS&RS727504215|https://civicdb.org/links/molecular-profiles/1643|NM_000551.3:c.351G>T&NP_000542.1:p.Trp117Cys&NC_000003.11:g.10188208G>T&ENST00000256474.2:c.351G>T|CA020294|167827|22.5|evidence|5295|https://civicdb.org/links/evidence/5295|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.351G>T||W117C (c.351G>T)|1767|C.351G>T&TRP117CYS&RS727504215|https://civicdb.org/links/variants/1767|VHL W117C (c.351G>T)|1643|C.351G>T&TRP117CYS&RS727504215|https://civicdb.org/links/molecular-profiles/1643|NM_000551.3:c.351G>T&NP_000542.1:p.Trp117Cys&NC_000003.11:g.10188208G>T&ENST00000256474.2:c.351G>T|CA020294|167827|22.5|evidence|5044|https://civicdb.org/links/evidence/5044|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=W117C (c.351G>T)
3	10188209	1841	C	CA	.	.	VT=L118fs (c.352_353insA);GN=VHL;CSQ=A|Plus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|||L118fs (c.352_353insA)|1841|LEU118FS&RS869025641|https://civicdb.org/links/variants/1841|VHL L118fs (c.352_353insA)|1717|LEU118FS&RS869025641|https://civicdb.org/links/molecular-profiles/1717|NC_000003.11:g.10188209_10188210insA&NC_000003.12:g.10146525_10146526insA&NM_000551.3:c.352_353insA&NP_000542.1:p.Leu118fs|CA357125|223198|7.5|evidence|5045|https://civicdb.org/links/evidence/5045|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188210	1798	T	C	.	.	VT=L118P (c.353T>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.353T>C||L118P (c.353T>C)|1798|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/variants/1798|VHL L118P (c.353T>C)|1674|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/molecular-profiles/1674|ENST00000256474.2:c.353T>C&NM_000551.3:c.353T>C&NP_000542.1:p.Leu118Pro&NC_000003.11:g.10188210T>C|CA70049399|428807|45.0|evidence|5143|https://civicdb.org/links/evidence/5143|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.353T>C||L118P (c.353T>C)|1798|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/variants/1798|VHL L118P (c.353T>C)|1674|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/molecular-profiles/1674|ENST00000256474.2:c.353T>C&NM_000551.3:c.353T>C&NP_000542.1:p.Leu118Pro&NC_000003.11:g.10188210T>C|CA70049399|428807|45.0|evidence|4971|https://civicdb.org/links/evidence/4971|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.353T>C||L118P (c.353T>C)|1798|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/variants/1798|VHL L118P (c.353T>C)|1674|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/molecular-profiles/1674|ENST00000256474.2:c.353T>C&NM_000551.3:c.353T>C&NP_000542.1:p.Leu118Pro&NC_000003.11:g.10188210T>C|CA70049399|428807|45.0|evidence|5276|https://civicdb.org/links/evidence/5276|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.353T>C||L118P (c.353T>C)|1798|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/variants/1798|VHL L118P (c.353T>C)|1674|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/molecular-profiles/1674|ENST00000256474.2:c.353T>C&NM_000551.3:c.353T>C&NP_000542.1:p.Leu118Pro&NC_000003.11:g.10188210T>C|CA70049399|428807|45.0|evidence|8998|https://civicdb.org/links/evidence/8998|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.353T>C||L118P (c.353T>C)|1798|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/variants/1798|VHL L118P (c.353T>C)|1674|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/molecular-profiles/1674|ENST00000256474.2:c.353T>C&NM_000551.3:c.353T>C&NP_000542.1:p.Leu118Pro&NC_000003.11:g.10188210T>C|CA70049399|428807|45.0|evidence|5435|https://civicdb.org/links/evidence/5435|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.353T>C||L118P (c.353T>C)|1798|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/variants/1798|VHL L118P (c.353T>C)|1674|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/molecular-profiles/1674|ENST00000256474.2:c.353T>C&NM_000551.3:c.353T>C&NP_000542.1:p.Leu118Pro&NC_000003.11:g.10188210T>C|CA70049399|428807|45.0|evidence|5477|https://civicdb.org/links/evidence/5477|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.353T>C||L118P (c.353T>C)|1798|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/variants/1798|VHL L118P (c.353T>C)|1674|C.353T>C&LEU118PRO&RS5030830|https://civicdb.org/links/molecular-profiles/1674|ENST00000256474.2:c.353T>C&NM_000551.3:c.353T>C&NP_000542.1:p.Leu118Pro&NC_000003.11:g.10188210T>C|CA70049399|428807|45.0|evidence|6905|https://civicdb.org/links/evidence/6905|7915601 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||
3	10188214	1743	C	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L (c.357C>G)|1743|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/variants/1743|VHL F119L (c.357C>G)|1619|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/molecular-profiles/1619|ENST00000256474.2:c.357C>G&NC_000003.11:g.10188214C>G&NM_000551.3:c.357C>G&NP_000542.1:p.Phe119Leu|CA351753726|625240|22.5|evidence|5411|https://civicdb.org/links/evidence/5411|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L (c.357C>G)|1743|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/variants/1743|VHL F119L (c.357C>G)|1619|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/molecular-profiles/1619|ENST00000256474.2:c.357C>G&NC_000003.11:g.10188214C>G&NM_000551.3:c.357C>G&NP_000542.1:p.Phe119Leu|CA351753726|625240|22.5|evidence|4908|https://civicdb.org/links/evidence/4908|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L (c.357C>G)|1743|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/variants/1743|VHL F119L (c.357C>G)|1619|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/molecular-profiles/1619|ENST00000256474.2:c.357C>G&NC_000003.11:g.10188214C>G&NM_000551.3:c.357C>G&NP_000542.1:p.Phe119Leu|CA351753726|625240|22.5|evidence|5436|https://civicdb.org/links/evidence/5436|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.357C>G||F119L (c.357C>G)|1743|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/variants/1743|VHL F119L (c.357C>G)|1619|C.357C>G&PHE119LEU&RS1559428077|https://civicdb.org/links/molecular-profiles/1619|ENST00000256474.2:c.357C>G&NC_000003.11:g.10188214C>G&NM_000551.3:c.357C>G&NP_000542.1:p.Phe119Leu|CA351753726|625240|22.5|evidence|5454|https://civicdb.org/links/evidence/5454|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=F119L (c.357C>G)
3	10188215	1914	A	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.358A>G||R120G (c.358A>G)|1914|C.358A>G&ARG120GLY&RS869025642|https://civicdb.org/links/variants/1914|VHL R120G (c.358A>G)|1790|C.358A>G&ARG120GLY&RS869025642|https://civicdb.org/links/molecular-profiles/1790|NM_000551.3:c.358A>G&NP_000542.1:p.Arg120Gly&NC_000003.11:g.10188215A>G&ENST00000256474.2:c.358A>G|CA357028|223199|22.5|evidence|5178|https://civicdb.org/links/evidence/5178|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.358A>G||R120G (c.358A>G)|1914|C.358A>G&ARG120GLY&RS869025642|https://civicdb.org/links/variants/1914|VHL R120G (c.358A>G)|1790|C.358A>G&ARG120GLY&RS869025642|https://civicdb.org/links/molecular-profiles/1790|NM_000551.3:c.358A>G&NP_000542.1:p.Arg120Gly&NC_000003.11:g.10188215A>G&ENST00000256474.2:c.358A>G|CA357028|223199|22.5|evidence|6511|https://civicdb.org/links/evidence/6511|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.358A>G||R120G (c.358A>G)|1914|C.358A>G&ARG120GLY&RS869025642|https://civicdb.org/links/variants/1914|VHL R120G (c.358A>G)|1790|C.358A>G&ARG120GLY&RS869025642|https://civicdb.org/links/molecular-profiles/1790|NM_000551.3:c.358A>G&NP_000542.1:p.Arg120Gly&NC_000003.11:g.10188215A>G&ENST00000256474.2:c.358A>G|CA357028|223199|22.5|evidence|6605|https://civicdb.org/links/evidence/6605|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=R120G (c.358A>G);GN=VHL
3	10188215	3244	A	AAC	.	.	CSQ=AC|Frameshift Truncation&Plus 2 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|||R120fs (c.358_359insAC)|3244|R120NFS*40|https://civicdb.org/links/variants/3244|VHL R120fs (c.358_359insAC)|3113|R120NFS*40|https://civicdb.org/links/molecular-profiles/3113|NC_000003.12:g.10146531_10146532insAC&NC_000003.11:g.10188215_10188216insAC&NM_000551.3:c.358_359insAC&NP_000542.1:p.Arg120AsnfsTer?|CA2573106245|NONE FOUND|7.5|evidence|8995|https://civicdb.org/links/evidence/8995|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=R120fs (c.358_359insAC)
3	10188219	1813	A	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.362A>G||D121G (c.362A>G)|1813|C.362A>G&ASP121GLY&RS5030832|https://civicdb.org/links/variants/1813|VHL D121G (c.362A>G)|1689|C.362A>G&ASP121GLY&RS5030832|https://civicdb.org/links/molecular-profiles/1689|NM_000551.3:c.362A>G&NP_000542.1:p.Asp121Gly&NC_000003.11:g.10188219A>G&ENST00000256474.2:c.362A>G|CA357083|223200|17.5|evidence|5578|https://civicdb.org/links/evidence/5578|14722919 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.362A>G||D121G (c.362A>G)|1813|C.362A>G&ASP121GLY&RS5030832|https://civicdb.org/links/variants/1813|VHL D121G (c.362A>G)|1689|C.362A>G&ASP121GLY&RS5030832|https://civicdb.org/links/molecular-profiles/1689|NM_000551.3:c.362A>G&NP_000542.1:p.Asp121Gly&NC_000003.11:g.10188219A>G&ENST00000256474.2:c.362A>G|CA357083|223200|17.5|evidence|5437|https://civicdb.org/links/evidence/5437|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.362A>G||D121G (c.362A>G)|1813|C.362A>G&ASP121GLY&RS5030832|https://civicdb.org/links/variants/1813|VHL D121G (c.362A>G)|1689|C.362A>G&ASP121GLY&RS5030832|https://civicdb.org/links/molecular-profiles/1689|NM_000551.3:c.362A>G&NP_000542.1:p.Asp121Gly&NC_000003.11:g.10188219A>G&ENST00000256474.2:c.362A>G|CA357083|223200|17.5|evidence|5455|https://civicdb.org/links/evidence/5455|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=D121G (c.362A>G)
3	10188221	2028	GC	AT	.	.	CSQ=AT|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.364_365delinsAT||A122I (c.364_365GC>AT)|2028|C.364_365GC>AT&ALA122ILE|https://civicdb.org/links/variants/2028|VHL A122I (c.364_365GC>AT)|1904|C.364_365GC>AT&ALA122ILE|https://civicdb.org/links/molecular-profiles/1904|NM_000551.3:c.364_365delinsAT&ENST00000256474.2:c.364_365delinsAT&NC_000003.11:g.10188221_10188222delinsAT&NC_000003.12:g.10146537_10146538delinsAT|CA658820874|NONE FOUND|12.5|evidence|6417|https://civicdb.org/links/evidence/6417|12000816 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,AT|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.364_365delinsAT||A122I (c.364_365GC>AT)|2028|C.364_365GC>AT&ALA122ILE|https://civicdb.org/links/variants/2028|VHL A122I (c.364_365GC>AT)|1904|C.364_365GC>AT&ALA122ILE|https://civicdb.org/links/molecular-profiles/1904|NM_000551.3:c.364_365delinsAT&ENST00000256474.2:c.364_365delinsAT&NC_000003.11:g.10188221_10188222delinsAT&NC_000003.12:g.10146537_10146538delinsAT|CA658820874|NONE FOUND|12.5|evidence|5456|https://civicdb.org/links/evidence/5456|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=A122I (c.364_365GC>AT)
3	10188225	2135	GGACACAC	G	.	.	GN=VHL;VT=G123fs (c.369_375delGACACAC);CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.369_375delGACACAC||G123fs (c.369_375delGACACAC)|2135|GLY123FS&C.369_375DELGACACAC|https://civicdb.org/links/variants/2135|VHL G123fs (c.369_375delGACACAC)|2011|GLY123FS&C.369_375DELGACACAC|https://civicdb.org/links/molecular-profiles/2011|ENST00000256474.2:c.369_375delGACACAC|CA913189240|NONE FOUND|2.5|evidence|5732|https://civicdb.org/links/evidence/5732|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||
3	10188232	1918	C	CC	.	.	CSQ=C|Inframe Insertion|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.375_376insC||D126FS (c.375_376insC)|1918|C.375_376INSC&ASP126FS|https://civicdb.org/links/variants/1918|VHL D126FS (c.375_376insC)|1794|C.375_376INSC&ASP126FS|https://civicdb.org/links/molecular-profiles/1794|ENST00000256474.2:c.375_376insC|CA16621931|NONE FOUND|5.0|evidence|5188|https://civicdb.org/links/evidence/5188|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=D126FS (c.375_376insC)
3	10188239	3066	C	T	.	.	VT=L128F (c.382C>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|||L128F (c.382C>T)|3066||https://civicdb.org/links/variants/3066|VHL L128F (c.382C>T)|2935||https://civicdb.org/links/molecular-profiles/2935||CA351753886||5.0|evidence|5478|https://civicdb.org/links/evidence/5478|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL
3	10188240	1886	T	G	.	.	VT=L128R (c.383T>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.383T>G||L128R (c.383T>G)|1886|C.383T>G&LEU128ARG|https://civicdb.org/links/variants/1886|VHL L128R (c.383T>G)|1762|C.383T>G&LEU128ARG|https://civicdb.org/links/molecular-profiles/1762|ENST00000256474.2:c.383T>G&NC_000003.11:g.10188240T>G&NM_000551.3:c.383T>G&NP_000542.1:p.Leu128Arg|CA351753891|NONE FOUND|17.5|evidence|5144|https://civicdb.org/links/evidence/5144|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.383T>G||L128R (c.383T>G)|1886|C.383T>G&LEU128ARG|https://civicdb.org/links/variants/1886|VHL L128R (c.383T>G)|1762|C.383T>G&LEU128ARG|https://civicdb.org/links/molecular-profiles/1762|ENST00000256474.2:c.383T>G&NC_000003.11:g.10188240T>G&NM_000551.3:c.383T>G&NP_000542.1:p.Leu128Arg|CA351753891|NONE FOUND|17.5|evidence|6114|https://civicdb.org/links/evidence/6114|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188240	1996	TT	T	.	.	CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.384delT||L129fs (c.384delT)|1996|C.384DELT&LEU129FS|https://civicdb.org/links/variants/1996|VHL L129fs (c.384delT)|1872|C.384DELT&LEU129FS|https://civicdb.org/links/molecular-profiles/1872|ENST00000256474.2:c.384delT|CA70049452|NONE FOUND|7.5|evidence|5365|https://civicdb.org/links/evidence/5365|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=L129fs (c.384delT)
3	10188243	2508	T	C	.	.	GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.386T>C||L129P (c.386T>C)|2508|L129P (C.386T>G)|https://civicdb.org/links/variants/2508|VHL L129P (c.386T>C)|2381|L129P (C.386T>G)|https://civicdb.org/links/molecular-profiles/2381|ENST00000256474.2:c.386T>C&NC_000003.11:g.10188243T>C&NM_000551.3:c.386T>C&NP_000542.1:p.Leu129Pro&ENSP00000256474.2:p.Leu129Pro&NC_000003.12:g.10146559T>C|CA351753904|625242|5.0|evidence|5479|https://civicdb.org/links/evidence/5479|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=L129P (c.386T>C)
3	10188245	1970	G	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.388G>C||V130L (c.388G>C)|1970|C.388G>C&VAL130LEU&RS104893830|https://civicdb.org/links/variants/1970|VHL V130L (c.388G>C)|1846|C.388G>C&VAL130LEU&RS104893830|https://civicdb.org/links/molecular-profiles/1846|NM_000551.3:c.388G>C&NP_000542.1:p.Val130Leu&NC_000003.11:g.10188245G>C&ENST00000256474.2:c.388G>C|CA020325|2229|12.5|evidence|6115|https://civicdb.org/links/evidence/6115|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.388G>C||V130L (c.388G>C)|1970|C.388G>C&VAL130LEU&RS104893830|https://civicdb.org/links/variants/1970|VHL V130L (c.388G>C)|1846|C.388G>C&VAL130LEU&RS104893830|https://civicdb.org/links/molecular-profiles/1846|NM_000551.3:c.388G>C&NP_000542.1:p.Val130Leu&NC_000003.11:g.10188245G>C&ENST00000256474.2:c.388G>C|CA020325|2229|12.5|evidence|5301|https://civicdb.org/links/evidence/5301|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=V130L (c.388G>C)
3	10188246	1800	TTA	T	.	.	CSQ=-|Minus 2 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.390_391delTA||N131fs (c.390_391del)|1800|C.390_391DELTA&ASN131PRO&N131PFS*3&ASN131PROFSTER3|https://civicdb.org/links/variants/1800|VHL N131fs (c.390_391del)|1676|C.390_391DELTA&ASN131PRO&N131PFS*3&ASN131PROFSTER3|https://civicdb.org/links/molecular-profiles/1676|ENST00000256474.2:c.390_391delTA&NC_000003.11:g.10188247_10188248del&NC_000003.12:g.10146563_10146564del&NM_000551.3:c.390_391delTA&NP_000542.1:p.Asn131fs&NP_000542.1:p.Asn131ProfsTer3|CA658795179|NONE FOUND|15.0|evidence|4973|https://civicdb.org/links/evidence/4973|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Minus 2 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.390_391delTA||N131fs (c.390_391del)|1800|C.390_391DELTA&ASN131PRO&N131PFS*3&ASN131PROFSTER3|https://civicdb.org/links/variants/1800|VHL N131fs (c.390_391del)|1676|C.390_391DELTA&ASN131PRO&N131PFS*3&ASN131PROFSTER3|https://civicdb.org/links/molecular-profiles/1676|ENST00000256474.2:c.390_391delTA&NC_000003.11:g.10188247_10188248del&NC_000003.12:g.10146563_10146564del&NM_000551.3:c.390_391delTA&NP_000542.1:p.Asn131fs&NP_000542.1:p.Asn131ProfsTer3|CA658795179|NONE FOUND|15.0|evidence|5128|https://civicdb.org/links/evidence/5128|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=N131fs (c.390_391del)
3	10188249	2001	A	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|||N131S (c.392A>G)|2001||https://civicdb.org/links/variants/2001|VHL N131S (c.392A>G)|1877||https://civicdb.org/links/molecular-profiles/1877|NC_000003.11:g.10188249A>G&NC_000003.12:g.10146565A>G&NP_000542.1:p.Asn131Ser|CA351753941|496062|7.5|evidence|5380|https://civicdb.org/links/evidence/5380|10761708 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=N131S (c.392A>G);GN=VHL
3	10188249	2580	A	C	.	.	VT=N131T (c.392A>C);GN=VHL;CSQ=C|Non Conservative Missense Variant|VHL|7428|transcript|ENST00000256474.2|||N131T (c.392A>C)|2580||https://civicdb.org/links/variants/2580|VHL N131T (c.392A>C)|2453||https://civicdb.org/links/molecular-profiles/2453|NC_000003.11:g.10188249A>C&CM000665.1:g.10188249A>C&NP_000542.1:p.Asn131Thr&NM_000551.3:c.392A>C|CA351753944|NONE FOUND|15.0|evidence|5046|https://civicdb.org/links/evidence/5046|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Non Conservative Missense Variant|VHL|7428|transcript|ENST00000256474.2|||N131T (c.392A>C)|2580||https://civicdb.org/links/variants/2580|VHL N131T (c.392A>C)|2453||https://civicdb.org/links/molecular-profiles/2453|NC_000003.11:g.10188249A>C&CM000665.1:g.10188249A>C&NP_000542.1:p.Asn131Thr&NM_000551.3:c.392A>C|CA351753944|NONE FOUND|15.0|evidence|6606|https://civicdb.org/links/evidence/6606|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188250	1953	C	A	.	.	VT=N131K (c.393C>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.393C>A||N131K (c.393C>A)|1953|C.393C>A&ASN131LYS&RS1064794272|https://civicdb.org/links/variants/1953|VHL N131K (c.393C>A)|1829|C.393C>A&ASN131LYS&RS1064794272|https://civicdb.org/links/molecular-profiles/1829|NM_000551.3:c.393C>A&NP_000542.1:p.Asn131Lys&NC_000003.11:g.10188250C>A&ENST00000256474.2:c.393C>A|CA16617789|420074|10.0|evidence|5266|https://civicdb.org/links/evidence/5266|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.393C>A||N131K (c.393C>A)|1953|C.393C>A&ASN131LYS&RS1064794272|https://civicdb.org/links/variants/1953|VHL N131K (c.393C>A)|1829|C.393C>A&ASN131LYS&RS1064794272|https://civicdb.org/links/molecular-profiles/1829|NM_000551.3:c.393C>A&NP_000542.1:p.Asn131Lys&NC_000003.11:g.10188250C>A&ENST00000256474.2:c.393C>A|CA16617789|420074|10.0|evidence|5457|https://civicdb.org/links/evidence/5457|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188251	1994	C	T	.	.	GN=VHL;CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.394C>T||Q132* (c.394C>T)|1994|C.394C>T&Q132X&GLN132TER&RS5030813|https://civicdb.org/links/variants/1994|VHL Q132* (c.394C>T)|1870|C.394C>T&Q132X&GLN132TER&RS5030813|https://civicdb.org/links/molecular-profiles/1870|NM_000551.3:c.394C>T&NP_000542.1:p.Gln132Ter&NC_000003.11:g.10188251C>T&ENST00000256474.2:c.394C>T|CA10606205|288749|10.0|evidence|5358|https://civicdb.org/links/evidence/5358|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.394C>T||Q132* (c.394C>T)|1994|C.394C>T&Q132X&GLN132TER&RS5030813|https://civicdb.org/links/variants/1994|VHL Q132* (c.394C>T)|1870|C.394C>T&Q132X&GLN132TER&RS5030813|https://civicdb.org/links/molecular-profiles/1870|NM_000551.3:c.394C>T&NP_000542.1:p.Gln132Ter&NC_000003.11:g.10188251C>T&ENST00000256474.2:c.394C>T|CA10606205|288749|10.0|evidence|5458|https://civicdb.org/links/evidence/5458|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=Q132* (c.394C>T)
3	10188251	1843	CA	C	.	.	CSQ=-|Minus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||T133fs (c.397del)|1843|Q132FS (C.395DELA)&T133LFS*26|https://civicdb.org/links/variants/1843|VHL T133fs (c.397del)|1719|Q132FS (C.395DELA)&T133LFS*26|https://civicdb.org/links/molecular-profiles/1719|NC_000003.11:g.10188254del&NP_000542.1:p.Thr133fs&NC_000003.12:g.10146570del&NM_000551.4:c.397del&NP_000542.1:p.Thr133LeufsTer26|CA432421843|625244|15.0|evidence|5047|https://civicdb.org/links/evidence/5047|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Minus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||T133fs (c.397del)|1843|Q132FS (C.395DELA)&T133LFS*26|https://civicdb.org/links/variants/1843|VHL T133fs (c.397del)|1719|Q132FS (C.395DELA)&T133LFS*26|https://civicdb.org/links/molecular-profiles/1719|NC_000003.11:g.10188254del&NP_000542.1:p.Thr133fs&NC_000003.12:g.10146570del&NM_000551.4:c.397del&NP_000542.1:p.Thr133LeufsTer26|CA432421843|625244|15.0|evidence|6607|https://civicdb.org/links/evidence/6607|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=T133fs (c.397del);GN=VHL
3	10188252	2125	A	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.395A>C||Q132P (c.395A>C)|2125|C.395A>C&GLN132PRO&RS1347416980|https://civicdb.org/links/variants/2125|VHL Q132P (c.395A>C)|2001|C.395A>C&GLN132PRO&RS1347416980|https://civicdb.org/links/molecular-profiles/2001|ENST00000256474.2:c.395A>C&NC_000003.11:g.10188252A>C&NM_000551.3:c.395A>C&NP_000542.1:p.Gln132Pro|CA351753958|496063|17.5|evidence|5131|https://civicdb.org/links/evidence/5131|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.395A>C||Q132P (c.395A>C)|2125|C.395A>C&GLN132PRO&RS1347416980|https://civicdb.org/links/variants/2125|VHL Q132P (c.395A>C)|2001|C.395A>C&GLN132PRO&RS1347416980|https://civicdb.org/links/molecular-profiles/2001|ENST00000256474.2:c.395A>C&NC_000003.11:g.10188252A>C&NM_000551.3:c.395A>C&NP_000542.1:p.Gln132Pro|CA351753958|496063|17.5|evidence|8218|https://civicdb.org/links/evidence/8218|11148816 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||;VT=Q132P (c.395A>C);GN=VHL
3	10188259	1906	AT	A	.	.	CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.404del||L135fs (c.404del)|1906|C.404DELT&LEU135FS&L135Y*24|https://civicdb.org/links/variants/1906|VHL L135fs (c.404del)|1782|C.404DELT&LEU135FS&L135Y*24|https://civicdb.org/links/molecular-profiles/1782|NC_000003.11:g.10188261del&NP_000542.1:p.Leu135TyrfsTer24&ENST00000256474.2:c.404del&NM_000551.3:c.404del&NC_000003.12:g.10146577del|CA432421852|NONE FOUND|7.5|evidence|5165|https://civicdb.org/links/evidence/5165|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=L135fs (c.404del)
3	10188261	1769	T	A	.	.	VT=L135* (c.404T>A);GN=VHL;CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.404T>A||L135* (c.404T>A)|1769|C.404T>A&L135X&LEU135TER|https://civicdb.org/links/variants/1769|VHL L135* (c.404T>A)|1645|C.404T>A&L135X&LEU135TER|https://civicdb.org/links/molecular-profiles/1645|ENST00000256474.2:c.404T>A&NC_000003.11:g.10188261T>A&NM_000551.3:c.404T>A&NP_000542.1:p.Leu135Ter|CA351754021|NONE FOUND|17.5|evidence|4935|https://civicdb.org/links/evidence/4935|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.404T>A||L135* (c.404T>A)|1769|C.404T>A&L135X&LEU135TER|https://civicdb.org/links/variants/1769|VHL L135* (c.404T>A)|1645|C.404T>A&L135X&LEU135TER|https://civicdb.org/links/molecular-profiles/1645|ENST00000256474.2:c.404T>A&NC_000003.11:g.10188261T>A&NM_000551.3:c.404T>A&NP_000542.1:p.Leu135Ter|CA351754021|NONE FOUND|17.5|evidence|6608|https://civicdb.org/links/evidence/6608|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188264	1814	T	G	.	.	GN=VHL;VT=F136C (c.407T>G);CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>G||F136C (c.407T>G)|1814|C.407T>G&PHE136CYS&RS5030833|https://civicdb.org/links/variants/1814|VHL F136C (c.407T>G)|1690|C.407T>G&PHE136CYS&RS5030833|https://civicdb.org/links/molecular-profiles/1690|ENST00000256474.2:c.407T>G&NC_000003.11:g.10188264T>G&NM_000551.3:c.407T>G&NP_000542.1:p.Phe136Cys|CA70049495|496065|12.5|evidence|5412|https://civicdb.org/links/evidence/5412|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>G||F136C (c.407T>G)|1814|C.407T>G&PHE136CYS&RS5030833|https://civicdb.org/links/variants/1814|VHL F136C (c.407T>G)|1690|C.407T>G&PHE136CYS&RS5030833|https://civicdb.org/links/molecular-profiles/1690|ENST00000256474.2:c.407T>G&NC_000003.11:g.10188264T>G&NM_000551.3:c.407T>G&NP_000542.1:p.Phe136Cys|CA70049495|496065|12.5|evidence|5480|https://civicdb.org/links/evidence/5480|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188264	1801	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>C||F136S (c.407T>C)|1801|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/variants/1801|VHL F136S (c.407T>C)|1677|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/molecular-profiles/1677|ENST00000256474.2:c.407T>C&NC_000003.11:g.10188264T>C&NM_000551.3:c.407T>C&NP_000542.1:p.Phe136Ser|CA040847|496064|47.5|evidence|5152|https://civicdb.org/links/evidence/5152|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>C||F136S (c.407T>C)|1801|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/variants/1801|VHL F136S (c.407T>C)|1677|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/molecular-profiles/1677|ENST00000256474.2:c.407T>C&NC_000003.11:g.10188264T>C&NM_000551.3:c.407T>C&NP_000542.1:p.Phe136Ser|CA040847|496064|47.5|evidence|4974|https://civicdb.org/links/evidence/4974|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>C||F136S (c.407T>C)|1801|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/variants/1801|VHL F136S (c.407T>C)|1677|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/molecular-profiles/1677|ENST00000256474.2:c.407T>C&NC_000003.11:g.10188264T>C&NM_000551.3:c.407T>C&NP_000542.1:p.Phe136Ser|CA040847|496064|47.5|evidence|5284|https://civicdb.org/links/evidence/5284|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>C||F136S (c.407T>C)|1801|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/variants/1801|VHL F136S (c.407T>C)|1677|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/molecular-profiles/1677|ENST00000256474.2:c.407T>C&NC_000003.11:g.10188264T>C&NM_000551.3:c.407T>C&NP_000542.1:p.Phe136Ser|CA040847|496064|47.5|evidence|5543|https://civicdb.org/links/evidence/5543|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>C||F136S (c.407T>C)|1801|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/variants/1801|VHL F136S (c.407T>C)|1677|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/molecular-profiles/1677|ENST00000256474.2:c.407T>C&NC_000003.11:g.10188264T>C&NM_000551.3:c.407T>C&NP_000542.1:p.Phe136Ser|CA040847|496064|47.5|evidence|6512|https://civicdb.org/links/evidence/6512|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>C||F136S (c.407T>C)|1801|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/variants/1801|VHL F136S (c.407T>C)|1677|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/molecular-profiles/1677|ENST00000256474.2:c.407T>C&NC_000003.11:g.10188264T>C&NM_000551.3:c.407T>C&NP_000542.1:p.Phe136Ser|CA040847|496064|47.5|evidence|5202|https://civicdb.org/links/evidence/5202|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.407T>C||F136S (c.407T>C)|1801|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/variants/1801|VHL F136S (c.407T>C)|1677|C.407T>C&PHE136SER&RS5030833|https://civicdb.org/links/molecular-profiles/1677|ENST00000256474.2:c.407T>C&NC_000003.11:g.10188264T>C&NM_000551.3:c.407T>C&NP_000542.1:p.Phe136Ser|CA040847|496064|47.5|evidence|6573|https://civicdb.org/links/evidence/6573|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;GN=VHL;VT=F136S (c.407T>C)
3	10188269	1928	C	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.412C>A||P138T (c.412C>A)|1928|PRO138THR&C.412C>A|https://civicdb.org/links/variants/1928|VHL P138T (c.412C>A)|1804|PRO138THR&C.412C>A|https://civicdb.org/links/molecular-profiles/1804|ENST00000256474.2:c.412C>A&NC_000003.11:g.10188269C>A&NM_000551.3:c.412C>A&NP_000542.1:p.Pro138Thr|CA16621932|NONE FOUND|10.0|evidence|5205|https://civicdb.org/links/evidence/5205|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.412C>A||P138T (c.412C>A)|1928|PRO138THR&C.412C>A|https://civicdb.org/links/variants/1928|VHL P138T (c.412C>A)|1804|PRO138THR&C.412C>A|https://civicdb.org/links/molecular-profiles/1804|ENST00000256474.2:c.412C>A&NC_000003.11:g.10188269C>A&NM_000551.3:c.412C>A&NP_000542.1:p.Pro138Thr|CA16621932|NONE FOUND|10.0|evidence|6574|https://civicdb.org/links/evidence/6574|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=P138T (c.412C>A)
3	10188270	2440	C	G	.	.	VT=P138R (c.413C>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.413C>G||P138R (c.413C>G)|2440|C.413C>G&PRO138ARG|https://civicdb.org/links/variants/2440|VHL P138R (c.413C>G)|2313|C.413C>G&PRO138ARG|https://civicdb.org/links/molecular-profiles/2313|ENST00000256474.2:c.413C>G&NC_000003.11:g.10188270C>G&NM_000551.3:c.413C>G&NP_000542.1:p.Pro138Arg|CA351754085|NONE FOUND|2.5|evidence|6915|https://civicdb.org/links/evidence/6915|7915601 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||
3	10188284	3247	GACGGACAGCCT	G	.	.	VT=G144fs (c.429_439del);CSQ=-|Frameshift Truncation&Minus 2 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|||G144fs (c.429_439del)|3247|G144FFS*26&C.428_438DEL|https://civicdb.org/links/variants/3247|VHL G144fs (c.429_439del)|3116|G144FFS*26&C.428_438DEL|https://civicdb.org/links/molecular-profiles/3116|NC_000003.12:g.10146602_10146612del&NC_000003.11:g.10188286_10188296del&NM_000551.3:c.429_439del&NP_000542.1:p.Gly144PhefsTer26|CA2573106247|NONE FOUND|7.5|evidence|9000|https://civicdb.org/links/evidence/9000|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10188287	1850	G	T	.	.	GN=VHL;VT=G144* (c.430G>T);CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.430G>T||G144* (c.430G>T)|1850|C.430G>T&G144X&GLY144TER&RS869025650|https://civicdb.org/links/variants/1850|VHL G144* (c.430G>T)|1726|C.430G>T&G144X&GLY144TER&RS869025650|https://civicdb.org/links/molecular-profiles/1726|NM_000551.3:c.430G>T&NP_000542.1:p.Gly144Ter&NC_000003.11:g.10188287G>T&ENST00000256474.2:c.430G>T|CA357109|223208|7.5|evidence|5064|https://civicdb.org/links/evidence/5064|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.430G>T||G144* (c.430G>T)|1850|C.430G>T&G144X&GLY144TER&RS869025650|https://civicdb.org/links/variants/1850|VHL G144* (c.430G>T)|1726|C.430G>T&G144X&GLY144TER&RS869025650|https://civicdb.org/links/molecular-profiles/1726|NM_000551.3:c.430G>T&NP_000542.1:p.Gly144Ter&NC_000003.11:g.10188287G>T&ENST00000256474.2:c.430G>T|CA357109|223208|7.5|evidence|8607|https://civicdb.org/links/evidence/8607|20151405 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188288	2290	G	A	.	.	GN=VHL;VT=G144E (c.431G>A);CSQ=A||VHL|7428|transcript|ENST00000256474.2|||G144E (c.431G>A)|2290||https://civicdb.org/links/variants/2290|VHL G144E (c.431G>A)|2166||https://civicdb.org/links/molecular-profiles/2166||CA351754206||5.0|evidence|6106|https://civicdb.org/links/evidence/6106|9663592 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Adrenal Gland Pheochromocytoma||||C|2|||||
3	10188290	1883	C	T	.	.	GN=VHL;VT=Q145* (c.433C>T);CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.433C>T||Q145* (c.433C>T)|1883|C.433C>T&Q145X&GLN145TER|https://civicdb.org/links/variants/1883|VHL Q145* (c.433C>T)|1759|C.433C>T&Q145X&GLN145TER|https://civicdb.org/links/molecular-profiles/1759|ENST00000256474.2:c.433C>T&NC_000003.11:g.10188290C>T&NM_000551.3:c.433C>T&NP_000542.1:p.Gln145Ter|CA351754219|625249|10.0|evidence|5248|https://civicdb.org/links/evidence/5248|21972040 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.433C>T||Q145* (c.433C>T)|1883|C.433C>T&Q145X&GLN145TER|https://civicdb.org/links/variants/1883|VHL Q145* (c.433C>T)|1759|C.433C>T&Q145X&GLN145TER|https://civicdb.org/links/molecular-profiles/1759|ENST00000256474.2:c.433C>T&NC_000003.11:g.10188290C>T&NM_000551.3:c.433C>T&NP_000542.1:p.Gln145Ter|CA351754219|625249|10.0|evidence|5798|https://civicdb.org/links/evidence/5798|25586603 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188292	2055	GC	G	.	.	CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.437del||P146fs (c.437del)|2055|C.436DELC&PRO146FS&C.437DELC&P146LFS*13|https://civicdb.org/links/variants/2055|VHL P146fs (c.437del)|1931|C.436DELC&PRO146FS&C.437DELC&P146LFS*13|https://civicdb.org/links/molecular-profiles/1931|NC_000003.12:g.10146610del&ENST00000256474.2:c.437del&NC_000003.11:g.10188294del&NM_000551.3:c.437del&NP_000542.1:p.Pro146LeufsTer13|CA432421892|NONE FOUND|7.5|evidence|5544|https://civicdb.org/links/evidence/5544|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=P146fs (c.437del)
3	10188301	2042	TG	T	.	.	VT=A149fs (c.445delG);GN=VHL;CSQ=-|Frameshift Variant&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445delG||A149fs (c.445delG)|2042|C.445DELG&ALA149FS|https://civicdb.org/links/variants/2042|VHL A149fs (c.445delG)|1918|C.445DELG&ALA149FS|https://civicdb.org/links/molecular-profiles/1918|ENST00000256474.2:c.445delG&NC_000003.11:g.10188302delG&NM_000551.3:c.445delG&NP_000542.1:p.Ala149ProfsTer10|CA432421902|NONE FOUND|5.0|evidence|5501|https://civicdb.org/links/evidence/5501|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188301	2029	TGCCAATATCACACT	T	.	.	VT=N150fs (c.445_458del);GN=VHL;CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445_458delGCCAATATCACACT||N150fs (c.445_458del)|2029|C.445_458DEL&ASN150FS|https://civicdb.org/links/variants/2029|VHL N150fs (c.445_458del)|1905|C.445_458DEL&ASN150FS|https://civicdb.org/links/molecular-profiles/1905|ENST00000256474.2:c.445_458delGCCAATATCACACT|CA658820719|NONE FOUND|5.0|evidence|5459|https://civicdb.org/links/evidence/5459|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188302	820	G	T	.	.	CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445G>T||A149S (c.445G>T)|820|ALA149SER&C.445G>T&RS587780077|https://civicdb.org/links/variants/820|VHL A149S (c.445G>T)|798|ALA149SER&C.445G>T&RS587780077|https://civicdb.org/links/molecular-profiles/798|NP_000542.1:p.Ala149Ser&NM_000551.2:c.445G>T&ENST00000256474.2:c.445G>T&NC_000003.11:g.10188302G>T|CA020355|127829|17.5|evidence|1896|https://civicdb.org/links/evidence/1896|9435426 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445G>T||A149S (c.445G>T)|820|ALA149SER&C.445G>T&RS587780077|https://civicdb.org/links/variants/820|VHL A149S (c.445G>T)|798|ALA149SER&C.445G>T&RS587780077|https://civicdb.org/links/molecular-profiles/798|NP_000542.1:p.Ala149Ser&NM_000551.2:c.445G>T&ENST00000256474.2:c.445G>T&NC_000003.11:g.10188302G>T|CA020355|127829|17.5|evidence|5679|https://civicdb.org/links/evidence/5679|23673869 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=A149S (c.445G>T);GN=VHL
3	10188302	1744	G	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.445G>A||A149T (c.445G>A)|1744|C.445G>A&ALA149THR&RS587780077|https://civicdb.org/links/variants/1744|VHL A149T (c.445G>A)|1620|C.445G>A&ALA149THR&RS587780077|https://civicdb.org/links/molecular-profiles/1620|ENST00000256474.2:c.445G>A&NM_000551.3:c.445G>A&NP_000542.1:p.Ala149Thr&NC_000003.11:g.10188302G>A|CA357066|223213|5.0|evidence|4909|https://civicdb.org/links/evidence/4909|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=A149T (c.445G>A)
3	10188302	2561	GC	G	.	.	VT=N150fs (c.447del);GN=VHL;CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.447del||N150fs (c.447del)|2561|C.446DELC&N150IFS*9&A149FS|https://civicdb.org/links/variants/2561|VHL N150fs (c.447del)|2434|C.446DELC&N150IFS*9&A149FS|https://civicdb.org/links/molecular-profiles/2434|NP_000542.1:p.Asn150IlefsTer9&ENST00000256474.2:c.447del&NC_000003.12:g.10146620del&NC_000003.11:g.10188304del&NM_000551.3:c.447del|CA432421904|NONE FOUND|2.5|evidence|6918|https://civicdb.org/links/evidence/6918|7915601 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Renal Carcinoma||||C|1|||||
3	10188306	2162	A	G	.	.	GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.449A>G||N150S (c.449A>G)|2162|C.449A>G&ASN150SER&RS760184234|https://civicdb.org/links/variants/2162|VHL N150S (c.449A>G)|2038|C.449A>G&ASN150SER&RS760184234|https://civicdb.org/links/molecular-profiles/2038|NM_000551.3:c.449A>G&NP_000542.1:p.Asn150Ser&NC_000003.11:g.10188306A>G&ENST00000256474.2:c.449A>G|CA041030|371992|5.0|evidence|5799|https://civicdb.org/links/evidence/5799|25586603 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=N150S (c.449A>G)
3	10188308	2150	A	T	.	.	GN=VHL;VT=I151F (c.451A>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.451A>T||I151F (c.451A>T)|2150|C.451A>T&ILE151PHE|https://civicdb.org/links/variants/2150|VHL I151F (c.451A>T)|2026|C.451A>T&ILE151PHE|https://civicdb.org/links/molecular-profiles/2026|ENST00000256474.2:c.451A>T&NC_000003.11:g.10188308A>T&NM_000551.3:c.451A>T&NP_000542.1:p.Ile151Phe|CA351754353|NONE FOUND|5.0|evidence|5773|https://civicdb.org/links/evidence/5773|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188309	1871	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.452T>C||I151T (c.452T>C)|1871|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/variants/1871|VHL I151T (c.452T>C)|1747|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/molecular-profiles/1747|NM_000551.3:c.452T>C&NP_000542.1:p.Ile151Thr&NC_000003.11:g.10188309T>C&ENST00000256474.2:c.452T>C|CA351754359|428803|25.0|evidence|5101|https://civicdb.org/links/evidence/5101|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.452T>C||I151T (c.452T>C)|1871|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/variants/1871|VHL I151T (c.452T>C)|1747|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/molecular-profiles/1747|NM_000551.3:c.452T>C&NP_000542.1:p.Ile151Thr&NC_000003.11:g.10188309T>C&ENST00000256474.2:c.452T>C|CA351754359|428803|25.0|evidence|6696|https://civicdb.org/links/evidence/6696|28469506 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.452T>C||I151T (c.452T>C)|1871|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/variants/1871|VHL I151T (c.452T>C)|1747|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/molecular-profiles/1747|NM_000551.3:c.452T>C&NP_000542.1:p.Ile151Thr&NC_000003.11:g.10188309T>C&ENST00000256474.2:c.452T>C|CA351754359|428803|25.0|evidence|5141|https://civicdb.org/links/evidence/5141|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.452T>C||I151T (c.452T>C)|1871|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/variants/1871|VHL I151T (c.452T>C)|1747|C.452T>C&ILE151THR&RS869025655|https://civicdb.org/links/molecular-profiles/1747|NM_000551.3:c.452T>C&NP_000542.1:p.Ile151Thr&NC_000003.11:g.10188309T>C&ENST00000256474.2:c.452T>C|CA351754359|428803|25.0|evidence|5720|https://civicdb.org/links/evidence/5720|10567493 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=I151T (c.452T>C);GN=VHL
3	10188310	2030	C	G	.	.	GN=VHL;VT=I151M (c.453C>G);CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.453C>G||I151M (c.453C>G)|2030|C.453C>G&ILE151MET|https://civicdb.org/links/variants/2030|VHL I151M (c.453C>G)|1906|C.453C>G&ILE151MET|https://civicdb.org/links/molecular-profiles/1906|ENST00000256474.2:c.453C>G&NC_000003.11:g.10188310C>G&NM_000551.3:c.453C>G&NP_000542.1:p.Ile151Met|CA351754364|NONE FOUND|5.0|evidence|5460|https://civicdb.org/links/evidence/5460|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188315	1923	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.458T>C||L153P (c.458T>C)|1923|C.458T>C&LEU153PRO|https://civicdb.org/links/variants/1923|VHL L153P (c.458T>C)|1799|C.458T>C&LEU153PRO|https://civicdb.org/links/molecular-profiles/1799|ENST00000256474.2:c.458T>C&NC_000003.11:g.10188315T>C&NM_000551.3:c.458T>C&NP_000542.1:p.Leu153Pro|CA16621942|NONE FOUND|7.5|evidence|5196|https://civicdb.org/links/evidence/5196|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.458T>C||L153P (c.458T>C)|1923|C.458T>C&LEU153PRO|https://civicdb.org/links/variants/1923|VHL L153P (c.458T>C)|1799|C.458T>C&LEU153PRO|https://civicdb.org/links/molecular-profiles/1799|ENST00000256474.2:c.458T>C&NC_000003.11:g.10188315T>C&NM_000551.3:c.458T>C&NP_000542.1:p.Leu153Pro|CA16621942|NONE FOUND|7.5|evidence|6576|https://civicdb.org/links/evidence/6576|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;GN=VHL;VT=L153P (c.458T>C)
3	10188316	1802	GC	G	.	.	GN=VHL;VT=L153fs (c.457delC);CSQ=-|Deletion|VHL|7428|transcript|ENST00000256474.2|||L153fs (c.457delC)|1802|C.457DELC&LEU153FS|https://civicdb.org/links/variants/1802|VHL L153fs (c.457delC)|1678|C.457DELC&LEU153FS|https://civicdb.org/links/molecular-profiles/1678|NM_000551.3:c.457delC|CA432421924|NONE FOUND|17.5|evidence|5145|https://civicdb.org/links/evidence/5145|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,-|Deletion|VHL|7428|transcript|ENST00000256474.2|||L153fs (c.457delC)|1802|C.457DELC&LEU153FS|https://civicdb.org/links/variants/1802|VHL L153fs (c.457delC)|1678|C.457DELC&LEU153FS|https://civicdb.org/links/molecular-profiles/1678|NM_000551.3:c.457delC|CA432421924|NONE FOUND|17.5|evidence|4975|https://civicdb.org/links/evidence/4975|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188318	1782	C	T	.	.	GN=VHL;VT=P154L (c.461C>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.461C>T||P154L (c.461C>T)|1782|C.461C>T&PRO154LEU|https://civicdb.org/links/variants/1782|VHL P154L (c.461C>T)|1658|C.461C>T&PRO154LEU|https://civicdb.org/links/molecular-profiles/1658|ENST00000256474.2:c.461C>T&NC_000003.11:g.10188318C>T&NM_000551.3:c.461C>T&NP_000542.1:p.Pro154Leu|CA351754410|NONE FOUND|25.0|evidence|4976|https://civicdb.org/links/evidence/4976|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.461C>T||P154L (c.461C>T)|1782|C.461C>T&PRO154LEU|https://civicdb.org/links/variants/1782|VHL P154L (c.461C>T)|1658|C.461C>T&PRO154LEU|https://civicdb.org/links/molecular-profiles/1658|ENST00000256474.2:c.461C>T&NC_000003.11:g.10188318C>T&NM_000551.3:c.461C>T&NP_000542.1:p.Pro154Leu|CA351754410|NONE FOUND|25.0|evidence|6609|https://civicdb.org/links/evidence/6609|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.461C>T||P154L (c.461C>T)|1782|C.461C>T&PRO154LEU|https://civicdb.org/links/variants/1782|VHL P154L (c.461C>T)|1658|C.461C>T&PRO154LEU|https://civicdb.org/links/molecular-profiles/1658|ENST00000256474.2:c.461C>T&NC_000003.11:g.10188318C>T&NM_000551.3:c.461C>T&NP_000542.1:p.Pro154Leu|CA351754410|NONE FOUND|25.0|evidence|5154|https://civicdb.org/links/evidence/5154|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.461C>T||P154L (c.461C>T)|1782|C.461C>T&PRO154LEU|https://civicdb.org/links/variants/1782|VHL P154L (c.461C>T)|1658|C.461C>T&PRO154LEU|https://civicdb.org/links/molecular-profiles/1658|ENST00000256474.2:c.461C>T&NC_000003.11:g.10188318C>T&NM_000551.3:c.461C>T&NP_000542.1:p.Pro154Leu|CA351754410|NONE FOUND|25.0|evidence|5461|https://civicdb.org/links/evidence/5461|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188318	1771	CA	C	.	.	GN=VHL;VT=P154fs (c.462delA);CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462delA||P154fs (c.462delA)|1771|C.462DELA&PRO154FS|https://civicdb.org/links/variants/1771|VHL P154fs (c.462delA)|1647|C.462DELA&PRO154FS|https://civicdb.org/links/molecular-profiles/1647|ENST00000256474.2:c.462delA&NC_000003.11:g.10188319del&NM_000551.3:c.462del&NP_000542.1:p.Val155CysfsTer4|CA432421926|NONE FOUND|7.5|evidence|4937|https://civicdb.org/links/evidence/4937|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10188319	1962	A	C	.	.	CSQ=C|Synonymous Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462A>C||P154P (c.462A>C)|1962|C.462A>C&PRO154PRO&P154P (C.462A>C)|https://civicdb.org/links/variants/1962|VHL P154P (c.462A>C)|1838|C.462A>C&PRO154PRO&P154P (C.462A>C)|https://civicdb.org/links/molecular-profiles/1838|ENST00000256474.2:c.462A>C&NC_000003.11:g.10188319A>C&NM_000551.3:c.462A>C&NP_000542.1:p.Pro154=|CA16621934|NONE FOUND|15.0|evidence|6513|https://civicdb.org/links/evidence/6513|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Synonymous Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462A>C||P154P (c.462A>C)|1962|C.462A>C&PRO154PRO&P154P (C.462A>C)|https://civicdb.org/links/variants/1962|VHL P154P (c.462A>C)|1838|C.462A>C&PRO154PRO&P154P (C.462A>C)|https://civicdb.org/links/molecular-profiles/1838|ENST00000256474.2:c.462A>C&NC_000003.11:g.10188319A>C&NM_000551.3:c.462A>C&NP_000542.1:p.Pro154=|CA16621934|NONE FOUND|15.0|evidence|5285|https://civicdb.org/links/evidence/5285|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Synonymous Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.462A>C||P154P (c.462A>C)|1962|C.462A>C&PRO154PRO&P154P (C.462A>C)|https://civicdb.org/links/variants/1962|VHL P154P (c.462A>C)|1838|C.462A>C&PRO154PRO&P154P (C.462A>C)|https://civicdb.org/links/molecular-profiles/1838|ENST00000256474.2:c.462A>C&NC_000003.11:g.10188319A>C&NM_000551.3:c.462A>C&NP_000542.1:p.Pro154=|CA16621934|NONE FOUND|15.0|evidence|6577|https://civicdb.org/links/evidence/6577|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;GN=VHL;VT=P154P (c.462A>C)
3	10188321	1998	G	C	.	.	VT=Splice Site (c.463+1G>C);GN=VHL;CSQ=C|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+1G>C||Splice Site (c.463+1G>C)|1998|C.463+1G>C&RS869025657|https://civicdb.org/links/variants/1998|VHL Splice Site (c.463+1G>C)|1874|C.463+1G>C&RS869025657|https://civicdb.org/links/molecular-profiles/1874|NM_000551.3:c.463+1G>C&NC_000003.11:g.10188321G>C&ENST00000256474.2:c.463+1G>C|CA357023|223217|5.0|evidence|5373|https://civicdb.org/links/evidence/5373|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Renal Cell Carcinoma||||C|2|||||
3	10188322	2075	T	C	.	.	VT=Splice Site (c.463+2T>C);GN=VHL;CSQ=C|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+2T>C||Splice Site (c.463+2T>C)|2075|C.463+2T>C&RS5030814|https://civicdb.org/links/variants/2075|VHL Splice Site (c.463+2T>C)|1951|C.463+2T>C&RS5030814|https://civicdb.org/links/molecular-profiles/1951|NM_000551.3:c.463+2T>C&NC_000003.11:g.10188322T>C&ENST00000256474.2:c.463+2T>C&NP_000542.1:p.?&NC_000003.12:g.10146638T>C|CA16621936|569414|27.5|evidence|5610|https://civicdb.org/links/evidence/5610|22156657 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+2T>C||Splice Site (c.463+2T>C)|2075|C.463+2T>C&RS5030814|https://civicdb.org/links/variants/2075|VHL Splice Site (c.463+2T>C)|1951|C.463+2T>C&RS5030814|https://civicdb.org/links/molecular-profiles/1951|NM_000551.3:c.463+2T>C&NC_000003.11:g.10188322T>C&ENST00000256474.2:c.463+2T>C&NP_000542.1:p.?&NC_000003.12:g.10146638T>C|CA16621936|569414|27.5|evidence|6514|https://civicdb.org/links/evidence/6514|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+2T>C||Splice Site (c.463+2T>C)|2075|C.463+2T>C&RS5030814|https://civicdb.org/links/variants/2075|VHL Splice Site (c.463+2T>C)|1951|C.463+2T>C&RS5030814|https://civicdb.org/links/molecular-profiles/1951|NM_000551.3:c.463+2T>C&NC_000003.11:g.10188322T>C&ENST00000256474.2:c.463+2T>C&NP_000542.1:p.?&NC_000003.12:g.10146638T>C|CA16621936|569414|27.5|evidence|6610|https://civicdb.org/links/evidence/6610|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Splice Donor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+2T>C||Splice Site (c.463+2T>C)|2075|C.463+2T>C&RS5030814|https://civicdb.org/links/variants/2075|VHL Splice Site (c.463+2T>C)|1951|C.463+2T>C&RS5030814|https://civicdb.org/links/molecular-profiles/1951|NM_000551.3:c.463+2T>C&NC_000003.11:g.10188322T>C&ENST00000256474.2:c.463+2T>C&NP_000542.1:p.?&NC_000003.12:g.10146638T>C|CA16621936|569414|27.5|evidence|5356|https://civicdb.org/links/evidence/5356|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10188328	2292	C	T	.	.	VT=Splice Region (c.463+8C>T);GN=VHL;CSQ=T|Splicing Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.463+8C>T||Splice Region (c.463+8C>T)|2292||https://civicdb.org/links/variants/2292|VHL Splice Region (c.463+8C>T)|2168||https://civicdb.org/links/molecular-profiles/2168|NC_000003.11:g.10188328C>T&ENST00000256474.2:c.463+8C>T&NM_000551.3:c.463+8C>T|CA020379|127830|5.0|evidence|6108|https://civicdb.org/links/evidence/6108|9663592 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Adrenal Gland Pheochromocytoma||||C|2|||||
3	10191469	2078	A	G	.	.	CSQ=G|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>G||Splice Site (c.464-2A>G)|2078|C.464-2A>G&RS5030816|https://civicdb.org/links/variants/2078|VHL Splice Site (c.464-2A>G)|1954|C.464-2A>G&RS5030816|https://civicdb.org/links/molecular-profiles/1954|NM_000551.3:c.464-2A>G&NC_000003.11:g.10191469A>G&ENST00000256474.2:c.464-2A>G|CA357046|223222|15.0|evidence|5462|https://civicdb.org/links/evidence/5462|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>G||Splice Site (c.464-2A>G)|2078|C.464-2A>G&RS5030816|https://civicdb.org/links/variants/2078|VHL Splice Site (c.464-2A>G)|1954|C.464-2A>G&RS5030816|https://civicdb.org/links/molecular-profiles/1954|NM_000551.3:c.464-2A>G&NC_000003.11:g.10191469A>G&ENST00000256474.2:c.464-2A>G|CA357046|223222|15.0|evidence|5724|https://civicdb.org/links/evidence/5724|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||,G|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>G||Splice Site (c.464-2A>G)|2078|C.464-2A>G&RS5030816|https://civicdb.org/links/variants/2078|VHL Splice Site (c.464-2A>G)|1954|C.464-2A>G&RS5030816|https://civicdb.org/links/molecular-profiles/1954|NM_000551.3:c.464-2A>G&NC_000003.11:g.10191469A>G&ENST00000256474.2:c.464-2A>G|CA357046|223222|15.0|evidence|5851|https://civicdb.org/links/evidence/5851|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=Splice Site (c.464-2A>G)
3	10191469	1992	A	T	.	.	VT=Splice Site (c.464-2A>T);CSQ=T|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-2A>T||Splice Site (c.464-2A>T)|1992|C.464-2A>T&RS5030816|https://civicdb.org/links/variants/1992|VHL Splice Site (c.464-2A>T)|1868|C.464-2A>T&RS5030816|https://civicdb.org/links/molecular-profiles/1868|NM_000551.3:c.464-2A>T&NC_000003.11:g.10191469A>T&ENST00000256474.2:c.464-2A>T&NP_000542.1:p.=|CA70052157|NONE FOUND|5.0|evidence|5351|https://civicdb.org/links/evidence/5351|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL
3	10191470	1974	G	A	.	.	CSQ=A|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>A||Splice Site (c.464-1G>A)|1974|C.464-1G>A&RS5030817|https://civicdb.org/links/variants/1974|VHL Splice Site (c.464-1G>A)|1850|C.464-1G>A&RS5030817|https://civicdb.org/links/molecular-profiles/1850|NM_000551.3:c.464-1G>A&NC_000003.11:g.10191470G>A&ENST00000256474.2:c.464-1G>A|CA020389|43603|5.0|evidence|5357|https://civicdb.org/links/evidence/5357|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=Splice Site (c.464-1G>A)
3	10191470	2077	G	C	.	.	VT=Splice Site (c.464-1G>C);GN=VHL;CSQ=C|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>C||Splice Site (c.464-1G>C)|2077|C.464-1G>C&RS5030817&IVS2-1G>C|https://civicdb.org/links/variants/2077|VHL Splice Site (c.464-1G>C)|1953|C.464-1G>C&RS5030817&IVS2-1G>C|https://civicdb.org/links/molecular-profiles/1953|NM_000551.3:c.464-1G>C&NC_000003.11:g.10191470G>C&ENST00000256474.2:c.464-1G>C&NP_000542.1:p.=&NC_000003.12:g.10149786G>C|CA357081|223220|5.0|evidence|5745|https://civicdb.org/links/evidence/5745|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||
3	10191470	1990	G	T	.	.	CSQ=T|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>T||Splice Site (c.464-1G>T)|1990|C.464-1G>T&RS5030817&IVS2-1G>T|https://civicdb.org/links/variants/1990|VHL Splice Site (c.464-1G>T)|1866|C.464-1G>T&RS5030817&IVS2-1G>T|https://civicdb.org/links/molecular-profiles/1866|NC_000003.11:g.10191470G>T&NM_000551.3:c.464-1G>T&ENST00000256474.2:c.464-1G>T&NC_000003.12:g.10149786G>T&NP_000542.1:p.?|CA357144|223221|12.5|evidence|5642|https://civicdb.org/links/evidence/5642|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Splice Acceptor Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464-1G>T||Splice Site (c.464-1G>T)|1990|C.464-1G>T&RS5030817&IVS2-1G>T|https://civicdb.org/links/variants/1990|VHL Splice Site (c.464-1G>T)|1866|C.464-1G>T&RS5030817&IVS2-1G>T|https://civicdb.org/links/molecular-profiles/1866|NC_000003.11:g.10191470G>T&NM_000551.3:c.464-1G>T&ENST00000256474.2:c.464-1G>T&NC_000003.12:g.10149786G>T&NP_000542.1:p.?|CA357144|223221|12.5|evidence|5343|https://civicdb.org/links/evidence/5343|8641976 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=Splice Site (c.464-1G>T)
3	10191471	1909	T	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464T>A||V155E (c.464T>A)|1909|C.464T>A&VAL155GLU|https://civicdb.org/links/variants/1909|VHL V155E (c.464T>A)|1785|C.464T>A&VAL155GLU|https://civicdb.org/links/molecular-profiles/1785|ENST00000256474.2:c.464T>A&NC_000003.11:g.10191471T>A&NM_000551.3:c.464T>A&NP_000542.1:p.Val155Glu|CA351756032|NONE FOUND|10.0|evidence|5171|https://civicdb.org/links/evidence/5171|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=V155E (c.464T>A)
3	10191471	1934	T	G	.	.	GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.464T>G||V155G (c.464T>G)|1934|C.464T>G&VAL155GLY|https://civicdb.org/links/variants/1934|VHL V155G (c.464T>G)|1810|C.464T>G&VAL155GLY|https://civicdb.org/links/molecular-profiles/1810|ENST00000256474.2:c.464T>G&NC_000003.11:g.10191471T>G&NM_000551.3:c.464T>G&NP_000542.1:p.Val155Gly|CA16621938|NONE FOUND|2.5|evidence|6579|https://civicdb.org/links/evidence/6579|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;VT=V155G (c.464T>G)
3	10191473	1967	T	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.466T>G||Y156D (c.466T>G)|1967|C.466T>G&TYR156ASP|https://civicdb.org/links/variants/1967|VHL Y156D (c.466T>G)|1843|C.466T>G&TYR156ASP|https://civicdb.org/links/molecular-profiles/1843|ENST00000256474.2:c.466T>G&NC_000003.11:g.10191473T>G&NM_000551.3:c.466T>G&NP_000542.1:p.Tyr156Asp|CA351756043|NONE FOUND|17.5|evidence|6112|https://civicdb.org/links/evidence/6112|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.466T>G||Y156D (c.466T>G)|1967|C.466T>G&TYR156ASP|https://civicdb.org/links/variants/1967|VHL Y156D (c.466T>G)|1843|C.466T>G&TYR156ASP|https://civicdb.org/links/molecular-profiles/1843|ENST00000256474.2:c.466T>G&NC_000003.11:g.10191473T>G&NM_000551.3:c.466T>G&NP_000542.1:p.Tyr156Asp|CA351756043|NONE FOUND|17.5|evidence|5297|https://civicdb.org/links/evidence/5297|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=Y156D (c.466T>G)
3	10191473	2013	T	A	.	.	VT=Y156N (c.466T>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.466T>A||Y156N (c.466T>A)|2013|C.466T>A&TYR156ASN|https://civicdb.org/links/variants/2013|VHL Y156N (c.466T>A)|1889|C.466T>A&TYR156ASN|https://civicdb.org/links/molecular-profiles/1889|ENST00000256474.2:c.466T>A&NC_000003.11:g.10191473T>A&NM_000551.3:c.466T>A&NP_000542.1:p.Tyr156Asn|CA351756038|NONE FOUND|7.5|evidence|5416|https://civicdb.org/links/evidence/5416|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191474	1946	A	G	.	.	VT=Y156C (c.467A>G);CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C (c.467A>G)|1946|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/variants/1946|VHL Y156C (c.467A>G)|1822|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/molecular-profiles/1822|NM_000551.3:c.467A>G&NP_000542.1:p.Tyr156Cys&NC_000003.11:g.10191474A>G&ENST00000256474.2:c.467A>G|CA020394|43600|27.5|evidence|5298|https://civicdb.org/links/evidence/5298|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C (c.467A>G)|1946|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/variants/1946|VHL Y156C (c.467A>G)|1822|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/molecular-profiles/1822|NM_000551.3:c.467A>G&NP_000542.1:p.Tyr156Cys&NC_000003.11:g.10191474A>G&ENST00000256474.2:c.467A>G|CA020394|43600|27.5|evidence|5417|https://civicdb.org/links/evidence/5417|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C (c.467A>G)|1946|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/variants/1946|VHL Y156C (c.467A>G)|1822|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/molecular-profiles/1822|NM_000551.3:c.467A>G&NP_000542.1:p.Tyr156Cys&NC_000003.11:g.10191474A>G&ENST00000256474.2:c.467A>G|CA020394|43600|27.5|evidence|6516|https://civicdb.org/links/evidence/6516|24132471 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.467A>G||Y156C (c.467A>G)|1946|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/variants/1946|VHL Y156C (c.467A>G)|1822|C.467A>G&TYR156CYS&RS397516441|https://civicdb.org/links/molecular-profiles/1822|NM_000551.3:c.467A>G&NP_000542.1:p.Tyr156Cys&NC_000003.11:g.10191474A>G&ENST00000256474.2:c.467A>G|CA020394|43600|27.5|evidence|5463|https://civicdb.org/links/evidence/5463|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL
3	10191475	1968	T	G	.	.	VT=Y156* (c.468T>G);GN=VHL;CSQ=G|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.468T>G||Y156* (c.468T>G)|1968|C.468T>G&Y156X&TYR156TER|https://civicdb.org/links/variants/1968|VHL Y156* (c.468T>G)|1844|C.468T>G&Y156X&TYR156TER|https://civicdb.org/links/molecular-profiles/1844|ENST00000256474.2:c.468T>G&NC_000003.11:g.10191475T>G&NM_000551.3:c.468T>G&NP_000542.1:p.Tyr156Ter|CA351756053|NONE FOUND|7.5|evidence|5299|https://civicdb.org/links/evidence/5299|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191477	1745	C	T	.	.	GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I (c.470C>T)|1745|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/variants/1745|VHL T157I (c.470C>T)|1621|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/molecular-profiles/1621|NM_000551.3:c.470C>T&NP_000542.1:p.Thr157Ile&NC_000003.11:g.10191477C>T&ENST00000256474.2:c.470C>T|CA357133|223223|32.5|evidence|4910|https://civicdb.org/links/evidence/4910|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I (c.470C>T)|1745|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/variants/1745|VHL T157I (c.470C>T)|1621|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/molecular-profiles/1621|NM_000551.3:c.470C>T&NP_000542.1:p.Thr157Ile&NC_000003.11:g.10191477C>T&ENST00000256474.2:c.470C>T|CA357133|223223|32.5|evidence|6612|https://civicdb.org/links/evidence/6612|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I (c.470C>T)|1745|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/variants/1745|VHL T157I (c.470C>T)|1621|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/molecular-profiles/1621|NM_000551.3:c.470C>T&NP_000542.1:p.Thr157Ile&NC_000003.11:g.10191477C>T&ENST00000256474.2:c.470C>T|CA357133|223223|32.5|evidence|8988|https://civicdb.org/links/evidence/8988|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I (c.470C>T)|1745|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/variants/1745|VHL T157I (c.470C>T)|1621|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/molecular-profiles/1621|NM_000551.3:c.470C>T&NP_000542.1:p.Thr157Ile&NC_000003.11:g.10191477C>T&ENST00000256474.2:c.470C>T|CA357133|223223|32.5|evidence|5294|https://civicdb.org/links/evidence/5294|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.470C>T||T157I (c.470C>T)|1745|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/variants/1745|VHL T157I (c.470C>T)|1621|C.470C>T&THR157ILE&RS869025660|https://civicdb.org/links/molecular-profiles/1621|NM_000551.3:c.470C>T&NP_000542.1:p.Thr157Ile&NC_000003.11:g.10191477C>T&ENST00000256474.2:c.470C>T|CA357133|223223|32.5|evidence|6581|https://civicdb.org/links/evidence/6581|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;VT=T157I (c.470C>T)
3	10191478	1783	T	TT	.	.	GN=VHL;VT=L158fs (c.471dupT);CSQ=T|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.471dup||L158fs (c.471dupT)|1783|C.685INST|https://civicdb.org/links/variants/1783|VHL L158fs (c.471dupT)|1659|C.685INST|https://civicdb.org/links/molecular-profiles/1659|NC_000003.11:g.10191478dup&NC_000003.12:g.10149794dup&NM_000551.3:c.471dup&NP_000542.1:p.Leu158SerfsTer16&ENST00000256474.2:c.471dup&ENSP00000256474.2:p.Leu158SerfsTer16|CA357050|NONE FOUND|5.0|evidence|5646|https://civicdb.org/links/evidence/5646|8956040 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||
3	10191479	1803	C	G	.	.	VT=L158V (c.472C>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.472C>G||L158V (c.472C>G)|1803|C.472C>G&LEU158VAL|https://civicdb.org/links/variants/1803|VHL L158V (c.472C>G)|1679|C.472C>G&LEU158VAL|https://civicdb.org/links/molecular-profiles/1679|ENST00000256474.2:c.472C>G&NC_000003.11:g.10191479C>G&NM_000551.3:c.472C>G&NP_000542.1:p.Leu158Val|CA351756068|NONE FOUND|22.5|evidence|5146|https://civicdb.org/links/evidence/5146|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.472C>G||L158V (c.472C>G)|1803|C.472C>G&LEU158VAL|https://civicdb.org/links/variants/1803|VHL L158V (c.472C>G)|1679|C.472C>G&LEU158VAL|https://civicdb.org/links/molecular-profiles/1679|ENST00000256474.2:c.472C>G&NC_000003.11:g.10191479C>G&NM_000551.3:c.472C>G&NP_000542.1:p.Leu158Val|CA351756068|NONE FOUND|22.5|evidence|4977|https://civicdb.org/links/evidence/4977|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.472C>G||L158V (c.472C>G)|1803|C.472C>G&LEU158VAL|https://civicdb.org/links/variants/1803|VHL L158V (c.472C>G)|1679|C.472C>G&LEU158VAL|https://civicdb.org/links/molecular-profiles/1679|ENST00000256474.2:c.472C>G&NC_000003.11:g.10191479C>G&NM_000551.3:c.472C>G&NP_000542.1:p.Leu158Val|CA351756068|NONE FOUND|22.5|evidence|5464|https://civicdb.org/links/evidence/5464|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191480	1872	T	TT	.	.	GN=VHL;VT=K159fs (c.473dup);CSQ=T|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473dup||K159fs (c.473dup)|1872|C.473INST&C.473DUPT|https://civicdb.org/links/variants/1872|VHL K159fs (c.473dup)|1748|C.473INST&C.473DUPT|https://civicdb.org/links/molecular-profiles/1748|NM_000551.3:c.473dup&NP_000542.1:p.Lys159GlufsTer15&ENST00000256474.2:c.473dup&ENSP00000256474.2:p.Lys159GlufsTer15&NC_000003.11:g.10191480dup&NC_000003.12:g.10149796dup|None|NONE FOUND|7.5|evidence|5280|https://civicdb.org/links/evidence/5280|9829912 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191480	2137	TGAA	TC	.	.	GN=VHL;CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.474_476delGAAinsC||K159fs (c.474_476delGAAinsC)|2137|C.474_476DELGAAINSC&LEU158FS&LYS159FS&K159FS|https://civicdb.org/links/variants/2137|VHL K159fs (c.474_476delGAAinsC)|2013|C.474_476DELGAAINSC&LEU158FS&LYS159FS&K159FS|https://civicdb.org/links/molecular-profiles/2013|ENST00000256474.2:c.474_476delGAAinsC|CA658683298|NONE FOUND|7.5|evidence|5735|https://civicdb.org/links/evidence/5735|17024664 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||;VT=K159fs (c.474_476delGAAinsC)
3	10191480	1738	T	C	.	.	GN=VHL;VT=L158P (c.473T>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P (c.473T>C)|1738|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/variants/1738|VHL L158P (c.473T>C)|1614|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/molecular-profiles/1614|NM_000551.3:c.473T>C&NP_000542.1:p.Leu158Pro&NC_000003.11:g.10191480T>C&ENST00000256474.2:c.473T>C|CA020399|182980|30.0|evidence|4938|https://civicdb.org/links/evidence/4938|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P (c.473T>C)|1738|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/variants/1738|VHL L158P (c.473T>C)|1614|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/molecular-profiles/1614|NM_000551.3:c.473T>C&NP_000542.1:p.Leu158Pro&NC_000003.11:g.10191480T>C&ENST00000256474.2:c.473T>C|CA020399|182980|30.0|evidence|5103|https://civicdb.org/links/evidence/5103|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P (c.473T>C)|1738|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/variants/1738|VHL L158P (c.473T>C)|1614|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/molecular-profiles/1614|NM_000551.3:c.473T>C&NP_000542.1:p.Leu158Pro&NC_000003.11:g.10191480T>C&ENST00000256474.2:c.473T>C|CA020399|182980|30.0|evidence|5281|https://civicdb.org/links/evidence/5281|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P (c.473T>C)|1738|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/variants/1738|VHL L158P (c.473T>C)|1614|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/molecular-profiles/1614|NM_000551.3:c.473T>C&NP_000542.1:p.Leu158Pro&NC_000003.11:g.10191480T>C&ENST00000256474.2:c.473T>C|CA020399|182980|30.0|evidence|6613|https://civicdb.org/links/evidence/6613|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.473T>C||L158P (c.473T>C)|1738|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/variants/1738|VHL L158P (c.473T>C)|1614|C.473T>C&LEU158PRO&RS121913346|https://civicdb.org/links/molecular-profiles/1614|NM_000551.3:c.473T>C&NP_000542.1:p.Leu158Pro&NC_000003.11:g.10191480T>C&ENST00000256474.2:c.473T>C|CA020399|182980|30.0|evidence|9537|https://civicdb.org/links/evidence/9537|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191481	2098	GA	G	.	.	VT=E160fs (c.477del);GN=VHL;CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.475del||E160fs (c.477del)|2098|C.475DELA&LYS159FS&E160SFS*10|https://civicdb.org/links/variants/2098|VHL E160fs (c.477del)|1974|C.475DELA&LYS159FS&E160SFS*10|https://civicdb.org/links/molecular-profiles/1974|ENST00000256474.2:c.475del&NP_000542.1:p.Glu160SerfsTer10&NM_000551.3:c.477del&NC_000003.12:g.10149800del&NC_000003.11:g.10191484del|CA020404|182959|7.5|evidence|5651|https://civicdb.org/links/evidence/5651|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191484	2040	A	ACA	.	.	CSQ=CA|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.477_478insCA||K159fs (c.477_478insCA)|2040|LYS159FS&C.477_478INSCA|https://civicdb.org/links/variants/2040|VHL K159fs (c.477_478insCA)|1916|LYS159FS&C.477_478INSCA|https://civicdb.org/links/molecular-profiles/1916|ENST00000256474.2:c.477_478insCA|CA645525053|NONE FOUND|5.0|evidence|5496|https://civicdb.org/links/evidence/5496|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=K159fs (c.477_478insCA)
3	10191485	1919	GAG	G	.	.	CSQ=-|Frameshift Truncation&Minus 2 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.479_480delAG||E160fs (c.479_480delAG)|1919|GLU160FS&C.479_480DELAG&G160AFS*13&C.477_478DEL|https://civicdb.org/links/variants/1919|VHL E160fs (c.479_480delAG)|1795|GLU160FS&C.479_480DELAG&G160AFS*13&C.477_478DEL|https://civicdb.org/links/molecular-profiles/1795|ENST00000256474.2:c.479_480delAG&NC_000003.11:g.10191486_10191487delAG&NM_000551.3:c.479_480delAG&NP_000542.1:p.Glu160AlafsTer13|CA020404|NONE FOUND|10.0|evidence|5191|https://civicdb.org/links/evidence/5191|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,-|Frameshift Truncation&Minus 2 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.479_480delAG||E160fs (c.479_480delAG)|1919|GLU160FS&C.479_480DELAG&G160AFS*13&C.477_478DEL|https://civicdb.org/links/variants/1919|VHL E160fs (c.479_480delAG)|1795|GLU160FS&C.479_480DELAG&G160AFS*13&C.477_478DEL|https://civicdb.org/links/molecular-profiles/1795|ENST00000256474.2:c.479_480delAG&NC_000003.11:g.10191486_10191487delAG&NM_000551.3:c.479_480delAG&NP_000542.1:p.Glu160AlafsTer13|CA020404|NONE FOUND|10.0|evidence|5465|https://civicdb.org/links/evidence/5465|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=E160fs (c.479_480delAG)
3	10191488	1804	C	T	.	.	VT=R161* (c.481C>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|5761|https://civicdb.org/links/evidence/5761|20151405 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|5049|https://civicdb.org/links/evidence/5049|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|5263|https://civicdb.org/links/evidence/5263|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|5375|https://civicdb.org/links/evidence/5375|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Renal Cell Carcinoma||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|5483|https://civicdb.org/links/evidence/5483|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|6116|https://civicdb.org/links/evidence/6116|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|6221|https://civicdb.org/links/evidence/6221|27617348 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|6614|https://civicdb.org/links/evidence/6614|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|8222|https://civicdb.org/links/evidence/8222|11148816 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|9540|https://civicdb.org/links/evidence/9540|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|6201|https://civicdb.org/links/evidence/6201|28630796 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>T||R161* (c.481C>T)|1804|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/variants/1804|VHL R161* (c.481C>T)|1680|C.481C>T&R161X&ARG161TER&RS5030818|https://civicdb.org/links/molecular-profiles/1680|NM_000551.3:c.481C>T&NP_000542.1:p.Arg161Ter&NC_000003.11:g.10191488C>T&ENST00000256474.2:c.481C>T|CA020408|2217|85.0|evidence|6583|https://civicdb.org/links/evidence/6583|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;GN=VHL
3	10191488	2148	C	A	.	.	CSQ=A|Synonymous Variant|VHL|7428|transcript|ENST00000256474.2|||R161R (c.481C>A)|2148|R161R (C.481C>A)|https://civicdb.org/links/variants/2148|VHL R161R (c.481C>A)|2024|R161R (C.481C>A)|https://civicdb.org/links/molecular-profiles/2024|NC_000003.11:g.10191488C>A&NC_000003.12:g.10149804C>A&NP_000542.1:p.Arg161=|CA432423146|NONE FOUND|5.0|evidence|5768|https://civicdb.org/links/evidence/5768|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=R161R (c.481C>A)
3	10191488	1915	C	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>G||R161G (c.481C>G)|1915|C.481C>G&ARG161GLY&RS5030818|https://civicdb.org/links/variants/1915|VHL R161G (c.481C>G)|1791|C.481C>G&ARG161GLY&RS5030818|https://civicdb.org/links/molecular-profiles/1791|ENST00000256474.2:c.481C>G&NC_000003.11:g.10191488C>G&NM_000551.3:c.481C>G&NP_000542.1:p.Arg161Gly|CA16621941|NONE FOUND|7.5|evidence|5353|https://civicdb.org/links/evidence/5353|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.481C>G||R161G (c.481C>G)|1915|C.481C>G&ARG161GLY&RS5030818|https://civicdb.org/links/variants/1915|VHL R161G (c.481C>G)|1791|C.481C>G&ARG161GLY&RS5030818|https://civicdb.org/links/molecular-profiles/1791|ENST00000256474.2:c.481C>G&NC_000003.11:g.10191488C>G&NM_000551.3:c.481C>G&NP_000542.1:p.Arg161Gly|CA16621941|NONE FOUND|7.5|evidence|6582|https://civicdb.org/links/evidence/6582|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;GN=VHL;VT=R161G (c.481C>G)
3	10191489	2035	GA	G	.	.	CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.483del||C162fs (c.483del)|2035|C.483DELA&CYS162FS&C162AFS*8|https://civicdb.org/links/variants/2035|VHL C162fs (c.483del)|1911|C.483DELA&CYS162FS&C162AFS*8|https://civicdb.org/links/molecular-profiles/1911|NC_000003.11:g.10191490del&NP_000542.1:p.Cys162AlafsTer8&ENST00000256474.2:c.483del&NM_000551.3:c.483del&NC_000003.12:g.10149806del|CA658795183|928822|5.0|evidence|5482|https://civicdb.org/links/evidence/5482|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=C162fs (c.483del)
3	10191489	1855	G	C	.	.	VT=R161P (c.482G>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>C||R161P (c.482G>C)|1855|C.482G>C&ARG161PRO|https://civicdb.org/links/variants/1855|VHL R161P (c.482G>C)|1731|C.482G>C&ARG161PRO|https://civicdb.org/links/molecular-profiles/1731|ENST00000256474.2:c.482G>C&NC_000003.11:g.10191489G>C&NM_000551.3:c.482G>C&NP_000542.1:p.Arg161Pro|CA351756111|NONE FOUND|7.5|evidence|5401|https://civicdb.org/links/evidence/5401|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191489	1746	G	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|4911|https://civicdb.org/links/evidence/4911|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|5061|https://civicdb.org/links/evidence/5061|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|5125|https://civicdb.org/links/evidence/5125|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|5179|https://civicdb.org/links/evidence/5179|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|5262|https://civicdb.org/links/evidence/5262|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|5400|https://civicdb.org/links/evidence/5400|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|7141|https://civicdb.org/links/evidence/7141|29662268 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|7891|https://civicdb.org/links/evidence/7891|11850829 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|5466|https://civicdb.org/links/evidence/5466|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.482G>A||R161Q (c.482G>A)|1746|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/variants/1746|VHL R161Q (c.482G>A)|1622|C.482G>A&ARG161GLN&RS730882035|https://civicdb.org/links/molecular-profiles/1622|NM_000551.3:c.482G>A&NP_000542.1:p.Arg161Gln&NC_000003.11:g.10191489G>A&ENST00000256474.2:c.482G>A|CA020413|182983|72.5|evidence|5481|https://civicdb.org/links/evidence/5481|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=R161Q (c.482G>A)
3	10191491	1772	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.484T>C||C162R (c.484T>C)|1772|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/variants/1772|VHL C162R (c.484T>C)|1648|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/molecular-profiles/1648|ENST00000256474.2:c.484T>C&NM_000551.3:c.484T>C&NC_000003.11:g.10191491T>C&NP_000542.1:p.Cys162Arg|CA351756117|496067|22.5|evidence|8989|https://civicdb.org/links/evidence/8989|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.484T>C||C162R (c.484T>C)|1772|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/variants/1772|VHL C162R (c.484T>C)|1648|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/molecular-profiles/1648|ENST00000256474.2:c.484T>C&NM_000551.3:c.484T>C&NC_000003.11:g.10191491T>C&NP_000542.1:p.Cys162Arg|CA351756117|496067|22.5|evidence|4939|https://civicdb.org/links/evidence/4939|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.484T>C||C162R (c.484T>C)|1772|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/variants/1772|VHL C162R (c.484T>C)|1648|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/molecular-profiles/1648|ENST00000256474.2:c.484T>C&NM_000551.3:c.484T>C&NC_000003.11:g.10191491T>C&NP_000542.1:p.Cys162Arg|CA351756117|496067|22.5|evidence|5175|https://civicdb.org/links/evidence/5175|19270817 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.484T>C||C162R (c.484T>C)|1772|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/variants/1772|VHL C162R (c.484T>C)|1648|RS1553620313&C.484T>C&CYS162ARG|https://civicdb.org/links/molecular-profiles/1648|ENST00000256474.2:c.484T>C&NM_000551.3:c.484T>C&NC_000003.11:g.10191491T>C&NP_000542.1:p.Cys162Arg|CA351756117|496067|22.5|evidence|5349|https://civicdb.org/links/evidence/5349|8641976 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=C162R (c.484T>C)
3	10191492	1773	G	T	.	.	VT=C162F (c.485G>T);GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F (c.485G>T)|1773|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/variants/1773|VHL C162F (c.485G>T)|1649|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/molecular-profiles/1649|NM_000551.3:c.485G>T&NP_000542.1:p.Cys162Phe&NC_000003.11:g.10191492G>T&ENST00000256474.2:c.485G>T|CA020418|43604|22.5|evidence|4940|https://civicdb.org/links/evidence/4940|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F (c.485G>T)|1773|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/variants/1773|VHL C162F (c.485G>T)|1649|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/molecular-profiles/1649|NM_000551.3:c.485G>T&NP_000542.1:p.Cys162Phe&NC_000003.11:g.10191492G>T&ENST00000256474.2:c.485G>T|CA020418|43604|22.5|evidence|5050|https://civicdb.org/links/evidence/5050|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F (c.485G>T)|1773|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/variants/1773|VHL C162F (c.485G>T)|1649|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/molecular-profiles/1649|NM_000551.3:c.485G>T&NP_000542.1:p.Cys162Phe&NC_000003.11:g.10191492G>T&ENST00000256474.2:c.485G>T|CA020418|43604|22.5|evidence|5189|https://civicdb.org/links/evidence/5189|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>T||C162F (c.485G>T)|1773|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/variants/1773|VHL C162F (c.485G>T)|1649|C.485G>T&CYS162PHE&RS397516444|https://civicdb.org/links/molecular-profiles/1649|NM_000551.3:c.485G>T&NP_000542.1:p.Cys162Phe&NC_000003.11:g.10191492G>T&ENST00000256474.2:c.485G>T|CA020418|43604|22.5|evidence|6584|https://civicdb.org/links/evidence/6584|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||
3	10191492	1824	G	A	.	.	GN=VHL;VT=C162Y (c.485G>A);CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>A||C162Y (c.485G>A)|1824|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/variants/1824|VHL C162Y (c.485G>A)|1700|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/molecular-profiles/1700|NM_000551.3:c.485G>A&NP_000542.1:p.Cys162Tyr&NC_000003.11:g.10191492G>A&ENST00000256474.2:c.485G>A|CA357010|223225|27.5|evidence|5383|https://civicdb.org/links/evidence/5383|10761708 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>A||C162Y (c.485G>A)|1824|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/variants/1824|VHL C162Y (c.485G>A)|1700|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/molecular-profiles/1700|NM_000551.3:c.485G>A&NP_000542.1:p.Cys162Tyr&NC_000003.11:g.10191492G>A&ENST00000256474.2:c.485G>A|CA357010|223225|27.5|evidence|6615|https://civicdb.org/links/evidence/6615|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>A||C162Y (c.485G>A)|1824|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/variants/1824|VHL C162Y (c.485G>A)|1700|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/molecular-profiles/1700|NM_000551.3:c.485G>A&NP_000542.1:p.Cys162Tyr&NC_000003.11:g.10191492G>A&ENST00000256474.2:c.485G>A|CA357010|223225|27.5|evidence|8990|https://civicdb.org/links/evidence/8990|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.485G>A||C162Y (c.485G>A)|1824|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/variants/1824|VHL C162Y (c.485G>A)|1700|C.485G>A&CYS162TYR&RS397516444|https://civicdb.org/links/molecular-profiles/1700|NM_000551.3:c.485G>A&NP_000542.1:p.Cys162Tyr&NC_000003.11:g.10191492G>A&ENST00000256474.2:c.485G>A|CA357010|223225|27.5|evidence|5493|https://civicdb.org/links/evidence/5493|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191493	1774	C	G	.	.	VT=C162W (c.486C>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W (c.486C>G)|1774|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/variants/1774|VHL C162W (c.486C>G)|1650|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/molecular-profiles/1650|NM_000551.3:c.486C>G&NP_000542.1:p.Cys162Trp&NC_000003.11:g.10191493C>G&ENST00000256474.2:c.486C>G|CA357016|223227|32.5|evidence|6616|https://civicdb.org/links/evidence/6616|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W (c.486C>G)|1774|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/variants/1774|VHL C162W (c.486C>G)|1650|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/molecular-profiles/1650|NM_000551.3:c.486C>G&NP_000542.1:p.Cys162Trp&NC_000003.11:g.10191493C>G&ENST00000256474.2:c.486C>G|CA357016|223227|32.5|evidence|7895|https://civicdb.org/links/evidence/7895|11850829 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W (c.486C>G)|1774|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/variants/1774|VHL C162W (c.486C>G)|1650|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/molecular-profiles/1650|NM_000551.3:c.486C>G&NP_000542.1:p.Cys162Trp&NC_000003.11:g.10191493C>G&ENST00000256474.2:c.486C>G|CA357016|223227|32.5|evidence|4941|https://civicdb.org/links/evidence/4941|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W (c.486C>G)|1774|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/variants/1774|VHL C162W (c.486C>G)|1650|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/molecular-profiles/1650|NM_000551.3:c.486C>G&NP_000542.1:p.Cys162Trp&NC_000003.11:g.10191493C>G&ENST00000256474.2:c.486C>G|CA357016|223227|32.5|evidence|5267|https://civicdb.org/links/evidence/5267|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W (c.486C>G)|1774|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/variants/1774|VHL C162W (c.486C>G)|1650|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/molecular-profiles/1650|NM_000551.3:c.486C>G&NP_000542.1:p.Cys162Trp&NC_000003.11:g.10191493C>G&ENST00000256474.2:c.486C>G|CA357016|223227|32.5|evidence|5355|https://civicdb.org/links/evidence/5355|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.486C>G||C162W (c.486C>G)|1774|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/variants/1774|VHL C162W (c.486C>G)|1650|C.486C>G&CYS162TRP&RS869025662|https://civicdb.org/links/molecular-profiles/1650|NM_000551.3:c.486C>G&NP_000542.1:p.Cys162Trp&NC_000003.11:g.10191493C>G&ENST00000256474.2:c.486C>G|CA357016|223227|32.5|evidence|6585|https://civicdb.org/links/evidence/6585|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||
3	10191495	2033	T	A	.	.	GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.488T>A||L163H (c.488T>A)|2033|C.488T>A&LEU163HIS|https://civicdb.org/links/variants/2033|VHL L163H (c.488T>A)|1909|C.488T>A&LEU163HIS|https://civicdb.org/links/molecular-profiles/1909|ENST00000256474.2:c.488T>A&NC_000003.11:g.10191495T>A&NM_000551.3:c.488T>A&NP_000542.1:p.Leu163His|CA351756137|NONE FOUND|5.0|evidence|5467|https://civicdb.org/links/evidence/5467|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=L163H (c.488T>A)
3	10191497	1845	C	T	.	.	VT=Q164* (c.490C>T);GN=VHL;CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.490C>T||Q164* (c.490C>T)|1845|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/variants/1845|VHL Q164* (c.490C>T)|1721|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/molecular-profiles/1721|NM_000551.3:c.490C>T&NP_000542.1:p.Gln164Ter&NC_000003.11:g.10191497C>T&ENST00000256474.2:c.490C>T|CA357060|223228|30.0|evidence|5051|https://civicdb.org/links/evidence/5051|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.490C>T||Q164* (c.490C>T)|1845|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/variants/1845|VHL Q164* (c.490C>T)|1721|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/molecular-profiles/1721|NM_000551.3:c.490C>T&NP_000542.1:p.Gln164Ter&NC_000003.11:g.10191497C>T&ENST00000256474.2:c.490C>T|CA357060|223228|30.0|evidence|5096|https://civicdb.org/links/evidence/5096|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.490C>T||Q164* (c.490C>T)|1845|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/variants/1845|VHL Q164* (c.490C>T)|1721|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/molecular-profiles/1721|NM_000551.3:c.490C>T&NP_000542.1:p.Gln164Ter&NC_000003.11:g.10191497C>T&ENST00000256474.2:c.490C>T|CA357060|223228|30.0|evidence|5403|https://civicdb.org/links/evidence/5403|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.490C>T||Q164* (c.490C>T)|1845|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/variants/1845|VHL Q164* (c.490C>T)|1721|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/molecular-profiles/1721|NM_000551.3:c.490C>T&NP_000542.1:p.Gln164Ter&NC_000003.11:g.10191497C>T&ENST00000256474.2:c.490C>T|CA357060|223228|30.0|evidence|5359|https://civicdb.org/links/evidence/5359|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.490C>T||Q164* (c.490C>T)|1845|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/variants/1845|VHL Q164* (c.490C>T)|1721|C.490C>T&Q164X&GLN164TER&RS5030819|https://civicdb.org/links/molecular-profiles/1721|NM_000551.3:c.490C>T&NP_000542.1:p.Gln164Ter&NC_000003.11:g.10191497C>T&ENST00000256474.2:c.490C>T|CA357060|223228|30.0|evidence|6925|https://civicdb.org/links/evidence/6925|7915601 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|1|||||
3	10191498	2079	A	T	.	.	CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.491A>T||Q164L (c.491A>T)|2079|C.491A>T&GLN164LEU|https://civicdb.org/links/variants/2079|VHL Q164L (c.491A>T)|1955|C.491A>T&GLN164LEU|https://civicdb.org/links/molecular-profiles/1955|ENST00000256474.2:c.491A>T&NC_000003.11:g.10191498A>T&NM_000551.3:c.491A>T&NP_000542.1:p.Gln164Leu|CA351756149|NONE FOUND|7.5|evidence|6617|https://civicdb.org/links/evidence/6617|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=Q164L (c.491A>T)
3	10191498	1856	A	G	.	.	VT=Q164R (c.491A>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.491A>G||Q164R (c.491A>G)|1856|C.491A>G&GLN164ARG&RS267607170|https://civicdb.org/links/variants/1856|VHL Q164R (c.491A>G)|1732|C.491A>G&GLN164ARG&RS267607170|https://civicdb.org/links/molecular-profiles/1732|NM_000551.3:c.491A>G&NP_000542.1:p.Gln164Arg&NC_000003.11:g.10191498A>G&ENST00000256474.2:c.491A>G|CA020429|2238|20.0|evidence|5133|https://civicdb.org/links/evidence/5133|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.491A>G||Q164R (c.491A>G)|1856|C.491A>G&GLN164ARG&RS267607170|https://civicdb.org/links/variants/1856|VHL Q164R (c.491A>G)|1732|C.491A>G&GLN164ARG&RS267607170|https://civicdb.org/links/molecular-profiles/1732|NM_000551.3:c.491A>G&NP_000542.1:p.Gln164Arg&NC_000003.11:g.10191498A>G&ENST00000256474.2:c.491A>G|CA020429|2238|20.0|evidence|5444|https://civicdb.org/links/evidence/5444|20583150 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.491A>G||Q164R (c.491A>G)|1856|C.491A>G&GLN164ARG&RS267607170|https://civicdb.org/links/variants/1856|VHL Q164R (c.491A>G)|1732|C.491A>G&GLN164ARG&RS267607170|https://civicdb.org/links/molecular-profiles/1732|NM_000551.3:c.491A>G&NP_000542.1:p.Gln164Arg&NC_000003.11:g.10191498A>G&ENST00000256474.2:c.491A>G|CA020429|2238|20.0|evidence|10177|https://civicdb.org/links/evidence/10177|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191503	1825	G	T	.	.	CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.496G>T||V166F (c.496G>T)|1825|C.496G>T&VAL166PHE&RS104893825|https://civicdb.org/links/variants/1825|VHL V166F (c.496G>T)|1701|C.496G>T&VAL166PHE&RS104893825|https://civicdb.org/links/molecular-profiles/1701|NM_000551.3:c.496G>T&NP_000542.1:p.Val166Phe&NC_000003.11:g.10191503G>T&ENST00000256474.2:c.496G>T|CA020436|2224|17.5|evidence|5024|https://civicdb.org/links/evidence/5024|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.496G>T||V166F (c.496G>T)|1825|C.496G>T&VAL166PHE&RS104893825|https://civicdb.org/links/variants/1825|VHL V166F (c.496G>T)|1701|C.496G>T&VAL166PHE&RS104893825|https://civicdb.org/links/molecular-profiles/1701|NM_000551.3:c.496G>T&NP_000542.1:p.Val166Phe&NC_000003.11:g.10191503G>T&ENST00000256474.2:c.496G>T|CA020436|2224|17.5|evidence|5302|https://civicdb.org/links/evidence/5302|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.496G>T||V166F (c.496G>T)|1825|C.496G>T&VAL166PHE&RS104893825|https://civicdb.org/links/variants/1825|VHL V166F (c.496G>T)|1701|C.496G>T&VAL166PHE&RS104893825|https://civicdb.org/links/molecular-profiles/1701|NM_000551.3:c.496G>T&NP_000542.1:p.Val166Phe&NC_000003.11:g.10191503G>T&ENST00000256474.2:c.496G>T|CA020436|2224|17.5|evidence|8606|https://civicdb.org/links/evidence/8606|20151405 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=V166F (c.496G>T);GN=VHL
3	10191504	2437	T	C	.	.	GN=VHL;VT=V166A (c.497T>C);CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.497T>C||V166A (c.497T>C)|2437|VAL166ALA|https://civicdb.org/links/variants/2437|VHL V166A (c.497T>C)|2310|VAL166ALA|https://civicdb.org/links/molecular-profiles/2310|NC_000003.11:g.10191504T>C&NM_000551.3:c.497T>C&NP_000542.1:p.Val166Ala&ENST00000256474.2:c.497T>C|CA020442|43605|7.5|evidence|6518|https://civicdb.org/links/evidence/6518|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191504	1775	T	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.497T>A||V166D (c.497T>A)|1775|C.497T>A&VAL166ASP|https://civicdb.org/links/variants/1775|VHL V166D (c.497T>A)|1651|C.497T>A&VAL166ASP|https://civicdb.org/links/molecular-profiles/1651|ENST00000256474.2:c.497T>A&NC_000003.11:g.10191504T>A&NM_000551.3:c.497T>A&NP_000542.1:p.Val166Asp|CA351756176|625254|10.0|evidence|4942|https://civicdb.org/links/evidence/4942|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=V166D (c.497T>A)
3	10191506	1747	C	T	.	.	VT=R167W (c.499C>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5052|https://civicdb.org/links/evidence/5052|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5265|https://civicdb.org/links/evidence/5265|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5786|https://civicdb.org/links/evidence/5786|25563310 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|6416|https://civicdb.org/links/evidence/6416|12000816 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|8652|https://civicdb.org/links/evidence/8652|28094316 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|4912|https://civicdb.org/links/evidence/4912|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5382|https://civicdb.org/links/evidence/5382|10761708 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5468|https://civicdb.org/links/evidence/5468|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5545|https://civicdb.org/links/evidence/5545|12624160 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|6519|https://civicdb.org/links/evidence/6519|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|6618|https://civicdb.org/links/evidence/6618|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|8469|https://civicdb.org/links/evidence/8469|16042317 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|8968|https://civicdb.org/links/evidence/8968|21382250 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|8991|https://civicdb.org/links/evidence/8991|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5184|https://civicdb.org/links/evidence/5184|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5484|https://civicdb.org/links/evidence/5484|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|5769|https://civicdb.org/links/evidence/5769|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.499C>T||R167W (c.499C>T)|1747|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/variants/1747|VHL R167W (c.499C>T)|1623|C.499C>T&ARG167TRP&R126W&RS5030820|https://civicdb.org/links/molecular-profiles/1623|NM_000551.3:c.499C>T&NP_000542.1:p.Arg167Trp&NC_000003.11:g.10191506C>T&ENST00000256474.2:c.499C>T|CA020450|2218|127.5|evidence|8605|https://civicdb.org/links/evidence/8605|20151405 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL
3	10191507	1916	G	T	.	.	GN=VHL;CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>T||R167L (c.500G>T)|1916|RS5030821&C.500G>T&ARG167LEU|https://civicdb.org/links/variants/1916|VHL R167L (c.500G>T)|1792|RS5030821&C.500G>T&ARG167LEU|https://civicdb.org/links/molecular-profiles/1792|NC_000003.11:g.10191507G>T&NM_000551.3:c.500G>T&NP_000542.1:p.Arg167Leu&ENST00000256474.2:c.500G>T|CA351756178|526685|7.5|evidence|5183|https://civicdb.org/links/evidence/5183|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>T||R167L (c.500G>T)|1916|RS5030821&C.500G>T&ARG167LEU|https://civicdb.org/links/variants/1916|VHL R167L (c.500G>T)|1792|RS5030821&C.500G>T&ARG167LEU|https://civicdb.org/links/molecular-profiles/1792|NC_000003.11:g.10191507G>T&NM_000551.3:c.500G>T&NP_000542.1:p.Arg167Leu&ENST00000256474.2:c.500G>T|CA351756178|526685|7.5|evidence|6588|https://civicdb.org/links/evidence/6588|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;VT=R167L (c.500G>T)
3	10191507	2458	G	C	.	.	GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>C||R167P (c.500G>C)|2458|RS5030821&C.500G>C&ARG167PRO|https://civicdb.org/links/variants/2458|VHL R167P (c.500G>C)|2331|RS5030821&C.500G>C&ARG167PRO|https://civicdb.org/links/molecular-profiles/2331|ENST00000256474.2:c.500G>C&NM_000551.3:c.500G>C&NP_000542.1:p.Arg167Pro&NC_000003.11:g.10191507G>C|CA351756177|428799|7.5|evidence|6620|https://civicdb.org/links/evidence/6620|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=R167P (c.500G>C)
3	10191507	1739	G	A	.	.	VT=R167Q (c.500G>A);CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5062|https://civicdb.org/links/evidence/5062|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|4913|https://civicdb.org/links/evidence/4913|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5264|https://civicdb.org/links/evidence/5264|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5381|https://civicdb.org/links/evidence/5381|10761708 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5402|https://civicdb.org/links/evidence/5402|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5546|https://civicdb.org/links/evidence/5546|12624160 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|6222|https://civicdb.org/links/evidence/6222|29396065 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|6520|https://civicdb.org/links/evidence/6520|24132471 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|6619|https://civicdb.org/links/evidence/6619|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|8992|https://civicdb.org/links/evidence/8992|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|9538|https://civicdb.org/links/evidence/9538|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5354|https://civicdb.org/links/evidence/5354|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5469|https://civicdb.org/links/evidence/5469|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5485|https://civicdb.org/links/evidence/5485|20846682 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|5487|https://civicdb.org/links/evidence/5487|12114495 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|evidence|6587|https://civicdb.org/links/evidence/6587|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.500G>A||R167Q (c.500G>A)|1739|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/variants/1739|VHL R167Q (c.500G>A)|1615|C.500G>A&ARG167GLN&RS5030821|https://civicdb.org/links/molecular-profiles/1615|NM_000551.3:c.500G>A&NP_000542.1:p.Arg167Gln&NC_000003.11:g.10191507G>A&ENST00000256474.2:c.500G>A|CA020454|2216|110.0|assertion|4|https://civicdb.org/links/assertion/4||RARE_GERMLINE|accepted|PATHOGENIC|SUPPORTS|Von Hippel-Lindau Disease (DOID 14175)||||||PS4&PM1&PM2&PP4&PP1||||;GN=VHL
3	10191513	1887	T	C	.	.	VT=L169P (c.506T>C);GN=VHL;CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.506T>C||L169P (c.506T>C)|1887|C.506T>C&LEU169PRO&RS1131690962|https://civicdb.org/links/variants/1887|VHL L169P (c.506T>C)|1763|C.506T>C&LEU169PRO&RS1131690962|https://civicdb.org/links/molecular-profiles/1763|NM_000551.3:c.506T>C&NP_000542.1:p.Leu169Pro&NC_000003.11:g.10191513T>C&ENST00000256474.2:c.506T>C|CA351756191|428809|17.5|evidence|5147|https://civicdb.org/links/evidence/5147|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.506T>C||L169P (c.506T>C)|1887|C.506T>C&LEU169PRO&RS1131690962|https://civicdb.org/links/variants/1887|VHL L169P (c.506T>C)|1763|C.506T>C&LEU169PRO&RS1131690962|https://civicdb.org/links/molecular-profiles/1763|NM_000551.3:c.506T>C&NP_000542.1:p.Leu169Pro&NC_000003.11:g.10191513T>C&ENST00000256474.2:c.506T>C|CA351756191|428809|17.5|evidence|5197|https://civicdb.org/links/evidence/5197|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.506T>C||L169P (c.506T>C)|1887|C.506T>C&LEU169PRO&RS1131690962|https://civicdb.org/links/variants/1887|VHL L169P (c.506T>C)|1763|C.506T>C&LEU169PRO&RS1131690962|https://civicdb.org/links/molecular-profiles/1763|NM_000551.3:c.506T>C&NP_000542.1:p.Leu169Pro&NC_000003.11:g.10191513T>C&ENST00000256474.2:c.506T>C|CA351756191|428809|17.5|evidence|6589|https://civicdb.org/links/evidence/6589|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||
3	10191515	1806	G	T	.	.	GN=VHL;VT=V170F (c.508G>T);CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.508G>T||V170F (c.508G>T)|1806|C.508G>T&VAL170PHE|https://civicdb.org/links/variants/1806|VHL V170F (c.508G>T)|1682|C.508G>T&VAL170PHE|https://civicdb.org/links/molecular-profiles/1682|ENST00000256474.2:c.508G>T&NC_000003.11:g.10191515G>T&NM_000551.3:c.508G>T&NP_000542.1:p.Val170Phe|CA351756193|NONE FOUND|7.5|evidence|4982|https://civicdb.org/links/evidence/4982|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191516	1826	T	A	.	.	GN=VHL;VT=V170D (c.509T>A);CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D (c.509T>A)|1826|C.509T>A&VAL170ASP|https://civicdb.org/links/variants/1826|VHL V170D (c.509T>A)|1702|C.509T>A&VAL170ASP|https://civicdb.org/links/molecular-profiles/1702|ENST00000256474.2:c.509T>A&NC_000003.11:g.10191516T>A&NM_000551.3:c.509T>A&NP_000542.1:p.Val170Asp|CA351756195|625256|40.0|evidence|5863|https://civicdb.org/links/evidence/5863|9681858 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D (c.509T>A)|1826|C.509T>A&VAL170ASP|https://civicdb.org/links/variants/1826|VHL V170D (c.509T>A)|1702|C.509T>A&VAL170ASP|https://civicdb.org/links/molecular-profiles/1702|ENST00000256474.2:c.509T>A&NC_000003.11:g.10191516T>A&NM_000551.3:c.509T>A&NP_000542.1:p.Val170Asp|CA351756195|625256|40.0|evidence|5013|https://civicdb.org/links/evidence/5013|8730290 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D (c.509T>A)|1826|C.509T>A&VAL170ASP|https://civicdb.org/links/variants/1826|VHL V170D (c.509T>A)|1702|C.509T>A&VAL170ASP|https://civicdb.org/links/molecular-profiles/1702|ENST00000256474.2:c.509T>A&NC_000003.11:g.10191516T>A&NM_000551.3:c.509T>A&NP_000542.1:p.Val170Asp|CA351756195|625256|40.0|evidence|5029|https://civicdb.org/links/evidence/5029|17661816 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D (c.509T>A)|1826|C.509T>A&VAL170ASP|https://civicdb.org/links/variants/1826|VHL V170D (c.509T>A)|1702|C.509T>A&VAL170ASP|https://civicdb.org/links/molecular-profiles/1702|ENST00000256474.2:c.509T>A&NC_000003.11:g.10191516T>A&NM_000551.3:c.509T>A&NP_000542.1:p.Val170Asp|CA351756195|625256|40.0|evidence|5092|https://civicdb.org/links/evidence/5092|8956040 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>A||V170D (c.509T>A)|1826|C.509T>A&VAL170ASP|https://civicdb.org/links/variants/1826|VHL V170D (c.509T>A)|1702|C.509T>A&VAL170ASP|https://civicdb.org/links/molecular-profiles/1702|ENST00000256474.2:c.509T>A&NC_000003.11:g.10191516T>A&NM_000551.3:c.509T>A&NP_000542.1:p.Val170Asp|CA351756195|625256|40.0|evidence|6522|https://civicdb.org/links/evidence/6522|24132471 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||
3	10191516	1935	T	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>G||V170G (c.509T>G)|1935|C.509T>G&VAL170GLY|https://civicdb.org/links/variants/1935|VHL V170G (c.509T>G)|1811|C.509T>G&VAL170GLY|https://civicdb.org/links/molecular-profiles/1811|ENST00000256474.2:c.509T>G&NC_000003.11:g.10191516T>G&NM_000551.3:c.509T>G&NP_000542.1:p.Val170Gly|CA351756196|NONE FOUND|15.0|evidence|5303|https://civicdb.org/links/evidence/5303|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>G||V170G (c.509T>G)|1935|C.509T>G&VAL170GLY|https://civicdb.org/links/variants/1935|VHL V170G (c.509T>G)|1811|C.509T>G&VAL170GLY|https://civicdb.org/links/molecular-profiles/1811|ENST00000256474.2:c.509T>G&NC_000003.11:g.10191516T>G&NM_000551.3:c.509T>G&NP_000542.1:p.Val170Gly|CA351756196|NONE FOUND|15.0|evidence|5172|https://civicdb.org/links/evidence/5172|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.509T>G||V170G (c.509T>G)|1935|C.509T>G&VAL170GLY|https://civicdb.org/links/variants/1935|VHL V170G (c.509T>G)|1811|C.509T>G&VAL170GLY|https://civicdb.org/links/molecular-profiles/1811|ENST00000256474.2:c.509T>G&NC_000003.11:g.10191516T>G&NM_000551.3:c.509T>G&NP_000542.1:p.Val170Gly|CA351756196|NONE FOUND|15.0|evidence|6590|https://civicdb.org/links/evidence/6590|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;GN=VHL;VT=V170G (c.509T>G)
3	10191530	1846	T	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.523T>G||Y175D (c.523T>G)|1846|C.523T>G&TYR175ASP|https://civicdb.org/links/variants/1846|VHL Y175D (c.523T>G)|1722|C.523T>G&TYR175ASP|https://civicdb.org/links/molecular-profiles/1722|ENST00000256474.2:c.523T>G&NC_000003.11:g.10191530T>G&NM_000551.3:c.523T>G&NP_000542.1:p.Tyr175Asp|CA351756228|NONE FOUND|7.5|evidence|5053|https://civicdb.org/links/evidence/5053|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=Y175D (c.523T>G)
3	10191530	2066	T	A	.	.	CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.523T>A||Y175N (c.523T>A)|2066|C.523T>A&TYR175ASN|https://civicdb.org/links/variants/2066|VHL Y175N (c.523T>A)|1942|C.523T>A&TYR175ASN|https://civicdb.org/links/molecular-profiles/1942|ENST00000256474.2:c.523T>A&NC_000003.11:g.10191530T>A&NM_000551.3:c.523T>A&NP_000542.1:p.Tyr175Asn|CA351756226|NONE FOUND|7.5|evidence|5576|https://civicdb.org/links/evidence/5576|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=Y175N (c.523T>A)
3	10191531	2138	AC	A	.	.	GN=VHL;VT=Y175* (c.525delC);CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525delC||Y175* (c.525delC)|2138|TYR175FS&C.525DELC|https://civicdb.org/links/variants/2138|VHL Y175* (c.525delC)|2014|TYR175FS&C.525DELC|https://civicdb.org/links/molecular-profiles/2014|ENST00000256474.2:c.525delC&NP_000542.1:p.Tyr175Ter&NC_000003.11:g.10191532del&NM_000551.3:c.525del|CA913185019|NONE FOUND|7.5|evidence|5736|https://civicdb.org/links/evidence/5736|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191531	2067	A	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.524A>G||Y175C (c.524A>G)|2067|C.524A>G&TYR175CYS&RS193922613|https://civicdb.org/links/variants/2067|VHL Y175C (c.524A>G)|1943|C.524A>G&TYR175CYS&RS193922613|https://civicdb.org/links/molecular-profiles/1943|NM_000551.3:c.524A>G&NP_000542.1:p.Tyr175Cys&NC_000003.11:g.10191531A>G&ENST00000256474.2:c.524A>G|CA020462|36905|7.5|evidence|5577|https://civicdb.org/links/evidence/5577|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=Y175C (c.524A>G)
3	10191532	1780	CA	C	.	.	VT=R176fs (c.526del);GN=VHL;CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.526delA||R176fs (c.526del)|1780|C.526DELA&ARG176FS&RS1559429711&R176GFS*26 (C.526DEL)|https://civicdb.org/links/variants/1780|VHL R176fs (c.526del)|1656|C.526DELA&ARG176FS&RS1559429711&R176GFS*26 (C.526DEL)|https://civicdb.org/links/molecular-profiles/1656|ENST00000256474.2:c.526delA&NC_000003.11:g.10191533del&NM_000551.3:c.526del&NP_000542.1:p.Arg176GlyfsTer26|CA16602180|625257|17.5|evidence|5166|https://civicdb.org/links/evidence/5166|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.526delA||R176fs (c.526del)|1780|C.526DELA&ARG176FS&RS1559429711&R176GFS*26 (C.526DEL)|https://civicdb.org/links/variants/1780|VHL R176fs (c.526del)|1656|C.526DELA&ARG176FS&RS1559429711&R176GFS*26 (C.526DEL)|https://civicdb.org/links/molecular-profiles/1656|ENST00000256474.2:c.526delA&NC_000003.11:g.10191533del&NM_000551.3:c.526del&NP_000542.1:p.Arg176GlyfsTer26|CA16602180|625257|17.5|evidence|4947|https://civicdb.org/links/evidence/4947|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191532	1932	C	A	.	.	CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>A||Y175* (c.525C>A)|1932|Y175X&TYR175TER&C.525C>A|https://civicdb.org/links/variants/1932|VHL Y175* (c.525C>A)|1808|Y175X&TYR175TER&C.525C>A|https://civicdb.org/links/molecular-profiles/1808|ENST00000256474.2:c.525C>A&NP_000542.1:p.Tyr175Ter&NC_000003.11:g.10191532C>A&NM_000551.3:c.525C>A|CA351756231|NONE FOUND|5.0|evidence|6621|https://civicdb.org/links/evidence/6621|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=Y175* (c.525C>A)
3	10191532	1969	C	G	.	.	CSQ=G|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>G||Y175* (c.525C>G)|1969|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/variants/1969|VHL Y175* (c.525C>G)|1845|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/molecular-profiles/1845|ENST00000256474.2:c.525C>G&NC_000003.11:g.10191532C>G&NM_000551.3:c.525C>G&NP_000542.1:p.Tyr175Ter|CA020466|182974|30.0|evidence|9542|https://civicdb.org/links/evidence/9542|12202531 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>G||Y175* (c.525C>G)|1969|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/variants/1969|VHL Y175* (c.525C>G)|1845|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/molecular-profiles/1845|ENST00000256474.2:c.525C>G&NC_000003.11:g.10191532C>G&NM_000551.3:c.525C>G&NP_000542.1:p.Tyr175Ter|CA020466|182974|30.0|evidence|5300|https://civicdb.org/links/evidence/5300|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>G||Y175* (c.525C>G)|1969|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/variants/1969|VHL Y175* (c.525C>G)|1845|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/molecular-profiles/1845|ENST00000256474.2:c.525C>G&NC_000003.11:g.10191532C>G&NM_000551.3:c.525C>G&NP_000542.1:p.Tyr175Ter|CA020466|182974|30.0|evidence|5440|https://civicdb.org/links/evidence/5440|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.525C>G||Y175* (c.525C>G)|1969|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/variants/1969|VHL Y175* (c.525C>G)|1845|C.525C>G&Y175X&TYR175TER&RS5030835|https://civicdb.org/links/molecular-profiles/1845|ENST00000256474.2:c.525C>G&NC_000003.11:g.10191532C>G&NM_000551.3:c.525C>G&NP_000542.1:p.Tyr175Ter|CA020466|182974|30.0|evidence|7005|https://civicdb.org/links/evidence/7005|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;VT=Y175* (c.525C>G);GN=VHL
3	10191534	1907	GG	G	.	.	GN=VHL;CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.528delG||R177fs (c.528del)|1907|ARG176FS&C.528DELG&R177DFS*25 (C.528DELG)&R176FS (C.528DELG)&R176FS (C.528DEL)|https://civicdb.org/links/variants/1907|VHL R177fs (c.528del)|1783|ARG176FS&C.528DELG&R177DFS*25 (C.528DELG)&R176FS (C.528DELG)&R176FS (C.528DEL)|https://civicdb.org/links/molecular-profiles/1783|ENST00000256474.2:c.528delG&NC_000003.11:g.10191535del&NM_000551.3:c.528del&NP_000542.1:p.Arg177AspfsTer25|CA432423454|NONE FOUND|15.0|evidence|5167|https://civicdb.org/links/evidence/5167|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.528delG||R177fs (c.528del)|1907|ARG176FS&C.528DELG&R177DFS*25 (C.528DELG)&R176FS (C.528DELG)&R176FS (C.528DEL)|https://civicdb.org/links/variants/1907|VHL R177fs (c.528del)|1783|ARG176FS&C.528DELG&R177DFS*25 (C.528DELG)&R176FS (C.528DELG)&R176FS (C.528DEL)|https://civicdb.org/links/molecular-profiles/1783|ENST00000256474.2:c.528delG&NC_000003.11:g.10191535del&NM_000551.3:c.528del&NP_000542.1:p.Arg177AspfsTer25|CA432423454|NONE FOUND|15.0|evidence|5643|https://civicdb.org/links/evidence/5643|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=R177fs (c.528del)
3	10191536	1827	A	T	.	.	VT=R177* (c.529A>T);CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.529A>T||R177* (c.529A>T)|1827|C.529A>T&R177X&ARG177TER&RS1559429717|https://civicdb.org/links/variants/1827|VHL R177* (c.529A>T)|1703|C.529A>T&R177X&ARG177TER&RS1559429717|https://civicdb.org/links/molecular-profiles/1703|ENST00000256474.2:c.529A>T&NC_000003.11:g.10191536A>T&NM_000551.3:c.529A>T&NP_000542.1:p.Arg177Ter|CA351756239|625258|7.5|evidence|5331|https://civicdb.org/links/evidence/5331|20518900 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10191540	1748	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>C||L178P (c.533T>C)|1748|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/variants/1748|VHL L178P (c.533T>C)|1624|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/molecular-profiles/1624|ENST00000256474.2:c.533T>C&NM_000551.3:c.533T>C&NP_000542.1:p.Leu178Pro&NC_000003.11:g.10191540T>C|CA351756245|428795|50.0|evidence|5149|https://civicdb.org/links/evidence/5149|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>C||L178P (c.533T>C)|1748|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/variants/1748|VHL L178P (c.533T>C)|1624|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/molecular-profiles/1624|ENST00000256474.2:c.533T>C&NM_000551.3:c.533T>C&NP_000542.1:p.Leu178Pro&NC_000003.11:g.10191540T>C|CA351756245|428795|50.0|evidence|4914|https://civicdb.org/links/evidence/4914|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>C||L178P (c.533T>C)|1748|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/variants/1748|VHL L178P (c.533T>C)|1624|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/molecular-profiles/1624|ENST00000256474.2:c.533T>C&NM_000551.3:c.533T>C&NP_000542.1:p.Leu178Pro&NC_000003.11:g.10191540T>C|CA351756245|428795|50.0|evidence|4983|https://civicdb.org/links/evidence/4983|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>C||L178P (c.533T>C)|1748|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/variants/1748|VHL L178P (c.533T>C)|1624|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/molecular-profiles/1624|ENST00000256474.2:c.533T>C&NM_000551.3:c.533T>C&NP_000542.1:p.Leu178Pro&NC_000003.11:g.10191540T>C|CA351756245|428795|50.0|evidence|8993|https://civicdb.org/links/evidence/8993|8634692 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>C||L178P (c.533T>C)|1748|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/variants/1748|VHL L178P (c.533T>C)|1624|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/molecular-profiles/1624|ENST00000256474.2:c.533T>C&NM_000551.3:c.533T>C&NP_000542.1:p.Leu178Pro&NC_000003.11:g.10191540T>C|CA351756245|428795|50.0|evidence|5198|https://civicdb.org/links/evidence/5198|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>C||L178P (c.533T>C)|1748|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/variants/1748|VHL L178P (c.533T>C)|1624|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/molecular-profiles/1624|ENST00000256474.2:c.533T>C&NM_000551.3:c.533T>C&NP_000542.1:p.Leu178Pro&NC_000003.11:g.10191540T>C|CA351756245|428795|50.0|evidence|5470|https://civicdb.org/links/evidence/5470|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>C||L178P (c.533T>C)|1748|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/variants/1748|VHL L178P (c.533T>C)|1624|C.533T>C&LEU178PRO&RS5030822|https://civicdb.org/links/molecular-profiles/1624|ENST00000256474.2:c.533T>C&NM_000551.3:c.533T>C&NP_000542.1:p.Leu178Pro&NC_000003.11:g.10191540T>C|CA351756245|428795|50.0|evidence|7004|https://civicdb.org/links/evidence/7004|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=L178P (c.533T>C)
3	10191540	1997	T	A	.	.	VT=L178Q (c.533T>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>A||L178Q (c.533T>A)|1997|C.533T>A&LEU178GLN&RS5030822|https://civicdb.org/links/variants/1997|VHL L178Q (c.533T>A)|1873|C.533T>A&LEU178GLN&RS5030822|https://civicdb.org/links/molecular-profiles/1873|NC_000003.11:g.10191540T>A&NM_000551.3:c.533T>A&NP_000542.1:p.Leu178Gln&ENST00000256474.2:c.533T>A|CA70052370|625260|12.5|evidence|7890|https://civicdb.org/links/evidence/7890|11850829 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>A||L178Q (c.533T>A)|1997|C.533T>A&LEU178GLN&RS5030822|https://civicdb.org/links/variants/1997|VHL L178Q (c.533T>A)|1873|C.533T>A&LEU178GLN&RS5030822|https://civicdb.org/links/molecular-profiles/1873|NC_000003.11:g.10191540T>A&NM_000551.3:c.533T>A&NP_000542.1:p.Leu178Gln&ENST00000256474.2:c.533T>A|CA70052370|625260|12.5|evidence|5366|https://civicdb.org/links/evidence/5366|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191540	1888	T	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>G||L178R (c.533T>G)|1888|C.533T>G&LEU178ARG|https://civicdb.org/links/variants/1888|VHL L178R (c.533T>G)|1764|C.533T>G&LEU178ARG|https://civicdb.org/links/molecular-profiles/1764|ENST00000256474.2:c.533T>G&NC_000003.11:g.10191540T>G&NM_000551.3:c.533T>G&NP_000542.1:p.Leu178Arg|CA351756248|625261|15.0|evidence|5148|https://civicdb.org/links/evidence/5148|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.533T>G||L178R (c.533T>G)|1888|C.533T>G&LEU178ARG|https://civicdb.org/links/variants/1888|VHL L178R (c.533T>G)|1764|C.533T>G&LEU178ARG|https://civicdb.org/links/molecular-profiles/1764|ENST00000256474.2:c.533T>G&NC_000003.11:g.10191540T>G&NM_000551.3:c.533T>G&NP_000542.1:p.Leu178Arg|CA351756248|625261|15.0|evidence|5774|https://civicdb.org/links/evidence/5774|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=L178R (c.533T>G)
3	10191545	1807	A	G	.	.	VT=I180V (c.538A>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.538A>G||I180V (c.538A>G)|1807|C.538A>G&ILE180VAL&RS377715747|https://civicdb.org/links/variants/1807|VHL I180V (c.538A>G)|1683|C.538A>G&ILE180VAL&RS377715747|https://civicdb.org/links/molecular-profiles/1683|NM_000551.3:c.538A>G&NP_000542.1:p.Ile180Val&NC_000003.11:g.10191545A>G&ENST00000256474.2:c.538A>G|CA020469|161401|7.5|evidence|4984|https://civicdb.org/links/evidence/4984|7987306 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191546	1847	TCGTC	T	.	.	CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|||V181fs (c.540_543del)|1847|VAL181FS&C.540_543DELCGTC&RS869025664|https://civicdb.org/links/variants/1847|VHL V181fs (c.540_543del)|1723|VAL181FS&C.540_543DELCGTC&RS869025664|https://civicdb.org/links/molecular-profiles/1723|NC_000003.11:g.10191547_10191550del&NC_000003.12:g.10149863_10149866del&NM_000551.3:c.540_543del&NP_000542.1:p.Val181fs|CA357022|223230|7.5|evidence|5054|https://civicdb.org/links/evidence/5054|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=V181fs (c.540_543del)
3	10191555	1784	C	A	.	.	GN=VHL;CSQ=A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.548C>A||S183* (c.548C>A)|1784|C.548C>A&S183X&SER183TER&RS5030823|https://civicdb.org/links/variants/1784|VHL S183* (c.548C>A)|1660|C.548C>A&S183X&SER183TER&RS5030823|https://civicdb.org/links/molecular-profiles/1660|NM_000551.3:c.548C>A&NP_000542.1:p.Ser183Ter&NC_000003.11:g.10191555C>A&ENST00000256474.2:c.548C>A|CA020473|2215|15.0|evidence|5370|https://civicdb.org/links/evidence/5370|8707293 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Renal Cell Carcinoma||||C|3|||||,A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.548C>A||S183* (c.548C>A)|1784|C.548C>A&S183X&SER183TER&RS5030823|https://civicdb.org/links/variants/1784|VHL S183* (c.548C>A)|1660|C.548C>A&S183X&SER183TER&RS5030823|https://civicdb.org/links/molecular-profiles/1660|NM_000551.3:c.548C>A&NP_000542.1:p.Ser183Ter&NC_000003.11:g.10191555C>A&ENST00000256474.2:c.548C>A|CA020473|2215|15.0|evidence|5471|https://civicdb.org/links/evidence/5471|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,A|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.548C>A||S183* (c.548C>A)|1784|C.548C>A&S183X&SER183TER&RS5030823|https://civicdb.org/links/variants/1784|VHL S183* (c.548C>A)|1660|C.548C>A&S183X&SER183TER&RS5030823|https://civicdb.org/links/molecular-profiles/1660|NM_000551.3:c.548C>A&NP_000542.1:p.Ser183Ter&NC_000003.11:g.10191555C>A&ENST00000256474.2:c.548C>A|CA020473|2215|15.0|evidence|6592|https://civicdb.org/links/evidence/6592|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;VT=S183* (c.548C>A)
3	10191558	1776	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P (c.551T>C)|1776|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/variants/1776|VHL L184P (c.551T>C)|1652|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/molecular-profiles/1652|NM_000551.3:c.551T>C&NP_000542.1:p.Leu184Pro&NC_000003.11:g.10191558T>C&ENST00000256474.2:c.551T>C|CA16617792|419447|32.5|evidence|6119|https://civicdb.org/links/evidence/6119|14722919 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P (c.551T>C)|1776|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/variants/1776|VHL L184P (c.551T>C)|1652|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/molecular-profiles/1652|NM_000551.3:c.551T>C&NP_000542.1:p.Leu184Pro&NC_000003.11:g.10191558T>C&ENST00000256474.2:c.551T>C|CA16617792|419447|32.5|evidence|8491|https://civicdb.org/links/evidence/8491|18474773 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P (c.551T>C)|1776|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/variants/1776|VHL L184P (c.551T>C)|1652|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/molecular-profiles/1652|NM_000551.3:c.551T>C&NP_000542.1:p.Leu184Pro&NC_000003.11:g.10191558T>C&ENST00000256474.2:c.551T>C|CA16617792|419447|32.5|evidence|4943|https://civicdb.org/links/evidence/4943|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P (c.551T>C)|1776|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/variants/1776|VHL L184P (c.551T>C)|1652|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/molecular-profiles/1652|NM_000551.3:c.551T>C&NP_000542.1:p.Leu184Pro&NC_000003.11:g.10191558T>C&ENST00000256474.2:c.551T>C|CA16617792|419447|32.5|evidence|5055|https://civicdb.org/links/evidence/5055|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P (c.551T>C)|1776|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/variants/1776|VHL L184P (c.551T>C)|1652|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/molecular-profiles/1652|NM_000551.3:c.551T>C&NP_000542.1:p.Leu184Pro&NC_000003.11:g.10191558T>C&ENST00000256474.2:c.551T>C|CA16617792|419447|32.5|evidence|6167|https://civicdb.org/links/evidence/6167|11505222 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Clear Cell Renal Cell Carcinoma||||C|2|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P (c.551T>C)|1776|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/variants/1776|VHL L184P (c.551T>C)|1652|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/molecular-profiles/1652|NM_000551.3:c.551T>C&NP_000542.1:p.Leu184Pro&NC_000003.11:g.10191558T>C&ENST00000256474.2:c.551T>C|CA16617792|419447|32.5|evidence|6027|https://civicdb.org/links/evidence/6027|7591282 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Renal Cell Carcinoma||||C|1|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>C||L184P (c.551T>C)|1776|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/variants/1776|VHL L184P (c.551T>C)|1652|C.551T>C&LEU184PRO&RS1064793878|https://civicdb.org/links/molecular-profiles/1652|NM_000551.3:c.551T>C&NP_000542.1:p.Leu184Pro&NC_000003.11:g.10191558T>C&ENST00000256474.2:c.551T>C|CA16617792|419447|32.5|assertion|41|https://civicdb.org/links/assertion/41||RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease (DOID 14175)||||||PM1&PM2&PP4||||;GN=VHL;VT=L184P (c.551T>C)
3	10191558	1808	T	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>G||L184R (c.551T>G)|1808|C.551T>G&LEU184ARG|https://civicdb.org/links/variants/1808|VHL L184R (c.551T>G)|1684|C.551T>G&LEU184ARG|https://civicdb.org/links/molecular-profiles/1684|ENST00000256474.2:c.551T>G&NC_000003.11:g.10191558T>G&NM_000551.3:c.551T>G&NP_000542.1:p.Leu184Arg|CA351756355|NONE FOUND|7.5|evidence|5199|https://civicdb.org/links/evidence/5199|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.551T>G||L184R (c.551T>G)|1808|C.551T>G&LEU184ARG|https://civicdb.org/links/variants/1808|VHL L184R (c.551T>G)|1684|C.551T>G&LEU184ARG|https://civicdb.org/links/molecular-profiles/1684|ENST00000256474.2:c.551T>G&NC_000003.11:g.10191558T>G&NM_000551.3:c.551T>G&NP_000542.1:p.Leu184Arg|CA351756355|NONE FOUND|7.5|evidence|6593|https://civicdb.org/links/evidence/6593|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;VT=L184R (c.551T>G);GN=VHL
3	10191562	1809	C	G	.	.	VT=Y185* (c.555C>G);GN=VHL;CSQ=G|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.555C>G||Y185* (c.555C>G)|1809|C.555C>G&Y185X&TYR185TER&RS864622109|https://civicdb.org/links/variants/1809|VHL Y185* (c.555C>G)|1685|C.555C>G&Y185X&TYR185TER&RS864622109|https://civicdb.org/links/molecular-profiles/1685|NM_000551.3:c.555C>G&NP_000542.1:p.Tyr185Ter&NC_000003.11:g.10191562C>G&ENST00000256474.2:c.555C>G|CA357075|223233|15.0|evidence|5056|https://civicdb.org/links/evidence/5056|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.555C>G||Y185* (c.555C>G)|1809|C.555C>G&Y185X&TYR185TER&RS864622109|https://civicdb.org/links/variants/1809|VHL Y185* (c.555C>G)|1685|C.555C>G&Y185X&TYR185TER&RS864622109|https://civicdb.org/links/molecular-profiles/1685|NM_000551.3:c.555C>G&NP_000542.1:p.Tyr185Ter&NC_000003.11:g.10191562C>G&ENST00000256474.2:c.555C>G|CA357075|223233|15.0|evidence|5170|https://civicdb.org/links/evidence/5170|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191563	1777	G	T	.	.	VT=E186* (c.556G>T);CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.556G>T||E186* (c.556G>T)|1777|C.556G>T&E186X&GLU186TER&RS367545984|https://civicdb.org/links/variants/1777|VHL E186* (c.556G>T)|1653|C.556G>T&E186X&GLU186TER&RS367545984|https://civicdb.org/links/molecular-profiles/1653|NM_000551.3:c.556G>T&NP_000542.1:p.Glu186Ter&NC_000003.11:g.10191563G>T&ENST00000256474.2:c.556G>T|CA16604432|381602|15.0|evidence|4944|https://civicdb.org/links/evidence/4944|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.556G>T||E186* (c.556G>T)|1777|C.556G>T&E186X&GLU186TER&RS367545984|https://civicdb.org/links/variants/1777|VHL E186* (c.556G>T)|1653|C.556G>T&E186X&GLU186TER&RS367545984|https://civicdb.org/links/molecular-profiles/1653|NM_000551.3:c.556G>T&NP_000542.1:p.Glu186Ter&NC_000003.11:g.10191563G>T&ENST00000256474.2:c.556G>T|CA16604432|381602|15.0|evidence|5057|https://civicdb.org/links/evidence/5057|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10191563	1778	G	A	.	.	VT=E186K (c.556G>A);GN=VHL;CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.556G>A||E186K (c.556G>A)|1778|C.556G>A&GLU186LYS&RS367545984|https://civicdb.org/links/variants/1778|VHL E186K (c.556G>A)|1654|C.556G>A&GLU186LYS&RS367545984|https://civicdb.org/links/molecular-profiles/1654|NM_000551.3:c.556G>A&NP_000542.1:p.Glu186Lys&NC_000003.11:g.10191563G>A&ENST00000256474.2:c.556G>A|CA020480|161403|5.0|evidence|4945|https://civicdb.org/links/evidence/4945|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191568	2139	TC	T	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.562delC||L188fs (c.562delC)|2139|C.562DELC&LEU188FS|https://civicdb.org/links/variants/2139|VHL L188fs (c.562delC)|2015|C.562DELC&LEU188FS|https://civicdb.org/links/molecular-profiles/2015|ENST00000256474.2:c.562delC&NC_000003.11:g.10191569del&NM_000551.3:c.562delC&NP_000542.1:p.Leu188TrpfsTer14|CA432423671|NONE FOUND|10.0|evidence|5737|https://civicdb.org/links/evidence/5737|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=L188fs (c.562delC)
3	10191569	1836	C	G	.	.	VT=L188V (c.562C>G);GN=VHL;CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.562C>G||L188V (c.562C>G)|1836|C.562C>G&LEU188VAL&RS5030824|https://civicdb.org/links/variants/1836|VHL L188V (c.562C>G)|1712|C.562C>G&LEU188VAL&RS5030824|https://civicdb.org/links/molecular-profiles/1712|NM_000551.3:c.562C>G&NP_000542.1:p.Leu188Val&NC_000003.11:g.10191569C>G&ENST00000256474.2:c.562C>G|CA020488|2225|15.0|evidence|5409|https://civicdb.org/links/evidence/5409|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.562C>G||L188V (c.562C>G)|1836|C.562C>G&LEU188VAL&RS5030824|https://civicdb.org/links/variants/1836|VHL L188V (c.562C>G)|1712|C.562C>G&LEU188VAL&RS5030824|https://civicdb.org/links/molecular-profiles/1712|NM_000551.3:c.562C>G&NP_000542.1:p.Leu188Val&NC_000003.11:g.10191569C>G&ENST00000256474.2:c.562C>G|CA020488|2225|15.0|evidence|7889|https://civicdb.org/links/evidence/7889|11850829 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191570	1852	T	C	.	.	CSQ=C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>C||L188P (c.563T>C)|1852|C.563T>C&LEU188PRO|https://civicdb.org/links/variants/1852|VHL L188P (c.563T>C)|1728|C.563T>C&LEU188PRO|https://civicdb.org/links/molecular-profiles/1728|ENST00000256474.2:c.563T>C&NC_000003.11:g.10191570T>C&NM_000551.3:c.563T>C&NP_000542.1:p.Leu188Pro|CA351756399|625266|15.0|evidence|5066|https://civicdb.org/links/evidence/5066|9829911 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,C|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>C||L188P (c.563T>C)|1852|C.563T>C&LEU188PRO|https://civicdb.org/links/variants/1852|VHL L188P (c.563T>C)|1728|C.563T>C&LEU188PRO|https://civicdb.org/links/molecular-profiles/1728|ENST00000256474.2:c.563T>C&NC_000003.11:g.10191570T>C&NM_000551.3:c.563T>C&NP_000542.1:p.Leu188Pro|CA351756399|625266|15.0|evidence|5282|https://civicdb.org/links/evidence/5282|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=L188P (c.563T>C);GN=VHL
3	10191570	1861	T	A	.	.	GN=VHL;VT=L188Q (c.563T>A);CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>A||L188Q (c.563T>A)|1861|C.563T>A&LEU188GLN|https://civicdb.org/links/variants/1861|VHL L188Q (c.563T>A)|1737|C.563T>A&LEU188GLN|https://civicdb.org/links/molecular-profiles/1737|ENST00000256474.2:c.563T>A&NC_000003.11:g.10191570T>A&NM_000551.3:c.563T>A&NP_000542.1:p.Leu188Gln|CA351756398|625265|10.0|evidence|6061|https://civicdb.org/links/evidence/6061|7728151 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||
3	10191570	1924	T	G	.	.	CSQ=G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>G||L188R (c.563T>G)|1924|C.563T>G&LEU188ARG|https://civicdb.org/links/variants/1924|VHL L188R (c.563T>G)|1800|C.563T>G&LEU188ARG|https://civicdb.org/links/molecular-profiles/1800|ENST00000256474.2:c.563T>G&NC_000003.11:g.10191570T>G&NM_000551.3:c.563T>G&NP_000542.1:p.Leu188Arg|CA351756400|NONE FOUND|7.5|evidence|5200|https://civicdb.org/links/evidence/5200|21463266 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,G|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.563T>G||L188R (c.563T>G)|1924|C.563T>G&LEU188ARG|https://civicdb.org/links/variants/1924|VHL L188R (c.563T>G)|1800|C.563T>G&LEU188ARG|https://civicdb.org/links/molecular-profiles/1800|ENST00000256474.2:c.563T>G&NC_000003.11:g.10191570T>G&NM_000551.3:c.563T>G&NP_000542.1:p.Leu188Arg|CA351756400|NONE FOUND|7.5|evidence|6595|https://civicdb.org/links/evidence/6595|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||;VT=L188R (c.563T>G);GN=VHL
3	10191571	1869	GG	G	.	.	VT=E189fs (c.565del);CSQ=-|Minus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||E189fs (c.565del)|1869|E189FS (C.565DELG)&E189KFS*13 (C.565DEL)&GLU189LYSFS*13|https://civicdb.org/links/variants/1869|VHL E189fs (c.565del)|1745|E189FS (C.565DELG)&E189KFS*13 (C.565DEL)&GLU189LYSFS*13|https://civicdb.org/links/molecular-profiles/1745|NC_000003.11:g.10191572del&NC_000003.12:g.10149888del&NM_000551.4:c.565del&NP_000542.1:p.Glu189fs|CA432423686|625267|15.0|evidence|5098|https://civicdb.org/links/evidence/5098|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,-|Minus 1 Frameshift Variant&Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|||E189fs (c.565del)|1869|E189FS (C.565DELG)&E189KFS*13 (C.565DEL)&GLU189LYSFS*13|https://civicdb.org/links/variants/1869|VHL E189fs (c.565del)|1745|E189FS (C.565DELG)&E189KFS*13 (C.565DEL)&GLU189LYSFS*13|https://civicdb.org/links/molecular-profiles/1745|NC_000003.11:g.10191572del&NC_000003.12:g.10149888del&NM_000551.4:c.565del&NP_000542.1:p.Glu189fs|CA432423686|625267|15.0|evidence|6523|https://civicdb.org/links/evidence/6523|24132471 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL
3	10191577	1958	CC	C	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.571delC||H191FS (c.571delC)|1958|C.571DELC&HIS191FS|https://civicdb.org/links/variants/1958|VHL H191FS (c.571delC)|1834|C.571DELC&HIS191FS|https://civicdb.org/links/molecular-profiles/1834|ENST00000256474.2:c.571delC&NC_000003.11:g.10191578del&NM_000551.3:c.571delC&NP_000542.1:p.His191ThrfsTer11|CA658795182|NONE FOUND|7.5|evidence|5275|https://civicdb.org/links/evidence/5275|9829912 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=H191FS (c.571delC)
3	10191586	1977	TTG	T	.	.	GN=VHL;CSQ=-|Minus 2 Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.579_580delTG||V194fs (c.581_582del)|1977|C.579_580DELTG&VAL194FSX39&C.581_582DELTG&V153FS&V194FS (C.581_582DELTG)|https://civicdb.org/links/variants/1977|VHL V194fs (c.581_582del)|1853|C.579_580DELTG&VAL194FSX39&C.581_582DELTG&V153FS&V194FS (C.581_582DELTG)|https://civicdb.org/links/molecular-profiles/1853|ENST00000256474.2:c.579_580delTG|CA70052556|NONE FOUND|7.5|evidence|5441|https://civicdb.org/links/evidence/5441|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;VT=V194fs (c.581_582del)
3	10191590	2140	CAG	C	.	.	CSQ=-|Frameshift Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.584_585delAG||K196fs (c.584_585delAG)|2140|C.584_585DELAG&GLN195FS|https://civicdb.org/links/variants/2140|VHL K196fs (c.584_585delAG)|2016|C.584_585DELAG&GLN195FS|https://civicdb.org/links/molecular-profiles/2016|ENST00000256474.2:c.584_585delAG|CA645529570|NONE FOUND|10.0|evidence|5738|https://civicdb.org/links/evidence/5738|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=K196fs (c.584_585delAG)
3	10191590	1810	C	T	.	.	VT=Q195* (c.583C>T);GN=VHL;CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|5134|https://civicdb.org/links/evidence/5134|17024664 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|4987|https://civicdb.org/links/evidence/4987|7987306 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|5097|https://civicdb.org/links/evidence/5097|17661816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|5404|https://civicdb.org/links/evidence/5404|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|5691|https://civicdb.org/links/evidence/5691|23298237 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|6623|https://civicdb.org/links/evidence/6623|25867206 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|5360|https://civicdb.org/links/evidence/5360|8707293 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|5472|https://civicdb.org/links/evidence/5472|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|evidence|6596|https://civicdb.org/links/evidence/6596|26763786 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|1|||||,T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.583C>T||Q195* (c.583C>T)|1810|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/variants/1810|VHL Q195* (c.583C>T)|1686|C.583C>T&Q195X&GLN195TER&RS5030825|https://civicdb.org/links/molecular-profiles/1686|NM_000551.3:c.583C>T&NP_000542.1:p.Gln195Ter&NC_000003.11:g.10191590C>T&ENST00000256474.2:c.583C>T|CA70052558|428794|60.0|assertion|18|https://civicdb.org/links/assertion/18||RARE_GERMLINE|accepted|PATHOGENIC|SUPPORTS|Von Hippel-Lindau Disease (DOID 14175)||||||PVS1&PM2&PP4||||
3	10191593	1913	A	T	.	.	CSQ=T|Stop Gained|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.586A>T||K196* (c.586A>T)|1913|C.586A>T&K196X&LYS196TER&RS281860296|https://civicdb.org/links/variants/1913|VHL K196* (c.586A>T)|1789|C.586A>T&K196X&LYS196TER&RS281860296|https://civicdb.org/links/molecular-profiles/1789|NM_000551.3:c.586A>T&NP_000542.1:p.Lys196Ter&NC_000003.11:g.10191593A>T&ENST00000256474.2:c.586A>T|CA020507|196284|5.0|evidence|5176|https://civicdb.org/links/evidence/5176|19270817 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=K196* (c.586A>T)
3	10191595	2141	AG	A	.	.	CSQ=-|Frameshift Truncation|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.589delG||D197FS (c.589delG)|2141|C.589DELG&ASP197FS|https://civicdb.org/links/variants/2141|VHL D197FS (c.589delG)|2017|C.589DELG&ASP197FS|https://civicdb.org/links/molecular-profiles/2017|ENST00000256474.2:c.589delG&NC_000003.11:g.10191596del&NM_000551.3:c.589del&NP_000542.1:p.Asp197ThrfsTer5|CA913189233|NONE FOUND|7.5|evidence|5739|https://civicdb.org/links/evidence/5739|17024664 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||;GN=VHL;VT=D197FS (c.589delG)
3	10191600	2010	T	A	.	.	GN=VHL;VT=L198Q  (c.593T>A);CSQ=A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.593T>A||L198Q  (c.593T>A)|2010|C.593T>A&LEU198GLN|https://civicdb.org/links/variants/2010|VHL L198Q  (c.593T>A)|1886|C.593T>A&LEU198GLN|https://civicdb.org/links/molecular-profiles/1886|ENST00000256474.2:c.593T>A&NC_000003.11:g.10191600T>A&NM_000551.3:c.593T>A&NP_000542.1:p.Leu198Gln|CA351756548|NONE FOUND|12.5|evidence|5410|https://civicdb.org/links/evidence/5410|12000816 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|3|||||,A|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.593T>A||L198Q  (c.593T>A)|2010|C.593T>A&LEU198GLN|https://civicdb.org/links/variants/2010|VHL L198Q  (c.593T>A)|1886|C.593T>A&LEU198GLN|https://civicdb.org/links/molecular-profiles/1886|ENST00000256474.2:c.593T>A&NC_000003.11:g.10191600T>A&NM_000551.3:c.593T>A&NP_000542.1:p.Leu198Gln|CA351756548|NONE FOUND|12.5|evidence|5473|https://civicdb.org/links/evidence/5473|20660572 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191605	631	C	T	.	.	CSQ=T|Missense Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.598C>T||R200W (c.598C>T)|631|ARG200TRP&C.598C>T&RS28940298|https://civicdb.org/links/variants/631|VHL R200W (c.598C>T)|627|ARG200TRP&C.598C>T&RS28940298|https://civicdb.org/links/molecular-profiles/627|NM_000551.3:c.598C>T&NP_000542.1:p.Arg200Trp&ENST00000256474.2:c.598C>T&NC_000003.11:g.10191605C>T|CA020510|2232|10.0|evidence|1608|https://civicdb.org/links/evidence/1608|27518686 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chuvash Polycythemia|Ruxolitinib (NCIt ID C77888)|||C|4|||||;GN=VHL;VT=R200W (c.598C>T)
3	10191647	2488	T	G	.	.	CSQ=G|Stop Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.640T>G||*214G (c.640T>G)|2488|X214G&TER214GLY&C.640T>G&X > GLY + 14AA|https://civicdb.org/links/variants/2488|VHL *214G (c.640T>G)|2361|X214G&TER214GLY&C.640T>G&X > GLY + 14AA|https://civicdb.org/links/molecular-profiles/2361|ENST00000256474.2:c.640T>G&NM_000551.3:c.640T>G&NP_000542.1:p.Ter214Gly&ENSP00000256474.2:p.Ter214Gly|CA351756720|NONE FOUND|5.0|evidence|6723|https://civicdb.org/links/evidence/6723|12673678 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=*214G (c.640T>G)
3	10191648	2489	G	GC	.	.	GN=VHL;VT=*214C (c.641_642insC);CSQ=C|Stop Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.641_642insC||*214C (c.641_642insC)|2489|X214C&TER214CYS&C.641INSC|https://civicdb.org/links/variants/2489|VHL *214C (c.641_642insC)|2362|X214C&TER214CYS&C.641INSC|https://civicdb.org/links/molecular-profiles/2362|ENST00000256474.2:c.641_642insC&NC_000003.11:g.10191648_10191649insC&NM_000551.3:c.641_642insC&NP_000542.1:p.Ter214CysextTer?|CA913189243|NONE FOUND|5.0|evidence|6724|https://civicdb.org/links/evidence/6724|12673678 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Von Hippel-Lindau Disease||||C|2|||||
3	10191648	1986	G	T	.	.	CSQ=T|Stop Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.641G>T||*214L (c.641G>T)|1986|X214L&*214LEXT*15&RS869025668|https://civicdb.org/links/variants/1986|VHL *214L (c.641G>T)|1862|X214L&*214LEXT*15&RS869025668|https://civicdb.org/links/molecular-profiles/1862|NM_000551:c.641G>T&ENST00000256474.2:c.641G>T&NP_000542.1:p.Ter214Leu&NC_000003.11:g.10191648G>T|CA357103|223236|10.0|evidence|5334|https://civicdb.org/links/evidence/5334|20560986 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|4|||||;GN=VHL;VT=*214L (c.641G>T)
3	10191649	1988	A	T	.	.	VT=*214C (c.642A>T);GN=VHL;CSQ=T|Stop Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.642A>T||*214C (c.642A>T)|1988|C.642A>T&X214C&TER214CYS&RS1559430011|https://civicdb.org/links/variants/1988|VHL *214C (c.642A>T)|1864|C.642A>T&X214C&TER214CYS&RS1559430011|https://civicdb.org/links/molecular-profiles/1864|ENST00000256474.2:c.642A>T&NC_000003.11:g.10191649A>T&NM_000551.3:c.642A>T&NP_000542.1:p.Ter214Cys|CA351756724|625270|5.0|evidence|5336|https://civicdb.org/links/evidence/5336|20560986 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191649	1987	A	G	.	.	VT=*214W (c.642A>G);GN=VHL;CSQ=G|Stop Lost|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.642A>G||*214W (c.642A>G)|1987|C.642A>G&TER214TRP&NM_000551:*214WEXT*14|https://civicdb.org/links/variants/1987|VHL *214W (c.642A>G)|1863|C.642A>G&TER214TRP&NM_000551:*214WEXT*14|https://civicdb.org/links/molecular-profiles/1863|NM_000551.3:c.642A>G&NP_000542.1:p.Ter214Trp&ENST00000256474.2:c.642A>G&NC_000003.11:g.10191649A>G|CA351756723|36907&625269|5.0|evidence|5335|https://civicdb.org/links/evidence/5335|20560986 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	10191656	2024	C	G	.	.	CSQ=G|3 Prime UTR Variant|VHL|7428|transcript|ENST00000256474.2|ENST00000256474.2:c.639+10C>G||3'UTR alteration (c.639+10C>G)|2024|C.639+10C>G|https://civicdb.org/links/variants/2024|VHL 3'UTR alteration (c.639+10C>G)|1900|C.639+10C>G|https://civicdb.org/links/molecular-profiles/1900|ENST00000256474.2:c.639+10C>G|CA16042064|NONE FOUND|5.0|evidence|5443|https://civicdb.org/links/evidence/5443|11409863 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||;GN=VHL;VT=3'UTR alteration (c.639+10C>G)
3	10191719	2152	C	A	.	.	VT=3'UTR alteration (c.*70C>A);GN=VHL;CSQ=A|3 Prime UTR Variant|VHL|7428|transcript|None|||3'UTR alteration (c.*70C>A)|2152|C.*70C>A&(C.642+70C>A)|https://civicdb.org/links/variants/2152|VHL 3'UTR alteration (c.*70C>A)|2028|C.*70C>A&(C.642+70C>A)|https://civicdb.org/links/molecular-profiles/2028|NC_000003.11:g.10191719C>A&ENST00000256474.2:c.*70C>A&NM_000551.3:c.*70C>A&NP_000542.1:p.=|CA658820858|NONE FOUND|5.0|evidence|5777|https://civicdb.org/links/evidence/5777|22357542 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Von Hippel-Lindau Disease||||C|2|||||
3	12633229	1680	T	A	.	.	GN=RAF1;CSQ=A|Missense Variant|RAF1|5894|transcript|ENST00000251849.4|ENST00000251849.4:c.1171A>T||R391W|1680|R176W&R270W&R310W&R411W|https://civicdb.org/links/variants/1680|RAF1 R391W|1588|R176W&R270W&R310W&R411W|https://civicdb.org/links/molecular-profiles/1588|ENST00000251849.4:c.1171A>T|CA2259575|NONE FOUND|3.0|evidence|11044|https://civicdb.org/links/evidence/11044|27273450 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||;VT=R391W
3	37035039	747	A	T	.	.	CSQ=T|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1A>T||M1L|747|MET1LEU|https://civicdb.org/links/variants/747|MLH1 M1L|728|MET1LEU|https://civicdb.org/links/molecular-profiles/728|NC_000003.11:g.37035039A>T&ENST00000231790.2:c.1A>T|CA352059785|NONE FOUND|2.5|evidence|1811|https://civicdb.org/links/evidence/1811|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;GN=MLH1;VT=M1L
3	37035074	725	CG	C	.	.	CSQ=-|Frameshift Truncation&Minus 1 Frameshift Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.37delG||E13fs|725|GLU13ARGFS&RS63750081&E13FS*3|https://civicdb.org/links/variants/725|MLH1 E13fs|706|GLU13ARGFS&RS63750081&E13FS*3|https://civicdb.org/links/molecular-profiles/706|NM_000249.3:c.37delG&NP_000240.1:p.Glu13Argfs&ENST00000231790.2:c.37delG&NC_000003.11:g.37035075del|CA010006|90190|2.5|evidence|1788|https://civicdb.org/links/evidence/1788|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Cancer||||C|1|||||;GN=MLH1;VT=E13fs
3	37038139	745	T	C	.	.	GN=MLH1;VT=V49A;CSQ=C|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.146T>C||V49A|745|VAL49ALA|https://civicdb.org/links/variants/745|MLH1 V49A|726|VAL49ALA|https://civicdb.org/links/molecular-profiles/726|ENST00000231790.2:c.146T>C&NC_000003.11:g.37038139T>C|CA352035388|NONE FOUND|2.5|evidence|1808|https://civicdb.org/links/evidence/1808|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37038187	759	G	A	.	.	GN=MLH1;CSQ=A|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.194G>A||G65D|759|GLY65ASP&RS63751465|https://civicdb.org/links/variants/759|MLH1 G65D|740|GLY65ASP&RS63751465|https://civicdb.org/links/molecular-profiles/740|NM_000249.3:c.194G>A&NP_000240.1:p.Gly65Asp&ENST00000231790.2:c.194G>A&NC_000003.11:g.37038187G>A|CA007735|89955|2.5|evidence|1823|https://civicdb.org/links/evidence/1823|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;VT=G65D
3	37038192	757	G	A	.	.	CSQ=A|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.199G>A||G67R|757|GLY67ARG&RS63750206|https://civicdb.org/links/variants/757|MLH1 G67R|738|GLY67ARG&RS63750206|https://civicdb.org/links/molecular-profiles/738|NC_000003.11:g.37038192G>A&NP_000240.1:p.Gly67Arg&ENST00000231790.2:c.199G>A&NM_000249.3:c.199G>A|CA008104|89992|2.5|evidence|1821|https://civicdb.org/links/evidence/1821|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;GN=MLH1;VT=G67R
3	37038196	758	T	G	.	.	GN=MLH1;CSQ=G|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.203T>G||I68S|758|ILE68SER|https://civicdb.org/links/variants/758|MLH1 I68S|739|ILE68SER|https://civicdb.org/links/molecular-profiles/739|ENST00000231790.2:c.203T>G&NC_000003.11:g.37038196T>G|CA352035494|NONE FOUND|2.5|evidence|1822|https://civicdb.org/links/evidence/1822|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;VT=I68S
3	37042536	741	C	T	.	.	GN=MLH1;VT=R100*;CSQ=T|Stop Gained|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.298C>T||R100*|741|ARG100TER&R100X&RS63751221|https://civicdb.org/links/variants/741|MLH1 R100*|722|ARG100TER&R100X&RS63751221|https://civicdb.org/links/molecular-profiles/722|NM_000249.3:c.298C>T&NP_000240.1:p.Arg100Ter&ENST00000231790.2:c.298C>T&NC_000003.11:g.37042536C>T|CA009575|36550|2.5|evidence|1804|https://civicdb.org/links/evidence/1804|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37045935	743	C	T	.	.	GN=MLH1;CSQ=T|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.350C>T||T117M|743|THR117MET&RS63750781|https://civicdb.org/links/variants/743|MLH1 T117M|724|THR117MET&RS63750781|https://civicdb.org/links/molecular-profiles/724|NM_000249.3:c.350C>T&NP_000240.1:p.Thr117Met&ENST00000231790.2:c.350C>T&NC_000003.11:g.37045935C>T|CA009872|17094|2.5|evidence|1806|https://civicdb.org/links/evidence/1806|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;VT=T117M
3	37048546	753	C	T	.	.	GN=MLH1;VT=Q149*;CSQ=T|Stop Gained|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.445C>T||Q149*|753|Q149X&GLN149TER&RS63751302|https://civicdb.org/links/variants/753|MLH1 Q149*|734|Q149X&GLN149TER&RS63751302|https://civicdb.org/links/molecular-profiles/734|NM_000249.3:c.445C>T&NP_000240.1:p.Gln149Ter&ENST00000231790.2:c.445C>T&NC_000003.11:g.37048546C>T|CA010427|90219|2.5|evidence|1817|https://civicdb.org/links/evidence/1817|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37053550	750	GT	G	.	.	GN=MLH1;CSQ=-|Frameshift Truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.638delT||V213FS|750|VAL213FS|https://civicdb.org/links/variants/750|MLH1 V213FS|731|VAL213FS|https://civicdb.org/links/molecular-profiles/731|ENST00000231790.2:c.638delT&NC_000003.11:g.37053551del|CA913102758|NONE FOUND|2.5|evidence|1814|https://civicdb.org/links/evidence/1814|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;VT=V213FS
3	37053589	754	C	T	.	.	CSQ=T|Stop Gained|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.676C>T||R226*|754|R226X&ARG226TER&R128*&RS63751615|https://civicdb.org/links/variants/754|MLH1 R226*|735|R226X&ARG226TER&R128*&RS63751615|https://civicdb.org/links/molecular-profiles/735|NM_000249.3:c.676C>T&NP_000240.1:p.Arg226Ter&ENST00000231790.2:c.676C>T&NC_000003.11:g.37053589C>T|CA011496|17087|2.5|evidence|1818|https://civicdb.org/links/evidence/1818|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;GN=MLH1;VT=R226*
3	37056036	731	G	A	.	.	GN=MLH1;VT=c.790+1G>A;CSQ=A|Splice Donor Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.790+1G>A||c.790+1G>A|731|RS267607789|https://civicdb.org/links/variants/731|MLH1 c.790+1G>A|712|RS267607789|https://civicdb.org/links/molecular-profiles/712|NM_000249.3:c.790+1G>A&NC_000003.11:g.37056036G>A&ENST00000231790.2:c.790+1G>A|CA012109|90356|2.5|evidence|1794|https://civicdb.org/links/evidence/1794|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37058999	749	C	G	.	.	CSQ=G|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.793C>G||R265G|749|ARG265GLY|https://civicdb.org/links/variants/749|MLH1 R265G|730|ARG265GLY|https://civicdb.org/links/molecular-profiles/730|ENST00000231790.2:c.793C>G&NC_000003.11:g.37058999C>G|CA352045752|NONE FOUND|2.5|evidence|1813|https://civicdb.org/links/evidence/1813|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;GN=MLH1;VT=R265G
3	37067359	752	G	A	.	.	GN=MLH1;CSQ=A|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1270G>A||A424T|752|ALA424THR&RS377433038|https://civicdb.org/links/variants/752|MLH1 A424T|733|ALA424THR&RS377433038|https://civicdb.org/links/molecular-profiles/733|NM_000249.3:c.1270G>A&NP_000240.1:p.Ala424Thr&ENST00000231790.2:c.1270G>A&NC_000003.11:g.37067359G>A|CA028060|220203|2.5|evidence|1816|https://civicdb.org/links/evidence/1816|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;VT=A424T
3	37067364	744	GC	G	.	.	GN=MLH1;VT=Q426FS;CSQ=-|Frameshift Truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1276delC||Q426FS|744|GLN426FS|https://civicdb.org/links/variants/744|MLH1 Q426FS|725|GLN426FS|https://civicdb.org/links/molecular-profiles/725|ENST00000231790.2:c.1276delC&NC_000003.11:g.37067365del|CA913102760|NONE FOUND|2.5|evidence|1807|https://civicdb.org/links/evidence/1807|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37070334	769	T	C	.	.	GN=MLH1;CSQ=C|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1469T>C||M490T|769|MET490THR|https://civicdb.org/links/variants/769|MLH1 M490T|750|MET490THR|https://civicdb.org/links/molecular-profiles/750|ENST00000231790.2:c.1469T>C&NC_000003.11:g.37070334T>C|CA352056416|NONE FOUND|2.5|evidence|1833|https://civicdb.org/links/evidence/1833|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Cancer||||C|1|||||;VT=M490T
3	37081718	728	GT	AG	.	.	CSQ=AG|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1600_1601delinsAG||V534R|728|VAL534ARG|https://civicdb.org/links/variants/728|MLH1 V534R|709|VAL534ARG|https://civicdb.org/links/molecular-profiles/709|ENST00000231790.2:c.1600_1601delinsAG&NC_000003.11:g.37081718_37081719delinsAG|CA913102764|NONE FOUND|2.5|evidence|1791|https://civicdb.org/links/evidence/1791|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;GN=MLH1;VT=V534R
3	37081725	756	CT	C	.	.	GN=MLH1;CSQ=-|Frameshift Truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1608del||P536FS|756|PRO536FS|https://civicdb.org/links/variants/756|MLH1 P536FS|737|PRO536FS|https://civicdb.org/links/molecular-profiles/737|NC_000003.11:g.37081726del&ENST00000231790.2:c.1608del|CA913102765|NONE FOUND|2.5|evidence|1820|https://civicdb.org/links/evidence/1820|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||;VT=P536FS
3	37081770	751	A	C	.	.	GN=MLH1;VT=N551T;CSQ=C|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1652A>C||N551T|751|ASN551THR&RS63750271|https://civicdb.org/links/variants/751|MLH1 N551T|732|ASN551THR&RS63750271|https://civicdb.org/links/molecular-profiles/732|NM_000249.3:c.1652A>C&NP_000240.1:p.Asn551Thr&ENST00000231790.2:c.1652A>C&NC_000003.11:g.37081770A>C|CA006238|89819|2.5|evidence|1815|https://civicdb.org/links/evidence/1815|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37089093	730	AGG	A	.	.	GN=MLH1;VT=G606FS*2;CSQ=-|Frameshift Truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1816_1817delGG||G606FS*2|730|GLY606FS|https://civicdb.org/links/variants/730|MLH1 G606FS*2|711|GLY606FS|https://civicdb.org/links/molecular-profiles/711|ENST00000231790.2:c.1816_1817delGG&NC_000003.11:g.37089094_37089095del|CA913102766|NONE FOUND|2.5|evidence|1793|https://civicdb.org/links/evidence/1793|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Cancer||||C|1|||||
3	37089129	733	GAAG	G	.	.	GN=MLH1;VT=K618DEL;CSQ=-|Inframe Deletion|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.1852_1854delAAG||K618DEL|733|RS63751247&LYS618DEL|https://civicdb.org/links/variants/733|MLH1 K618DEL|714|RS63751247&LYS618DEL|https://civicdb.org/links/molecular-profiles/714|NC_000003.11:g.37089130_37089132del&ENST00000231790.2:c.1852_1854delAAG&NM_000249.3:c.1852_1854delAAG&NP_000240.1:p.Lys618del|CA007087|17080|2.5|evidence|1796|https://civicdb.org/links/evidence/1796|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37090405	746	AC	A	.	.	VT=D667FS;GN=MLH1;CSQ=-|Frameshift Truncation|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2001del||D667FS|746|ASP667FS|https://civicdb.org/links/variants/746|MLH1 D667FS|727|ASP667FS|https://civicdb.org/links/molecular-profiles/727|NC_000003.11:g.37090406del&ENST00000231790.2:c.2001del|CA913102767|NONE FOUND|2.5|evidence|1810|https://civicdb.org/links/evidence/1810|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37090447	760	C	T	.	.	GN=MLH1;VT=A681V;CSQ=T|Missense Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2042C>T||A681V|760|ALA681VAL&A440V&RS63750864|https://civicdb.org/links/variants/760|MLH1 A681V|741|ALA681VAL&A440V&RS63750864|https://civicdb.org/links/molecular-profiles/741|NM_000249.3:c.2042C>T&NP_000240.1:p.Ala681Val&ENST00000231790.2:c.2042C>T&NC_000003.11:g.37090447C>T|CA008313|90011|2.5|evidence|1824|https://civicdb.org/links/evidence/1824|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37090463	735	CC	C	.	.	VT=R687FS;GN=MLH1;CSQ=-|Frameshift Variant|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2059delC||R687FS|735|ARG687GLYFS&RS863225381|https://civicdb.org/links/variants/735|MLH1 R687FS|716|ARG687GLYFS&RS863225381|https://civicdb.org/links/molecular-profiles/716|NM_000249.3:c.2059delC&NP_000240.1:p.Arg687Glyfs&ENST00000231790.2:c.2059delC&NC_000003.11:g.37090464del|CA279809|218022|2.5|evidence|1798|https://civicdb.org/links/evidence/1798|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Colorectal Cancer||||C|1|||||
3	37092143	748	A	T	.	.	GN=MLH1;VT=*757L;CSQ=T|Stop Lost|MLH1|4292|transcript|ENST00000231790.2|ENST00000231790.2:c.2270A>T||*757L|748|X757L|https://civicdb.org/links/variants/748|MLH1 *757L|729|X757L|https://civicdb.org/links/molecular-profiles/729|ENST00000231790.2:c.2270A>T&NC_000003.11:g.37092143A>T|CA352069936|NONE FOUND|2.5|evidence|1812|https://civicdb.org/links/evidence/1812|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Villous Adenoma||||C|1|||||
3	38182641	424	T	C	.	.	VT=L265P;CSQ=C|Missense Variant&Gain Of Function Variant|MYD88|4615|transcript|ENST00000396334.3|ENST00000396334.3:c.794T>C||L265P|424|LEU265PRO&L273P&LEU273PRO&RS387907272|https://civicdb.org/links/variants/424|MYD88 L265P|420|LEU265PRO&L273P&LEU273PRO&RS387907272|https://civicdb.org/links/molecular-profiles/420|NC_000003.11:g.38182641T>C&NP_002459.2:p.L265P&NM_002468.4:c.794T>C&ENST00000396334.3:c.794T>C|CA130043|37055|31.0|evidence|986|https://civicdb.org/links/evidence/986|25853747 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lymphoplasmacytic Lymphoma|Ibrutinib (NCIt ID C81934)|||B|4|||||,C|Missense Variant&Gain Of Function Variant|MYD88|4615|transcript|ENST00000396334.3|ENST00000396334.3:c.794T>C||L265P|424|LEU265PRO&L273P&LEU273PRO&RS387907272|https://civicdb.org/links/variants/424|MYD88 L265P|420|LEU265PRO&L273P&LEU273PRO&RS387907272|https://civicdb.org/links/molecular-profiles/420|NC_000003.11:g.38182641T>C&NP_002459.2:p.L265P&NM_002468.4:c.794T>C&ENST00000396334.3:c.794T>C|CA130043|37055|31.0|evidence|1489|https://civicdb.org/links/evidence/1489|24943832 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Chronic Lymphocytic Leukemia||||B|2|||||,C|Missense Variant&Gain Of Function Variant|MYD88|4615|transcript|ENST00000396334.3|ENST00000396334.3:c.794T>C||L265P|424|LEU265PRO&L273P&LEU273PRO&RS387907272|https://civicdb.org/links/variants/424|MYD88 L265P|420|LEU265PRO&L273P&LEU273PRO&RS387907272|https://civicdb.org/links/molecular-profiles/420|NC_000003.11:g.38182641T>C&NP_002459.2:p.L265P&NM_002468.4:c.794T>C&ENST00000396334.3:c.794T>C|CA130043|37055|31.0|evidence|1641|https://civicdb.org/links/evidence/1641|22931316 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lymphoplasmacytic Lymphoma|IMG-2005-5&IRAK-1/4 Inhibitor|SUBSTITUTES||D|1|||||;GN=MYD88
3	41266124	1285	A	G	.	.	GN=CTNNB1;VT=T41A;CSQ=G|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.121A>G||T41A|1285|THR41ALA&RS121913412|https://civicdb.org/links/variants/1285|CTNNB1 T41A|1259|THR41ALA&RS121913412|https://civicdb.org/links/molecular-profiles/1259|NM_001904.3:c.121A>G&NP_001895.1:p.Thr41Ala&NC_000003.11:g.41266124A>G&ENST00000349496.5:c.121A>G|CA127269|17580|55.0|evidence|2973|https://civicdb.org/links/evidence/2973|18832571 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Desmoid Tumor||||B|4|||||,G|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.121A>G||T41A|1285|THR41ALA&RS121913412|https://civicdb.org/links/variants/1285|CTNNB1 T41A|1259|THR41ALA&RS121913412|https://civicdb.org/links/molecular-profiles/1259|NM_001904.3:c.121A>G&NP_001895.1:p.Thr41Ala&NC_000003.11:g.41266124A>G&ENST00000349496.5:c.121A>G|CA127269|17580|55.0|evidence|5070|https://civicdb.org/links/evidence/5070|22766794 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Desmoid Tumor||||B|4|||||,G|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.121A>G||T41A|1285|THR41ALA&RS121913412|https://civicdb.org/links/variants/1285|CTNNB1 T41A|1259|THR41ALA&RS121913412|https://civicdb.org/links/molecular-profiles/1259|NM_001904.3:c.121A>G&NP_001895.1:p.Thr41Ala&NC_000003.11:g.41266124A>G&ENST00000349496.5:c.121A>G|CA127269|17580|55.0|evidence|3044|https://civicdb.org/links/evidence/3044|18832571 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Desmoid Tumor||||B|3|||||
3	41266136	1287	T	C	.	.	VT=S45P;CSQ=C|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.133T>C||S45P|1287|SER45PRO&RS121913407|https://civicdb.org/links/variants/1287|CTNNB1 S45P|1261|SER45PRO&RS121913407|https://civicdb.org/links/molecular-profiles/1261|NM_001904.3:c.133T>C&NP_001895.1:p.Ser45Pro&NC_000003.11:g.41266136T>C&ENST00000349496.5:c.133T>C|CA127285|17589|35.0|evidence|2975|https://civicdb.org/links/evidence/2975|18832571 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Desmoid Tumor||||B|3|||||,C|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.133T>C||S45P|1287|SER45PRO&RS121913407|https://civicdb.org/links/variants/1287|CTNNB1 S45P|1261|SER45PRO&RS121913407|https://civicdb.org/links/molecular-profiles/1261|NM_001904.3:c.133T>C&NP_001895.1:p.Ser45Pro&NC_000003.11:g.41266136T>C&ENST00000349496.5:c.133T>C|CA127285|17589|35.0|evidence|5072|https://civicdb.org/links/evidence/5072|22766794 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Desmoid Tumor||||B|3|||||,C|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.133T>C||S45P|1287|SER45PRO&RS121913407|https://civicdb.org/links/variants/1287|CTNNB1 S45P|1261|SER45PRO&RS121913407|https://civicdb.org/links/molecular-profiles/1261|NM_001904.3:c.133T>C&NP_001895.1:p.Ser45Pro&NC_000003.11:g.41266136T>C&ENST00000349496.5:c.133T>C|CA127285|17589|35.0|evidence|3043|https://civicdb.org/links/evidence/3043|18832571 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Desmoid Tumor||||B|1|||||;GN=CTNNB1
3	41266137	1286	C	T	.	.	VT=S45F;GN=CTNNB1;CSQ=T|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|SER45PHE&RS121913409|https://civicdb.org/links/variants/1286|CTNNB1 S45F|1260|SER45PHE&RS121913409|https://civicdb.org/links/molecular-profiles/1260|NM_001904.3:c.134C>T&NP_001895.1:p.Ser45Phe&NC_000003.11:g.41266137C>T&ENST00000349496.5:c.134C>T|CA127283|17588|80.0|evidence|2974|https://civicdb.org/links/evidence/2974|18832571 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Desmoid Tumor||||B|4|||||,T|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|SER45PHE&RS121913409|https://civicdb.org/links/variants/1286|CTNNB1 S45F|1260|SER45PHE&RS121913409|https://civicdb.org/links/molecular-profiles/1260|NM_001904.3:c.134C>T&NP_001895.1:p.Ser45Phe&NC_000003.11:g.41266137C>T&ENST00000349496.5:c.134C>T|CA127283|17588|80.0|evidence|5071|https://civicdb.org/links/evidence/5071|22766794 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Desmoid Tumor||||B|4|||||,T|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|SER45PHE&RS121913409|https://civicdb.org/links/variants/1286|CTNNB1 S45F|1260|SER45PHE&RS121913409|https://civicdb.org/links/molecular-profiles/1260|NM_001904.3:c.134C>T&NP_001895.1:p.Ser45Phe&NC_000003.11:g.41266137C>T&ENST00000349496.5:c.134C>T|CA127283|17588|80.0|evidence|9788|https://civicdb.org/links/evidence/9788|25341748 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Desmoid Tumor||||B|4|||||,T|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|SER45PHE&RS121913409|https://civicdb.org/links/variants/1286|CTNNB1 S45F|1260|SER45PHE&RS121913409|https://civicdb.org/links/molecular-profiles/1260|NM_001904.3:c.134C>T&NP_001895.1:p.Ser45Phe&NC_000003.11:g.41266137C>T&ENST00000349496.5:c.134C>T|CA127283|17588|80.0|evidence|2976|https://civicdb.org/links/evidence/2976|18832571 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Desmoid Tumor||||B|3|||||,T|Missense Variant|CTNNB1|1499|transcript|ENST00000349496.5|ENST00000349496.5:c.134C>T||S45F|1286|SER45PHE&RS121913409|https://civicdb.org/links/variants/1286|CTNNB1 S45F|1260|SER45PHE&RS121913409|https://civicdb.org/links/molecular-profiles/1260|NM_001904.3:c.134C>T&NP_001895.1:p.Ser45Phe&NC_000003.11:g.41266137C>T&ENST00000349496.5:c.134C>T|CA127283|17588|80.0|evidence|6049|https://civicdb.org/links/evidence/6049|24788118 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Desmoid Tumor|Meloxicam (NCIt ID C61439)|||C|2|||||
3	105439026	643	G	A	.	.	VT=RS2305035;CSQ=A|Synonymous Variant&Polymorphic Sequence Variant|CBLB|868|transcript|ENST00000264122.4|ENST00000264122.4:c.1272C>T||RS2305035|643|D424D|https://civicdb.org/links/variants/643|CBLB RS2305035|639|D424D|https://civicdb.org/links/molecular-profiles/639|NC_000003.11:g.105439026G>A&NM_001321788.1:c.1272C>T&ENST00000264122.4:c.1272C>T|CA2524814|NONE FOUND|10.0|evidence|1637|https://civicdb.org/links/evidence/1637|26732495 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|2|||||;GN=CBLB
3	138665163	198	G	C	.	.	CSQ=C|Missense Variant|FOXL2|668|transcript|ENST00000330315.3|||C134W|198||https://civicdb.org/links/variants/198|FOXL2 C134W|198||https://civicdb.org/links/molecular-profiles/198|NC_000003.11:g.138665163G>C|CA16602790||70.0|evidence|6034|https://civicdb.org/links/evidence/6034|26033501 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Ovarian Sex-cord Stromal Tumor||||A|5|||||,C|Missense Variant|FOXL2|668|transcript|ENST00000330315.3|||C134W|198||https://civicdb.org/links/variants/198|FOXL2 C134W|198||https://civicdb.org/links/molecular-profiles/198|NC_000003.11:g.138665163G>C|CA16602790||70.0|evidence|479|https://civicdb.org/links/evidence/479|20693978 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Granulosa Cell Tumor||||B|4|||||;GN=FOXL2;VT=C134W
3	178916854	1500	G	A	.	.	CSQ=A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.241G>A||E81K|1500|GLU81LYS&RS1057519929|https://civicdb.org/links/variants/1500|PIK3CA E81K|1408|GLU81LYS&RS1057519929|https://civicdb.org/links/molecular-profiles/1408|NM_006218.3:c.241G>A&NP_006209.2:p.Glu81Lys&NC_000003.11:g.178916854G>A&ENST00000263967.3:c.241G>A|CA16602912|376478|5.0|evidence|4464|https://civicdb.org/links/evidence/4464|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Fluorouracil (NCIt ID C505)&Oxaliplatin (NCIt ID C1181)|COMBINATION||C|2|||||;VT=E81K;GN=PIK3CA
3	178916876	929	G	A	.	.	CSQ=A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|||R88Q|929|RS121913287&ARG88GLN|https://civicdb.org/links/variants/929|PIK3CA R88Q|903|RS121913287&ARG88GLN|https://civicdb.org/links/molecular-profiles/903|NC_000003.12:g.179199088G>A&NC_000003.11:g.178916876G>A&NM_006218.4:c.263G>A&NP_006209.2:p.Arg88Gln|CA16602516|376049|7.5|evidence|12034|https://civicdb.org/links/evidence/12034|37256976 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Negative Breast Cancer|Capivasertib (NCIt ID C102564)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|||R88Q|929|RS121913287&ARG88GLN|https://civicdb.org/links/variants/929|PIK3CA R88Q|903|RS121913287&ARG88GLN|https://civicdb.org/links/molecular-profiles/903|NC_000003.12:g.179199088G>A&NC_000003.11:g.178916876G>A&NM_006218.4:c.263G>A&NP_006209.2:p.Arg88Gln|CA16602516|376049|7.5|evidence|3832|https://civicdb.org/links/evidence/3832|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||;VT=R88Q;GN=PIK3CA
3	178916890	1178	C	T	.	.	VT=R93W;GN=PIK3CA;CSQ=T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.277C>T||R93W|1178|ARG93TRP|https://civicdb.org/links/variants/1178|PIK3CA R93W|1152|ARG93TRP|https://civicdb.org/links/molecular-profiles/1152|ENST00000263967.3:c.277C>T&NC_000003.11:g.178916890C>T&NM_006218.2:c.277C>T&NP_006209.2:p.Arg93Trp|CA355272477|NONE FOUND|5.0|evidence|4467|https://civicdb.org/links/evidence/4467|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Fluorouracil (NCIt ID C505)&Oxaliplatin (NCIt ID C1181)|COMBINATION||C|2|||||
3	178916946	1234	G	C	.	.	VT=K111N;GN=PIK3CA;CSQ=C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.333G>C||K111N|1234|LYS111ASN&RS1057519934|https://civicdb.org/links/variants/1234|PIK3CA K111N|1208|LYS111ASN&RS1057519934|https://civicdb.org/links/molecular-profiles/1208|NM_006218.3:c.333G>C&NP_006209.2:p.Lys111Asn&NC_000003.11:g.178916946G>C&ENST00000263967.3:c.333G>C|CA16602917|376483|13.0|evidence|2085|https://civicdb.org/links/evidence/2085|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Pictilisib (NCIt ID C165479)|||D|4|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.333G>C||K111N|1234|LYS111ASN&RS1057519934|https://civicdb.org/links/variants/1234|PIK3CA K111N|1208|LYS111ASN&RS1057519934|https://civicdb.org/links/molecular-profiles/1208|NM_006218.3:c.333G>C&NP_006209.2:p.Lys111Asn&NC_000003.11:g.178916946G>C&ENST00000263967.3:c.333G>C|CA16602917|376483|13.0|evidence|2866|https://civicdb.org/links/evidence/2866|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab Emtansine (NCIt ID C82492)|||D|3|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.333G>C||K111N|1234|LYS111ASN&RS1057519934|https://civicdb.org/links/variants/1234|PIK3CA K111N|1208|LYS111ASN&RS1057519934|https://civicdb.org/links/molecular-profiles/1208|NM_006218.3:c.333G>C&NP_006209.2:p.Lys111Asn&NC_000003.11:g.178916946G>C&ENST00000263967.3:c.333G>C|CA16602917|376483|13.0|evidence|8183|https://civicdb.org/links/evidence/8183|19010894 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Dactolisib (NCIt ID C74072)&Lapatinib (NCIt ID C26653)&Trastuzumab (NCIt ID C1647)|SUBSTITUTES||D|2|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.333G>C||K111N|1234|LYS111ASN&RS1057519934|https://civicdb.org/links/variants/1234|PIK3CA K111N|1208|LYS111ASN&RS1057519934|https://civicdb.org/links/molecular-profiles/1208|NM_006218.3:c.333G>C&NP_006209.2:p.Lys111Asn&NC_000003.11:g.178916946G>C&ENST00000263967.3:c.333G>C|CA16602917|376483|13.0|evidence|8662|https://civicdb.org/links/evidence/8662|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||D|2|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.333G>C||K111N|1234|LYS111ASN&RS1057519934|https://civicdb.org/links/variants/1234|PIK3CA K111N|1208|LYS111ASN&RS1057519934|https://civicdb.org/links/molecular-profiles/1208|NM_006218.3:c.333G>C&NP_006209.2:p.Lys111Asn&NC_000003.11:g.178916946G>C&ENST00000263967.3:c.333G>C|CA16602917|376483|13.0|evidence|8011|https://civicdb.org/links/evidence/8011|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|PI-103|||D|1|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.333G>C||K111N|1234|LYS111ASN&RS1057519934|https://civicdb.org/links/variants/1234|PIK3CA K111N|1208|LYS111ASN&RS1057519934|https://civicdb.org/links/molecular-profiles/1208|NM_006218.3:c.333G>C&NP_006209.2:p.Lys111Asn&NC_000003.11:g.178916946G>C&ENST00000263967.3:c.333G>C|CA16602917|376483|13.0|evidence|8020|https://civicdb.org/links/evidence/8020|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|PI3Ka/Di|||D|1|||||
3	178917598	1499	C	T	.	.	VT=S158L;CSQ=T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.473C>T||S158L|1499|SER158LEU|https://civicdb.org/links/variants/1499|PIK3CA S158L|1407|SER158LEU|https://civicdb.org/links/molecular-profiles/1407|ENST00000263967.3:c.473C>T&NC_000003.11:g.178917598C>T&NM_006218.2:c.473C>T&NP_006209.2:p.Ser158Leu|CA355274155|NONE FOUND|7.5|evidence|4463|https://civicdb.org/links/evidence/4463|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||;GN=PIK3CA
3	178921553	930	T	A	.	.	VT=N345K;CSQ=A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1035T>A||N345K|930|RS121913284&ASN345LYS|https://civicdb.org/links/variants/930|PIK3CA N345K|904|RS121913284&ASN345LYS|https://civicdb.org/links/molecular-profiles/904|NM_006218.3:c.1035T>A&NP_006209.2:p.Asn345Lys&NC_000003.11:g.178921553T>A&ENST00000263967.3:c.1035T>A|CA16602517|376050|2.5|evidence|4047|https://civicdb.org/links/evidence/4047|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|1|||||;GN=PIK3CA
3	178921567	1653	A	G	.	.	VT=D350G;GN=PIK3CA;CSQ=G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1049A>G||D350G|1653|ASP350GLY|https://civicdb.org/links/variants/1653|PIK3CA D350G|1561|ASP350GLY|https://civicdb.org/links/molecular-profiles/1561|ENST00000263967.3:c.1049A>G&NC_000003.11:g.178921567A>G&NM_006218.2:c.1049A>G&NP_006209.2:p.Asp350Gly|CA355281594|521363|2.0|evidence|4784|https://civicdb.org/links/evidence/4784|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|2|||||
3	178927410	1235	A	G	.	.	VT=I391M;GN=PIK3CA;CSQ=G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1173A>G||I391M|1235|ILE391MET&RS2230461|https://civicdb.org/links/variants/1235|PIK3CA I391M|1209|ILE391MET&RS2230461|https://civicdb.org/links/molecular-profiles/1209|NM_006218.3:c.1173A>G&NP_006209.2:p.Ile391Met&NC_000003.11:g.178927410A>G&ENST00000263967.3:c.1173A>G|CA161490|135038|5.0|evidence|2867|https://civicdb.org/links/evidence/2867|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab Emtansine (NCIt ID C82492)|||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1173A>G||I391M|1235|ILE391MET&RS2230461|https://civicdb.org/links/variants/1235|PIK3CA I391M|1209|ILE391MET&RS2230461|https://civicdb.org/links/molecular-profiles/1209|NM_006218.3:c.1173A>G&NP_006209.2:p.Ile391Met&NC_000003.11:g.178927410A>G&ENST00000263967.3:c.1173A>G|CA161490|135038|5.0|evidence|8663|https://civicdb.org/links/evidence/8663|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||D|2|||||
3	178927980	931	T	C	.	.	CSQ=C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1258T>C||C420R|931|RS121913272&CYS420ARG|https://civicdb.org/links/variants/931|PIK3CA C420R|905|RS121913272&CYS420ARG|https://civicdb.org/links/molecular-profiles/905|NM_006218.3:c.1258T>C&NP_006209.2:p.Cys420Arg&NC_000003.11:g.178927980T>C&ENST00000263967.3:c.1258T>C|CA180900|31945|15.5|evidence|11275|https://civicdb.org/links/evidence/11275|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|4|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1258T>C||C420R|931|RS121913272&CYS420ARG|https://civicdb.org/links/variants/931|PIK3CA C420R|905|RS121913272&CYS420ARG|https://civicdb.org/links/molecular-profiles/905|NM_006218.3:c.1258T>C&NP_006209.2:p.Cys420Arg&NC_000003.11:g.178927980T>C&ENST00000263967.3:c.1258T>C|CA180900|31945|15.5|evidence|1999|https://civicdb.org/links/evidence/1999|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|3|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1258T>C||C420R|931|RS121913272&CYS420ARG|https://civicdb.org/links/variants/931|PIK3CA C420R|905|RS121913272&CYS420ARG|https://civicdb.org/links/molecular-profiles/905|NM_006218.3:c.1258T>C&NP_006209.2:p.Cys420Arg&NC_000003.11:g.178927980T>C&ENST00000263967.3:c.1258T>C|CA180900|31945|15.5|evidence|2078|https://civicdb.org/links/evidence/2078|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Pictilisib (NCIt ID C165479)|||D|3|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1258T>C||C420R|931|RS121913272&CYS420ARG|https://civicdb.org/links/variants/931|PIK3CA C420R|905|RS121913272&CYS420ARG|https://civicdb.org/links/molecular-profiles/905|NM_006218.3:c.1258T>C&NP_006209.2:p.Cys420Arg&NC_000003.11:g.178927980T>C&ENST00000263967.3:c.1258T>C|CA180900|31945|15.5|evidence|2346|https://civicdb.org/links/evidence/2346|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab Emtansine (NCIt ID C82492)|||D|3|||||,C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1258T>C||C420R|931|RS121913272&CYS420ARG|https://civicdb.org/links/variants/931|PIK3CA C420R|905|RS121913272&CYS420ARG|https://civicdb.org/links/molecular-profiles/905|NM_006218.3:c.1258T>C&NP_006209.2:p.Cys420Arg&NC_000003.11:g.178927980T>C&ENST00000263967.3:c.1258T>C|CA180900|31945|15.5|evidence|8549|https://civicdb.org/links/evidence/8549|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||D|2|||||;GN=PIK3CA;VT=C420R
3	178928226	294	C	T	.	.	VT=P471L;GN=PIK3CA;CSQ=T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1412C>T||P471L|294|PRO471LEU&RS1057519872|https://civicdb.org/links/variants/294|PIK3CA P471L|290|PRO471LEU&RS1057519872|https://civicdb.org/links/molecular-profiles/290|NC_000003.11:g.178928226C>T&ENST00000263967.3:c.1412C>T&NM_006218.3:c.1412C>T&NP_006209.2:p.Pro471Leu|CA16602799|376359|7.5|evidence|739|https://civicdb.org/links/evidence/739|26466009 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Merkel Cell Carcinoma|Idelalisib (NCIt ID C78825)|||C|3|||||
3	178936082	103	G	A	.	.	VT=E542K;CSQ=A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|7315|https://civicdb.org/links/evidence/7315|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|83|https://civicdb.org/links/evidence/83|26184520 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||B|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|4424|https://civicdb.org/links/evidence/4424|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|1549|https://civicdb.org/links/evidence/1549|26787751 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Squamous Cell Carcinoma|Apitolisib (NCIt ID C91731)|||C|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|310|https://civicdb.org/links/evidence/310|21558396 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Izorlisib (NCIt ID C158603)|||D|4|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|311|https://civicdb.org/links/evidence/311|15647370 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Sirolimus (NCIt ID C1212)|||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|1626|https://civicdb.org/links/evidence/1626|19706758 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Thyroid Cancer|Perifosine (NCIt ID C1727)&Temsirolimus (NCIt ID C1844)|SUBSTITUTES||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|2022|https://civicdb.org/links/evidence/2022|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Pictilisib (NCIt ID C165479)|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|2026|https://civicdb.org/links/evidence/2026|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Pictilisib (NCIt ID C165479)|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|2058|https://civicdb.org/links/evidence/2058|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|PI-103|||D|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|8007|https://civicdb.org/links/evidence/8007|20453058 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|PI-103|||D|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|8013|https://civicdb.org/links/evidence/8013|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|PI3Ka/Di|||D|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/molecular-profiles/103|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|75.5|evidence|8016|https://civicdb.org/links/evidence/8016|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|PI3Ka/Di|||D|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1624G>A||E542K|103|GLU542LYS&RS121913273|https://civicdb.org/links/variants/103|PIK3CA E542K OR PIK3CA E545K OR PIK3CA H1047R|5416||https://civicdb.org/links/molecular-profiles/5416|NM_006218.3:c.1624G>A&NP_006209.2:p.Glu542Lys&ENST00000263967.3:c.1624G>A&NC_000003.11:g.178936082G>A|CA333572|31944|0.0|evidence|6191|https://civicdb.org/links/evidence/6191|18371219 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Breast Cancer|FAC Regimen (NCIt ID C138099)&FEC Regimen (NCIt ID C63420)|SUBSTITUTES||B|3|||||;GN=PIK3CA
3	178936091	104	G	A	.	.	GN=PIK3CA;CSQ=A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2106|https://civicdb.org/links/evidence/2106|19903786 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Rectum Cancer||||B|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|387|https://civicdb.org/links/evidence/387|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2217|https://civicdb.org/links/evidence/2217|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|1670|https://civicdb.org/links/evidence/1670|27304188 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||C|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2037|https://civicdb.org/links/evidence/2037|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|1550|https://civicdb.org/links/evidence/1550|26787751 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Apitolisib (NCIt ID C91731)|||C|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2062|https://civicdb.org/links/evidence/2062|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Pictilisib (NCIt ID C165479)|||D|4|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|710|https://civicdb.org/links/evidence/710|23888070 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Akt Inhibitor MK2206 (NCIt ID C90581)&Pictilisib (NCIt ID C165479)|SUBSTITUTES||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2036|https://civicdb.org/links/evidence/2036|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab Emtansine (NCIt ID C82492)|||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2984|https://civicdb.org/links/evidence/2984|27489350 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cervix Carcinoma|Cisplatin (NCIt ID C376)&Pictilisib (NCIt ID C165479)|COMBINATION||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2985|https://civicdb.org/links/evidence/2985|27489350 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cervical Cancer|Cisplatin (NCIt ID C376)|||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|6211|https://civicdb.org/links/evidence/6211|19010894 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Her2-receptor Positive Breast Cancer|Lapatinib (NCIt ID C26653)&Trastuzumab (NCIt ID C1647)|COMBINATION||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|6213|https://civicdb.org/links/evidence/6213|19010894 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Dactolisib (NCIt ID C74072)|||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|8112|https://civicdb.org/links/evidence/8112|27489350 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cervical Cancer|Cisplatin (NCIt ID C376)&Ionizing Radiotherapy (NCIt ID C15846)|SEQUENTIAL||D|3|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|1171|https://civicdb.org/links/evidence/1171|16906227 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Gefitinib (NCIt ID C1855)|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|1453|https://civicdb.org/links/evidence/1453|18829560 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2034|https://civicdb.org/links/evidence/2034|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Pictilisib (NCIt ID C165479)|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|2040|https://civicdb.org/links/evidence/2040|19513541 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|PI103|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|3722|https://civicdb.org/links/evidence/3722|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|8547|https://civicdb.org/links/evidence/8547|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||D|2|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|8008|https://civicdb.org/links/evidence/8008|20453058 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|PI-103|||D|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|8017|https://civicdb.org/links/evidence/8017|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|PI3Ka/Di|||D|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/molecular-profiles/104|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|77.5|evidence|8018|https://civicdb.org/links/evidence/8018|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|PI3Ka/Di|||D|1|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E545K OR PIK3CA E545A OR PIK3CA E545G OR PIK3CA E545D|5296||https://civicdb.org/links/molecular-profiles/5296|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|0.0|evidence|7468|https://civicdb.org/links/evidence/7468|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|4|||||,A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>A||E545K|104|GLU545LYS&RS104886003|https://civicdb.org/links/variants/104|PIK3CA E542K OR PIK3CA E545K OR PIK3CA H1047R|5416||https://civicdb.org/links/molecular-profiles/5416|NM_006218.3:c.1633G>A&NP_006209.2:p.Glu545Lys&ENST00000263967.3:c.1633G>A&NC_000003.11:g.178936091G>A|CA123334|13655|0.0|evidence|6191|https://civicdb.org/links/evidence/6191|18371219 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Breast Cancer|FAC Regimen (NCIt ID C138099)&FEC Regimen (NCIt ID C63420)|SUBSTITUTES||B|3|||||;VT=E545K
3	178936091	881	G	C	.	.	CSQ=C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1633G>C||E545Q|881|RS104886003&GLU545GLN|https://civicdb.org/links/variants/881|PIK3CA E545Q|855|RS104886003&GLU545GLN|https://civicdb.org/links/molecular-profiles/855|NM_006218.3:c.1633G>C&NP_006209.2:p.Glu545Gln&NC_000003.11:g.178936091G>C&ENST00000263967.3:c.1633G>C|CA16602379|375896|7.5|evidence|2213|https://civicdb.org/links/evidence/2213|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||;GN=PIK3CA;VT=E545Q
3	178936092	882	A	C	.	.	GN=PIK3CA;VT=E545A;CSQ=C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1634A>C||E545A|882|RS121913274&GLU545ALA|https://civicdb.org/links/variants/882|PIK3CA E545K OR PIK3CA E545A OR PIK3CA E545G OR PIK3CA E545D|5296||https://civicdb.org/links/molecular-profiles/5296|NM_006218.3:c.1634A>C&NP_006209.2:p.Glu545Ala&NC_000003.11:g.178936092A>C&ENST00000263967.3:c.1634A>C|CA123342|13659|0.0|evidence|7468|https://civicdb.org/links/evidence/7468|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|4|||||
3	178936092	883	A	G	.	.	VT=E545G;GN=PIK3CA;CSQ=G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1634A>G||E545G|883|RS121913274&GLU545GLY|https://civicdb.org/links/variants/883|PIK3CA E545G|857|RS121913274&GLU545GLY|https://civicdb.org/links/molecular-profiles/857|NM_006218.3:c.1634A>G&NP_006209.2:p.Glu545Gly&NC_000003.11:g.178936092A>G&ENST00000263967.3:c.1634A>G|CA123336|13656|2.0|evidence|3724|https://civicdb.org/links/evidence/3724|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1634A>G||E545G|883|RS121913274&GLU545GLY|https://civicdb.org/links/variants/883|PIK3CA E545K OR PIK3CA E545A OR PIK3CA E545G OR PIK3CA E545D|5296||https://civicdb.org/links/molecular-profiles/5296|NM_006218.3:c.1634A>G&NP_006209.2:p.Glu545Gly&NC_000003.11:g.178936092A>G&ENST00000263967.3:c.1634A>G|CA123336|13656|0.0|evidence|7468|https://civicdb.org/links/evidence/7468|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|4|||||
3	178936093	934	G	C	.	.	VT=E545D;CSQ=C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1635G>C||E545D|934|RS121913275&GLU545ASP|https://civicdb.org/links/variants/934|PIK3CA E545K OR PIK3CA E545A OR PIK3CA E545G OR PIK3CA E545D|5296||https://civicdb.org/links/molecular-profiles/5296|NM_006218.3:c.1635G>C&NP_006209.2:p.Glu545Asp&NC_000003.11:g.178936093G>C&ENST00000263967.3:c.1635G>C|CA16602698|376245|0.0|evidence|7468|https://civicdb.org/links/evidence/7468|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|4|||||;GN=PIK3CA
3	178936094	886	C	G	.	.	VT=Q546E;GN=PIK3CA;CSQ=G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1636C>G||Q546E|886|RS121913286&GLN546GLU|https://civicdb.org/links/variants/886|PIK3CA Q546E OR PIK3CA Q546R|5299||https://civicdb.org/links/molecular-profiles/5299|NM_006218.3:c.1636C>G&NP_006209.2:p.Gln546Glu&NC_000003.11:g.178936094C>G&ENST00000263967.3:c.1636C>G|CA123331|13654|0.0|evidence|7316|https://civicdb.org/links/evidence/7316|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|5|||||
3	178936094	885	C	A	.	.	VT=Q546K;CSQ=A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.1636C>A||Q546K|885|RS121913286&GLN546LYS|https://civicdb.org/links/variants/885|PIK3CA Q546K|859|RS121913286&GLN546LYS|https://civicdb.org/links/molecular-profiles/859|NM_006218.3:c.1636C>A&NP_006209.2:p.Gln546Lys&NC_000003.11:g.178936094C>A&ENST00000263967.3:c.1636C>A|CA123338|13657|5.0|evidence|2198|https://civicdb.org/links/evidence/2198|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|2|||||;GN=PIK3CA
3	178936095	888	A	G	.	.	GN=PIK3CA;VT=Q546R;CSQ=G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|||Q546R|888||https://civicdb.org/links/variants/888|PIK3CA Q546E OR PIK3CA Q546R|5299||https://civicdb.org/links/molecular-profiles/5299|NC_000003.11:g.178936095A>G&NC_000003.12:g.179218307A>G&NP_006209.2:p.Gln546Arg&NM_006218.4:c.1637A>G|CA136371|45466|0.0|evidence|7316|https://civicdb.org/links/evidence/7316|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|5|||||
3	178948091	3001	G	A	.	.	CSQ=A|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.2863G>A||V955I|3001|VAL955ILE|https://civicdb.org/links/variants/3001|PIK3CA V955I|2870|VAL955ILE|https://civicdb.org/links/molecular-profiles/2870|NC_000003.11:g.178948091G>A&NM_006218.2:c.2863G>A&ENST00000263967.3:c.2863G>A&NP_006209.2:p.Val955Ile|CA355281422|NONE FOUND|10.0|evidence|8063|https://civicdb.org/links/evidence/8063|28424201 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|4|||||;GN=PIK3CA;VT=V955I
3	178952084	938	C	T	.	.	VT=H1047Y;GN=PIK3CA;CSQ=T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3139C>T||H1047Y|938|RS121913281&HIS1047TYR|https://civicdb.org/links/variants/938|PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L|5288||https://civicdb.org/links/molecular-profiles/5288|NM_006218.3:c.3139C>T&NP_006209.2:p.His1047Tyr&NC_000003.11:g.178952084C>T&ENST00000263967.3:c.3139C>T|CA130471|39705|0.0|evidence|7318|https://civicdb.org/links/evidence/7318|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|5|||||
3	178952085	1151	A	T	.	.	VT=H1047L;GN=PIK3CA;CSQ=T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>T||H1047L|1151|RS121913279&HIS1047LEU|https://civicdb.org/links/variants/1151|PIK3CA H1047L|1125|RS121913279&HIS1047LEU|https://civicdb.org/links/molecular-profiles/1125|NM_006218.3:c.3140A>T&NP_006209.2:p.His1047Leu&NC_000003.11:g.178952085A>T&ENST00000263967.3:c.3140A>T|CA123328|13653|12.5|evidence|4432|https://civicdb.org/links/evidence/4432|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||,T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>T||H1047L|1151|RS121913279&HIS1047LEU|https://civicdb.org/links/variants/1151|PIK3CA H1047L|1125|RS121913279&HIS1047LEU|https://civicdb.org/links/molecular-profiles/1125|NM_006218.3:c.3140A>T&NP_006209.2:p.His1047Leu&NC_000003.11:g.178952085A>T&ENST00000263967.3:c.3140A>T|CA123328|13653|12.5|evidence|2089|https://civicdb.org/links/evidence/2089|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Pictilisib (NCIt ID C165479)|||D|3|||||,T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>T||H1047L|1151|RS121913279&HIS1047LEU|https://civicdb.org/links/variants/1151|PIK3CA H1047L|1125|RS121913279&HIS1047LEU|https://civicdb.org/links/molecular-profiles/1125|NM_006218.3:c.3140A>T&NP_006209.2:p.His1047Leu&NC_000003.11:g.178952085A>T&ENST00000263967.3:c.3140A>T|CA123328|13653|12.5|evidence|8009|https://civicdb.org/links/evidence/8009|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|PI-103|||D|1|||||,T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>T||H1047L|1151|RS121913279&HIS1047LEU|https://civicdb.org/links/variants/1151|PIK3CA H1047L|1125|RS121913279&HIS1047LEU|https://civicdb.org/links/molecular-profiles/1125|NM_006218.3:c.3140A>T&NP_006209.2:p.His1047Leu&NC_000003.11:g.178952085A>T&ENST00000263967.3:c.3140A>T|CA123328|13653|12.5|evidence|8019|https://civicdb.org/links/evidence/8019|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|PI3Ka/Di|||D|1|||||,T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>T||H1047L|1151|RS121913279&HIS1047LEU|https://civicdb.org/links/variants/1151|PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L|5288||https://civicdb.org/links/molecular-profiles/5288|NM_006218.3:c.3140A>T&NP_006209.2:p.His1047Leu&NC_000003.11:g.178952085A>T&ENST00000263967.3:c.3140A>T|CA123328|13653|0.0|evidence|7318|https://civicdb.org/links/evidence/7318|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|5|||||,T|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>T||H1047L|1151|RS121913279&HIS1047LEU|https://civicdb.org/links/variants/1151|PIK3CA H1047R OR PIK3CA H1047L|5319||https://civicdb.org/links/molecular-profiles/5319|NM_006218.3:c.3140A>T&NP_006209.2:p.His1047Leu&NC_000003.11:g.178952085A>T&ENST00000263967.3:c.3140A>T|CA123328|13653|0.0|evidence|3047|https://civicdb.org/links/evidence/3047|28269754 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Tubular Carcinoma||||B|1|||||
3	178952085	107	A	G	.	.	CSQ=G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|258|https://civicdb.org/links/evidence/258|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||B|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|2097|https://civicdb.org/links/evidence/2097|19671852 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Breast Cancer||||B|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|2100|https://civicdb.org/links/evidence/2100|17202311 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Breast Cancer||||B|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|3841|https://civicdb.org/links/evidence/3841|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|388|https://civicdb.org/links/evidence/388|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1623|https://civicdb.org/links/evidence/1623|27445490 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Everolimus (NCIt ID C48387)&Fulvestrant (NCIt ID C1379)|COMBINATION||C|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|314|https://civicdb.org/links/evidence/314|21558396 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Izorlisib (NCIt ID C158603)|||D|4|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|2096|https://civicdb.org/links/evidence/2096|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Pictilisib (NCIt ID C165479)|||D|4|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|6204|https://civicdb.org/links/evidence/6204|19010894 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Her2-receptor Positive Breast Cancer|Lapatinib (NCIt ID C26653)&Trastuzumab (NCIt ID C1647)|COMBINATION||D|4|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|6206|https://civicdb.org/links/evidence/6206|19010894 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Dactolisib (NCIt ID C74072)|||D|4|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1447|https://civicdb.org/links/evidence/1447|19029981 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Dactolisib (NCIt ID C74072)|||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1505|https://civicdb.org/links/evidence/1505|22294718 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Capivasertib (NCIt ID C102564)&Trastuzumab (NCIt ID C1647)|COMBINATION||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1506|https://civicdb.org/links/evidence/1506|22294718 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Her2-receptor Positive Breast Cancer|Capivasertib (NCIt ID C102564)&Lapatinib (NCIt ID C26653)|COMBINATION||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1625|https://civicdb.org/links/evidence/1625|19706758 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Thyroid Cancer|Perifosine (NCIt ID C1727)&Temsirolimus (NCIt ID C1844)|SUBSTITUTES||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|2103|https://civicdb.org/links/evidence/2103|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Her2-receptor Positive Breast Cancer|Trastuzumab Emtansine (NCIt ID C82492)|||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|3733|https://civicdb.org/links/evidence/3733|22180495 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Vemurafenib (NCIt ID C64768)|||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|8364|https://civicdb.org/links/evidence/8364|22180495 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Akt Inhibitor MK2206 (NCIt ID C90581)&Vemurafenib (NCIt ID C64768)|COMBINATION||D|3|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1362|https://civicdb.org/links/evidence/1362|23619167 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Cancer|Dactolisib (NCIt ID C74072)|||D|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1363|https://civicdb.org/links/evidence/1363|23619167 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Cancer|Cetuximab (NCIt ID C1723)&Dactolisib (NCIt ID C74072)|COMBINATION||D|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1465|https://civicdb.org/links/evidence/1465|26589432 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Squamous Cell Carcinoma|Taselisib (NCIt ID C116876)|||D|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|2102|https://civicdb.org/links/evidence/2102|20453058 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Pictilisib (NCIt ID C165479)|||D|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|8548|https://civicdb.org/links/evidence/8548|26920887 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Her2-receptor Positive Breast Cancer|Trastuzumab (NCIt ID C1647)|||D|2|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1361|https://civicdb.org/links/evidence/1361|25855885 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Cancer|Dactolisib (NCIt ID C74072)|||D|1|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/molecular-profiles/107|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|96.5|evidence|1401|https://civicdb.org/links/evidence/1401|25550549 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Cancer|Alpelisib (NCIt ID C94214)|||D|1|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R OR PIK3CA H1047Y OR PIK3CA H1047L|5288||https://civicdb.org/links/molecular-profiles/5288|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|0.0|evidence|7318|https://civicdb.org/links/evidence/7318|31091374 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Alpelisib (NCIt ID C94214)&Fulvestrant (NCIt ID C1379)|COMBINATION||A|5|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA H1047R OR PIK3CA H1047L|5319||https://civicdb.org/links/molecular-profiles/5319|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|0.0|evidence|3047|https://civicdb.org/links/evidence/3047|28269754 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Tubular Carcinoma||||B|1|||||,G|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3140A>G||H1047R|107|HIS1047ARG&RS121913279|https://civicdb.org/links/variants/107|PIK3CA E542K OR PIK3CA E545K OR PIK3CA H1047R|5416||https://civicdb.org/links/molecular-profiles/5416|NM_006218.3:c.3140A>G&NP_006209.2:p.His1047Arg&ENST00000263967.3:c.3140A>G&NC_000003.11:g.178952085A>G|CA123326|13652|0.0|evidence|6191|https://civicdb.org/links/evidence/6191|18371219 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Breast Cancer|FAC Regimen (NCIt ID C138099)&FEC Regimen (NCIt ID C63420)|SUBSTITUTES||B|3|||||;GN=PIK3CA;VT=H1047R
3	178952090	940	G	C	.	.	CSQ=C|Missense Variant|PIK3CA|5290|transcript|ENST00000263967.3|ENST00000263967.3:c.3145G>C||G1049R|940|RS121913277&GLY1049ARG|https://civicdb.org/links/variants/940|PIK3CA G1049R|914|RS121913277&GLY1049ARG|https://civicdb.org/links/molecular-profiles/914|NM_006218.3:c.3145G>C&NP_006209.2:p.Gly1049Arg&NC_000003.11:g.178952090G>C&ENST00000263967.3:c.3145G>C|CA16602520|376053|7.5|evidence|3847|https://civicdb.org/links/evidence/3847|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|3|||||;VT=G1049R;GN=PIK3CA
4	1803564	2403	C	T	.	.	GN=FGFR3;VT=R248C;CSQ=T|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|ENST00000340107.4:c.742C>T||R248C|2403|RS121913482&ARG248CYS|https://civicdb.org/links/variants/2403|FGFR3 R248C|2276|RS121913482&ARG248CYS|https://civicdb.org/links/molecular-profiles/2276|NC_000004.11:g.1803564C>T&NM_000142.4:c.742C>T&NP_000133.1:p.Arg248Cys&ENST00000340107.4:c.742C>T|CA126378|16332|8.0|evidence|8946|https://civicdb.org/links/evidence/8946|8640234 (PUBMED)|RARE_GERMLINE|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|5|||||,T|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|ENST00000340107.4:c.742C>T||R248C|2403|RS121913482&ARG248CYS|https://civicdb.org/links/variants/2403|FGFR3 R248C|2276|RS121913482&ARG248CYS|https://civicdb.org/links/molecular-profiles/2276|NC_000004.11:g.1803564C>T&NM_000142.4:c.742C>T&NP_000133.1:p.Arg248Cys&ENST00000340107.4:c.742C>T|CA126378|16332|8.0|evidence|8321|https://civicdb.org/links/evidence/8321|19381019 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|R3Mab|||D|3|||||
4	1803568	628	C	G	.	.	GN=FGFR3;VT=S249C;CSQ=G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|SER249CYS&RS121913483|https://civicdb.org/links/variants/628|FGFR3 S249C|624|SER249CYS&RS121913483|https://civicdb.org/links/molecular-profiles/624|NC_000004.11:g.1803568C>G&NM_000142.4:c.746C>G&NP_000133.1:p.Ser249Cys&ENST00000340107.4c.746C>G|CA126380|16339|21.0|evidence|1603|https://civicdb.org/links/evidence/1603|25766722 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Transitional Cell Carcinoma|Pazopanib (NCIt ID C74547)|||C|2|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|SER249CYS&RS121913483|https://civicdb.org/links/variants/628|FGFR3 S249C|624|SER249CYS&RS121913483|https://civicdb.org/links/molecular-profiles/624|NC_000004.11:g.1803568C>G&NM_000142.4:c.746C>G&NP_000133.1:p.Ser249Cys&ENST00000340107.4c.746C>G|CA126380|16339|21.0|evidence|8853|https://civicdb.org/links/evidence/8853|16338952 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Bladder Urothelial Carcinoma||||D|4|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|SER249CYS&RS121913483|https://civicdb.org/links/variants/628|FGFR3 S249C|624|SER249CYS&RS121913483|https://civicdb.org/links/molecular-profiles/624|NC_000004.11:g.1803568C>G&NM_000142.4:c.746C>G&NP_000133.1:p.Ser249Cys&ENST00000340107.4c.746C>G|CA126380|16339|21.0|evidence|7941|https://civicdb.org/links/evidence/7941|23786770 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Lung Squamous Cell Carcinoma||||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|SER249CYS&RS121913483|https://civicdb.org/links/variants/628|FGFR3 S249C|624|SER249CYS&RS121913483|https://civicdb.org/links/molecular-profiles/624|NC_000004.11:g.1803568C>G&NM_000142.4:c.746C>G&NP_000133.1:p.Ser249Cys&ENST00000340107.4c.746C>G|CA126380|16339|21.0|evidence|8642|https://civicdb.org/links/evidence/8642|31316618 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Transitional Cell Carcinoma|Cisplatin (NCIt ID C376)|||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|SER249CYS&RS121913483|https://civicdb.org/links/variants/628|FGFR3 S249C|624|SER249CYS&RS121913483|https://civicdb.org/links/molecular-profiles/624|NC_000004.11:g.1803568C>G&NM_000142.4:c.746C>G&NP_000133.1:p.Ser249Cys&ENST00000340107.4c.746C>G|CA126380|16339|21.0|evidence|8854|https://civicdb.org/links/evidence/8854|25606676 (PUBMED)|NA|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|SER249CYS&RS121913483|https://civicdb.org/links/variants/628|FGFR3 S249C|624|SER249CYS&RS121913483|https://civicdb.org/links/molecular-profiles/624|NC_000004.11:g.1803568C>G&NM_000142.4:c.746C>G&NP_000133.1:p.Ser249Cys&ENST00000340107.4c.746C>G|CA126380|16339|21.0|evidence|8855|https://civicdb.org/links/evidence/8855|19749790 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Transitional Cell Carcinoma||||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||S249C|628|SER249CYS&RS121913483|https://civicdb.org/links/variants/628|FGFR3 S249C|624|SER249CYS&RS121913483|https://civicdb.org/links/molecular-profiles/624|NC_000004.11:g.1803568C>G&NM_000142.4:c.746C>G&NP_000133.1:p.Ser249Cys&ENST00000340107.4c.746C>G|CA126380|16339|21.0|assertion|55|https://civicdb.org/links/assertion/55||SOMATIC|accepted|ONCOGENIC|SUPPORTS|Cancer (DOID 162)||||||||||
4	1806089	2406	G	T	.	.	GN=FGFR3;VT=G370C;CSQ=T|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|||G370C|2406|GLY370CYS&G372C&GLY372CYS|https://civicdb.org/links/variants/2406|FGFR3 G370C|2279|GLY370CYS&G372C&GLY372CYS|https://civicdb.org/links/molecular-profiles/2279|NC_000004.11:g.1806089G>T&NC_000004.12:g.1804362G>T&NM_000142.5:c.1108G>T&NP_000133.1:p.Gly370Cys&NP_001156685.1:p.Gly372Cys|CA129946|16359|3.0|evidence|10353|https://civicdb.org/links/evidence/10353|19381019 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|R3Mab|||D|3|||||
4	1806099	2404	A	G	.	.	CSQ=G|Missense Variant|FGFR3|2261|transcript|ENST00000440486.2|||Y373C|2404|TYR375CYS&RS121913485&Y375C&TYR373CYS|https://civicdb.org/links/variants/2404|FGFR3 Y373C|2277|TYR375CYS&RS121913485&Y375C&TYR373CYS|https://civicdb.org/links/molecular-profiles/2277|NC_000004.11:g.1806099A>G&NM_001163213.1:c.1124A>G&NP_000133.1:p.Tyr373Cys&NM_000142.5:c.1118A>G&NC_000004.12:g.1804372A>G|CA341413|16342|21.0|evidence|477|https://civicdb.org/links/evidence/477|20542753 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Bladder Carcinoma||||B|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000440486.2|||Y373C|2404|TYR375CYS&RS121913485&Y375C&TYR373CYS|https://civicdb.org/links/variants/2404|FGFR3 Y373C|2277|TYR375CYS&RS121913485&Y375C&TYR373CYS|https://civicdb.org/links/molecular-profiles/2277|NC_000004.11:g.1806099A>G&NM_001163213.1:c.1124A>G&NP_000133.1:p.Tyr373Cys&NM_000142.5:c.1118A>G&NC_000004.12:g.1804372A>G|CA341413|16342|21.0|evidence|8881|https://civicdb.org/links/evidence/8881|16338952 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Urinary Bladder Cancer||||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000440486.2|||Y373C|2404|TYR375CYS&RS121913485&Y375C&TYR373CYS|https://civicdb.org/links/variants/2404|FGFR3 Y373C|2277|TYR375CYS&RS121913485&Y375C&TYR373CYS|https://civicdb.org/links/molecular-profiles/2277|NC_000004.11:g.1806099A>G&NM_001163213.1:c.1124A>G&NP_000133.1:p.Tyr373Cys&NM_000142.5:c.1118A>G&NC_000004.12:g.1804372A>G|CA341413|16342|21.0|evidence|10354|https://civicdb.org/links/evidence/10354|19381019 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|R3Mab|||D|3|||||;GN=FGFR3;VT=Y373C
4	1806119	2405	G	C	.	.	VT=G380R;GN=FGFR3;CSQ=C|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||G380R|2405|GLY380ARG&G382R&GLY382ARG|https://civicdb.org/links/variants/2405|FGFR3 G380R|2278|GLY380ARG&G382R&GLY382ARG|https://civicdb.org/links/molecular-profiles/2278|NC_000004.11:g.1806119G>C&NC_000004.12:g.1804392G>C&NM_000142.5:c.1138G>C&NP_000133.1:p.Gly380Arg&NP_001156685.1:p.Gly382Arg&NM_001163213.1:c.1144G>C|CA280218|16328|2.0|evidence|10416|https://civicdb.org/links/evidence/10416|8754806 (PUBMED)|UNKNOWN|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||
4	1806153	4023	C	A	.	.	GN=FGFR3;VT=A391E;CSQ=A|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1172C>A||A391E|4023|ALA391GLU&ALA393GLU&A393E|https://civicdb.org/links/variants/4023|FGFR3 A391E|3891|ALA391GLU&ALA393GLU&A393E|https://civicdb.org/links/molecular-profiles/3891|NC_000004.12:g.1804426C>A&NC_000004.11:g.1806153C>A&ENST00000440486.8:c.1172C>A&NM_000142.5:c.1172C>A&ENSP00000414914.2:p.Ala391Glu&NP_000133.1:p.Ala391Glu |CA249860|16329|4.0|evidence|10513|https://civicdb.org/links/evidence/10513|26725515 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|4|||||
4	1807494	2400	G	A	.	.	VT=V555M;GN=FGFR3;CSQ=A|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1663G>A||V555M|2400|VAL443MET&V443M&VAL555MET&ENSP00000414914.2:P.VAL555MET |https://civicdb.org/links/variants/2400|FGFR3 V555M|2273|VAL443MET&V443M&VAL555MET&ENSP00000414914.2:P.VAL555MET |https://civicdb.org/links/molecular-profiles/2273|NM_022965.4:c.1327G>A&NC_000004.11:g.1807494G>A&NM_000142.5:c.1663G>A &NP_000133.1:p.Val555Met&ENST00000440486.8:c.1663G>A&ENSP00000414914.2:p.Val555Met |CA355981674||2.0|evidence|6408|https://civicdb.org/links/evidence/6408|22869148 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Myeloid Neoplasm|AZ12908010&Fexagratinib (NCIt ID C88272)&PD173074|SUBSTITUTES||D|2|||||
4	1807889	4024	AAG	GAC	.	.	GN=FGFR3;CSQ=GAC|Delins|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1948_1950delinsGAC||K650D|4024|LYS650ASP|https://civicdb.org/links/variants/4024|FGFR3 K650D|3892|LYS650ASP|https://civicdb.org/links/molecular-profiles/3892|NC_000004.12:g.1806162_1806164delinsGAC&NC_000004.11:g.1807889_1807891delinsGAC&ENST00000440486.8:c.1948_1950delinsGAC&ENSP00000414914.2:p.Lys650Asp &NM_000142.5:c.1948_1950delinsGAC&NP_000133.1:p.Lys650Asp|CA2573130206|NONE FOUND|3.0|evidence|10400|https://civicdb.org/links/evidence/10400|8754806 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||;VT=K650D
4	1807889	1400	A	G	.	.	GN=FGFR3;CSQ=G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||K650E|1400|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/variants/1400|FGFR3 K650E|1308|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/molecular-profiles/1308|NC_000004.11:g.1807889A>G&NC_000004.12:g.1806162A>G&NM_000142.5:c.1948A>G&NP_000133.1:p.Lys650Glu|CA126376|16331|10.0|evidence|10355|https://civicdb.org/links/evidence/10355|19381019 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|R3Mab|||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||K650E|1400|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/variants/1400|FGFR3 K650E|1308|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/molecular-profiles/1308|NC_000004.11:g.1807889A>G&NC_000004.12:g.1806162A>G&NM_000142.5:c.1948A>G&NP_000133.1:p.Lys650Glu|CA126376|16331|10.0|evidence|10393|https://civicdb.org/links/evidence/10393|8754806 (PUBMED)|COMMON_GERMLINE|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||K650E|1400|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/variants/1400|FGFR3 K650E|1308|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/molecular-profiles/1308|NC_000004.11:g.1807889A>G&NC_000004.12:g.1806162A>G&NM_000142.5:c.1948A>G&NP_000133.1:p.Lys650Glu|CA126376|16331|10.0|evidence|10493|https://civicdb.org/links/evidence/10493|15843401 (PUBMED)|NA|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||,G|Missense Variant|FGFR3|2261|transcript|ENST00000340107.4|||K650E|1400|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/variants/1400|FGFR3 K650E|1308|RS78311289&LYS650GLU&K652E&LYS652GLU&TDII|https://civicdb.org/links/molecular-profiles/1308|NC_000004.11:g.1807889A>G&NC_000004.12:g.1806162A>G&NM_000142.5:c.1948A>G&NP_000133.1:p.Lys650Glu|CA126376|16331|10.0|evidence|10381|https://civicdb.org/links/evidence/10381|11055896 (PUBMED)|NA|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|1|||||;VT=K650E
4	1807889	4025	AA	CT	.	.	GN=FGFR3;CSQ=CT||FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1948_1949delinsCT||K650L|4025|LYS650LEU|https://civicdb.org/links/variants/4025|FGFR3 K650L|3893|LYS650LEU|https://civicdb.org/links/molecular-profiles/3893|NC_000004.12:g.1806162_1806163delinsCT&NC_000004.11:g.1807889_1807890delinsCT&ENST00000440486.8:c.1948_1949delinsCT&ENSP00000414914.2:p.Lys650Leu&NM_000142.5:c.1948_1949delinsCT&NP_000133.1:p.Lys650Leu|CA2573130207|NONE FOUND|2.0|evidence|10402|https://civicdb.org/links/evidence/10402|8754806 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||;VT=K650L
4	1807889	4019	A	C	.	.	GN=FGFR3;CSQ=C|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1948A>C||K650Q|4019|LYS650GLN&LYS652GLN&LYS538GLN&LYS651GLN&K652Q&K538Q&K651Q|https://civicdb.org/links/variants/4019|FGFR3 K650Q|3887|LYS650GLN&LYS652GLN&LYS538GLN&LYS651GLN&K652Q&K538Q&K651Q|https://civicdb.org/links/molecular-profiles/3887|NC_000004.12:g.1806162A>C&NC_000004.11:g.1807889A>C&ENST00000440486.8:c.1948A>C&NM_000142.5:c.1948A>C&ENSP00000414914.2:p.Lys650Gln &NP_000133.1:p.Lys650Gln|CA170755|16348|4.0|evidence|10378|https://civicdb.org/links/evidence/10378|11055896 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||,C|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1948A>C||K650Q|4019|LYS650GLN&LYS652GLN&LYS538GLN&LYS651GLN&K652Q&K538Q&K651Q|https://civicdb.org/links/variants/4019|FGFR3 K650Q|3887|LYS650GLN&LYS652GLN&LYS538GLN&LYS651GLN&K652Q&K538Q&K651Q|https://civicdb.org/links/molecular-profiles/3887|NC_000004.12:g.1806162A>C&NC_000004.11:g.1807889A>C&ENST00000440486.8:c.1948A>C&NM_000142.5:c.1948A>C&ENSP00000414914.2:p.Lys650Gln &NP_000133.1:p.Lys650Gln|CA170755|16348|4.0|evidence|10401|https://civicdb.org/links/evidence/10401|8754806 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||;VT=K650Q
4	1807890	4013	A	T	.	.	VT=K650M;GN=FGFR3;CSQ=T|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1949A>T||K650M|4013|LYS650MET|https://civicdb.org/links/variants/4013|FGFR3 K650M|3881|LYS650MET|https://civicdb.org/links/molecular-profiles/3881|NC_000004.12:g.1806163A>T&NC_000004.11:g.1807890A>T&ENST00000440486.8:c.1949A>T&ENSP00000414914.2:p.Lys650Met&NM_000142.5:c.1949A>T&NP_000133.1:p.Lys650Met|CA126382|16341|1.0|evidence|10380|https://civicdb.org/links/evidence/10380|11055896 (PUBMED)|NA|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||
4	1807890	4021	A	C	.	.	CSQ=C|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1949A>C||K650T|4021|LYS650THR&LYS652THR&LYS538THR&LYS651THR&K652T&K538T&K651T|https://civicdb.org/links/variants/4021|FGFR3 K650T|3889|LYS650THR&LYS652THR&LYS538THR&LYS651THR&K652T&K538T&K651T|https://civicdb.org/links/molecular-profiles/3889|NC_000004.12:g.1806163A>&NC_000004.11:g.1807890A>C&ENST00000440486.8:c.1949A>C&NM_000142.5:c.1949A>C&ENSP00000414914.2:p.Lys650Thr &NP_000133.1:p.Lys650Thr|CA345185|65855|2.0|evidence|10382|https://civicdb.org/links/evidence/10382|11055896 (PUBMED)|NA|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||;GN=FGFR3;VT=K650T
4	1807891	3695	G	C	.	.	GN=FGFR3;CSQ=C|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8:c.1950G>C||K650N|3695|LYS650ASN|https://civicdb.org/links/variants/3695|FGFR3 K650N|3563|LYS650ASN|https://civicdb.org/links/molecular-profiles/3563|NC_000004.12:g.1806164G>C&NC_000004.11:g.1807891G>C&ENST00000440486.8:c.1950G>C&NM_000142.5:c.1950G>C&ENSP00000414914.2:p.Lys650Asn&NP_000133.1:p.Lys650Asn|CA280221|16347&16346|2.0|evidence|10377|https://civicdb.org/links/evidence/10377|11055896 (PUBMED)|NA|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||;VT=K650N
4	1808331	4030	G	T	.	.	GN=FGFR3;VT=G697C;CSQ=T|Missense Variant|FGFR3|2261|transcript|ENST00000440486.8|ENST00000440486.8%3Ac.2089G>T||G697C|4030|GLY697CYS&GLY699CYS&G699C|https%3A//civicdb.org/links/variants/4030|FGFR3 G697C|3898|GLY697CYS&GLY699CYS&G699C|https%3A//civicdb.org/links/molecular-profiles/3898|NC_000004.12%3Ag.1806604G>T&NC_000004.11%3Ag.1808331G>T&ENST00000440486.8%3Ac.2089G>T&ENSP00000414914.2%3Ap.Gly697Cys &NM_000142.5%3Ac.2089G>T&NP_000133.1%3Ap.Gly697Cys &NM_001163213.2%3Ac.2095G>T%09&NP_001156685.1%3Ap.Gly699Cys |CA16602701|376248|0.0|evidence|10839|https%3A//civicdb.org/links/evidence/10839|26992226 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|DOES_NOT_SUPPORT|Cancer||||D|3|||||
4	55141036	247	T	C	.	.	CSQ=C|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>C||V561A|247|VAL561ALA&RS121908586|https://civicdb.org/links/variants/247|PDGFRA V561A|243|VAL561ALA&RS121908586|https://civicdb.org/links/molecular-profiles/243|ENST00000257290.5:c.1682T>C&NC_000004.11:g.55141036T>C&NM_006206.5:c.1682T>C&NP_006197.1:p.Val561Ala|CA16602796|376354|3.0|evidence|652|https://civicdb.org/links/evidence/652|12949711 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||D|3|||||;VT=V561A;GN=PDGFRA
4	55141036	941	T	A	.	.	CSQ=A|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|https://civicdb.org/links/variants/941|PDGFRA V561D|915|RS121908586|https://civicdb.org/links/molecular-profiles/915|NM_006206.5:c.1682T>A&NP_006197.1:p.Val561Asp&NC_000004.11:g.55141036T>A&ENST00000257290.5:c.1682T>A|CA123203|13546|8.5|evidence|2474|https://civicdb.org/links/evidence/2474|18955451 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|1|||||,A|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|https://civicdb.org/links/variants/941|PDGFRA V561D|915|RS121908586|https://civicdb.org/links/molecular-profiles/915|NM_006206.5:c.1682T>A&NP_006197.1:p.Val561Asp&NC_000004.11:g.55141036T>A&ENST00000257290.5:c.1682T>A|CA123203|13546|8.5|evidence|2454|https://civicdb.org/links/evidence/2454|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||,A|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|https://civicdb.org/links/variants/941|PDGFRA V561D|915|RS121908586|https://civicdb.org/links/molecular-profiles/915|NM_006206.5:c.1682T>A&NP_006197.1:p.Val561Asp&NC_000004.11:g.55141036T>A&ENST00000257290.5:c.1682T>A|CA123203|13546|8.5|evidence|4056|https://civicdb.org/links/evidence/4056|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Sunitinib (NCIt ID C71622)|||D|2|||||,A|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1682T>A||V561D|941|RS121908586|https://civicdb.org/links/variants/941|PDGFRA V561D|915|RS121908586|https://civicdb.org/links/molecular-profiles/915|NM_006206.5:c.1682T>A&NP_006197.1:p.Val561Asp&NC_000004.11:g.55141036T>A&ENST00000257290.5:c.1682T>A|CA123203|13546|8.5|evidence|5347|https://civicdb.org/links/evidence/5347|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||;VT=V561D;GN=PDGFRA
4	55141083	862	C	T	.	.	VT=P577S;CSQ=T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.1729C>T||P577S|862|PRO577SER&RS1057519811|https://civicdb.org/links/variants/862|PDGFRA P577S|836|PRO577SER&RS1057519811|https://civicdb.org/links/molecular-profiles/836|NM_006206.4:c.1729C>T&NP_006197.1:p.Pro577Ser&NC_000004.11:g.55141083C>T&ENST00000257290.5:c.1729C>T|CA16602636|376181|3.0|evidence|1974|https://civicdb.org/links/evidence/1974|24132921 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Crenolanib (NCIt ID C64639)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||;GN=PDGFRA
4	55144547	577	C	T	.	.	VT=T674I;CSQ=T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5%3Ac.2021C>T||T674I|577|THR674ILE&RS121908587|https%3A//civicdb.org/links/variants/577|FIP1L1%3A%3APDGFRA Fusion AND PDGFRA T674I|5074||https%3A//civicdb.org/links/molecular-profiles/5074|NC_000004.11%3Ag.55144547C>T&ENST00000257290.5%3Ac.2021C>T&NM_006206.5%3Ac.2021C>T&NP_006197.1%3Ap.Thr674Ile|CA123215|13550|0.0|evidence|7020|https%3A//civicdb.org/links/evidence/7020|21818111 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA%2C PDGFRB%2C And FGFR1|Imatinib (NCIt ID C62035)|||C|3|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5%3Ac.2021C>T||T674I|577|THR674ILE&RS121908587|https%3A//civicdb.org/links/variants/577|FIP1L1%3A%3APDGFRA Fusion AND PDGFRA T674I|5074||https%3A//civicdb.org/links/molecular-profiles/5074|NC_000004.11%3Ag.55144547C>T&ENST00000257290.5%3Ac.2021C>T&NM_006206.5%3Ac.2021C>T&NP_006197.1%3Ap.Thr674Ile|CA123215|13550|0.0|evidence|1446|https%3A//civicdb.org/links/evidence/1446|12660384 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA%2C PDGFRB%2C And FGFR1|Imatinib (NCIt ID C62035)|||C|2|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5%3Ac.2021C>T||T674I|577|THR674ILE&RS121908587|https%3A//civicdb.org/links/variants/577|FIP1L1%3A%3APDGFRA Fusion AND PDGFRA T674I|5074||https%3A//civicdb.org/links/molecular-profiles/5074|NC_000004.11%3Ag.55144547C>T&ENST00000257290.5%3Ac.2021C>T&NM_006206.5%3Ac.2021C>T&NP_006197.1%3Ap.Thr674Ile|CA123215|13550|0.0|evidence|1779|https%3A//civicdb.org/links/evidence/1779|24407160 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA%2C PDGFRB%2C And FGFR1|Ponatinib (NCIt ID C95777)|||D|3|||||;GN=PDGFRA
4	55152090	863	G	A	.	.	VT=R841K;CSQ=A|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2522G>A||R841K|863|ARG841LYS&RS1057519813|https://civicdb.org/links/variants/863|PDGFRA R841K|837|ARG841LYS&RS1057519813|https://civicdb.org/links/molecular-profiles/837|NM_006206.4:c.2522G>A&NP_006197.1:p.Arg841Lys&NC_000004.11:g.55152090G>A&ENST00000257290.5:c.2522G>A|CA16602638|376183|3.0|evidence|1975|https://civicdb.org/links/evidence/1975|24132921 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Crenolanib (NCIt ID C64639)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||;GN=PDGFRA
4	55152092	98	GA	AT	.	.	CSQ=AT|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2524_2525delinsAT||D842I|98|ASP842ILE|https://civicdb.org/links/variants/98|PDGFRA D842I|98|ASP842ILE|https://civicdb.org/links/molecular-profiles/98|NC_000004.11:g.55152092_55152093delinsAT&ENST00000257290.5:c.2524_2525delinsAT&NP_006197.1:p.Asp842Ile&NM_006206.5:c.2524_2525delGAinsAT|CA16602522|376055|4.0|evidence|43|https://civicdb.org/links/evidence/43|22745105 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Crenolanib (NCIt ID C64639)|||D|4|||||;VT=D842I;GN=PDGFRA
4	55152092	100	G	T	.	.	CSQ=T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2524G>T||D842Y|100|ASP842TYR&RS121913265|https://civicdb.org/links/variants/100|PDGFRA D842Y|100|ASP842TYR&RS121913265|https://civicdb.org/links/molecular-profiles/100|ENST00000257290.5:c.2524G>T&NC_000004.11:g.55152092G>T&NM_006206.5:c.2524G>T&NP_006197.1:p.Asp842Tyr|CA16602703|376250|4.0|evidence|45|https://civicdb.org/links/evidence/45|22745105 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Crenolanib (NCIt ID C64639)|||D|4|||||;VT=D842Y;GN=PDGFRA
4	55152093	99	A	T	.	.	CSQ=T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|15|https://civicdb.org/links/evidence/15|15928335 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||B|4|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|16|https://civicdb.org/links/evidence/16|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||B|4|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|738|https://civicdb.org/links/evidence/738|26130666 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||B|4|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|2|https://civicdb.org/links/evidence/2|15146165 (PUBMED)|SOMATIC|accepted|NEGATIVE|SUPPORTS|Gastrointestinal Stromal Tumor||||B|3|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|4597|https://civicdb.org/links/evidence/4597|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|3|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|2478|https://civicdb.org/links/evidence/2478|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|2|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|44|https://civicdb.org/links/evidence/44|22745105 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Crenolanib (NCIt ID C64639)|||D|4|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|651|https://civicdb.org/links/evidence/651|12949711 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||D|3|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|2463|https://civicdb.org/links/evidence/2463|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|4060|https://civicdb.org/links/evidence/4060|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Sunitinib (NCIt ID C71622)|||D|2|||||,T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2525A>T||D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/variants/99|PDGFRA D842V|99|ASP842VAL&RS121908585|https://civicdb.org/links/molecular-profiles/99|NM_006206.4:c.2525A>T&NP_006197.1:p.Asp842Val&ENST00000257290.5:c.2525A>T&NC_000004.11:g.55152093A>T|CA123194|13543|100.5|evidence|5346|https://civicdb.org/links/evidence/5346|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||;VT=D842V;GN=PDGFRA
4	55152093	102	ACATC	TCATG	.	.	CSQ=TCATG|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|||D842_I843delinsVM|102||https://civicdb.org/links/variants/102|PDGFRA D842_I843delinsVM|102||https://civicdb.org/links/molecular-profiles/102|NC_000004.11:g.55152093_55152097delinsTCATG|CA658820703|NONE FOUND|4.0|evidence|47|https://civicdb.org/links/evidence/47|22745105 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Crenolanib (NCIt ID C64639)|||D|4|||||;VT=D842_I843delinsVM;GN=PDGFRA
4	55152094	101	CATC	C	.	.	VT=I843DEL;CSQ=-|Inframe Deletion|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2527_2529delATC||I843DEL|101|DELI843|https://civicdb.org/links/variants/101|PDGFRA I843DEL|101|DELI843|https://civicdb.org/links/molecular-profiles/101|NC_000004.11:g.55152095_55152097del&ENST00000257290.5:c.2527_2529delATC|CA645526434|NONE FOUND|5.0|evidence|46|https://civicdb.org/links/evidence/46|22745105 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Crenolanib (NCIt ID C64639)|||D|3|||||,-|Inframe Deletion|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2527_2529delATC||I843DEL|101|DELI843|https://civicdb.org/links/variants/101|PDGFRA I843DEL|101|DELI843|https://civicdb.org/links/molecular-profiles/101|NC_000004.11:g.55152095_55152097del&ENST00000257290.5:c.2527_2529delATC|CA645526434|NONE FOUND|5.0|evidence|1309|https://civicdb.org/links/evidence/1309|14645423 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||D|2|||||;GN=PDGFRA
4	55152101	864	C	T	.	.	CSQ=T|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2533C>T||H845Y|864|HIS845TYR&RS1057519814|https://civicdb.org/links/variants/864|PDGFRA H845Y|838|HIS845TYR&RS1057519814|https://civicdb.org/links/molecular-profiles/838|NM_006206.4:c.2533C>T&NP_006197.1:p.His845Tyr&NC_000004.11:g.55152101C>T&ENST00000257290.5:c.2533C>T|CA16602639|376184|3.0|evidence|1976|https://civicdb.org/links/evidence/1976|24132921 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Crenolanib (NCIt ID C64639)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||;VT=H845Y;GN=PDGFRA
4	55152126	865	G	A	.	.	CSQ=A|Missense Variant|PDGFRA|5156|transcript|ENST00000257290.5|ENST00000257290.5:c.2558G>A||G853D|865|GLY853ASP&RS763576329|https://civicdb.org/links/variants/865|PDGFRA G853D|839|GLY853ASP&RS763576329|https://civicdb.org/links/molecular-profiles/839|NM_006206.4:c.2558G>A&NP_006197.1:p.Gly853Asp&NC_000004.11:g.55152126G>A&ENST00000257290.5:c.2558G>A|CA16602640|376185|3.0|evidence|1977|https://civicdb.org/links/evidence/1977|24132921 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Crenolanib (NCIt ID C64639)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||;VT=G853D;GN=PDGFRA
4	55592185	946	T	TGCCTAT	.	.	GN=KIT;VT=Y503_F504insAY;CSQ=GCCTAT|Inframe Insertion|KIT|3815|transcript|ENST00000288135.5|||Y503_F504insAY|946||https://civicdb.org/links/variants/946|KIT Y503_F504insAY|920||https://civicdb.org/links/molecular-profiles/920|NC_000004.11:g.55592185_55592186insGCCTAT|CA645516719||2.0|evidence|2484|https://civicdb.org/links/evidence/2484|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||
4	55593464	201	A	C	.	.	CSQ=C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1621A>C||M541L|201|MET541LEU&RS3822214|https://civicdb.org/links/variants/201|KIT M541L|201|MET541LEU&RS3822214|https://civicdb.org/links/molecular-profiles/201|NM_000222.2:c.1621A>C&NP_000213.1:p.Met541Leu&ENST00000288135.5:c.1621A>C&NC_000004.11:g.55593464A>C|CA160347|41599|25.5|evidence|485|https://civicdb.org/links/evidence/485|16307017 (PUBMED)|COMMON_GERMLINE|accepted|POSITIVE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia||||B|4|||||,C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1621A>C||M541L|201|MET541LEU&RS3822214|https://civicdb.org/links/variants/201|KIT M541L|201|MET541LEU&RS3822214|https://civicdb.org/links/molecular-profiles/201|NM_000222.2:c.1621A>C&NP_000213.1:p.Met541Leu&ENST00000288135.5:c.1621A>C&NC_000004.11:g.55593464A>C|CA160347|41599|25.5|evidence|1423|https://civicdb.org/links/evidence/1423|25015329 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1621A>C||M541L|201|MET541LEU&RS3822214|https://civicdb.org/links/variants/201|KIT M541L|201|MET541LEU&RS3822214|https://civicdb.org/links/molecular-profiles/201|NM_000222.2:c.1621A>C&NP_000213.1:p.Met541Leu&ENST00000288135.5:c.1621A>C&NC_000004.11:g.55593464A>C|CA160347|41599|25.5|evidence|7195|https://civicdb.org/links/evidence/7195|28595259 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colon Signet Ring Adenocarcinoma|Imatinib (NCIt ID C62035)|||E|2|||||;GN=KIT;VT=M541L
4	55593581	949	GAAACCCATGTATGAAGTACAGTGGAAG	G	.	.	VT=K550_K558del;GN=KIT;CSQ=-|Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1648_1674del27||K550_K558del|949|RS121913234&KPMYEVQWK550-558DEL|https://civicdb.org/links/variants/949|KIT K550_K558del|923|RS121913234&KPMYEVQWK550-558DEL|https://civicdb.org/links/molecular-profiles/923|NM_000222.2:c.1648_1674del27&NP_000213.1:p.Lys550_Lys558del&NC_000004.11:g.55593582_55593608del27&ENST00000288135.5:c.1648_1674del27|CA123524|13857|5.0|evidence|4062|https://civicdb.org/links/evidence/4062|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|2|||||
4	55593581	2696	GAAACCCATGTATGAAGTACAGTGGAAGGTT	G	.	.	GN=KIT;CSQ=-||KIT|3815|transcript|ENST00000288135.5|||K550_K559DEL|2696||https://civicdb.org/links/variants/2696|KIT K550_K559DEL|2565||https://civicdb.org/links/molecular-profiles/2565||CA645516734||5.0|evidence|7289|https://civicdb.org/links/evidence/7289|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|2|||||;VT=K550_K559DEL
4	55593581	948	GAAACCCATGTATGAAGTACAGTGG	G	.	.	CSQ=-|Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1648_1671del AAACCCATGTATGAAGTACAGTGG||K550_W557del|948||https://civicdb.org/links/variants/948|KIT K550_W557del|922||https://civicdb.org/links/molecular-profiles/922|ENST00000288135.5:c.1648_1671del AAACCCATGTATGAAGTACAGTGG|CA645516733|NONE FOUND|2.0|evidence|4583|https://civicdb.org/links/evidence/4583|25239608 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Ponatinib (NCIt ID C95777)&Regorafenib (NCIt ID C78204)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|2|||||;GN=KIT;VT=K550_W557del
4	55593602	961	GTGGAAG	G	.	.	CSQ=-|Conservative Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|||W557_K558del|961||https://civicdb.org/links/variants/961|KIT W557_K558del|935||https://civicdb.org/links/molecular-profiles/935||CA356974|222957|14.5|evidence|4082|https://civicdb.org/links/evidence/4082|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|3|||||,-|Conservative Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|||W557_K558del|961||https://civicdb.org/links/variants/961|KIT W557_K558del|935||https://civicdb.org/links/molecular-profiles/935||CA356974|222957|14.5|evidence|4084|https://civicdb.org/links/evidence/4084|25239608 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Ponatinib (NCIt ID C95777)|SUBSTITUTES||D|3|||||,-|Conservative Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|||W557_K558del|961||https://civicdb.org/links/variants/961|KIT W557_K558del|935||https://civicdb.org/links/molecular-profiles/935||CA356974|222957|14.5|evidence|2481|https://civicdb.org/links/evidence/2481|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||,-|Conservative Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|||W557_K558del|961||https://civicdb.org/links/variants/961|KIT W557_K558del|935||https://civicdb.org/links/molecular-profiles/935||CA356974|222957|14.5|evidence|4087|https://civicdb.org/links/evidence/4087|25239608 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Regorafenib (NCIt ID C78204)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|2|||||,-|Conservative Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|||W557_K558del|961||https://civicdb.org/links/variants/961|KIT A829P AND ( KIT W557_K558del OR KIT V560_Y578del )|5469||https://civicdb.org/links/molecular-profiles/5469||CA356974|222957|0.0|evidence|7415|https://civicdb.org/links/evidence/7415|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|4|||||;GN=KIT;VT=W557_K558del
4	55593605	964	GAAGGTT	G	.	.	VT=K558_V559del;GN=KIT;CSQ=-||KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1672_1677delAAGGTT||K558_V559del|964||https://civicdb.org/links/variants/964|KIT K558_V559del|938||https://civicdb.org/links/molecular-profiles/938|ENST00000288135.5:c.1672_1677delAAGGTT|CA645516838|NONE FOUND|5.0|evidence|4095|https://civicdb.org/links/evidence/4095|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|2|||||
4	55593610	968	T	A	.	.	GN=KIT;CSQ=A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1676T>A||V559D|968|RS121913517&VAL559ASP|https://civicdb.org/links/variants/968|KIT V559D|942|RS121913517&VAL559ASP|https://civicdb.org/links/molecular-profiles/942|NM_000222.2:c.1676T>A&NP_000213.1:p.Val559Asp&NC_000004.11:g.55593610T>A&ENST00000288135.5:c.1676T>A|CA123522|13856|11.5|evidence|3028|https://civicdb.org/links/evidence/3028|22114577 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1676T>A||V559D|968|RS121913517&VAL559ASP|https://civicdb.org/links/variants/968|KIT V559D|942|RS121913517&VAL559ASP|https://civicdb.org/links/molecular-profiles/942|NM_000222.2:c.1676T>A&NP_000213.1:p.Val559Asp&NC_000004.11:g.55593610T>A&ENST00000288135.5:c.1676T>A|CA123522|13856|11.5|evidence|3029|https://civicdb.org/links/evidence/3029|16046538 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)&PD-180970&Sunitinib (NCIt ID C71622)&Tandutinib (NCIt ID C48404)|SUBSTITUTES||D|2|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1676T>A||V559D|968|RS121913517&VAL559ASP|https://civicdb.org/links/variants/968|KIT V559D|942|RS121913517&VAL559ASP|https://civicdb.org/links/molecular-profiles/942|NM_000222.2:c.1676T>A&NP_000213.1:p.Val559Asp&NC_000004.11:g.55593610T>A&ENST00000288135.5:c.1676T>A|CA123522|13856|11.5|evidence|4459|https://civicdb.org/links/evidence/4459|25239608 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Ponatinib (NCIt ID C95777)&Regorafenib (NCIt ID C78204)|SUBSTITUTES||D|2|||||;VT=V559D
4	55593611	202	TGTT	T	.	.	CSQ=-|Amino Acid Deletion&Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1675_1677delGTT||V560DEL|202|VAL560DEL&V559DEL&V555DEL&V556DEL|https://civicdb.org/links/variants/202|KIT V560DEL|202|VAL560DEL&V559DEL&V555DEL&V556DEL|https://civicdb.org/links/molecular-profiles/202|NC_000004.11:g.55593612_55593614del&ENST00000288135.5:c.1675_1677delGTT&NM_000222.2:c.1675_1677delGTT&NP_000213.1:p.Val560del|CA123529|13859|12.5|evidence|486|https://civicdb.org/links/evidence/486|15201427 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Thymic Carcinoma|Imatinib (NCIt ID C62035)|||C|5|||||;VT=V560DEL;GN=KIT
4	55593613	971	T	A	.	.	VT=V560D;GN=KIT;CSQ=A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|VAL560ASP&RS121913521|https://civicdb.org/links/variants/971|KIT V560D|945|VAL560ASP&RS121913521|https://civicdb.org/links/molecular-profiles/945|ENST00000288135.5:c.1679T>A&NM_000222.2:c.1679T>A&NP_000213.1:p.Val560Asp&NC_000004.11:g.55593613T>A|CA16602396|375914|14.5|evidence|4122|https://civicdb.org/links/evidence/4122|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|3|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|VAL560ASP&RS121913521|https://civicdb.org/links/variants/971|KIT V560D|945|VAL560ASP&RS121913521|https://civicdb.org/links/molecular-profiles/945|ENST00000288135.5:c.1679T>A&NM_000222.2:c.1679T>A&NP_000213.1:p.Val560Asp&NC_000004.11:g.55593613T>A|CA16602396|375914|14.5|evidence|4127|https://civicdb.org/links/evidence/4127|25239608 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Ponatinib (NCIt ID C95777)&Regorafenib (NCIt ID C78204)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|3|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|VAL560ASP&RS121913521|https://civicdb.org/links/variants/971|KIT V560D|945|VAL560ASP&RS121913521|https://civicdb.org/links/molecular-profiles/945|ENST00000288135.5:c.1679T>A&NM_000222.2:c.1679T>A&NP_000213.1:p.Val560Asp&NC_000004.11:g.55593613T>A|CA16602396|375914|14.5|evidence|4077|https://civicdb.org/links/evidence/4077|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Sunitinib (NCIt ID C71622)|||D|2|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>A||V560D|971|VAL560ASP&RS121913521|https://civicdb.org/links/variants/971|KIT V560D|945|VAL560ASP&RS121913521|https://civicdb.org/links/molecular-profiles/945|ENST00000288135.5:c.1679T>A&NM_000222.2:c.1679T>A&NP_000213.1:p.Val560Asp&NC_000004.11:g.55593613T>A|CA16602396|375914|14.5|evidence|5348|https://civicdb.org/links/evidence/5348|18955458 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||
4	55593613	972	T	G	.	.	CSQ=G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>G||V560G|972|RS121913521&VAL560GLY|https://civicdb.org/links/variants/972|KIT V560G|946|RS121913521&VAL560GLY|https://civicdb.org/links/molecular-profiles/946|NM_000222.2:c.1679T>G&NP_000213.1:p.Val560Gly&NC_000004.11:g.55593613T>G&ENST00000288135.5:c.1679T>G|CA16602398|375916&376735|5.0|evidence|7395|https://civicdb.org/links/evidence/7395|25239608 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Ponatinib (NCIt ID C95777)&Regorafenib (NCIt ID C78204)|SUBSTITUTES||D|3|||||,G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1679T>G||V560G|972|RS121913521&VAL560GLY|https://civicdb.org/links/variants/972|KIT V560G|946|RS121913521&VAL560GLY|https://civicdb.org/links/molecular-profiles/946|NM_000222.2:c.1679T>G&NP_000213.1:p.Val560Gly&NC_000004.11:g.55593613T>G&ENST00000288135.5:c.1679T>G|CA16602398|375916&376735|5.0|evidence|2469|https://civicdb.org/links/evidence/2469|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||;GN=KIT;VT=V560G
4	55593661	72	T	C	.	.	CSQ=C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/variants/72|KIT L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/molecular-profiles/72|NM_000222.2:c.1727T>C&NP_000213.1:p.Leu576Pro&ENST00000288135.5:c.1727T>C&NC_000004.11:g.55593661T>C|CA16602401|375919|16.0|evidence|4136|https://civicdb.org/links/evidence/4136|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|2|||||,C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/variants/72|KIT L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/molecular-profiles/72|NM_000222.2:c.1727T>C&NP_000213.1:p.Leu576Pro&ENST00000288135.5:c.1727T>C&NC_000004.11:g.55593661T>C|CA16602401|375919|16.0|evidence|34|https://civicdb.org/links/evidence/34|19671763 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Imatinib (NCIt ID C62035)&Nilotinib (NCIt ID C48375)&Sorafenib (NCIt ID C61948)|SUBSTITUTES||D|3|||||,C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/variants/72|KIT L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/molecular-profiles/72|NM_000222.2:c.1727T>C&NP_000213.1:p.Leu576Pro&ENST00000288135.5:c.1727T>C&NC_000004.11:g.55593661T>C|CA16602401|375919|16.0|evidence|42|https://civicdb.org/links/evidence/42|19671763 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dasatinib (NCIt ID C38713)|||D|3|||||,C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/variants/72|KIT L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/molecular-profiles/72|NM_000222.2:c.1727T>C&NP_000213.1:p.Leu576Pro&ENST00000288135.5:c.1727T>C&NC_000004.11:g.55593661T>C|CA16602401|375919|16.0|evidence|303|https://civicdb.org/links/evidence/303|17372901 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1727T>C||L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/variants/72|KIT L576P|72|RS121913513&LEU576PRO|https://civicdb.org/links/molecular-profiles/72|NM_000222.2:c.1727T>C&NP_000213.1:p.Leu576Pro&ENST00000288135.5:c.1727T>C&NC_000004.11:g.55593661T>C|CA16602401|375919|16.0|evidence|4141|https://civicdb.org/links/evidence/4141|25317746 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|2|||||;VT=L576P;GN=KIT
4	55593668	977	TGAT	T	.	.	CSQ=-|Conservative Inframe Deletion|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1735_1737delGAT||D579del|977|ASP579DEL&RS1060502543|https://civicdb.org/links/variants/977|KIT D579del|951|ASP579DEL&RS1060502543|https://civicdb.org/links/molecular-profiles/951|ENST00000288135.5:c.1735_1737delGAT&NM_000222.2:c.1735_1737delGAT&NP_000213.1:p.Asp579del&NC_000004.11:g.55593669_55593671delGAT|CA16611553|409725|5.0|evidence|4142|https://civicdb.org/links/evidence/4142|18955458 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||C|2|||||;VT=D579del;GN=KIT
4	55594180	1659	G	A	.	.	GN=KIT;CSQ=A|Missense Variant|KIT|3815|transcript|None|||S628N|1659|S624N|https://civicdb.org/links/variants/1659|KIT S628N|1567|S624N|https://civicdb.org/links/molecular-profiles/1567||CA356908374||9.5|evidence|7463|https://civicdb.org/links/evidence/7463|25317746 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Melanoma|Imatinib (NCIt ID C62035)|||C|3|||||,A|Missense Variant|KIT|3815|transcript|None|||S628N|1659|S624N|https://civicdb.org/links/variants/1659|KIT S628N|1567|S624N|https://civicdb.org/links/molecular-profiles/1567||CA356908374||9.5|evidence|4791|https://civicdb.org/links/evidence/4791|25317746 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|2|||||;VT=S628N
4	55594221	978	A	G	.	.	VT=K642E;CSQ=G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|RS121913512&LYS642GLU|https://civicdb.org/links/variants/978|KIT K642E|952|RS121913512&LYS642GLU|https://civicdb.org/links/molecular-profiles/952|NM_000222.2:c.1924A>G&NP_000213.1:p.Lys642Glu&NC_000004.11:g.55594221A>G&ENST00000288135.5:c.1924A>G|CA123547|13866|10.0|evidence|4147|https://civicdb.org/links/evidence/4147|21523734 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dasatinib (NCIt ID C38713)|||C|None|||||,G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|RS121913512&LYS642GLU|https://civicdb.org/links/variants/978|KIT K642E|952|RS121913512&LYS642GLU|https://civicdb.org/links/molecular-profiles/952|NM_000222.2:c.1924A>G&NP_000213.1:p.Lys642Glu&NC_000004.11:g.55594221A>G&ENST00000288135.5:c.1924A>G|CA123547|13866|10.0|evidence|2889|https://civicdb.org/links/evidence/2889|18510589 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Mucosal Melanoma|Imatinib (NCIt ID C62035)|||C|2|||||,G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|RS121913512&LYS642GLU|https://civicdb.org/links/variants/978|KIT K642E|952|RS121913512&LYS642GLU|https://civicdb.org/links/molecular-profiles/952|NM_000222.2:c.1924A>G&NP_000213.1:p.Lys642Glu&NC_000004.11:g.55594221A>G&ENST00000288135.5:c.1924A>G|CA123547|13866|10.0|evidence|7397|https://civicdb.org/links/evidence/7397|25239608 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Ponatinib (NCIt ID C95777)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|3|||||,G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1924A>G||K642E|978|RS121913512&LYS642GLU|https://civicdb.org/links/variants/978|KIT K642E|952|RS121913512&LYS642GLU|https://civicdb.org/links/molecular-profiles/952|NM_000222.2:c.1924A>G&NP_000213.1:p.Lys642Glu&NC_000004.11:g.55594221A>G&ENST00000288135.5:c.1924A>G|CA123547|13866|10.0|evidence|2472|https://civicdb.org/links/evidence/2472|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||;GN=KIT
4	55594258	73	T	C	.	.	VT=V654A;GN=KIT;CSQ=C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1961T>C||V654A|73|RS121913523&VAL654ALA|https://civicdb.org/links/variants/73|KIT V654A|73|RS121913523&VAL654ALA|https://civicdb.org/links/molecular-profiles/73|NC_000004.11:g.55594258T>C&NM_000222.2:c.1961T>C&NP_000213.1:p.Val654Ala&ENST00000288135.5:c.1961T>C|CA16602402|375921|18.0|evidence|304|https://civicdb.org/links/evidence/304|16638875 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Sunitinib (NCIt ID C71622)|||B|3|||||,C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.1961T>C||V654A|73|RS121913523&VAL654ALA|https://civicdb.org/links/variants/73|KIT V654A|73|RS121913523&VAL654ALA|https://civicdb.org/links/molecular-profiles/73|NC_000004.11:g.55594258T>C&NM_000222.2:c.1961T>C&NP_000213.1:p.Val654Ala&ENST00000288135.5:c.1961T>C|CA16602402|375921|18.0|evidence|249|https://civicdb.org/links/evidence/249|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||D|3|||||
4	55595519	1267	C	T	.	.	VT=T670I;GN=KIT;CSQ=T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|THR670ILE&RS121913516|https://civicdb.org/links/variants/1267|KIT T670I|1241|THR670ILE&RS121913516|https://civicdb.org/links/molecular-profiles/1241|NM_000222.2:c.2009C>T&NP_000213.1:p.Thr670Ile&NC_000004.11:g.55595519C>T&ENST00000288135.5:c.2009C>T|CA16602525|376058|21.5|evidence|2924|https://civicdb.org/links/evidence/2924|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|THR670ILE&RS121913516|https://civicdb.org/links/variants/1267|KIT T670I|1241|THR670ILE&RS121913516|https://civicdb.org/links/molecular-profiles/1241|NM_000222.2:c.2009C>T&NP_000213.1:p.Thr670Ile&NC_000004.11:g.55595519C>T&ENST00000288135.5:c.2009C>T|CA16602525|376058|21.5|evidence|7416|https://civicdb.org/links/evidence/7416|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||D|5|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|THR670ILE&RS121913516|https://civicdb.org/links/variants/1267|KIT T670I|1241|THR670ILE&RS121913516|https://civicdb.org/links/molecular-profiles/1241|NM_000222.2:c.2009C>T&NP_000213.1:p.Thr670Ile&NC_000004.11:g.55595519C>T&ENST00000288135.5:c.2009C>T|CA16602525|376058|21.5|evidence|7417|https://civicdb.org/links/evidence/7417|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Gastrointestinal Stromal Tumor|Ponatinib (NCIt ID C95777)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|5|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2009C>T||T670I|1267|THR670ILE&RS121913516|https://civicdb.org/links/variants/1267|KIT T670I|1241|THR670ILE&RS121913516|https://civicdb.org/links/molecular-profiles/1241|NM_000222.2:c.2009C>T&NP_000213.1:p.Thr670Ile&NC_000004.11:g.55595519C>T&ENST00000288135.5:c.2009C>T|CA16602525|376058|21.5|evidence|4510|https://civicdb.org/links/evidence/4510|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Regorafenib (NCIt ID C78204)|||D|4|||||
4	55599299	1264	T	G	.	.	CSQ=G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2425T>G||C809G|1264|CYS809GLY|https://civicdb.org/links/variants/1264|KIT C809G|1238|CYS809GLY|https://civicdb.org/links/molecular-profiles/1238|ENST00000288135.5:c.2425T>G&NC_000004.11:g.55599299T>G&NM_000222.2:c.2425T>G&NP_000213.1:p.Cys809Gly|CA356911727|NONE FOUND|7.5|evidence|2920|https://civicdb.org/links/evidence/2920|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||;GN=KIT;VT=C809G
4	55599320	983	G	C	.	.	CSQ=C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2446G>C||D816H|983|ASP816HIS&RS121913506|https://civicdb.org/links/variants/983|KIT D816H|957|ASP816HIS&RS121913506|https://civicdb.org/links/molecular-profiles/957|NM_000222.2:c.2446G>C&NP_000213.1:p.Asp816His&NC_000004.11:g.55599320G>C&ENST00000288135.5:c.2446G>C|CA123540|13863|7.5|evidence|2923|https://civicdb.org/links/evidence/2923|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||;VT=D816H;GN=KIT
4	55599321	65	A	T	.	.	CSQ=T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/variants/65|KIT D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/molecular-profiles/65|NM_000222.2:c.2447A>T&NP_000213.1:p.Asp816Val&ENST00000288135.5:c.2447A>T&NC_000004.11:g.55599321A>T|CA123513|13852|67.0|evidence|26|https://civicdb.org/links/evidence/26|16384925 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Acute Myeloid Leukemia||||B|4|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/variants/65|KIT D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/molecular-profiles/65|NM_000222.2:c.2447A>T&NP_000213.1:p.Asp816Val&ENST00000288135.5:c.2447A>T&NC_000004.11:g.55599321A>T|CA123513|13852|67.0|evidence|1725|https://civicdb.org/links/evidence/1725|27355533 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Systemic Mastocytosis|Midostaurin (NCIt ID C1872)|||B|4|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/variants/65|KIT D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/molecular-profiles/65|NM_000222.2:c.2447A>T&NP_000213.1:p.Asp816Val&ENST00000288135.5:c.2447A>T&NC_000004.11:g.55599321A>T|CA123513|13852|67.0|evidence|1726|https://civicdb.org/links/evidence/1726|26464169 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Systemic Mastocytosis||||B|4|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/variants/65|KIT D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/molecular-profiles/65|NM_000222.2:c.2447A>T&NP_000213.1:p.Asp816Val&ENST00000288135.5:c.2447A>T&NC_000004.11:g.55599321A>T|CA123513|13852|67.0|evidence|7465|https://civicdb.org/links/evidence/7465|25317746 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)|SUBSTITUTES||C|2|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/variants/65|KIT D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/molecular-profiles/65|NM_000222.2:c.2447A>T&NP_000213.1:p.Asp816Val&ENST00000288135.5:c.2447A>T&NC_000004.11:g.55599321A>T|CA123513|13852|67.0|evidence|2451|https://civicdb.org/links/evidence/2451|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2447A>T||D816V|65|ASP816VAL&RS121913507|https://civicdb.org/links/variants/65|NOT KIT D816V|4353||https://civicdb.org/links/molecular-profiles/4353|NM_000222.2:c.2447A>T&NP_000213.1:p.Asp816Val&ENST00000288135.5:c.2447A>T&NC_000004.11:g.55599321A>T|CA123513|13852|5.0|evidence|11158|https://civicdb.org/links/evidence/11158|19193436 (PUBMED)|NA|accepted|SENSITIVITYRESPONSE|SUPPORTS|Systemic Mastocytosis|Imatinib Mesylate (NCIt ID C1687)|||B|1|||||;GN=KIT;VT=D816V
4	55599322	1559	C	G	.	.	GN=KIT;CSQ=G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2448C>G||D816E|1559|D812E&ASP816GLU|https://civicdb.org/links/variants/1559|KIT D816E|1467|D812E&ASP816GLU|https://civicdb.org/links/molecular-profiles/1467|ENST00000288135.5:c.2448C>G&NC_000004.11:g.55599322C>G&NM_000222.2:c.2448C>G&NP_000213.1:p.Asp816Glu|CA356911882|NONE FOUND|8.0|evidence|4631|https://civicdb.org/links/evidence/4631|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|4|||||,G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2448C>G||D816E|1559|D812E&ASP816GLU|https://civicdb.org/links/variants/1559|KIT D816E|1467|D812E&ASP816GLU|https://civicdb.org/links/molecular-profiles/1467|ENST00000288135.5:c.2448C>G&NC_000004.11:g.55599322C>G&NM_000222.2:c.2448C>G&NP_000213.1:p.Asp816Glu|CA356911882|NONE FOUND|8.0|evidence|7401|https://civicdb.org/links/evidence/7401|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Gastrointestinal Stromal Tumor|Ponatinib (NCIt ID C95777)|||D|4|||||;VT=D816E
4	55599332	986	G	T	.	.	CSQ=T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2458G>T||D820Y|986|ASP820TYR&RS1057519710|https://civicdb.org/links/variants/986|KIT D820Y|960|ASP820TYR&RS1057519710|https://civicdb.org/links/molecular-profiles/960|NM_000222.2:c.2458G>T&NP_000213.1:p.Asp820Tyr&NC_000004.11:g.55599332G>T&ENST00000288135.5:c.2458G>T|CA16602408|375928|14.5|evidence|2886|https://civicdb.org/links/evidence/2886|21642685 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Imatinib (NCIt ID C62035)|||C|3|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2458G>T||D820Y|986|ASP820TYR&RS1057519710|https://civicdb.org/links/variants/986|KIT D820Y|960|ASP820TYR&RS1057519710|https://civicdb.org/links/molecular-profiles/960|NM_000222.2:c.2458G>T&NP_000213.1:p.Asp820Tyr&NC_000004.11:g.55599332G>T&ENST00000288135.5:c.2458G>T|CA16602408|375928|14.5|evidence|4589|https://civicdb.org/links/evidence/4589|22614970 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Regorafenib (NCIt ID C78204)|||C|2|||||,T|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2458G>T||D820Y|986|ASP820TYR&RS1057519710|https://civicdb.org/links/variants/986|KIT D820Y|960|ASP820TYR&RS1057519710|https://civicdb.org/links/molecular-profiles/960|NM_000222.2:c.2458G>T&NP_000213.1:p.Asp820Tyr&NC_000004.11:g.55599332G>T&ENST00000288135.5:c.2458G>T|CA16602408|375928|14.5|evidence|2888|https://civicdb.org/links/evidence/2888|19035443 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Sunitinib (NCIt ID C71622)|||D|2|||||;VT=D820Y;GN=KIT
4	55599333	1265	A	C	.	.	CSQ=C|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2459A>C||D820A|1265|ASP820ALA|https://civicdb.org/links/variants/1265|KIT D820A|1239|ASP820ALA|https://civicdb.org/links/molecular-profiles/1239|ENST00000288135.5:c.2459A>C&NC_000004.11:g.55599333A>C&NM_000222.2:c.2459A>C&NP_000213.1:p.Asp820Ala|CA356911952|NONE FOUND|7.5|evidence|2921|https://civicdb.org/links/evidence/2921|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||;GN=KIT;VT=D820A
4	55599333	1266	A	G	.	.	CSQ=G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2459A>G||D820G|1266|ASP820GLY&RS121913682|https://civicdb.org/links/variants/1266|KIT D820G|1240|ASP820GLY&RS121913682|https://civicdb.org/links/molecular-profiles/1240|NM_000222.2:c.2459A>G&NP_000213.1:p.Asp820Gly&NC_000004.11:g.55599333A>G&ENST00000288135.5:c.2459A>G|CA123516|13853|7.5|evidence|2922|https://civicdb.org/links/evidence/2922|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||;GN=KIT;VT=D820G
4	55599338	987	A	C	.	.	GN=KIT;CSQ=C|Missense Variant|KIT|3815|transcript|None|||N822H|987||https://civicdb.org/links/variants/987|KIT N822H|961||https://civicdb.org/links/molecular-profiles/961||CA356911968||2.0|evidence|2445|https://civicdb.org/links/evidence/2445|14645423 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||;VT=N822H
4	55599340	1263	T	A	.	.	VT=N822K;GN=KIT;CSQ=A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|2918|https://civicdb.org/links/evidence/2918|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|4595|https://civicdb.org/links/evidence/4595|22614970 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Stromal Tumor|Regorafenib (NCIt ID C78204)|||C|2|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|7414|https://civicdb.org/links/evidence/7414|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|4|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|4167|https://civicdb.org/links/evidence/4167|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Gastrointestinal Stromal Tumor|Ponatinib (NCIt ID C95777)|||D|3|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|4169|https://civicdb.org/links/evidence/4169|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Regorafenib (NCIt ID C78204)|||D|3|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|7370|https://civicdb.org/links/evidence/7370|21482694 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Acute Myeloid Leukemia|Sorafenib (NCIt ID C61948)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|3|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|2448|https://civicdb.org/links/evidence/2448|14645423 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Imatinib (NCIt ID C62035)|||D|2|||||,A|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2466T>A||N822K|1263|ASN822LYS&RS121913514|https://civicdb.org/links/variants/1263|KIT N822K|1237|ASN822LYS&RS121913514|https://civicdb.org/links/molecular-profiles/1237|NM_000222.2:c.2466T>A&NP_000213.1:p.Asn822Lys&NC_000004.11:g.55599340T>A&ENST00000288135.5:c.2466T>A|CA16602411|375931|29.5|evidence|7379|https://civicdb.org/links/evidence/7379|21482694 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Ponatinib (NCIt ID C95777)|||D|2|||||
4	55599341	989	T	G	.	.	GN=KIT;VT=Y823D;CSQ=G|Missense Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2467T>G||Y823D|989|TYR823ASP&RS1057519761|https://civicdb.org/links/variants/989|KIT Y823D|963|TYR823ASP&RS1057519761|https://civicdb.org/links/molecular-profiles/963|NM_000222.2:c.2467T>G&NP_000213.1:p.Tyr823Asp&NC_000004.11:g.55599341T>G&ENST00000288135.5:c.2467T>G|CA16602561|376101|7.5|evidence|2919|https://civicdb.org/links/evidence/2919|16954519 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)|||C|3|||||
4	55602664	990	G	C	.	.	VT=A829P;GN=KIT;CSQ=C|Missense Variant|KIT|3815|transcript|None|||A829P|990|RS1057519713&ALA829PRO|https://civicdb.org/links/variants/990|KIT A829P|964|RS1057519713&ALA829PRO|https://civicdb.org/links/molecular-profiles/964|NC_000004.11:g.55602664G>C&NM_000222.2:c.2485G>C&NP_000213.1:p.Ala829Pro|CA16602413|375933|8.0|evidence|7413|https://civicdb.org/links/evidence/7413|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Gastrointestinal Stromal Tumor|Ponatinib (NCIt ID C95777)|||D|4|||||,C|Missense Variant|KIT|3815|transcript|None|||A829P|990|RS1057519713&ALA829PRO|https://civicdb.org/links/variants/990|KIT A829P AND ( KIT W557_K558del OR KIT V560_Y578del )|5469||https://civicdb.org/links/molecular-profiles/5469|NC_000004.11:g.55602664G>C&NM_000222.2:c.2485G>C&NP_000213.1:p.Ala829Pro|CA16602413|375933|0.0|evidence|7415|https://civicdb.org/links/evidence/7415|25239608 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Gastrointestinal Stromal Tumor|Imatinib (NCIt ID C62035)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|4|||||
4	55602765	482	G	C	.	.	VT=RS3733542;GN=KIT;CSQ=C|Synonymous Variant|KIT|3815|transcript|ENST00000288135.5|ENST00000288135.5:c.2586G>C||RS3733542|482|LEU862=|https://civicdb.org/links/variants/482|KIT RS3733542|478|LEU862=|https://civicdb.org/links/molecular-profiles/478|NC_000004.11:g.55602765G>C&NM_000222.2:c.2586G>C&NP_000213.1:p.Leu862=&ENST00000288135.5:c.2586G>C|CA2923796|255572|5.0|evidence|1136|https://civicdb.org/links/evidence/1136|24178622 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Selumetinib (NCIt ID C66939)|||B|1|||||
4	55604940	256	G	A	.	.	GN=KIT;VT=rs17084733;CSQ=A|3 Prime UTR Variant|KIT|3815|transcript|ENST00000288135.5|||rs17084733|256|3' UTR MUTATION|https://civicdb.org/links/variants/256|KIT rs17084733|252|3' UTR MUTATION|https://civicdb.org/links/molecular-profiles/252|NC_000004.11:g.55604940G>A|CA10621234||15.0|evidence|666|https://civicdb.org/links/evidence/666|21119596 (PUBMED)|COMMON_GERMLINE|accepted|POSITIVE|SUPPORTS|Acral Lentiginous Melanoma||||B|3|||||
4	55955969	467	C	T	.	.	VT=A1065T;CSQ=T|Missense Variant|KDR|3791|transcript|ENST00000263923.4|ENST00000263923.4:c.3193G>A||A1065T|467|ALA1065THR&RS56302315|https://civicdb.org/links/variants/467|KDR A1065T|463|ALA1065THR&RS56302315|https://civicdb.org/links/molecular-profiles/463|NC_000004.11:g.55955969C>T&NM_002253.2:c.3193G>A&NP_002244.1:p.Ala1065Thr&ENST00000263923.4:c.3193G>A|CA2924178|NONE FOUND|3.0|evidence|1106|https://civicdb.org/links/evidence/1106|19723655 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Angiosarcoma|Sorafenib (NCIt ID C61948)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|3|||||;GN=KDR
4	55961059	502	G	A	.	.	CSQ=A|Missense Variant|KDR|3791|transcript|ENST00000263923.4|ENST00000263923.4:c.2881C>T||R961W|502|ARG961TRP&RS530419081|https://civicdb.org/links/variants/502|KDR R961W|498|ARG961TRP&RS530419081|https://civicdb.org/links/molecular-profiles/498|NC_000004.11:g.55961059G>A&NM_002253.2:c.2881C>T&NP_002244.1:p.Arg961Trp&ENST00000263923.4:c.2881C>T|CA2924278|NONE FOUND|2.5|evidence|1191|https://civicdb.org/links/evidence/1191|27004155 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Adenocarcinoma|Regorafenib (NCIt ID C78204)|||C|1|||||;VT=R961W;GN=KDR
4	55968180	468	T	A	.	.	VT=D717V;CSQ=A|Missense Variant|KDR|3791|transcript|ENST00000263923.4|ENST00000263923.4:c.2150A>T||D717V|468|ASP717VAL|https://civicdb.org/links/variants/468|KDR D717V|464|ASP717VAL|https://civicdb.org/links/molecular-profiles/464|NC_000004.11:g.55968180T>A&ENST00000263923.4:c.2150A>T|CA356908090|NONE FOUND|3.0|evidence|1107|https://civicdb.org/links/evidence/1107|19723655 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Angiosarcoma|Sorafenib (NCIt ID C61948)&Sunitinib (NCIt ID C71622)|SUBSTITUTES||D|3|||||;GN=KDR
4	89052323	260	G	T	.	.	CSQ=T|Missense Variant|ABCG2|9429|transcript|ENST00000237612.3|ENST00000237612.3:c.421C>A||Q141K|260|GLN141LYS&RS2231142|https://civicdb.org/links/variants/260|ABCG2 Q141K|256|GLN141LYS&RS2231142|https://civicdb.org/links/molecular-profiles/256|NC_000004.11:g.89052323G>T&NM_004827.2:c.421C>A&NP_004818.2:p.Gln141Lys&ENST00000237612.3:c.421C>A|CA129179|30389|15.0|evidence|671|https://civicdb.org/links/evidence/671|22112610 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Ovarian Cancer||||B|3|||||;VT=Q141K;GN=ABCG2
5	1286516	421	C	A	.	.	CSQ=A|Coding Transcript Intron Variant&Polymorphic Sequence Variant|TERT|7015|transcript|ENST00000310581.5|ENST00000310581.5:c.1574-3777G>T||RS2736100|421||https://civicdb.org/links/variants/421|TERT RS2736100|417||https://civicdb.org/links/molecular-profiles/417|NC_000005.9:g.1286516C>A&ENST00000310581.5:c.1574-3777G>T&NM_001193376.1:c.1574-3777G>T&NP_001180305.1:p.=|CA11915794|375480|10.0|evidence|980|https://civicdb.org/links/evidence/980|26765760 (PUBMED)|COMMON_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Brain Glioma||||B|2|||||;VT=RS2736100;GN=TERT
5	1295228	248	G	A	.	.	VT=C228T;GN=TERT;CSQ=A|Regulatory Region Variant|TERT|7015|transcript|ENST00000310581.5|||C228T|248|-124C>T|https://civicdb.org/links/variants/248|TERT C228T|244|-124C>T|https://civicdb.org/links/molecular-profiles/244|NC_000005.9:g.1295228G>A|CA557858711|NONE FOUND|40.0|evidence|655|https://civicdb.org/links/evidence/655|25024077 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|5|||||,A|Regulatory Region Variant|TERT|7015|transcript|ENST00000310581.5|||C228T|248|-124C>T|https://civicdb.org/links/variants/248|TERT C228T|244|-124C>T|https://civicdb.org/links/molecular-profiles/244|NC_000005.9:g.1295228G>A|CA557858711|NONE FOUND|40.0|evidence|1646|https://civicdb.org/links/evidence/1646|25121551 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Thyroid Cancer||||B|3|||||
5	170837547	87	G	GTCTG	.	.	VT=W288FS;CSQ=TCTG|Frameshift Elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|NPM1-A&RS587776806&TRP288FS|https://civicdb.org/links/variants/87|NPM1 W288FS|87|NPM1-A&RS587776806&TRP288FS|https://civicdb.org/links/molecular-profiles/87|NM_002520.6:c.860_863dupTCTG&NC_000005.9:g.170837544_170837547dupTCTG&NP_002511.1:p.Trp288Cysfs&ENST00000517671.1:c.860_863dupTCTG|CA280199|13998|13.75|evidence|109|https://civicdb.org/links/evidence/109|21067377 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|DOES_NOT_SUPPORT|Acute Myeloid Leukemia||||B|2|||||,TCTG|Frameshift Elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|NPM1-A&RS587776806&TRP288FS|https://civicdb.org/links/variants/87|NPM1 W288FS|87|NPM1-A&RS587776806&TRP288FS|https://civicdb.org/links/molecular-profiles/87|NM_002520.6:c.860_863dupTCTG&NC_000005.9:g.170837544_170837547dupTCTG&NP_002511.1:p.Trp288Cysfs&ENST00000517671.1:c.860_863dupTCTG|CA280199|13998|13.75|evidence|152|https://civicdb.org/links/evidence/152|21719597 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|NSC348884|||D|3|||||,TCTG|Frameshift Elongation|NPM1|4869|transcript|ENST00000517671.1|ENST00000517671.1:c.860_863dupTCTG||W288FS|87|NPM1-A&RS587776806&TRP288FS|https://civicdb.org/links/variants/87|NPM1 W288FS|87|NPM1-A&RS587776806&TRP288FS|https://civicdb.org/links/molecular-profiles/87|NM_002520.6:c.860_863dupTCTG&NC_000005.9:g.170837544_170837547dupTCTG&NP_002511.1:p.Trp288Cysfs&ENST00000517671.1:c.860_863dupTCTG|CA280199|13998|13.75|evidence|153|https://civicdb.org/links/evidence/153|15659725 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Cytarabine (NCIt ID C408)&Daunorubicin (NCIt ID C62091)&Etoposide (NCIt ID C491)|COMBINATION||E|3|||||;GN=NPM1
5	176942767	814	G	A	.	.	VT=R164W;CSQ=A|Missense Variant|DDX41|51428|transcript|ENST00000507955.1|||R164W|814||https://civicdb.org/links/variants/814|DDX41 R164W|792||https://civicdb.org/links/molecular-profiles/792||CA358665||7.5|evidence|1887|https://civicdb.org/links/evidence/1887|26712909 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Hematologic Cancer||||C|3|||||;GN=DDX41
6	117630062	517	A	G	.	.	VT=L2155S;CSQ=G|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6464T>C||L2155S|517|L2149S&LEU2155SER&LEU2149SER|https://civicdb.org/links/variants/517|ROS1 L2155S AND CD74::ROS1 Fusion|5125||https://civicdb.org/links/molecular-profiles/5125|NC_000006.11:g.117630062A>G&NM_002944.2:c.6464T>C&NP_002935.2:p.Leu2155Ser&ENST00000368508.3:c.6464T>C&ENSP00000357493.3:p.Leu2149Ser&NP_001365831.1:p.Leu2149Ser &ENST00000368507.8:c.6446T>C&NM_001378902.1:c.6446T>C|CA365440144|NONE FOUND|0.0|evidence|1256|https://civicdb.org/links/evidence/1256|25688157 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|ALK Inhibitor TAE684 (NCIt ID C171615)&Crizotinib (NCIt ID C74061)&Foretinib (NCIt ID C80058)|SUBSTITUTES||D|3|||||;GN=ROS1
6	117631376	518	C	G	.	.	VT=G2101A;CSQ=G|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6302G>C||G2101A|518|GLY2095ALA&G2095A&GLY2101ALA|https://civicdb.org/links/variants/518|ROS1 G2101A AND CD74::ROS1 Fusion|5111||https://civicdb.org/links/molecular-profiles/5111|NC_000006.11:g.117631376C>G&ENST00000368508.3:c.6302G>C&NM_002944.2:c.6302G>C&NP_002935.2:p.Gly2101Ala&ENST00000368507.8:c.6284G>C&NM_001378902.1:c.6284G>C&NP_001365831.1:p.Gly2095Ala|CA365440505|NONE FOUND|0.0|evidence|1259|https://civicdb.org/links/evidence/1259|25688157 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|2|||||,G|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6302G>C||G2101A|518|GLY2095ALA&G2095A&GLY2101ALA|https://civicdb.org/links/variants/518|ROS1 G2101A AND CD74::ROS1 Fusion|5111||https://civicdb.org/links/molecular-profiles/5111|NC_000006.11:g.117631376C>G&ENST00000368508.3:c.6302G>C&NM_002944.2:c.6302G>C&NP_002935.2:p.Gly2101Ala&ENST00000368507.8:c.6284G>C&NM_001378902.1:c.6284G>C&NP_001365831.1:p.Gly2095Ala|CA365440505|NONE FOUND|0.0|evidence|1260|https://civicdb.org/links/evidence/1260|25688157 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Foretinib (NCIt ID C80058)|||D|2|||||;GN=ROS1
6	117638347	1271	C	T	.	.	VT=G2032R;CSQ=T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R|1245|GLY2032ARG&RS1057519788&GLY2026ARG&GLY2028ARG&G2026R&G2028R|https://civicdb.org/links/molecular-profiles/1245|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|2.5|evidence|2934|https://civicdb.org/links/evidence/2934|23724914 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Crizotinib (NCIt ID C74061)|||C|1|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND v::ROS1 Fusion|5066||https://civicdb.org/links/molecular-profiles/5066|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|1251|https://civicdb.org/links/evidence/1251|25733882 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Lorlatinib (NCIt ID C113655)|||D|3|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND CD74::ROS1 Fusion|5075||https://civicdb.org/links/molecular-profiles/5075|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|1100|https://civicdb.org/links/evidence/1100|23724914 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Crizotinib (NCIt ID C74061)|||C|4|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND CD74::ROS1 Fusion|5075||https://civicdb.org/links/molecular-profiles/5075|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|1254|https://civicdb.org/links/evidence/1254|25688157 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|3|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND CD74::ROS1 Fusion|5075||https://civicdb.org/links/molecular-profiles/5075|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|1101|https://civicdb.org/links/evidence/1101|25351743 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Cabozantinib (NCIt ID C52200)|||D|3|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND CD74::ROS1 Fusion|5075||https://civicdb.org/links/molecular-profiles/5075|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|1249|https://civicdb.org/links/evidence/1249|26372962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Cabozantinib (NCIt ID C52200)&Foretinib (NCIt ID C80058)|SUBSTITUTES||D|3|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND CD74::ROS1 Fusion|5075||https://civicdb.org/links/molecular-profiles/5075|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|1250|https://civicdb.org/links/evidence/1250|26372962 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|AZD3463&Brigatinib (NCIt ID C98831)&Ceritinib (NCIt ID C115112)&Crizotinib (NCIt ID C74061)|SUBSTITUTES||D|3|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND CD74::ROS1 Fusion|5075||https://civicdb.org/links/molecular-profiles/5075|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|1255|https://civicdb.org/links/evidence/1255|25688157 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Foretinib (NCIt ID C80058)|||D|2|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6094G>A||G2032R|1271|GLY2032ARG&GLY2026ARG&GLY2028ARG&G2026R&G2028R&RS1057519788|https://civicdb.org/links/variants/1271|ROS1 G2032R AND SLC4A4::ROS1 Fusion|5076||https://civicdb.org/links/molecular-profiles/5076|NC_000006.11:g.117638347C>T&NM_002944.2:c.6094G>A&NP_002935.2:p.Gly2032Arg&ENST00000368508.3:c.6094G>A&NM_001378902.1:c.6076G>A&NP_001365831.1:p.Gly2026Arg&NP_001365820.1:p.Gly2028Arg&NM_001378891.1:c.6082G>A&NC_000006.12:g.117317184C>T&ENST00000368507.8:c.6076G>A|CA16602597|376139|0.0|evidence|7538|https://civicdb.org/links/evidence/7538|31399568 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|DS-6501b|||D|3|||||;GN=ROS1
6	117638365	516	G	T	.	.	VT=L2026M;GN=ROS1;CSQ=T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||L2026M|516|LEU2026MET|https://civicdb.org/links/variants/516|ROS1 L2026M AND CD74::ROS1 Fusion|5073||https://civicdb.org/links/molecular-profiles/5073|NC_000006.11:g.117638365G>T&ENST00000368508.3:c.6076C>A&NM_002944.2:c.6076C>A&NP_002935.2:p.Leu2026Met|CA365441006|NONE FOUND|0.0|evidence|1253|https://civicdb.org/links/evidence/1253|25733882 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Lorlatinib (NCIt ID C113655)|||D|3|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||L2026M|516|LEU2026MET|https://civicdb.org/links/variants/516|ROS1 L2026M AND CD74::ROS1 Fusion|5073||https://civicdb.org/links/molecular-profiles/5073|NC_000006.11:g.117638365G>T&ENST00000368508.3:c.6076C>A&NM_002944.2:c.6076C>A&NP_002935.2:p.Leu2026Met|CA365441006|NONE FOUND|0.0|evidence|1252|https://civicdb.org/links/evidence/1252|25733882 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|2|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||L2026M|516|LEU2026MET|https://civicdb.org/links/variants/516|ROS1 L2026M AND CD74::ROS1 Fusion|5073||https://civicdb.org/links/molecular-profiles/5073|NC_000006.11:g.117638365G>T&ENST00000368508.3:c.6076C>A&NM_002944.2:c.6076C>A&NP_002935.2:p.Leu2026Met|CA365441006|NONE FOUND|0.0|evidence|1257|https://civicdb.org/links/evidence/1257|25688157 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||D|2|||||,T|Missense Variant|ROS1|6098|transcript|ENST00000368508.3|ENST00000368508.3:c.6076C>A||L2026M|516|LEU2026MET|https://civicdb.org/links/variants/516|ROS1 L2026M AND CD74::ROS1 Fusion|5073||https://civicdb.org/links/molecular-profiles/5073|NC_000006.11:g.117638365G>T&ENST00000368508.3:c.6076C>A&NM_002944.2:c.6076C>A&NP_002935.2:p.Leu2026Met|CA365441006|NONE FOUND|0.0|evidence|1258|https://civicdb.org/links/evidence/1258|25688157 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Foretinib (NCIt ID C80058)|||D|2|||||
6	152415537	692	T	C	.	.	CSQ=C|Missense Variant|ESR1|2099|transcript|ENST00000440973.1|ENST00000440973.1:c.1387T>C||S463P|692|SER463PRO&RS1057519714|https://civicdb.org/links/variants/692|ESR1 S463P|673|SER463PRO&RS1057519714|https://civicdb.org/links/molecular-profiles/673|NC_000006.11:g.152415537T>C&ENST00000440973.1:c.1387T>C&NM_000125.3:c.1387T>C&NP_000116.2:p.Ser463Pro|CA16602414|375934|2.0|evidence|1727|https://civicdb.org/links/evidence/1727|24185512 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Estrogen-receptor Positive Breast Cancer|Aromatase Inhibitor (NCIt ID C1740)|||D|2|||||;GN=ESR1;VT=S463P
6	152419920	46	TC	AG	.	.	GN=ESR1;VT=L536Q;CSQ=AG|Missense Variant|ESR1|2099|transcript|ENST00000440973.1|ENST00000440973.1:c.1607_1608delinsAG||L536Q|46|LEU536GLN|https://civicdb.org/links/variants/46|ESR1 L536Q|46|LEU536GLN|https://civicdb.org/links/molecular-profiles/46|NC_000006.11:g.152419920_152419921delinsAG&ENST00000440973.1:c.1607_1608delinsAG|CA645542628|NONE FOUND|8.0|evidence|290|https://civicdb.org/links/evidence/290|24185510 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Fulvestrant (NCIt ID C1379)&Tamoxifen (NCIt ID C62078)|SUBSTITUTES||D|5|||||,AG|Missense Variant|ESR1|2099|transcript|ENST00000440973.1|ENST00000440973.1:c.1607_1608delinsAG||L536Q|46|LEU536GLN|https://civicdb.org/links/variants/46|ESR1 L536Q|46|LEU536GLN|https://civicdb.org/links/molecular-profiles/46|NC_000006.11:g.152419920_152419921delinsAG&ENST00000440973.1:c.1607_1608delinsAG|CA645542628|NONE FOUND|8.0|evidence|242|https://civicdb.org/links/evidence/242|24185512 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Hormone Therapy (NCIt ID C15445)|||D|3|||||
6	152419922	49	T	A	.	.	GN=ESR1;CSQ=A|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1609T>A||Y537N|49|GLY537ASN|https://civicdb.org/links/variants/49|ESR1 Y537N|49|GLY537ASN|https://civicdb.org/links/molecular-profiles/49|NC_000006.11:g.152419922T>A&ENST00000206249.3:c.1609T>A&NM_000125.3:c.1609T>A&NP_000116.2:p.Tyr537Asn|CA366085693|NONE FOUND|8.0|evidence|293|https://civicdb.org/links/evidence/293|24185510 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Fulvestrant (NCIt ID C1379)&Tamoxifen (NCIt ID C62078)|SUBSTITUTES||D|5|||||,A|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1609T>A||Y537N|49|GLY537ASN|https://civicdb.org/links/variants/49|ESR1 Y537N|49|GLY537ASN|https://civicdb.org/links/molecular-profiles/49|NC_000006.11:g.152419922T>A&ENST00000206249.3:c.1609T>A&NM_000125.3:c.1609T>A&NP_000116.2:p.Tyr537Asn|CA366085693|NONE FOUND|8.0|evidence|245|https://civicdb.org/links/evidence/245|24185512 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Hormone Therapy (NCIt ID C15445)|||D|3|||||;VT=Y537N
6	152419923	48	A	G	.	.	GN=ESR1;CSQ=G|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>G||Y537C|48|GLY537CYS|https://civicdb.org/links/variants/48|ESR1 Y537C|48|GLY537CYS|https://civicdb.org/links/molecular-profiles/48|ENST00000206249.3:c.1610A>G&NC_000006.11:g.152419923A>G&NM_000125.3:c.1610A>G&NP_000116.2:p.Tyr537Cys|CA366085697|NONE FOUND|8.0|evidence|292|https://civicdb.org/links/evidence/292|24185510 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Fulvestrant (NCIt ID C1379)&Tamoxifen (NCIt ID C62078)|SUBSTITUTES||D|5|||||,G|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>G||Y537C|48|GLY537CYS|https://civicdb.org/links/variants/48|ESR1 Y537C|48|GLY537CYS|https://civicdb.org/links/molecular-profiles/48|ENST00000206249.3:c.1610A>G&NC_000006.11:g.152419923A>G&NM_000125.3:c.1610A>G&NP_000116.2:p.Tyr537Cys|CA366085697|NONE FOUND|8.0|evidence|244|https://civicdb.org/links/evidence/244|24185512 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Hormone Therapy (NCIt ID C15445)|||D|3|||||;VT=Y537C
6	152419923	50	A	C	.	.	GN=ESR1;CSQ=C|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>C||Y537S|50|GLY537SER|https://civicdb.org/links/variants/50|ESR1 Y537S|50|GLY537SER|https://civicdb.org/links/molecular-profiles/50|NC_000006.11:g.152419923A>C&ENST00000206249.3:c.1610A>C&NM_000125.3:c.1610A>C&NP_000116.2:p.Tyr537Ser|CA366085696|NONE FOUND|8.0|evidence|294|https://civicdb.org/links/evidence/294|24185510 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Fulvestrant (NCIt ID C1379)&Tamoxifen (NCIt ID C62078)|SUBSTITUTES||D|5|||||,C|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1610A>C||Y537S|50|GLY537SER|https://civicdb.org/links/variants/50|ESR1 Y537S|50|GLY537SER|https://civicdb.org/links/molecular-profiles/50|NC_000006.11:g.152419923A>C&ENST00000206249.3:c.1610A>C&NM_000125.3:c.1610A>C&NP_000116.2:p.Tyr537Ser|CA366085696|NONE FOUND|8.0|evidence|246|https://civicdb.org/links/evidence/246|24185512 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Hormone Therapy (NCIt ID C15445)|||D|3|||||;VT=Y537S
6	152419926	47	A	G	.	.	GN=ESR1;CSQ=G|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|https://civicdb.org/links/variants/47|ESR1 D538G|47|ASP538GLY|https://civicdb.org/links/molecular-profiles/47|NC_000006.11:g.152419926A>G&ENST00000206249.3:c.1613A>G&NM_000125.3:c.1613A>G&NP_000116.2:p.Asp538Gly|CA366085705|NONE FOUND|18.0|evidence|4814|https://civicdb.org/links/evidence/4814|27556863 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Breast Cancer|Letrozole (NCIt ID C1527)&Palbociclib (NCIt ID C49176)|COMBINATION||B|2|||||,G|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|https://civicdb.org/links/variants/47|ESR1 D538G|47|ASP538GLY|https://civicdb.org/links/molecular-profiles/47|NC_000006.11:g.152419926A>G&ENST00000206249.3:c.1613A>G&NM_000125.3:c.1613A>G&NP_000116.2:p.Asp538Gly|CA366085705|NONE FOUND|18.0|evidence|291|https://civicdb.org/links/evidence/291|24185510 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Fulvestrant (NCIt ID C1379)&Tamoxifen (NCIt ID C62078)|SUBSTITUTES||D|5|||||,G|Missense Variant|ESR1|2099|transcript|ENST00000206249.3|ENST00000206249.3:c.1613A>G||D538G|47|ASP538GLY|https://civicdb.org/links/variants/47|ESR1 D538G|47|ASP538GLY|https://civicdb.org/links/molecular-profiles/47|NC_000006.11:g.152419926A>G&ENST00000206249.3:c.1613A>G&NM_000125.3:c.1613A>G&NP_000116.2:p.Asp538Gly|CA366085705|NONE FOUND|18.0|evidence|243|https://civicdb.org/links/evidence/243|24185512 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Hormone Therapy (NCIt ID C15445)|||D|3|||||;VT=D538G
7	6031649	768	G	A	.	.	VT=R315*;GN=PMS2;CSQ=A|Stop Gained|PMS2|5395|transcript|ENST00000265849.7|||R315*|768|ARG315TER&RS200640585&R315X|https://civicdb.org/links/variants/768|PMS2 R315*|749|ARG315TER&RS200640585&R315X|https://civicdb.org/links/molecular-profiles/749|NM_000535.6:c.943C>T&NP_000526.2:p.Arg315Ter&NC_000007.13:g.6031649G>A|CA013335|91382|2.5|evidence|1832|https://civicdb.org/links/evidence/1832|25111426 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Cancer||||C|1|||||
7	6426892	367	C	T	.	.	CSQ=T|Missense Variant|RAC1|5879|transcript|ENST00000356142.4|ENST00000356142.4:c.85C>T||P29S|367|PRO29SER|https://civicdb.org/links/variants/367|RAC1 P29S|363|PRO29SER|https://civicdb.org/links/molecular-profiles/363|ENST00000356142.4:c.85C>T&NC_000007.13:g.6426892C>T|CA16602801|376362|4.0|evidence|873|https://civicdb.org/links/evidence/873|25056119 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Vemurafenib (NCIt ID C64768)|SUBSTITUTES||D|4|||||;GN=RAC1;VT=P29S
7	55211080	994	G	A	.	.	GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.323G>A||R108K|994|ARG108LYS|https://civicdb.org/links/variants/994|EGFR R108K|968|ARG108LYS|https://civicdb.org/links/molecular-profiles/968|NM_005228.4:c.323G>A&NP_005219.2:p.Arg108Lys&NC_000007.13:g.55211080G>A&ENST00000275493.2:c.323G>A|CA16602662|376207|3.0|evidence|4186|https://civicdb.org/links/evidence/4186|17177598 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|High Grade Glioma|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=R108K
7	55211097	3464	G	A	.	.	CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|||E114K|3464|GLU114LYS|https://civicdb.org/links/variants/3464|EGFR E114K|3332|GLU114LYS|https://civicdb.org/links/molecular-profiles/3332|NC_000007.14:g.55143404G>A&NC_000007.13:g.55211097G>A&ENST00000275493.7:c.340G>A&ENSP00000275493.2:p.Glu114Lys&NM_005228.5:c.340G>A&NP_005219.2:p.Glu114Lys|CA367575828|1059673|0.0|evidence|9584|https://civicdb.org/links/evidence/9584|29533785 (PUBMED)|SOMATIC|accepted|UNALTERED_FUNCTION|SUPPORTS|||||D|2|||||;GN=EGFR;VT=E114K
7	55220274	3344	C	T	.	.	GN=EGFR;VT=R222C;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|||R222C|3344|ARG222CYS|https://civicdb.org/links/variants/3344|EGFR R222C|3212|ARG222CYS|https://civicdb.org/links/molecular-profiles/3212||CA367577392|1000203|2.0|evidence|9333|https://civicdb.org/links/evidence/9333|29533785 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||
7	55221743	995	A	C	.	.	VT=T263P;GN=EGFR;CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.787A>C||T263P|995|THR263PRO|https://civicdb.org/links/variants/995|EGFR T263P|969|THR263PRO|https://civicdb.org/links/molecular-profiles/969|NM_005228.4:c.787A>C&NP_005219.2:p.Thr263Pro&NC_000007.13:g.55221743A>C&ENST00000275493.2:c.787A>C|CA16602663|376208|3.0|evidence|4187|https://civicdb.org/links/evidence/4187|17177598 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|High Grade Glioma|Erlotinib (NCIt ID C65530)|||D|3|||||
7	55221822	996	C	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.866C>T||A289V|996|RS149840192&ALA289VAL|https://civicdb.org/links/variants/996|EGFR A289V|970|RS149840192&ALA289VAL|https://civicdb.org/links/molecular-profiles/970|NM_005228.4:c.866C>T&NP_005219.2:p.Ala289Val&NC_000007.13:g.55221822C>T&ENST00000275493.2:c.866C>T|CA16602664|376209|3.0|evidence|4188|https://civicdb.org/links/evidence/4188|17177598 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|High Grade Glioma|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=A289V
7	55227854	2613	G	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|||V441F|2613|VAL441PHE|https://civicdb.org/links/variants/2613|EGFR V441F|2486|VAL441PHE|https://civicdb.org/links/molecular-profiles/2486||CA367579353|NONE FOUND|0.5|evidence|7096|https://civicdb.org/links/evidence/7096|29196463 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||E|2|||||;VT=V441F
7	55227884	454	C	T	.	.	GN=EGFR;VT=R451C;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1351C>T||R451C|454|ARG451CYS&RS377567759|https://civicdb.org/links/variants/454|EGFR R451C|450|ARG451CYS&RS377567759|https://civicdb.org/links/molecular-profiles/450|NC_000007.13:g.55227884C>T&ENST00000275493.2:c.1351C>T&NM_001346898.1:c.1351C>T&NP_001333827.1:p.Arg451Cys|CA158917074|NONE FOUND|2.0|evidence|1081|https://civicdb.org/links/evidence/1081|26888827 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Futuximab/Modotuximab Mixture (NCIt ID C91381)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||D|2|||||
7	55227926	443	G	A	.	.	CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1393G>A||G465R|443|GLY465ARG|https://civicdb.org/links/variants/443|EGFR G465R|439|GLY465ARG|https://civicdb.org/links/molecular-profiles/439|ENST00000275493.2:c.1393G>A&NC_000007.13:g.55227926G>A&NM_005228.3:c.1393G>A&NP_005219.2:p.Gly465Arg|CA367579504|NONE FOUND|20.0|evidence|1057|https://civicdb.org/links/evidence/1057|26888827 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Futuximab/Modotuximab Mixture (NCIt ID C91381)|||C|4|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1393G>A||G465R|443|GLY465ARG|https://civicdb.org/links/variants/443|EGFR G465R|439|GLY465ARG|https://civicdb.org/links/molecular-profiles/439|ENST00000275493.2:c.1393G>A&NC_000007.13:g.55227926G>A&NM_005228.3:c.1393G>A&NP_005219.2:p.Gly465Arg|CA367579504|NONE FOUND|20.0|evidence|1058|https://civicdb.org/links/evidence/1058|26888827 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|4|||||;GN=EGFR;VT=G465R
7	55227933	455	A	C	.	.	GN=EGFR;CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1400A>C||K467T|455|LYS467THR|https://civicdb.org/links/variants/455|EGFR K467T|451|LYS467THR|https://civicdb.org/links/molecular-profiles/451|ENST00000275493.2:c.1400A>C&NC_000007.13:g.55227933A>C&NM_005228.3:c.1400A>C&NP_005219.2:p.Lys467Thr|CA367579521|NONE FOUND|6.0|evidence|1082|https://civicdb.org/links/evidence/1082|26888827 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Futuximab/Modotuximab Mixture (NCIt ID C91381)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||D|3|||||,C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1400A>C||K467T|455|LYS467THR|https://civicdb.org/links/variants/455|EGFR K467T|451|LYS467THR|https://civicdb.org/links/molecular-profiles/451|ENST00000275493.2:c.1400A>C&NC_000007.13:g.55227933A>C&NM_005228.3:c.1400A>C&NP_005219.2:p.Lys467Thr|CA367579521|NONE FOUND|6.0|evidence|1083|https://civicdb.org/links/evidence/1083|26888827 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|3|||||;VT=K467T
7	55228009	453	C	A	.	.	CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG&RS1057519860|https://civicdb.org/links/variants/453|EGFR S492R|449|SER492ARG&RS1057519860|https://civicdb.org/links/molecular-profiles/449|ENST00000275493.2:c.1476C>A&NC_000007.13:g.55228009C>A&NP_005219.2:p.Ser492Arg&NM_005228.4:c.1476C>A|CA16602784|376341|23.0|evidence|717|https://civicdb.org/links/evidence/717|22270724 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|4|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG&RS1057519860|https://civicdb.org/links/variants/453|EGFR S492R|449|SER492ARG&RS1057519860|https://civicdb.org/links/molecular-profiles/449|ENST00000275493.2:c.1476C>A&NC_000007.13:g.55228009C>A&NP_005219.2:p.Ser492Arg&NM_005228.4:c.1476C>A|CA16602784|376341|23.0|evidence|1078|https://civicdb.org/links/evidence/1078|22270724 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|2|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG&RS1057519860|https://civicdb.org/links/variants/453|EGFR S492R|449|SER492ARG&RS1057519860|https://civicdb.org/links/molecular-profiles/449|ENST00000275493.2:c.1476C>A&NC_000007.13:g.55228009C>A&NP_005219.2:p.Ser492Arg&NM_005228.4:c.1476C>A|CA16602784|376341|23.0|evidence|1079|https://civicdb.org/links/evidence/1079|26888827 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Futuximab/Modotuximab Mixture (NCIt ID C91381)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||D|4|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.1476C>A||S492R|453|SER492ARG&RS1057519860|https://civicdb.org/links/variants/453|EGFR S492R|449|SER492ARG&RS1057519860|https://civicdb.org/links/molecular-profiles/449|ENST00000275493.2:c.1476C>A&NC_000007.13:g.55228009C>A&NP_005219.2:p.Ser492Arg&NM_005228.4:c.1476C>A|CA16602784|376341|23.0|evidence|1080|https://civicdb.org/links/evidence/1080|26888827 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|4|||||;GN=EGFR;VT=S492R
7	55233043	997	G	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|||G598V|997|RS139236063|https://civicdb.org/links/variants/997|EGFR G598V|971|RS139236063|https://civicdb.org/links/molecular-profiles/971|NC_000007.13:g.55233043G>T&NM_001346898.2:c.1793G>T&NP_001333827.1:p.Gly598Val|CA4265696|376210|3.0|evidence|10066|https://civicdb.org/links/evidence/10066|17177598 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=G598V
7	55241666	2333	G	A	.	.	GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2114G>A||R705K|2333|ARG705LYS|https://civicdb.org/links/variants/2333|EGFR R705K|2206|ARG705LYS|https://civicdb.org/links/molecular-profiles/2206|ENST00000275493.2:c.2114G>A&NC_000007.13:g.55241666G>A&NM_005228.3:c.2114G>A&NP_005219.2:p.Arg705Lys|CA367583561|NONE FOUND|5.0|evidence|6182|https://civicdb.org/links/evidence/6182|23749122 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||C|2|||||;VT=R705K
7	55241707	134	G	A	.	.	GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/variants/134|EGFR G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/molecular-profiles/134|ENST00000275493.2:c.2155G>A&NC_000007.13:g.55241707G>A&NM_005228.4:c.2155G>A&NP_005219.2:p.Gly719Ser|CA126722|16612|23.0|evidence|1736|https://civicdb.org/links/evidence/1736|26124334 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|3|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/variants/134|EGFR G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/molecular-profiles/134|ENST00000275493.2:c.2155G>A&NC_000007.13:g.55241707G>A&NM_005228.4:c.2155G>A&NP_005219.2:p.Gly719Ser|CA126722|16612|23.0|evidence|4190|https://civicdb.org/links/evidence/4190|19147750 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/variants/134|EGFR G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/molecular-profiles/134|ENST00000275493.2:c.2155G>A&NC_000007.13:g.55241707G>A&NM_005228.4:c.2155G>A&NP_005219.2:p.Gly719Ser|CA126722|16612|23.0|evidence|274|https://civicdb.org/links/evidence/274|15118125 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||D|4|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2155G>A||G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/variants/134|EGFR G719S|134|GLY719SER&RS28929495|https://civicdb.org/links/molecular-profiles/134|ENST00000275493.2:c.2155G>A&NC_000007.13:g.55241707G>A&NM_005228.4:c.2155G>A&NP_005219.2:p.Gly719Ser|CA126722|16612|23.0|evidence|787|https://civicdb.org/links/evidence/787|24894453 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|4|||||;VT=G719S
7	55241708	999	G	C	.	.	GN=EGFR;CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2156G>C||G719A|999|RS121913428&GLY719ALA|https://civicdb.org/links/variants/999|EGFR S768I OR EGFR G719A OR EGFR L861Q|4499||https://civicdb.org/links/molecular-profiles/4499|NM_005228.4:c.2156G>C&NP_005219.2:p.Gly719Ala&NC_000007.13:g.55241708G>C&ENST00000275493.2:c.2156G>C|CA135775|45225|50.0|evidence|11229|https://civicdb.org/links/evidence/11229|22452895 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||A|3|||||,C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2156G>C||G719A|999|RS121913428&GLY719ALA|https://civicdb.org/links/variants/999|EGFR G719A|973|RS121913428&GLY719ALA|https://civicdb.org/links/molecular-profiles/973|NM_005228.4:c.2156G>C&NP_005219.2:p.Gly719Ala&NC_000007.13:g.55241708G>C&ENST00000275493.2:c.2156G>C|CA135775|45225|5.0|evidence|2508|https://civicdb.org/links/evidence/2508|20038723 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|None|||||,C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2156G>C||G719A|999|RS121913428&GLY719ALA|https://civicdb.org/links/variants/999|EGFR G719A|973|RS121913428&GLY719ALA|https://civicdb.org/links/molecular-profiles/973|NM_005228.4:c.2156G>C&NP_005219.2:p.Gly719Ala&NC_000007.13:g.55241708G>C&ENST00000275493.2:c.2156G>C|CA135775|45225|5.0|evidence|6181|https://civicdb.org/links/evidence/6181|23749122 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||C|2|||||;VT=G719A
7	55241708	1420	G	A	.	.	VT=G719D;GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|None|||G719D|1420|RS121913428&GLY719ASP|https://civicdb.org/links/variants/1420|EGFR G719D|1328|RS121913428&GLY719ASP|https://civicdb.org/links/molecular-profiles/1328|NC_000007.14:g.55174015G>A&NC_000007.13:g.55241708G>A&ENST00000275493.7:c.2156G>A&ENSP00000275493.2:p.Gly719Asp&NM_005228.5:c.2156G>A&NP_005219.2:p.Gly719Asp|CA16602537|376075|7.5|evidence|4210|https://civicdb.org/links/evidence/4210|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||C|3|||||
7	55241722	317	G	A	.	.	GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2170G>A||G724S|317|GLY724SER&RS1051753269|https://civicdb.org/links/variants/317|EGFR G724S|313|GLY724SER&RS1051753269|https://civicdb.org/links/molecular-profiles/313|NC_000007.13:g.55241722G>A&ENST00000275493.2:c.2170G>A&NM_005228.4:c.2170G>A&NP_005219.2:p.Gly724Ser|CA16602800|376360|4.0|evidence|786|https://civicdb.org/links/evidence/786|24894453 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|4|||||;VT=G724S
7	55242422	1571	G	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2192G>T||W731L|1571|W678L&W686L&RS397517089|https://civicdb.org/links/variants/1571|EGFR W731L|1479|W678L&W686L&RS397517089|https://civicdb.org/links/molecular-profiles/1479|ENST00000275493.2:c.2192G>T|CA367583965|NONE FOUND|3.0|evidence|4655|https://civicdb.org/links/evidence/4655|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=W731L
7	55242430	1572	G	C	.	.	GN=EGFR;VT=E734Q;CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000|ENST00000275493.2:c.2200G>C||E734Q|1572|RS121913420&E681Q&E689Q|https://civicdb.org/links/variants/1572|EGFR E734Q|1480|RS121913420&E681Q&E689Q|https://civicdb.org/links/molecular-profiles/1480|ENST00000275493.2:c.2200G>C|CA367583997|NONE FOUND|3.0|evidence|4656|https://civicdb.org/links/evidence/4656|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||
7	55242455	1001	T	C	.	.	CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2225T>C||V742A|1001|RS121913466|https://civicdb.org/links/variants/1001|EGFR V742A|975|RS121913466|https://civicdb.org/links/molecular-profiles/975|NM_005228.4:c.2225T>C&NP_005219.2:p.Val742Ala&NC_000007.13:g.55242455T>C&ENST00000275493.2:c.2225T>C|CA16602541|376079|0.0|evidence|4197|https://civicdb.org/links/evidence/4197|19147750 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||;GN=EGFR;VT=V742A
7	55242464	1002	AGGAATTAAGAGAAGC	A	.	.	CSQ=-|Inframe Deletion|EGFR|1956|transcript|ENST00000275493.2|||E746_A750del|1002|RS121913421&E746_A750DELELREA|https://civicdb.org/links/variants/1002|EGFR E746_A750del|976|RS121913421&E746_A750DELELREA|https://civicdb.org/links/molecular-profiles/976||CA175996|163343|19.5|evidence|4198|https://civicdb.org/links/evidence/4198|15329413 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|4|||||,-|Inframe Deletion|EGFR|1956|transcript|ENST00000275493.2|||E746_A750del|1002|RS121913421&E746_A750DELELREA|https://civicdb.org/links/variants/1002|EGFR E746_A750del|976|RS121913421&E746_A750DELELREA|https://civicdb.org/links/molecular-profiles/976||CA175996|163343|19.5|evidence|2513|https://civicdb.org/links/evidence/2513|15329413 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Bronchiolo-alveolar Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|3|||||,-|Inframe Deletion|EGFR|1956|transcript|ENST00000275493.2|||E746_A750del|1002|RS121913421&E746_A750DELELREA|https://civicdb.org/links/variants/1002|EGFR E746_A750del|976|RS121913421&E746_A750DELELREA|https://civicdb.org/links/molecular-profiles/976||CA175996|163343|19.5|evidence|2625|https://civicdb.org/links/evidence/2625|24893891 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||D|2|||||;GN=EGFR;VT=E746_A750del
7	55242467	724	A	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2237A>G||E746G|724|GLU746GLY|https://civicdb.org/links/variants/724|EGFR E746G|705|GLU746GLY|https://civicdb.org/links/molecular-profiles/705|ENST00000275493.2:c.2237A>G&NC_000007.13:g.55242467A>G&NM_005228.3:c.2237A>G&NP_005219.2:p.Glu746Gly|CA367584149|NONE FOUND|2.5|evidence|1787|https://civicdb.org/links/evidence/1787|26773740 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|1|||||;VT=E746G
7	55242469	1891	TT	CC	.	.	VT=L747P;GN=EGFR;CSQ=CC|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2239_2240delTTinsCC||L747P|1891|LEU747PRO|https://civicdb.org/links/variants/1891|EGFR L747P|1767|LEU747PRO|https://civicdb.org/links/molecular-profiles/1767|NM_005228.4:c.2239_2240delTTinsCC&NP_005219.2:p.Leu747Pro&NC_000007.13:g.55242469_55242470delTTinsCC&ENST00000275493.2:c.2239_2240delTTinsCC|CA135800|45235|5.0|evidence|4220|https://civicdb.org/links/evidence/4220|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||C|2|||||
7	55242469	1012	TTAAGAGAAGCAACATCTC	T	.	.	GN=EGFR;VT=L747_P753delinsS;CSQ=-|Inframe Deletion|EGFR|1956|transcript|ENST00000275493.2|||L747_P753delinsS|1012|RS121913438|https://civicdb.org/links/variants/1012|EGFR L747_P753delinsS|986|RS121913438|https://civicdb.org/links/molecular-profiles/986||CA126710|16608|7.5|evidence|6005|https://civicdb.org/links/evidence/6005|28874593 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Pancreatic Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|3|||||,-|Inframe Deletion|EGFR|1956|transcript|ENST00000275493.2|||L747_P753delinsS|1012|RS121913438|https://civicdb.org/links/variants/1012|EGFR L747_P753delinsS|986|RS121913438|https://civicdb.org/links/molecular-profiles/986||CA126710|16608|7.5|evidence|4266|https://civicdb.org/links/evidence/4266|19147750 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||
7	55242487	460	C	T	.	.	VT=P753S;GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2257C>T||P753S|460|PRO753SER&RS121913231|https://civicdb.org/links/variants/460|EGFR P753S|456|PRO753SER&RS121913231|https://civicdb.org/links/molecular-profiles/456|NC_000007.13:g.55242487C>T&ENST00000275493.2:c.2257C>T&NM_005228.4:c.2257C>T&NP_005219.2:p.Pro753Ser|CA4266020|376081|7.5|evidence|1089|https://civicdb.org/links/evidence/1089|24934779 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Squamous Cell Carcinoma|Cetuximab (NCIt ID C1723)&Sirolimus (NCIt ID C1212)|COMBINATION||C|3|||||
7	55242500	723	A	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2270A>G||K757R|723|LYS757ARG&RS397517102|https://civicdb.org/links/variants/723|EGFR K757R|704|LYS757ARG&RS397517102|https://civicdb.org/links/molecular-profiles/704|ENST00000275493.2:c.2270A>G&NC_000007.13:g.55242500A>G&NM_005228.3:c.2270A>G&NP_005219.2:p.Lys757Arg&NM_005228.5:c.2270A>G&NC_000007.14:g.55174807A>G|CA4266023|560009|7.5|evidence|1786|https://civicdb.org/links/evidence/1786|26773740 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|3|||||;VT=K757R
7	55242511	712	G	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2281G>T||D761Y|712|ASP761TYR&RS121913418|https://civicdb.org/links/variants/712|EGFR D761Y|693|ASP761TYR&RS121913418|https://civicdb.org/links/molecular-profiles/693|ENST00000275493.2:c.2281G>T&NM_005228.4:c.2281G>T&NP_005219.2:p.Asp761Tyr&NC_000007.13:g.55242511G>T|CA135827|45244|7.5|evidence|1763|https://civicdb.org/links/evidence/1763|17085664 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||C|3|||||;VT=D761Y
7	55248992	1515	T	TTCCAGGAAGCCT	.	.	VT=A763_Y764insFQEA;GN=EGFR;CSQ=TCCAGGAAGCCT|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||A763_Y764insFQEA|1515|RS397517106|https://civicdb.org/links/variants/1515|EGFR A763_Y764insFQEA|1423|RS397517106|https://civicdb.org/links/molecular-profiles/1423|NP_001333827.1:p.Ala763_Tyr764insPheGlnGluAla&NC_000007.13:g.55248992_55248993insTCCAGGAAGCCT&NM_001346898.1:c.2290_2291insTCCAGGAAGCCT|CA135833|NONE FOUND|5.0|evidence|9225|https://civicdb.org/links/evidence/9225|31208370 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||C|2|||||,TCCAGGAAGCCT|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||A763_Y764insFQEA|1515|RS397517106|https://civicdb.org/links/variants/1515|EGFR A763_Y764insFQEA|1423|RS397517106|https://civicdb.org/links/molecular-profiles/1423|NP_001333827.1:p.Ala763_Tyr764insPheGlnGluAla&NC_000007.13:g.55248992_55248993insTCCAGGAAGCCT&NM_001346898.1:c.2290_2291insTCCAGGAAGCCT|CA135833|NONE FOUND|5.0|evidence|4497|https://civicdb.org/links/evidence/4497|24353160 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||
7	55248994	1665	C	CCACCAC	.	.	GN=EGFR;CSQ=CACCAC|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||Y764_V765insHH|1665||https://civicdb.org/links/variants/1665|EGFR Y764_V765insHH|1573||https://civicdb.org/links/molecular-profiles/1573||CA2573051277||0.0|evidence|4800|https://civicdb.org/links/evidence/4800|24353160 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||;VT=Y764_V765insHH
7	55249000	1579	G	GGCCAGCGTG	.	.	CSQ=GCCAGCGTG|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||A767_V769dupASV|1579||https://civicdb.org/links/variants/1579|EGFR A767_V769dupASV|1487||https://civicdb.org/links/molecular-profiles/1487||CA180588||7.5|evidence|4665|https://civicdb.org/links/evidence/4665|24353160 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|None|||||,GCCAGCGTG|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||A767_V769dupASV|1579||https://civicdb.org/links/variants/1579|EGFR A767_V769dupASV|1487||https://civicdb.org/links/molecular-profiles/1487||CA180588||7.5|evidence|9220|https://civicdb.org/links/evidence/9220|31208370 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||C|3|||||;GN=EGFR;VT=A767_V769dupASV
7	55249000	1664	G	GGCCATA	.	.	CSQ=GCCATA|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||M766_A767insAI|1664||https://civicdb.org/links/variants/1664|EGFR M766_A767insAI|1572||https://civicdb.org/links/molecular-profiles/1572||CA645561560||0.0|evidence|4799|https://civicdb.org/links/evidence/4799|24353160 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||;GN=EGFR;VT=M766_A767insAI
7	55249005	562	G	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|SER768ILE&RS121913465|https://civicdb.org/links/variants/562|EGFR S768I OR EGFR G719A OR EGFR L861Q|4499||https://civicdb.org/links/molecular-profiles/4499|NC_000007.13:g.55249005G>T&ENST00000275493.2:c.2303G>T&NM_005228.4:c.2303G>T&NP_005219.2:p.Ser768Ile|CA135840|45251|50.0|evidence|11229|https://civicdb.org/links/evidence/11229|22452895 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||A|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|SER768ILE&RS121913465|https://civicdb.org/links/variants/562|EGFR S768I|558|SER768ILE&RS121913465|https://civicdb.org/links/molecular-profiles/558|NC_000007.13:g.55249005G>T&ENST00000275493.2:c.2303G>T&NM_005228.4:c.2303G>T&NP_005219.2:p.Ser768Ile|CA135840|45251|20.5|evidence|4273|https://civicdb.org/links/evidence/4273|22895145 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|None|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|SER768ILE&RS121913465|https://civicdb.org/links/variants/562|EGFR S768I|558|SER768ILE&RS121913465|https://civicdb.org/links/molecular-profiles/558|NC_000007.13:g.55249005G>T&ENST00000275493.2:c.2303G>T&NM_005228.4:c.2303G>T&NP_005219.2:p.Ser768Ile|CA135840|45251|20.5|evidence|1394|https://civicdb.org/links/evidence/1394|25521405 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|SER768ILE&RS121913465|https://civicdb.org/links/variants/562|EGFR S768I|558|SER768ILE&RS121913465|https://civicdb.org/links/molecular-profiles/558|NC_000007.13:g.55249005G>T&ENST00000275493.2:c.2303G>T&NM_005228.4:c.2303G>T&NP_005219.2:p.Ser768Ile|CA135840|45251|20.5|evidence|1395|https://civicdb.org/links/evidence/1395|20522446 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Gefitinib (NCIt ID C1855)|||C|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|SER768ILE&RS121913465|https://civicdb.org/links/variants/562|EGFR S768I|558|SER768ILE&RS121913465|https://civicdb.org/links/molecular-profiles/558|NC_000007.13:g.55249005G>T&ENST00000275493.2:c.2303G>T&NM_005228.4:c.2303G>T&NP_005219.2:p.Ser768Ile|CA135840|45251|20.5|evidence|2906|https://civicdb.org/links/evidence/2906|27211795 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||C|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2303G>T||S768I|562|SER768ILE&RS121913465|https://civicdb.org/links/variants/562|EGFR S768I|558|SER768ILE&RS121913465|https://civicdb.org/links/molecular-profiles/558|NC_000007.13:g.55249005G>T&ENST00000275493.2:c.2303G>T&NM_005228.4:c.2303G>T&NP_005219.2:p.Ser768Ile|CA135840|45251|20.5|evidence|4274|https://civicdb.org/links/evidence/4274|19147750 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||D|3|||||;VT=S768I
7	55249009	736	G	GGCCAGCGTG	.	.	CSQ=GCCAGCGTG|Direct Tandem Duplication|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2%3Ac.2300_2308dupCCAGCGTGG||V769_D770insASV|736|VAL769_ASP770INSALASERVAL%2C V769_770INSASV|https%3A//civicdb.org/links/variants/736|EGFR V769_D770insASV|717|VAL769_ASP770INSALASERVAL%2C V769_770INSASV|https%3A//civicdb.org/links/molecular-profiles/717|NM_005228.4%3Ac.2300_2308dupCCAGCGTGG&NP_005219.2%3Ap.Val769_Asp770insAlaSerVal&ENST00000275493.2%3Ac.2300_2308dupCCAGCGTGG|CA180588|177678|7.5|evidence|1799|https%3A//civicdb.org/links/evidence/1799|26773740 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|3|||||;GN=EGFR;VT=V769_D770insASV
7	55249012	1512	C	CGGT	.	.	GN=EGFR;VT=D770_N771insG;CSQ=GGT|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||D770_N771insG|1512|ASP770_ASN771INSGLY|https://civicdb.org/links/variants/1512|EGFR D770_N771insG|1420|ASP770_ASN771INSGLY|https://civicdb.org/links/molecular-profiles/1420|NC_000007.14:g.55181319_55181320insGGT&NC_000007.13:g.55249012_55249013insGGT&ENST00000275493.7:c.2310_2311insGGT&ENSP00000275493.2:p.Asp770_Asn771insGly&NM_005228.5:c.2310_2311insGGT&NP_005219.2:p.Asp770_Asn771insGly|CA645561591|NONE FOUND|7.5|evidence|9223|https://civicdb.org/links/evidence/9223|31208370 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||C|3|||||
7	55249012	1514	C	CGGGTTA	.	.	GN=EGFR;CSQ=GGGTTA|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||D770_N771insGL|1514|RS397517111|https://civicdb.org/links/variants/1514|EGFR D770_N771insGL|1422|RS397517111|https://civicdb.org/links/molecular-profiles/1422|NC_000007.13:g.55249012_55249013insGGGTTA&NM_005228.3:c.2310_2311insGGGTTA&NP_005219.2:p.Asp770_Asn771insGlyLeu|CA645561585|45257|10.0|evidence|4494|https://civicdb.org/links/evidence/4494|24353160 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|4|||||;VT=D770_N771insGL
7	55249012	1566	C	CGGCACA	.	.	GN=EGFR;VT=D770_N771insGT;CSQ=GGCACA|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||D770_N771insGT|1566|ASP770_ASN771INSGLYTHR|https://civicdb.org/links/variants/1566|EGFR D770_N771insGT|1474|ASP770_ASN771INSGLYTHR|https://civicdb.org/links/molecular-profiles/1474|NC_000007.13:g.55249012_55249013insGGCACA&NM_005228.3:c.2310_2311insGGCACA&NP_005219.2:p.Cys770_Gly771insGlyThr&NC_000007.14:g.55181319_55181320insGGCACA&ENST00000275493.7:c.2310_2311insGGCACA&ENSP00000275493.2:p.Asp770_Asn771insGlyThr|CA645561586|NONE FOUND|0.0|evidence|4643|https://civicdb.org/links/evidence/4643|23371856 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|None|||||
7	55249012	1513	C	CAACCCCCAC	.	.	GN=EGFR;CSQ=AACCCCCAC|Inframe Insertion|EGFR|1956|transcript|ENST00000275493.2|||H773_V774insNPH|1513||https://civicdb.org/links/variants/1513|EGFR H773_V774insNPH|1421||https://civicdb.org/links/molecular-profiles/1421||CA180983|177911|7.5|evidence|4493|https://civicdb.org/links/evidence/4493|24353160 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||C|3|||||;VT=H773_V774insNPH
7	55249013	1445	A	AGCGTGGACA	.	.	GN=EGFR;CSQ=GCGTGGACA||EGFR|1956|transcript|ENST00000275493.2|||D770_N771insSVD|1445|S768_D770DUP&ASP770_ASN771INSSERVALASP|https://civicdb.org/links/variants/1445|EGFR D770_N771insSVD|1353|S768_D770DUP&ASP770_ASN771INSSERVALASP|https://civicdb.org/links/molecular-profiles/1353|NC_000007.14:g.55181312_55181320dup&NC_000007.13:g.55249005_55249013dup&ENST00000275493.7:c.2303_2311dup&ENSP00000275493.2:p.Asp770_Asn771insSerValAsp&NM_005228.5:c.2303_2311dup&NP_005219.2:p.Asp770_Asn771insSerValAsp|CA135844|45253|0.0|evidence|4275|https://civicdb.org/links/evidence/4275|24353160 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||;VT=D770_N771insSVD
7	55249021	1446	C	CCAC	.	.	VT=H773_V774insH;GN=EGFR;CSQ=CAC||EGFR|1956|transcript|ENST00000275493.2|||H773_V774insH|1446||https://civicdb.org/links/variants/1446|EGFR H773_V774insH|1354||https://civicdb.org/links/molecular-profiles/1354|p.His773dup&c.55249019_55249021dup|CA135866||0.0|evidence|4276|https://civicdb.org/links/evidence/4276|24353160 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||
7	55249022	1894	G	A	.	.	GN=EGFR;VT=V774M;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2320G>A||V774M|1894|VAL774MET|https://civicdb.org/links/variants/1894|EGFR V774M|1770|VAL774MET|https://civicdb.org/links/molecular-profiles/1770|ENST00000275493.2:c.2320G>A|CA158928427|NONE FOUND|5.0|evidence|4231|https://civicdb.org/links/evidence/4231|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||C|2|||||
7	55249023	1892	T	C	.	.	GN=EGFR;CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2321T>C||V774A|1892|VAL774ALA|https://civicdb.org/links/variants/1892|EGFR V774A|1768|VAL774ALA|https://civicdb.org/links/molecular-profiles/1768|ENST00000275493.2:c.2321T>C|CA367578723|NONE FOUND|7.5|evidence|4226|https://civicdb.org/links/evidence/4226|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|3|||||;VT=V774A
7	55249028	1181	C	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2326C>T||R776C|1181|R723C&R731C|https://civicdb.org/links/variants/1181|EGFR R776C|1155|R723C&R731C|https://civicdb.org/links/molecular-profiles/1155|ENST00000275493.2:c.2326C>T|CA367578749|NONE FOUND|0.0|evidence|4468|https://civicdb.org/links/evidence/4468|19147750 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||;VT=R776C
7	55249055	1573	A	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2353A>G||T785A|1573|T732A&T740A|https://civicdb.org/links/variants/1573|EGFR T785A|1481|T732A&T740A|https://civicdb.org/links/molecular-profiles/1481|ENST00000275493.2:c.2353A>G|CA367578819|NONE FOUND|3.0|evidence|4657|https://civicdb.org/links/evidence/4657|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=T785A
7	55249071	34	C	T	.	.	GN=EGFR;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|238|https://civicdb.org/links/evidence/238|25668228 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||A|5|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|1592|https://civicdb.org/links/evidence/1592|26729184 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||A|5|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|1867|https://civicdb.org/links/evidence/1867|27959700 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||A|5|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|240|https://civicdb.org/links/evidence/240|21430269 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||B|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|369|https://civicdb.org/links/evidence/369|24623981 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|370|https://civicdb.org/links/evidence/370|24729716 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|646|https://civicdb.org/links/evidence/646|25923550 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Rociletinib (NCIt ID C99905)|||B|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|965|https://civicdb.org/links/evidence/965|25923549 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||B|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|1863|https://civicdb.org/links/evidence/1863|24035188 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||B|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|239|https://civicdb.org/links/evidence/239|15728811 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||B|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|966|https://civicdb.org/links/evidence/966|26720284 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||B|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|1391|https://civicdb.org/links/evidence/1391|23470965 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|1667|https://civicdb.org/links/evidence/1667|27304188 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2159|https://civicdb.org/links/evidence/2159|17020982 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||B|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2158|https://civicdb.org/links/evidence/2158|15737014 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||C|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|277|https://civicdb.org/links/evidence/277|24636847 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Pemetrexed (NCIt ID C61614)|COMBINATION||C|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2157|https://civicdb.org/links/evidence/2157|26269204 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Osimertinib (NCIt ID C116377)|||C|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|6006|https://civicdb.org/links/evidence/6006|28874593 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Pancreatic Adenocarcinoma|Osimertinib (NCIt ID C116377)|||C|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|642|https://civicdb.org/links/evidence/642|18227510 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Cancer|Gefitinib (NCIt ID C1855)&Multikinase Inhibitor AEE788 (NCIt ID C48369)|SEQUENTIAL||D|5|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2160|https://civicdb.org/links/evidence/2160|18408761 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Lapatinib (NCIt ID C26653)|||D|4|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|762|https://civicdb.org/links/evidence/762|24065731 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Rociletinib (NCIt ID C99905)|||D|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|963|https://civicdb.org/links/evidence/963|24893891 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||D|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2161|https://civicdb.org/links/evidence/2161|18089823 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||D|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|3810|https://civicdb.org/links/evidence/3810|19147750 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)&Multikinase Inhibitor AEE788 (NCIt ID C48369)|SUBSTITUTES||D|3|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|967|https://civicdb.org/links/evidence/967|26515464 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)&Rociletinib (NCIt ID C99905)|SUBSTITUTES||D|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2162|https://civicdb.org/links/evidence/2162|16818618 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Neratinib (NCIt ID C49094)|||D|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2163|https://civicdb.org/links/evidence/2163|18408761 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||D|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2164|https://civicdb.org/links/evidence/2164|21732342 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||D|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|2165|https://civicdb.org/links/evidence/2165|18408761 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Canertinib (NCIt ID C77588)|||D|2|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M|34|THR790MET&RS121434569|https://civicdb.org/links/molecular-profiles/34|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|406.25|evidence|278|https://civicdb.org/links/evidence/278|24658966 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Staurosporine (NCIt ID C1237)|||E|1|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M AND EGFR Exon 19 Deletion|4659||https://civicdb.org/links/molecular-profiles/4659|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|0.0|evidence|1397|https://civicdb.org/links/evidence/1397|26181354 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Osimertinib (NCIt ID C116377)|||C|1|||||,T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2369C>T||T790M|34|THR790MET&RS121434569|https://civicdb.org/links/variants/34|EGFR T790M AND EGFR Exon 19 Deletion AND EGFR C797S|5513||https://civicdb.org/links/molecular-profiles/5513|ENST00000275493.2:c.2369C>T&NC_000007.13:g.55249071C>T&NM_005228.4:c.2369C>T&NP_005219.2:p.Thr790Met|CA090928|16613|0.0|evidence|1396|https://civicdb.org/links/evidence/1396|26181354 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Osimertinib (NCIt ID C116377)|||C|1|||||;VT=T790M
7	55249091	415	T	A	.	.	GN=EGFR;VT=C797S;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2389T>A||C797S|415|CYS797SER&RS1057519861|https://civicdb.org/links/variants/415|EGFR C797S|411|CYS797SER&RS1057519861|https://civicdb.org/links/molecular-profiles/411|NC_000007.13:g.55249091T>A&ENST00000275493.2:c.2389T>A&NM_005228.4:c.2389T>A&NP_005219.2:p.Cys797Ser|CA16602785|376342|17.5|evidence|964|https://civicdb.org/links/evidence/964|25939061 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||B|3|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2389T>A||C797S|415|CYS797SER&RS1057519861|https://civicdb.org/links/variants/415|EGFR T790M AND EGFR Exon 19 Deletion AND EGFR C797S|5513||https://civicdb.org/links/molecular-profiles/5513|NC_000007.13:g.55249091T>A&ENST00000275493.2:c.2389T>A&NM_005228.4:c.2389T>A&NP_005219.2:p.Cys797Ser|CA16602785|376342|0.0|evidence|1396|https://civicdb.org/links/evidence/1396|26181354 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Osimertinib (NCIt ID C116377)|||C|1|||||
7	55249092	1574	G	A	.	.	GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2390G>A||C797Y|1574|C744Y&C752Y&CYS797TYR|https://civicdb.org/links/variants/1574|EGFR C797Y|1482|C744Y&C752Y&CYS797TYR|https://civicdb.org/links/molecular-profiles/1482|ENST00000275493.2:c.2390G>A&NM_005228.3:c.2390G>A&NC_000007.13:g.55249092G>A&NP_005219.2:p.Cys797Tyr|CA367578897|NONE FOUND|3.0|evidence|4658|https://civicdb.org/links/evidence/4658|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=C797Y
7	55249103	1575	T	C	.	.	GN=EGFR;CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2401T>C||Y801H|1575|Y748H&Y756H|https://civicdb.org/links/variants/1575|EGFR Y801H|1483|Y748H&Y756H|https://civicdb.org/links/molecular-profiles/1483|ENST00000275493.2:c.2401T>C|CA4266065|NONE FOUND|3.0|evidence|4659|https://civicdb.org/links/evidence/4659|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=Y801H
7	55249118	1895	A	G	.	.	GN=EGFR;VT=K806E;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2416A>G||K806E|1895|LYS806GLU&RS754652044|https://civicdb.org/links/variants/1895|EGFR K806E|1771|LYS806GLU&RS754652044|https://civicdb.org/links/molecular-profiles/1771|ENST00000275493.2:c.2416A>G&NM_001346898.1:c.2416A>G&NP_001333827.1:p.Lys806Glu&NC_000007.13:g.55249118A>G|CA4266068|NONE FOUND|5.0|evidence|4239|https://civicdb.org/links/evidence/4239|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|2|||||
7	55259418	1896	A	T	.	.	GN=EGFR;VT=N826Y;CSQ=T|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2476A>T||N826Y|1896|ASN826TYR|https://civicdb.org/links/variants/1896|EGFR N826Y|1772|ASN826TYR|https://civicdb.org/links/molecular-profiles/1772|ENST00000275493.2:c.2476A>T&NC_000007.13:g.55259418A>T&NC_000007.14:g.55191725A>T&NM_005228.3:c.2476A>T&NP_005219.2:p.Asn826Tyr|CA367580076|NONE FOUND|5.0|evidence|4244|https://civicdb.org/links/evidence/4244|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|2|||||
7	55259419	1188	A	G	.	.	CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2477A>G||N826S|1188|N773S&N781S|https://civicdb.org/links/variants/1188|EGFR N826S|1162|N773S&N781S|https://civicdb.org/links/molecular-profiles/1162|ENST00000275493.2:c.2477A>G|CA367580077|NONE FOUND|0.0|evidence|4496|https://civicdb.org/links/evidence/4496|19147750 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||;GN=EGFR;VT=N826S
7	55259434	1017	G	A	.	.	GN=EGFR;VT=R831H;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2492G>A||R831H|1017|RS150036236&ARG831HIS|https://civicdb.org/links/variants/1017|EGFR R831H|991|RS150036236&ARG831HIS|https://civicdb.org/links/molecular-profiles/991|ENST00000275493.2:c.2492G>A&NC_000007.13:g.55259434G>A&NM_005228.4:c.2492G>A&NP_005219.2:p.Arg831His&NC_000007.14:g.55191741G>A|CA4266102|560007|3.0|evidence|4279|https://civicdb.org/links/evidence/4279|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||
7	55259454	1018	C	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2512C>G||L838V|1018|LEU838VAL|https://civicdb.org/links/variants/1018|EGFR L838V|992|LEU838VAL|https://civicdb.org/links/molecular-profiles/992|NM_005228.4:c.2512C>G&NP_005219.2:p.Leu838Val&NC_000007.13:g.55259454C>G&ENST00000275493.2:c.2512C>G|CA350916|208822|2.0|evidence|4280|https://civicdb.org/links/evidence/4280|19147750 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||D|2|||||;VT=L838V
7	55259455	1457	T	C	.	.	VT=L838P;GN=EGFR;CSQ=C|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|||L838P|1457|LEU838PRO|https://civicdb.org/links/variants/1457|EGFR L838P|1365|LEU838PRO|https://civicdb.org/links/molecular-profiles/1365|NC_000007.14:g.55191762T>C&NC_000007.13:g.55259455T>C&ENST00000275493.7:c.2513T>C&ENSP00000275493.2:p.Leu838Pro&NM_005228.5:c.2513T>C&NP_005219.2:p.Leu838Pro|CA367580150|NONE FOUND|7.5|evidence|4252|https://civicdb.org/links/evidence/4252|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|3|||||
7	55259467	1899	A	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2525A>G||N842S|1899|ASN842SER|https://civicdb.org/links/variants/1899|EGFR N842S|1775|ASN842SER|https://civicdb.org/links/molecular-profiles/1775|ENST00000275493.2:c.2525A>G|CA367580172|NONE FOUND|5.0|evidence|4256|https://civicdb.org/links/evidence/4256|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|2|||||;VT=N842S
7	55259482	1463	C	T	.	.	CSQ=T|Missense Variant|EGFR|1956|transcript|None|||T847I|1463||https://civicdb.org/links/variants/1463|EGFR T847I|1371||https://civicdb.org/links/molecular-profiles/1371||CA367580204||5.0|evidence|4260|https://civicdb.org/links/evidence/4260|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|2|||||;GN=EGFR;VT=T847I
7	55259493	1466	G	A	.	.	VT=V851I;GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|None|||V851I|1466||https://civicdb.org/links/variants/1466|EGFR V851I|1374||https://civicdb.org/links/molecular-profiles/1374||CA367580229||5.0|evidence|4264|https://civicdb.org/links/evidence/4264|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|2|||||
7	55259515	33	T	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|11219|https://civicdb.org/links/evidence/11219|32955177 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||A|5|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|11239|https://civicdb.org/links/evidence/11239|28958502 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||A|5|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|11240|https://civicdb.org/links/evidence/11240|31591063 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Ramucirumab (NCIt ID C70792)|COMBINATION||A|5|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|12015|https://civicdb.org/links/evidence/12015|37937763 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Chemotherapy (NCIt ID C15632)&Osimertinib (NCIt ID C116377)|COMBINATION||A|5|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|7363|https://civicdb.org/links/evidence/7363|28958502 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||A|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|11241|https://civicdb.org/links/evidence/11241|24263064 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||A|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|12131|https://civicdb.org/links/evidence/12131|38942080 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Amivantamab (NCIt ID C124993)&Lazertinib (NCIt ID C148147)|COMBINATION||A|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|12156|https://civicdb.org/links/evidence/12156|37879444 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Amivantamab (NCIt ID C124993)&Carboplatin (NCIt ID C1282)&Pemetrexed (NCIt ID C61614)|COMBINATION||A|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|3791|https://civicdb.org/links/evidence/3791|22285168 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||B|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|4759|https://civicdb.org/links/evidence/4759|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R OR EGFR Exon 19 Deletion|4432||https://civicdb.org/links/molecular-profiles/4432|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|410.0|evidence|2156|https://civicdb.org/links/evidence/2156|24755888 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2994|https://civicdb.org/links/evidence/2994|24868098 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||A|5|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2997|https://civicdb.org/links/evidence/2997|23982599 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||A|5|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4860|https://civicdb.org/links/evidence/4860|26768165 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||B|5|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|275|https://civicdb.org/links/evidence/275|24457318 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|879|https://civicdb.org/links/evidence/879|23816960 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Afatinib (NCIt ID C66940)|||B|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|982|https://civicdb.org/links/evidence/982|24439929 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Afatinib (NCIt ID C66940)|||B|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2621|https://civicdb.org/links/evidence/2621|20038723 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||B|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|229|https://civicdb.org/links/evidence/229|24736073 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|347|https://civicdb.org/links/evidence/347|24662454 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|883|https://civicdb.org/links/evidence/883|22452895 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Afatinib (NCIt ID C66940)|||B|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|885|https://civicdb.org/links/evidence/885|22285168 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||B|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|1665|https://civicdb.org/links/evidence/1665|18509184 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||B|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2634|https://civicdb.org/links/evidence/2634|22370314 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Gefitinib (NCIt ID C1855)|||B|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4290|https://civicdb.org/links/evidence/4290|27032107 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||B|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|6183|https://civicdb.org/links/evidence/6183|27022112 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Gefitinib (NCIt ID C1855)|||B|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4288|https://civicdb.org/links/evidence/4288|22235099 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2632|https://civicdb.org/links/evidence/2632|15329413 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||C|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2624|https://civicdb.org/links/evidence/2624|15329413 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Gefitinib (NCIt ID C1855)|||C|1|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|276|https://civicdb.org/links/evidence/276|15118125 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||D|4|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2626|https://civicdb.org/links/evidence/2626|18408761 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Lapatinib (NCIt ID C26653)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2627|https://civicdb.org/links/evidence/2627|18089823 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2628|https://civicdb.org/links/evidence/2628|16818618 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Neratinib (NCIt ID C49094)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2631|https://civicdb.org/links/evidence/2631|18408761 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Canertinib (NCIt ID C77588)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|3811|https://civicdb.org/links/evidence/3811|19147750 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)&Multikinase Inhibitor AEE788 (NCIt ID C48369)|SUBSTITUTES||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4265|https://civicdb.org/links/evidence/4265|17877814 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4286|https://civicdb.org/links/evidence/4286|24353160 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4292|https://civicdb.org/links/evidence/4292|27102076 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Adenocarcinoma|Cetuximab (NCIt ID C1723)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4295|https://civicdb.org/links/evidence/4295|17177598 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|High Grade Glioma|Erlotinib (NCIt ID C65530)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|5922|https://civicdb.org/links/evidence/5922|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|968|https://civicdb.org/links/evidence/968|26515464 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||D|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|2629|https://civicdb.org/links/evidence/2629|18408761 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||D|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4284|https://civicdb.org/links/evidence/4284|18408761 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4285|https://civicdb.org/links/evidence/4285|21132006 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4291|https://civicdb.org/links/evidence/4291|27102076 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)|||D|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4293|https://civicdb.org/links/evidence/4293|24893891 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4294|https://civicdb.org/links/evidence/4294|24893891 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Osimertinib (NCIt ID C116377)|||D|2|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|evidence|4287|https://civicdb.org/links/evidence/4287|27612423 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|1|||||,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|assertion|5|https://civicdb.org/links/assertion/5||SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma (DOID 3908)|Erlotinib (NCIt ID C65530)||||||TIER_I_LEVEL_A|{'name': 'Non-Small Cell Lung Cancer'} (v3.2018)|True|True,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|assertion|105|https://civicdb.org/links/assertion/105||SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma (DOID 3908)|Gefitinib (NCIt ID C1855)||||||TIER_I_LEVEL_A|{'name': 'Non-Small Cell Lung Cancer'} (v3.2018)|True|True,G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2573T>G||L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/variants/33|EGFR L858R|33|LEU858ARG&RS121434568&L813R&LEU813ARG|https://civicdb.org/links/molecular-profiles/33|NC_000007.13:g.55259515T>G&NM_005228.4:c.2573T>G&ENST00000275493.2:c.2573T>G&NP_005219.2:p.Leu858Arg|CA126713|16609&376282&376280|379.0|assertion|6|https://civicdb.org/links/assertion/6||SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma (DOID 3908)|Afatinib (NCIt ID C66940)||||||TIER_I_LEVEL_A|{'name': 'Non-Small Cell Lung Cancer'} (v3.2018)|True|True;VT=L858R
7	55259524	1020	T	A	.	.	GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2582T>A||L861Q|1020|RS121913444|https://civicdb.org/links/variants/1020|EGFR S768I OR EGFR G719A OR EGFR L861Q|4499||https://civicdb.org/links/molecular-profiles/4499|NM_005228.4:c.2582T>A&NP_005219.2:p.Leu861Gln&NC_000007.13:g.55259524T>A&ENST00000275493.2:c.2582T>A|CA176021|163380|50.0|evidence|11229|https://civicdb.org/links/evidence/11229|22452895 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)|||A|3|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2582T>A||L861Q|1020|RS121913444|https://civicdb.org/links/variants/1020|EGFR L861Q|994|RS121913444|https://civicdb.org/links/molecular-profiles/994|NM_005228.4:c.2582T>A&NP_005219.2:p.Leu861Gln&NC_000007.13:g.55259524T>A&ENST00000275493.2:c.2582T>A|CA176021|163380|10.5|evidence|3802|https://civicdb.org/links/evidence/3802|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|3|||||,A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2582T>A||L861Q|1020|RS121913444|https://civicdb.org/links/variants/1020|EGFR L861Q|994|RS121913444|https://civicdb.org/links/molecular-profiles/994|NM_005228.4:c.2582T>A&NP_005219.2:p.Leu861Gln&NC_000007.13:g.55259524T>A&ENST00000275493.2:c.2582T>A|CA176021|163380|10.5|evidence|4299|https://civicdb.org/links/evidence/4299|17177598 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|High Grade Glioma|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=L861Q
7	55259524	1477	T	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000|ENST00000275493.2:c.2582T>G||L861R|1477|RS121913444|https://civicdb.org/links/variants/1477|EGFR L861R|1385|RS121913444|https://civicdb.org/links/molecular-profiles/1385|NM_005228.4:c.2582T>G&NP_005219.2:p.Leu861Arg&NC_000007.13:g.55259524T>G&ENST00000275493.2:c.2582T>G|CA135940|45287|7.5|evidence|4669|https://civicdb.org/links/evidence/4669|21531810 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gefitinib (NCIt ID C1855)|||C|3|||||;VT=L861R
7	55259532	1187	G	A	.	.	GN=EGFR;CSQ=A|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2590G>A||A864T|1187|A811T&A819T&ALA864THR&RS1171287261|https://civicdb.org/links/variants/1187|EGFR A864T|1161|A811T&A819T&ALA864THR&RS1171287261|https://civicdb.org/links/molecular-profiles/1161|ENST00000275493.2:c.2590G>A&NC_000007.13:g.55259532G>A&NM_005228.3:c.2590G>A&NP_005219.2:p.Ala864Thr|CA367580302|NONE FOUND|0.0|evidence|4495|https://civicdb.org/links/evidence/4495|19147750 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)|||D|None|||||;VT=A864T
7	55259545	1482	A	G	.	.	GN=EGFR;CSQ=G|Missense Variant|EGFR|1956|transcript|ENST00000275493.2|ENST00000275493.2:c.2603A>G||E868G|1482|GLU868GLY|https://civicdb.org/links/variants/1482|EGFR E868G|1390|GLU868GLY|https://civicdb.org/links/molecular-profiles/1390|ENST00000275493.2:c.2603A>G&NC_000007.14:g.55191852A>G&NC_000007.13:g.55259545A>G&ENST00000275493.7:c.2603A>G&ENSP00000275493.2:p.Glu868Gly&NM_005228.5:c.2603A>G&NP_005219.2:p.Glu868Gly|CA367580333|NONE FOUND|3.0|evidence|4301|https://civicdb.org/links/evidence/4301|20942962 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Erlotinib (NCIt ID C65530)|||D|3|||||;VT=E868G
7	87138645	263	A	G	.	.	CSQ=G|Synonymous Variant|ABCB1|5243|transcript|ENST00000265724.3|ENST00000265724.3:c.3435T>C||I1145I|263|T3435C&RS1045642&3435C-T&ILE1145=|https://civicdb.org/links/variants/263|ABCB1 I1145I|259|T3435C&RS1045642&3435C-T&ILE1145=|https://civicdb.org/links/molecular-profiles/259|NM_000927.4:c.3435T>C&NP_000918.2:p.Ile1145=&NC_000007.13:g.87138645A>G&ENST00000265724.3:c.3435T>C|CA4327768|225939|25.0|evidence|1076|https://civicdb.org/links/evidence/1076|22906996 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,G|Synonymous Variant|ABCB1|5243|transcript|ENST00000265724.3|ENST00000265724.3:c.3435T>C||I1145I|263|T3435C&RS1045642&3435C-T&ILE1145=|https://civicdb.org/links/variants/263|ABCB1 I1145I|259|T3435C&RS1045642&3435C-T&ILE1145=|https://civicdb.org/links/molecular-profiles/259|NM_000927.4:c.3435T>C&NP_000918.2:p.Ile1145=&NC_000007.13:g.87138645A>G&ENST00000265724.3:c.3435T>C|CA4327768|225939|25.0|evidence|675|https://civicdb.org/links/evidence/675|22296372 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Carboplatin (NCIt ID C1282)&Cisplatin (NCIt ID C376)|SUBSTITUTES||B|2|||||;GN=ABCB1;VT=I1145I
7	87160618	451	A	C	.	.	VT=S893A/T;GN=ABCB1;CSQ=C|Missense Variant|ABCB1|5243|transcript|ENST00000265724.3|||S893A/T|451|RS2032582|https://civicdb.org/links/variants/451|ABCB1 S893A/T|447|RS2032582|https://civicdb.org/links/molecular-profiles/447|NC_000007.13:g.87160618A>C|CA179699|166619&166622|15.0|evidence|1075|https://civicdb.org/links/evidence/1075|22906996 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||
7	87160618	262	A	T	.	.	VT=S893T;CSQ=T|Missense Variant|ABCB1|5243|transcript|ENST00000265724.3|ENST00000265724.3:c.2677T>A||S893T|262|A893S&SER893THR&RS2032582|https://civicdb.org/links/variants/262|ABCB1 S893T|258|A893S&SER893THR&RS2032582|https://civicdb.org/links/molecular-profiles/258|NM_000927.4:c.2677T>A&NP_000918.2:p.Ser893Thr&NC_000007.13:g.87160618A>T&ENST00000265724.3:c.2677T>A|CA179696|166619|15.0|evidence|674|https://civicdb.org/links/evidence/674|16467099 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Paclitaxel (NCIt ID C1411)|||B|3|||||;GN=ABCB1
7	116412025	2774	C	G	.	.	VT=R1004G;GN=MET;CSQ=G|Missense Variant|MET|4233|transcript|ENST00000397752.8|ENST00000397752.8:c.3010C>G||R1004G|2774|ARG1004GLY|https://civicdb.org/links/variants/2774|MET R1004G|2643|ARG1004GLY|https://civicdb.org/links/molecular-profiles/2643|NC_000007.14:g.116771971C>G&NC_000007.13:g.116412025C>G&ENST00000397752.8:c.3010C>G&ENSP00000380860.3:p.Arg1004Gly&NM_000245.4:c.3010C>G&NP_000236.2:p.Arg1004Gly|CA368987455|NONE FOUND|7.5|evidence|7498|https://civicdb.org/links/evidence/7498|31391294 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Cancer|Crizotinib (NCIt ID C74061)|||C|3|||||
7	116412043	4386	G	A	.	.	CSQ=A|Splice Donor Variant|MET|4233|transcript|None|||Splice Site (c.3028G>A)|4386|EXON 14 SPLICE DONOR VARIANT|https://civicdb.org/links/variants/4386|MET Amplification AND MET Splice Site (c.3028G>A)|4366||https://civicdb.org/links/molecular-profiles/4366|NC_000007.14:g.116771989G>A&NC_000007.13:g.116412043G>A&ENST00000397752.8:c.3028G>A&NM_000245.4:c.3028G>A|CA368987525|983225|7.5|evidence|1095|https://civicdb.org/links/evidence/1095|26729443 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|3|||||;VT=Splice Site (c.3028G>A);GN=MET
7	116423407	649	G	A	.	.	VT=D1228N;CSQ=A|Missense Variant|MET|4233|transcript|ENST00000397752.3|||D1228N|649|D1246N&ASP1246ASN&ASP1228ASN|https://civicdb.org/links/variants/649|MET D1228N|645|D1246N&ASP1246ASN&ASP1228ASN|https://civicdb.org/links/molecular-profiles/645|NC_000007.13:g.116423407G>A&NC_000007.14:g.116783353G>A&ENST00000397752.8:c.3682G>A&ENSP00000380860.3:p.Asp1228Asn&ENST00000397752.7:c.3682G>A&ENSP00000380860.3:p.Asp1228Asn&NM_000245.4:c.3682G>A&NP_000236.2:p.Asp1228Asn&NM_000245.3:c.3682G>A&NP_000236.2:p.Asp1228Asn|CA257000|13884|5.0|evidence|1652|https://civicdb.org/links/evidence/1652|27343442 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Crizotinib (NCIt ID C74061)|||C|2|||||;GN=MET
7	116423408	798	A	T	.	.	VT=D1228V;GN=MET;CSQ=T|Missense Variant|MET|4233|transcript|ENST00000397752.3|||D1228V|798|ASP1228VAL&D1246V&ASP1246VAL|https://civicdb.org/links/variants/798|MET D1228V|776|ASP1228VAL&D1246V&ASP1246VAL|https://civicdb.org/links/molecular-profiles/776|ENST00000318493.11:c.3737A>T&ENSP00000317272.6:p.Asp1246Val&NM_001127500.3:c.3737A>T&NP_001120972.1:p.Asp1246Val|CA368991571|NONE FOUND|20.0|evidence|1864|https://civicdb.org/links/evidence/1864|27694386 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Cabozantinib (NCIt ID C52200)|||C|4|||||,T|Missense Variant|MET|4233|transcript|ENST00000397752.3|||D1228V|798|ASP1228VAL&D1246V&ASP1246VAL|https://civicdb.org/links/variants/798|MET D1228V|776|ASP1228VAL&D1246V&ASP1246VAL|https://civicdb.org/links/molecular-profiles/776|ENST00000318493.11:c.3737A>T&ENSP00000317272.6:p.Asp1246Val&NM_001127500.3:c.3737A>T&NP_001120972.1:p.Asp1246Val|CA368991571|NONE FOUND|20.0|evidence|1865|https://civicdb.org/links/evidence/1865|27694386 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Savolitinib (NCIt ID C104732)|||C|4|||||
7	128846398	1570	C	T	.	.	GN=SMO;CSQ=T|Missense Variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1234C>T||L412F|1570||https://civicdb.org/links/variants/1570|SMO L412F|1478||https://civicdb.org/links/molecular-profiles/1478|NM_005631.4:c.1234C>T&NP_005622.1:p.Leu412Phe&NC_000007.13:g.128846398C>T&ENST00000249373.3:c.1234C>T|CA10584652|245609|0.0|evidence|4654|https://civicdb.org/links/evidence/4654|26822128 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Basal Cell Carcinoma|Vismodegib (NCIt ID C74038)|||C|None|||||,T|Missense Variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1234C>T||L412F|1570||https://civicdb.org/links/variants/1570|SMO L412F|1478||https://civicdb.org/links/molecular-profiles/1478|NM_005631.4:c.1234C>T&NP_005622.1:p.Leu412Phe&NC_000007.13:g.128846398C>T&ENST00000249373.3:c.1234C>T|CA10584652|245609|0.0|evidence|4653|https://civicdb.org/links/evidence/4653|25759020 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Basal Cell Carcinoma|Vismodegib (NCIt ID C74038)|||D|None|||||;VT=L412F
7	128849189	299	G	C	.	.	CSQ=C|Missense Variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1417G>A||D473H|299|ASP473HIS|https://civicdb.org/links/variants/299|SMO D473H|295|ASP473HIS|https://civicdb.org/links/molecular-profiles/295|NM_005631.4:c.1417G>A&NP_005622.1:p.Asp473His&ENST00000249373.3:c.1417G>A&NC_000007.13:g.128849189G>C|CA16602418|375938|13.5|evidence|745|https://civicdb.org/links/evidence/745|19726788 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Medulloblastoma|Vismodegib (NCIt ID C74038)|||C|3|||||,C|Missense Variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1417G>A||D473H|299|ASP473HIS|https://civicdb.org/links/variants/299|SMO D473H|295|ASP473HIS|https://civicdb.org/links/molecular-profiles/295|NM_005631.4:c.1417G>A&NP_005622.1:p.Asp473His&ENST00000249373.3:c.1417G>A&NC_000007.13:g.128849189G>C|CA16602418|375938|13.5|evidence|755|https://civicdb.org/links/evidence/755|25759020 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Basal Cell Carcinoma|Vismodegib (NCIt ID C74038)|||D|3|||||,C|Missense Variant|SMO|6608|transcript|ENST00000249373.3|ENST00000249373.3:c.1417G>A||D473H|299|ASP473HIS|https://civicdb.org/links/variants/299|SMO D473H|295|ASP473HIS|https://civicdb.org/links/molecular-profiles/295|NM_005631.4:c.1417G>A&NP_005622.1:p.Asp473His&ENST00000249373.3:c.1417G>A&NC_000007.13:g.128849189G>C|CA16602418|375938|13.5|evidence|1099|https://civicdb.org/links/evidence/1099|22550175 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Medulloblastoma|Patidegib (NCIt ID C80063)|||D|3|||||;GN=SMO;VT=D473H
7	140434507	2224	G	T	.	.	GN=BRAF;CSQ=T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.2193G>T||P731T|2224|PRO731THR|https://civicdb.org/links/variants/2224|BRAF P731T|2100|PRO731THR|https://civicdb.org/links/molecular-profiles/2100|ENST00000288602.6:c.2193G>T|CA369537254|NONE FOUND|5.0|evidence|5972|https://civicdb.org/links/evidence/5972|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||;VT=P731T
7	140434515	1198	G	A	.	.	GN=BRAF;VT=A728V;CSQ=A|Missense Variant|BRAF|673|transcript|None|||A728V|1198|A336V|https://civicdb.org/links/variants/1198|BRAF A728V|1172|A336V|https://civicdb.org/links/molecular-profiles/1172||CA369537269||2.0|evidence|7614|https://civicdb.org/links/evidence/7614|15035987 (PUBMED)|UNKNOWN|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|2|||||
7	140453118	2223	C	T	.	.	GN=BRAF;VT=G606E;CSQ=T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|||G606E|2223|GLY606GLU|https://civicdb.org/links/variants/2223|BRAF G606E|2099|GLY606GLU|https://civicdb.org/links/molecular-profiles/2099||CA369542941|NONE FOUND|5.0|evidence|5970|https://civicdb.org/links/evidence/5970|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||
7	140453134	584	T	C	.	.	GN=BRAF;VT=K601E;CSQ=C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1801A>G||K601E|584|LYS601GLU&RS121913364|https://civicdb.org/links/variants/584|BRAF V600E OR BRAF K601E|4707||https://civicdb.org/links/molecular-profiles/4707|NM_004333.4:c.1801A>G&NP_004324.2:p.Lys601Glu&NC_000007.13:g.140453134T>C&ENST00000288602.6:c.1801A>G|CA123645|13966|15.0|evidence|11670|https://civicdb.org/links/evidence/11670|36409971 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cobimetinib (NCIt ID C68923)&Vemurafenib (NCIt ID C64768)|COMBINATION||B|3|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1801A>G||K601E|584|LYS601GLU&RS121913364|https://civicdb.org/links/variants/584|BRAF K601E|580|LYS601GLU&RS121913364|https://civicdb.org/links/molecular-profiles/580|NM_004333.4:c.1801A>G&NP_004324.2:p.Lys601Glu&NC_000007.13:g.140453134T>C&ENST00000288602.6:c.1801A>G|CA123645|13966|3.0|evidence|1462|https://civicdb.org/links/evidence/1462|22798288 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Trametinib (NCIt ID C77908)&Vemurafenib (NCIt ID C64768)|SUBSTITUTES||D|3|||||
7	140453135	11	CA	AT	.	.	GN=BRAF;CSQ=AT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/variants/11|BRAF V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/molecular-profiles/11|NM_004333.4:c.1799_1800delTGinsAT&NP_004324.2:p.Val600Asp&ENST00000288602.6:c.1799_1800delTGinsAT&NC_000007.13:g.140453135_140453136delinsAT|CA16602419|375939|47.0|evidence|94|https://civicdb.org/links/evidence/94|23463675 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)|||B|5|||||,AT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/variants/11|BRAF V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/molecular-profiles/11|NM_004333.4:c.1799_1800delTGinsAT&NP_004324.2:p.Val600Asp&ENST00000288602.6:c.1799_1800delTGinsAT&NC_000007.13:g.140453135_140453136delinsAT|CA16602419|375939|47.0|evidence|7616|https://civicdb.org/links/evidence/7616|31580757 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|BRAF Inhibitor (NCIt ID C155322)|||C|3|||||,AT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/variants/11|BRAF V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/molecular-profiles/11|NM_004333.4:c.1799_1800delTGinsAT&NP_004324.2:p.Val600Asp&ENST00000288602.6:c.1799_1800delTGinsAT&NC_000007.13:g.140453135_140453136delinsAT|CA16602419|375939|47.0|evidence|7629|https://civicdb.org/links/evidence/7629|31580757 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|BRAF Inhibitor (NCIt ID C155322)&Mitogen-Activated Protein Kinase Kinase Inhibitor (NCIt ID C69145)|COMBINATION||C|3|||||,AT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/variants/11|BRAF V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/molecular-profiles/11|NM_004333.4:c.1799_1800delTGinsAT&NP_004324.2:p.Val600Asp&ENST00000288602.6:c.1799_1800delTGinsAT&NC_000007.13:g.140453135_140453136delinsAT|CA16602419|375939|47.0|evidence|4489|https://civicdb.org/links/evidence/4489|20551065 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|4|||||,AT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799_1800delTGinsAT||V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/variants/11|BRAF V600D|11|RS121913377&VAL600ASP|https://civicdb.org/links/molecular-profiles/11|NM_004333.4:c.1799_1800delTGinsAT&NP_004324.2:p.Val600Asp&ENST00000288602.6:c.1799_1800delTGinsAT&NC_000007.13:g.140453135_140453136delinsAT|CA16602419|375939|47.0|evidence|4488|https://civicdb.org/links/evidence/4488|18287029 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|3|||||;VT=V600D
7	140453136	12	A	T	.	.	GN=BRAF;VT=V600E;CSQ=T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1409|https://civicdb.org/links/evidence/1409|21639808 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Vemurafenib (NCIt ID C64768)|||A|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|9851|https://civicdb.org/links/evidence/9851|31566309 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Encorafenib (NCIt ID C98283)|COMBINATION||A|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3017|https://civicdb.org/links/evidence/3017|27283860 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||A|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|12161|https://civicdb.org/links/evidence/12161|37059834 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Solid Tumor|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||A|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|12162|https://civicdb.org/links/evidence/12162|36375115 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||A|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|80|https://civicdb.org/links/evidence/80|24570209 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Papillary Thyroid Carcinoma||||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|95|https://civicdb.org/links/evidence/95|24583796 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|102|https://civicdb.org/links/evidence/102|24354346 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|DOES_NOT_SUPPORT|Papillary Thyroid Carcinoma||||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|103|https://civicdb.org/links/evidence/103|24594804 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|656|https://civicdb.org/links/evidence/656|25024077 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1398|https://civicdb.org/links/evidence/1398|24508103 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|6178|https://civicdb.org/links/evidence/6178|28891408 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|6938|https://civicdb.org/links/evidence/6938|25265492 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|7612|https://civicdb.org/links/evidence/7612|31566309 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Binimetinib (NCIt ID C84865)&Cetuximab (NCIt ID C1723)&Encorafenib (NCIt ID C98283)|COMBINATION||B|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|816|https://civicdb.org/links/evidence/816|25989278 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1127|https://civicdb.org/links/evidence/1127|21663470 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Hairy Cell Leukemia||||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1405|https://civicdb.org/links/evidence/1405|26460303 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Colorectal Cancer|Vemurafenib (NCIt ID C64768)|||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1421|https://civicdb.org/links/evidence/1421|25265494 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Cobimetinib (NCIt ID C68923)&Vemurafenib (NCIt ID C64768)|COMBINATION||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1749|https://civicdb.org/links/evidence/1749|20818844 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1902|https://civicdb.org/links/evidence/1902|27729313 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)&Vemurafenib (NCIt ID C64768)|COMBINATION||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1940|https://civicdb.org/links/evidence/1940|27302369 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2135|https://civicdb.org/links/evidence/2135|22663011 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Trametinib (NCIt ID C77908)|||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2137|https://civicdb.org/links/evidence/2137|18682506 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3739|https://civicdb.org/links/evidence/3739|25666295 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&FOLFOX-4 Regimen (NCIt ID C63590)|COMBINATION||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3750|https://civicdb.org/links/evidence/3750|23569304 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3758|https://civicdb.org/links/evidence/3758|25399551 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5958|https://civicdb.org/links/evidence/5958|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Vemurafenib (NCIt ID C64768)|||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|6123|https://civicdb.org/links/evidence/6123|29431699 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dabrafenib (NCIt ID C82386)&Panitumumab (NCIt ID C1857)&Trametinib (NCIt ID C77908)|COMBINATION||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|6940|https://civicdb.org/links/evidence/6940|23020132 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|6975|https://civicdb.org/links/evidence/6975|29072975 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Anaplastic Thyroid Carcinoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|7156|https://civicdb.org/links/evidence/7156|20008640 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|7157|https://civicdb.org/links/evidence/7157|21502544 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|7191|https://civicdb.org/links/evidence/7191|29948154 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Childhood Low-grade Glioma||||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|7583|https://civicdb.org/links/evidence/7583|31513482 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Langerhans Cell Sarcoma|Vemurafenib (NCIt ID C64768)|||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|9018|https://civicdb.org/links/evidence/9018|27460442 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Papillary Thyroid Carcinoma|Vemurafenib (NCIt ID C64768)|||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|9170|https://civicdb.org/links/evidence/9170|16174717 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|79|https://civicdb.org/links/evidence/79|21594703 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Thyroid Cancer||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|104|https://civicdb.org/links/evidence/104|24388723 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Melanoma||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|105|https://civicdb.org/links/evidence/105|21594703 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|106|https://civicdb.org/links/evidence/106|24396464 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|107|https://civicdb.org/links/evidence/107|21594703 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|126|https://civicdb.org/links/evidence/126|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|463|https://civicdb.org/links/evidence/463|23612012 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Multiple Myeloma||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1406|https://civicdb.org/links/evidence/1406|22608338 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Colorectal Cancer|Dabrafenib (NCIt ID C82386)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1410|https://civicdb.org/links/evidence/1410|22356324 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1413|https://civicdb.org/links/evidence/1413|25589621 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Colorectal Cancer|Panitumumab (NCIt ID C1857)&Vemurafenib (NCIt ID C64768)|COMBINATION||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1552|https://civicdb.org/links/evidence/1552|27404270 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1591|https://civicdb.org/links/evidence/1591|27460442 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Papillary Thyroid Carcinoma|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2115|https://civicdb.org/links/evidence/2115|19001320 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2116|https://civicdb.org/links/evidence/2116|19603024 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2117|https://civicdb.org/links/evidence/2117|19603024 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Oxaliplatin (NCIt ID C1181)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2118|https://civicdb.org/links/evidence/2118|19603024 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Irinotecan (NCIt ID C62040)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2121|https://civicdb.org/links/evidence/2121|19571295 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Bevacizumab (NCIt ID C2039)&Capecitabine (NCIt ID C1794)&Oxaliplatin (NCIt ID C1181)|COMBINATION||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2503|https://civicdb.org/links/evidence/2503|21882184 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Papillary Thyroid Carcinoma||||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3755|https://civicdb.org/links/evidence/3755|26557775 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3757|https://civicdb.org/links/evidence/3757|25524477 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5959|https://civicdb.org/links/evidence/5959|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|6045|https://civicdb.org/links/evidence/6045|26287849 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Anaplastic Thyroid Carcinoma|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|6124|https://civicdb.org/links/evidence/6124|29431699 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Colorectal Adenocarcinoma|Panitumumab (NCIt ID C1857)&Trametinib (NCIt ID C77908)|COMBINATION||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|7260|https://civicdb.org/links/evidence/7260|168986 (ASCO)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Binimetinib (NCIt ID C84865)&Cetuximab (NCIt ID C1723)&Encorafenib (NCIt ID C98283)|COMBINATION||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|7264|https://civicdb.org/links/evidence/7264|169315 (ASCO)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Biliary Tract Cancer|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|11672|https://civicdb.org/links/evidence/11672|32758030 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|11770|https://civicdb.org/links/evidence/11770|32523649 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|82|https://civicdb.org/links/evidence/82|24586605 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|DOES_NOT_SUPPORT|Melanoma||||B|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|994|https://civicdb.org/links/evidence/994|24947927 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Melanoma|MEK Inhibitor RO4987655 (NCIt ID C82696)|||B|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1579|https://civicdb.org/links/evidence/1579|26352686 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Hairy Cell Leukemia|Vemurafenib (NCIt ID C64768)|||B|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1414|https://civicdb.org/links/evidence/1414|24987354 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Papillary Thyroid Carcinoma|Vemurafenib (NCIt ID C64768)|||C|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1430|https://civicdb.org/links/evidence/1430|27048246 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Gastrointestinal Neuroendocrine Tumor|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1698|https://civicdb.org/links/evidence/1698|24997557 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Multiple Myeloma|Vemurafenib (NCIt ID C64768)|||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3777|https://civicdb.org/links/evidence/3777|25524464 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Childhood Pilocytic Astrocytoma|Vemurafenib (NCIt ID C64768)|||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3787|https://civicdb.org/links/evidence/3787|26490654 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Serous Carcinoma|Vemurafenib (NCIt ID C64768)|||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|3827|https://civicdb.org/links/evidence/3827|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5902|https://civicdb.org/links/evidence/5902|28480077 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cholangiocarcinoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5903|https://civicdb.org/links/evidence/5903|28078132 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Intrahepatic Cholangiocarcinoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5904|https://civicdb.org/links/evidence/5904|25435907 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Intrahepatic Cholangiocarcinoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5906|https://civicdb.org/links/evidence/5906|26687137 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cholangiocarcinoma|Irinotecan (NCIt ID C62040)&Panitumumab (NCIt ID C1857)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5961|https://civicdb.org/links/evidence/5961|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Anaplastic Thyroid Carcinoma|Pertuzumab (NCIt ID C38692)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5962|https://civicdb.org/links/evidence/5962|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Laryngeal Squamous Cell Carcinoma|Vemurafenib (NCIt ID C64768)|||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|757|https://civicdb.org/links/evidence/757|25370471 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Pictilisib (NCIt ID C165479)|||C|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1589|https://civicdb.org/links/evidence/1589|27325282 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1699|https://civicdb.org/links/evidence/1699|24997557 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Multiple Myeloma|Vemurafenib (NCIt ID C64768)|||C|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|2362|https://civicdb.org/links/evidence/2362|19903786 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|DOES_NOT_SUPPORT|Colorectal Cancer||||C|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|5960|https://civicdb.org/links/evidence/5960|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|86|https://civicdb.org/links/evidence/86|24576830 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Melanoma|Mirdametinib (NCIt ID C52195)&Trametinib (NCIt ID C77908)|SUBSTITUTES||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|89|https://civicdb.org/links/evidence/89|19001320 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)&Sorafenib (NCIt ID C61948)|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|96|https://civicdb.org/links/evidence/96|23845441 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|PLX4720&Pictilisib Bismesylate (NCIt ID C82380)|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|97|https://civicdb.org/links/evidence/97|23812671 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Nutlin-3&PLX4720|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|98|https://civicdb.org/links/evidence/98|22180495 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Bevacizumab (NCIt ID C2039)&Capecitabine (NCIt ID C1794)&Vemurafenib (NCIt ID C64768)|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1141|https://civicdb.org/links/evidence/1141|23934108 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Cobimetinib (NCIt ID C68923)|||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1408|https://civicdb.org/links/evidence/1408|22281684 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Gefitinib (NCIt ID C1855)&Vemurafenib (NCIt ID C64768)|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1428|https://civicdb.org/links/evidence/1428|23549875 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&GDC-0879|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|8506|https://civicdb.org/links/evidence/8506|22180495 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)&Vemurafenib (NCIt ID C64768)|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|8507|https://civicdb.org/links/evidence/8507|22180495 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Erlotinib (NCIt ID C65530)&Vemurafenib (NCIt ID C64768)|COMBINATION||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|99|https://civicdb.org/links/evidence/99|22180495 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Vemurafenib (NCIt ID C64768)|||D|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|evidence|1005|https://civicdb.org/links/evidence/1005|26678033 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|assertion|20|https://civicdb.org/links/assertion/20||SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer (DOID 9256)|||||||TIER_I_LEVEL_A|{'name': 'Colon Cancer'} (v2.2017)||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|assertion|7|https://civicdb.org/links/assertion/7||SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma (DOID 1909)|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION|||||TIER_I_LEVEL_A|{'name': 'Melanoma'} (v2.2018)|True|True,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/molecular-profiles/12|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1433.5|assertion|10|https://civicdb.org/links/assertion/10||SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma (DOID 1909)|Cobimetinib (NCIt ID C68923)&Vemurafenib (NCIt ID C64768)|COMBINATION|||||TIER_I_LEVEL_A|{'name': 'Melanoma'} (v2.2018)|True|True,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E OR BRAF K601E|4707||https://civicdb.org/links/molecular-profiles/4707|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|15.0|evidence|11670|https://civicdb.org/links/evidence/11670|36409971 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cobimetinib (NCIt ID C68923)&Vemurafenib (NCIt ID C64768)|COMBINATION||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF Amplification AND ( BRAF V600E OR BRAF V600K )|4174||https://civicdb.org/links/molecular-profiles/4174|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|10.0|evidence|6262|https://civicdb.org/links/evidence/6262|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Vemurafenib (NCIt ID C64768)|SUBSTITUTES||B|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E AND BRAF V600M|4170||https://civicdb.org/links/molecular-profiles/4170|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|2.5|evidence|73|https://civicdb.org/links/evidence/73|23031422 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)|||C|1|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E AND BRAF Amplification|4173||https://civicdb.org/links/molecular-profiles/4173|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|1.0|evidence|92|https://civicdb.org/links/evidence/92|21098728 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Selumetinib (NCIt ID C66939)|||E|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E AND EZH2 Y646F|4241||https://civicdb.org/links/molecular-profiles/4241|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|0.0|evidence|6952|https://civicdb.org/links/evidence/6952|27135738 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|JQEZ5|||D|4|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E OR KIAA1549::BRAF Fusion|4453||https://civicdb.org/links/molecular-profiles/4453|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|0.0|evidence|12016|https://civicdb.org/links/evidence/12016|37978284 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Childhood Low-grade Glioma|Tovorafenib (NCIt ID C106254)|||A|5|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E OR NRAS Mutation OR HRAS Mutation OR KRAS Mutation OR NF1 Mutation|4715||https://civicdb.org/links/molecular-profiles/4715|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|0.0|evidence|11681|https://civicdb.org/links/evidence/11681|35363510 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Selumetinib (NCIt ID C66939)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E OR NRAS Mutation OR HRAS Mutation OR KRAS Mutation OR NF1 Inactivating Mutation|4748||https://civicdb.org/links/molecular-profiles/4748|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|0.0|evidence|11696|https://civicdb.org/links/evidence/11696|35363510 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Selumetinib (NCIt ID C66939)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E AND NF1 Loss|5379||https://civicdb.org/links/molecular-profiles/5379|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|0.0|evidence|90|https://civicdb.org/links/evidence/90|24576830 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E AND GNAS R201C|5491||https://civicdb.org/links/molecular-profiles/5491|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|0.0|evidence|1906|https://civicdb.org/links/evidence/1906|27729313 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1799T>A||V600E|12|RS113488022&VAL600GLU&V640E&VAL640GLU|https://civicdb.org/links/variants/12|BRAF V600E AND ARAF S490T|5492||https://civicdb.org/links/molecular-profiles/5492|NM_004333.4:c.1799T>A&NP_004324.2:p.Val600Glu&NC_000007.13:g.140453136A>T&ENST00000288602.6:c.1799T>A|CA123643|13961&376069|0.0|evidence|1905|https://civicdb.org/links/evidence/1905|27729313 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|1|||||
7	140453136	563	AC	TT	.	.	GN=BRAF;CSQ=TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|2505|https://civicdb.org/links/evidence/2505|21343559 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)|||B|None|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|1399|https://civicdb.org/links/evidence/1399|24508103 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|4|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|6179|https://civicdb.org/links/evidence/6179|28891408 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|4|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|6965|https://civicdb.org/links/evidence/6965|25265494 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|4|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|4180|https://civicdb.org/links/evidence/4180|25524477 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|3|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|4181|https://civicdb.org/links/evidence/4181|25399551 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|3|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|6939|https://civicdb.org/links/evidence/6939|25265492 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||B|3|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|2506|https://civicdb.org/links/evidence/2506|22663011 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Trametinib (NCIt ID C77908)|||B|2|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|evidence|1400|https://civicdb.org/links/evidence/1400|26989536 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||C|3|||||,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|assertion|11|https://civicdb.org/links/assertion/11||SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma (DOID 1909)|Cobimetinib (NCIt ID C68923)&Vemurafenib (NCIt ID C64768)|COMBINATION|||||TIER_I_LEVEL_A|{'name': 'Melanoma'} (v2.2018)|True|True,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF V600K|559|VAL600LYS&RS121913227|https://civicdb.org/links/molecular-profiles/559|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|122.5|assertion|13|https://civicdb.org/links/assertion/13||SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma (DOID 1909)|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION|||||TIER_I_LEVEL_A|{'name': 'Melanoma'} (v2.2018)|True|True,TT|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1798_1799delinsAA||V600K|563|VAL600LYS&RS121913227|https://civicdb.org/links/variants/563|BRAF Amplification AND ( BRAF V600E OR BRAF V600K )|4174||https://civicdb.org/links/molecular-profiles/4174|ENST00000288602.6:c.1798_1799delinsAA&NC_000007.13:g.140453136_140453137delinsTT&NM_004333.4:c.1798_1799delGTinsAA&NP_004324.2:p.Val600Lys|CA16602420|375941|10.0|evidence|6262|https://civicdb.org/links/evidence/6262|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)&Vemurafenib (NCIt ID C64768)|SUBSTITUTES||B|2|||||;VT=V600K
7	140453137	1405	C	T	.	.	GN=BRAF;CSQ=T|Missense Variant|BRAF|673|transcript|None|||V600M|1405|RS121913378|https://civicdb.org/links/variants/1405|BRAF V600E AND BRAF V600M|4170||https://civicdb.org/links/molecular-profiles/4170||CA135101||2.5|evidence|73|https://civicdb.org/links/evidence/73|23031422 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)|||C|1|||||;VT=V600M
7	140453142	2826	G	A	.	.	GN=BRAF;CSQ=A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|||A598V|2826|ALA598VAL|https://civicdb.org/links/variants/2826|BRAF A598V|2695|ALA598VAL|https://civicdb.org/links/molecular-profiles/2695||CA369543099|NONE FOUND|7.5|evidence|7635|https://civicdb.org/links/evidence/7635|31580757 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Melanoma|BRAF Inhibitor (NCIt ID C155322)&Mitogen-Activated Protein Kinase Kinase Inhibitor (NCIt ID C69145)|COMBINATION||C|3|||||;VT=A598V
7	140453145	583	A	T	.	.	GN=BRAF;CSQ=T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>A||L597Q|583|LEU597GLN&RS121913366|https://civicdb.org/links/variants/583|BRAF L597Q|579|LEU597GLN&RS121913366|https://civicdb.org/links/molecular-profiles/579|NM_004333.4:c.1790T>A&NP_004324.2:p.Leu597Gln&NC_000007.13:g.140453145A>T&ENST00000288602.6:c.1790T>A|CA16602257|76687|14.5|evidence|4905|https://civicdb.org/links/evidence/4905|24933606 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Trametinib (NCIt ID C77908)|||C|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>A||L597Q|583|LEU597GLN&RS121913366|https://civicdb.org/links/variants/583|BRAF L597Q|579|LEU597GLN&RS121913366|https://civicdb.org/links/molecular-profiles/579|NM_004333.4:c.1790T>A&NP_004324.2:p.Leu597Gln&NC_000007.13:g.140453145A>T&ENST00000288602.6:c.1790T>A|CA16602257|76687|14.5|evidence|5971|https://civicdb.org/links/evidence/5971|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>A||L597Q|583|LEU597GLN&RS121913366|https://civicdb.org/links/variants/583|BRAF L597Q|579|LEU597GLN&RS121913366|https://civicdb.org/links/molecular-profiles/579|NM_004333.4:c.1790T>A&NP_004324.2:p.Leu597Gln&NC_000007.13:g.140453145A>T&ENST00000288602.6:c.1790T>A|CA16602257|76687|14.5|evidence|1461|https://civicdb.org/links/evidence/1461|22798288 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Trametinib (NCIt ID C77908)&Vemurafenib (NCIt ID C64768)|SUBSTITUTES||D|2|||||;VT=L597Q
7	140453145	288	A	C	.	.	GN=BRAF;CSQ=C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>G||L597R|288|LEU597ARG&RS121913366|https://civicdb.org/links/variants/288|BRAF L597R|284|LEU597ARG&RS121913366|https://civicdb.org/links/molecular-profiles/284|NC_000007.13:g.140453145A>C&NM_004333.4:c.1790T>G&NP_004324.2:p.Leu597Arg&ENST00000288602.6:c.1790T>G|CA123649|13968|12.0|evidence|728|https://civicdb.org/links/evidence/728|23715574 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||C|4|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1790T>G||L597R|288|LEU597ARG&RS121913366|https://civicdb.org/links/variants/288|BRAF L597R|284|LEU597ARG&RS121913366|https://civicdb.org/links/molecular-profiles/284|NC_000007.13:g.140453145A>C&NM_004333.4:c.1790T>G&NP_004324.2:p.Leu597Arg&ENST00000288602.6:c.1790T>G|CA123649|13968|12.0|evidence|1458|https://civicdb.org/links/evidence/1458|22798288 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Trametinib (NCIt ID C77908)&Vemurafenib (NCIt ID C64768)|SUBSTITUTES||D|2|||||;VT=L597R
7	140453145	582	AG	GA	.	.	GN=BRAF;CSQ=GA|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1789_1790delCTinsTC||L597S|582|LEU597SER|https://civicdb.org/links/variants/582|BRAF L597S|578|LEU597SER|https://civicdb.org/links/molecular-profiles/578|NC_000007.13:g.140453145_140453146delinsGA&NM_004333.4:c.1789_1790delCTinsTC&NP_004324.2:p.Leu597Ser&ENST00000288602.6:c.1789_1790delCTinsTC|CA16602421|375942|9.5|evidence|1460|https://civicdb.org/links/evidence/1460|22798288 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|MEK Inhibitor REC-4881 (NCIt ID C84858)|||C|3|||||,GA|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1789_1790delCTinsTC||L597S|582|LEU597SER|https://civicdb.org/links/variants/582|BRAF L597S|578|LEU597SER|https://civicdb.org/links/molecular-profiles/578|NC_000007.13:g.140453145_140453146delinsGA&NM_004333.4:c.1789_1790delCTinsTC&NP_004324.2:p.Leu597Ser&ENST00000288602.6:c.1789_1790delCTinsTC|CA16602421|375942|9.5|evidence|1459|https://civicdb.org/links/evidence/1459|22798288 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Trametinib (NCIt ID C77908)&Vemurafenib (NCIt ID C64768)|SUBSTITUTES||D|2|||||;VT=L597S
7	140453146	585	G	C	.	.	GN=BRAF;CSQ=C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1789C>G||L597V|585|LEU597VAL&RS121913369|https://civicdb.org/links/variants/585|BRAF L597V|581|LEU597VAL&RS121913369|https://civicdb.org/links/molecular-profiles/581|NM_004333.4:c.1789C>G&NP_004324.2:p.Leu597Val&NC_000007.13:g.140453146G>C&ENST00000288602.6:c.1789C>G|CA123651|13969|7.5|evidence|1463|https://civicdb.org/links/evidence/1463|22805292 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Trametinib (NCIt ID C77908)|||C|3|||||;VT=L597V
7	140453149	694	C	A	.	.	GN=BRAF;VT=G596C;CSQ=A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1786G>T||G596C|694|GLY596CYS&RS121913361|https://civicdb.org/links/variants/694|BRAF G596C|675|GLY596CYS&RS121913361|https://civicdb.org/links/molecular-profiles/675|NM_004333.4:c.1786G>T&NP_004324.2:p.Gly596Cys&NC_000007.13:g.140453149C>A&ENST00000288602.6:c.1786G>T|CA135098|44814|2.0|evidence|1738|https://civicdb.org/links/evidence/1738|28947956 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dabrafenib (NCIt ID C82386)&Trametinib (NCIt ID C77908)|COMBINATION||D|2|||||
7	140453149	1627	C	G	.	.	GN=BRAF;VT=G596R;CSQ=G|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1786G>C||G596R|1627|RS121913361&G204R&G24R&GLY596ARG|https://civicdb.org/links/variants/1627|BRAF G596R|1535|RS121913361&G204R&G24R&GLY596ARG|https://civicdb.org/links/molecular-profiles/1535|NM_004333.4:c.1786G>C&NP_004324.2:p.Gly596Arg&NC_000007.13:g.140453149C>G&ENST00000288602.6:c.1786G>C|CA16602422|375943|6.0|evidence|5969|https://civicdb.org/links/evidence/5969|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||,G|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1786G>C||G596R|1627|RS121913361&G204R&G24R&GLY596ARG|https://civicdb.org/links/variants/1627|BRAF G596R|1535|RS121913361&G204R&G24R&GLY596ARG|https://civicdb.org/links/molecular-profiles/1535|NM_004333.4:c.1786G>C&NP_004324.2:p.Gly596Arg&NC_000007.13:g.140453149C>G&ENST00000288602.6:c.1786G>C|CA16602422|375943|6.0|evidence|4729|https://civicdb.org/links/evidence/4729|22180495 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Colorectal Cancer|Vemurafenib (NCIt ID C64768)|||D|1|||||
7	140453154	579	T	G	.	.	GN=BRAF;VT=D594A;CSQ=G|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>C||D594A|579|ASP594ALA&RS121913338|https://civicdb.org/links/variants/579|BRAF D594A|575|ASP594ALA&RS121913338|https://civicdb.org/links/molecular-profiles/575|ENST00000288602.6:c.1781A>C&NC_000007.13:g.140453154T>G&NM_004333.4:c.1781A>C&NP_004324.2:p.Asp594Ala|CA16602532|376070|0.75|evidence|1454|https://civicdb.org/links/evidence/1454|20141835 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Mitogen-Activated Protein Kinase Kinase Inhibitor (NCIt ID C69145)&Sorafenib (NCIt ID C61948)|SUBSTITUTES||E|3|||||
7	140453154	611	T	C	.	.	GN=BRAF;CSQ=C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|1553|https://civicdb.org/links/evidence/1553|27404270 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|2|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|1551|https://civicdb.org/links/evidence/1551|27404270 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|1|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|2201|https://civicdb.org/links/evidence/2201|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|4472|https://civicdb.org/links/evidence/4472|26989027 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|1554|https://civicdb.org/links/evidence/1554|27404270 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|1|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|6001|https://civicdb.org/links/evidence/6001|18794803 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Sorafenib (NCIt ID C61948)|||D|3|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|6002|https://civicdb.org/links/evidence/6002|18794803 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|U0126|||D|3|||||,C|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>G||D594G|611|ASP594GLY&RS121913338|https://civicdb.org/links/variants/611|BRAF D594G|607|ASP594GLY&RS121913338|https://civicdb.org/links/molecular-profiles/607|NM_004333.4:c.1781A>G&NP_004324.2:p.Asp594Gly&NC_000007.13:g.140453154T>C&ENST00000288602.6:c.1781A>G|CA123657|13972|43.5|evidence|7556|https://civicdb.org/links/evidence/7556|28783719 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||D|3|||||;VT=D594G
7	140453154	580	T	A	.	.	GN=BRAF;CSQ=A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1781A>T||D594V|580|ASP594VAL&RS121913338|https://civicdb.org/links/variants/580|BRAF D594V|576|ASP594VAL&RS121913338|https://civicdb.org/links/molecular-profiles/576|NM_004333.4:c.1781A>T&NP_004324.2:p.Asp594Val&NC_000007.13:g.140453154T>A&ENST00000288602.6:c.1781A>T|CA16602425|375946|0.75|evidence|1456|https://civicdb.org/links/evidence/1456|20141835 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Sorafenib (NCIt ID C61948)&Trametinib (NCIt ID C77908)|SUBSTITUTES||E|3|||||;VT=D594V
7	140453193	1186	T	C	.	.	GN=BRAF;CSQ=C|Missense Variant|BRAF|673|transcript|None|||N581S|1186|N189S&N9S&RS121913370|https://civicdb.org/links/variants/1186|BRAF N581S|1160|N189S&N9S&RS121913370|https://civicdb.org/links/molecular-profiles/1160||CA180747||5.0|evidence|5967|https://civicdb.org/links/evidence/5967|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||;VT=N581S
7	140477794	658	A	T	.	.	GN=BRAF;VT=L505H;CSQ=T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1514T>A||L505H|658|LEU505HIS|https://civicdb.org/links/variants/658|BRAF L505H|654|LEU505HIS|https://civicdb.org/links/molecular-profiles/654|ENST00000288602.6:c.1514T>A&NC_000007.13:g.140477794A>T&NM_004333.4:c.1514T>A&NP_004324.2:p.Leu505His|CA369588358|NONE FOUND|19.0|evidence|1669|https://civicdb.org/links/evidence/1669|25515853 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||B|3|||||,T|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1514T>A||L505H|658|LEU505HIS|https://civicdb.org/links/variants/658|BRAF L505H|654|LEU505HIS|https://civicdb.org/links/molecular-profiles/654|ENST00000288602.6:c.1514T>A&NC_000007.13:g.140477794A>T&NM_004333.4:c.1514T>A&NP_004324.2:p.Leu505His|CA369588358|NONE FOUND|19.0|evidence|1668|https://civicdb.org/links/evidence/1668|24112705 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|4|||||
7	140477837	522	TAGGTGCTGTCACATTCAA	T	.	.	GN=BRAF;CSQ=-|Inframe Deletion|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1453_1470del||DEL 485-490|522||https://civicdb.org/links/variants/522|BRAF DEL 485-490|518||https://civicdb.org/links/molecular-profiles/518|ENST00000288602.6:c.1453_1470del|unregistered|NONE FOUND|3.0|evidence|1267|https://civicdb.org/links/evidence/1267|26732095 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Pan-RAF Inhibitor LY3009120 (NCIt ID C116861)|||D|3|||||;VT=DEL 485-490
7	140477859	581	TT	CA	.	.	GN=BRAF;CSQ=CA|Missense Variant&Loss Of Function Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1448_1449delinsTG||K483M|581|LYS483MET|https://civicdb.org/links/variants/581|BRAF K483M|577|LYS483MET|https://civicdb.org/links/molecular-profiles/577|NC_000007.13:g.140477859_140477860delinsCA&ENST00000288602.6:c.1448_1449delinsTG|CA913112072|NONE FOUND|0.75|evidence|1457|https://civicdb.org/links/evidence/1457|20141835 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Mitogen-Activated Protein Kinase Kinase Inhibitor (NCIt ID C69145)&Sorafenib (NCIt ID C61948)|SUBSTITUTES||E|3|||||;VT=K483M
7	140481402	992	C	G	.	.	GN=BRAF;VT=G469A;CSQ=G|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1406G>C||G469A|992|RS121913355&GLY469ALA|https://civicdb.org/links/variants/992|BRAF G469A|966|RS121913355&GLY469ALA|https://civicdb.org/links/molecular-profiles/966|NM_004333.4:c.1406G>C&NP_004324.2:p.Gly469Ala&NC_000007.13:g.140481402C>G&ENST00000288602.6:c.1406G>C|CA123655|13971|5.0|evidence|5965|https://civicdb.org/links/evidence/5965|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||
7	140481402	993	C	T	.	.	GN=BRAF;VT=G469E;CSQ=T|Missense Variant|BRAF|673|transcript|None|||G469E|993|RS121913355|https://civicdb.org/links/variants/993|BRAF G469E|967|RS121913355|https://civicdb.org/links/molecular-profiles/967||CA279970||6.0|evidence|6003|https://civicdb.org/links/evidence/6003|18794803 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Sorafenib (NCIt ID C61948)|||D|3|||||,T|Missense Variant|BRAF|673|transcript|None|||G469E|993|RS121913355|https://civicdb.org/links/variants/993|BRAF G469E|967|RS121913355|https://civicdb.org/links/molecular-profiles/967||CA279970||6.0|evidence|6004|https://civicdb.org/links/evidence/6004|18794803 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|U0126|||D|3|||||
7	140481411	2222	C	A	.	.	GN=BRAF;CSQ=A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|GLY466VAL&RS121913351|https://civicdb.org/links/variants/2222|BRAF G466V|2098|GLY466VAL&RS121913351|https://civicdb.org/links/molecular-profiles/2098|NC_000007.13:g.140481411C>A&NM_004333.4:c.1397G>T&NP_004324.2:p.Gly466Val&ENST00000288602.6:c.1397G>T|CA123647|13967|14.0|evidence|5968|https://civicdb.org/links/evidence/5968|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||,A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|GLY466VAL&RS121913351|https://civicdb.org/links/variants/2222|BRAF G466V|2098|GLY466VAL&RS121913351|https://civicdb.org/links/molecular-profiles/2098|NC_000007.13:g.140481411C>A&NM_004333.4:c.1397G>T&NP_004324.2:p.Gly466Val&ENST00000288602.6:c.1397G>T|CA123647|13967|14.0|evidence|7552|https://civicdb.org/links/evidence/7552|28783719 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Irinotecan (NCIt ID C62040)&Panitumumab (NCIt ID C1857)|COMBINATION||D|3|||||,A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|GLY466VAL&RS121913351|https://civicdb.org/links/variants/2222|BRAF G466V|2098|GLY466VAL&RS121913351|https://civicdb.org/links/molecular-profiles/2098|NC_000007.13:g.140481411C>A&NM_004333.4:c.1397G>T&NP_004324.2:p.Gly466Val&ENST00000288602.6:c.1397G>T|CA123647|13967|14.0|evidence|7553|https://civicdb.org/links/evidence/7553|28783719 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Colorectal Cancer|Vemurafenib (NCIt ID C64768)|||D|3|||||,A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1397G>T||G466V|2222|GLY466VAL&RS121913351|https://civicdb.org/links/variants/2222|BRAF G466V|2098|GLY466VAL&RS121913351|https://civicdb.org/links/molecular-profiles/2098|NC_000007.13:g.140481411C>A&NM_004333.4:c.1397G>T&NP_004324.2:p.Gly466Val&ENST00000288602.6:c.1397G>T|CA123647|13967|14.0|evidence|7554|https://civicdb.org/links/evidence/7554|28783719 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Solid Tumor|Vemurafenib (NCIt ID C64768)|||D|3|||||;VT=G466V
7	140481417	1106	C	A	.	.	GN=BRAF;CSQ=A|Missense Variant|BRAF|673|transcript|ENST00000288602.6|ENST00000288602.6:c.1391G>T||G464V|1106|RS121913348&GLY464VAL|https://civicdb.org/links/variants/1106|BRAF G464V|1080|RS121913348&GLY464VAL|https://civicdb.org/links/molecular-profiles/1080|NM_004333.4:c.1391G>T&NP_004324.2:p.Gly464Val&NC_000007.13:g.140481417C>A&ENST00000288602.6:c.1391G>T|CA135076|40364|5.0|evidence|5964|https://civicdb.org/links/evidence/5964|29320312 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Cancer|Vemurafenib (NCIt ID C64768)|||C|2|||||;VT=G464V
7	148506437	4414	G	A	.	.	VT=A692V;CSQ=A|Missense Variant|EZH2|2146|transcript|ENST00000320356.2|||A692V|4414|A687V&ALA692VAL&ALA687VAL|https://civicdb.org/links/variants/4414|EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G|4344|COBAS EZH2 MUTATION TEST|https://civicdb.org/links/molecular-profiles/4344|NC_000007.14:g.148809345G>A&NC_000007.13:g.148506437G>A&ENST00000320356.7:c.2075C>T&NM_004456.5:c.2075C>T&ENSP00000320147.2:p.Ala692Val&NP_004447.2:p.Ala692Val|CA369712244||20.0|evidence|11109|https://civicdb.org/links/evidence/11109|34159682 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Follicular Lymphoma|Tazemetostat (NCIt ID C107506)|||B|4|||||;GN=EZH2
7	148506467	4415	G	C	.	.	VT=A682G;GN=EZH2;CSQ=C|Missense Variant|EZH2|2146|transcript|ENST00000320356.2|||A682G|4415|ALA682GLY&A677G&ALA677GLY|https://civicdb.org/links/variants/4415|EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G|4344|COBAS EZH2 MUTATION TEST|https://civicdb.org/links/molecular-profiles/4344|NC_000007.14:g.148809375G>C&NC_000007.13:g.148506467G>C&ENST00000320356.7:c.2045C>G&NM_004456.5:c.2045C>G&NP_004447.2:p.Ala682Gly&ENSP00000320147.2:p.Ala682Gly|CA16602672|376219|20.0|evidence|11109|https://civicdb.org/links/evidence/11109|34159682 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Follicular Lymphoma|Tazemetostat (NCIt ID C107506)|||B|4|||||
7	148508727	3607	T	C	.	.	VT=Y646C;CSQ=C|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>G||Y646C|3607|TYR646CYS&Y641C&TYR641CYS|https://civicdb.org/links/variants/3607|EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G|4344|COBAS EZH2 MUTATION TEST|https://civicdb.org/links/molecular-profiles/4344|NC_000007.14:g.148811635T>C&NC_000007.13:g.148508727T>C&ENST00000320356.7:c.1937A>G&ENSP00000320147.2:p.Tyr646Cys&NM_004456.5:c.1937A>G&NP_004447.2:p.Tyr646Cys|CA369713035|NONE FOUND|20.0|evidence|11109|https://civicdb.org/links/evidence/11109|34159682 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Follicular Lymphoma|Tazemetostat (NCIt ID C107506)|||B|4|||||,C|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>G||Y646C|3607|TYR646CYS&Y641C&TYR641CYS|https://civicdb.org/links/variants/3607|EZH2 Y646C|3475|TYR646CYS&Y641C&TYR641CYS|https://civicdb.org/links/molecular-profiles/3475|NC_000007.14:g.148811635T>C&NC_000007.13:g.148508727T>C&ENST00000320356.7:c.1937A>G&ENSP00000320147.2:p.Tyr646Cys&NM_004456.5:c.1937A>G&NP_004447.2:p.Tyr646Cys|CA369713035|NONE FOUND|2.0|evidence|9868|https://civicdb.org/links/evidence/9868|20601953 (PUBMED)|UNKNOWN|accepted|LOSS_OF_FUNCTION|SUPPORTS|||||D|2|||||;GN=EZH2
7	148508727	2989	T	A	.	.	VT=Y646F;CSQ=A|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>T||Y646F|2989|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/variants/2989|EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G|4344|COBAS EZH2 MUTATION TEST|https://civicdb.org/links/molecular-profiles/4344|ENST00000320356.7:c.1937A>T&NC_000007.14:g.148811635T>A&NC_000007.13:g.148508727T>A&ENSP00000320147.2:p.Tyr646Phe&ENST00000460911.5:c.1922A>T&ENSP00000419711.1:p.Tyr641Phe&NM_004456.5:c.1937A>T&NP_004447.2:p.Tyr646Phe&NM_001203247.2:c.1922A>T&NP_001190176.1:p.Tyr641Phe|CA16602259|76768|20.0|evidence|11109|https://civicdb.org/links/evidence/11109|34159682 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Follicular Lymphoma|Tazemetostat (NCIt ID C107506)|||B|4|||||,A|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>T||Y646F|2989|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/variants/2989|EZH2 Y646F|2858|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/molecular-profiles/2858|ENST00000320356.7:c.1937A>T&NC_000007.14:g.148811635T>A&NC_000007.13:g.148508727T>A&ENSP00000320147.2:p.Tyr646Phe&ENST00000460911.5:c.1922A>T&ENSP00000419711.1:p.Tyr641Phe&NM_004456.5:c.1937A>T&NP_004447.2:p.Tyr646Phe&NM_001203247.2:c.1922A>T&NP_001190176.1:p.Tyr641Phe|CA16602259|76768|14.0|evidence|10394|https://civicdb.org/links/evidence/10394|27135738 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|B-cell Lymphoma||||D|4|||||,A|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>T||Y646F|2989|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/variants/2989|EZH2 Y646F|2858|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/molecular-profiles/2858|ENST00000320356.7:c.1937A>T&NC_000007.14:g.148811635T>A&NC_000007.13:g.148508727T>A&ENSP00000320147.2:p.Tyr646Phe&ENST00000460911.5:c.1922A>T&ENSP00000419711.1:p.Tyr641Phe&NM_004456.5:c.1937A>T&NP_004447.2:p.Tyr646Phe&NM_001203247.2:c.1922A>T&NP_001190176.1:p.Tyr641Phe|CA16602259|76768|14.0|evidence|9517|https://civicdb.org/links/evidence/9517|21190999 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||,A|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>T||Y646F|2989|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/variants/2989|EZH2 Y646F|2858|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/molecular-profiles/2858|ENST00000320356.7:c.1937A>T&NC_000007.14:g.148811635T>A&NC_000007.13:g.148508727T>A&ENSP00000320147.2:p.Tyr646Phe&ENST00000460911.5:c.1922A>T&ENSP00000419711.1:p.Tyr641Phe&NM_004456.5:c.1937A>T&NP_004447.2:p.Tyr646Phe&NM_001203247.2:c.1922A>T&NP_001190176.1:p.Tyr641Phe|CA16602259|76768|14.0|evidence|9519|https://civicdb.org/links/evidence/9519|21190999 (PUBMED)|SOMATIC|accepted|LOSS_OF_FUNCTION|SUPPORTS|||||D|3|||||,A|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>T||Y646F|2989|Y641F&TYR641PHE&TYR646PHE|https://civicdb.org/links/variants/2989|BRAF V600E AND EZH2 Y646F|4241||https://civicdb.org/links/molecular-profiles/4241|ENST00000320356.7:c.1937A>T&NC_000007.14:g.148811635T>A&NC_000007.13:g.148508727T>A&ENSP00000320147.2:p.Tyr646Phe&ENST00000460911.5:c.1922A>T&ENSP00000419711.1:p.Tyr641Phe&NM_004456.5:c.1937A>T&NP_004447.2:p.Tyr646Phe&NM_001203247.2:c.1922A>T&NP_001190176.1:p.Tyr641Phe|CA16602259|76768|0.0|evidence|6952|https://civicdb.org/links/evidence/6952|27135738 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|JQEZ5|||D|4|||||;GN=EZH2
7	148508727	2666	T	G	.	.	VT=Y646S;GN=EZH2;CSQ=G|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>C||Y646S|2666|Y641S&TYR641SER&TYR646SER|https://civicdb.org/links/variants/2666|EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G|4344|COBAS EZH2 MUTATION TEST|https://civicdb.org/links/molecular-profiles/4344|NC_000007.14:g.148811635&NC_000007.13:g.148508727&ENST00000320356.7:c.1937A>C&ENSP00000320147.2:p.Tyr646Ser&NM_004456.5:c.1937A>C&NP_004447.2:p.Tyr646Ser|CA16602671|376218|20.0|evidence|11109|https://civicdb.org/links/evidence/11109|34159682 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Follicular Lymphoma|Tazemetostat (NCIt ID C107506)|||B|4|||||,G|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1937A>C||Y646S|2666|Y641S&TYR641SER&TYR646SER|https://civicdb.org/links/variants/2666|EZH2 Y646S|2535|Y641S&TYR641SER&TYR646SER|https://civicdb.org/links/molecular-profiles/2535|NC_000007.14:g.148811635&NC_000007.13:g.148508727&ENST00000320356.7:c.1937A>C&ENSP00000320147.2:p.Tyr646Ser&NM_004456.5:c.1937A>C&NP_004447.2:p.Tyr646Ser|CA16602671|376218|3.0|evidence|9522|https://civicdb.org/links/evidence/9522|21190999 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||
7	148508728	3364	A	G	.	.	CSQ=G|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1936T>C||Y646H|3364|Y641H&TYR641HIS&TYR646HIS|https://civicdb.org/links/variants/3364|EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G|4344|COBAS EZH2 MUTATION TEST|https://civicdb.org/links/molecular-profiles/4344|NC_000007.14:g.148811636A>G&NC_000007.13:g.148508728A>G&ENSP00000320147.2:p.Tyr646His&ENST00000460911.5:c.1921T>C&ENSP00000419711.1:p.Tyr641His&NM_004456.5:c.1936T>C&NP_004447.2:p.Tyr646His&NM_001203247.2:c.1921T>C&NP_001190176.1:p.Tyr641His&ENST00000320356.7:c.1936T>C|CA16602260|76769|20.0|evidence|11109|https://civicdb.org/links/evidence/11109|34159682 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Follicular Lymphoma|Tazemetostat (NCIt ID C107506)|||B|4|||||,G|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1936T>C||Y646H|3364|Y641H&TYR641HIS&TYR646HIS|https://civicdb.org/links/variants/3364|EZH2 Y646H|3232|Y641H&TYR641HIS&TYR646HIS|https://civicdb.org/links/molecular-profiles/3232|NC_000007.14:g.148811636A>G&NC_000007.13:g.148508728A>G&ENSP00000320147.2:p.Tyr646His&ENST00000460911.5:c.1921T>C&ENSP00000419711.1:p.Tyr641His&NM_004456.5:c.1936T>C&NP_004447.2:p.Tyr646His&NM_001203247.2:c.1921T>C&NP_001190176.1:p.Tyr641His&ENST00000320356.7:c.1936T>C|CA16602260|76769|8.0|evidence|9377|https://civicdb.org/links/evidence/9377|29650362 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Diffuse Large B-cell Lymphoma|Tazemetostat (NCIt ID C107506)|||C|2|||||,G|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1936T>C||Y646H|3364|Y641H&TYR641HIS&TYR646HIS|https://civicdb.org/links/variants/3364|EZH2 Y646H|3232|Y641H&TYR641HIS&TYR646HIS|https://civicdb.org/links/molecular-profiles/3232|NC_000007.14:g.148811636A>G&NC_000007.13:g.148508728A>G&ENSP00000320147.2:p.Tyr646His&ENST00000460911.5:c.1921T>C&ENSP00000419711.1:p.Tyr641His&NM_004456.5:c.1936T>C&NP_004447.2:p.Tyr646His&NM_001203247.2:c.1921T>C&NP_001190176.1:p.Tyr641His&ENST00000320356.7:c.1936T>C|CA16602260|76769|8.0|evidence|9521|https://civicdb.org/links/evidence/9521|21190999 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||;VT=Y646H;GN=EZH2
7	148508728	4090	A	T	.	.	CSQ=T|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1936T>A||Y646N|4090|Y641N&TYR646ASN&TYR641ASN|https://civicdb.org/links/variants/4090|EZH2 Y646S OR EZH2 Y646F OR EZH2 Y646H OR EZH2 Y646C OR EZH2 Y646N OR EZH2 A692V OR EZH2 A682G|4344|COBAS EZH2 MUTATION TEST|https://civicdb.org/links/molecular-profiles/4344|NC_000007.14:g.148811636A>T&NC_000007.13:g.148508728A>T&ENST00000320356.7:c.1936T>A&ENSP00000320147.2:p.Tyr646Asn&NM_004456.5:c.1936T>A&NP_004447.2:p.Tyr646Asn&NM_001203247.2:c.1921T>A&NP_001190176.1:p.Tyr641Asn&ENST00000460911.5:c.1921T>A&ENSP00000419711.1:p.Tyr641Asn|CA16602670|376217|20.0|evidence|11109|https://civicdb.org/links/evidence/11109|34159682 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Follicular Lymphoma|Tazemetostat (NCIt ID C107506)|||B|4|||||,T|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1936T>A||Y646N|4090|Y641N&TYR646ASN&TYR641ASN|https://civicdb.org/links/variants/4090|EZH2 Y646N|3958|Y641N&TYR646ASN&TYR641ASN|https://civicdb.org/links/molecular-profiles/3958|NC_000007.14:g.148811636A>T&NC_000007.13:g.148508728A>T&ENST00000320356.7:c.1936T>A&ENSP00000320147.2:p.Tyr646Asn&NM_004456.5:c.1936T>A&NP_004447.2:p.Tyr646Asn&NM_001203247.2:c.1921T>A&NP_001190176.1:p.Tyr641Asn&ENST00000460911.5:c.1921T>A&ENSP00000419711.1:p.Tyr641Asn|CA16602670|376217|6.0|evidence|9518|https://civicdb.org/links/evidence/9518|21190999 (PUBMED)|SOMATIC|accepted|GAIN_OF_FUNCTION|SUPPORTS|||||D|3|||||,T|Missense Variant|EZH2|2146|transcript|ENST00000320356.7|ENST00000320356.7:c.1936T>A||Y646N|4090|Y641N&TYR646ASN&TYR641ASN|https://civicdb.org/links/variants/4090|EZH2 Y646N|3958|Y641N&TYR646ASN&TYR641ASN|https://civicdb.org/links/molecular-profiles/3958|NC_000007.14:g.148811636A>T&NC_000007.13:g.148508728A>T&ENST00000320356.7:c.1936T>A&ENSP00000320147.2:p.Tyr646Asn&NM_004456.5:c.1936T>A&NP_004447.2:p.Tyr646Asn&NM_001203247.2:c.1921T>A&NP_001190176.1:p.Tyr641Asn&ENST00000460911.5:c.1921T>A&ENSP00000419711.1:p.Tyr641Asn|CA16602670|376217|6.0|evidence|9520|https://civicdb.org/links/evidence/9520|21190999 (PUBMED)|SOMATIC|accepted|LOSS_OF_FUNCTION|SUPPORTS|||||D|3|||||;VT=Y646N;GN=EZH2
7	148524752	257	C	C	.	.	VT=Intron 6 Mutation;CSQ=C|Intron Variant|EZH2|2146|transcript|ENST00000320356.2|||Intron 6 Mutation|257|RS3757441|https://civicdb.org/links/variants/257|EZH2 Intron 6 Mutation|253|RS3757441|https://civicdb.org/links/molecular-profiles/253|NC_000007.14:g.148827660C=&NC_000007.13:g.148524752C=&ENST00000320356.7:c.626-394G=&ENSP00000320147.2:n.626-394G=&NM_004456.5:c.626-394G=&NP_004447.2:n.626-394G=|CA1139771703|NONE FOUND|20.0|evidence|668|https://civicdb.org/links/evidence/668|21926398 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Colorectal Cancer||||B|4|||||;GN=EZH2
8	38274849	515	G	T	.	.	CSQ=T|Missense Variant|FGFR1|2260|transcript|ENST00000341462.5|ENST00000341462.5:c.1638C>A||N546K|515|ASN546LYS&RS779707422|https://civicdb.org/links/variants/515|FGFR1 N546K|511|ASN546LYS&RS779707422|https://civicdb.org/links/molecular-profiles/511|NM_023110.2:c.1638C>A&NP_075598.2:p.Asn546Lys&ENST00000341462.5:c.1638C>A&NC_000008.10:g.38274849G>T|CA357830|224896|8.0|evidence|10325|https://civicdb.org/links/evidence/10325|35507888 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Pilocytic Astrocytoma|Pemigatinib (NCIt ID C121553)|||C|3|||||,T|Missense Variant|FGFR1|2260|transcript|ENST00000341462.5|ENST00000341462.5:c.1638C>A||N546K|515|ASN546LYS&RS779707422|https://civicdb.org/links/variants/515|FGFR1 N546K|511|ASN546LYS&RS779707422|https://civicdb.org/links/molecular-profiles/511|NM_023110.2:c.1638C>A&NP_075598.2:p.Asn546Lys&ENST00000341462.5:c.1638C>A&NC_000008.10:g.38274849G>T|CA357830|224896|8.0|evidence|1246|https://civicdb.org/links/evidence/1246|26179511 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ewing Sarcoma Of Bone|Ponatinib (NCIt ID C95777)|||E|2|||||;GN=FGFR1;VT=N546K
8	68939530	2364	G	T	.	.	GN=PREX2;VT=R172I;CSQ=T|Missense Variant|PREX2|80243|transcript|ENST00000288368.4|||R172I|2364|ARG172ILE|https://civicdb.org/links/variants/2364|PREX2 R172I|2237|ARG172ILE|https://civicdb.org/links/molecular-profiles/2237||CA371196220|NONE FOUND|10.0|evidence|6268|https://civicdb.org/links/evidence/6268|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||C|4|||||
9	5070053	615	G	GG	.	.	CSQ=G||JAK2|3717|transcript|ENST00000381652.3|||c.1641+1dup|615||https://civicdb.org/links/variants/615|JAK2 c.1641+1dup|611||https://civicdb.org/links/molecular-profiles/611|NC_000009.11:g.5070053_5070054insG|CA913189235||10.0|evidence|1568|https://civicdb.org/links/evidence/1568|27433843 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|Pembrolizumab (NCIt ID C106432)|||C|4|||||;GN=JAK2;VT=c.1641+1dup
9	5070054	1681	T	G	.	.	VT=Splice Site (c.1641+2T>G);GN=JAK2;CSQ=G|Splice Donor Variant|JAK2|3717|transcript|None|||Splice Site (c.1641+2T>G)|1681|F547 SPLICE SITE MUTATION&(C.1641+2T>G) F547 SPLICE SITE|https://civicdb.org/links/variants/1681|JAK2 Splice Site (c.1641+2T>G)|1589|F547 SPLICE SITE MUTATION&(C.1641+2T>G) F547 SPLICE SITE|https://civicdb.org/links/molecular-profiles/1589|NC_000009.11:g.5070054T>G&NM_004972.3:c.1641+2T>G&NP_004963.1:p.=|CA372825751|NONE FOUND|7.5|evidence|4825|https://civicdb.org/links/evidence/4825|27433843 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Pembrolizumab (NCIt ID C106432)|||C|3|||||
9	5073770	64	G	T	.	.	VT=V617F;GN=JAK2;CSQ=T|Missense Variant&Gain Of Function Variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/variants/64|JAK2 V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/molecular-profiles/64|NC_000009.11:g.5073770G>T&NM_004972.3:c.1849G>T&NP_004963.1:p.Val617Phe&ENST00000381652.3:c.1849G>T|CA124183|14662|103.0|evidence|1|https://civicdb.org/links/evidence/1|16081687 (PUBMED)|SOMATIC|accepted|NEGATIVE|SUPPORTS|Lymphoid Leukemia||||B|4|||||,T|Missense Variant&Gain Of Function Variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/variants/64|JAK2 V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/molecular-profiles/64|NC_000009.11:g.5073770G>T&NM_004972.3:c.1849G>T&NP_004963.1:p.Val617Phe&ENST00000381652.3:c.1849G>T|CA124183|14662|103.0|evidence|5|https://civicdb.org/links/evidence/5|16081687 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Chronic Myeloid Leukemia||||B|4|||||,T|Missense Variant&Gain Of Function Variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/variants/64|JAK2 V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/molecular-profiles/64|NC_000009.11:g.5073770G>T&NM_004972.3:c.1849G>T&NP_004963.1:p.Val617Phe&ENST00000381652.3:c.1849G>T|CA124183|14662|103.0|evidence|6|https://civicdb.org/links/evidence/6|16081687 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Chronic Myeloid Leukemia||||B|4|||||,T|Missense Variant&Gain Of Function Variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/variants/64|JAK2 V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/molecular-profiles/64|NC_000009.11:g.5073770G>T&NM_004972.3:c.1849G>T&NP_004963.1:p.Val617Phe&ENST00000381652.3:c.1849G>T|CA124183|14662|103.0|evidence|7|https://civicdb.org/links/evidence/7|19287384 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Bone Marrow Cancer||||B|4|||||,T|Missense Variant&Gain Of Function Variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/variants/64|JAK2 V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/molecular-profiles/64|NC_000009.11:g.5073770G>T&NM_004972.3:c.1849G>T&NP_004963.1:p.Val617Phe&ENST00000381652.3:c.1849G>T|CA124183|14662|103.0|evidence|19|https://civicdb.org/links/evidence/19|16709929 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Polycythemia Vera|Peginterferon Alfa-2b (NCIt ID C1845)|||B|4|||||,T|Missense Variant&Gain Of Function Variant|JAK2|3717|transcript|ENST00000381652.3|ENST00000381652.3:c.1849G>T||V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/variants/64|JAK2 V617F|64|VAL617PHE&RS77375493|https://civicdb.org/links/molecular-profiles/64|NC_000009.11:g.5073770G>T&NM_004972.3:c.1849G>T&NP_004963.1:p.Val617Phe&ENST00000381652.3:c.1849G>T|CA124183|14662|103.0|evidence|20|https://civicdb.org/links/evidence/20|18394554 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Polycythemia Vera|Fedratinib (NCIt ID C88293)|||D|3|||||
9	8521481	792	C	T	.	.	GN=PTPRD;CSQ=T|Missense Variant|PTPRD|5789|transcript|ENST00000381196.4|||V253I|792|VAL253ILE|https://civicdb.org/links/variants/792|PTPRD V253I|770|VAL253ILE|https://civicdb.org/links/molecular-profiles/770|NM_002839.3:c.757G>A&NP_002830.1:p.Val253Ile&NC_000009.11:g.8521481C>T|CA4984656|NONE FOUND|10.0|evidence|1856|https://civicdb.org/links/evidence/1856|23800680 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ewing Sarcoma Of Bone|Cixutumumab (NCIt ID C79828)&Teprotumumab (NCIt ID C95797)|SUBSTITUTES||C|4|||||;VT=V253I
9	21975017	641	C	T	.	.	GN=CDKN2A;CSQ=T|5 Prime UTR Exon Variant|CDKN2A|1029|transcript|ENST00000498124.1|||RS3814960|641||https://civicdb.org/links/variants/641|CDKN2A RS3814960|637||https://civicdb.org/links/molecular-profiles/637|NC_000009.11:g.21975017C>T&NM_000077.4:c.-191G>A|CA12951936|NONE FOUND|15.0|evidence|1635|https://civicdb.org/links/evidence/1635|27414035 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Esophagus Squamous Cell Carcinoma||||B|3|||||;VT=RS3814960
9	80409488	604	T	G	.	.	VT=Q209P;CSQ=G|Missense Variant|GNAQ|2776|transcript|ENST00000286548.4|ENST00000286548.4:c.626A>C||Q209P|604|GLN209PRO&RS121913492|https://civicdb.org/links/variants/604|GNAQ Q209P|600|GLN209PRO&RS121913492|https://civicdb.org/links/molecular-profiles/600|NC_000009.11:g.80409488T>G&NM_002072.4:c.626A>C&NP_002063.2:p.Gln209Pro&ENST00000286548.4:c.626A>C|CA16602436|375957|8.0|evidence|1533|https://civicdb.org/links/evidence/1533|24504448 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|Vemurafenib (NCIt ID C64768)|||C|2|||||,G|Missense Variant|GNAQ|2776|transcript|ENST00000286548.4|ENST00000286548.4:c.626A>C||Q209P|604|GLN209PRO&RS121913492|https://civicdb.org/links/variants/604|GNAQ Q209P|600|GLN209PRO&RS121913492|https://civicdb.org/links/molecular-profiles/600|NC_000009.11:g.80409488T>G&NM_002072.4:c.626A>C&NP_002063.2:p.Gln209Pro&ENST00000286548.4:c.626A>C|CA16602436|375957|8.0|evidence|1537|https://civicdb.org/links/evidence/1537|24504448 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|PLX4720|||D|3|||||;GN=GNAQ
9	133738330	4597	A	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|4302|https://civicdb.org/links/evidence/4302|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|2636|https://civicdb.org/links/evidence/2636|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|4305|https://civicdb.org/links/evidence/4305|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|4307|https://civicdb.org/links/evidence/4307|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|4308|https://civicdb.org/links/evidence/4308|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|6994|https://civicdb.org/links/evidence/6994|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|4304|https://civicdb.org/links/evidence/4304|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|7042|https://civicdb.org/links/evidence/7042|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|7825|https://civicdb.org/links/evidence/7825|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|2638|https://civicdb.org/links/evidence/2638|15930265 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Imatinib (NCIt ID C62035)|||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|2640|https://civicdb.org/links/evidence/2640|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Dasatinib (NCIt ID C38713)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|7850|https://civicdb.org/links/evidence/7850|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Bafetinib (NCIt ID C62516)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|6242|https://civicdb.org/links/evidence/6242|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 M244V|4662||https://civicdb.org/links/molecular-profiles/4662|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|7771|https://civicdb.org/links/evidence/7771|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.730A>G||M244V|4597|RS121913456&M263V&MET263VAL|https://civicdb.org/links/variants/4597|BCR::ABL1 Fusion AND ABL1 L364I AND ABL1 M244V|4888||https://civicdb.org/links/molecular-profiles/4888|NM_005157.5:c.730A>G&NP_005148.2:p.Met244Val&NC_000009.11:g.133738330A>G&ENST00000318560.5:c.730A>G|CA16602545||0.0|evidence|7943|https://civicdb.org/links/evidence/7943|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||;VT=M244V;GN=ABL1
9	133738342	4632	C	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|6308|https://civicdb.org/links/evidence/6308|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|2642|https://civicdb.org/links/evidence/2642|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|4310|https://civicdb.org/links/evidence/4310|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|7029|https://civicdb.org/links/evidence/7029|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|7044|https://civicdb.org/links/evidence/7044|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|2641|https://civicdb.org/links/evidence/2641|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|2644|https://civicdb.org/links/evidence/2644|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|4311|https://civicdb.org/links/evidence/4311|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.742C>G||L248V|4632|RS121913455&LEU248VAL&L267V|https://civicdb.org/links/variants/4632|BCR::ABL1 Fusion AND ABL1 L248V|4714||https://civicdb.org/links/molecular-profiles/4714|NM_005157.5:c.742C>G&NP_005148.2:p.Leu248Val&NC_000009.11:g.133738342C>G&ENST00000318560.5:c.742C>G|CA16602546|376085|0.0|evidence|6236|https://civicdb.org/links/evidence/6236|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|COMBINATION||D|2|||||;GN=ABL1;VT=L248V
9	133738343	2340	T	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.743T>G||L248R|2340|LEU248ARG|https://civicdb.org/links/variants/2340|BCR::ABL1 Fusion AND ABL1 L248R|4875||https://civicdb.org/links/molecular-profiles/4875|ENST00000318560.5:c.743T>G&NC_000009.11:g.133738343T>G&NM_005157.6:c.743T>G&NP_005148.2:p.Leu248Arg|CA375263224|NONE FOUND|0.0|evidence|6210|https://civicdb.org/links/evidence/6210|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.743T>G||L248R|2340|LEU248ARG|https://civicdb.org/links/variants/2340|BCR::ABL1 Fusion AND ABL1 L248R|4875||https://civicdb.org/links/molecular-profiles/4875|ENST00000318560.5:c.743T>G&NC_000009.11:g.133738343T>G&NM_005157.6:c.743T>G&NP_005148.2:p.Leu248Arg|CA375263224|NONE FOUND|0.0|evidence|6243|https://civicdb.org/links/evidence/6243|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.743T>G||L248R|2340|LEU248ARG|https://civicdb.org/links/variants/2340|BCR::ABL1 Fusion AND ABL1 L248R|4875||https://civicdb.org/links/molecular-profiles/4875|ENST00000318560.5:c.743T>G&NC_000009.11:g.133738343T>G&NM_005157.6:c.743T>G&NP_005148.2:p.Leu248Arg|CA375263224|NONE FOUND|0.0|evidence|7776|https://civicdb.org/links/evidence/7776|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.743T>G||L248R|2340|LEU248ARG|https://civicdb.org/links/variants/2340|BCR::ABL1 Fusion AND ABL1 L248R AND ABL1 F359I|4876||https://civicdb.org/links/molecular-profiles/4876|ENST00000318560.5:c.743T>G&NC_000009.11:g.133738343T>G&NM_005157.6:c.743T>G&NP_005148.2:p.Leu248Arg|CA375263224|NONE FOUND|0.0|evidence|7775|https://civicdb.org/links/evidence/7775|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;VT=L248R;GN=ABL1
9	133738349	1023	G	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|4316|https://civicdb.org/links/evidence/4316|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|7041|https://civicdb.org/links/evidence/7041|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||B|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|6993|https://civicdb.org/links/evidence/6993|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|2646|https://civicdb.org/links/evidence/2646|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|4313|https://civicdb.org/links/evidence/4313|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|4314|https://civicdb.org/links/evidence/4314|22371878 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|4318|https://civicdb.org/links/evidence/4318|17264298 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|2645|https://civicdb.org/links/evidence/2645|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|2649|https://civicdb.org/links/evidence/2649|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Nilotinib (NCIt ID C48375)|||D|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|7853|https://civicdb.org/links/evidence/7853|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Bafetinib (NCIt ID C62516)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|9083|https://civicdb.org/links/evidence/9083|18191450 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)|||D|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|2647|https://civicdb.org/links/evidence/2647|15930265 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|2648|https://civicdb.org/links/evidence/2648|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|4320|https://civicdb.org/links/evidence/4320|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|4321|https://civicdb.org/links/evidence/4321|26582647 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|6244|https://civicdb.org/links/evidence/6244|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.749G>A||G250E|1023|RS121913453&GLY250GLU|https://civicdb.org/links/variants/1023|BCR::ABL1 Fusion AND ABL1 G250E|4555||https://civicdb.org/links/molecular-profiles/4555|NM_005157.5:c.749G>A&NP_005148.2:p.Gly250Glu&NC_000009.11:g.133738349G>A&ENST00000318560.5:c.749G>A|CA16602547|376086|67.0|evidence|6267|https://civicdb.org/links/evidence/6267|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|2|||||;GN=ABL1;VT=G250E
9	133738356	4634	G	C	.	.	VT=Q252H;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|2651|https://civicdb.org/links/evidence/2651|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|4327|https://civicdb.org/links/evidence/4327|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|2650|https://civicdb.org/links/evidence/2650|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|2653|https://civicdb.org/links/evidence/2653|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Dasatinib (NCIt ID C38713)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|7849|https://civicdb.org/links/evidence/7849|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Bafetinib (NCIt ID C62516)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|4323|https://civicdb.org/links/evidence/4323|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|4324|https://civicdb.org/links/evidence/4324|26582647 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|6245|https://civicdb.org/links/evidence/6245|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|6274|https://civicdb.org/links/evidence/6274|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.756G>C||Q252H|4634|GLN252HIS&Q271H&RS121913458|https://civicdb.org/links/variants/4634|BCR::ABL1 Fusion AND ABL1 Q252H|4719||https://civicdb.org/links/molecular-profiles/4719|NM_005157.5:c.756G>C&NP_005148.2:p.Gln252His&NC_000009.11:g.133738356G>C&ENST00000318560.5:c.756G>C|CA16602548|376087|31.0|evidence|6219|https://civicdb.org/links/evidence/6219|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|1|||||;GN=ABL1
9	133738357	4529	T	C	.	.	VT=Y253H;GN=ABL1;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|4335|https://civicdb.org/links/evidence/4335|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|7040|https://civicdb.org/links/evidence/7040|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||B|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|4336|https://civicdb.org/links/evidence/4336|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|4|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|4332|https://civicdb.org/links/evidence/4332|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|6200|https://civicdb.org/links/evidence/6200|19652056 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|6992|https://civicdb.org/links/evidence/6992|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|7947|https://civicdb.org/links/evidence/7947|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Acute Lymphoblastic Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|7949|https://civicdb.org/links/evidence/7949|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|4331|https://civicdb.org/links/evidence/4331|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|4334|https://civicdb.org/links/evidence/4334|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|2654|https://civicdb.org/links/evidence/2654|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|4329|https://civicdb.org/links/evidence/4329|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|4330|https://civicdb.org/links/evidence/4330|26582647 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.757T>C||Y253H|4529|RS121913461&Y272H&TYR272HIS|https://civicdb.org/links/variants/4529|BCR::ABL1 Fusion AND ABL1 Y253H|4550||https://civicdb.org/links/molecular-profiles/4550|NM_005157.5:c.757T>C&NP_005148.2:p.Tyr253His&NC_000009.11:g.133738357T>C&ENST00000318560.5:c.757T>C|CA122584|12627|82.0|evidence|6237|https://civicdb.org/links/evidence/6237|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|COMBINATION||D|2|||||
9	133738363	3	G	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|4350|https://civicdb.org/links/evidence/4350|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|2660|https://civicdb.org/links/evidence/2660|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|4|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|4353|https://civicdb.org/links/evidence/4353|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|4718|https://civicdb.org/links/evidence/4718|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Lymphoblastic Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|6232|https://civicdb.org/links/evidence/6232|19652056 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|4347|https://civicdb.org/links/evidence/4347|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|4348|https://civicdb.org/links/evidence/4348|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|4352|https://civicdb.org/links/evidence/4352|17264298 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|6991|https://civicdb.org/links/evidence/6991|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|7039|https://civicdb.org/links/evidence/7039|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|233|https://civicdb.org/links/evidence/233|15194504 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|4|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|2659|https://civicdb.org/links/evidence/2659|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|2661|https://civicdb.org/links/evidence/2661|15930265 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|6214|https://civicdb.org/links/evidence/6214|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)|SUBSTITUTES||D|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|2662|https://civicdb.org/links/evidence/2662|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|4355|https://civicdb.org/links/evidence/4355|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|6193|https://civicdb.org/links/evidence/6193|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)|COMBINATION||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|6194|https://civicdb.org/links/evidence/6194|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K|4431||https://civicdb.org/links/molecular-profiles/4431|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|83.0|evidence|6282|https://civicdb.org/links/evidence/6282|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.763G>A||E255K|3|E274K&RS121913448|https://civicdb.org/links/variants/3|BCR::ABL1 Fusion AND ABL1 E255K AND ABL1 V299L|4729||https://civicdb.org/links/molecular-profiles/4729|NC_000009.11:g.133738363G>A&NM_005157.5:c.763G>A&NP_005148.2:p.Glu255Lys&ENST00000318560.5:c.763G>A|CA16602551|376090|0.0|evidence|7781|https://civicdb.org/links/evidence/7781|25686603 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Ponatinib (NCIt ID C95777)|SUBSTITUTES||D|2|||||;VT=E255K;GN=ABL1
9	133738364	4606	A	T	.	.	VT=E255V;GN=ABL1;CSQ=T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|4447|https://civicdb.org/links/evidence/4447|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|2656|https://civicdb.org/links/evidence/2656|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|4448|https://civicdb.org/links/evidence/4448|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|6971|https://civicdb.org/links/evidence/6971|19652056 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||C|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|4443|https://civicdb.org/links/evidence/4443|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|4444|https://civicdb.org/links/evidence/4444|22371878 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|6986|https://civicdb.org/links/evidence/6986|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|2850|https://civicdb.org/links/evidence/2850|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|2851|https://civicdb.org/links/evidence/2851|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|4441|https://civicdb.org/links/evidence/4441|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.764A>T||E255V|4606|RS121913449&GLU255VAL|https://civicdb.org/links/variants/4606|BCR::ABL1 Fusion AND ABL1 E255V|4673||https://civicdb.org/links/molecular-profiles/4673|NM_005157.5:c.764A>T&NP_005148.2:p.Glu255Val&NC_000009.11:g.133738364A>T&ENST00000318560.5:c.764A>T|CA16602552|376091|54.5|evidence|4442|https://civicdb.org/links/evidence/4442|26582647 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||
9	133747520	4218	A	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||D276G|4218|RS121913447&ASP276GLY&D295G|https://civicdb.org/links/variants/4218|BCR::ABL1 Fusion AND ABL1 D276G|4553||https://civicdb.org/links/molecular-profiles/4553|ENST00000318560.5:c.827A>G&NP_005148.2:p.Asp276Gly&NM_005157.5:c.827A>G&NC_000009.11:g.133747520A>G|CA200645023||18.0|evidence|4359|https://civicdb.org/links/evidence/4359|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||D276G|4218|RS121913447&ASP276GLY&D295G|https://civicdb.org/links/variants/4218|BCR::ABL1 Fusion AND ABL1 D276G|4553||https://civicdb.org/links/molecular-profiles/4553|ENST00000318560.5:c.827A>G&NP_005148.2:p.Asp276Gly&NM_005157.5:c.827A>G&NC_000009.11:g.133747520A>G|CA200645023||18.0|evidence|4357|https://civicdb.org/links/evidence/4357|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||D276G|4218|RS121913447&ASP276GLY&D295G|https://civicdb.org/links/variants/4218|BCR::ABL1 Fusion AND ABL1 D276G|4553||https://civicdb.org/links/molecular-profiles/4553|ENST00000318560.5:c.827A>G&NP_005148.2:p.Asp276Gly&NM_005157.5:c.827A>G&NC_000009.11:g.133747520A>G|CA200645023||18.0|evidence|2663|https://civicdb.org/links/evidence/2663|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||D276G|4218|RS121913447&ASP276GLY&D295G|https://civicdb.org/links/variants/4218|BCR::ABL1 Fusion AND ABL1 D276G|4553||https://civicdb.org/links/molecular-profiles/4553|ENST00000318560.5:c.827A>G&NP_005148.2:p.Asp276Gly&NM_005157.5:c.827A>G&NC_000009.11:g.133747520A>G|CA200645023||18.0|evidence|2666|https://civicdb.org/links/evidence/2666|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||D276G|4218|RS121913447&ASP276GLY&D295G|https://civicdb.org/links/variants/4218|BCR::ABL1 Fusion AND ABL1 D276G|4553||https://civicdb.org/links/molecular-profiles/4553|ENST00000318560.5:c.827A>G&NP_005148.2:p.Asp276Gly&NM_005157.5:c.827A>G&NC_000009.11:g.133747520A>G|CA200645023||18.0|evidence|4360|https://civicdb.org/links/evidence/4360|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.827A>G||D276G|4218|RS121913447&ASP276GLY&D295G|https://civicdb.org/links/variants/4218|BCR::ABL1 Fusion AND ABL1 D276G|4553||https://civicdb.org/links/molecular-profiles/4553|ENST00000318560.5:c.827A>G&NP_005148.2:p.Asp276Gly&NM_005157.5:c.827A>G&NC_000009.11:g.133747520A>G|CA200645023||18.0|evidence|6246|https://civicdb.org/links/evidence/6246|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||;VT=D276G;GN=ABL1
9	133747528	1526	G	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.835G>A||E279K|1526|GLU279LYS&E298K|https://civicdb.org/links/variants/1526|BCR::ABL1 Fusion AND ABL1 E279K|4743||https://civicdb.org/links/molecular-profiles/4743|ENST00000318560.5:c.835G>A&NC_000009.11:g.133747528G>A&NM_005157.5:c.835G>A&NP_005148.2:p.Glu279Lys|CA375249162|NONE FOUND|0.0|evidence|4543|https://civicdb.org/links/evidence/4543|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.835G>A||E279K|1526|GLU279LYS&E298K|https://civicdb.org/links/variants/1526|BCR::ABL1 Fusion AND ABL1 E279K|4743||https://civicdb.org/links/molecular-profiles/4743|ENST00000318560.5:c.835G>A&NC_000009.11:g.133747528G>A&NM_005157.5:c.835G>A&NP_005148.2:p.Glu279Lys|CA375249162|NONE FOUND|0.0|evidence|7772|https://civicdb.org/links/evidence/7772|25686603 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;VT=E279K;GN=ABL1
9	133747558	1604	G	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.865G>A||V289I|1604|V308I&VAL289ILE|https://civicdb.org/links/variants/1604|BCR::ABL1 Fusion AND ABL1 V289I|5241||https://civicdb.org/links/molecular-profiles/5241|ENST00000318560.5:c.865G>A&NC_000009.11:g.133747558G>A&NM_005157.5:c.865G>A&NP_005148.2:p.Val289Ile|CA375249232|NONE FOUND|0.0|evidence|7946|https://civicdb.org/links/evidence/7946|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||;VT=V289I;GN=ABL1
9	133747568	1183	A	T	.	.	CSQ=T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.875A>T||E292V|1183|E311V&GLU311VAL&GLU292VAL|https://civicdb.org/links/variants/1183|BCR::ABL1 Fusion AND ABL1 E292V|4745||https://civicdb.org/links/molecular-profiles/4745|ENST00000318560.5:c.875A>T&NC_000009.11:g.133747568A>T&NM_005157.5:c.875A>T&NP_005148.2:p.Glu292Val|CA375249260|NONE FOUND|0.0|evidence|2853|https://civicdb.org/links/evidence/2853|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|2|||||;GN=ABL1;VT=E292V
9	133747585	1506	C	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.892C>G||L298V|1506|L317V&LEU298VAL|https://civicdb.org/links/variants/1506|ABL1 L298V|1414|L317V&LEU298VAL|https://civicdb.org/links/molecular-profiles/1414|ENST00000318560.5:c.892C>G&NC_000009.11:g.133747585C>G&NM_005157.5:c.892C>G&NP_005148.2:p.Leu298Val|CA375249299|NONE FOUND|2.5|evidence|4475|https://civicdb.org/links/evidence/4475|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||;VT=L298V;GN=ABL1
9	133747588	4639	G	C	.	.	VT=V299L;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|6982|https://civicdb.org/links/evidence/6982|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||B|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|4538|https://civicdb.org/links/evidence/4538|22371878 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|4540|https://civicdb.org/links/evidence/4540|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|2862|https://civicdb.org/links/evidence/2862|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|6216|https://civicdb.org/links/evidence/6216|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|4537|https://civicdb.org/links/evidence/4537|26582647 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|6241|https://civicdb.org/links/evidence/6241|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)|COMBINATION||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|6247|https://civicdb.org/links/evidence/6247|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 V299L|4730||https://civicdb.org/links/molecular-profiles/4730|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||22.0|evidence|7767|https://civicdb.org/links/evidence/7767|25686603 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.895G>C||V299L|4639|RS1057519771&VAL299LEU|https://civicdb.org/links/variants/4639|BCR::ABL1 Fusion AND ABL1 E255K AND ABL1 V299L|4729||https://civicdb.org/links/molecular-profiles/4729|NM_005157.5:c.895G>C&NP_005148.2:p.Val299Leu&NC_000009.11:g.133747588G>C&ENST00000318560.5:c.895G>C|CA16602575||0.0|evidence|7781|https://civicdb.org/links/evidence/7781|25686603 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Ponatinib (NCIt ID C95777)|SUBSTITUTES||D|2|||||;GN=ABL1
9	133747592	1527	A	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.899A>G||Q300R|1527|Q319R&GLN300ARG&GLN319ARG|https://civicdb.org/links/variants/1527|BCR::ABL1 Fusion AND ABL1 Q300R|4901||https://civicdb.org/links/molecular-profiles/4901|ENST00000318560.5:c.899A>G&NC_000009.11:g.133747592A>G&NM_005157.5:c.899A>G&NP_005148.2:p.Gln300Arg|CA375249312|NONE FOUND|0.0|evidence|4545|https://civicdb.org/links/evidence/4545|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.899A>G||Q300R|1527|Q319R&GLN300ARG&GLN319ARG|https://civicdb.org/links/variants/1527|BCR::ABL1 Fusion AND ABL1 Q300R|4901||https://civicdb.org/links/molecular-profiles/4901|ENST00000318560.5:c.899A>G&NC_000009.11:g.133747592A>G&NM_005157.5:c.899A>G&NP_005148.2:p.Gln300Arg|CA375249312|NONE FOUND|0.0|evidence|6983|https://civicdb.org/links/evidence/6983|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||;GN=ABL1;VT=Q300R
9	133748270	1507	T	A	.	.	VT=F311I;CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.931T>A||F311I|1507|F330I&RS137853304|https://civicdb.org/links/variants/1507|BCR::ABL1 Fusion AND ABL1 F311I|4374|BCR-ABL PHE311ILE&BCR-ABL1 F311I&BCR-ABL1 PHE311ILE&BCR-ABL F311I|https://civicdb.org/links/molecular-profiles/4374|ENST00000318560.5:c.931T>A&NC_000009.11:g.133748270T>A&NM_005157.5:c.931T>A&NP_005148.2:p.Phe311Ile|CA375249388|NONE FOUND|5.0|evidence|4478|https://civicdb.org/links/evidence/4478|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.931T>A||F311I|1507|F330I&RS137853304|https://civicdb.org/links/variants/1507|BCR::ABL1 Fusion AND ABL1 F311I|4374|BCR-ABL PHE311ILE&BCR-ABL1 F311I&BCR-ABL1 PHE311ILE&BCR-ABL F311I|https://civicdb.org/links/molecular-profiles/4374|ENST00000318560.5:c.931T>A&NC_000009.11:g.133748270T>A&NM_005157.5:c.931T>A&NP_005148.2:p.Phe311Ile|CA375249388|NONE FOUND|5.0|evidence|4477|https://civicdb.org/links/evidence/4477|26582647 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;GN=ABL1
9	133748270	1528	T	C	.	.	VT=F311L;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.931T>C||F311L|1528|RS137853304&F330L&PHE311LEU|https://civicdb.org/links/variants/1528|BCR::ABL1 Fusion AND ABL1 F311L|4835||https://civicdb.org/links/molecular-profiles/4835|NM_005157.5:c.931T>C&NP_005148.2:p.Phe311Leu&NC_000009.11:g.133748270T>C&ENST00000318560.5:c.931T>C|CA122587|12628|0.0|evidence|4546|https://civicdb.org/links/evidence/4546|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.931T>C||F311L|1528|RS137853304&F330L&PHE311LEU|https://civicdb.org/links/variants/1528|BCR::ABL1 Fusion AND ABL1 F311L|4835||https://civicdb.org/links/molecular-profiles/4835|NM_005157.5:c.931T>C&NP_005148.2:p.Phe311Leu&NC_000009.11:g.133748270T>C&ENST00000318560.5:c.931T>C|CA122587|12628|0.0|evidence|6238|https://civicdb.org/links/evidence/6238|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|COMBINATION||D|2|||||;GN=ABL1
9	133748282	4645	A	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript| ENST00000318560.5|||T315A|4645|THR315ALA&T334A&RS1057519772|https://civicdb.org/links/variants/4645|BCR::ABL1 Fusion AND ABL1 T315A|4742||https://civicdb.org/links/molecular-profiles/4742|NM_005157.5:c.943A>G&NP_005148.2:p.Thr315Ala&NC_000009.11:g.133748282A>G&ENST00000318560.5:c.943A>G|CA16602576|376118|0.0|evidence|6190|https://civicdb.org/links/evidence/6190|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|3|||||,G|Missense Variant|ABL1|25|transcript| ENST00000318560.5|||T315A|4645|THR315ALA&T334A&RS1057519772|https://civicdb.org/links/variants/4645|BCR::ABL1 Fusion AND ABL1 T315A|4742||https://civicdb.org/links/molecular-profiles/4742|NM_005157.5:c.943A>G&NP_005148.2:p.Thr315Ala&NC_000009.11:g.133748282A>G&ENST00000318560.5:c.943A>G|CA16602576|376118|0.0|evidence|7842|https://civicdb.org/links/evidence/7842|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Bafetinib (NCIt ID C62516)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript| ENST00000318560.5|||T315A|4645|THR315ALA&T334A&RS1057519772|https://civicdb.org/links/variants/4645|BCR::ABL1 Fusion AND ABL1 T315A|4742||https://civicdb.org/links/molecular-profiles/4742|NM_005157.5:c.943A>G&NP_005148.2:p.Thr315Ala&NC_000009.11:g.133748282A>G&ENST00000318560.5:c.943A>G|CA16602576|376118|0.0|evidence|7844|https://civicdb.org/links/evidence/7844|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript| ENST00000318560.5|||T315A|4645|THR315ALA&T334A&RS1057519772|https://civicdb.org/links/variants/4645|BCR::ABL1 Fusion AND ABL1 T315A|4742||https://civicdb.org/links/molecular-profiles/4742|NM_005157.5:c.943A>G&NP_005148.2:p.Thr315Ala&NC_000009.11:g.133748282A>G&ENST00000318560.5:c.943A>G|CA16602576|376118|0.0|evidence|7768|https://civicdb.org/links/evidence/7768|25686603 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;VT=T315A;GN=ABL1
9	133748283	2	C	T	.	.	VT=T315I;GN=ABL1;CSQ=T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|639|https://civicdb.org/links/evidence/639|25349473 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Ponatinib (NCIt ID C95777)|||B|5|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|234|https://civicdb.org/links/evidence/234|20537386 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||B|4|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|1390|https://civicdb.org/links/evidence/1390|23190221 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Ponatinib (NCIt ID C95777)|||B|4|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|4365|https://civicdb.org/links/evidence/4365|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|4369|https://civicdb.org/links/evidence/4369|25686603 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||C|4|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|2668|https://civicdb.org/links/evidence/2668|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|4373|https://civicdb.org/links/evidence/4373|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|6990|https://civicdb.org/links/evidence/6990|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|4362|https://civicdb.org/links/evidence/4362|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|4364|https://civicdb.org/links/evidence/4364|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|4376|https://civicdb.org/links/evidence/4376|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Lymphoblastic Leukemia|Dasatinib (NCIt ID C38713)|||C|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|7038|https://civicdb.org/links/evidence/7038|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|235|https://civicdb.org/links/evidence/235|15194504 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|4|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|2667|https://civicdb.org/links/evidence/2667|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|4|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|2669|https://civicdb.org/links/evidence/2669|15930265 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|4|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|2670|https://civicdb.org/links/evidence/2670|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|4|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|2671|https://civicdb.org/links/evidence/2671|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Bafetinib (NCIt ID C62516)&Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|6234|https://civicdb.org/links/evidence/6234|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)|COMBINATION||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|6235|https://civicdb.org/links/evidence/6235|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Nilotinib (NCIt ID C48375)|COMBINATION||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|6285|https://civicdb.org/links/evidence/6285|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|7777|https://civicdb.org/links/evidence/7777|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Acute Lymphoblastic Leukemia|Axitinib (NCIt ID C38718)&Ponatinib (NCIt ID C95777)|SUBSTITUTES||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|7778|https://civicdb.org/links/evidence/7778|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Lymphoblastic Leukemia|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|7779|https://civicdb.org/links/evidence/7779|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Ponatinib (NCIt ID C95777)|||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|7780|https://civicdb.org/links/evidence/7780|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|4371|https://civicdb.org/links/evidence/4371|26582647 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|6192|https://civicdb.org/links/evidence/6192|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)|COMBINATION||D|2|||||,T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||T315I|2|THR334ILE&RS121913459|https://civicdb.org/links/variants/2|BCR::ABL1 Fusion AND ABL1 T315I|4373||https://civicdb.org/links/molecular-profiles/4373|NM_007313.2:c.1001C>T&NP_005148.2:p.Thr315Ile&ENST00000372348.2:c.1001C>T&NC_000009.11:g.133748283C>T|CA122575|12624|174.0|evidence|6196|https://civicdb.org/links/evidence/6196|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|COMBINATION||D|2|||||
9	133748288	1625	T	A	.	.	VT=F317I;CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>A||F317I|1625|F336I&RS1057519773&PHE317ILE|https://civicdb.org/links/variants/1625|BCR::ABL1 Fusion AND ABL1 F317I|4837||https://civicdb.org/links/molecular-profiles/4837|NM_005157.5:c.949T>A&NP_005148.2:p.Phe317Ile&NC_000009.11:g.133748288T>A&ENST00000318560.5:c.949T>A|CA16602577|376119|0.0|evidence|6251|https://civicdb.org/links/evidence/6251|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>A||F317I|1625|F336I&RS1057519773&PHE317ILE|https://civicdb.org/links/variants/1625|BCR::ABL1 Fusion AND ABL1 F317I|4837||https://civicdb.org/links/molecular-profiles/4837|NM_005157.5:c.949T>A&NP_005148.2:p.Phe317Ile&NC_000009.11:g.133748288T>A&ENST00000318560.5:c.949T>A|CA16602577|376119|0.0|evidence|6217|https://civicdb.org/links/evidence/6217|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|1|||||;GN=ABL1
9	133748288	1525	T	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||F317V|1525|F336V&RS1057519773|https://civicdb.org/links/variants/1525|BCR::ABL1 Fusion AND ABL1 F317V|4381||https://civicdb.org/links/molecular-profiles/4381|NM_005157.5:c.949T>G&NP_005148.2:p.Phe317Val&NC_000009.11:g.133748288T>G&ENST00000318560.5:c.949T>G|CA16602578|376120|13.0|evidence|6208|https://civicdb.org/links/evidence/6208|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||F317V|1525|F336V&RS1057519773|https://civicdb.org/links/variants/1525|BCR::ABL1 Fusion AND ABL1 F317V|4381||https://civicdb.org/links/molecular-profiles/4381|NM_005157.5:c.949T>G&NP_005148.2:p.Phe317Val&NC_000009.11:g.133748288T>G&ENST00000318560.5:c.949T>G|CA16602578|376120|13.0|evidence|7843|https://civicdb.org/links/evidence/7843|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Bafetinib (NCIt ID C62516)&Imatinib (NCIt ID C62035)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||F317V|1525|F336V&RS1057519773|https://civicdb.org/links/variants/1525|BCR::ABL1 Fusion AND ABL1 F317V|4381||https://civicdb.org/links/molecular-profiles/4381|NM_005157.5:c.949T>G&NP_005148.2:p.Phe317Val&NC_000009.11:g.133748288T>G&ENST00000318560.5:c.949T>G|CA16602578|376120|13.0|evidence|7845|https://civicdb.org/links/evidence/7845|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)|||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||F317V|1525|F336V&RS1057519773|https://civicdb.org/links/variants/1525|BCR::ABL1 Fusion AND ABL1 F317V|4381||https://civicdb.org/links/molecular-profiles/4381|NM_005157.5:c.949T>G&NP_005148.2:p.Phe317Val&NC_000009.11:g.133748288T>G&ENST00000318560.5:c.949T>G|CA16602578|376120|13.0|evidence|4535|https://civicdb.org/links/evidence/4535|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.949T>G||F317V|1525|F336V&RS1057519773|https://civicdb.org/links/variants/1525|BCR::ABL1 Fusion AND ABL1 F317V|4381||https://civicdb.org/links/molecular-profiles/4381|NM_005157.5:c.949T>G&NP_005148.2:p.Phe317Val&NC_000009.11:g.133748288T>G&ENST00000318560.5:c.949T>G|CA16602578|376120|13.0|evidence|6253|https://civicdb.org/links/evidence/6253|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|2|||||;GN=ABL1;VT=F317V
9	133748289	2359	T	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317C|2359|PHE317CYS&F336C&RS1057519774|https://civicdb.org/links/variants/2359|BCR::ABL1 Fusion AND ABL1 F317C|4836||https://civicdb.org/links/molecular-profiles/4836|ENST00000318560:c.950T>G&NC_000009.11:g.133748289T>G&NM_005157.6:c.950T>G&NP_005148.2:p.Phe317Cys|CA16602579|376121|0.0|evidence|6250|https://civicdb.org/links/evidence/6250|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|2|||||;VT=F317C;GN=ABL1
9	133748289	2343	T	C	.	.	CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.950T>C||F317S|2343|PHE317SER|https://civicdb.org/links/variants/2343|BCR::ABL1 Fusion AND ABL1 F317S|4839||https://civicdb.org/links/molecular-profiles/4839|ENST00000318560.5:c.950T>C&NC_000009.11:g.133748289T>C&NM_005157.6:c.950T>C&NP_005148.2:p.Phe317Ser|CA375249431|NONE FOUND|0.0|evidence|6218|https://civicdb.org/links/evidence/6218|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|1|||||;VT=F317S;GN=ABL1
9	133748290	1028	C	G	.	.	VT=F317L;GN=ABL1;CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|637|https://civicdb.org/links/evidence/637|18818391 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|5|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|6309|https://civicdb.org/links/evidence/6309|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|4381|https://civicdb.org/links/evidence/4381|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|6978|https://civicdb.org/links/evidence/6978|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|2675|https://civicdb.org/links/evidence/2675|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|8509|https://civicdb.org/links/evidence/8509|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|4382|https://civicdb.org/links/evidence/4382|22371878 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|7030|https://civicdb.org/links/evidence/7030|17264298 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|7045|https://civicdb.org/links/evidence/7045|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|638|https://civicdb.org/links/evidence/638|24236021 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Ponatinib (NCIt ID C95777)|||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|2677|https://civicdb.org/links/evidence/2677|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Bafetinib (NCIt ID C62516)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|6215|https://civicdb.org/links/evidence/6215|15705718 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|7839|https://civicdb.org/links/evidence/7839|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)&Imatinib (NCIt ID C62035)|SUBSTITUTES||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|2674|https://civicdb.org/links/evidence/2674|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|2676|https://civicdb.org/links/evidence/2676|15930265 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|2680|https://civicdb.org/links/evidence/2680|15930265 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|4390|https://civicdb.org/links/evidence/4390|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|4391|https://civicdb.org/links/evidence/4391|26582647 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|6252|https://civicdb.org/links/evidence/6252|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F317L|1028|RS121913451&F336L&PHE317LEU&RS1057519773|https://civicdb.org/links/variants/1028|BCR::ABL1 Fusion AND ABL1 F317L|4376||https://civicdb.org/links/molecular-profiles/4376|NM_005157.5:c.951C>G&NP_005148.2:p.Phe317Leu&NC_000009.11:g.133748290C>G&ENST00000318560.5:c.951C>G&NC_000009.11:g.133748288T>C&NM_005157.5:c.949T>C&ENST00000318560.5:c.949T>C|CA16602555|376094&376352|96.5|evidence|6270|https://civicdb.org/links/evidence/6270|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|2|||||
9	133748300	1657	GG	CT	.	.	CSQ=CT|Coding Sequence Variant|ABL1|25|transcript|ENST00000372348.2|||G340L|1657|GLY340LEU|https://civicdb.org/links/variants/1657|ABL1 G340L|1565|GLY340LEU|https://civicdb.org/links/molecular-profiles/1565||unregistered||3.0|evidence|4788|https://civicdb.org/links/evidence/4788|26758680 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)&Imatinib Mesylate (NCIt ID C1687)|SUBSTITUTES||D|3|||||;GN=ABL1;VT=G340L
9	133748331	1529	A	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.992A>G||N331S|1529|N350S&RS144448357&ASN331SER&ASN350SER|https://civicdb.org/links/variants/1529|BCR::ABL1 Fusion AND ABL1 N331S|4897||https://civicdb.org/links/molecular-profiles/4897|ENST00000318560.5:c.992A>G&NC_000009.11:g.133748331A>G&NM_005157.5:c.992A>G&NP_005148.2:p.Asn331Ser|CA5285356|NONE FOUND|0.0|evidence|4549|https://civicdb.org/links/evidence/4549|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||;GN=ABL1;VT=N331S
9	133748333	1656	C	T	.	.	VT=R351W;GN=ABL1;CSQ=T|Missense Variant|ABL1|25|transcript|ENST00000372348.2|ENST00000372348.2:c.1051C>T||R351W|1656|R332W&ARG351TRP&RS779478267|https://civicdb.org/links/variants/1656|ABL1 R351W|1564|R332W&ARG351TRP&RS779478267|https://civicdb.org/links/molecular-profiles/1564|ENST00000372348.2:c.1051C>T&NC_000009.11:g.133748333C>T&NM_007313.2:c.1051C>T&NP_009297.2:p.Arg351Trp|CA5285359|NONE FOUND|9.0|evidence|6376|https://civicdb.org/links/evidence/6376|26758680 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Imatinib (NCIt ID C62035)|||D|5|||||,T|Missense Variant|ABL1|25|transcript|ENST00000372348.2|ENST00000372348.2:c.1051C>T||R351W|1656|R332W&ARG351TRP&RS779478267|https://civicdb.org/links/variants/1656|ABL1 R351W|1564|R332W&ARG351TRP&RS779478267|https://civicdb.org/links/molecular-profiles/1564|ENST00000372348.2:c.1051C>T&NC_000009.11:g.133748333C>T&NM_007313.2:c.1051C>T&NP_009297.2:p.Arg351Trp|CA5285359|NONE FOUND|9.0|evidence|4787|https://civicdb.org/links/evidence/4787|26758680 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dasatinib (NCIt ID C38713)|||D|4|||||
9	133748346	1640	A	G	.	.	VT=N336S;GN=ABL1;CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1007A>G||N336S|1640|N355S&ASN336SER&ASN355SER|https://civicdb.org/links/variants/1640|BCR::ABL1 Fusion AND ABL1 N336S|4898||https://civicdb.org/links/molecular-profiles/4898|ENST00000318560.5:c.1007A>G&NC_000009.11:g.133748346A>G&NM_005157.5:c.1007A>G&NP_005148.2:p.Asn336Ser|CA375249553|NONE FOUND|0.0|evidence|4769|https://civicdb.org/links/evidence/4769|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1007A>G||N336S|1640|N355S&ASN336SER&ASN355SER|https://civicdb.org/links/variants/1640|BCR::ABL1 Fusion AND ABL1 N336S|4898||https://civicdb.org/links/molecular-profiles/4898|ENST00000318560.5:c.1007A>G&NC_000009.11:g.133748346A>G&NM_005157.5:c.1007A>G&NP_005148.2:p.Asn336Ser|CA375249553|NONE FOUND|0.0|evidence|6979|https://civicdb.org/links/evidence/6979|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||
9	133748367	1524	T	C	.	.	CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1028T>C||M343T|1524|M362T&MET343THR&MET362THR|https://civicdb.org/links/variants/1524|BCR::ABL1 Fusion AND ABL1 M343T|4889||https://civicdb.org/links/molecular-profiles/4889|ENST00000318560.5:c.1028T>C&NC_000009.11:g.133748367T>C&NM_005157.5:c.1028T>C&NP_005148.2:p.Met343Thr|CA375249596|NONE FOUND|0.0|evidence|4534|https://civicdb.org/links/evidence/4534|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;GN=ABL1;VT=M343T
9	133748391	1029	T	C	.	.	CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|4396|https://civicdb.org/links/evidence/4396|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|4|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|2683|https://civicdb.org/links/evidence/2683|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|4|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|4398|https://civicdb.org/links/evidence/4398|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|4394|https://civicdb.org/links/evidence/4394|22371878 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|4397|https://civicdb.org/links/evidence/4397|17264298 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|6989|https://civicdb.org/links/evidence/6989|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|7037|https://civicdb.org/links/evidence/7037|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|2682|https://civicdb.org/links/evidence/2682|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|2685|https://civicdb.org/links/evidence/2685|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|2686|https://civicdb.org/links/evidence/2686|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Bafetinib (NCIt ID C62516)&Dasatinib (NCIt ID C38713)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|7841|https://civicdb.org/links/evidence/7841|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Imatinib (NCIt ID C62035)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|2684|https://civicdb.org/links/evidence/2684|15930265 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|4399|https://civicdb.org/links/evidence/4399|26582647 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|6254|https://civicdb.org/links/evidence/6254|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1052T>C||M351T|1029|RS121913457&M370T&MET351THR&MET370THR|https://civicdb.org/links/variants/1029|BCR::ABL1 Fusion AND ABL1 M351T|4556||https://civicdb.org/links/molecular-profiles/4556|NM_005157.5:c.1052T>C&NP_005148.2:p.Met351Thr&NC_000009.11:g.133748391T>C&ENST00000318560.5:c.1052T>C|CA122590|12629|65.5|evidence|7769|https://civicdb.org/links/evidence/7769|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;GN=ABL1;VT=M351T
9	133748403	4609	A	G	.	.	VT=E355G;GN=ABL1;CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|4403|https://civicdb.org/links/evidence/4403|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|2664|https://civicdb.org/links/evidence/2664|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|4404|https://civicdb.org/links/evidence/4404|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|8090|https://civicdb.org/links/evidence/8090|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|4400|https://civicdb.org/links/evidence/4400|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|4402|https://civicdb.org/links/evidence/4402|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|7036|https://civicdb.org/links/evidence/7036|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1064A>G||E355G|4609|RS121913450&GLU355GLY|https://civicdb.org/links/variants/4609|BCR::ABL1 Fusion AND ABL1 E355G|4678||https://civicdb.org/links/molecular-profiles/4678|NM_005157.5:c.1064A>G&NP_005148.2:p.Glu355Gly&NC_000009.11:g.133748403A>G&ENST00000318560.5:c.1064A>G|CA16602556|376095|0.0|evidence|6255|https://civicdb.org/links/evidence/6255|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||
9	133748414	4607	T	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||F359I|4607|RS121913452&F378I&PHE359ILE|https://civicdb.org/links/variants/4607|BCR::ABL1 Fusion AND ABL1 F359I|4675||https://civicdb.org/links/molecular-profiles/4675|NM_005157.5:c.1075T>A&NP_005148.2:p.Phe359Ile&NC_000009.11:g.133748414T>A&ENST00000318560.5:c.1075T>A|CA16602580|376122|0.0|evidence|4532|https://civicdb.org/links/evidence/4532|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||F359I|4607|RS121913452&F378I&PHE359ILE|https://civicdb.org/links/variants/4607|BCR::ABL1 Fusion AND ABL1 F359I|4675||https://civicdb.org/links/molecular-profiles/4675|NM_005157.5:c.1075T>A&NP_005148.2:p.Phe359Ile&NC_000009.11:g.133748414T>A&ENST00000318560.5:c.1075T>A|CA16602580|376122|0.0|evidence|4533|https://civicdb.org/links/evidence/4533|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||F359I|4607|RS121913452&F378I&PHE359ILE|https://civicdb.org/links/variants/4607|BCR::ABL1 Fusion AND ABL1 F359I|4675||https://civicdb.org/links/molecular-profiles/4675|NM_005157.5:c.1075T>A&NP_005148.2:p.Phe359Ile&NC_000009.11:g.133748414T>A&ENST00000318560.5:c.1075T>A|CA16602580|376122|0.0|evidence|4530|https://civicdb.org/links/evidence/4530|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||F359I|4607|RS121913452&F378I&PHE359ILE|https://civicdb.org/links/variants/4607|BCR::ABL1 Fusion AND ABL1 F359I|4675||https://civicdb.org/links/molecular-profiles/4675|NM_005157.5:c.1075T>A&NP_005148.2:p.Phe359Ile&NC_000009.11:g.133748414T>A&ENST00000318560.5:c.1075T>A|CA16602580|376122|0.0|evidence|4531|https://civicdb.org/links/evidence/4531|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||F359I|4607|RS121913452&F378I&PHE359ILE|https://civicdb.org/links/variants/4607|BCR::ABL1 Fusion AND ABL1 F359I|4675||https://civicdb.org/links/molecular-profiles/4675|NM_005157.5:c.1075T>A&NP_005148.2:p.Phe359Ile&NC_000009.11:g.133748414T>A&ENST00000318560.5:c.1075T>A|CA16602580|376122|0.0|evidence|6984|https://civicdb.org/links/evidence/6984|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||F359I|4607|RS121913452&F378I&PHE359ILE|https://civicdb.org/links/variants/4607|BCR::ABL1 Fusion AND ABL1 F359I|4675||https://civicdb.org/links/molecular-profiles/4675|NM_005157.5:c.1075T>A&NP_005148.2:p.Phe359Ile&NC_000009.11:g.133748414T>A&ENST00000318560.5:c.1075T>A|CA16602580|376122|0.0|evidence|4529|https://civicdb.org/links/evidence/4529|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1075T>A||F359I|4607|RS121913452&F378I&PHE359ILE|https://civicdb.org/links/variants/4607|BCR::ABL1 Fusion AND ABL1 L248R AND ABL1 F359I|4876||https://civicdb.org/links/molecular-profiles/4876|NM_005157.5:c.1075T>A&NP_005148.2:p.Phe359Ile&NC_000009.11:g.133748414T>A&ENST00000318560.5:c.1075T>A|CA16602580|376122|0.0|evidence|7775|https://civicdb.org/links/evidence/7775|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;GN=ABL1;VT=F359I
9	133748414	4598	T	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|3819|https://civicdb.org/links/evidence/3819|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|6970|https://civicdb.org/links/evidence/6970|19652056 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|2168|https://civicdb.org/links/evidence/2168|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|2169|https://civicdb.org/links/evidence/2169|15930265 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|3815|https://civicdb.org/links/evidence/3815|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|3820|https://civicdb.org/links/evidence/3820|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|3816|https://civicdb.org/links/evidence/3816|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|3817|https://civicdb.org/links/evidence/3817|17264298 (PUBMED)|SOMATIC|accepted|REDUCED_SENSITIVITY|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|6995|https://civicdb.org/links/evidence/6995|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|7043|https://civicdb.org/links/evidence/7043|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|8002|https://civicdb.org/links/evidence/8002|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|2170|https://civicdb.org/links/evidence/2170|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|2167|https://civicdb.org/links/evidence/2167|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|3822|https://civicdb.org/links/evidence/3822|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||F359V|4598|RS121913452|https://civicdb.org/links/variants/4598|BCR::ABL1 Fusion AND ABL1 F359V|4664||https://civicdb.org/links/molecular-profiles/4664|NM_005157.5:c.1075T>G&NP_005148.2:p.Phe359Val&NC_000009.11:g.133748414T>G&NST00000318560.5:c.1075T>G|CA16602557|376096|0.0|evidence|6256|https://civicdb.org/links/evidence/6256|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||;GN=ABL1;VT=F359V
9	133748415	4610	T	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|4483|https://civicdb.org/links/evidence/4483|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|4|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|4482|https://civicdb.org/links/evidence/4482|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|6233|https://civicdb.org/links/evidence/6233|19652056 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|4481|https://civicdb.org/links/evidence/4481|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|4480|https://civicdb.org/links/evidence/4480|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|6985|https://civicdb.org/links/evidence/6985|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|7035|https://civicdb.org/links/evidence/7035|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|2854|https://civicdb.org/links/evidence/2854|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1076T>G||F359C|4610|RS1057519775&F378C&PHE359CYS|https://civicdb.org/links/variants/4610|BCR::ABL1 Fusion AND ABL1 F359C|4680|BCR-ABL1 F359C&BCR-ABL1 PHE359CYS&BCR-ABL F359C&BCR-ABL PHE359CYS&BCR::ABL1 F359C|https://civicdb.org/links/molecular-profiles/4680|NM_005157.5:c.1076T>G&NP_005148.2:p.Phe359Cys&NC_000009.11:g.133748415T>G&ENST00000318560.5:c.1076T>G|CA16602582|376124|0.0|evidence|6239|https://civicdb.org/links/evidence/6239|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|COMBINATION||D|2|||||;GN=ABL1;VT=F359C
9	133750259	1508	C	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1090C>A||L364I|1508|L383I&LEU364ILE|https://civicdb.org/links/variants/1508|BCR::ABL1 Fusion AND ABL1 L364I|4877||https://civicdb.org/links/molecular-profiles/4877|ENST00000318560.5:c.1090C>A&NC_000009.11:g.133750259C>A&NM_005157.5:c.1090C>A&NP_005148.2:p.Leu364Ile|CA375249753|NONE FOUND|0.0|evidence|4434|https://civicdb.org/links/evidence/4434|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1090C>A||L364I|1508|L383I&LEU364ILE|https://civicdb.org/links/variants/1508|BCR::ABL1 Fusion AND ABL1 L364I|4877||https://civicdb.org/links/molecular-profiles/4877|ENST00000318560.5:c.1090C>A&NC_000009.11:g.133750259C>A&NM_005157.5:c.1090C>A&NP_005148.2:p.Leu364Ile|CA375249753|NONE FOUND|0.0|evidence|7826|https://civicdb.org/links/evidence/7826|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1090C>A||L364I|1508|L383I&LEU364ILE|https://civicdb.org/links/variants/1508|BCR::ABL1 Fusion AND ABL1 L364I AND ABL1 M244V|4888||https://civicdb.org/links/molecular-profiles/4888|ENST00000318560.5:c.1090C>A&NC_000009.11:g.133750259C>A&NM_005157.5:c.1090C>A&NP_005148.2:p.Leu364Ile|CA375249753|NONE FOUND|0.0|evidence|7943|https://civicdb.org/links/evidence/7943|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||;VT=L364I;GN=ABL1
9	133750260	1530	T	C	.	.	CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1091T>C||L364P|1530|L383P&LEU364PRO&LEU383PRO|https://civicdb.org/links/variants/1530|BCR::ABL1 Fusion AND ABL1 L364P|4884||https://civicdb.org/links/molecular-profiles/4884|ENST00000318560.5:c.1091T>C&NC_000009.11:g.133750260T>C&NM_005157.5:c.1091T>C&NP_005148.2:p.Leu364Pro|CA375249757|NONE FOUND|0.0|evidence|4551|https://civicdb.org/links/evidence/4551|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||;VT=L364P;GN=ABL1
9	133750304	1609	G	A	.	.	VT=V379I;CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||V379I|1609|V398I&VAL379ILE&VAL398ILE|https://civicdb.org/links/variants/1609|ABL1 V379I|1517|V398I&VAL379ILE&VAL398ILE|https://civicdb.org/links/molecular-profiles/1517|ENST00000318560.5:c.1135G>A&NC_000009.11:g.133750304G>A&NM_005157.5:c.1135G>A&NP_005148.2:p.Val379Ile|CA375249852|NONE FOUND|19.5|evidence|4704|https://civicdb.org/links/evidence/4704|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||V379I|1609|V398I&VAL379ILE&VAL398ILE|https://civicdb.org/links/variants/1609|BCR::ABL1 Fusion AND ABL1 V379I|5238||https://civicdb.org/links/molecular-profiles/5238|ENST00000318560.5:c.1135G>A&NC_000009.11:g.133750304G>A&NM_005157.5:c.1135G>A&NP_005148.2:p.Val379Ile|CA375249852|NONE FOUND|0.0|evidence|4702|https://civicdb.org/links/evidence/4702|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||V379I|1609|V398I&VAL379ILE&VAL398ILE|https://civicdb.org/links/variants/1609|BCR::ABL1 Fusion AND ABL1 V379I|5238||https://civicdb.org/links/molecular-profiles/5238|ENST00000318560.5:c.1135G>A&NC_000009.11:g.133750304G>A&NM_005157.5:c.1135G>A&NP_005148.2:p.Val379Ile|CA375249852|NONE FOUND|0.0|evidence|7033|https://civicdb.org/links/evidence/7033|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1135G>A||V379I|1609|V398I&VAL379ILE&VAL398ILE|https://civicdb.org/links/variants/1609|BCR::ABL1 Fusion AND ABL1 V379I|5238||https://civicdb.org/links/molecular-profiles/5238|ENST00000318560.5:c.1135G>A&NC_000009.11:g.133750304G>A&NM_005157.5:c.1135G>A&NP_005148.2:p.Val379Ile|CA375249852|NONE FOUND|0.0|evidence|6257|https://civicdb.org/links/evidence/6257|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||;GN=ABL1
9	133750319	1230	C	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1150C>A||L384M|1230|L403M&LEU403MET&LEU384MET|https://civicdb.org/links/variants/1230|BCR::ABL1 Fusion AND ABL1 L384M|4885||https://civicdb.org/links/molecular-profiles/4885|ENST00000318560.5:c.1150C>A&NC_000009.11:g.133750319C>A&NM_005157.5:c.1150C>A&NP_005148.2:p.Leu384Met|CA375249885|NONE FOUND|0.0|evidence|4527|https://civicdb.org/links/evidence/4527|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1150C>A||L384M|1230|L403M&LEU403MET&LEU384MET|https://civicdb.org/links/variants/1230|BCR::ABL1 Fusion AND ABL1 L384M|4885||https://civicdb.org/links/molecular-profiles/4885|ENST00000318560.5:c.1150C>A&NC_000009.11:g.133750319C>A&NM_005157.5:c.1150C>A&NP_005148.2:p.Leu384Met|CA375249885|NONE FOUND|0.0|evidence|4525|https://civicdb.org/links/evidence/4525|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1150C>A||L384M|1230|L403M&LEU403MET&LEU384MET|https://civicdb.org/links/variants/1230|BCR::ABL1 Fusion AND ABL1 L384M|4885||https://civicdb.org/links/molecular-profiles/4885|ENST00000318560.5:c.1150C>A&NC_000009.11:g.133750319C>A&NM_005157.5:c.1150C>A&NP_005148.2:p.Leu384Met|CA375249885|NONE FOUND|0.0|evidence|2861|https://civicdb.org/links/evidence/2861|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|1|||||;GN=ABL1;VT=L384M
9	133750328	1488	T	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1159T>A||L387M|1488|LEU387MET|https://civicdb.org/links/variants/1488|BCR::ABL1 Fusion AND ABL1 L387M|4887||https://civicdb.org/links/molecular-profiles/4887|ENST00000318560.5:c.1159T>A&NC_000009.11:g.133750328T>A&NM_005157.5:c.1159T>A&NP_005148.2:p.Leu387Met|CA375249905|NONE FOUND|0.0|evidence|4406|https://civicdb.org/links/evidence/4406|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1159T>A||L387M|1488|LEU387MET|https://civicdb.org/links/variants/1488|BCR::ABL1 Fusion AND ABL1 L387M|4887||https://civicdb.org/links/molecular-profiles/4887|ENST00000318560.5:c.1159T>A&NC_000009.11:g.133750328T>A&NM_005157.5:c.1159T>A&NP_005148.2:p.Leu387Met|CA375249905|NONE FOUND|0.0|evidence|4407|https://civicdb.org/links/evidence/4407|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||;GN=ABL1;VT=L387M
9	133750330	1232	G	C	.	.	VT=L387F;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1161G>C||L387F|1232|L406F&LEU406PHE&LEU387PHE|https://civicdb.org/links/variants/1232|BCR::ABL1 Fusion AND ABL1 L387F|4886||https://civicdb.org/links/molecular-profiles/4886|ENST00000318560.5:c.1161G>C&NC_000009.11:g.133750330G>C&NM_005157.5:c.1161G>C&NP_005148.2:p.Leu387Phe|CA375249910|NONE FOUND|0.0|evidence|4552|https://civicdb.org/links/evidence/4552|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1161G>C||L387F|1232|L406F&LEU406PHE&LEU387PHE|https://civicdb.org/links/variants/1232|BCR::ABL1 Fusion AND ABL1 L387F|4886||https://civicdb.org/links/molecular-profiles/4886|ENST00000318560.5:c.1161G>C&NC_000009.11:g.133750330G>C&NM_005157.5:c.1161G>C&NP_005148.2:p.Leu387Phe|CA375249910|NONE FOUND|0.0|evidence|6981|https://civicdb.org/links/evidence/6981|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1161G>C||L387F|1232|L406F&LEU406PHE&LEU387PHE|https://civicdb.org/links/variants/1232|BCR::ABL1 Fusion AND ABL1 L387F|4886||https://civicdb.org/links/molecular-profiles/4886|ENST00000318560.5:c.1161G>C&NC_000009.11:g.133750330G>C&NM_005157.5:c.1161G>C&NP_005148.2:p.Leu387Phe|CA375249910|NONE FOUND|0.0|evidence|2863|https://civicdb.org/links/evidence/2863|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|2|||||;GN=ABL1
9	133750331	1610	A	T	.	.	VT=M388L;CSQ=T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1162A>T||M388L|1610|M407L&MET388LEU|https://civicdb.org/links/variants/1610|BCR::ABL1 Fusion AND ABL1 M388L|4890||https://civicdb.org/links/molecular-profiles/4890|ENST00000318560.5:c.1162A>T&NC_000009.11:g.133750331A>T&NM_005157.5:c.1162A>T&NP_005148.2:p.Met388Leu|CA375249914|NONE FOUND|0.0|evidence|7950|https://civicdb.org/links/evidence/7950|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||;GN=ABL1
9	133750356	1531	A	C	.	.	VT=H396P;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||H396P|1531|HIS396PRO&H415P|https://civicdb.org/links/variants/1531|BCR::ABL1 Fusion AND ABL1 H396P|4873||https://civicdb.org/links/molecular-profiles/4873|ENST00000318560.5:c.1187A>C&NC_000009.11:g.133750356A>C&NM_005157.5:c.1187A>C&NP_005148.2:p.His396Pro|CA375249969|NONE FOUND|0.0|evidence|4554|https://civicdb.org/links/evidence/4554|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||H396P|1531|HIS396PRO&H415P|https://civicdb.org/links/variants/1531|BCR::ABL1 Fusion AND ABL1 H396P|4873||https://civicdb.org/links/molecular-profiles/4873|ENST00000318560.5:c.1187A>C&NC_000009.11:g.133750356A>C&NM_005157.5:c.1187A>C&NP_005148.2:p.His396Pro|CA375249969|NONE FOUND|0.0|evidence|7846|https://civicdb.org/links/evidence/7846|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Bafetinib (NCIt ID C62516)&Nilotinib (NCIt ID C48375)|SUBSTITUTES||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||H396P|1531|HIS396PRO&H415P|https://civicdb.org/links/variants/1531|BCR::ABL1 Fusion AND ABL1 H396P|4873||https://civicdb.org/links/molecular-profiles/4873|ENST00000318560.5:c.1187A>C&NC_000009.11:g.133750356A>C&NM_005157.5:c.1187A>C&NP_005148.2:p.His396Pro|CA375249969|NONE FOUND|0.0|evidence|7847|https://civicdb.org/links/evidence/7847|18191450 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Imatinib (NCIt ID C62035)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||H396P|1531|HIS396PRO&H415P|https://civicdb.org/links/variants/1531|BCR::ABL1 Fusion AND ABL1 H396P|4873||https://civicdb.org/links/molecular-profiles/4873|ENST00000318560.5:c.1187A>C&NC_000009.11:g.133750356A>C&NM_005157.5:c.1187A>C&NP_005148.2:p.His396Pro|CA375249969|NONE FOUND|0.0|evidence|9084|https://civicdb.org/links/evidence/9084|18191450 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Dasatinib (NCIt ID C38713)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||H396P|1531|HIS396PRO&H415P|https://civicdb.org/links/variants/1531|BCR::ABL1 Fusion AND ABL1 H396P|4873||https://civicdb.org/links/molecular-profiles/4873|ENST00000318560.5:c.1187A>C&NC_000009.11:g.133750356A>C&NM_005157.5:c.1187A>C&NP_005148.2:p.His396Pro|CA375249969|NONE FOUND|0.0|evidence|6240|https://civicdb.org/links/evidence/6240|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)&Nilotinib (NCIt ID C48375)|COMBINATION||D|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>C||H396P|1531|HIS396PRO&H415P|https://civicdb.org/links/variants/1531|BCR::ABL1 Fusion AND ABL1 H396P|4873||https://civicdb.org/links/molecular-profiles/4873|ENST00000318560.5:c.1187A>C&NC_000009.11:g.133750356A>C&NM_005157.5:c.1187A>C&NP_005148.2:p.His396Pro|CA375249969|NONE FOUND|0.0|evidence|7770|https://civicdb.org/links/evidence/7770|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;GN=ABL1
9	133750356	4611	A	G	.	.	VT=H396R;CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|4413|https://civicdb.org/links/evidence/4413|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|7823|https://civicdb.org/links/evidence/7823|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|2688|https://civicdb.org/links/evidence/2688|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|4410|https://civicdb.org/links/evidence/4410|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|4411|https://civicdb.org/links/evidence/4411|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|6988|https://civicdb.org/links/evidence/6988|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|2687|https://civicdb.org/links/evidence/2687|19075254 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|2689|https://civicdb.org/links/evidence/2689|15930265 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|4417|https://civicdb.org/links/evidence/4417|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||,G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1187A>G||H396R|4611|RS121913454&HIS396ARG|https://civicdb.org/links/variants/4611|BCR::ABL1 Fusion AND ABL1 H396R|4683|BCR-ABL1 H396R&BCR-ABL H396R&BCR::ABL H396R&BCR::ABL1 H396R|https://civicdb.org/links/molecular-profiles/4683|NM_005157.5:c.1187A>G&NP_005148.2:p.His396Arg&NC_000009.11:g.133750356A>G&ENST00000318560.5:c.1187A>G|CA16602558|376097|0.0|evidence|6258|https://civicdb.org/links/evidence/6258|16772610 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||D|2|||||;GN=ABL1
9	133750358	4636	G	C	.	.	VT=A397P;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1189G>C||A397P|4636|A416P&ALA397PRO|https://civicdb.org/links/variants/4636|BCR::ABL1 Fusion AND ABL1 A397P|4723||https://civicdb.org/links/molecular-profiles/4723|ENST00000318560.5:c.1189G>C&NC_000009.11:g.133750358G>C&NM_005157.5:c.1189G>C&NP_005148.2:p.Ala397Pro|CA375249974|NONE FOUND|0.0|evidence|4710|https://civicdb.org/links/evidence/4710|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1189G>C||A397P|4636|A416P&ALA397PRO|https://civicdb.org/links/variants/4636|BCR::ABL1 Fusion AND ABL1 A397P|4723||https://civicdb.org/links/molecular-profiles/4723|ENST00000318560.5:c.1189G>C&NC_000009.11:g.133750358G>C&NM_005157.5:c.1189G>C&NP_005148.2:p.Ala397Pro|CA375249974|NONE FOUND|0.0|evidence|7034|https://civicdb.org/links/evidence/7034|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||;GN=ABL1
9	133750361	1233	G	C	.	.	CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1192G>C||G398R|1233|G417R&GLY398ARG&GLY417ARG|https://civicdb.org/links/variants/1233|BCR::ABL1 Fusion AND ABL1 G398R|4872||https://civicdb.org/links/molecular-profiles/4872|ENST00000318560.5:c.1192G>C&NC_000009.11:g.133750361G>C&NM_005157.5:c.1192G>C&NP_005148.2:p.Gly398Arg|CA375249980|NONE FOUND|0.0|evidence|2864|https://civicdb.org/links/evidence/2864|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1192G>C||G398R|1233|G417R&GLY398ARG&GLY417ARG|https://civicdb.org/links/variants/1233|BCR::ABL1 Fusion AND ABL1 G398R|4872||https://civicdb.org/links/molecular-profiles/4872|ENST00000318560.5:c.1192G>C&NC_000009.11:g.133750361G>C&NM_005157.5:c.1192G>C&NP_005148.2:p.Gly398Arg|CA375249980|NONE FOUND|0.0|evidence|4561|https://civicdb.org/links/evidence/4561|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||D|2|||||;GN=ABL1;VT=G398R
9	133750419	1613	C	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1250C>A||S417Y|1613|SER417TYR|https://civicdb.org/links/variants/1613|BCR::ABL1 Fusion AND ABL1 S417Y|4902||https://civicdb.org/links/molecular-profiles/4902|ENST00000318560.5:c.1250C>A&NC_000009.11:g.133750419C>A&NM_005157.5:c.1250C>A&NP_005148.2:p.Ser417Tyr|CA375250115|NONE FOUND|0.0|evidence|2679|https://civicdb.org/links/evidence/2679|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||;VT=S417Y;GN=ABL1
9	133750431	4638	A	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|||D421G|4638|ASP421GLY|https://civicdb.org/links/variants/4638|BCR::ABL1 Fusion AND ABL1 D421G|4727||https://civicdb.org/links/molecular-profiles/4727||CA375250143|NONE FOUND|0.0|evidence|4559|https://civicdb.org/links/evidence/4559|21865346 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||;VT=D421G;GN=ABL1
9	133753844	1495	C	G	.	.	VT=S438C;GN=ABL1;CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1313C>G||S438C|1495|S457C&SER438CYS&SER457CYS|https://civicdb.org/links/variants/1495|BCR::ABL1 Fusion AND ABL1 S438C|4903||https://civicdb.org/links/molecular-profiles/4903|ENST00000318560.5:c.1313C>G|CA375251077|NONE FOUND|0.0|evidence|7948|https://civicdb.org/links/evidence/7948|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|3|||||
9	133753879	1618	G	C	.	.	CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1348G>C||E450Q|1618|E469Q&GLU450GLN|https://civicdb.org/links/variants/1618|BCR::ABL1 Fusion AND ABL1 E450Q|4746||https://civicdb.org/links/molecular-profiles/4746|ENST00000318560.5:c.1348G>C&NC_000009.11:g.133753879G>C&NM_005157.5:c.1348G>C&NP_005148.2:p.Glu450Gln|CA375251152|NONE FOUND|0.0|evidence|7942|https://civicdb.org/links/evidence/7942|16775234 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|4|||||;GN=ABL1;VT=E450Q
9	133753880	1534	A	T	.	.	CSQ=T|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1349A>T||E450V|1534|E469V&GLU450VAL|https://civicdb.org/links/variants/1534|BCR::ABL1 Fusion AND ABL1 E450V|4828||https://civicdb.org/links/molecular-profiles/4828|ENST00000318560.5:c.1349A>T&NC_000009.11:g.133753880A>T&NM_005157.5:c.1349A>T&NP_005148.2:p.Glu450Val|CA375251155|NONE FOUND|0.0|evidence|4563|https://civicdb.org/links/evidence/4563|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||;VT=E450V;GN=ABL1
9	133753888	1535	G	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1357G>A||E453K|1535|E472K&GLU453LYS|https://civicdb.org/links/variants/1535|BCR::ABL1 Fusion AND ABL1 E453K|4830||https://civicdb.org/links/molecular-profiles/4830|ENST00000318560.5:c.1357G>A&NC_000009.11:g.133753888G>A&NM_005157.5:c.1357G>A&NP_005148.2:p.Glu453Lys|CA375251169|NONE FOUND|0.0|evidence|4565|https://civicdb.org/links/evidence/4565|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||;VT=E453K;GN=ABL1
9	133753888	1509	G	C	.	.	VT=E453Q;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1357G>C||E453Q|1509|E472Q&GLU453GLN|https://civicdb.org/links/variants/1509|BCR::ABL1 Fusion AND ABL1 E453Q|4832||https://civicdb.org/links/molecular-profiles/4832|ENST00000318560.5:c.1357G>C&NC_000009.11:g.133753888G>C&NM_005157.5:c.1357G>C&NP_005148.2:p.Glu453Gln|CA375251170|NONE FOUND|0.0|evidence|4486|https://civicdb.org/links/evidence/4486|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|2|||||;GN=ABL1
9	133753889	1536	A	C	.	.	CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1358A>C||E453A|1536|E472A&GLU453ALA|https://civicdb.org/links/variants/1536|BCR::ABL1 Fusion AND ABL1 E453A|4829||https://civicdb.org/links/molecular-profiles/4829|ENST00000318560.5:c.1358A>C&NC_000009.11:g.133753889A>C&NM_005157.5:c.1358A>C&NP_005148.2:p.Glu453Ala|CA375251172|NONE FOUND|0.0|evidence|4567|https://civicdb.org/links/evidence/4567|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1358A>C||E453A|1536|E472A&GLU453ALA|https://civicdb.org/links/variants/1536|BCR::ABL1 Fusion AND ABL1 E453A|4829||https://civicdb.org/links/molecular-profiles/4829|ENST00000318560.5:c.1358A>C&NC_000009.11:g.133753889A>C&NM_005157.5:c.1358A>C&NP_005148.2:p.Glu453Ala|CA375251172|NONE FOUND|0.0|evidence|6980|https://civicdb.org/links/evidence/6980|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||;VT=E453A;GN=ABL1
9	133753906	2370	G	A	.	.	CSQ=A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||E459K|2370|RS1064156&GLU459LYS|https://civicdb.org/links/variants/2370|BCR::ABL1 Fusion AND ABL1 E459K|4833||https://civicdb.org/links/molecular-profiles/4833|ENST00000318560.5:c.1375G>A&NC_000009.11:g.133753906G>A&NM_005157.5:c.1375G>A&NP_005148.2:p.Glu459Lys|CA200648598|NONE FOUND|0.0|evidence|6310|https://civicdb.org/links/evidence/6310|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||E459K|2370|RS1064156&GLU459LYS|https://civicdb.org/links/variants/2370|BCR::ABL1 Fusion AND ABL1 E459K|4833||https://civicdb.org/links/molecular-profiles/4833|ENST00000318560.5:c.1375G>A&NC_000009.11:g.133753906G>A&NM_005157.5:c.1375G>A&NP_005148.2:p.Glu459Lys|CA200648598|NONE FOUND|0.0|evidence|8092|https://civicdb.org/links/evidence/8092|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||E459K|2370|RS1064156&GLU459LYS|https://civicdb.org/links/variants/2370|BCR::ABL1 Fusion AND ABL1 E459K|4833||https://civicdb.org/links/molecular-profiles/4833|ENST00000318560.5:c.1375G>A&NC_000009.11:g.133753906G>A&NM_005157.5:c.1375G>A&NP_005148.2:p.Glu459Lys|CA200648598|NONE FOUND|0.0|evidence|7031|https://civicdb.org/links/evidence/7031|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||C|1|||||,A|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1375G>A||E459K|2370|RS1064156&GLU459LYS|https://civicdb.org/links/variants/2370|BCR::ABL1 Fusion AND ABL1 E459K|4833||https://civicdb.org/links/molecular-profiles/4833|ENST00000318560.5:c.1375G>A&NC_000009.11:g.133753906G>A&NM_005157.5:c.1375G>A&NP_005148.2:p.Glu459Lys|CA200648598|NONE FOUND|0.0|evidence|7046|https://civicdb.org/links/evidence/7046|17264298 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||;GN=ABL1;VT=E459K
9	133755469	1537	C	G	.	.	CSQ=G|Missense Variant|ABL1|25|transcript|ENST00000318560.5|ENST00000318560.5:c.1438C>G||P480A|1537|P499A&PRO480ALA&PRO499ALA|https://civicdb.org/links/variants/1537|BCR::ABL1 Fusion AND ABL1 P480A|4899||https://civicdb.org/links/molecular-profiles/4899|ENST00000318560.5:c.1438C>G&NC_000009.11:g.133755469C>G&NM_005157.5:c.1438C>G&NP_005148.2:p.Pro480Ala|CA375251559|NONE FOUND|0.0|evidence|4568|https://civicdb.org/links/evidence/4568|21865346 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||;VT=P480A;GN=ABL1
9	133755488	4635	T	C	.	.	VT=F486S;CSQ=C|Missense Variant|ABL1|25|transcript|ENST00000318560.6|||F486S|4635|PHE486SER&F505S|https://civicdb.org/links/variants/4635|BCR::ABL1 Fusion AND ABL1 F486S|4721||https://civicdb.org/links/molecular-profiles/4721|ENST00000318560.5:c.1457T>C&NC_000009.11:g.133755488T>C&NM_005157.5:c.1457T>C&NP_005148.2:p.Phe486Ser|CA375251598|NONE FOUND|0.0|evidence|4571|https://civicdb.org/links/evidence/4571|19779040 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Dasatinib (NCIt ID C38713)|||B|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.6|||F486S|4635|PHE486SER&F505S|https://civicdb.org/links/variants/4635|BCR::ABL1 Fusion AND ABL1 F486S|4721||https://civicdb.org/links/molecular-profiles/4721|ENST00000318560.5:c.1457T>C&NC_000009.11:g.133755488T>C&NM_005157.5:c.1457T>C&NP_005148.2:p.Phe486Ser|CA375251598|NONE FOUND|0.0|evidence|8091|https://civicdb.org/links/evidence/8091|12623848 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib (NCIt ID C62035)|||C|2|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.6|||F486S|4635|PHE486SER&F505S|https://civicdb.org/links/variants/4635|BCR::ABL1 Fusion AND ABL1 F486S|4721||https://civicdb.org/links/molecular-profiles/4721|ENST00000318560.5:c.1457T>C&NC_000009.11:g.133755488T>C&NM_005157.5:c.1457T>C&NP_005148.2:p.Phe486Ser|CA375251598|NONE FOUND|0.0|evidence|4440|https://civicdb.org/links/evidence/4440|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Bosutinib (NCIt ID C60809)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.6|||F486S|4635|PHE486SER&F505S|https://civicdb.org/links/variants/4635|BCR::ABL1 Fusion AND ABL1 F486S|4721||https://civicdb.org/links/molecular-profiles/4721|ENST00000318560.5:c.1457T>C&NC_000009.11:g.133755488T>C&NM_005157.5:c.1457T>C&NP_005148.2:p.Phe486Ser|CA375251598|NONE FOUND|0.0|evidence|6987|https://civicdb.org/links/evidence/6987|22371878 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Myeloid Leukemia|Imatinib Mesylate (NCIt ID C1687)|||C|1|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.6|||F486S|4635|PHE486SER&F505S|https://civicdb.org/links/variants/4635|BCR::ABL1 Fusion AND ABL1 F486S|4721||https://civicdb.org/links/molecular-profiles/4721|ENST00000318560.5:c.1457T>C&NC_000009.11:g.133755488T>C&NM_005157.5:c.1457T>C&NP_005148.2:p.Phe486Ser|CA375251598|NONE FOUND|0.0|evidence|2829|https://civicdb.org/links/evidence/2829|19075254 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Chronic Myeloid Leukemia|Nilotinib (NCIt ID C48375)|||D|3|||||,C|Missense Variant|ABL1|25|transcript|ENST00000318560.6|||F486S|4635|PHE486SER&F505S|https://civicdb.org/links/variants/4635|BCR::ABL1 Fusion AND ABL1 F486S|4721||https://civicdb.org/links/molecular-profiles/4721|ENST00000318560.5:c.1457T>C&NC_000009.11:g.133755488T>C&NM_005157.5:c.1457T>C&NP_005148.2:p.Phe486Ser|CA375251598|NONE FOUND|0.0|evidence|4438|https://civicdb.org/links/evidence/4438|25686603 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Myeloid Leukemia|Axitinib (NCIt ID C38718)|||D|2|||||;GN=ABL1
9	135771933	714	G	A	.	.	CSQ=A|Missense Variant|TSC1|7248|transcript|ENST00000298552.3|ENST00000298552.3:c.3184C>T||R1062W|714|ARG1062TRP|https://civicdb.org/links/variants/714|TSC1 R1062W|695|ARG1062TRP|https://civicdb.org/links/molecular-profiles/695|NM_000368.3:c.3184C>T&NP_000359.1:p.Arg1062Trp&ENST00000298552.3:c.3184C>T&NC_000009.11:g.135771933G>A|CA007223|49015|8.0|evidence|1768|https://civicdb.org/links/evidence/1768|20165957 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Tuberous Sclerosis||||C|2|||||,A|Missense Variant|TSC1|7248|transcript|ENST00000298552.3|ENST00000298552.3:c.3184C>T||R1062W|714|ARG1062TRP|https://civicdb.org/links/variants/714|TSC1 R1062W|695|ARG1062TRP|https://civicdb.org/links/molecular-profiles/695|NM_000368.3:c.3184C>T&NP_000359.1:p.Arg1062Trp&ENST00000298552.3:c.3184C>T&NC_000009.11:g.135771933G>A|CA007223|49015|8.0|evidence|1921|https://civicdb.org/links/evidence/1921|21309039 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Tuberous Sclerosis||||D|3|||||;GN=TSC1;VT=R1062W
9	139390861	137	GG	GTGT	.	.	GN=NOTCH1;CSQ=TGT|Frameshift Variant|NOTCH1|4851|transcript|ENST00000277541.6|ENST00000277541.6:c.7330delinsACA||V2444FS|137|VAL2444FS|https://civicdb.org/links/variants/137|NOTCH1 V2444FS|137|VAL2444FS|https://civicdb.org/links/molecular-profiles/137|ENST00000277541.6:c.7330delinsACA|CA913157307|NONE FOUND|20.0|evidence|383|https://civicdb.org/links/evidence/383|20007775 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|4|||||;VT=V2444FS
9	139391212	136	G	A	.	.	GN=NOTCH1;CSQ=A|Missense Variant|NOTCH1|4851|transcript|ENST00000277541.6|||R2327W|136|ARG2327TRP|https://civicdb.org/links/variants/136|NOTCH1 R2327W|136|ARG2327TRP|https://civicdb.org/links/molecular-profiles/136|NM_017617.4:c.6979C>T&NP_060087.3:p.Arg2327Trp&NC_000009.11:g.139391212G>A|CA5339772|376346|20.0|evidence|381|https://civicdb.org/links/evidence/381|20007775 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|4|||||;VT=R2327W
9	139391369	138	G	GA	.	.	GN=NOTCH1;VT=S2275FS;CSQ=A|Plus 1 Frameshift Variant|NOTCH1|4851|transcript|ENST00000277541.6|ENST00000277541.6:c.6821_6822insT||S2275FS|138||https://civicdb.org/links/variants/138|NOTCH1 S2275FS|138||https://civicdb.org/links/molecular-profiles/138|ENST00000277541.6:c.6821_6822insT&NC_000009.11:g.139391369_139391370insA|CA645544343|NONE FOUND|20.0|evidence|382|https://civicdb.org/links/evidence/382|20007775 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|4|||||
9	139399219	135	C	G	.	.	GN=NOTCH1;CSQ=G|Missense Variant|NOTCH1|4851|transcript|ENST00000277541.6|ENST00000277541.6:c.4924G>C||D1642H|135|ASP1642HIS|https://civicdb.org/links/variants/135|NOTCH1 D1642H|135|ASP1642HIS|https://civicdb.org/links/molecular-profiles/135|NC_000009.11:g.139399219C>G&ENST00000277541.6:c.4924G>C&NM_017617.4:c.4924G>C&NP_060087.3:p.Asp1642His|CA16602788|376345|20.0|evidence|380|https://civicdb.org/links/evidence/380|20007775 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|4|||||;VT=D1642H
10	43609070	1260	G	A	.	.	CSQ=A|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.1826G>A||C609Y|1260|CYS609TYR|https://civicdb.org/links/variants/1260|RET C609Y|1234|CYS609TYR|https://civicdb.org/links/molecular-profiles/1234|NM_020630.4:c.1826G>A&NC_000010.10:g.43609070G>A&NP_065681.1:p.Cys609Tyr&ENST00000355710.3:c.1826G>A|CA007824|13933|20.0|evidence|2913|https://civicdb.org/links/evidence/2913|19472011 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Medullary Thyroid Carcinoma||||B|4|||||;VT=C609Y;GN=RET
10	43609950	112	C	G	.	.	VT=C634W;CSQ=G|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.1902C>G||C634W|112|CYS634TRP|https://civicdb.org/links/variants/112|RET C634W|112|CYS634TRP|https://civicdb.org/links/molecular-profiles/112|NM_020975.4:c.1902C>G&NP_065681.1:p.Cys634Trp&ENST00000355710.3:c.1902C>G&NC_000010.10:g.43609950C>G|CA008378|13918|3.0|evidence|75|https://civicdb.org/links/evidence/75|21422803 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Medullary Thyroid Carcinoma|Motesanib (NCIt ID C71896)|||D|3|||||;GN=RET
10	43617416	113	T	C	.	.	VT=M918T;GN=RET;CSQ=C|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|MET918THR&RS74799832|https://civicdb.org/links/variants/113|RET M918T|113|MET918THR&RS74799832|https://civicdb.org/links/molecular-profiles/113|NM_020975.4:c.2753T>C&NP_065681.1:p.Met918Thr&ENST00000355710.3:c.2753T>C&NC_000010.10:g.43617416T>C|CA009082|13919|86.0|evidence|74|https://civicdb.org/links/evidence/74|18073307 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Medullary Thyroid Carcinoma||||B|5|||||,C|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|MET918THR&RS74799832|https://civicdb.org/links/variants/113|RET M918T|113|MET918THR&RS74799832|https://civicdb.org/links/molecular-profiles/113|NM_020975.4:c.2753T>C&NP_065681.1:p.Met918Thr&ENST00000355710.3:c.2753T>C&NC_000010.10:g.43617416T>C|CA009082|13919|86.0|evidence|78|https://civicdb.org/links/evidence/78|9839497 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Medullary Thyroid Carcinoma||||B|4|||||,C|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|MET918THR&RS74799832|https://civicdb.org/links/variants/113|RET M918T|113|MET918THR&RS74799832|https://civicdb.org/links/molecular-profiles/113|NM_020975.4:c.2753T>C&NP_065681.1:p.Met918Thr&ENST00000355710.3:c.2753T>C&NC_000010.10:g.43617416T>C|CA009082|13919|86.0|evidence|7710|https://civicdb.org/links/evidence/7710|27525386 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Medullary Thyroid Carcinoma|Cabozantinib (NCIt ID C52200)|||B|4|||||,C|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|MET918THR&RS74799832|https://civicdb.org/links/variants/113|RET M918T|113|MET918THR&RS74799832|https://civicdb.org/links/molecular-profiles/113|NM_020975.4:c.2753T>C&NP_065681.1:p.Met918Thr&ENST00000355710.3:c.2753T>C&NC_000010.10:g.43617416T>C|CA009082|13919|86.0|evidence|1365|https://civicdb.org/links/evidence/1365|20368568 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Medullary Thyroid Carcinoma|Sorafenib (NCIt ID C61948)|||B|3|||||,C|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|MET918THR&RS74799832|https://civicdb.org/links/variants/113|RET M918T|113|MET918THR&RS74799832|https://civicdb.org/links/molecular-profiles/113|NM_020975.4:c.2753T>C&NP_065681.1:p.Met918Thr&ENST00000355710.3:c.2753T>C&NC_000010.10:g.43617416T>C|CA009082|13919|86.0|evidence|76|https://civicdb.org/links/evidence/76|21422803 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Medullary Thyroid Carcinoma|Motesanib (NCIt ID C71896)|||D|3|||||,C|Missense Variant|RET|5979|transcript|ENST00000355710.3|ENST00000355710.3:c.2753T>C||M918T|113|MET918THR&RS74799832|https://civicdb.org/links/variants/113|RET M918T|113|MET918THR&RS74799832|https://civicdb.org/links/molecular-profiles/113|NM_020975.4:c.2753T>C&NP_065681.1:p.Met918Thr&ENST00000355710.3:c.2753T>C&NC_000010.10:g.43617416T>C|CA009082|13919|86.0|evidence|77|https://civicdb.org/links/evidence/77|23056499 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Medullary Thyroid Carcinoma|JAK2 Inhibitor AZD1480 (NCIt ID C91394)|||D|3|||||
10	89692904	636	C	T	.	.	CSQ=T|Stop Gained|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.388C>T||R130*|636|R130X&ARG130TER&RS121909224|https://civicdb.org/links/variants/636|PTEN R130*|632|R130X&ARG130TER&RS121909224|https://civicdb.org/links/molecular-profiles/632|NM_000314.6:c.388C>T&NP_000305.3:p.Arg130Ter&ENST00000371953.3:c.388C>T&NC_000010.10:g.89692904C>T|CA000433|7819|2.0|evidence|1627|https://civicdb.org/links/evidence/1627|19706758 (PUBMED)|NA|accepted|SENSITIVITYRESPONSE|SUPPORTS|Thyroid Cancer|Perifosine (NCIt ID C1727)&Temsirolimus (NCIt ID C1844)|SUBSTITUTES||D|2|||||;GN=PTEN;VT=R130*
10	89711899	838	C	T	.	.	VT=R173C;GN=PTEN;CSQ=T|Missense Variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.517C>T||R173C|838|ARG173CYS&RS121913293|https://civicdb.org/links/variants/838|PTEN R173C|812|ARG173CYS&RS121913293|https://civicdb.org/links/molecular-profiles/812|NM_000314.6:c.517C>T&NP_000305.3:p.Arg173Cys&ENST00000371953.3:c.517C>T&NC_000010.10:g.89711899C>T|CA000498|189500|13.0|evidence|1935|https://civicdb.org/links/evidence/1935|22628360 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|PTEN Hamartoma Tumor Syndrome||||C|3|||||,T|Missense Variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.517C>T||R173C|838|ARG173CYS&RS121913293|https://civicdb.org/links/variants/838|PTEN R173C|812|ARG173CYS&RS121913293|https://civicdb.org/links/molecular-profiles/812|NM_000314.6:c.517C>T&NP_000305.3:p.Arg173Cys&ENST00000371953.3:c.517C>T&NC_000010.10:g.89711899C>T|CA000498|189500|13.0|evidence|1934|https://civicdb.org/links/evidence/1934|9635567 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Endometrial Hyperplasia||||C|1|||||,T|Missense Variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.517C>T||R173C|838|ARG173CYS&RS121913293|https://civicdb.org/links/variants/838|PTEN R173C|812|ARG173CYS&RS121913293|https://civicdb.org/links/molecular-profiles/812|NM_000314.6:c.517C>T&NP_000305.3:p.Arg173Cys&ENST00000371953.3:c.517C>T&NC_000010.10:g.89711899C>T|CA000498|189500|13.0|evidence|1930|https://civicdb.org/links/evidence/1930|10866302 (PUBMED)|NA|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Cancer||||D|3|||||
10	89717672	110	C	T	.	.	CSQ=T|Stop Gained&Loss Of Function Variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.697C>T||R233*|110|R233X&ARG233TER&RS121909219|https://civicdb.org/links/variants/110|PTEN R233*|110|R233X&ARG233TER&RS121909219|https://civicdb.org/links/molecular-profiles/110|NM_000314.6:c.697C>T&NP_000305.3:p.Arg233Ter&ENST00000371953.3:c.697C>T&NC_000010.10:g.89717672C>T|CA000549|7813|19.0|evidence|343|https://civicdb.org/links/evidence/343|22479427 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|DOES_NOT_SUPPORT|Glioblastoma||||B|3|||||,T|Stop Gained&Loss Of Function Variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.697C>T||R233*|110|R233X&ARG233TER&RS121909219|https://civicdb.org/links/variants/110|PTEN R233*|110|R233X&ARG233TER&RS121909219|https://civicdb.org/links/molecular-profiles/110|NM_000314.6:c.697C>T&NP_000305.3:p.Arg233Ter&ENST00000371953.3:c.697C>T&NC_000010.10:g.89717672C>T|CA000549|7813|19.0|evidence|317|https://civicdb.org/links/evidence/317|20085938 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|MTOR Inhibitor (NCIt ID C2201)|||D|4|||||;GN=PTEN;VT=R233*
10	89720798	605	GTACT	G	.	.	CSQ=-|Frameshift Variant|PTEN|5728|transcript|ENST00000371953.3|ENST00000371953.3:c.950_953delTACT||V317FS|605|VAL317FS|https://civicdb.org/links/variants/605|PTEN V317FS|601|VAL317FS|https://civicdb.org/links/molecular-profiles/601|ENST00000371953.3:c.950_953delTACT&NC_000010.10:g.89720799_89720802del|CA000646|NONE FOUND|3.0|evidence|1534|https://civicdb.org/links/evidence/1534|24504448 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Akt Inhibitor MK2206 (NCIt ID C90581)&MEK Inhibitor CI-1040 (NCIt ID C2670)|COMBINATION||D|3|||||;GN=PTEN;VT=V317FS
10	104850483	2897	G	A	.	.	GN=NT5C2;CSQ=A|Gain Of Function Variant&Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||S445F|2897||https://civicdb.org/links/variants/2897|NT5C2 S445F|2766||https://civicdb.org/links/molecular-profiles/2766||CA377969059|NONE FOUND|13.0|evidence|7864|https://civicdb.org/links/evidence/7864|23377183 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Childhood Acute Lymphocytic Leukemia||||C|2|||||,A|Gain Of Function Variant&Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||S445F|2897||https://civicdb.org/links/variants/2897|NT5C2 S445F|2766||https://civicdb.org/links/molecular-profiles/2766||CA377969059|NONE FOUND|13.0|evidence|7814|https://civicdb.org/links/evidence/7814|23377183 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Childhood Acute Lymphocytic Leukemia|Mercaptopurine (NCIt ID C195)&Thioguanine (NCIt ID C876)|SUBSTITUTES||D|4|||||,A|Gain Of Function Variant&Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||S445F|2897||https://civicdb.org/links/variants/2897|NT5C2 S445F|2766||https://civicdb.org/links/molecular-profiles/2766||CA377969059|NONE FOUND|13.0|evidence|7817|https://civicdb.org/links/evidence/7817|23377183 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Childhood Acute Lymphocytic Leukemia|Cytarabine (NCIt ID C408)&Doxorubicin (NCIt ID C456)&Gemcitabine (NCIt ID C66876)&Prednisolone (NCIt ID C769)|SUBSTITUTES||D|4|||||;VT=S445F
10	104850745	240	T	G	.	.	GN=NT5C2;VT=D407A;CSQ=G|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1220A>C||D407A|240|ASP407ALA|https://civicdb.org/links/variants/240|NT5C2 D407A|236|ASP407ALA|https://civicdb.org/links/molecular-profiles/236|NC_000010.10:g.104850745T>G&NM_012229.4:c.1220A>C&NP_036361.1:p.Asp407Ala&ENST00000343289.5:c.1220A>C|CA16602793|376351|8.0|evidence|632|https://civicdb.org/links/evidence/632|23377281 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|T-cell Acute Lymphoblastic Leukemia|Mercaptopurine (NCIt ID C195)&Thioguanine (NCIt ID C876)|SUBSTITUTES||D|4|||||,G|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1220A>C||D407A|240|ASP407ALA|https://civicdb.org/links/variants/240|NT5C2 D407A|236|ASP407ALA|https://civicdb.org/links/molecular-profiles/236|NC_000010.10:g.104850745T>G&NM_012229.4:c.1220A>C&NP_036361.1:p.Asp407Ala&ENST00000343289.5:c.1220A>C|CA16602793|376351|8.0|evidence|635|https://civicdb.org/links/evidence/635|23377281 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|T-cell Acute Lymphoblastic Leukemia|Arabinosylguanine&Nelarabine (NCIt ID C1704)|SUBSTITUTES||D|4|||||
10	104852955	238	C	T	.	.	GN=NT5C2;VT=R367Q;CSQ=T|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|https://civicdb.org/links/variants/238|NT5C2 R367Q|234|ARG367GLN|https://civicdb.org/links/molecular-profiles/234|NC_000010.10:g.104852955C>T|CA16602791|376349|21.0|evidence|7812|https://civicdb.org/links/evidence/7812|23377183 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Childhood Acute Lymphocytic Leukemia|Mercaptopurine (NCIt ID C195)&Thioguanine (NCIt ID C876)|SUBSTITUTES||C|2|||||,T|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|https://civicdb.org/links/variants/238|NT5C2 R367Q|234|ARG367GLN|https://civicdb.org/links/molecular-profiles/234|NC_000010.10:g.104852955C>T|CA16602791|376349|21.0|evidence|630|https://civicdb.org/links/evidence/630|23377281 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|T-cell Acute Lymphoblastic Leukemia|Mercaptopurine (NCIt ID C195)&Thioguanine (NCIt ID C876)|SUBSTITUTES||D|4|||||,T|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|https://civicdb.org/links/variants/238|NT5C2 R367Q|234|ARG367GLN|https://civicdb.org/links/molecular-profiles/234|NC_000010.10:g.104852955C>T|CA16602791|376349|21.0|evidence|633|https://civicdb.org/links/evidence/633|23377281 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|T-cell Acute Lymphoblastic Leukemia|Arabinosylguanine&Nelarabine (NCIt ID C1704)|SUBSTITUTES||D|4|||||,T|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|https://civicdb.org/links/variants/238|NT5C2 R367Q|234|ARG367GLN|https://civicdb.org/links/molecular-profiles/234|NC_000010.10:g.104852955C>T|CA16602791|376349|21.0|evidence|7815|https://civicdb.org/links/evidence/7815|23377183 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Childhood Acute Lymphocytic Leukemia|Cytarabine (NCIt ID C408)&Doxorubicin (NCIt ID C456)&Gemcitabine (NCIt ID C66876)&Prednisolone (NCIt ID C769)|SUBSTITUTES||D|4|||||,T|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|||R367Q|238|ARG367GLN|https://civicdb.org/links/variants/238|NT5C2 R367Q|234|ARG367GLN|https://civicdb.org/links/molecular-profiles/234|NC_000010.10:g.104852955C>T|CA16602791|376349|21.0|evidence|7862|https://civicdb.org/links/evidence/7862|23377183 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Childhood Acute Lymphocytic Leukemia|Mercaptopurine (NCIt ID C195)&Thioguanine (NCIt ID C876)|SUBSTITUTES||D|4|||||
10	104852980	239	T	G	.	.	GN=NT5C2;VT=K359Q;CSQ=G|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1075A>C||K359Q|239|LYS359GLN|https://civicdb.org/links/variants/239|NT5C2 K359Q|235|LYS359GLN|https://civicdb.org/links/molecular-profiles/235|NC_000010.10:g.104852980T>G&NM_012229.4:c.1075A>C&NP_036361.1:p.Lys359Gln&ENST00000343289.5:c.1075A>C|CA16602792|376350|28.0|evidence|667|https://civicdb.org/links/evidence/667|23377281 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Acute Lymphoblastic Leukemia||||B|4|||||,G|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1075A>C||K359Q|239|LYS359GLN|https://civicdb.org/links/variants/239|NT5C2 K359Q|235|LYS359GLN|https://civicdb.org/links/molecular-profiles/235|NC_000010.10:g.104852980T>G&NM_012229.4:c.1075A>C&NP_036361.1:p.Lys359Gln&ENST00000343289.5:c.1075A>C|CA16602792|376350|28.0|evidence|631|https://civicdb.org/links/evidence/631|23377281 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|T-cell Acute Lymphoblastic Leukemia|Mercaptopurine (NCIt ID C195)&Thioguanine (NCIt ID C876)|SUBSTITUTES||D|4|||||,G|Missense Variant|NT5C2|22978|transcript|ENST00000343289.5|ENST00000343289.5:c.1075A>C||K359Q|239|LYS359GLN|https://civicdb.org/links/variants/239|NT5C2 K359Q|235|LYS359GLN|https://civicdb.org/links/molecular-profiles/235|NC_000010.10:g.104852980T>G&NM_012229.4:c.1075A>C&NP_036361.1:p.Lys359Gln&ENST00000343289.5:c.1075A>C|CA16602792|376350|28.0|evidence|636|https://civicdb.org/links/evidence/636|23377281 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|T-cell Acute Lymphoblastic Leukemia|Arabinosylguanine&Nelarabine (NCIt ID C1704)|SUBSTITUTES||D|4|||||
10	104857107	2896	G	A	.	.	GN=NT5C2;CSQ=A||NT5C2|22978|transcript|ENST00000343289.5|||R238W|2896||https://civicdb.org/links/variants/2896|NT5C2 R238W|2765||https://civicdb.org/links/molecular-profiles/2765||CA377975023||13.0|evidence|7863|https://civicdb.org/links/evidence/7863|23377183 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Childhood Acute Lymphocytic Leukemia||||C|2|||||,A||NT5C2|22978|transcript|ENST00000343289.5|||R238W|2896||https://civicdb.org/links/variants/2896|NT5C2 R238W|2765||https://civicdb.org/links/molecular-profiles/2765||CA377975023||13.0|evidence|7813|https://civicdb.org/links/evidence/7813|23377183 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Childhood Acute Lymphocytic Leukemia|Mercaptopurine (NCIt ID C195)&Thioguanine (NCIt ID C876)|SUBSTITUTES||D|4|||||,A||NT5C2|22978|transcript|ENST00000343289.5|||R238W|2896||https://civicdb.org/links/variants/2896|NT5C2 R238W|2765||https://civicdb.org/links/molecular-profiles/2765||CA377975023||13.0|evidence|7816|https://civicdb.org/links/evidence/7816|23377183 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Childhood Acute Lymphocytic Leukemia|Cytarabine (NCIt ID C408)&Doxorubicin (NCIt ID C456)&Gemcitabine (NCIt ID C66876)&Prednisolone (NCIt ID C769)|SUBSTITUTES||D|4|||||;VT=R238W
10	123258034	545	A	T	.	.	CSQ=T|Missense Variant&Gain Of Function Variant|FGFR2|2263|transcript|ENST00000457416.2|ENST00000457416.2:c.1650T>A||N550K|545|ASN550LYS&N549K&RS121913476|https://civicdb.org/links/variants/545|FGFR2 N550K|541|ASN550LYS&N549K&RS121913476|https://civicdb.org/links/molecular-profiles/541|NC_000010.10:g.123258034A>T&NM_022970.3:c.1650T>A&NP_075259.4:p.Asn550Lys&ENST00000457416.2:c.1650T>A|CA16602614|376157|3.0|evidence|1322|https://civicdb.org/links/evidence/1322|18757403 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Endometrial Cancer|PD173074|||D|3|||||;GN=FGFR2;VT=N550K
10	131265545	338	C	T	.	.	CSQ=T|Synonymous Variant|MGMT|4255|transcript|ENST00000306010.7|||RS16906252|338||https://civicdb.org/links/variants/338|MGMT RS16906252|334||https://civicdb.org/links/molecular-profiles/334|NC_000010.10:g.131265545C>T|CA5747879||15.0|evidence|822|https://civicdb.org/links/evidence/822|25910840 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Glioblastoma|Temozolomide (NCIt ID C1244)|||B|3|||||;VT=RS16906252;GN=MGMT
11	534285	274	C	T	.	.	VT=G13D;CSQ=T|Missense Variant|HRAS|3265|transcript|ENST00000451590.1|ENST00000451590.1:c.38G>A||G13D|274|GLY13ASP&RS104894226|https://civicdb.org/links/variants/274|HRAS G13D|270|GLY13ASP&RS104894226|https://civicdb.org/links/molecular-profiles/270|NC_000011.9:g.534285C>T&NP_005334.1:p.Gly13Asp&NM_005343.3:c.38G>A&ENST00000451590.1:c.38G>A|CA256488|12604|7.5|evidence|699|https://civicdb.org/links/evidence/699|26561417 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (NCIt ID C2167)|||C|3|||||,T|Missense Variant|HRAS|3265|transcript|ENST00000451590.1|ENST00000451590.1:c.38G>A||G13D|274|GLY13ASP&RS104894226|https://civicdb.org/links/variants/274|HRAS G13D|270|GLY13ASP&RS104894226|https://civicdb.org/links/molecular-profiles/270|NC_000011.9:g.534285C>T&NP_005334.1:p.Gly13Asp&NM_005343.3:c.38G>A&ENST00000451590.1:c.38G>A|CA256488|12604|7.5|evidence|3851|https://civicdb.org/links/evidence/3851|22256804 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Squamous Cell Carcinoma|Vemurafenib (NCIt ID C64768)|||C|1|||||,T|Missense Variant|HRAS|3265|transcript|ENST00000451590.1|ENST00000451590.1:c.38G>A||G13D|274|GLY13ASP&RS104894226|https://civicdb.org/links/variants/274|HRAS G13D|270|GLY13ASP&RS104894226|https://civicdb.org/links/molecular-profiles/270|NC_000011.9:g.534285C>T&NP_005334.1:p.Gly13Asp&NM_005343.3:c.38G>A&ENST00000451590.1:c.38G>A|CA256488|12604|7.5|evidence|3852|https://civicdb.org/links/evidence/3852|26561417 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|None|||||;GN=HRAS
11	9599943	331	A	G	.	.	GN=WEE1;CSQ=G|Intron Variant&Polymorphic Sequence Variant|WEE1|7465|transcript|ENST00000450114.2|ENST00000450114.2:c.1141+1133A>G||RS3910384|331|INTRON POLYMORPHISM|https://civicdb.org/links/variants/331|WEE1 RS3910384|327|INTRON POLYMORPHISM|https://civicdb.org/links/molecular-profiles/327|NC_000011.9:g.9599943A>G&ENST00000450114.2:c.1141+1133A>G|CA15681425|NONE FOUND|15.0|evidence|814|https://civicdb.org/links/evidence/814|26057002 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Gemcitabine (NCIt ID C66876)&Platinum Compound (NCIt ID C1450)|COMBINATION||B|3|||||;VT=RS3910384
11	17741694	3032	T	G	.	.	VT=L122R;CSQ=G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|8193|https://civicdb.org/links/evidence/8193|27562493 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|4|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|9532|https://civicdb.org/links/evidence/9532|34166060 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Rhabdomyosarcoma||||B|4|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|11582|https://civicdb.org/links/evidence/11582|24824843 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|4|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|11583|https://civicdb.org/links/evidence/11583|24824843 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|4|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|11585|https://civicdb.org/links/evidence/11585|31949721 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|4|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|11587|https://civicdb.org/links/evidence/11587|26501226 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|4|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|11588|https://civicdb.org/links/evidence/11588|26501226 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|4|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|8313|https://civicdb.org/links/evidence/8313|30604891 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|3|||||,G|Missense Variant|MYOD1|4654|transcript|ENST00000250003.3|||L122R|3032|LEU122ARG|https://civicdb.org/links/variants/3032|MYOD1 L122R|2901|LEU122ARG|https://civicdb.org/links/molecular-profiles/2901||CA379790889|NONE FOUND|165.0|evidence|8194|https://civicdb.org/links/evidence/8194|27562493 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Spindle Cell Rhabdomyosarcoma||||B|2|||||;GN=MYOD1
11	64572091	667	CC	C	.	.	VT=FRAMESHIFT TRUNCATION;GN=MEN1;CSQ=-|Frameshift Truncation|MEN1|4221|transcript|ENST00000337652.1|||FRAMESHIFT TRUNCATION|667||https://civicdb.org/links/variants/667|MEN1 FRAMESHIFT TRUNCATION|663||https://civicdb.org/links/molecular-profiles/663|NC_000011.9:g.64572092del|CA16044439||5.0|evidence|1695|https://civicdb.org/links/evidence/1695|25625803 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Oncocytic Carcinoma Of The Thyroid||||C|2|||||
11	67352689	259	A	G	.	.	CSQ=G|Missense Variant|GSTP1|2950|transcript|ENST00000398606.3|ENST00000398606.3:c.313A>G||I105V|259|ILE105VAL|https://civicdb.org/links/variants/259|GSTP1 I105V|255|ILE105VAL|https://civicdb.org/links/molecular-profiles/255|NM_000852.3:c.313A>G&NP_000843.1:p.Ile105Val&ENST00000398606.3:c.313A>G&NC_000011.9:g.67352689A>G|CA6142790|37340|20.0|evidence|670|https://civicdb.org/links/evidence/670|19922504 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|FOLFOX Regimen (NCIt ID C11197)|||B|4|||||;GN=GSTP1;VT=I105V
11	108115729	1155	A	T	.	.	GN=ATM;VT=K293*;CSQ=T|Stop Gained|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.877A>T||K293*|1155|K293X&LYS293TER&RS1057516442|https://civicdb.org/links/variants/1155|ATM K293*|1129|K293X&LYS293TER&RS1057516442|https://civicdb.org/links/molecular-profiles/1129|ENST00000278616.4:c.877A>T&NM_000051.3:c.877A>T&NP_000042.3:p.Lys293Ter&NC_000011.9:g.108115729A>T|CA16041383|370378|3.0|evidence|2832|https://civicdb.org/links/evidence/2832|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||
11	108121593	1166	CAA	C	.	.	GN=ATM;VT=K468FS;CSQ=-|Frameshift Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.1402_1403delAA||K468FS|1166|LYS468GLUFS|https://civicdb.org/links/variants/1166|ATM K468FS|1140|LYS468GLUFS|https://civicdb.org/links/molecular-profiles/1140|NM_000051.3:c.1402_1403delAA&NP_000042.3:p.Lys468Glufs&NC_000011.9:g.108121594_108121595delAA&ENST00000278616.4:c.1402_1403delAA&NC_000011.9:g.108121594_108121595del|CA163840|140889|2.0|evidence|2843|https://civicdb.org/links/evidence/2843|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|2|||||
11	108142131	1158	T	G	.	.	GN=ATM;CSQ=G|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.3075T>G||F1025L|1158|PHE1025LEU|https://civicdb.org/links/variants/1158|ATM F1025L|1132|PHE1025LEU|https://civicdb.org/links/molecular-profiles/1132|ENST00000278616.4:c.3075T>G&NC_000011.9:g.108142131T>G&NM_000051.3:c.3075T>G&NP_000042.3:p.Phe1025Leu|CA382547708|NONE FOUND|3.0|evidence|2835|https://civicdb.org/links/evidence/2835|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||;VT=F1025L
11	108170479	1168	G	C	.	.	GN=ATM;CSQ=C|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.5044G>C||D1682H|1168|RS121434217&ASP1682HIS|https://civicdb.org/links/variants/1168|ATM D1682H|1142|RS121434217&ASP1682HIS|https://civicdb.org/links/molecular-profiles/1142|NM_000051.3:c.5044G>C&NP_000042.3:p.Asp1682His&NC_000011.9:g.108170479G>C&ENST00000278616.4:c.5044G>C|CA115932|3026|3.0|evidence|2845|https://civicdb.org/links/evidence/2845|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||;VT=D1682H
11	108180913	1160	A	T	.	.	GN=ATM;CSQ=T|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.5789A>T||D1930V|1160|M72L&ASP1930VAL&MET72LEU|https://civicdb.org/links/variants/1160|ATM D1930V|1134|M72L&ASP1930VAL&MET72LEU|https://civicdb.org/links/molecular-profiles/1134|ENST00000278616.4:c.5789A>T&NC_000011.9:g.108180913A>T&NM_000051.3:c.5789A>T&NP_000042.3:p.Asp1930Val|CA382548326|NONE FOUND|2.0|evidence|2837|https://civicdb.org/links/evidence/2837|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|2|||||;VT=D1930V
11	108186827	1169	C	T	.	.	GN=ATM;VT=A2062V;CSQ=T|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.6185C>T||A2062V|1169|ALA2062VAL|https://civicdb.org/links/variants/1169|ATM A2062V|1143|ALA2062VAL|https://civicdb.org/links/molecular-profiles/1143|ENST00000278616.4:c.6185C>T&NC_000011.9:g.108186827C>T&NM_000051.3:c.6185C>T&NP_000042.3:p.Ala2062Val|CA382550752|NONE FOUND|3.0|evidence|2846|https://civicdb.org/links/evidence/2846|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||
11	108192134	1162	G	T	.	.	GN=ATM;CSQ=T|Stop Gained|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.6559G>T||E2187*|1162|E2187X&GLU2187TER|https://civicdb.org/links/variants/1162|ATM E2187*|1136|E2187X&GLU2187TER|https://civicdb.org/links/molecular-profiles/1136|ENST00000278616.4:c.6559G>T&NC_000011.9:g.108192134G>T&NM_000051.3:c.6559G>T&NP_000042.3:p.Glu2187Ter|CA382554382|NONE FOUND|3.0|evidence|2839|https://civicdb.org/links/evidence/2839|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||;VT=E2187*
11	108196839	243	GTC	G	.	.	GN=ATM;VT=S2289*;CSQ=-|Frameshift Truncation|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.6863_6864delTC||S2289*|243|V2288FS*1|https://civicdb.org/links/variants/243|ATM S2289*|239|V2288FS*1|https://civicdb.org/links/molecular-profiles/239|ENST00000278616.4:c.6863_6864delTC|CA10588507|NONE FOUND|7.5|evidence|647|https://civicdb.org/links/evidence/647|26510020 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Prostate Cancer|Olaparib (NCIt ID C71721)|||C|3|||||
11	108199938	1163	T	C	.	.	GN=ATM;CSQ=C|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.7280T>C||L2427P|1163|LEU2427PRO|https://civicdb.org/links/variants/1163|ATM L2427P|1137|LEU2427PRO|https://civicdb.org/links/molecular-profiles/1137|ENST00000278616.4:c.7280T>C&NC_000011.9:g.108199938T>C&NM_000051.3:c.7280T>C&NP_000042.3:p.Leu2427Pro|CA382559785|NONE FOUND|3.0|evidence|2840|https://civicdb.org/links/evidence/2840|23585524 (PUBMED)|UNKNOWN|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||;VT=L2427P
11	108201096	1172	G	A	.	.	GN=ATM;CSQ=A|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.7463G>A||C2488Y|1172|CYS2488TYR&RS774281788|https://civicdb.org/links/variants/1172|ATM C2488Y|1146|CYS2488TYR&RS774281788|https://civicdb.org/links/molecular-profiles/1146|NM_000051.3:c.7463G>A&NP_000042.3:p.Cys2488Tyr&NC_000011.9:g.108201096G>A&ENST00000278616.4:c.7463G>A|CA196568|187037|3.0|evidence|2849|https://civicdb.org/links/evidence/2849|23585524 (PUBMED)|RARE_GERMLINE|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||;VT=C2488Y
11	108204681	901	A	G	.	.	GN=ATM;VT=T2666A;CSQ=G|Missense Variant|ATM|472|transcript|ENST00000278616.4|||T2666A|901||https://civicdb.org/links/variants/901|ATM T2666A|875||https://civicdb.org/links/molecular-profiles/875|NC_000011.9:g.108204681A>G|CA349494|219594|3.0|evidence|2221|https://civicdb.org/links/evidence/2221|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||
11	108206614	1164	T	G	.	.	GN=ATM;VT=F2732V;CSQ=G|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.8194T>G||F2732V|1164|PHE2732VAL&RS876659619|https://civicdb.org/links/variants/1164|ATM F2732V|1138|PHE2732VAL&RS876659619|https://civicdb.org/links/molecular-profiles/1138|ENST00000278616.4:c.8194T>G&NC_000011.9:g.108206614T>G&NM_000051.3:c.8194T>G&NP_000042.3:p.Phe2732Val|CA16619250|422531|3.0|evidence|2841|https://civicdb.org/links/evidence/2841|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||
11	108218044	244	A	C	.	.	GN=ATM;CSQ=C|Missense Variant|ATM|472|transcript|ENST00000278616.4|ENST00000278616.4:c.8623A>C||N2875H|244|ASN2875HIS&RS1057519869|https://civicdb.org/links/variants/244|ATM N2875H|240|ASN2875HIS&RS1057519869|https://civicdb.org/links/molecular-profiles/240|ENST00000278616.4:c.8623A>C&NC_000011.9:g.108218044A>C&NM_000051.3:c.8623A>C&NP_000042.3:p.Asn2875His|CA16602795|376353|7.5|evidence|648|https://civicdb.org/links/evidence/648|26510020 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Prostate Cancer|Olaparib (NCIt ID C71721)|||C|3|||||;VT=N2875H
11	108236086	903	C	T	.	.	GN=ATM;CSQ=T|Missense Variant|ATM|472|transcript|ENST00000278616.4|||R3008C|903||https://civicdb.org/links/variants/903|ATM R3008C|877||https://civicdb.org/links/molecular-profiles/877|NC_000011.9:g.108236086C>T|CA294307||3.0|evidence|2223|https://civicdb.org/links/evidence/2223|23585524 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Doxorubicin (NCIt ID C456)|||D|3|||||;VT=R3008C
12	21329738	778	A	G	.	.	CSQ=G|Missense Variant|SLCO1B1|10599|transcript|ENST00000256958.2|||N130D|778|ASN130ASP&RS2306283|https://civicdb.org/links/variants/778|SLCO1B1 N130D|759|ASN130ASP&RS2306283|https://civicdb.org/links/molecular-profiles/759|NC_000012.11:g.21329738A>G|CA6476674|259983|15.0|evidence|1842|https://civicdb.org/links/evidence/1842|23652803 (PUBMED)|COMMON_GERMLINE|accepted|ADVERSE_RESPONSE|SUPPORTS|Cancer|Methotrexate (NCIt ID C642)|||B|3|||||;VT=N130D;GN=SLCO1B1
12	21331549	777	T	C	.	.	CSQ=C|Missense Variant&Polymorphic Sequence Variant|SLCO1B1|10599|transcript|ENST00000256958.2|ENST00000256958.2:c.521T>C||RS4149056|777|VAL174ALA&V174A|https://civicdb.org/links/variants/777|SLCO1B1 RS4149056|758|VAL174ALA&V174A|https://civicdb.org/links/molecular-profiles/758|NC_000012.11:g.21331549T>C&NM_006446.4:c.521T>C&NP_006437.3:p.Val174Ala&ENST00000256958.2:c.521T>C|CA6476722|37346|15.0|evidence|1841|https://civicdb.org/links/evidence/1841|23652803 (PUBMED)|COMMON_GERMLINE|accepted|ADVERSE_RESPONSE|SUPPORTS|Cancer|Methotrexate (NCIt ID C642)|||B|3|||||;GN=SLCO1B1;VT=RS4149056
12	25360224	254	A	C	.	.	CSQ=C|3 Prime UTR Variant|KRAS|3845|transcript|ENST00000311936.3|ENST00000311936.3:c.*2505T>G||RS61764370|254||https://civicdb.org/links/variants/254|KRAS RS61764370|250||https://civicdb.org/links/molecular-profiles/250|NC_000012.11:g.25360224A>C&NM_004985.4:c.*2505T>G&ENST00000311936.3:c.*2505T>G|CA10637079|308084|30.0|evidence|664|https://civicdb.org/links/evidence/664|22139083 (PUBMED)|COMMON_GERMLINE|accepted|RESISTANCE|SUPPORTS|Epithelial Ovarian Cancer|Carboplatin (NCIt ID C1282)&Paclitaxel (NCIt ID C1411)|SUBSTITUTES||B|3|||||,C|3 Prime UTR Variant|KRAS|3845|transcript|ENST00000311936.3|ENST00000311936.3:c.*2505T>G||RS61764370|254||https://civicdb.org/links/variants/254|KRAS RS61764370|250||https://civicdb.org/links/molecular-profiles/250|NC_000012.11:g.25360224A>C&NM_004985.4:c.*2505T>G&ENST00000311936.3:c.*2505T>G|CA10637079|308084|30.0|evidence|872|https://civicdb.org/links/evidence/872|25081901 (PUBMED)|COMMON_GERMLINE|accepted|RESISTANCE|SUPPORTS|Head And Neck Squamous Cell Carcinoma|Cisplatin (NCIt ID C376)|||B|3|||||;GN=KRAS;VT=RS61764370
12	25368454	1207	C	T	.	.	VT=R164Q;CSQ=T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|||R164Q|1207|ARG164GLN&RS758575947|https://civicdb.org/links/variants/1207|KRAS R164Q|1181|ARG164GLN&RS758575947|https://civicdb.org/links/molecular-profiles/1181|NC_000012.11:g.25368454C>T&NC_000012.12:g.25215520C>T&NP_203524.1:p.Arg164Gln&NM_033360.4:c.491G>A|CA6486860|NONE FOUND|3.0|evidence|7935|https://civicdb.org/links/evidence/7935|20147967 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|DOES_NOT_SUPPORT|Cancer||||D|3|||||;GN=KRAS
12	25378561	322	G	A	.	.	VT=A146V;GN=KRAS;CSQ=A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.437C>T||A146V|322|ALA146VAL&RS1057519725|https://civicdb.org/links/variants/322|KRAS A146V|318|ALA146VAL&RS1057519725|https://civicdb.org/links/molecular-profiles/318|ENST00000256078.4:c.437C>T&NC_000012.11:g.25378561G>A&NP_004976.2:p.Ala146Val&NM_004985.4:c.437C>T|CA16602440|375962|8.0|evidence|794|https://civicdb.org/links/evidence/794|24836576 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Abemaciclib (NCIt ID C97660)|||C|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.437C>T||A146V|322|ALA146VAL&RS1057519725|https://civicdb.org/links/variants/322|KRAS A146V|318|ALA146VAL&RS1057519725|https://civicdb.org/links/molecular-profiles/318|ENST00000256078.4:c.437C>T&NC_000012.11:g.25378561G>A&NP_004976.2:p.Ala146Val&NM_004985.4:c.437C>T|CA16602440|375962|8.0|evidence|2209|https://civicdb.org/links/evidence/2209|22392911 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|3|||||
12	25378562	905	C	G	.	.	GN=KRAS;CSQ=G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>C||A146P|905|RS121913527&ALA146PRO|https://civicdb.org/links/variants/905|KRAS A146P|879|RS121913527&ALA146PRO|https://civicdb.org/links/molecular-profiles/879|NM_004985.4:c.436G>C&NP_004976.2:p.Ala146Pro&NC_000012.11:g.25378562C>G&ENST00000256078.4:c.436G>C|CA16602441|375963|7.5|evidence|2225|https://civicdb.org/links/evidence/2225|19603018 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||;VT=A146P
12	25378562	906	C	T	.	.	GN=KRAS;CSQ=T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>A||A146T|906|RS121913527&ALA146THR|https://civicdb.org/links/variants/906|KRAS A146T|880|RS121913527&ALA146THR|https://civicdb.org/links/molecular-profiles/880|NM_004985.4:c.436G>A&NP_004976.2:p.Ala146Thr&NC_000012.11:g.25378562C>T&ENST00000256078.4:c.436G>A|CA245262|197243|21.0|evidence|3858|https://civicdb.org/links/evidence/3858|25666295 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&FOLFOX-4 Regimen (NCIt ID C63590)|COMBINATION||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>A||A146T|906|RS121913527&ALA146THR|https://civicdb.org/links/variants/906|KRAS A146T|880|RS121913527&ALA146THR|https://civicdb.org/links/molecular-profiles/880|NM_004985.4:c.436G>A&NP_004976.2:p.Ala146Thr&NC_000012.11:g.25378562C>T&ENST00000256078.4:c.436G>A|CA245262|197243|21.0|evidence|2206|https://civicdb.org/links/evidence/2206|22392911 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.436G>A||A146T|906|RS121913527&ALA146THR|https://civicdb.org/links/variants/906|KRAS A146T|880|RS121913527&ALA146THR|https://civicdb.org/links/molecular-profiles/880|NM_004985.4:c.436G>A&NP_004976.2:p.Ala146Thr&NC_000012.11:g.25378562C>T&ENST00000256078.4:c.436G>A|CA245262|197243|21.0|evidence|2943|https://civicdb.org/links/evidence/2943|20570890 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|3|||||;VT=A146T
12	25380275	907	T	G	.	.	VT=Q61H;GN=KRAS;CSQ=G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.183A>C||Q61H|907|RS17851045&GLN61HIS|https://civicdb.org/links/variants/907|KRAS Q61H|881|RS17851045&GLN61HIS|https://civicdb.org/links/molecular-profiles/881|NM_004985.4:c.183A>C&NP_004976.2:p.Gln61His&NC_000012.11:g.25380275T>G&ENST00000256078.4:c.183A>C|CA180922|177881|10.5|evidence|3862|https://civicdb.org/links/evidence/3862|22722830 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||C|None|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.183A>C||Q61H|907|RS17851045&GLN61HIS|https://civicdb.org/links/variants/907|KRAS Q61H|881|RS17851045&GLN61HIS|https://civicdb.org/links/molecular-profiles/881|NM_004985.4:c.183A>C&NP_004976.2:p.Gln61His&NC_000012.11:g.25380275T>G&ENST00000256078.4:c.183A>C|CA180922|177881|10.5|evidence|3861|https://civicdb.org/links/evidence/3861|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Chemotherapy (NCIt ID C15632)|COMBINATION||C|3|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.183A>C||Q61H|907|RS17851045&GLN61HIS|https://civicdb.org/links/variants/907|KRAS Q61H|881|RS17851045&GLN61HIS|https://civicdb.org/links/molecular-profiles/881|NM_004985.4:c.183A>C&NP_004976.2:p.Gln61His&NC_000012.11:g.25380275T>G&ENST00000256078.4:c.183A>C|CA180922|177881|10.5|evidence|7936|https://civicdb.org/links/evidence/7936|20147967 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Cancer||||D|3|||||
12	25380276	908	T	A	.	.	VT=Q61L;GN=KRAS;CSQ=A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.182A>T||Q61L|908|RS121913240&GLN61LEU|https://civicdb.org/links/variants/908|KRAS Q61L|882|RS121913240&GLN61LEU|https://civicdb.org/links/molecular-profiles/882|NM_004985.4:c.182A>T&NP_004976.2:p.Gln61Leu&NC_000012.11:g.25380276T>A&ENST00000256078.4:c.182A>T|CA210876|45116|7.5|evidence|3867|https://civicdb.org/links/evidence/3867|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Chemotherapy (NCIt ID C15632)|COMBINATION||C|3|||||
12	25380276	909	T	C	.	.	VT=Q61R;GN=KRAS;CSQ=C|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.182A>G||Q61R|909|RS121913240&GLN61ARG|https://civicdb.org/links/variants/909|KRAS Q61R|883|RS121913240&GLN61ARG|https://civicdb.org/links/molecular-profiles/883|NM_004985.4:c.182A>G&NP_004976.2:p.Gln61Arg&NC_000012.11:g.25380276T>C&ENST00000256078.4:c.182A>G|CA261702|45115|7.5|evidence|3870|https://civicdb.org/links/evidence/3870|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)|COMBINATION||C|3|||||
12	25380277	910	G	T	.	.	CSQ=T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.181C>A||Q61K|910|RS121913238&GLN61LYS|https://civicdb.org/links/variants/910|KRAS Q61K|884|RS121913238&GLN61LYS|https://civicdb.org/links/molecular-profiles/884|NM_004985.4:c.181C>A&NP_004976.2:p.Gln61Lys&NC_000012.11:g.25380277G>T&ENST00000256078.4:c.181C>A|CA180750|177777|7.5|evidence|3872|https://civicdb.org/links/evidence/3872|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Chemotherapy (NCIt ID C15632)|COMBINATION||C|3|||||;GN=KRAS;VT=Q61K
12	25398255	479	G	A	.	.	VT=Q22*;GN=KRAS;CSQ=A|Stop Gained|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.64C>T||Q22*|479|Q22X&GLN22TER|https://civicdb.org/links/variants/479|KRAS Q22*|475|Q22X&GLN22TER|https://civicdb.org/links/molecular-profiles/475|NC_000012.11:g.25398255G>A&ENST00000256078.4:c.64C>T&NM_004985.4:c.64C>T&NP_004976.2:p.Gln22Ter|CA384157370|NONE FOUND|5.0|evidence|1131|https://civicdb.org/links/evidence/1131|19661358 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colon Mucinous Adenocarcinoma|Panitumumab (NCIt ID C1857)|||C|2|||||
12	25398280	1517	GC	AA	.	.	CSQ=AA|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38_39delinsTT||G13V|1517|RS397517040&GLY13VAL|https://civicdb.org/links/variants/1517|KRAS G13V|1425|RS397517040&GLY13VAL|https://civicdb.org/links/molecular-profiles/1425|NC_000012.11:g.25398280_25398281delinsAA&ENST00000256078.4:c.38_39delinsTT&NM_004985.4:c.38_39delinsTT&NP_004976.2:p.Gly13Val|CA645572107|45124|5.0|evidence|6312|https://civicdb.org/links/evidence/6312|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||;GN=KRAS;VT=G13V
12	25398281	81	C	T	.	.	CSQ=T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|3882|https://civicdb.org/links/evidence/3882|25666295 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|None|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|306|https://civicdb.org/links/evidence/306|20978259 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|4|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|1181|https://civicdb.org/links/evidence/1181|26812186 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|4|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|1180|https://civicdb.org/links/evidence/1180|26371285 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|3881|https://civicdb.org/links/evidence/3881|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|806|https://civicdb.org/links/evidence/806|26623049 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|2178|https://civicdb.org/links/evidence/2178|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|6320|https://civicdb.org/links/evidence/6320|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|6322|https://civicdb.org/links/evidence/6322|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|3878|https://civicdb.org/links/evidence/3878|22722830 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|None|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|145|https://civicdb.org/links/evidence/145|20978259 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|4|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|2041|https://civicdb.org/links/evidence/2041|20453058 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Pictilisib (NCIt ID C165479)|||D|4|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|2183|https://civicdb.org/links/evidence/2183|22392911 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.38G>A||G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/variants/81|KRAS G13D|81|GLY13ASP&RS112445441|https://civicdb.org/links/molecular-profiles/81|NM_033360.3:c.38G>A&NP_004976.2:p.Gly13Asp&NC_000012.11:g.25398281C>T&ENST00000256078.4:c.38G>A|CA122534|12580|108.5|evidence|3889|https://civicdb.org/links/evidence/3889|26161928 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||D|1|||||;VT=G13D;GN=KRAS
12	25398284	148	C	G	.	.	VT=G12A;CSQ=G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|251|https://civicdb.org/links/evidence/251|19794967 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Adenocarcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|3|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|4429|https://civicdb.org/links/evidence/4429|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|3|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|2008|https://civicdb.org/links/evidence/2008|17409929 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Cancer|Gefitinib (NCIt ID C1855)|||B|2|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|2009|https://civicdb.org/links/evidence/2009|19284554 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||B|2|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|6319|https://civicdb.org/links/evidence/6319|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|2012|https://civicdb.org/links/evidence/2012|11050000 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|2013|https://civicdb.org/links/evidence/2013|12483530 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|2014|https://civicdb.org/links/evidence/2014|16497971 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>C||G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/variants/148|KRAS G12A|148|GLY12ALA&RS121913529|https://civicdb.org/links/molecular-profiles/148|NM_004985.4:c.35G>C&NP_004976.2:p.Gly12Ala&NC_000012.11:g.25398284C>G&ENST00000256078.4:c.35G>C|CA135567|45122|63.0|evidence|3710|https://civicdb.org/links/evidence/3710|26161928 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||D|2|||||;GN=KRAS
12	25398284	79	C	T	.	.	VT=G12D;CSQ=T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|1300|https://civicdb.org/links/evidence/1300|27010960 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Pancreatic Cancer||||B|4|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|228|https://civicdb.org/links/evidence/228|23014527 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Lung Cancer||||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|1215|https://civicdb.org/links/evidence/1215|22948721 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Colorectal Cancer||||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|1311|https://civicdb.org/links/evidence/1311|23565280 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Malignant Exocrine Pancreas Neoplasm||||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|1732|https://civicdb.org/links/evidence/1732|27010960 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Pancreatic Ductal Carcinoma||||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2207|https://civicdb.org/links/evidence/2207|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2240|https://civicdb.org/links/evidence/2240|17409929 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Cancer|Gefitinib (NCIt ID C1855)|||B|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2247|https://civicdb.org/links/evidence/2247|19284554 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||B|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2236|https://civicdb.org/links/evidence/2236|18316791 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|None|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|1898|https://civicdb.org/links/evidence/1898|27959684 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Therapeutic Tumor Infiltrating Lymphocytes (NCIt ID C28699)|||C|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2193|https://civicdb.org/links/evidence/2193|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|91|https://civicdb.org/links/evidence/91|23524406 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Dabrafenib (NCIt ID C82386)|||C|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|937|https://civicdb.org/links/evidence/937|22025163 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Pancreatic Carcinoma|Akt Inhibitor MK2206 (NCIt ID C90581)|||C|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|1580|https://civicdb.org/links/evidence/1580|26352686 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Hairy Cell Leukemia|Vemurafenib (NCIt ID C64768)|||C|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|6316|https://civicdb.org/links/evidence/6316|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2251|https://civicdb.org/links/evidence/2251|12483530 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|None|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|305|https://civicdb.org/links/evidence/305|19029981 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|4|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2218|https://civicdb.org/links/evidence/2218|22392911 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|3958|https://civicdb.org/links/evidence/3958|22246397 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Ovarian Cancer|Cetuximab (NCIt ID C1723)|||D|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2250|https://civicdb.org/links/evidence/2250|11050000 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|2252|https://civicdb.org/links/evidence/2252|16497971 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|3957|https://civicdb.org/links/evidence/3957|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>A||G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/variants/79|KRAS G12D|79|GLY12ASP&RS121913529|https://civicdb.org/links/molecular-profiles/79|NM_004985.4:c.35G>A&NP_004976.2:p.Gly12Asp&NC_000012.11:g.25398284C>T&ENST00000256078.4:c.35G>A|CA122538|12582|167.0|evidence|3946|https://civicdb.org/links/evidence/3946|26161928 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||D|1|||||;GN=KRAS
12	25398284	425	C	A	.	.	VT=G12V;GN=KRAS;CSQ=A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|987|https://civicdb.org/links/evidence/987|26372703 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|2219|https://civicdb.org/links/evidence/2219|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|1143|https://civicdb.org/links/evidence/1143|26125448 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Docetaxel (NCIt ID C1526)&Selumetinib (NCIt ID C66939)|COMBINATION||B|1|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|2232|https://civicdb.org/links/evidence/2232|18316791 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|None|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|3824|https://civicdb.org/links/evidence/3824|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|1715|https://civicdb.org/links/evidence/1715|25232318 (PUBMED)|SOMATIC|accepted|RESISTANCE|DOES_NOT_SUPPORT|Cancer|Crizotinib (NCIt ID C74061)|||C|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|2268|https://civicdb.org/links/evidence/2268|17409929 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Cancer|Gefitinib (NCIt ID C1855)|||C|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|6323|https://civicdb.org/links/evidence/6323|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|136|https://civicdb.org/links/evidence/136|20978259 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|4|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|2001|https://civicdb.org/links/evidence/2001|22392911 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|3924|https://civicdb.org/links/evidence/3924|26161928 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||D|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.35G>T||G12V|425|GLY12VAL&RS121913529|https://civicdb.org/links/variants/425|KRAS G12V|421|GLY12VAL&RS121913529|https://civicdb.org/links/molecular-profiles/421|NM_004985.4:c.35G>T&NP_004976.2:p.Gly12Val&NC_000012.11:g.25398284C>A&ENST00000256078.4:c.35G>T|CA122540|12583|67.5|evidence|795|https://civicdb.org/links/evidence/795|20609353 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Palbociclib (NCIt ID C49176)|||D|1|||||
12	25398285	78	C	A	.	.	VT=G12C;GN=KRAS;CSQ=A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|9431|https://civicdb.org/links/evidence/9431|34096690 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Sotorasib (NCIt ID C154287)|||A|5|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|12063|https://civicdb.org/links/evidence/12063|38587856 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Adagrasib (NCIt ID C157493)&Cetuximab (NCIt ID C1723)|COMBINATION||A|4|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|12264|https://civicdb.org/links/evidence/12264|37870968 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)&Sotorasib (NCIt ID C154287)|COMBINATION||A|4|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|11652|https://civicdb.org/links/evidence/11652|37611121 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Divarasib (NCIt ID C173995)|||B|4|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|1216|https://civicdb.org/links/evidence/1216|23313110 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|1217|https://civicdb.org/links/evidence/1217|22247021 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|3967|https://civicdb.org/links/evidence/3967|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Chemotherapy (NCIt ID C15632)|COMBINATION||B|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|227|https://civicdb.org/links/evidence/227|23014527 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Lung Cancer||||B|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|1142|https://civicdb.org/links/evidence/1142|26125448 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Docetaxel (NCIt ID C1526)&Selumetinib (NCIt ID C66939)|COMBINATION||B|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|2257|https://civicdb.org/links/evidence/2257|17409929 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Cancer|Gefitinib (NCIt ID C1855)|||B|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|2258|https://civicdb.org/links/evidence/2258|19284554 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||B|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|2253|https://civicdb.org/links/evidence/2253|18316791 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|2262|https://civicdb.org/links/evidence/2262|12483530 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|None|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|1173|https://civicdb.org/links/evidence/1173|26739882 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|ARS-853&Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (NCIt ID C2167)|COMBINATION||D|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|7572|https://civicdb.org/links/evidence/7572|177193 (ASCO)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Solid Tumor|Adagrasib (NCIt ID C157493)|||D|3|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|2212|https://civicdb.org/links/evidence/2212|22392911 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Dactolisib (NCIt ID C74072)&Selumetinib (NCIt ID C66939)|COMBINATION||D|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|2261|https://civicdb.org/links/evidence/2261|11050000 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|2263|https://civicdb.org/links/evidence/2263|16497971 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,A|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>T||G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/variants/78|KRAS G12C|78|GLY12CYS&RS121913530|https://civicdb.org/links/molecular-profiles/78|NM_004985.4:c.34G>T&NP_004976.2:p.Gly12Cys&NC_000012.11:g.25398285C>A&ENST00000256078.4:c.34G>T|CA122528|12578|256.5|evidence|3973|https://civicdb.org/links/evidence/3973|26161928 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||D|2|||||
12	25398285	530	C	G	.	.	VT=G12R;CSQ=G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|GLY12ARG&RS121913530|https://civicdb.org/links/variants/530|KRAS G12R|526|GLY12ARG&RS121913530|https://civicdb.org/links/molecular-profiles/526|NM_004985.4:c.34G>C&NP_004976.2:p.Gly12Arg&NC_000012.11:g.25398285C>G&ENST00000256078.4:c.34G>C|CA122531|12579|32.5|evidence|1298|https://civicdb.org/links/evidence/1298|22983505 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Pancreatic Cancer||||B|4|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|GLY12ARG&RS121913530|https://civicdb.org/links/variants/530|KRAS G12R|526|GLY12ARG&RS121913530|https://civicdb.org/links/molecular-profiles/526|NM_004985.4:c.34G>C&NP_004976.2:p.Gly12Arg&NC_000012.11:g.25398285C>G&ENST00000256078.4:c.34G>C|CA122531|12579|32.5|evidence|2264|https://civicdb.org/links/evidence/2264|18316791 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|None|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|GLY12ARG&RS121913530|https://civicdb.org/links/variants/530|KRAS G12R|526|GLY12ARG&RS121913530|https://civicdb.org/links/molecular-profiles/526|NM_004985.4:c.34G>C&NP_004976.2:p.Gly12Arg&NC_000012.11:g.25398285C>G&ENST00000256078.4:c.34G>C|CA122531|12579|32.5|evidence|3987|https://civicdb.org/links/evidence/3987|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Chemotherapy (NCIt ID C15632)|COMBINATION||C|3|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|GLY12ARG&RS121913530|https://civicdb.org/links/variants/530|KRAS G12R|526|GLY12ARG&RS121913530|https://civicdb.org/links/molecular-profiles/526|NM_004985.4:c.34G>C&NP_004976.2:p.Gly12Arg&NC_000012.11:g.25398285C>G&ENST00000256078.4:c.34G>C|CA122531|12579|32.5|evidence|3989|https://civicdb.org/links/evidence/3989|22722830 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||D|4|||||,G|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>C||G12R|530|GLY12ARG&RS121913530|https://civicdb.org/links/variants/530|KRAS G12R|526|GLY12ARG&RS121913530|https://civicdb.org/links/molecular-profiles/526|NM_004985.4:c.34G>C&NP_004976.2:p.Gly12Arg&NC_000012.11:g.25398285C>G&ENST00000256078.4:c.34G>C|CA122531|12579|32.5|evidence|3991|https://civicdb.org/links/evidence/3991|26161928 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||D|1|||||;GN=KRAS
12	25398285	913	C	T	.	.	VT=G12S;CSQ=T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|4006|https://civicdb.org/links/evidence/4006|20619739 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)|||B|3|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|2273|https://civicdb.org/links/evidence/2273|17409929 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Cancer|Gefitinib (NCIt ID C1855)|||B|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|2274|https://civicdb.org/links/evidence/2274|19284554 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||B|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|2269|https://civicdb.org/links/evidence/2269|18316791 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Panitumumab (NCIt ID C1857)|||C|None|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|6314|https://civicdb.org/links/evidence/6314|19223544 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Panitumumab (NCIt ID C1857)|SUBSTITUTES||C|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|2277|https://civicdb.org/links/evidence/2277|11050000 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|2278|https://civicdb.org/links/evidence/2278|12483530 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|2279|https://civicdb.org/links/evidence/2279|16497971 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Multiple Myeloma|Melphalan (NCIt ID C633)|||D|2|||||,T|Missense Variant|KRAS|3845|transcript|ENST00000256078.4|ENST00000256078.4:c.34G>A||G12S|913|RS121913530&GLY12SER|https://civicdb.org/links/variants/913|KRAS G12S|887|RS121913530&GLY12SER|https://civicdb.org/links/molecular-profiles/887|NM_004985.4:c.34G>A&NP_004976.2:p.Gly12Ser&NC_000012.11:g.25398285C>T&ENST00000256078.4:c.34G>A|CA135565|12584|48.0|evidence|4012|https://civicdb.org/links/evidence/4012|26161928 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Regorafenib (NCIt ID C78204)|||D|2|||||;GN=KRAS
12	56478851	702	C	G	.	.	CSQ=G|Missense Variant|ERBB3|2065|transcript|ENST00000267101.3|||R103G|702|ARG103GLY|https://civicdb.org/links/variants/702|ERBB3 R103G|683|ARG103GLY|https://civicdb.org/links/molecular-profiles/683|NC_000012.11:g.56478851C>G|CA385279657|NONE FOUND|15.0|evidence|1747|https://civicdb.org/links/evidence/1747|27044931 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Transitional Cell Carcinoma|Afatinib (NCIt ID C66940)|||B|3|||||;GN=ERBB3;VT=R103G
12	56478854	701	G	A	.	.	GN=ERBB3;CSQ=A|Missense Variant|ERBB3|2065|transcript|ENST00000267101.3|||V104M|701|VAL104MET|https://civicdb.org/links/variants/701|ERBB3 V104M|682|VAL104MET|https://civicdb.org/links/molecular-profiles/682|NC_000012.11:g.56478854G>A|CA16602847|376410|15.0|evidence|1746|https://civicdb.org/links/evidence/1746|27044931 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Transitional Cell Carcinoma|Afatinib (NCIt ID C66940)|||B|3|||||;VT=V104M
12	56481922	703	G	A	.	.	VT=G284R;GN=ERBB3;CSQ=A|Missense Variant|ERBB3|2065|transcript|ENST00000267101.3|||G284R|703|GLY284ARG|https://civicdb.org/links/variants/703|ERBB3 G284R|684|GLY284ARG|https://civicdb.org/links/molecular-profiles/684|NC_000012.11:g.56481922G>A|CA16602624|376167|15.0|evidence|1748|https://civicdb.org/links/evidence/1748|27044931 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Transitional Cell Carcinoma|Afatinib (NCIt ID C66940)|||B|3|||||
12	56491672	781	T	C	.	.	VT=V855A;GN=ERBB3;CSQ=C|Missense Variant|ERBB3|2065|transcript|ENST00000267101.3|||V855A|781|VAL855ALA|https://civicdb.org/links/variants/781|ERBB3 V855A|762|VAL855ALA|https://civicdb.org/links/molecular-profiles/762|NC_000012.11:g.56491672T>C&ENST000000267101.3:c.2564T>C|CA385313732|NONE FOUND|2.0|evidence|1845|https://civicdb.org/links/evidence/1845|26689995 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)&Pertuzumab (NCIt ID C38692)|SUBSTITUTES||D|2|||||
12	58145431	556	G	A	.	.	GN=CDK4;VT=R24C;CSQ=A|Missense Variant|CDK4|1019|transcript|ENST00000257904.6|ENST00000257904.6:c.70C>T||R24C|556|ARG24CYS&RS11547328|https://civicdb.org/links/variants/556|CDK4 R24C|552|ARG24CYS&RS11547328|https://civicdb.org/links/molecular-profiles/552|NM_000075.3:c.70C>T&NP_000066.1:p.Arg24Cys&ENST00000257904.6:c.70C>T&NC_000012.11:g.58145431G>A|CA126982|16928|1.0|evidence|1376|https://civicdb.org/links/evidence/1376|24495407 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Skin Melanoma|Palbociclib (NCIt ID C49176)|||D|1|||||
12	69202580	495	T	G	.	.	VT=SNP309;CSQ=G|Coding Transcript Intron Variant|MDM2|4193|transcript|ENST00000462284.1|||SNP309|495||https://civicdb.org/links/variants/495|MDM2 SNP309|491||https://civicdb.org/links/molecular-profiles/491|NC_000012.11:g.69202580T>G|CA123622|13904|10.0|evidence|1169|https://civicdb.org/links/evidence/1169|26916894 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Head And Neck Cancer||||B|2|||||;GN=MDM2
12	69234987	642	TA	T	.	.	CSQ=-|3 Prime UTR Truncation|MDM2|4193|transcript|ENST00000462284.1|||RS34886328|642||https://civicdb.org/links/variants/642|MDM2 RS34886328|638||https://civicdb.org/links/molecular-profiles/638||CA238461468||10.0|evidence|1636|https://civicdb.org/links/evidence/1636|27414035 (PUBMED)|SOMATIC|accepted|BETTER_OUTCOME|SUPPORTS|Esophagus Squamous Cell Carcinoma||||B|2|||||;GN=MDM2;VT=RS34886328
12	111884608	699	T	C	.	.	VT=RS3184504;CSQ=C|Missense Variant&Polymorphic Sequence Variant|SH2B3|10019|transcript|ENST00000341259.2|ENST00000341259.2:c.784T>C||RS3184504|699|ARG262TRP&R262W&TRP262ARG|https://civicdb.org/links/variants/699|SH2B3 RS3184504|680|ARG262TRP&R262W&TRP262ARG|https://civicdb.org/links/molecular-profiles/680|NC_000012.11:g.111884608T>C&NM_005475.2:c.784T>C&ENST00000341259.2:c.784T>C|CA6789733|NONE FOUND|10.0|evidence|1744|https://civicdb.org/links/evidence/1744|26621817 (PUBMED)|COMMON_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Colorectal Cancer||||B|2|||||;GN=SH2B3
13	28592641	1302	T	A	.	.	VT=D835V;GN=FLT3;CSQ=A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|4022|https://civicdb.org/links/evidence/4022|15459012 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Sunitinib (NCIt ID C71622)|||C|None|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|3012|https://civicdb.org/links/evidence/3012|23497317 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Acute Myeloid Leukemia|Quizartinib (NCIt ID C68936)|||D|4|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|3007|https://civicdb.org/links/evidence/3007|15256420 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Myeloid Leukemia|Tandutinib (NCIt ID C48404)|||D|3|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|3008|https://civicdb.org/links/evidence/3008|15304385 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Acute Myeloid Leukemia|Sunitinib (NCIt ID C71622)|||D|3|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|3034|https://civicdb.org/links/evidence/3034|17330097 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|AS602868&Tyrphostin AG 1296 (NCIt ID C1731)|SUBSTITUTES||D|3|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|3009|https://civicdb.org/links/evidence/3009|15304385 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Cytarabine (NCIt ID C408)&Sunitinib (NCIt ID C71622)|COMBINATION||D|2|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|3010|https://civicdb.org/links/evidence/3010|15304385 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Daunorubicin (NCIt ID C62091)&Sunitinib (NCIt ID C71622)|COMBINATION||D|2|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2504A>T||D835V|1302|RS121909646&ASP835VAL|https://civicdb.org/links/variants/1302|FLT3 D835V|1276|RS121909646&ASP835VAL|https://civicdb.org/links/molecular-profiles/1276|ENST00000241453.7:c.2504A>T&NM_004119.2:c.2504A>T&NP_004110.2:p.Asp835Val&NC_000013.10:g.28592641T>A|CA126344|16272|19.0|evidence|8518|https://civicdb.org/links/evidence/8518|27908881 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Gilteritinib (NCIt ID C116722)|||D|2|||||
13	28592642	612	C	G	.	.	CSQ=G|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2503G>C||D835H|612|ASP835HIS&RS121913488|https://civicdb.org/links/variants/612|FLT3 D835H|608|ASP835HIS&RS121913488|https://civicdb.org/links/molecular-profiles/608|NM_004119.2:c.2503G>C&NP_004110.2:p.Asp835His&ENST00000241453.7:c.2503G>C&NC_000013.10:g.28592642C>G|CA280208|16273|9.5|evidence|1556|https://civicdb.org/links/evidence/1556|23969938 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Myeloid Leukemia|Sorafenib (NCIt ID C61948)|||C|3|||||,G|Missense Variant|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.2503G>C||D835H|612|ASP835HIS&RS121913488|https://civicdb.org/links/variants/612|FLT3 D835H|608|ASP835HIS&RS121913488|https://civicdb.org/links/molecular-profiles/608|NM_004119.2:c.2503G>C&NP_004110.2:p.Asp835His&ENST00000241453.7:c.2503G>C&NC_000013.10:g.28592642C>G|CA280208|16273|9.5|evidence|8517|https://civicdb.org/links/evidence/8517|27908881 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Gilteritinib (NCIt ID C116722)|||D|2|||||;GN=FLT3;VT=D835H
13	28592642	3011	C	A	.	.	GN=FLT3;VT=D835Y;CSQ=A|Missense Variant|FLT3|2322|transcript|ENST00000241453.12|ENST00000241453.12:c.2503G>T||D835Y|3011|ASP835TYR&RS121913488|https://civicdb.org/links/variants/3011|FLT3 D835Y|2880|ASP835TYR&RS121913488|https://civicdb.org/links/molecular-profiles/2880|NC_000013.11:g.28018505C>A&NC_000013.10:g.28592642C>A&ENST00000241453.12:c.2503G>T&NM_004119.3:c.2503G>T&ENSP00000241453.7:p.Asp835Tyr&NP_004110.2:p.Asp835Tyr&LRG_457t1:c.2503G>T&NM_004119.2:c.2503G>T|CA126347||6.0|evidence|8106|https://civicdb.org/links/evidence/8106|28516360 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Gilteritinib (NCIt ID C116722)|||D|4|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.12|ENST00000241453.12:c.2503G>T||D835Y|3011|ASP835TYR&RS121913488|https://civicdb.org/links/variants/3011|FLT3 D835Y|2880|ASP835TYR&RS121913488|https://civicdb.org/links/molecular-profiles/2880|NC_000013.11:g.28018505C>A&NC_000013.10:g.28592642C>A&ENST00000241453.12:c.2503G>T&NM_004119.3:c.2503G>T&ENSP00000241453.7:p.Asp835Tyr&NP_004110.2:p.Asp835Tyr&LRG_457t1:c.2503G>T&NM_004119.2:c.2503G>T|CA126347||6.0|evidence|8108|https://civicdb.org/links/evidence/8108|27908881 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Acute Myeloid Leukemia|Gilteritinib (NCIt ID C116722)|||D|2|||||,A|Missense Variant|FLT3|2322|transcript|ENST00000241453.12|ENST00000241453.12:c.2503G>T||D835Y|3011|ASP835TYR&RS121913488|https://civicdb.org/links/variants/3011|FLT3 ITD AND FLT3 D835Y|4616||https://civicdb.org/links/molecular-profiles/4616|NC_000013.11:g.28018505C>A&NC_000013.10:g.28592642C>A&ENST00000241453.12:c.2503G>T&NM_004119.3:c.2503G>T&ENSP00000241453.7:p.Asp835Tyr&NP_004110.2:p.Asp835Tyr&LRG_457t1:c.2503G>T&NM_004119.2:c.2503G>T|CA126347||0.0|evidence|247|https://civicdb.org/links/evidence/247|22368270 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Myeloid Leukemia|Sorafenib (NCIt ID C61948)|||C|4|||||
13	28624294	540	G	A	.	.	VT=T227M;GN=FLT3;CSQ=A|Missense Variant&Snp|FLT3|2322|transcript|ENST00000241453.7|ENST00000241453.7:c.680C>T||T227M|540|RS1933437&THR227MET|https://civicdb.org/links/variants/540|FLT3 T227M|536|RS1933437&THR227MET|https://civicdb.org/links/molecular-profiles/536|NM_004119.2:c.680C>T&NP_004110.2:p.Thr227Met&ENST00000241453.7:c.680C>T&NC_000013.10:g.28624294G>A|CA159846|134447|15.0|evidence|1317|https://civicdb.org/links/evidence/1317|19667267 (PUBMED)|COMMON_GERMLINE|accepted|ADVERSE_RESPONSE|SUPPORTS|Renal Cell Carcinoma|Sunitinib (NCIt ID C71622)|||B|3|||||
13	32890599	1247	T	G	.	.	CSQ=G|Missense Variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.2T>G||M1R|1247|MET1ARG&RS80358547|https://civicdb.org/links/variants/1247|BRCA2 M1R|1221|MET1ARG&RS80358547|https://civicdb.org/links/molecular-profiles/1221|NM_000059.3:c.2T>G&NC_000013.10:g.32890599T>G&NP_000050.2:p.Met1Arg&ENST00000544455.1:c.2T>G|CA017013|51385|0.0|evidence|2879|https://civicdb.org/links/evidence/2879|27908594 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Rucaparib (NCIt ID C137800)|||C|None|||||;VT=M1R;GN=BRCA2
13	32890600	1248	G	T	.	.	CSQ=T|Missense Variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.3G>T||M1I|1248|MET1ILE&RS80358650|https://civicdb.org/links/variants/1248|BRCA2 M1I|1222|MET1ILE&RS80358650|https://civicdb.org/links/molecular-profiles/1222|NC_000013.10:g.32890600G>T&NM_000059.3:c.3G>T&NP_000050.2:p.Met1Ile&ENST00000544455.1:c.3G>T|CA019369|37871|0.0|evidence|2880|https://civicdb.org/links/evidence/2880|27908594 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Rucaparib (NCIt ID C137800)|||C|None|||||;VT=M1I;GN=BRCA2
13	32900287	1249	G	A	.	.	CSQ=A|Missense Variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.475G>A||V159M|1249|VAL159MET&RS80358702|https://civicdb.org/links/variants/1249|BRCA2 V159M|1223|VAL159MET&RS80358702|https://civicdb.org/links/molecular-profiles/1223|ENST00000544455.1:c.475G>A&NM_000059.3:c.475G>A&NP_000050.2:p.Val159Met&NC_000013.10:g.32900287G>A|CA020781|51711|0.0|evidence|2881|https://civicdb.org/links/evidence/2881|27908594 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Rucaparib (NCIt ID C137800)|||C|None|||||;VT=V159M;GN=BRCA2
13	32900751	1251	G	A	.	.	CSQ=A|Missense Variant|BRCA2|675|transcript|None|||V211I|1251||https://civicdb.org/links/variants/1251|BRCA2 V211I|1225||https://civicdb.org/links/molecular-profiles/1225|NC_000013.10:g.32900751G>A|CA023848||0.0|evidence|2883|https://civicdb.org/links/evidence/2883|27908594 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Rucaparib (NCIt ID C137800)|||C|None|||||;VT=V211I;GN=BRCA2
13	32900751	1250	G	C	.	.	CSQ=C|Missense Variant|BRCA2|675|transcript|None|||V211L|1250||https://civicdb.org/links/variants/1250|BRCA2 V211L|1224||https://civicdb.org/links/molecular-profiles/1224|NC_000013.10:g.32900751G>C|CA16619647||0.0|evidence|2882|https://civicdb.org/links/evidence/2882|27908594 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Rucaparib (NCIt ID C137800)|||C|None|||||;VT=V211L;GN=BRCA2
13	32921033	1252	G	C	.	.	VT=R2336P;CSQ=C|Missense Variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.7007G>C||R2336P|1252|ARG2336PRO&RS28897743|https://civicdb.org/links/variants/1252|BRCA2 R2336P|1226|ARG2336PRO&RS28897743|https://civicdb.org/links/molecular-profiles/1226|NM_000059.3:c.7007G>C&NP_000050.2:p.Arg2336Pro&NC_000013.10:g.32921033G>C&ENST00000544455.1:c.7007G>C|CA024716|52241|0.0|evidence|2884|https://civicdb.org/links/evidence/2884|27908594 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Rucaparib (NCIt ID C137800)|||C|None|||||;GN=BRCA2
13	32968854	661	C	A	.	.	VT=D3095E;CSQ=A|Missense Variant|BRCA2|675|transcript|ENST00000544455.1|ENST00000544455.1:c.9285C>A||D3095E|661|ASP3095GLU&RS80359198|https://civicdb.org/links/variants/661|BRCA2 D3095E|657|ASP3095GLU&RS80359198|https://civicdb.org/links/molecular-profiles/657|NM_000059.3:c.9285C>A&NP_000050.2:p.Asp3095Glu&ENST00000544455.1:c.9285C>A&NC_000013.10:g.32968854C>A|CA10586089|252859|7.5|evidence|1679|https://civicdb.org/links/evidence/1679|18951446 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Breast Cancer||||C|3|||||;GN=BRCA2
13	49033946	638	A	AA	.	.	VT=M695FS*26;GN=RB1;CSQ=A|Frameshift Truncation|RB1|5925|transcript|ENST00000267163.4|ENST00000267163.4:c.2083_2084insA||M695FS*26|638||https://civicdb.org/links/variants/638|RB1 M695FS*26|634||https://civicdb.org/links/molecular-profiles/634|ENST00000267163.4:c.2083_2084insA&NC_000013.10:g.49033946_49033947insA|CA913189236|NONE FOUND|2.0|evidence|1630|https://civicdb.org/links/evidence/1630|27020857 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Estrogen-receptor Positive Breast Cancer|Palbociclib (NCIt ID C49176)|||D|2|||||
13	103498198	255	A	G	.	.	VT=RS751402;GN=ERCC5;CSQ=G|5 Prime UTR Variant&Snp|ERCC5|2073|transcript|ENST00000355739.4|||RS751402|255||https://civicdb.org/links/variants/255|ERCC5 RS751402|251||https://civicdb.org/links/molecular-profiles/251|NC_000013.10:g.103498198A>G|CA10642711|310903|15.0|evidence|665|https://civicdb.org/links/evidence/665|26338418 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Parietal Lobe Ependymoma||||B|3|||||
14	62213848	433	T	C	.	.	GN=HIF1A;CSQ=C|3 Prime UTR Variant&Snp|HIF1A|3091|transcript|ENST00000394997.1|||3' UTR Polymorphism|433||https://civicdb.org/links/variants/433|HIF1A 3' UTR Polymorphism|429||https://civicdb.org/links/molecular-profiles/429|NC_000014.8:g.62213848T>C|CA7216212||10.0|evidence|1031|https://civicdb.org/links/evidence/1031|26872370 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Pancreatic Adenocarcinoma||||B|2|||||;VT=3' UTR Polymorphism
14	65453063	332	G	C	.	.	VT=RS11623866;GN=FNTB;CSQ=C|Regulatory Region Variant|FNTB|2342|transcript|ENST00000246166.2|||RS11623866|332||https://civicdb.org/links/variants/332|FNTB RS11623866|328||https://civicdb.org/links/molecular-profiles/328|NC_000014.8:g.65453063G>C|CA13941207||10.0|evidence|815|https://civicdb.org/links/evidence/815|26033044 (PUBMED)|COMMON_GERMLINE|accepted|RESISTANCE|SUPPORTS|Ovarian Cancer|Lonafarnib (NCIt ID C1829)|||B|2|||||
14	95557630	2052	C	G	.	.	VT=E1813Q;GN=DICER1;CSQ=G|Missense Variant|DICER1|23405|transcript|ENST00000526495.1|ENST00000526495.1:c.5437G>C||E1813Q|2052|GLU1813GLN|https://civicdb.org/links/variants/2052|DICER1 E1813Q|1928|GLU1813GLN|https://civicdb.org/links/molecular-profiles/1928|ENST00000526495.1:c.5437G>C|CA390864655|NONE FOUND|22.5|evidence|5535|https://civicdb.org/links/evidence/5535|26428316 (PUBMED)|SOMATIC|accepted|POSITIVE|DOES_NOT_SUPPORT|Sertoli-Leydig Cell Tumor||||B|4|||||,G|Missense Variant|DICER1|23405|transcript|ENST00000526495.1|ENST00000526495.1:c.5437G>C||E1813Q|2052|GLU1813GLN|https://civicdb.org/links/variants/2052|DICER1 E1813Q|1928|GLU1813GLN|https://civicdb.org/links/molecular-profiles/1928|ENST00000526495.1:c.5437G>C|CA390864655|NONE FOUND|22.5|evidence|5892|https://civicdb.org/links/evidence/5892|22187960 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Sertoli-Leydig Cell Tumor||||C|1|||||
14	95560476	2050	C	T	.	.	VT=E1705K;CSQ=T|Missense Variant|DICER1|23405|transcript|ENST00000526495.1|ENST00000526495.1:c.5113G>A||E1705K|2050|GLU1705LYS|https://civicdb.org/links/variants/2050|DICER1 E1705K|1926|GLU1705LYS|https://civicdb.org/links/molecular-profiles/1926|ENST00000526495.1:c.5113G>A|CA390865421|NONE FOUND|20.0|evidence|5533|https://civicdb.org/links/evidence/5533|26428316 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Sertoli-Leydig Cell Tumor||||B|4|||||,T|Missense Variant|DICER1|23405|transcript|ENST00000526495.1|ENST00000526495.1:c.5113G>A||E1705K|2050|GLU1705LYS|https://civicdb.org/links/variants/2050|DICER1 E1705K|1926|GLU1705LYS|https://civicdb.org/links/molecular-profiles/1926|ENST00000526495.1:c.5113G>A|CA390865421|NONE FOUND|20.0|evidence|11480|https://civicdb.org/links/evidence/11480|26428316 (PUBMED)|SOMATIC|accepted|POSITIVE|SUPPORTS|Gynandroblastoma||||C|2|||||;GN=DICER1
14	105243048	169	G	T	.	.	VT=Q79K;CSQ=T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.235C>A||Q79K|169|Q17K&GLN79LYS&RS1057519804|https://civicdb.org/links/variants/169|AKT1 Q79K|169|Q17K&GLN79LYS&RS1057519804|https://civicdb.org/links/molecular-profiles/169|NC_000014.8:g.105243048G>T&NM_001014432.1:c.235C>A&NP_001014432.1:p.Gln79Lys&ENST00000407796.2:c.235C>A|CA16602625|376168|16.0|evidence|6260|https://civicdb.org/links/evidence/6260|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Dabrafenib (NCIt ID C82386)|||C|4|||||,T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.235C>A||Q79K|169|Q17K&GLN79LYS&RS1057519804|https://civicdb.org/links/variants/169|AKT1 Q79K|169|Q17K&GLN79LYS&RS1057519804|https://civicdb.org/links/molecular-profiles/169|NC_000014.8:g.105243048G>T&NM_001014432.1:c.235C>A&NP_001014432.1:p.Gln79Lys&ENST00000407796.2:c.235C>A|CA16602625|376168|16.0|evidence|439|https://civicdb.org/links/evidence/439|24265152 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|4|||||,T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.235C>A||Q79K|169|Q17K&GLN79LYS&RS1057519804|https://civicdb.org/links/variants/169|AKT1 Q79K|169|Q17K&GLN79LYS&RS1057519804|https://civicdb.org/links/molecular-profiles/169|NC_000014.8:g.105243048G>T&NM_001014432.1:c.235C>A&NP_001014432.1:p.Gln79Lys&ENST00000407796.2:c.235C>A|CA16602625|376168|16.0|evidence|4498|https://civicdb.org/links/evidence/4498|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|2|||||;GN=AKT1
14	105246551	4	C	T	.	.	VT=E17K;CSQ=T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/variants/4|AKT1 E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/molecular-profiles/4|NC_000014.8:g.105246551C>T&NM_001014432.1:c.49G>A&NP_001014432.1:p.Glu17Lys&ENST00000407796.2:c.49G>A|CA123660|13983|33.5|evidence|3039|https://civicdb.org/links/evidence/3039|28489509 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Capivasertib (NCIt ID C102564)|||B|4|||||,T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/variants/4|AKT1 E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/molecular-profiles/4|NC_000014.8:g.105246551C>T&NM_001014432.1:c.49G>A&NP_001014432.1:p.Glu17Lys&ENST00000407796.2:c.49G>A|CA123660|13983|33.5|evidence|709|https://civicdb.org/links/evidence/709|26351323 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Capivasertib (NCIt ID C102564)|||C|3|||||,T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/variants/4|AKT1 E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/molecular-profiles/4|NC_000014.8:g.105246551C>T&NM_001014432.1:c.49G>A&NP_001014432.1:p.Glu17Lys&ENST00000407796.2:c.49G>A|CA123660|13983|33.5|evidence|231|https://civicdb.org/links/evidence/231|23888070 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Breast Cancer|Akt Inhibitor MK2206 (NCIt ID C90581)|||D|3|||||,T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/variants/4|AKT1 E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/molecular-profiles/4|NC_000014.8:g.105246551C>T&NM_001014432.1:c.49G>A&NP_001014432.1:p.Glu17Lys&ENST00000407796.2:c.49G>A|CA123660|13983|33.5|evidence|707|https://civicdb.org/links/evidence/707|24735930 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Melanoma|Uprosertib (NCIt ID C84870)|||D|2|||||,T|Missense Variant|AKT1|207|transcript|ENST00000407796.2|ENST00000407796.2:c.49G>A||E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/variants/4|AKT1 E17K|4|GLU17LYS&RS34409589|https://civicdb.org/links/molecular-profiles/4|NC_000014.8:g.105246551C>T&NM_001014432.1:c.49G>A&NP_001014432.1:p.Glu17Lys&ENST00000407796.2:c.49G>A|CA123660|13983|33.5|evidence|4029|https://civicdb.org/links/evidence/4029|24265155 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||D|1|||||;GN=AKT1
15	45003785	616	CTCTT	C	.	.	VT=S14FS;GN=B2M;CSQ=-|Frameshift Truncation|B2M|567|transcript|ENST00000558401.1|ENST00000558401.1:c.42_45delTCTT||S14FS|616||https://civicdb.org/links/variants/616|B2M S14FS|612||https://civicdb.org/links/molecular-profiles/612|ENST00000558401.1:c.42_45delTCTT&NC_000015.9:g.45003786_45003789del|CA645576720||7.5|evidence|1569|https://civicdb.org/links/evidence/1569|27433843 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Skin Melanoma|Pembrolizumab (NCIt ID C106432)|||C|3|||||
15	66727448	655	CCCAGAAGCAGAAGGT	C	.	.	GN=MAP2K1;CSQ=-|Inframe Deletion|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.165_179del||Q56_V60del|655||https://civicdb.org/links/variants/655|MAP2K1 Q56_V60del|651||https://civicdb.org/links/molecular-profiles/651|ENST00000307102.5:c.165_179del&NC_000015.9:g.66727449_66727463del|CA912992484|NONE FOUND|10.0|evidence|1661|https://civicdb.org/links/evidence/1661|26324360 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Serous Carcinoma|Selumetinib (NCIt ID C66939)|||C|4|||||;VT=Q56_V60del
15	66727451	83	A	C	.	.	GN=MAP2K1;VT=Q56P;CSQ=C|Missense Variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.167A>C||Q56P|83|GLN56PRO&RS1057519729|https://civicdb.org/links/variants/83|MAP2K1 Q56P|83|GLN56PRO&RS1057519729|https://civicdb.org/links/molecular-profiles/83|ENST00000307102.5:c.167A>C&NC_000015.9:g.66727451A>C&NM_002755.3:c.167A>C&NP_002746.1:p.Gln56Pro|CA16602453|375978|3.0|evidence|13|https://civicdb.org/links/evidence/13|19915144 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Selumetinib (NCIt ID C66939)|||D|3|||||
15	66727455	1272	G	T	.	.	GN=MAP2K1;CSQ=T|Missense Variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.171G>T||K57N|1272|LYS57ASN&RS869025608|https://civicdb.org/links/variants/1272|MAP2K1 K57N|1246|LYS57ASN&RS869025608|https://civicdb.org/links/molecular-profiles/1246|NM_002755.3:c.171G>T&NP_002746.1:p.Lys57Asn&NG_008305.1:g.53245G>T&NC_000015.9:g.66727455G>T&ENST00000307102.5:c.171G>T|CA356995|223140|17.0|evidence|2935|https://civicdb.org/links/evidence/2935|25351745 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Lung Adenocarcinoma||||B|3|||||,T|Missense Variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.171G>T||K57N|1272|LYS57ASN&RS869025608|https://civicdb.org/links/variants/1272|MAP2K1 K57N|1246|LYS57ASN&RS869025608|https://civicdb.org/links/molecular-profiles/1246|NM_002755.3:c.171G>T&NP_002746.1:p.Lys57Asn&NG_008305.1:g.53245G>T&NC_000015.9:g.66727455G>T&ENST00000307102.5:c.171G>T|CA356995|223140|17.0|evidence|2936|https://civicdb.org/links/evidence/2936|18632602 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Selumetinib (NCIt ID C66939)|||D|2|||||;VT=K57N
15	66729154	627	G	C	.	.	GN=MAP2K1;CSQ=C|Missense Variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.362G>C||C121S|627|CYS121SER|https://civicdb.org/links/variants/627|MAP2K1 C121S|623|CYS121SER|https://civicdb.org/links/molecular-profiles/623|ENST00000307102.5:c.362G>C&NC_000015.9:g.66729154G>C&NM_002755.3:c.362G>C&NP_002746.1:p.Cys121Ser|CA16602455|375980|10.0|evidence|1602|https://civicdb.org/links/evidence/1602|21383288 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Vemurafenib (NCIt ID C64768)|||C|4|||||;VT=C121S
15	66729162	82	C	T	.	.	GN=MAP2K1;CSQ=T|Missense Variant|MAP2K1|5604|transcript|ENST00000307102.5|ENST00000307102.5:c.370C>T||P124S|82|PRO124SER|https://civicdb.org/links/variants/82|MAP2K1 P124S|82|PRO124SER|https://civicdb.org/links/molecular-profiles/82|ENST00000307102.5:c.370C>T&NC_000015.9:g.66729162C>T&NM_002755.3:c.370C>T&NP_002746.1:p.Pro124Ser|CA16602456|375981|3.0|evidence|12|https://civicdb.org/links/evidence/12|19915144 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Melanoma|Selumetinib (NCIt ID C66939)|||D|3|||||;VT=P124S
15	74315213	462	C	T	.	.	GN=PML;CSQ=T|Missense Variant|PML|5371|transcript|ENST00000268058.3|||A216V|462||https://civicdb.org/links/variants/462|PML::RARA Fusion AND PML A216V|5239||https://civicdb.org/links/molecular-profiles/5239|NC_000015.9:g.74315213C>T|CA393121894|NONE FOUND|0.0|evidence|8177|https://civicdb.org/links/evidence/8177|26537301 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Promyelocytic Leukemia|Arsenic Trioxide (NCIt ID C1005)|||B|4|||||,T|Missense Variant|PML|5371|transcript|ENST00000268058.3|||A216V|462||https://civicdb.org/links/variants/462|PML::RARA Fusion AND PML A216V|5239||https://civicdb.org/links/molecular-profiles/5239|NC_000015.9:g.74315213C>T|CA393121894|NONE FOUND|0.0|evidence|1093|https://civicdb.org/links/evidence/1093|21613260 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Promyelocytic Leukemia|Tretinoin (NCIt ID C900)|||C|4|||||;VT=A216V
15	74315219	463	T	C	.	.	GN=PML;CSQ=C|Missense Variant|PML|5371|transcript|ENST00000268058.3|||L218P|463|LEU218PRO|https://civicdb.org/links/variants/463|PML::RARA Fusion AND PML L218P|5240||https://civicdb.org/links/molecular-profiles/5240|NC_000015.9:g.74315219T>C|CA393121927|NONE FOUND|0.0|evidence|1094|https://civicdb.org/links/evidence/1094|21613260 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Acute Promyelocytic Leukemia|Tretinoin (NCIt ID C900)|||C|3|||||;VT=L218P
15	88476265	2691	C	T	.	.	VT=G623R;CSQ=T|Missense Variant|NTRK3|4916|transcript|ENST00000360948.2|||G623R|2691||https://civicdb.org/links/variants/2691|ETV6::NTRK3 Fusion AND NTRK3 G623R|5161||https://civicdb.org/links/molecular-profiles/5161||CA393914380||10.0|evidence|1874|https://civicdb.org/links/evidence/1874|26884591 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Mammary Analogue Secretory Carcinoma|Entrectinib (NCIt ID C114984)|||C|4|||||,T|Missense Variant|NTRK3|4916|transcript|ENST00000360948.2|||G623R|2691||https://civicdb.org/links/variants/2691|ETV6::NTRK3 Fusion AND NTRK3 G623R|5161||https://civicdb.org/links/molecular-profiles/5161||CA393914380||10.0|evidence|10093|https://civicdb.org/links/evidence/10093|26884591 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|ALK/TRK Inhibitor TSR-011 (NCIt ID C114287)&Crizotinib (NCIt ID C74061)&Entrectinib (NCIt ID C114984)&Larotrectinib (NCIt ID C115977)|SUBSTITUTES||D|3|||||,T|Missense Variant|NTRK3|4916|transcript|ENST00000360948.2|||G623R|2691||https://civicdb.org/links/variants/2691|NTRK3 G623R AND EML4::NTRK3 Fusion|4596||https://civicdb.org/links/molecular-profiles/4596||CA393914380||5.0|evidence|11515|https://civicdb.org/links/evidence/11515|34625502 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Entrectinib (NCIt ID C114984)|||C|2|||||,T|Missense Variant|NTRK3|4916|transcript|ENST00000360948.2|||G623R|2691||https://civicdb.org/links/variants/2691|NTRK3 G623R AND EML4::NTRK3 Fusion|4596||https://civicdb.org/links/molecular-profiles/4596||CA393914380||5.0|evidence|11516|https://civicdb.org/links/evidence/11516|34625502 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Repotrectinib (NCIt ID C133821)|||C|2|||||;GN=NTRK3
15	90631838	63	C	T	.	.	CSQ=T|Missense Variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|ARG172LYS&R120K&RS121913503|https://civicdb.org/links/variants/63|IDH2 R172K|63|ARG172LYS&R120K&RS121913503|https://civicdb.org/links/molecular-profiles/63|NC_000015.9:g.90631838C>T&NM_002168.3:c.515G>A&NP_002159.2:p.Arg172Lys&ENST00000330062.3:c.515G>A|CA16602462|375987|35.0|evidence|375|https://civicdb.org/links/evidence/375|21596855 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Acute Myeloid Leukemia||||B|3|||||,T|Missense Variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|ARG172LYS&R120K&RS121913503|https://civicdb.org/links/variants/63|IDH2 R172K|63|ARG172LYS&R120K&RS121913503|https://civicdb.org/links/molecular-profiles/63|NC_000015.9:g.90631838C>T&NM_002168.3:c.515G>A&NP_002159.2:p.Arg172Lys&ENST00000330062.3:c.515G>A|CA16602462|375987|35.0|evidence|331|https://civicdb.org/links/evidence/331|22616558 (PUBMED)|SOMATIC|accepted|NA|DOES_NOT_SUPPORT|Acute Myeloid Leukemia||||B|2|||||,T|Missense Variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|ARG172LYS&R120K&RS121913503|https://civicdb.org/links/variants/63|IDH2 R172K|63|ARG172LYS&R120K&RS121913503|https://civicdb.org/links/molecular-profiles/63|NC_000015.9:g.90631838C>T&NM_002168.3:c.515G>A&NP_002159.2:p.Arg172Lys&ENST00000330062.3:c.515G>A|CA16602462|375987|35.0|evidence|332|https://civicdb.org/links/evidence/332|21997850 (PUBMED)|SOMATIC|accepted|NA|DOES_NOT_SUPPORT|Myelodysplastic Syndrome||||B|2|||||,T|Missense Variant|IDH2|3418|transcript|ENST00000330062.3|ENST00000330062.3:c.515G>A||R172K|63|ARG172LYS&R120K&RS121913503|https://civicdb.org/links/variants/63|IDH2 R172K OR IDH2 R172G OR IDH2 R172W|5297||https://civicdb.org/links/molecular-profiles/5297|NC_000015.9:g.90631838C>T&NM_002168.3:c.515G>A&NP_002159.2:p.Arg172Lys&ENST00000330062.3:c.515G>A|CA16602462|375987|0.0|evidence|11509|https://civicdb.org/links/evidence/11509|37272516 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Low Grade Glioma|Vorasidenib (NCIt ID C152914)|||A|5|||||;GN=IDH2;VT=R172K
16	2130300	469	C	T	.	.	CSQ=T|Stop Gained|TSC2|7249|transcript|ENST00000219476.3|ENST00000219476.3:c.3532C>T||Q1178*|469|Q1178X&GLN1178TER&RS45517297|https://civicdb.org/links/variants/469|TSC2 Q1178*|465|Q1178X&GLN1178TER&RS45517297|https://civicdb.org/links/molecular-profiles/465|NM_000548.4:c.3532C>T&NP_000539.2:p.Gln1178Ter&ENST00000219476.3:c.3532C>T&NC_000016.9:g.2130300C>T|CA019253|49263|12.5|evidence|1108|https://civicdb.org/links/evidence/1108|25295501 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Thyroid Gland Carcinoma|Everolimus (NCIt ID C48387)|||C|5|||||;GN=TSC2;VT=Q1178*
16	69745145	402	G	A	.	.	VT=P187S;CSQ=A|Missense Variant|NQO1|1728|transcript|ENST00000320623.5|||P187S|402|PRO187SER|https://civicdb.org/links/variants/402|NQO1 P187S|398|PRO187SER|https://civicdb.org/links/molecular-profiles/398|NM_000903.2:c.559C>T&NP_000894.1:p.Pro187Ser&NC_000016.9:g.69745145G>A|CA126904|16809|2.0|evidence|941|https://civicdb.org/links/evidence/941|21964527 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Cancer|Amrubicin (NCIt ID C80089)|||D|2|||||;GN=NQO1
17	7577093	1108	C	A	.	.	CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.845G>T||R282L|1108|ARG282LEU&R150L&R243L&RS730882008|https://civicdb.org/links/variants/1108|TP53 R282L|1082|ARG282LEU&R150L&R243L&RS730882008|https://civicdb.org/links/molecular-profiles/1082|NM_000546.5:c.845G>T&NP_000537.3:p.Arg282Leu&NC_000017.10:g.7577093C>A&ENST00000269305.4:c.845G>T|CA000456|182938|0.0|evidence|2818|https://civicdb.org/links/evidence/2818|14514923 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Stomach Carcinoma|EAP Protocol|||C|None|||||;VT=R282L;GN=TP53
17	7577111	1050	G	A	.	.	VT=A276V;CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.827C>T||A276V|1050|ALA276VAL|https://civicdb.org/links/variants/1050|TP53 A276V|1024|ALA276VAL|https://civicdb.org/links/molecular-profiles/1024|ENST00000269305.4:c.827C>T|CA397836916|N/A|3.0|evidence|10232|https://civicdb.org/links/evidence/10232|11896595 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|DOES_NOT_SUPPORT|||||D|3|||||;GN=TP53
17	7577120	122	C	T	.	.	VT=R273H;CSQ=T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/variants/122|TP53 R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/molecular-profiles/122|NM_000546.5:c.818G>A&NP_000537.3:p.Arg273His&NC_000017.10:g.7577120C>T&ENST00000269305.4:c.818G>A|CA000434|12366|41.0|evidence|397|https://civicdb.org/links/evidence/397|16489069 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/variants/122|TP53 R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/molecular-profiles/122|NM_000546.5:c.818G>A&NP_000537.3:p.Arg273His&NC_000017.10:g.7577120C>T&ENST00000269305.4:c.818G>A|CA000434|12366|41.0|evidence|398|https://civicdb.org/links/evidence/398|9569050 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/variants/122|TP53 R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/molecular-profiles/122|NM_000546.5:c.818G>A&NP_000537.3:p.Arg273His&NC_000017.10:g.7577120C>T&ENST00000269305.4:c.818G>A|CA000434|12366|41.0|evidence|4882|https://civicdb.org/links/evidence/4882|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/variants/122|TP53 R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/molecular-profiles/122|NM_000546.5:c.818G>A&NP_000537.3:p.Arg273His&NC_000017.10:g.7577120C>T&ENST00000269305.4:c.818G>A|CA000434|12366|41.0|evidence|7530|https://civicdb.org/links/evidence/7530|31395785 (PUBMED)|UNKNOWN|accepted|NEOMORPHIC|DOES_NOT_SUPPORT|||||D|4|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>A||R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/variants/122|TP53 R273H|122|ARG273HIS&RS28934576|https://civicdb.org/links/molecular-profiles/122|NM_000546.5:c.818G>A&NP_000537.3:p.Arg273His&NC_000017.10:g.7577120C>T&ENST00000269305.4:c.818G>A|CA000434|12366|41.0|evidence|7430|https://civicdb.org/links/evidence/7430|17363498 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Osteosarcoma|Doxorubicin (NCIt ID C456)&Methotrexate (NCIt ID C642)|SUBSTITUTES||D|3|||||;GN=TP53
17	7577120	918	C	A	.	.	VT=R273L;CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.818G>T||R273L|918|RS28934576&ARG273LEU|https://civicdb.org/links/variants/918|TP53 R273L|892|RS28934576&ARG273LEU|https://civicdb.org/links/molecular-profiles/892|NM_000546.5:c.818G>T&NP_000537.3:p.Arg273Leu&NC_000017.10:g.7577120C>A&ENST00000269305.4:c.818G>T|CA001530|376655|0.0|evidence|2286|https://civicdb.org/links/evidence/2286|11595686 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Ovarian Cancer|Carboplatin (NCIt ID C1282)&Cisplatin (NCIt ID C376)|SUBSTITUTES||C|None|||||;GN=TP53
17	7577121	121	G	A	.	.	VT=R273C;CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/variants/121|TP53 R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/molecular-profiles/121|NM_000546.5:c.817C>T&NP_000537.3:p.Arg273Cys&NC_000017.10:g.7577121G>A&ENST00000269305.4:c.817C>T|CA000432|43594|44.5|evidence|395|https://civicdb.org/links/evidence/395|16489069 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/variants/121|TP53 R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/molecular-profiles/121|NM_000546.5:c.817C>T&NP_000537.3:p.Arg273Cys&NC_000017.10:g.7577121G>A&ENST00000269305.4:c.817C>T|CA000432|43594|44.5|evidence|396|https://civicdb.org/links/evidence/396|9569050 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/variants/121|TP53 R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/molecular-profiles/121|NM_000546.5:c.817C>T&NP_000537.3:p.Arg273Cys&NC_000017.10:g.7577121G>A&ENST00000269305.4:c.817C>T|CA000432|43594|44.5|evidence|2292|https://civicdb.org/links/evidence/2292|14514923 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Stomach Carcinoma|Cisplatin (NCIt ID C376)&Etoposide (NCIt ID C491)&Mitomycin (NCIt ID C1820)|COMBINATION||C|3|||||,A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/variants/121|TP53 R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/molecular-profiles/121|NM_000546.5:c.817C>T&NP_000537.3:p.Arg273Cys&NC_000017.10:g.7577121G>A&ENST00000269305.4:c.817C>T|CA000432|43594|44.5|evidence|4881|https://civicdb.org/links/evidence/4881|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||,A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.817C>T||R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/variants/121|TP53 R273C|121|ARG273CYS&RS121913343|https://civicdb.org/links/molecular-profiles/121|NM_000546.5:c.817C>T&NP_000537.3:p.Arg273Cys&NC_000017.10:g.7577121G>A&ENST00000269305.4:c.817C>T|CA000432|43594|44.5|evidence|10256|https://civicdb.org/links/evidence/10256|11896595 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|3|||||;GN=TP53
17	7577535	119	C	G	.	.	VT=R249;CSQ=G|Protein Altering Variant|TP53|7157|transcript|ENST00000269305.4|||R249|119|ARG249|https://civicdb.org/links/variants/119|TP53 R249|119|ARG249|https://civicdb.org/links/molecular-profiles/119|NC_000017.10:g.7577535C>G|CA16602484|376015|30.0|evidence|393|https://civicdb.org/links/evidence/393|9569050 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,G|Protein Altering Variant|TP53|7157|transcript|ENST00000269305.4|||R249|119|ARG249|https://civicdb.org/links/variants/119|TP53 R249|119|ARG249|https://civicdb.org/links/molecular-profiles/119|NC_000017.10:g.7577535C>G|CA16602484|376015|30.0|evidence|399|https://civicdb.org/links/evidence/399|9569050 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Doxorubicin (NCIt ID C456)|||B|3|||||;GN=TP53
17	7577538	117	C	T	.	.	CSQ=T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/variants/117|TP53 R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/molecular-profiles/117|NM_000546.5:c.743G>A&NP_000537.3:p.Arg248Gln&NC_000017.10:g.7577538C>T&ENST00000269305.4:c.743G>A|CA000387|12356|46.0|evidence|390|https://civicdb.org/links/evidence/390|16489069 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/variants/117|TP53 R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/molecular-profiles/117|NM_000546.5:c.743G>A&NP_000537.3:p.Arg248Gln&NC_000017.10:g.7577538C>T&ENST00000269305.4:c.743G>A|CA000387|12356|46.0|evidence|391|https://civicdb.org/links/evidence/391|9569050 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/variants/117|TP53 R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/molecular-profiles/117|NM_000546.5:c.743G>A&NP_000537.3:p.Arg248Gln&NC_000017.10:g.7577538C>T&ENST00000269305.4:c.743G>A|CA000387|12356|46.0|evidence|3042|https://civicdb.org/links/evidence/3042|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/variants/117|TP53 R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/molecular-profiles/117|NM_000546.5:c.743G>A&NP_000537.3:p.Arg248Gln&NC_000017.10:g.7577538C>T&ENST00000269305.4:c.743G>A|CA000387|12356|46.0|evidence|7161|https://civicdb.org/links/evidence/7161|23538418 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Lymphoma||||D|4|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/variants/117|TP53 R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/molecular-profiles/117|NM_000546.5:c.743G>A&NP_000537.3:p.Arg248Gln&NC_000017.10:g.7577538C>T&ENST00000269305.4:c.743G>A|CA000387|12356|46.0|evidence|7525|https://civicdb.org/links/evidence/7525|31395785 (PUBMED)|UNKNOWN|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|4|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.743G>A||R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/variants/117|TP53 R248Q|117|ARG248GLN&RS11540652|https://civicdb.org/links/molecular-profiles/117|NM_000546.5:c.743G>A&NP_000537.3:p.Arg248Gln&NC_000017.10:g.7577538C>T&ENST00000269305.4:c.743G>A|CA000387|12356|46.0|evidence|7529|https://civicdb.org/links/evidence/7529|31395785 (PUBMED)|UNKNOWN|accepted|NEOMORPHIC|DOES_NOT_SUPPORT|||||D|4|||||;VT=R248Q;GN=TP53
17	7577539	118	G	A	.	.	VT=R248W;CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.742C>T||R248W|118|ARG248TRP&RS121912651|https://civicdb.org/links/variants/118|TP53 R248W|118|ARG248TRP&RS121912651|https://civicdb.org/links/molecular-profiles/118|NM_000546.5:c.742C>T&NP_000537.3:p.Arg248Trp&NC_000017.10:g.7577539G>A&ENST00000269305.4:c.742C>T|CA000382|12347|22.0|evidence|392|https://civicdb.org/links/evidence/392|16489069 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.742C>T||R248W|118|ARG248TRP&RS121912651|https://civicdb.org/links/variants/118|TP53 R248W|118|ARG248TRP&RS121912651|https://civicdb.org/links/molecular-profiles/118|NM_000546.5:c.742C>T&NP_000537.3:p.Arg248Trp&NC_000017.10:g.7577539G>A&ENST00000269305.4:c.742C>T|CA000382|12347|22.0|evidence|4879|https://civicdb.org/links/evidence/4879|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||,A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.742C>T||R248W|118|ARG248TRP&RS121912651|https://civicdb.org/links/variants/118|TP53 R248W|118|ARG248TRP&RS121912651|https://civicdb.org/links/molecular-profiles/118|NM_000546.5:c.742C>T&NP_000537.3:p.Arg248Trp&NC_000017.10:g.7577539G>A&ENST00000269305.4:c.742C>T|CA000382|12347|22.0|evidence|10261|https://civicdb.org/links/evidence/10261|11896595 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|3|||||;GN=TP53
17	7577548	879	C	T	.	.	VT=G245S;CSQ=T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.733G>A||G245S|879|RS28934575|https://civicdb.org/links/variants/879|TP53 G245S|853|RS28934575|https://civicdb.org/links/molecular-profiles/853|NC_000017.10:g.7577548C>T&NM_000546.5:c.733G>A&NP_000537.3:p.Gly245Ser&ENST00000269305.4:c.733G>A|CA000367|12365|10.0|evidence|4883|https://civicdb.org/links/evidence/4883|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.733G>A||G245S|879|RS28934575|https://civicdb.org/links/variants/879|TP53 G245S|853|RS28934575|https://civicdb.org/links/molecular-profiles/853|NC_000017.10:g.7577548C>T&NM_000546.5:c.733G>A&NP_000537.3:p.Gly245Ser&ENST00000269305.4:c.733G>A|CA000367|12365|10.0|evidence|10253|https://civicdb.org/links/evidence/10253|11896595 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.733G>A||G245S|879|RS28934575|https://civicdb.org/links/variants/879|TP53 G245S|853|RS28934575|https://civicdb.org/links/molecular-profiles/853|NC_000017.10:g.7577548C>T&NM_000546.5:c.733G>A&NP_000537.3:p.Gly245Ser&ENST00000269305.4:c.733G>A|CA000367|12365|10.0|evidence|10532|https://civicdb.org/links/evidence/10532|10519380 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|3|||||;GN=TP53
17	7577556	1062	C	A	.	.	CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.725G>T||C242F|1062|RS121912655|https://civicdb.org/links/variants/1062|TP53 C242F|1036|RS121912655|https://civicdb.org/links/molecular-profiles/1036|NM_000546.5:c.725G>T&NP_000537.3:p.Cys242Phe&NC_000017.10:g.7577556C>A&ENST00000269305.4:c.725G>T|CA501203|376578|0.0|evidence|9451|https://civicdb.org/links/evidence/9451|20407015 (PUBMED)|SOMATIC|accepted|LOSS_OF_FUNCTION|SUPPORTS|||||D|2|||||;VT=C242F;GN=TP53
17	7577556	1064	C	T	.	.	VT=C242Y;CSQ=T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.725G>A||C242Y|1064|RS121912655|https://civicdb.org/links/variants/1064|TP53 C242Y|1038|RS121912655|https://civicdb.org/links/molecular-profiles/1038|NM_000546.5:c.725G>A&NP_000537.3:p.Cys242Tyr&NC_000017.10:g.7577556C>T&ENST00000269305.4:c.725G>A|CA000361|12354|3.0|evidence|10251|https://civicdb.org/links/evidence/10251|11896595 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.725G>A||C242Y|1064|RS121912655|https://civicdb.org/links/variants/1064|TP53 C242Y|1038|RS121912655|https://civicdb.org/links/molecular-profiles/1038|NM_000546.5:c.725G>A&NP_000537.3:p.Cys242Tyr&NC_000017.10:g.7577556C>T&ENST00000269305.4:c.725G>A|CA000361|12354|3.0|evidence|9453|https://civicdb.org/links/evidence/9453|20407015 (PUBMED)|UNKNOWN|accepted|LOSS_OF_FUNCTION|SUPPORTS|||||D|2|||||;GN=TP53
17	7577568	2648	C	T	.	.	CSQ=T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.713G>A||C238Y|2648|CYS238TYR|https://civicdb.org/links/variants/2648|TP53 C238Y|2517|CYS238TYR|https://civicdb.org/links/molecular-profiles/2517|NC_000017.10:g.7577568C>T&NM_000546.5:c.713G>A&NP_000537.3:p.Cys238Tyr&ENST00000269305.4:c.713G>A|CA000351|182935|2.75|evidence|7215|https://civicdb.org/links/evidence/7215|21343334 (PUBMED)|RARE_GERMLINE|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|2|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.713G>A||C238Y|2648|CYS238TYR|https://civicdb.org/links/variants/2648|TP53 C238Y|2517|CYS238TYR|https://civicdb.org/links/molecular-profiles/2517|NC_000017.10:g.7577568C>T&NM_000546.5:c.713G>A&NP_000537.3:p.Cys238Tyr&ENST00000269305.4:c.713G>A|CA000351|182935|2.75|evidence|7173|https://civicdb.org/links/evidence/7173|11051239 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||E|3|||||;VT=C238Y;GN=TP53
17	7577570	1066	C	A	.	.	VT=M237I;CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.711G>T||M237I|1066|MET237ILE|https://civicdb.org/links/variants/1066|TP53 M237I|1040|MET237ILE|https://civicdb.org/links/molecular-profiles/1040|ENST00000269305.4:c.711G>T|CA287488024|NONE FOUND|7.0|evidence|7528|https://civicdb.org/links/evidence/7528|31395785 (PUBMED)|UNKNOWN|accepted|NEOMORPHIC|DOES_NOT_SUPPORT|||||D|4|||||,A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.711G>T||M237I|1066|MET237ILE|https://civicdb.org/links/variants/1066|TP53 M237I|1040|MET237ILE|https://civicdb.org/links/molecular-profiles/1040|ENST00000269305.4:c.711G>T|CA287488024|NONE FOUND|7.0|evidence|4885|https://civicdb.org/links/evidence/4885|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Glioblastoma|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|3|||||;GN=TP53
17	7577580	1068	T	C	.	.	CSQ=C|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.701A>G||Y234C|1068|TYR234CYS&Y102C&Y195C&RS587780073|https://civicdb.org/links/variants/1068|TP53 Y234C|1042|TYR234CYS&Y102C&Y195C&RS587780073|https://civicdb.org/links/molecular-profiles/1042|NM_000546.5:c.701A>G&NP_000537.3:p.Tyr234Cys&NC_000017.10:g.7577580T>C&ENST00000269305.4:c.701A>G|CA000337|127820|0.0|evidence|2745|https://civicdb.org/links/evidence/2745|11595686 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Ovarian Cancer|Carboplatin (NCIt ID C1282)&Cisplatin (NCIt ID C376)|SUBSTITUTES||C|None|||||;VT=Y234C;GN=TP53
17	7578190	922	T	C	.	.	VT=Y220C;CSQ=C|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.659A>G||Y220C|922|RS121912666&TYR220CYS|https://civicdb.org/links/variants/922|TP53 Y220C|896|RS121912666&TYR220CYS|https://civicdb.org/links/molecular-profiles/896|NM_000546.5:c.659A>G&NP_000537.3:p.Tyr220Cys&NC_000017.10:g.7578190T>C&ENST00000269305.4:c.659A>G|CA000315|127819|15.5|evidence|2306|https://civicdb.org/links/evidence/2306|14514923 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Stomach Carcinoma|Cisplatin (NCIt ID C376)&Etoposide (NCIt ID C491)&Mitomycin (NCIt ID C1820)|COMBINATION||C|3|||||,C|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.659A>G||Y220C|922|RS121912666&TYR220CYS|https://civicdb.org/links/variants/922|TP53 Y220C|896|RS121912666&TYR220CYS|https://civicdb.org/links/molecular-profiles/896|NM_000546.5:c.659A>G&NP_000537.3:p.Tyr220Cys&NC_000017.10:g.7578190T>C&ENST00000269305.4:c.659A>G|CA000315|127819|15.5|evidence|4884|https://civicdb.org/links/evidence/4884|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||,C|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.659A>G||Y220C|922|RS121912666&TYR220CYS|https://civicdb.org/links/variants/922|TP53 Y220C|896|RS121912666&TYR220CYS|https://civicdb.org/links/molecular-profiles/896|NM_000546.5:c.659A>G&NP_000537.3:p.Tyr220Cys&NC_000017.10:g.7578190T>C&ENST00000269305.4:c.659A>G|CA000315|127819|15.5|evidence|7527|https://civicdb.org/links/evidence/7527|31395785 (PUBMED)|UNKNOWN|accepted|NEOMORPHIC|DOES_NOT_SUPPORT|||||D|4|||||;GN=TP53
17	7578211	1109	C	G	.	.	VT=R213P;CSQ=G|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.638G>C||R213P|1109|ARG213PRO&R174P&R81P&RS587778720|https://civicdb.org/links/variants/1109|TP53 R213P|1083|ARG213PRO&R174P&R81P&RS587778720|https://civicdb.org/links/molecular-profiles/1083|NM_000546.5:c.638G>C&NP_000537.3:p.Arg213Pro&NC_000017.10:g.7578211C>G&ENST00000269305.4:c.638G>C|CA10580932|231214|0.0|evidence|2819|https://civicdb.org/links/evidence/2819|14514923 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Stomach Carcinoma|EAP Protocol|||C|None|||||;GN=TP53
17	7578406	116	C	T	.	.	CSQ=T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/variants/116|TP53 R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/molecular-profiles/116|NM_000546.5:c.524G>A&NP_000537.3:p.Arg175His&NC_000017.10:g.7578406C>T&ENST00000269305.4:c.524G>A|CA000251|12374|25.0|evidence|389|https://civicdb.org/links/evidence/389|16489069 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Breast Cancer||||B|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/variants/116|TP53 R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/molecular-profiles/116|NM_000546.5:c.524G>A&NP_000537.3:p.Arg175His&NC_000017.10:g.7578406C>T&ENST00000269305.4:c.524G>A|CA000251|12374|25.0|evidence|2310|https://civicdb.org/links/evidence/2310|14514923 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Stomach Carcinoma|EAP Protocol|||C|None|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/variants/116|TP53 R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/molecular-profiles/116|NM_000546.5:c.524G>A&NP_000537.3:p.Arg175His&NC_000017.10:g.7578406C>T&ENST00000269305.4:c.524G>A|CA000251|12374|25.0|evidence|4880|https://civicdb.org/links/evidence/4880|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/variants/116|TP53 R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/molecular-profiles/116|NM_000546.5:c.524G>A&NP_000537.3:p.Arg175His&NC_000017.10:g.7578406C>T&ENST00000269305.4:c.524G>A|CA000251|12374|25.0|evidence|319|https://civicdb.org/links/evidence/319|22698404 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Doxorubicin (NCIt ID C456)|||D|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.524G>A||R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/variants/116|TP53 R175H|116|ARG175HIS&RS28934578&R43H&R136H|https://civicdb.org/links/molecular-profiles/116|NM_000546.5:c.524G>A&NP_000537.3:p.Arg175His&NC_000017.10:g.7578406C>T&ENST00000269305.4:c.524G>A|CA000251|12374|25.0|evidence|10527|https://civicdb.org/links/evidence/10527|10519380 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|SUPPORTS|||||D|3|||||;VT=R175H;GN=TP53
17	7578449	1114	C	T	.	.	VT=A161T;CSQ=T|Missense Variant|TP53|7157|transcript|None|||A161T|1114||https://civicdb.org/links/variants/1114|TP53 A161T|1088||https://civicdb.org/links/molecular-profiles/1088||CA000234||3.0|evidence|9286|https://civicdb.org/links/evidence/9286|21232794 (PUBMED)|SOMATIC|accepted|LOSS_OF_FUNCTION|SUPPORTS|||||D|3|||||;GN=TP53
17	7578457	1695	C	T	.	.	VT=R158H;CSQ=T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.473G>A||R158H|1695|ARG158HIS|https://civicdb.org/links/variants/1695|TP53 R158H|1603|ARG158HIS|https://civicdb.org/links/molecular-profiles/1603|ENST00000269305.4:c.473G>A|CA000227|141963|9.0|evidence|4886|https://civicdb.org/links/evidence/4886|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Vulva Squamous Cell Carcinoma|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.473G>A||R158H|1695|ARG158HIS|https://civicdb.org/links/variants/1695|TP53 R158H|1603|ARG158HIS|https://civicdb.org/links/molecular-profiles/1603|ENST00000269305.4:c.473G>A|CA000227|141963|9.0|evidence|10237|https://civicdb.org/links/evidence/10237|11896595 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|DOES_NOT_SUPPORT|||||D|3|||||,T|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.473G>A||R158H|1695|ARG158HIS|https://civicdb.org/links/variants/1695|TP53 R158H|1603|ARG158HIS|https://civicdb.org/links/molecular-profiles/1603|ENST00000269305.4:c.473G>A|CA000227|141963|9.0|evidence|10561|https://civicdb.org/links/evidence/10561|10519380 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|DOES_NOT_SUPPORT|||||D|3|||||;GN=TP53
17	7578457	1699	C	A	.	.	CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.473G>T||R158L|1699|ARG158LEU|https://civicdb.org/links/variants/1699|TP53 R158L|1607|ARG158LEU|https://civicdb.org/links/molecular-profiles/1607|ENST00000269305.4:c.473G>T|CA397842028|528248|4.0|evidence|4891|https://civicdb.org/links/evidence/4891|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||;VT=R158L;GN=TP53
17	7578461	1092	C	A	.	.	CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.469G>T||V157F|1092|RS121912654&VAL157PHE|https://civicdb.org/links/variants/1092|TP53 V157F|1066|RS121912654&VAL157PHE|https://civicdb.org/links/molecular-profiles/1066|NM_000546.5:c.469G>T&NP_000537.3:p.Val157Phe&NC_000017.10:g.7578461C>A&ENST00000269305.4:c.469G>T|CA000222|12353|4.0|evidence|4887|https://civicdb.org/links/evidence/4887|25730903 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|MDM2 Inhibitor AMGMDS3 (NCIt ID C171616)|||D|4|||||;VT=V157F;GN=TP53
17	7578525	924	G	C	.	.	CSQ=C|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.405C>G||C135W|924|CYS135TRP&C3W&C96W|https://civicdb.org/links/variants/924|TP53 C135W|898|CYS135TRP&C3W&C96W|https://civicdb.org/links/molecular-profiles/898|NM_000546.5:c.405C>G&NP_000537.3:p.Cys135Trp&NC_000017.10:g.7578525G>C&ENST00000269305.4:c.405C>G|CA16602987|376561|3.0|evidence|10557|https://civicdb.org/links/evidence/10557|10519380 (PUBMED)|SOMATIC|accepted|DOMINANT_NEGATIVE|DOES_NOT_SUPPORT|||||D|3|||||;VT=C135W;GN=TP53
17	7579472	531	G	C	.	.	VT=P72R;CSQ=C|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.215C>G||P72R|531|PRO72ARG&P33R&RS1042522|https://civicdb.org/links/variants/531|TP53 P72R|527|PRO72ARG&P33R&RS1042522|https://civicdb.org/links/molecular-profiles/527|NM_000546.5:c.215C>G&NP_000537.3:p.Pro72Arg&NC_000017.10:g.7579472G>C&ENST00000269305.4:c.215C>G|CA000072|12351|45.0|evidence|1303|https://civicdb.org/links/evidence/1303|12840112 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|DOES_NOT_SUPPORT|Lung Carcinoma||||B|3|||||,C|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.215C>G||P72R|531|PRO72ARG&P33R&RS1042522|https://civicdb.org/links/variants/531|TP53 P72R|527|PRO72ARG&P33R&RS1042522|https://civicdb.org/links/molecular-profiles/527|NM_000546.5:c.215C>G&NP_000537.3:p.Pro72Arg&NC_000017.10:g.7579472G>C&ENST00000269305.4:c.215C>G|CA000072|12351|45.0|evidence|1304|https://civicdb.org/links/evidence/1304|11535556 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|DOES_NOT_SUPPORT|Cervical Cancer||||B|2|||||;GN=TP53
17	7579548	504	G	A	.	.	CSQ=A|Missense Variant|TP53|7157|transcript|ENST00000269305.4|ENST00000269305.4:c.139C>T||P47S|504|PRO47SER&RS1800371|https://civicdb.org/links/variants/504|TP53 P47S|500|PRO47SER&RS1800371|https://civicdb.org/links/molecular-profiles/500|NM_000546.5:c.139C>T&NP_000537.3:p.Pro47Ser&NC_000017.10:g.7579548G>A&ENST00000269305.4:c.139C>T|CA000053|43588|0.5|evidence|1209|https://civicdb.org/links/evidence/1209|27034505 (PUBMED)|COMMON_GERMLINE|accepted|RESISTANCE|SUPPORTS|Cancer|Cisplatin (NCIt ID C376)|||E|2|||||;VT=P47S;GN=TP53
17	17119708	3727	T	TG	.	.	CSQ=G||FLCN|201163|transcript|ENST00000285071.9|||c.1285dupC|3727|HIS429FS|https://civicdb.org/links/variants/3727|FLCN c.1285dupC|3595|HIS429FS|https://civicdb.org/links/molecular-profiles/3595|NM_144997.7:c.1285dup&NP_659434.2:p.His429fs|CA090951|3363|2.5|evidence|10137|https://civicdb.org/links/evidence/10137|23995526 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Renal Cell Carcinoma|Everolimus (NCIt ID C48387)|||C|1|||||;GN=FLCN;VT=c.1285dupC
17	33433425	471	G	A	.	.	CSQ=A|Stop Gained|RAD51D|5892|transcript|ENST00000345365.6|||R186*|471|R186X&ARG186TER&RS387906843|https://civicdb.org/links/variants/471|RAD51D R186*|467|R186X&ARG186TER&RS387906843|https://civicdb.org/links/molecular-profiles/467|NC_000017.10:g.33433425G>A|CA129082|30285|5.0|evidence|1111|https://civicdb.org/links/evidence/1111|25445424 (PUBMED)|RARE_GERMLINE|accepted|NA|NA|Breast Cancer||||C|2|||||;VT=R186*;GN=RAD51D
17	37868205	38	G	C	.	.	CSQ=C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.926G>C||G309A|38|GLY309ALA&GLY279ALA&GLY294ALA&G294A&G279A&RS1057519787|https://civicdb.org/links/variants/38|ERBB2 G309A|38|GLY309ALA&GLY279ALA&GLY294ALA&G294A&G279A&RS1057519787|https://civicdb.org/links/molecular-profiles/38|ENST00000269571.5:c.926G>C&NC_000017.10:g.37868205G>C&NM_004448.3:c.926G>C&NP_004439.2:p.Gly309Ala|CA16602660|376205|5.0|evidence|282|https://civicdb.org/links/evidence/282|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|5|||||;GN=ERBB2;VT=G309A
17	37879658	42	G	A	.	.	GN=ERBB2;CSQ=A|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2033G>A||R678Q|42|ARG678GLN&R648Q&R663Q&RS1057519862|https://civicdb.org/links/variants/42|ERBB2 R678Q|42|ARG678GLN&R648Q&R663Q&RS1057519862|https://civicdb.org/links/molecular-profiles/42|ENST00000269571.5:c.2033G>A&NC_000017.10:g.37879658G>A&NM_004448.3:c.2033G>A&NP_004439.2:p.Arg678Gln|CA16602787|376344|5.0|evidence|286|https://civicdb.org/links/evidence/286|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Lapatinib (NCIt ID C26653)&Neratinib (NCIt ID C49094)|SUBSTITUTES||D|5|||||;VT=R678Q
17	37880218	37	GTTGAGGGAAAACACA	G	.	.	GN=ERBB2;CSQ=-|Inframe Deletion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2263_2277del||L755_T759del|37|RS1131692241&LEU755_THR759DEL|https://civicdb.org/links/variants/37|ERBB2 L755_T759del|37|RS1131692241&LEU755_THR759DEL|https://civicdb.org/links/molecular-profiles/37|ENST00000269571.5:c.2263_2277del&NC_000017.10:g.37880219_37880233del&NP_004439.2:p.Leu755_Thr759del&NM_004448.3:c.2263_2277delTTGAGGGAAAACACA|CA645372623|375990|5.0|evidence|281|https://civicdb.org/links/evidence/281|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|5|||||;VT=L755_T759del
17	37880219	1304	TT	CC	.	.	GN=ERBB2;CSQ=CC|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2263_2264delinsCC||L755P|1304|LEU755PRO|https://civicdb.org/links/variants/1304|ERBB2 L755P|1278|LEU755PRO|https://civicdb.org/links/molecular-profiles/1278|NP_004439.2:p.Leu755Pro&NM_004448.3:c.2263_2264delinsCC&NC_000017.13:g.37880219_37880220delinsCC&ENST00000269571.5:c.2263_2264delinsCC|CA123587|13877|2.0|evidence|11754|https://civicdb.org/links/evidence/11754|37694347 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Trastuzumab Deruxtecan (NCIt ID C128799)|||A|2|||||,CC|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2263_2264delinsCC||L755P|1304|LEU755PRO|https://civicdb.org/links/variants/1304|ERBB2 L755P|1278|LEU755PRO|https://civicdb.org/links/molecular-profiles/1278|NP_004439.2:p.Leu755Pro&NM_004448.3:c.2263_2264delinsCC&NC_000017.13:g.37880219_37880220delinsCC&ENST00000269571.5:c.2263_2264delinsCC|CA123587|13877|2.0|evidence|3005|https://civicdb.org/links/evidence/3005|22046346 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|2|||||;VT=L755P
17	37880220	39	T	C	.	.	CSQ=C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/variants/39|ERBB2 L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/molecular-profiles/39|NC_000017.10:g.37880220T>C&ENST00000269571.5:c.2264T>C&NM_004448.3:c.2264T>C&NP_004439.2:p.Leu755Ser|CA16602502|376035|23.5|evidence|4955|https://civicdb.org/links/evidence/4955|27626067 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Colorectal Adenocarcinoma|Fluorouracil (NCIt ID C505)&Leucovorin (NCIt ID C71631)&Trastuzumab (NCIt ID C1647)|COMBINATION||C|3|||||,C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/variants/39|ERBB2 L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/molecular-profiles/39|NC_000017.10:g.37880220T>C&ENST00000269571.5:c.2264T>C&NM_004448.3:c.2264T>C&NP_004439.2:p.Leu755Ser|CA16602502|376035|23.5|evidence|241|https://civicdb.org/links/evidence/241|23220880 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Breast Cancer|Lapatinib (NCIt ID C26653)|||D|5|||||,C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/variants/39|ERBB2 L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/molecular-profiles/39|NC_000017.10:g.37880220T>C&ENST00000269571.5:c.2264T>C&NM_004448.3:c.2264T>C&NP_004439.2:p.Leu755Ser|CA16602502|376035|23.5|evidence|283|https://civicdb.org/links/evidence/283|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|5|||||,C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/variants/39|ERBB2 L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/molecular-profiles/39|NC_000017.10:g.37880220T>C&ENST00000269571.5:c.2264T>C&NM_004448.3:c.2264T>C&NP_004439.2:p.Leu755Ser|CA16602502|376035|23.5|evidence|1176|https://civicdb.org/links/evidence/1176|26243863 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colon Cancer|Lapatinib (NCIt ID C26653)&Neratinib (NCIt ID C49094)&Trastuzumab (NCIt ID C1647)|COMBINATION||D|4|||||,C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/variants/39|ERBB2 L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/molecular-profiles/39|NC_000017.10:g.37880220T>C&ENST00000269571.5:c.2264T>C&NM_004448.3:c.2264T>C&NP_004439.2:p.Leu755Ser|CA16602502|376035|23.5|evidence|4519|https://civicdb.org/links/evidence/4519|26243863 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cecum Adenocarcinoma|Cetuximab (NCIt ID C1723)|||D|3|||||,C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>C||L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/variants/39|ERBB2 L755S|39|LEU755SER&L725S&L740S|https://civicdb.org/links/molecular-profiles/39|NC_000017.10:g.37880220T>C&ENST00000269571.5:c.2264T>C&NM_004448.3:c.2264T>C&NP_004439.2:p.Leu755Ser|CA16602502|376035|23.5|evidence|3004|https://civicdb.org/links/evidence/3004|22046346 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|2|||||;GN=ERBB2;VT=L755S
17	37880220	40	T	G	.	.	CSQ=G|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2264T>G||L755W|40|LEU755TRP&L725W&L740W&RS121913470|https://civicdb.org/links/variants/40|ERBB2 L755W|40|LEU755TRP&L725W&L740W&RS121913470|https://civicdb.org/links/molecular-profiles/40|ENST00000269571.5:c.2264T>G&NC_000017.10:g.37880220T>G&NM_004448.3:c.2264T>G&NP_004439.2:p.Leu755Trp|CA16602786|376343|5.0|evidence|284|https://civicdb.org/links/evidence/284|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|5|||||;GN=ERBB2;VT=L755W
17	37880261	35	G	C	.	.	CSQ=C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2305G>C||D769H|35|ASP769HIS&D739H&D754H&ASP739HIS&ASP754HIS&D769H&RS121913468|https://civicdb.org/links/variants/35|ERBB2 D769H|35|ASP769HIS&D739H&D754H&ASP739HIS&ASP754HIS&D769H&RS121913468|https://civicdb.org/links/molecular-profiles/35|NM_001289937.1:c.2305G>C&NP_001276866.1:p.Asp769His&ENST00000269571.5:c.2305G>C&NC_000017.10:g.37880261G>C|CA16602465|375991|4.0|evidence|279|https://civicdb.org/links/evidence/279|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Lapatinib (NCIt ID C26653)&Neratinib (NCIt ID C49094)|SUBSTITUTES||D|4|||||;GN=ERBB2;VT=D769H
17	37880261	36	G	T	.	.	GN=ERBB2;CSQ=T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2305G>T||D769Y|36|D739Y&D754Y&RS121913468&ASP769TYR&D769Y&ASP754TYR&ASP739TYR|https://civicdb.org/links/variants/36|ERBB2 D769Y|36|D739Y&D754Y&RS121913468&ASP769TYR&D769Y&ASP754TYR&ASP739TYR|https://civicdb.org/links/molecular-profiles/36|ENST00000269571.5:c.2305G>T&NC_000017.10:g.37880261G>T&NM_004448.3:c.2305G>T&NP_004439.2:p.Asp769Tyr|CA16602466|375992|11.5|evidence|11688|https://civicdb.org/links/evidence/11688|35939768 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Extramammary Paget Disease|Afatinib (NCIt ID C66940)|||C|3|||||,T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2305G>T||D769Y|36|D739Y&D754Y&RS121913468&ASP769TYR&D769Y&ASP754TYR&ASP739TYR|https://civicdb.org/links/variants/36|ERBB2 D769Y|36|D739Y&D754Y&RS121913468&ASP769TYR&D769Y&ASP754TYR&ASP739TYR|https://civicdb.org/links/molecular-profiles/36|ENST00000269571.5:c.2305G>T&NC_000017.10:g.37880261G>T&NM_004448.3:c.2305G>T&NP_004439.2:p.Asp769Tyr|CA16602466|375992|11.5|evidence|11689|https://civicdb.org/links/evidence/11689|35939768 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Peritoneal Carcinoma|Afatinib (NCIt ID C66940)|||C|1|||||,T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2305G>T||D769Y|36|D739Y&D754Y&RS121913468&ASP769TYR&D769Y&ASP754TYR&ASP739TYR|https://civicdb.org/links/variants/36|ERBB2 D769Y|36|D739Y&D754Y&RS121913468&ASP769TYR&D769Y&ASP754TYR&ASP739TYR|https://civicdb.org/links/molecular-profiles/36|ENST00000269571.5:c.2305G>T&NC_000017.10:g.37880261G>T&NM_004448.3:c.2305G>T&NP_004439.2:p.Asp769Tyr|CA16602466|375992|11.5|evidence|280|https://civicdb.org/links/evidence/280|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|4|||||;VT=D769Y
17	37880989	872	T	C	.	.	GN=ERBB2;VT=V773A;CSQ=C|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2318T>C||V773A|872|VAL773ALA|https://civicdb.org/links/variants/872|ERBB2 V773A|846|VAL773ALA|https://civicdb.org/links/molecular-profiles/846|ENST00000269571.5:c.2318T>C&NC_000017.10:g.37880989T>C&NM_004448.3:c.2318T>C&NP_004439.2:p.Val773Ala|CA399302815|NONE FOUND|1.0|evidence|1987|https://civicdb.org/links/evidence/1987|22046346 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|2|||||
17	37880991	818	AA	ATGGCTGG	.	.	CSQ=TGGCTGG|Inframe Indel|ERBB2|2064|transcript|ENST00000269571.5|||M774DELINSWLV|818||https://civicdb.org/links/variants/818|ERBB2 M774DELINSWLV|796||https://civicdb.org/links/molecular-profiles/796||unregistered|NONE FOUND|7.5|evidence|1894|https://civicdb.org/links/evidence/1894|25899785 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||C|3|||||;GN=ERBB2;VT=M774DELINSWLV
17	37880996	414	T	TTACGTGATGGCT	.	.	GN=ERBB2;VT=Y772_A775DUP;CSQ=TACGTGATGGCT|Inframe Insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/variants/414|ERBB2 Y772_A775DUP|410|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/molecular-profiles/410|NC_000017.10:g.37880993_37880994insGCTTACGTGATG&NM_001005862.2:c.2224_2235dupTACGTGATGGCT&ENST00000269571.5:c.2314_2325dupTACGTGATGGCT&NC_000017.10:g.37880985_37880996dupTACGTGATGGCT|CA135369|44985|42.0|evidence|11764|https://civicdb.org/links/evidence/11764|37694347 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Trastuzumab Deruxtecan (NCIt ID C128799)|||A|4|||||,TACGTGATGGCT|Inframe Insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/variants/414|ERBB2 Y772_A775DUP|410|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/molecular-profiles/410|NC_000017.10:g.37880993_37880994insGCTTACGTGATG&NM_001005862.2:c.2224_2235dupTACGTGATGGCT&ENST00000269571.5:c.2314_2325dupTACGTGATGGCT&NC_000017.10:g.37880985_37880996dupTACGTGATGGCT|CA135369|44985|42.0|evidence|1893|https://civicdb.org/links/evidence/1893|25899785 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Lung Non-small Cell Carcinoma|Dacomitinib (NCIt ID C53398)|||B|2|||||,TACGTGATGGCT|Inframe Insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/variants/414|ERBB2 Y772_A775DUP|410|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/molecular-profiles/410|NC_000017.10:g.37880993_37880994insGCTTACGTGATG&NM_001005862.2:c.2224_2235dupTACGTGATGGCT&ENST00000269571.5:c.2314_2325dupTACGTGATGGCT&NC_000017.10:g.37880985_37880996dupTACGTGATGGCT|CA135369|44985|42.0|evidence|1045|https://civicdb.org/links/evidence/1045|26559459 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Afatinib (NCIt ID C66940)|||C|4|||||,TACGTGATGGCT|Inframe Insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/variants/414|ERBB2 Y772_A775DUP|410|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/molecular-profiles/410|NC_000017.10:g.37880993_37880994insGCTTACGTGATG&NM_001005862.2:c.2224_2235dupTACGTGATGGCT&ENST00000269571.5:c.2314_2325dupTACGTGATGGCT&NC_000017.10:g.37880985_37880996dupTACGTGATGGCT|CA135369|44985|42.0|evidence|1125|https://civicdb.org/links/evidence/1125|25789838 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Trastuzumab Emtansine (NCIt ID C82492)|||C|3|||||,TACGTGATGGCT|Inframe Insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/variants/414|ERBB2 Y772_A775DUP|410|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/molecular-profiles/410|NC_000017.10:g.37880993_37880994insGCTTACGTGATG&NM_001005862.2:c.2224_2235dupTACGTGATGGCT&ENST00000269571.5:c.2314_2325dupTACGTGATGGCT&NC_000017.10:g.37880985_37880996dupTACGTGATGGCT|CA135369|44985|42.0|evidence|1888|https://civicdb.org/links/evidence/1888|22325357 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Afatinib (NCIt ID C66940)|||C|3|||||,TACGTGATGGCT|Inframe Insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/variants/414|ERBB2 Y772_A775DUP|410|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/molecular-profiles/410|NC_000017.10:g.37880993_37880994insGCTTACGTGATG&NM_001005862.2:c.2224_2235dupTACGTGATGGCT&ENST00000269571.5:c.2314_2325dupTACGTGATGGCT&NC_000017.10:g.37880985_37880996dupTACGTGATGGCT|CA135369|44985|42.0|evidence|1047|https://civicdb.org/links/evidence/1047|19122144 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Carcinoma|Afatinib (NCIt ID C66940)|||D|4|||||,TACGTGATGGCT|Inframe Insertion|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2314_2325dupTACGTGATGGCT||Y772_A775DUP|414|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/variants/414|ERBB2 Y772_A775DUP|410|A775INSYVMA&P.A775_G776INSYVMA&P.E770_A771INSAYVM&TYR772_ALA775DUP&A775_G776INSYVMA&M774INSAYVM|https://civicdb.org/links/molecular-profiles/410|NC_000017.10:g.37880993_37880994insGCTTACGTGATG&NM_001005862.2:c.2224_2235dupTACGTGATGGCT&ENST00000269571.5:c.2314_2325dupTACGTGATGGCT&NC_000017.10:g.37880985_37880996dupTACGTGATGGCT|CA135369|44985|42.0|evidence|960|https://civicdb.org/links/evidence/960|19122144 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Afatinib (NCIt ID C66940)&Sirolimus (NCIt ID C1212)|COMBINATION||D|3|||||
17	37880997	816	GG	CT	.	.	GN=ERBB2;CSQ=CT|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2326_2327delinsCT||G776L|816|GLY776LEU|https://civicdb.org/links/variants/816|ERBB2 G776L|794|GLY776LEU|https://civicdb.org/links/molecular-profiles/794|ENST00000269571.5:c.2326_2327delinsCT&NC_000017.10:g.37880997_37880998delinsCT&NP_001276866.1:p.Gly776Leu&NM_001289937.1:c.2326_2327delinsCT|CA913189238|NONE FOUND|7.5|evidence|1889|https://civicdb.org/links/evidence/1889|22325357 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Adenocarcinoma|Afatinib (NCIt ID C66940)|||C|3|||||;VT=G776L
17	37881000	44	G	T	.	.	GN=ERBB2;CSQ=T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2329G>T||V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/variants/44|ERBB2 V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/molecular-profiles/44|NM_004448.3:c.2329G>T&NP_004439.2:p.Val777Leu&ENST00000269571.5:c.2329G>T&NC_000017.10:g.37881000G>T|CA135387|44991|11.0|evidence|11690|https://civicdb.org/links/evidence/11690|35939768 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Afatinib (NCIt ID C66940)|||C|1|||||,T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2329G>T||V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/variants/44|ERBB2 V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/molecular-profiles/44|NM_004448.3:c.2329G>T&NP_004439.2:p.Val777Leu&ENST00000269571.5:c.2329G>T&NC_000017.10:g.37881000G>T|CA135387|44991|11.0|evidence|288|https://civicdb.org/links/evidence/288|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|5|||||,T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2329G>T||V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/variants/44|ERBB2 V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/molecular-profiles/44|NM_004448.3:c.2329G>T&NP_004439.2:p.Val777Leu&ENST00000269571.5:c.2329G>T&NC_000017.10:g.37881000G>T|CA135387|44991|11.0|evidence|1177|https://civicdb.org/links/evidence/1177|26243863 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colon Cancer|Lapatinib (NCIt ID C26653)&Neratinib (NCIt ID C49094)&Trastuzumab (NCIt ID C1647)|COMBINATION||D|4|||||,T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2329G>T||V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/variants/44|ERBB2 V777L|44|V747L&V762L&VAL777LEU&RS121913471|https://civicdb.org/links/molecular-profiles/44|NM_004448.3:c.2329G>T&NP_004439.2:p.Val777Leu&ENST00000269571.5:c.2329G>T&NC_000017.10:g.37881000G>T|CA135387|44991|11.0|evidence|9697|https://civicdb.org/links/evidence/9697|22046346 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|2|||||;VT=V777L
17	37881064	2331	C	T	.	.	GN=ERBB2;CSQ=T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2393C>T||T798I|2331|THR798ILE|https://civicdb.org/links/variants/2331|ERBB2 T798I|2204|THR798ILE|https://civicdb.org/links/molecular-profiles/2204|ENST00000269571.5:c.2393C>T&NC_000017.10:g.37881064C>T&NM_001289937.1:c.2393C>T&NP_001276866.1:p.Thr798Ile|CA399303242|NONE FOUND|3.0|evidence|6174|https://civicdb.org/links/evidence/6174|28274957 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|DOES_NOT_SUPPORT|Breast Cancer|Osimertinib (NCIt ID C116377)|||D|3|||||;VT=T798I
17	37881064	1305	CA	TG	.	.	GN=ERBB2;CSQ=TG|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2393_2394delCAinsTG||T798M|1305|THR798MET|https://civicdb.org/links/variants/1305|ERBB2 T798M|1279|THR798MET|https://civicdb.org/links/molecular-profiles/1279|ENST00000269571.5:c.2393_2394delCAinsTG&NC_000017.10:g.37881064_37881065delinsTG&NM_004448.3:c.2393_2394delinsTG&NP_004439.2:p.Thr798Met|CA913012048|NONE FOUND|2.0|evidence|3006|https://civicdb.org/links/evidence/3006|22046346 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|2|||||;VT=T798M
17	37881332	45	G	A	.	.	GN=ERBB2;CSQ=A|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2524G>A||V842I|45|VAL842ILE&V812I&V827I&VAL812ILE&VAL827ILE&RS1057519738|https://civicdb.org/links/variants/45|ERBB2 V842I|45|VAL842ILE&V812I&V827I&VAL812ILE&VAL827ILE&RS1057519738|https://civicdb.org/links/molecular-profiles/45|ENST00000269571.5:c.2524G>A&NM_004448.3:c.2524G>A&NP_004439.2:p.Val842Ile&NC_000017.10:g.37881332G>A|CA16602468|375994|9.0|evidence|289|https://civicdb.org/links/evidence/289|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|5|||||,A|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2524G>A||V842I|45|VAL842ILE&V812I&V827I&VAL812ILE&VAL827ILE&RS1057519738|https://civicdb.org/links/variants/45|ERBB2 V842I|45|VAL842ILE&V812I&V827I&VAL812ILE&VAL827ILE&RS1057519738|https://civicdb.org/links/molecular-profiles/45|ENST00000269571.5:c.2524G>A&NM_004448.3:c.2524G>A&NP_004439.2:p.Val842Ile&NC_000017.10:g.37881332G>A|CA16602468|375994|9.0|evidence|1174|https://civicdb.org/links/evidence/1174|26243863 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colon Cancer|Lapatinib (NCIt ID C26653)&Neratinib (NCIt ID C49094)&Trastuzumab (NCIt ID C1647)|COMBINATION||D|4|||||;VT=V842I
17	37881378	873	A	G	.	.	GN=ERBB2;VT=N857S;CSQ=G|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2570A>G||N857S|873|ASN857SER&N827S&N842S&RS28933370|https://civicdb.org/links/variants/873|ERBB2 N857S|847|ASN857SER&N827S&N842S&RS28933370|https://civicdb.org/links/molecular-profiles/847|NC_000017.10:g.37881378A>G&NP_004439.2:p.Asn857Ser&NM_004448.3:c.2570A>G&ENST00000269571.5:c.2570A>G|CA123601|13880|1.0|evidence|1988|https://civicdb.org/links/evidence/1988|22046346 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|2|||||
17	37881392	871	A	G	.	.	CSQ=G|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2584A>G||T862A|871|THR862ALA|https://civicdb.org/links/variants/871|ERBB2 T862A|845|THR862ALA|https://civicdb.org/links/molecular-profiles/845|ENST00000269571.5:c.2584A>G&NC_000017.10:g.37881392A>G&NM_001289937.1:c.2584A>G&NP_001276866.1:p.Thr862Ala|CA399304738|NONE FOUND|3.0|evidence|1986|https://civicdb.org/links/evidence/1986|22046346 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|1|||||;GN=ERBB2;VT=T862A
17	37881404	496	C	A	.	.	CSQ=A|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2596C>A||L866M|496|LEU866MET|https://civicdb.org/links/variants/496|ERBB2 L866M|492|LEU866MET|https://civicdb.org/links/molecular-profiles/492|ENST00000269571.5:c.2596C>A&NC_000017.10:g.37881404C>A&NM_001289937.1:c.2596C>A&NP_001276866.1:p.Leu866Met|CA399304874|NONE FOUND|4.0|evidence|1178|https://civicdb.org/links/evidence/1178|26243863 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colon Cancer|Lapatinib (NCIt ID C26653)&Neratinib (NCIt ID C49094)&Trastuzumab (NCIt ID C1647)|COMBINATION||D|4|||||;GN=ERBB2;VT=L866M
17	37881440	874	C	T	.	.	CSQ=T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2632C>T||H878Y|874|HIS878TYR|https://civicdb.org/links/variants/874|ERBB2 H878Y|848|HIS878TYR|https://civicdb.org/links/molecular-profiles/848|ENST00000269571.5:c.2632C>T&NC_000017.10:g.37881440C>T&NM_001289937.1:c.2632C>T&NP_001276866.1:p.His878Tyr|CA399305170|NONE FOUND|1.0|evidence|1989|https://civicdb.org/links/evidence/1989|22046346 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cancer|Lapatinib (NCIt ID C26653)|||D|2|||||;GN=ERBB2;VT=H878Y
17	37881616	43	C	T	.	.	GN=ERBB2;CSQ=T|Missense Variant|ERBB2|2064|transcript|ENST00000269571.5|ENST00000269571.5:c.2686C>T||R896C|43|ARG896CYS&R866C&R881C&RS758222990|https://civicdb.org/links/variants/43|ERBB2 R896C|43|ARG896CYS&R866C&R881C&RS758222990|https://civicdb.org/links/molecular-profiles/43|NC_000017.10:g.37881616C>T&ENST00000269571.5:c.2686C>T&NM_004448.3:c.2686C>T&NP_004439.2:p.Arg896Cys|CA8534359|375995|5.0|evidence|287|https://civicdb.org/links/evidence/287|23220880 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Neratinib (NCIt ID C49094)|||D|5|||||;VT=R896C
17	41199682	1555	C	T	.	.	CSQ=T|Stop Gained|BRCA1|672|transcript|None|||W1815X|1555|W125X&W1519X&W1550X&W1576X&W1768X&W1836X&W306X&W48X&W632X&W664X&W673X&W711X|https://civicdb.org/links/variants/1555|BRCA1 W1815X|1463|W125X&W1519X&W1550X&W1576X&W1768X&W1836X&W306X&W48X&W632X&W664X&W673X&W711X|https://civicdb.org/links/molecular-profiles/1463||CA003600||2.0|evidence|4623|https://civicdb.org/links/evidence/4623|23415752 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Endometrioid Ovary Carcinoma|Olaparib (NCIt ID C71721)|||D|2|||||;VT=W1815X;GN=BRCA1
17	41228590	1246	G	A	.	.	GN=BRCA1;CSQ=A|Stop Gained|BRCA1|672|transcript|ENST00000357654.3|ENST00000357654.3:c.4399C>T||Q1467*|1246|Q1467X&GLN1467TER&RS397509171|https://civicdb.org/links/variants/1246|BRCA1 Q1467*|1220|Q1467X&GLN1467TER&RS397509171|https://civicdb.org/links/molecular-profiles/1220|NM_007294.3:c.4399C>T&NP_009225.1:p.Gln1467Ter&NC_000017.10:g.41228590G>A&ENST00000357654.3:c.4399C>T|CA002821|55191|0.0|evidence|2878|https://civicdb.org/links/evidence/2878|27908594 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Ovarian Cancer|Rucaparib (NCIt ID C137800)|||C|None|||||;VT=Q1467*
17	41244645	477	G	GGA	.	.	VT=P968FS;CSQ=GA|Frameshift Truncation|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.2902_2903insTC||P968FS|477|3021INSTC&PRO968LEUFS&RS398122670|https://civicdb.org/links/variants/477|BRCA1 P968FS|473|3021INSTC&PRO968LEUFS&RS398122670|https://civicdb.org/links/molecular-profiles/473|NM_007294.3:c.2902_2903insTC&NP_009225.1:p.Pro968Leufs&NC_000017.10:g.41244645_41244646insGA&ENST00000471181.2:c.2902_2903insTC|CA001889|91602|20.0|evidence|1123|https://civicdb.org/links/evidence/1123|24137399 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Breast Cancer||||C|4|||||,GA|Frameshift Truncation|BRCA1|672|transcript|ENST00000471181.2|ENST00000471181.2:c.2902_2903insTC||P968FS|477|3021INSTC&PRO968LEUFS&RS398122670|https://civicdb.org/links/variants/477|BRCA1 P968FS|473|3021INSTC&PRO968LEUFS&RS398122670|https://civicdb.org/links/molecular-profiles/473|NM_007294.3:c.2902_2903insTC&NP_009225.1:p.Pro968Leufs&NC_000017.10:g.41244645_41244646insGA&ENST00000471181.2:c.2902_2903insTC|CA001889|91602|20.0|evidence|1124|https://civicdb.org/links/evidence/1124|24137399 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Ovarian Cancer||||C|4|||||;GN=BRCA1
17	46805705	772	C	T	.	.	GN=HOXB13;VT=G84E;CSQ=T|Missense Variant|HOXB13|10481|transcript|ENST00000290295.7|ENST00000290295.7:c.251G>A||G84E|772|RS138213197&GLY84GLU|https://civicdb.org/links/variants/772|HOXB13 G84E|753|RS138213197&GLY84GLU|https://civicdb.org/links/molecular-profiles/753|NC_000017.10:g.46805705C>T&NM_006361.5:c.251G>A&NP_006352.2:p.Gly84Glu&ENST00000290295.7:c.251G>A|CA288225|128031|40.0|evidence|1760|https://civicdb.org/links/evidence/1760|26108461 (PUBMED)|COMMON_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Prostate Cancer||||B|4|||||,T|Missense Variant|HOXB13|10481|transcript|ENST00000290295.7|ENST00000290295.7:c.251G>A||G84E|772|RS138213197&GLY84GLU|https://civicdb.org/links/variants/772|HOXB13 G84E|753|RS138213197&GLY84GLU|https://civicdb.org/links/molecular-profiles/753|NC_000017.10:g.46805705C>T&NM_006361.5:c.251G>A&NP_006352.2:p.Gly84Glu&ENST00000290295.7:c.251G>A|CA288225|128031|40.0|evidence|1836|https://civicdb.org/links/evidence/1836|27626483 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Prostate Cancer||||B|4|||||
17	74732959	4304	G	T	.	.	GN=SRSF2;CSQ=T|Missense Variant|SRSF2|6427|transcript|ENST00000359995.10|ENST00000359995.10:c.284C>A||P95H|4304|PRO95HIS|https://civicdb.org/links/variants/4304|SRSF2 P95H|4180|PRO95HIS|https://civicdb.org/links/molecular-profiles/4180|NC_000017.11:g.76736877G>T&NC_000017.10:g.74732959G>T&ENST00000359995.10:c.284C>A&ENSP00000353089.5:p.Pro95His&NM_001195427.2:c.284C>A&NP_001182356.1:p.Pro95His|CA8790422|NONE FOUND|3.0|evidence|11028|https://civicdb.org/links/evidence/11028|10.1182/blood-2021-148205 (ASH)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Myeloid Neoplasm|CTX-712|||D|3|||||;VT=P95H
17	74732959	4303	G	A	.	.	GN=SRSF2;VT=P95L;CSQ=A|Missense Variant|SRSF2|6427|transcript|ENST00000359995.10:c.284C>T|ENST00000359995.10:c.284C>T||P95L|4303|PRO95LEU|https://civicdb.org/links/variants/4303|SRSF2 P95L|4179|PRO95LEU|https://civicdb.org/links/molecular-profiles/4179|NC_000017.11:g.76736877G>A&NC_000017.10:g.74732959G>A&ENST00000359995.10:c.284C>T&ENSP00000353089.5:p.Pro95Leu&NM_001195427.2:c.284C>T&NP_001182356.1:p.Pro95Leu|CA8790423|NONE FOUND|3.0|evidence|11027|https://civicdb.org/links/evidence/11027|10.1182/blood-2021-148205 (ASH)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Myeloid Neoplasm|CTX-712|||D|3|||||
18	42531913	351	G	A	.	.	CSQ=A|Missense Variant|SETBP1|26040|transcript|ENST00000282030.5|ENST00000282030.5:c.2608G>A||G870S|351|GLY870SER&RS267607040|https://civicdb.org/links/variants/351|SETBP1 G870S|347|GLY870SER&RS267607040|https://civicdb.org/links/molecular-profiles/347|NM_015559.2:c.2608G>A&NP_056374.2:p.Gly870Ser&ENST00000282030.5:c.2608G>A&NC_000018.9:g.42531913G>A|CA114719|1035|3.0|evidence|840|https://civicdb.org/links/evidence/840|23222956 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Chronic Myeloid Leukemia||||D|3|||||;VT=G870S;GN=SETBP1
18	60985590	3082	A	T	.	.	CSQ=T|Missense Variant|BCL2|596|transcript|ENST00000398117.1|||F104I|3082|PHE104ILE|https://civicdb.org/links/variants/3082|BCL2 F104I|2951|PHE104ILE|https://civicdb.org/links/molecular-profiles/2951|NC_000018.10:g.63318357A>T&NC_000018.9:g.60985590A>T&NM_000633.3:c.310T>A&NP_000624.2:p.Phe104Ile|CA402632320|NONE FOUND|8.0|evidence|8375|https://civicdb.org/links/evidence/8375|31234236 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Follicular Lymphoma|Venetoclax (NCIt ID C103147)|||C|2|||||,T|Missense Variant|BCL2|596|transcript|ENST00000398117.1|||F104I|3082|PHE104ILE|https://civicdb.org/links/variants/3082|BCL2 F104I|2951|PHE104ILE|https://civicdb.org/links/molecular-profiles/2951|NC_000018.10:g.63318357A>T&NC_000018.9:g.60985590A>T&NM_000633.3:c.310T>A&NP_000624.2:p.Phe104Ile|CA402632320|NONE FOUND|8.0|evidence|8376|https://civicdb.org/links/evidence/8376|31234236 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Follicular Lymphoma|Venetoclax (NCIt ID C103147)|||D|3|||||;VT=F104I;GN=BCL2
18	60985598	2960	C	A	.	.	VT=G101V;CSQ=A|Missense Variant|BCL2|596|transcript|ENST00000398117.1|ENST00000398117.1:c.302G>T||G101V|2960|GLY101VAL|https://civicdb.org/links/variants/2960|BCL2 G101V|2829|GLY101VAL|https://civicdb.org/links/molecular-profiles/2829|ENST00000398117.1:c.302G>T|CA402632336|NONE FOUND|8.0|evidence|8185|https://civicdb.org/links/evidence/8185|32232486 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma|Venetoclax (NCIt ID C103147)|||C|2|||||,A|Missense Variant|BCL2|596|transcript|ENST00000398117.1|ENST00000398117.1:c.302G>T||G101V|2960|GLY101VAL|https://civicdb.org/links/variants/2960|BCL2 G101V|2829|GLY101VAL|https://civicdb.org/links/molecular-profiles/2829|ENST00000398117.1:c.302G>T|CA402632336|NONE FOUND|8.0|evidence|8841|https://civicdb.org/links/evidence/8841|31160589 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Venetoclax (NCIt ID C103147)|||D|3|||||;GN=BCL2
19	1220489	634	C	A	.	.	CSQ=A|Missense Variant&Loss Of Heterozygosity|STK11|6794|transcript|ENST00000326873.7|ENST00000326873.7:c.582C>A||D194E|634|ASP194GLU&RS786202134|https://civicdb.org/links/variants/634|STK11 D194E|630|ASP194GLU&RS786202134|https://civicdb.org/links/molecular-profiles/630|NC_000019.9:g.1220489C>A&NM_000455.4:c.582C>A&NP_000446.1:p.Asp194Glu&ENST00000326873.7:c.582C>A|CA023096|185384|5.0|evidence|1617|https://civicdb.org/links/evidence/1617|21189378 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Pancreatic Cancer|Everolimus (NCIt ID C48387)|||C|2|||||;GN=STK11;VT=D194E
19	7975157	566	G	A	.	.	VT=E116K;GN=MAP2K7;CSQ=A|Missense Variant|MAP2K7|5609|transcript|ENST00000397979.3|||E116K|566|GLU116LYS|https://civicdb.org/links/variants/566|MAP2K7 E116K|562|GLU116LYS|https://civicdb.org/links/molecular-profiles/562|NC_000019.9:g.7975157G>A|CA304968685|NONE FOUND|25.0|evidence|1420|https://civicdb.org/links/evidence/1420|27028764 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Lung Cancer||||B|5|||||
19	44055726	261	T	C	.	.	GN=XRCC1;VT=Q399R;CSQ=C|Missense Variant|XRCC1|7515|transcript|ENST00000262887.5|ENST00000262887.5:c.1196A>G||Q399R|261|GLN399ARG&RS25487|https://civicdb.org/links/variants/261|XRCC1 Q399R|257|GLN399ARG&RS25487|https://civicdb.org/links/molecular-profiles/257|NM_006297.2:c.1196A>G&NP_006288.2:p.Gln399Arg&NC_000019.9:g.44055726T>C&ENST00000262887.5:c.1196A>G|CA9488516|225976|40.0|evidence|672|https://civicdb.org/links/evidence/672|22551904 (PUBMED)|RARE_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Lung Non-small Cell Carcinoma||||B|4|||||,C|Missense Variant|XRCC1|7515|transcript|ENST00000262887.5|ENST00000262887.5:c.1196A>G||Q399R|261|GLN399ARG&RS25487|https://civicdb.org/links/variants/261|XRCC1 Q399R|257|GLN399ARG&RS25487|https://civicdb.org/links/molecular-profiles/257|NM_006297.2:c.1196A>G&NP_006288.2:p.Gln399Arg&NC_000019.9:g.44055726T>C&ENST00000262887.5:c.1196A>G|CA9488516|225976|40.0|evidence|673|https://civicdb.org/links/evidence/673|16875718 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Cervical Cancer|Carboplatin (NCIt ID C1282)&Cisplatin (NCIt ID C376)|SUBSTITUTES||B|4|||||
19	44057574	249	G	A	.	.	CSQ=A|Missense Variant|XRCC1|7515|transcript|ENST00000262887.5|ENST00000262887.5:c.580C>T||R194W|249|RS1799782&ARG194TRP|https://civicdb.org/links/variants/249|XRCC1 R194W|245|RS1799782&ARG194TRP|https://civicdb.org/links/molecular-profiles/245|NC_000019.9:g.44057574G>A&NM_006297.2:c.580C>T&NP_006288.2:p.Arg194Trp&ENST00000262887.5:c.580C>T|CA9488737|376355|20.0|evidence|659|https://civicdb.org/links/evidence/659|19157633 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Docetaxel (NCIt ID C1526)&Gemcitabine (NCIt ID C66876)&Vinorelbine (NCIt ID C1275)|SUBSTITUTES||B|4|||||;GN=XRCC1;VT=R194W
19	45854919	264	T	G	.	.	CSQ=G|Missense Variant|ERCC2|2068|transcript|ENST00000391945.4|||K751Q|264|LYS751GLN|https://civicdb.org/links/variants/264|ERCC2 K751Q|260|LYS751GLN|https://civicdb.org/links/molecular-profiles/260|NC_000019.9:g.45854919T>G|CA158782|134105|35.0|evidence|676|https://civicdb.org/links/evidence/676|19434073 (PUBMED)|RARE_GERMLINE|accepted|RESISTANCE|SUPPORTS|Osteosarcoma|Cisplatin (NCIt ID C376)|||B|4|||||,G|Missense Variant|ERCC2|2068|transcript|ENST00000391945.4|||K751Q|264|LYS751GLN|https://civicdb.org/links/variants/264|ERCC2 K751Q|260|LYS751GLN|https://civicdb.org/links/molecular-profiles/260|NC_000019.9:g.45854919T>G|CA158782|134105|35.0|evidence|677|https://civicdb.org/links/evidence/677|19470925 (PUBMED)|RARE_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Carboplatin (NCIt ID C1282)&Paclitaxel (NCIt ID C1411)|COMBINATION||B|3|||||;VT=K751Q;GN=ERCC2
19	49377242	548	G	C	.	.	GN=PPP1R15A;CSQ=C|Missense Variant&Polymorphic Sequence Variant|PPP1R15A|23645|transcript|ENST00000200453.5|ENST00000200453.5:c.752G>C||RS557806|548|ARG251PRO&R251P|https://civicdb.org/links/variants/548|PPP1R15A RS557806|544|ARG251PRO&R251P|https://civicdb.org/links/molecular-profiles/544|NM_014330.3:c.752G>C&NP_055145.3:p.Arg251Pro&ENST00000200453.5:c.752G>C&NC_000019.9:g.49377242G>C|CA9560103|NONE FOUND|5.0|evidence|1325|https://civicdb.org/links/evidence/1325|27177629 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Colorectal Cancer|Bevacizumab (NCIt ID C2039)&FOLFIRI Regimen (NCIt ID C63593)|COMBINATION||B|1|||||;VT=RS557806
20	57428713	877	T	C	.	.	VT=c.393T>C;GN=GNAS;CSQ=C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|1997|https://civicdb.org/links/evidence/1997|17186357 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Breast Carcinoma||||B|4|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|2892|https://civicdb.org/links/evidence/2892|15824158 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Bladder Urothelial Carcinoma||||B|4|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|2893|https://civicdb.org/links/evidence/2893|16033819 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Colorectal Cancer||||B|4|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|2895|https://civicdb.org/links/evidence/2895|19274060 (PUBMED)|COMMON_GERMLINE|accepted|RESISTANCE|SUPPORTS|Esophageal Cancer|Cisplatin (NCIt ID C376)&Fluorouracil (NCIt ID C505)|COMBINATION||B|4|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|2896|https://civicdb.org/links/evidence/2896|16467086 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Clear Cell Renal Cell Carcinoma||||B|4|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|2897|https://civicdb.org/links/evidence/2897|17020971 (PUBMED)|COMMON_GERMLINE|accepted|BETTER_OUTCOME|SUPPORTS|Chronic Lymphocytic Leukemia||||B|4|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|2898|https://civicdb.org/links/evidence/2898|21156401 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Melanoma||||B|4|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|1996|https://civicdb.org/links/evidence/1996|17356712 (PUBMED)|COMMON_GERMLINE|accepted|POOR_OUTCOME|SUPPORTS|Intrahepatic Cholangiocarcinoma||||B|3|||||,C|Synonymous Variant|GNAS|2778|transcript|ENST00000371100.4|||c.393T>C|877|I131=&RS7121&L131=|https://civicdb.org/links/variants/877|GNAS c.393T>C|851|I131=&RS7121&L131=|https://civicdb.org/links/molecular-profiles/851|NC_000020.11:g.58903752C>T&NC_000020.10:g.57478807C>T&NM_000516.4:c.393C>T&NP_000507.1:p.Ile131=|CA409455494|197681|165.0|evidence|1995|https://civicdb.org/links/evidence/1995|24758907 (PUBMED)|COMMON_GERMLINE|accepted|RESISTANCE|SUPPORTS|Lung Non-small Cell Carcinoma|Erlotinib (NCIt ID C65530)&Gefitinib (NCIt ID C1855)|SUBSTITUTES||B|2|||||
20	57484420	826	C	T	.	.	CSQ=T|Missense Variant|GNAS|2778|transcript|ENST00000371085.3|ENST00000371085.3:c.601C>T||R201C|826|ARG201CYS&R202C&RS11554273|https://civicdb.org/links/variants/826|BRAF V600E AND GNAS R201C|5491||https://civicdb.org/links/molecular-profiles/5491|NM_000516.5:c.601C>T&NP_000507.1:p.Arg201Cys&NC_000020.10:g.57484420C>T&ENST00000371085.3:c.601C>T|CA126067|15933|0.0|evidence|1906|https://civicdb.org/links/evidence/1906|27729313 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|2|||||;GN=GNAS;VT=R201C
21	36171704	803	G	T	.	.	VT=Y260*;GN=RUNX1;CSQ=T|Stop Gained|RUNX1|861|transcript|ENST00000344691.4|ENST00000344691.4:c.780C>A||Y260*|803|Y260X&TYR260TER&RS121912499|https://civicdb.org/links/variants/803|RUNX1 Y260*|781|Y260X&TYR260TER&RS121912499|https://civicdb.org/links/molecular-profiles/781|NM_001001890.2:c.780C>A&NP_001001890.1:p.Tyr260Ter&NC_000021.8:g.36171704G>T&ENST00000344691.4:c.780C>A|CA248619|14467|7.5|evidence|1872|https://civicdb.org/links/evidence/1872|11830488 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Acute Myeloid Leukemia||||C|3|||||
21	36231792	806	C	A	.	.	CSQ=A|Missense Variant&Loss Of Function Variant|RUNX1|861|transcript|ENST00000300305.3|||D198Y|806|ASP198TYR|https://civicdb.org/links/variants/806|RUNX1 D198Y|784|ASP198TYR|https://civicdb.org/links/molecular-profiles/784|NC_000021.8:g.36231792C>A|CA410207975|NONE FOUND|7.5|evidence|1875|https://civicdb.org/links/evidence/1875|11675361 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Acute Myeloid Leukemia||||C|3|||||;VT=D198Y;GN=RUNX1
21	36252912	810	GGCTGCGGT	G	.	.	CSQ=-|Frameshift Truncation|RUNX1|861|transcript|ENST00000300305.3|ENST00000300305.3:c.442_449delACCGCAGC||T148HFSX9|810|C.442_449DEL&THR148HISFSX9&RS587776811|https://civicdb.org/links/variants/810|RUNX1 T148HFSX9|788|C.442_449DEL&THR148HISFSX9&RS587776811|https://civicdb.org/links/molecular-profiles/788|NM_001754.4:c.442_449delACCGCAGC&NP_001745.2:p.Thr148Hisfs&NC_000021.8:g.36252913_36252920del&ENST00000300305.3:c.442_449delACCGCAGC|CA248627|14470|5.0|evidence|1882|https://civicdb.org/links/evidence/1882|18478040 (PUBMED)|RARE_GERMLINE|accepted|UNCERTAIN_SIGNIFICANCE|SUPPORTS|Acute Myeloid Leukemia||||C|2|||||;VT=T148HFSX9;GN=RUNX1
21	36252962	807	C	G	.	.	VT=A107P;GN=RUNX1;CSQ=G|Missense Variant|RUNX1|861|transcript|ENST00000344691.4|ENST00000344691.4:c.400G>C||A107P|807|A134P&ALA134PRO&RS74315451|https://civicdb.org/links/variants/807|RUNX1 A107P|785|A134P&ALA134PRO&RS74315451|https://civicdb.org/links/molecular-profiles/785|NM_001754.4:c.400G>C&NP_001745.2:p.Ala134Pro&NC_000021.8:g.36252962C>G&ENST00000344691.4:c.400G>C|CA248623|14468|12.5|evidence|1876|https://civicdb.org/links/evidence/1876|12060124 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Acute Myeloid Leukemia||||C|5|||||
21	36259163	802	T	C	.	.	VT=K83E;GN=RUNX1;CSQ=C|Missense Variant|RUNX1|861|transcript|ENST00000344691.4|ENST00000344691.4:c.247A>G||K83E|802|LYS83GLU&K110E&RS121912498|https://civicdb.org/links/variants/802|RUNX1 K83E|780|LYS83GLU&K110E&RS121912498|https://civicdb.org/links/molecular-profiles/780|NC_000021.8:g.36259163T>C&NP_001001890.1:p.Lys83Glu&NM_001001890.2:c.247A>G&ENST00000344691.4:c.247A>G|CA248613|14465|10.0|evidence|1871|https://civicdb.org/links/evidence/1871|11830488 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Acute Myeloid Leukemia||||C|4|||||
21	40191638	445	A	G	.	.	GN=ETS2;VT=RS461155;CSQ=G|Synonymous Variant|ETS2|2114|transcript|ENST00000360214.3|ENST00000360214.3:c.1023A>G||RS461155|445|P341P&P481P&PRO341=|https://civicdb.org/links/variants/445|ETS2 RS461155|441|P341P&P481P&PRO341=|https://civicdb.org/links/molecular-profiles/441|NC_000021.8:g.40191638A>G&NM_005239.5:c.1023A>G&ENST00000360214.3:c.1023A>G&NP_005230.1:p.Pro341=|CA10025650|NONE FOUND|10.0|evidence|1060|https://civicdb.org/links/evidence/1060|26893365 (PUBMED)|COMMON_GERMLINE|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Cisplatin (NCIt ID C376)&Paclitaxel (NCIt ID C1411)|COMBINATION||B|2|||||
21	44514777	127	T	G	.	.	CSQ=G|Missense Variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||https://civicdb.org/links/variants/127|U2AF1 Q157P/R|127||https://civicdb.org/links/molecular-profiles/127|NC_000021.8:g.44514777T>G|None||50.0|evidence|400|https://civicdb.org/links/evidence/400|23861105 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Myelodysplastic Syndrome||||B|3|||||,G|Missense Variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||https://civicdb.org/links/variants/127|U2AF1 Q157P/R|127||https://civicdb.org/links/molecular-profiles/127|NC_000021.8:g.44514777T>G|None||50.0|evidence|338|https://civicdb.org/links/evidence/338|23029227 (PUBMED)|SOMATIC|accepted|NA|DOES_NOT_SUPPORT|Acute Myeloid Leukemia||||B|2|||||,G|Missense Variant|U2AF1|7307|transcript|ENST00000291552.4|||Q157P/R|127||https://civicdb.org/links/variants/127|U2AF1 Q157P/R|127||https://civicdb.org/links/molecular-profiles/127|NC_000021.8:g.44514777T>G|None||50.0|evidence|339|https://civicdb.org/links/evidence/339|23029227 (PUBMED)|SOMATIC|accepted|NA|DOES_NOT_SUPPORT|Myelodysplastic Syndrome||||B|2|||||;VT=Q157P/R;GN=U2AF1
21	44524456	128	G	A	.	.	CSQ=A|Missense Variant|U2AF1|7307|transcript|ENST00000291552.4|||S34Y/F|128||https://civicdb.org/links/variants/128|U2AF1 S34Y/F|128||https://civicdb.org/links/molecular-profiles/128|NC_000021.8:g.44524456G>A|None||25.0|evidence|401|https://civicdb.org/links/evidence/401|23861105 (PUBMED)|SOMATIC|accepted|POOR_OUTCOME|SUPPORTS|Myelodysplastic Syndrome||||B|3|||||,A|Missense Variant|U2AF1|7307|transcript|ENST00000291552.4|||S34Y/F|128||https://civicdb.org/links/variants/128|U2AF1 S34Y/F|128||https://civicdb.org/links/molecular-profiles/128|NC_000021.8:g.44524456G>A|None||25.0|evidence|340|https://civicdb.org/links/evidence/340|23029227 (PUBMED)|SOMATIC|accepted|NA|DOES_NOT_SUPPORT|Acute Myeloid Leukemia||||B|2|||||;VT=S34Y/F;GN=U2AF1
22	22127164	320	C	T	.	.	CSQ=T|Missense Variant&Gain Of Function Variant|MAPK1|5594|transcript|ENST00000215832.6|ENST00000215832.6:c.964G>A||E322K|320|GLU322LYS|https://civicdb.org/links/variants/320|MAPK1 E322K|316|GLU322LYS|https://civicdb.org/links/molecular-profiles/316|ENST00000215832.6:c.964G>A&NC_000002.11:g.22127164C>T&NP_002736.3:p.Glu322Lys&NM_002745.4:c.964G>A|CA16602885|376450|10.0|evidence|791|https://civicdb.org/links/evidence/791|26181029 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Head And Neck Squamous Cell Carcinoma|Erlotinib (NCIt ID C65530)|||C|4|||||;GN=MAPK1;VT=E322K
22	29091856	785	AG	A	.	.	CSQ=-|Frameshift Truncation|CHEK2|11200|transcript|ENST00000328354.6|ENST00000328354.6:c.1100delC||1100DELC|785|THR367METFS&RS555607708|https://civicdb.org/links/variants/785|CHEK2 1100DELC|766|THR367METFS&RS555607708|https://civicdb.org/links/molecular-profiles/766|NC_000022.10:g.29091857delG&NM_007194.3:c.1100delC&NP_009125.1:p.Thr367Metfs&ENST00000328354.6:c.1100delC&NC_000022.10:g.29091857del|CA288251|128042|15.0|evidence|1850|https://civicdb.org/links/evidence/1850|26629066 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Prostate Cancer||||B|3|||||;GN=CHEK2;VT=1100DELC
22	29121087	787	A	G	.	.	GN=CHEK2;VT=I157T;CSQ=G|Missense Variant|CHEK2|11200|transcript|ENST00000328354.6|ENST00000328354.6:c.470T>C||I157T|787|ILE157THR&I200T&RS17879961|https://civicdb.org/links/variants/787|CHEK2 I157T|768|ILE157THR&I200T&RS17879961|https://civicdb.org/links/molecular-profiles/768|NM_007194.3:c.470T>C&NP_009125.1:p.Ile157Thr&ENST00000328354.6:c.470T>C&NC_000022.10:g.29121087A>G|CA117630|5591|15.0|evidence|1852|https://civicdb.org/links/evidence/1852|26629066 (PUBMED)|RARE_GERMLINE|accepted|PREDISPOSITION|SUPPORTS|Prostate Cancer||||B|3|||||
22	30050673	279	AA	A	.	.	VT=K159fs;CSQ=-|Frameshift Truncation|NF2|4771|transcript|ENST00000338641.4|||K159fs|279|LYS159FS*16|https://civicdb.org/links/variants/279|NF2 K159fs|275|LYS159FS*16|https://civicdb.org/links/molecular-profiles/275|NC_000022.10:g.30050674del&NC_000022.11:g.29654685del&NM_000268.3:c.476del&NP_000259.1:p.Lys159SerfsTer15|CA915940524|NONE FOUND|7.5|evidence|715|https://civicdb.org/links/evidence/715|25878190 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Breast Cancer|Temsirolimus (NCIt ID C1844)|||C|3|||||;GN=NF2
22	30051593	245	T	TT	.	.	CSQ=T|Frameshift Elongation|NF2|4771|transcript|ENST00000338641.4|ENST00000338641.4:c.527_528insT||Y177fs|245|TYR177FS|https://civicdb.org/links/variants/245|NF2 Y177fs|241|TYR177FS|https://civicdb.org/links/molecular-profiles/241|ENST00000338641.4:c.527_528insT&NC_000022.10:g.30051593_30051594insT|CA645601016|NONE FOUND|7.5|evidence|649|https://civicdb.org/links/evidence/649|25798586 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Peritoneal Mesothelioma|Carboplatin (NCIt ID C1282)&Cisplatin (NCIt ID C376)|SUBSTITUTES||C|3|||||;VT=Y177fs;GN=NF2
X	47426121	10	C	G	.	.	CSQ=G|Missense Variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/variants/10|ARAF S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/molecular-profiles/10|NC_000023.10:g.47426121C>G&NM_001654.4:c.641C>G&NP_001645.1:p.Ser214Cys&ENST00000377045.4:c.641C>G|CA16602595|376137|14.0|evidence|17|https://civicdb.org/links/evidence/17|24569458 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Sorafenib (NCIt ID C61948)|||C|2|||||,G|Missense Variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/variants/10|ARAF S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/molecular-profiles/10|NC_000023.10:g.47426121C>G&NM_001654.4:c.641C>G&NP_001645.1:p.Ser214Cys&ENST00000377045.4:c.641C>G|CA16602595|376137|14.0|evidence|40|https://civicdb.org/links/evidence/40|24569458 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Sorafenib (NCIt ID C61948)|||D|3|||||,G|Missense Variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/variants/10|ARAF S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/molecular-profiles/10|NC_000023.10:g.47426121C>G&NM_001654.4:c.641C>G&NP_001645.1:p.Ser214Cys&ENST00000377045.4:c.641C>G|CA16602595|376137|14.0|evidence|41|https://civicdb.org/links/evidence/41|24569458 (PUBMED)|SOMATIC|accepted|SENSITIVITYRESPONSE|SUPPORTS|Lung Non-small Cell Carcinoma|Trametinib (NCIt ID C77908)|||D|3|||||,G|Missense Variant|ARAF|369|transcript|ENST00000377045.4|ENST00000377045.4:c.641C>G||S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/variants/10|ARAF S214C|10|SER214CYS&RS1057519786|https://civicdb.org/links/molecular-profiles/10|NC_000023.10:g.47426121C>G&NM_001654.4:c.641C>G&NP_001645.1:p.Ser214Cys&ENST00000377045.4:c.641C>G|CA16602595|376137|14.0|evidence|11147|https://civicdb.org/links/evidence/11147|27478040 (PUBMED)|SOMATIC|accepted|ONCOGENICITY|SUPPORTS|Lung Cancer||||D|3|||||;GN=ARAF;VT=S214C
X	47429340	825	T	A	.	.	VT=S490T;GN=ARAF;CSQ=A|Missense Variant|ARAF|369|transcript|ENST00000377045.4|||S490T|825|SER490THR|https://civicdb.org/links/variants/825|BRAF V600E AND ARAF S490T|5492||https://civicdb.org/links/molecular-profiles/5492||CA412818377|NONE FOUND|0.0|evidence|1905|https://civicdb.org/links/evidence/1905|27729313 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Colorectal Cancer|Cetuximab (NCIt ID C1723)&Irinotecan (NCIt ID C62040)&Vemurafenib (NCIt ID C64768)|COMBINATION||C|1|||||
X	66943549	175	T	C	.	.	CSQ=C|Missense Variant|AR|367|transcript|ENST00000374690.3|ENST00000374690.3:c.2629T>C||F877L|175|PHE877LEU|https://civicdb.org/links/variants/175|AR F877L|175|PHE877LEU|https://civicdb.org/links/molecular-profiles/175|ENST00000374690.3:c.2629T>C&NC_000023.10:g.66943549T>C&NM_000044.4:c.2629T>C&NP_000035.2:p.Phe877Leu|CA16602789|376347|4.0|evidence|447|https://civicdb.org/links/evidence/447|23779130 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Prostate Cancer|Apalutamide (NCIt ID C92574)&Enzalutamide (NCIt ID C71744)|SUBSTITUTES||D|4|||||;VT=F877L;GN=AR
X	100611165	168	A	T	.	.	CSQ=T|Missense Variant|BTK|695|transcript|ENST00000308731.7|ENST00000308731.7:c.1441T>A||C481S|168|CYS481SER&RS1057519826|https://civicdb.org/links/variants/168|BTK C481S|168|CYS481SER&RS1057519826|https://civicdb.org/links/molecular-profiles/168|NC_000023.10:g.100611165A>T&ENST00000308731.7:c.1441T>A&NM_000061.2:c.1441T>A&NP_000052.1:p.Cys481Ser|CA16602659|376204|40.0|evidence|436|https://civicdb.org/links/evidence/436|24869598 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Ibrutinib (NCIt ID C81934)|||B|4|||||,T|Missense Variant|BTK|695|transcript|ENST00000308731.7|ENST00000308731.7:c.1441T>A||C481S|168|CYS481SER&RS1057519826|https://civicdb.org/links/variants/168|BTK C481S|168|CYS481SER&RS1057519826|https://civicdb.org/links/molecular-profiles/168|NC_000023.10:g.100611165A>T&ENST00000308731.7:c.1441T>A&NM_000061.2:c.1441T>A&NP_000052.1:p.Cys481Ser|CA16602659|376204|40.0|evidence|1770|https://civicdb.org/links/evidence/1770|26182309 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Ibrutinib (NCIt ID C81934)|||B|4|||||;VT=C481S;GN=BTK
X	100613633	870	T	C	.	.	VT=T316A;CSQ=C|Missense Variant|BTK|695|transcript|ENST00000308731.7|ENST00000308731.7:c.946T>C||T316A|870|THR316ALA|https://civicdb.org/links/variants/870|BTK T316A|844|THR316ALA|https://civicdb.org/links/molecular-profiles/844|ENST00000308731.7:c.946T>C&NM_000061.2:c.946T>C&NC_000023.10:g.100613633T>C|CA413928923|NONE FOUND|10.0|evidence|1985|https://civicdb.org/links/evidence/1985|27626698 (PUBMED)|SOMATIC|accepted|RESISTANCE|SUPPORTS|Chronic Lymphocytic Leukemia|Ibrutinib (NCIt ID C81934)|||C|4|||||;GN=BTK
